id|sentence|entity1|entity2|pos1|pos2|arg1|arg2|ent1_type1|ent2_type|label|sent_id
16938288|  OBJECTIVE: Telmisartan, an angiotensin II type 1 receptor (AT1R) antagonist, was found to have a unique property: it is a partial agonist of peroxisome proliferator-activated receptor gamma (PPARgamma).|Telmisartan|peroxisome proliferator-activated receptor gamma|3|30|Arg1:T3|Arg2:T19|CHEMICAL|GENE|AGONIST|0
23541670|  We report the discovery of a novel series of ATP-competitive Janus kinase 3 (JAK3) inhibitors based on the 5H-pyrrolo[2,3-b]pyrazine scaffold.|5H-pyrrolo[2,3-b]pyrazine|JAK3|21|15|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INHIBITOR|1
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|PTK787|TK|38|3|Arg1:T25|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2
23220618|In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-α-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.|IMG|TNF-α|6|13|Arg1:T15|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3
9851542|  The cardiovascular effects of three different acetylcholinesterase inhibitors: physostigmine, tacrine and rivastigmine injected by intravenous (i.v.) route were compared in freely moving Wistar rats.|rivastigmine|acetylcholinesterase|14|7|Arg1:T2|Arg2:T32|CHEMICAL|GENE|INHIBITOR|4
23391485|Our results showed that low dose BPA and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of Oct4 and Nanog proteins, while only BPA could downregulate the expression of E-cadherin protein.|BPA|E-cadherin|30|36|Arg1:T1|Arg2:T14|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|5
23384997|Interestingly, GPx1a was the most sensitive to selenium availability in non stressful conditions, whereas GPx1b1 and GPx1b2 were highly induced by exposure to selenium levels that had some toxic effects on the cells.|selenium|GPx1b1|26|17|Arg1:T20|Arg2:T44|CHEMICAL|GENE|INDIRECT-UPREGULATOR|6
23583257|Interestingly, Nox4 activity is also stimulated by reducing agents that possibly act by reducing the disulfide bridge (Cys226, Cys270) located in the extracellular E-loop of Nox4.|Cys|Nox4|20|30|Arg1:T13|Arg2:T29|CHEMICAL|GENE|PART-OF|7
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|[3H]-MPP+|transmembrane transporters|4|24|Arg1:T4|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|8
15474503|These results suggest that pitavastatin efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.|pitavastatin|apoA-I|5|42|Arg1:T1|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|9
23221600|Previous report demonstrated that thyroid hormone (TH) negatively regulates mouse SCD-1 gene promoter before SREBP-1c was revealed.|thyroid hormone|mouse SCD-1 gene promoter|5|12|Arg1:T5|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|10
23182954|Ozone plus PM(2.5) exposure, however, induced CRP, IL-6, CK, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.|Ozone|LDH|1|18|Arg1:T4|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|11
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|CEP-701|kinase|31|44|Arg1:T19|Arg2:T35|CHEMICAL|GENE|INHIBITOR|12
17352685|Results of early clinical trials with both topically (cipamfylline, CP80,633) and systemically (CC-10004) active PDE4 inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC-10004, also in psoriasis.|CP80,633|PDE4|12|20|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INHIBITOR|13
23228697|Inhibition of this carboxylesterase probably presents a major source for altered therapeutic activity of these medicines if co-administered with orlistat.|orlistat|carboxylesterase|20|4|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INHIBITOR|14
9310349|Here we report that alendronate is a potent inhibitor of the protein-tyrosine-phosphatase-meg1 (PTPmeg1).|alendronate|protein-tyrosine-phosphatase-meg1|5|12|Arg1:T11|Arg2:T32|CHEMICAL|GENE|INHIBITOR|15
17768678|  Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.|PLZ|MAO|3|14|Arg1:T6|Arg2:T40|CHEMICAL|GENE|INHIBITOR|16
9712175|Lintitript markedly increased postprandial plasma CCK release (P<0.001) while distinctly reducing postprandial PP levels (P<0.01) as compared to placebo.|Lintitript|CCK|1|6|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|17
20421509|Using a unique biosensor-based assay, trifluoperazine (TFP) was identified as an inhibitor that disrupts the S100A4/myosin-IIA interaction.|TFP|myosin-IIA|9|20|Arg1:T12|Arg2:T38|CHEMICAL|GENE|INHIBITOR|18
23041257|DBDCT up-regulated the expression of Bax, down-regulated the expression of Bcl-2, and significantly increased the ratio of Bax/Bcl-2.|DBDCT|Bcl-2|1|12|Arg1:T13|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|19
7599160|Intracellular protein-bound [57Co]Cbl fractionated with methionine synthase (MS) and methylmalonyl-CoA mutase (MU) activity.|[57Co]Cbl|methylmalonyl-CoA mutase|3|15|Arg1:T24|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|20
23598904|Among the possible transporters involved in the uptake of Cd(2+) and Mn(2+), the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.|Mn(2+)|ZIP8|15|23|Arg1:T22|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|21
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|tert-butylhydroquinone|aldo-keto reductase (AKR) 1C1|32|44|Arg1:T2|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|22
23042954|Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.|LY293558|GluK1|7|4|Arg1:T13|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|23
16938288|CONCLUSION: Our data provides a novel insight into an effect of telmisartan: telmisartan inhibits AT1R gene expression through PPARgamma activation.|telmisartan|PPARgamma|15|21|Arg1:T7|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|24
9890894|Several site-specific alterations in the C-terminus of full-length FGFR1IIIc, an isoform that otherwise absolutely rejects FGF-7, resulted in gain of FGF-7 binding.|C|FGFR1IIIc|6|9|Arg1:T3|Arg2:T14|CHEMICAL|GENE|PART-OF|25
23391336|The enzyme (TcCA) has a very high catalytic activity for the CO(2) hydration reaction, being similar kinetically to the human (h) isoform hCA II, although it is devoid of the His64 proton shuttle.|His|hCA II|40|31|Arg1:T2|Arg2:T12|CHEMICAL|GENE|PART-OF|26
16835395|Epididymal tissue from wild-type mice responded in vitro to noradrenaline and isoprenaline with increased glycerol release, reduced IL-6 release, and increased cAMP accumulation.|noradrenaline|IL-6|10|19|Arg1:T4|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|27
16846546|METHODS: Cyclooxygenase activity and selectivity was determined in vitro by measuring prostaglandin E(2) (PGE(2)) production following incubation of varying concentrations of NSAID with human recombinant COX-1 or COX-2 and arachidonic acid.|prostaglandin E(2)|Cyclooxygenase|13|3|Arg1:T19|Arg2:T37|CHEMICAL|GENE|PRODUCT-OF|28
23220618|And, the effects of the compounds on expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were tested in tumor necrosis factor-(TNF)-α activated HUVECs. Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, both agents elicited anticoagulant effects in mouse.|hyperoside|thrombin|43|57|Arg1:T11|Arg2:T33|CHEMICAL|GENE|INHIBITOR|29
23578607|6-DHSG was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (GST).|6-DHSG|glutathione-S-transferase|1|28|Arg1:T20|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|30
20421509|Equilibrium sedimentation and cross-linking studies demonstrate the cooperative formation of a similarly sized S100A4/TFP oligomer in solution.|TFP|S100A4|15|14|Arg1:T6|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|31
23098818|The obtained results indicate that rat brain CYP2D isoforms catalyze the formation of serotonin from 5-methoxytryptamine, and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain.|serotonin|CYP2D|29|26|Arg1:T7|Arg2:T24|CHEMICAL|GENE|PRODUCT-OF|32
8294418|The protein kinase C inhibitor (+)-1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) abolished the effects of phorbol esters and NE and decreased basal mRNA levels by 52 +/- 3%.|(+)-1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride|protein kinase C|6|2|Arg1:T4|Arg2:T26|CHEMICAL|GENE|INHIBITOR|33
3134891|However, in contrast to the reversible binding of most phenothiazines to calmodulin, phenoxybenzamine bound to calmodulin irreversibly.|phenothiazines|calmodulin|11|13|Arg1:T18|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|34
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|okadaic acid|phosphatase|47|45|Arg1:T4|Arg2:T21|CHEMICAL|GENE|INHIBITOR|35
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|2'CMP|Pro42Ala|33|20|Arg1:T5|Arg2:T16|CHEMICAL|GENE|INHIBITOR|36
23410005|This work resulted in the discovery of the 5-morpholino-7H-thieno[3,2-b]pyran-7-one system as the foundation of a new compound class of potential PI3K inhibitors having improved potency toward PI3K.|5-morpholino-7H-thieno[3,2-b]pyran-7-one|PI3K|9|25|Arg1:T3|Arg2:T12|CHEMICAL|GENE|INHIBITOR|37
15985706|Using [(3)H]glucosamine-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.|PD153035|EGFR|34|30|Arg1:T6|Arg2:T31|CHEMICAL|GENE|INHIBITOR|38
9990013|These results suggest that SUR1 binds 8-azido-ATP strongly at NBF1 and that MgADP, either by direct binding to NBF2 or by hydrolysis of bound MgATP at NBF2, stabilizes prebound 8-azido-ATP binding at NBF1.|MgATP|NBF2|26|28|Arg1:T25|Arg2:T54|CHEMICAL|GENE|SUBSTRATE|39
23534442|New classes of pyrrole-derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as COX-2 selective inhibitors and NO donors were synthesized and are herein reported.|nitrooxyalkyl|COX-2|5|17|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INHIBITOR|40
7825862|We have cloned cDNAs for murine PGHS-1 and PGHS-2, expressed these enzymes in cos-1 cells, and compared the relative sensitivities of the two isozymes to some common NSAIDs. Indomethacin, piroxicam, and sulindac sulfide were found to preferentially inhibit PGHS-1.|sulindac sulfide|PGHS-1|37|44|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|41
23041257|DBDCT also caused the phosphorylation of JNK and p38(MAPK).|DBDCT|JNK|1|7|Arg1:T1|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|42
7837275|A phenomenological analysis of thermodynamic data showed that the amide substrates and p-ABZ interactions with zeta-thrombin were respectively, associated with a chemical compensation (i.e. the linear relationship between entropy and enthalpy of binding) and a hydrophobic phenomenon (i.e. a change in the standard heat capacity).|p-ABZ|zeta-thrombin|13|16|Arg1:T9|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|43
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|tert-butylhydroquinone|NRF2|32|21|Arg1:T2|Arg2:T7|CHEMICAL|GENE|ACTIVATOR|44
23564313|In addition, vinblastine induces the DNA-binding activities of the transcription factor NF-κB, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.|vinblastine|AP-1|4|17|Arg1:T1|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|45
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|benzydamine|FMO2|11|4|Arg1:T10|Arg2:T47|CHEMICAL|GENE|SUBSTRATE|46
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|L-cysteine|cystathionine-beta-synthase|13|23|Arg1:T18|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|47
23384997|Interestingly, GPx1a was the most sensitive to selenium availability in non stressful conditions, whereas GPx1b1 and GPx1b2 were highly induced by exposure to selenium levels that had some toxic effects on the cells.|selenium|GPx1b2|26|19|Arg1:T20|Arg2:T45|CHEMICAL|GENE|INDIRECT-UPREGULATOR|48
23098818|Human liver microsomes of the wild-type CYP2D6 metabolized 5-methoxytryptamine to serotonin more effectively than did the defective CYP2D6*4*4 ones.|serotonin|CYP2D6|11|7|Arg1:T4|Arg2:T21|CHEMICAL|GENE|PRODUCT-OF|49
23584358|In conclusion, agomelatine administration protects liver cells from paracetamol-induced hepatotoxicity via antioxidant activity and reduced proinflammatory cytokines, such as TNF-α and IL-6.|paracetamol|IL-6|10|24|Arg1:T12|Arg2:T41|CHEMICAL|GENE|INDIRECT-UPREGULATOR|50
19429089|These results suggest that fluoxetine inhibited the activity of VMAT2 by a mechanism different from that of reserpine and did not directly interact with the active site of VMAT2.|fluoxetine|VMAT2|5|10|Arg1:T23|Arg2:T31|CHEMICAL|GENE|INHIBITOR|51
8819507|Ka values in nM for rauwolscine (19), WB-4101 (265), SKF-104078 (197), spiroxatrine (128), and prazosin (1531) for blocking relaxation in rat arteries were consistent with their affinities for binding at the alpha-2D adrenoceptor subtype.|WB-4101|alpha-2D adrenoceptor|11|46|Arg1:T20|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|52
12614192|Sildenafil is inhibitory of PDE5 at a rate tenfold higher than for the next PDE (PDE6), which produces visual changes through the retinal rods.|Sildenafil|PDE5|1|5|Arg1:T5|Arg2:T12|CHEMICAL|GENE|INHIBITOR|53
17350061|Estrogen-regulated genes including cytokeratin 1-19 and Cyp2a4 were over-expressed, although Cyp3a25 was suppressed.|Estrogen|Cyp3a25|1|12|Arg1:T24|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|54
23600914|To confirm the role of each transporter, we analyzed HEK293 cells stably expressing human ABCA1 or ABCG1; we clearly observed 24-OHC efflux in the presence of HDL, whereas efflux in the presence of apolipoprotein A-I was marginal.|24-OHC|human ABCA1|23|15|Arg1:T12|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|55
22931533|The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.|codeine|AChE|5|21|Arg1:T5|Arg2:T13|CHEMICAL|GENE|DIRECT-REGULATOR|56
20596674|MXF or VP-16 slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of topo II.|VP-16|topo II|3|30|Arg1:T24|Arg2:T39|CHEMICAL|GENE|INHIBITOR|57
10606746|The inhibitor binds at the base of the active site gorge of TcAChE, interacting with both the choline-binding site (Trp-84) and the acyl-binding pocket (Phe-288, Phe-290).|Phe|TcAChE|29|13|Arg1:T6|Arg2:T21|CHEMICAL|GENE|PART-OF|58
17488480|To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and NK1-R in acinar cells.|sodium hydrosulphide|PPT-A|29|56|Arg1:T10|Arg2:T40|CHEMICAL|GENE|INDIRECT-UPREGULATOR|59
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|TFEC|beta-lyases|28|10|Arg1:T28|Arg2:T54|CHEMICAL|GENE|PRODUCT-OF|60
9990013|Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.|ATP|sulfonylurea receptor|4|9|Arg1:T28|Arg2:T56|CHEMICAL|GENE|DIRECT-REGULATOR|61
7768269|Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg).|SCH 39166|dopamine D1 receptor|35|31|Arg1:T23|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|62
23535516|Intravenous treatment, during coronary artery occlusion, with the melanocortin analogs [Nle(4), D-Phe(7)]α-melanocyte-stimulating hormone (NDP-α-MSH) and adrenocorticotropic hormone 1-24 [ACTH-(1-24)], induced a left ventricle up-regulation of pJAK2, pERK1/2 and pTyr-STAT3 (JAK-dependent), and a reduction in pJNK and TNF-α levels; these effects of NDP-α-MSH and ACTH-(1-24) were associated with over-expression of the pro-survival proteins HO-1 and Bcl-XL, and marked decrease of the myocardial infarct size.|Nle|α-MSH|14|28|Arg1:T1|Arg2:T8|CHEMICAL|GENE|PART-OF|63
15837926|PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.|folate|PSMA|16|1|Arg1:T2|Arg2:T10|CHEMICAL|GENE|SUBSTRATE|64
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Imatinib|kinase|9|6|Arg1:T35|Arg2:T53|CHEMICAL|GENE|INHIBITOR|65
21475861|In a recent study using protein-specific anti-acetyl lysine antibodies and immunological methods, we demonstrated the ability of aspirin to acetylate the tumor suppressor protein p53.|aspirin|tumor suppressor protein p53|19|23|Arg1:T2|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|66
23644213|These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor rivaroxaban with a mimic of the Arg-Gly-Asp (RGD) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity.|rivaroxaban|factor Xa|16|13|Arg1:T1|Arg2:T7|CHEMICAL|GENE|INHIBITOR|67
11292635|In conclusion, OMCD tubules from deoxycorticosterone pivalate-treated rats secrete Cl- into the luminal fluid through NKCC1-mediated Cl- uptake across the basolateral membrane in series with Cl- efflux across the apical membrane.|Cl-|NKCC1|11|17|Arg1:T2|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|68
8636122|The replacement of the conserved cysteine residues in e2 of CB2 by serine also eliminated CP 55,940 binding, but replacement of those in CB1 resulted in the sequestration of the mutated receptors in the cell cytoplasm.|cysteine|CB2|6|11|Arg1:T12|Arg2:T29|CHEMICAL|GENE|PART-OF|69
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|risperidone|D(1)|34|14|Arg1:T5|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|70
15704203|The Cl(-) secretory response is mediated via a non-CFTR pathway, and the driving force for Cl(-) secretion is enhanced by the effect of P2Y(2) activation to also inhibit epithelial Na(+) transport.|Cl(-)|CFTR|2|13|Arg1:T10|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|71
23098818|The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study.|serotonin|cytochrome P450|11|5|Arg1:T18|Arg2:T35|CHEMICAL|GENE|PRODUCT-OF|72
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|buserelin|gonadotrophin-releasing hormone (GnRH) receptor|11|23|Arg1:T5|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|73
23221006|In this study, uptake of phenformin and [(14)C]tetraethylammonium (TEA) and complex I inhibition by phenformin were examined in isolated liver and heart mitochondria.|phenformin|complex I|24|20|Arg1:T9|Arg2:T24|CHEMICAL|GENE|INHIBITOR|74
10742288|In alpha(2A)-adrenoceptor transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).|dexmedetomidine|alpha(2A)-adrenoceptor|26|2|Arg1:T3|Arg2:T22|CHEMICAL|GENE|AGONIST|75
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|neutral amino acid transporters|14|24|Arg1:T23|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|76
23440512|The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.|atRA|RARs|19|39|Arg1:T5|Arg2:T13|CHEMICAL|GENE|INDIRECT-UPREGULATOR|77
23506741|A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome.|benzo[d]imidazole|NLRP3|3|22|Arg1:T11|Arg2:T27|CHEMICAL|GENE|INHIBITOR|78
10701840|The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.|geldanamycin|Hsp90|4|2|Arg1:T8|Arg2:T30|CHEMICAL|GENE|INHIBITOR|79
23512754|Besides, CDM not only synergized TNF-α production combined with IFN-γ, but also prolonged its expression in time.|CDM|IFN-γ|3|11|Arg1:T1|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|80
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|dFdC|Ala70Thr|43|10|Arg1:T11|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|81
12881227|Nevertheless, 3 mM DMA, a higher concentration that inhibits NHE1, NHE2, and NHE3, significantly increased DBS.|DMA|NHE2|5|14|Arg1:T11|Arg2:T37|CHEMICAL|GENE|INHIBITOR|82
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|AMN107|c-KIT|46|57|Arg1:T12|Arg2:T46|CHEMICAL|GENE|INHIBITOR|83
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|CLS|inducible nitric oxide synthase|15|42|Arg1:T7|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|84
23609606|No effects were observed when fenclozic acid was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells.|fenclozic acid|efflux transporters|6|34|Arg1:T3|Arg2:T15|CHEMICAL|GENE|INHIBITOR|85
16343532|We have elucidated the crystal structures of the cyanotoxins, motuporin (nodularin-V) and dihydromicrocystin-LA bound to human protein phosphatase-1c (gamma isoform).|motuporin|human protein phosphatase-1c (gamma isoform)|11|19|Arg1:T9|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|86
23481236|Saturated palmitic and stearic acids increased ceramides, up-regulated PTP1B, and had AKt and PTP1B phosphorylation at Ser 50 impaired.|Ser|PTP1B|19|16|Arg1:T4|Arg2:T27|CHEMICAL|GENE|PART-OF|87
17459764|n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells.|n-3 and n-6 polyunsaturated fatty acids|PPARgamma|1|13|Arg1:T26|Arg2:T44|CHEMICAL|GENE|ACTIVATOR|88
23182954|Ozone plus PM(2.5) exposure, however, induced CRP, IL-6, CK, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.|Ozone|SOD|1|23|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|89
10095983|Orlistat is a new inhibitor of pancreatic lipase enzyme.|Orlistat|pancreatic lipase|1|7|Arg1:T7|Arg2:T10|CHEMICAL|GENE|INHIBITOR|90
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|syringic acid|EC 4.2.1.1|28|51|Arg1:T6|Arg2:T28|CHEMICAL|GENE|INHIBITOR|91
23564313|In addition, vinblastine induces the DNA-binding activities of the transcription factor NF-κB, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.|vinblastine|Bax|4|29|Arg1:T1|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|92
9015795|For example, clozapine revealed a radioligand-independent value of 1.6 nM at the dopamine D4 receptor, agreeing with the value directly measured with [3H]-clozapine at D4.|[3H]-clozapine|D4|25|30|Arg1:T5|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|93
23643933|The TSA-induced uc002mbe.2 expression was positively correlated with the apoptotic effect of TSA in HCC cells.|TSA|uc002mbe.2|2|3|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INDIRECT-UPREGULATOR|94
23220644|In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (JMC08-4) for human nonpancreatic secretory phospholipase A(2) (hnps-PLA(2)) and human leukotriene A(4) hydrolase (LTA(4)H-h) was found.|JMC08-4|hnps-PLA(2)|21|33|Arg1:T2|Arg2:T9|CHEMICAL|GENE|INHIBITOR|95
23143891|In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, budesonide, and fluticasone propionate, by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.|budesonide|CYP3A|19|27|Arg1:T16|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|96
23314320|The current U.S. military and civilian oxime countermeasure, 2-[(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride (2-PAM), is under consideration for replacement with a more effective acetylcholinesterase reactivator, 1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate (MMB-4).|1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate|acetylcholinesterase|35|32|Arg1:T5|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|97
20801130|The affinities of dfbp and dfbp-o for the regulatory domain of cTnC were measured in the absence and presence of cTnI by NMR spectroscopy, and dfbp-o was found to bind more strongly than dfbp.|dfbp|cTnC|4|12|Arg1:T17|Arg2:T39|CHEMICAL|GENE|DIRECT-REGULATOR|98
8819507|Ka values in nM for rauwolscine (19), WB-4101 (265), SKF-104078 (197), spiroxatrine (128), and prazosin (1531) for blocking relaxation in rat arteries were consistent with their affinities for binding at the alpha-2D adrenoceptor subtype.|prazosin|alpha-2D adrenoceptor|27|46|Arg1:T23|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|99
23432124|  IKM-159 was developed and identified as a member of a new class of heterotricyclic glutamate analogues that act as AMPA receptor-selective antagonists.|glutamate|AMPA receptor|15|20|Arg1:T9|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|100
23066089|Using site-directed mutagenesis, we identified three serines (Ser833, Ser836, and Ser840) within the membrane proximal region of the GluK5 C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs. Together, these data suggest that phosphorylation of key residues in the C-terminal domain changes the overall charge of this domain, resulting in potentiated agonist responses.|Ser|GluK5|15|24|Arg1:T11|Arg2:T31|CHEMICAL|GENE|PART-OF|101
2982865|However, in the presence of 100 mM Na+, which is required for opiate inhibition of adenylate cyclase activity, analysis of competition binding data revealed three sites: the first, consisting of 17.5% of total receptor population has a Kd = 0.38 +/- 0.18 nM; the second, 50.6% of the population, has a Kd = 6.8 +/- 2.2 nM; and the third, 31.9% of the population, has a Kd of 410 +/- 110 nM.|Na+|adenylate cyclase|9|18|Arg1:T22|Arg2:T29|CHEMICAL|GENE|INHIBITOR|102
12244038|Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS.|gemfibrozil|peroxisome proliferator-activated receptor-alpha|2|7|Arg1:T11|Arg2:T58|CHEMICAL|GENE|ACTIVATOR|103
23159529|Glutaraldehyde crosslinked albumin nanoparticles with a size of approximately 100nm were loaded with the multikinase inhibitor 17864-L(x)-a platinum-bound sunitinib analogue-which couples the drug to methionine residues of albumin and is released in a reductive environment.|17864|multikinase|17|15|Arg1:T2|Arg2:T17|CHEMICAL|GENE|INHIBITOR|104
12105857|Moreover, thalidomide reduced the LPS-induced TNF-alpha production by KCs by decreasing TNF-alpha messenger RNA.|thalidomide|TNF-alpha|3|13|Arg1:T9|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|105
23423570|In conclusion, IL-8 production and neutrophil infiltration are increased in high-glucose environment due to elevated ROS level and contributed to impaired wound healing in diabetic skin.|glucose|IL-8|13|4|Arg1:T2|Arg2:T6|CHEMICAL|GENE|INDIRECT-UPREGULATOR|106
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|gallic acid|metalloenzyme|25|45|Arg1:T5|Arg2:T25|CHEMICAL|GENE|INHIBITOR|107
16424790|Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.|enalapril|ACE|5|19|Arg1:T47|Arg2:T67|CHEMICAL|GENE|INHIBITOR|108
16324695|Preincubation with 1 microM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) caused a small but significant decrease in isoprenaline-induced E(max), indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization.|phorbol 12-myristate 13-acetate|PKC|14|35|Arg1:T9|Arg2:T23|CHEMICAL|GENE|ACTIVATOR|109
23703578|Drug-drug interactions are dependent on statins' pharmacokinetic profile: simvastatin, lovastatin and atorvastatin are metabolized through cytochrome P450 (CYP) 3A, while the metabolism of the other statins is independent of this CYP.|lovastatin|cytochrome P450 (CYP) 3A|13|19|Arg1:T21|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|110
23542578|An intermediate GTX2,3-aldehyde was first synthesized by activating the NH2 group of the 2nd and 8th amino acid residues with three different aldehydes and two artificial complete antigens GTX2,3-aldehyde-bovine serum albumin (BSA) and GTX2,3-aldehyde- keyhole limpet hemocyanin (KLH) were then prepared by cross-linking the intermediate with BSA or KLH.|GTX2,3-aldehyde|keyhole limpet hemocyanin|36|37|Arg1:T7|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|111
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|H(2)S|CSE|4|20|Arg1:T15|Arg2:T32|CHEMICAL|GENE|PRODUCT-OF|112
7773533|Incubation of rat aortic membranes with the irreversible alpha 1B-adrenoceptor antagonist, chloroethylclonidine (CEC: 10 microM) did not change the KD of [3H]-prazosin binding in comparison to untreated membranes, but reduced by 88% the total number of binding sites (Bmax).|[3H]-prazosin|alpha 1B-adrenoceptor|26|9|Arg1:T7|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|113
23550066|  Ketamine is primarily metabolized to norketamine by hepatic cytochrome P450 (CYP) 2B6 and CYP3A4-mediated N-demethylation.|Ketamine|CYP3A4|1|16|Arg1:T1|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|114
3735252|Gossypol and its isomers were non-competitive inhibitors of human and hamster LDH-X with respect to the coenzyme NADH, competitive inhibitors of human LDH-X and noncompetitive-competitive inhibitors of hamster LDH-X with respect to the substrate alpha-ketobutyrate.|alpha-ketobutyrate|hamster LDH-X|36|29|Arg1:T7|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|115
11344206|This mutation is the first described in exon 9 and impairs the last 27 amino acids of the hormone-binding domain.|amino acids|hormone-binding domain|15|19|Arg1:T3|Arg2:T9|CHEMICAL|GENE|PART-OF|116
17218486|Furthermore, because S-(+)-isomers of METH and AMPH are reported to be more potent and efficacious in vivo than R-(-), we determined the enantiomeric selectivity of all three species of TAAR1.|AMPH|TAAR1|12|39|Arg1:T26|Arg2:T53|CHEMICAL|GENE|ACTIVATOR|117
15452358|In contrast, intrathecal injection of a non-selective NMDA antagonist, memantine, significantly inhibited CCI-induced mechanical allodynia at a dose of 300 nmol, indicating the difference in the site of action between the non-selective NMDA antagonist and the NR2B-specific NMDA antagonist.|memantine|NMDA|12|9|Arg1:T3|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|118
23296837|In cultured primary microglia and astrocytes, EHT had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced NFκB activation, iNOS induction, and nitric oxide production.|EHT|iNOS|8|22|Arg1:T1|Arg2:T21|CHEMICAL|GENE|INHIBITOR|119
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|nomegestrol acetate|sulfatase|19|34|Arg1:T11|Arg2:T27|CHEMICAL|GENE|INHIBITOR|120
10727528|Salicylates do not promote dissociation of (125)I-ET-1 ETB receptor complexes.|(125)I|ET-1|7|11|Arg1:T14|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|121
18439678|Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.|imiquimod|TLR7|14|11|Arg1:T6|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|122
16988497|CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.|EFAs|D6D|22|30|Arg1:T3|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|123
12827214|However, other alpha(1)-adrenoceptor antagonists (tamsulosin, WB4101 and corynanthine) did not inhibit the binding at a range of concentrations that generally exhibit alpha(1)-adrenoceptor antagonism, and noradrenaline, rauwolscine and propranolol were without effect on the [(3)H]prazosin binding.|corynanthine|alpha(1)-adrenoceptor|15|4|Arg1:T38|Arg2:T46|CHEMICAL|GENE|ANTAGONIST|124
23250811|The anti-inflammatory actions of curcumin on colitis may involve inhibition of the TLR4/NF-κB signaling pathway and of IL-27 expression.|curcumin|TLR4|5|13|Arg1:T9|Arg2:T27|CHEMICAL|GENE|INHIBITOR|125
17334708|Mutation analysis of KYNU encoding kynureninase of the index case revealed homozygosity for a c.593 A > G substitution leading to a threonine-to-alanine (T198A) shift.|threonine|kynureninase|23|6|Arg1:T2|Arg2:T8|CHEMICAL|GENE|PART-OF|126
8294418|Neither ryanodine nor EGTA inhibited down-regulation of alpha-AR mRNA by NE.|NE|alpha-AR|11|8|Arg1:T11|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|127
11588409|Advances in antihypertensive combination therapy: benefits of low-dose thiazide diuretics in conjunction with omapatrilat, a vasopeptidase inhibitor.|omapatrilat|vasopeptidase|15|18|Arg1:T15|Arg2:T26|CHEMICAL|GENE|INHIBITOR|128
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|benzamide|5-HT4|19|23|Arg1:T1|Arg2:T32|CHEMICAL|GENE|AGONIST|129
12897749|Inhibition corresponded to increased cAMP production caused by rolipram alone or rolipram plus salmeterol and blocked proportionately the phosphorylation and activation of gIV-PLA(2) in FMLP/B-activated eosinophils.|salmeterol|gIV-PLA(2)|14|23|Arg1:T17|Arg2:T38|CHEMICAL|GENE|INHIBITOR|130
17015640|Moreover, licofelone inhibited COX-2 and 5-LOX protein expression in vascular lesions.|licofelone|COX-2|3|5|Arg1:T2|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|131
23220644|  Dual function inhibitors targeting phospholipase A(2) (PLA(2)) and leukotriene A(4) hydrolase (LTA(4)H) may balance the arachidonic acid (AA) metabolic network and be used as new anti-inflammatory drugs.|arachidonic acid|LTA(4)H|33|24|Arg1:T1|Arg2:T16|CHEMICAL|GENE|PRODUCT-OF|132
23506741|Furthermore, a decreased CD11c(+) macrophage infiltration in colons and inactivation of caspase-1 in peritoneal macrophages were detected in Fc11a-2-treated mice.|Fc11a|caspase-1|23|16|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INHIBITOR|133
9015795|However, because clozapine competes with endogenous dopamine, the in vivo concentration of clozapine (to occupy dopamine D4 receptors) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients.|clozapine|dopamine D4 receptors|4|19|Arg1:T6|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|134
11775064|The elevation in brain alanine levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of PLZ on alanine transaminase (ALA-T), although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced.|PLZ|alanine transaminase|24|26|Arg1:T25|Arg2:T37|CHEMICAL|GENE|INHIBITOR|135
22982218|The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.|PJ34|PARP|4|2|Arg1:T7|Arg2:T23|CHEMICAL|GENE|INHIBITOR|136
9204085|Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors, retinoic acid receptors (RARs).|adapalene|RARs|14|27|Arg1:T9|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|137
15837926|PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.|folate|GCPII|16|8|Arg1:T2|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|138
23396144|In another experiment, topical application of CFB, CFE or CLS prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of COX-2, iNOS, and TNF-α.|CLS|TNF-α|12|38|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|139
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|p50|7|41|Arg1:T2|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|140
10701840|Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.|geldanamycin|kinases|3|13|Arg1:T5|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|141
15991937|The current comprehensive losartan clinical end-point programme (4 large scale morbidity/mortality trials) should provide evidence regarding the efficacy of direct blockade of the AT(1) receptor with losartan compared to standard therapy: 1) The Losartan Heart Failure Survival Study - ELITE II, 2) The Losartan Post-Myocardial Infarction Survival Study - OPTIMAAL, 3) The Losartan Hypertension Survival Study - LIFE and 4) The Losartan Renal Protection Study - RENAAL.|losartan|AT(1) receptor|32|26|Arg1:T7|Arg2:T20|CHEMICAL|GENE|INHIBITOR|142
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane|NET|1|58|Arg1:T1|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|143
10424850|  The antidepressant desipramine has been shown to decrease synaptic membrane concentrations of the norepinephrine re-uptake transporter (NET) in vivo and in vitro, on both an acute and a chronic basis.|desipramine|norepinephrine re-uptake transporter|3|14|Arg1:T1|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|144
23305850|The treatment of U937 cells with NRF2 inducers including sulforaphane effectively elevated the expression of AKR1B1, 1B10, 1C1, 1C2, and 1C3.|sulforaphane|AKR1B1, 1B10, 1C1, 1C2, and 1C3|10|16|Arg1:T5|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|145
23182946|Also, reactive astrogliosis takes part of the early responses to the insult with (PhTe)(2), evidenced by upregulated GFAP in Western blot, PCR and immunofluorescence analysis.|(PhTe)(2)|GFAP|15|25|Arg1:T10|Arg2:T36|CHEMICAL|GENE|INDIRECT-UPREGULATOR|146
1978244|Radioligand binding studies with the nonselective alpha 1-adrenoceptor antagonist radioligand 125I-BE2254 showed that 73-87% of the binding sites in rabbit aorta are CEC sensitive and they are predominantly low affinity sites both for WB4101 (pKd = 8.1) and for 5-methylurapidil (pKd = 7.1).|125I-BE2254|alpha 1-adrenoceptor|11|7|Arg1:T21|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|147
23454148|Conclusively, protein malnutrition alters CP, FU and MMC metabolism in rat stomach by enhancing CCBL pathway for CP activation, delaying FU elimination and activating two-electron reduction of MMC, potentiating their gastrotoxicity.|MMC|CCBL|10|17|Arg1:T5|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|148
8384716|Within the conserved transmembrane domains, the sequences exhibit approximately 52%, 59%, 65%, and 68% amino acid identity with the known rat 5-HT1A, rat 5-HT1B, rat 5-HT1D, and human 5-HT1E receptors, respectively.|amino acid|human 5-HT1E|23|39|Arg1:T21|Arg2:T44|CHEMICAL|GENE|PART-OF|149
1680855|In contrast to adrenaline and somatostatin, galanin, another inhibitor of insulin secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner.|adrenaline|insulin|4|13|Arg1:T21|Arg2:T52|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|150
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|carbachol|AChE|19|4|Arg1:T7|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|151
15777622|  Megalin, a family of endocytic receptors related to the low-density lipoprotein (LDL) receptor, is a major pathway for proximal tubular aminoglycoside accumulation.|aminoglycoside|endocytic receptors|25|6|Arg1:T6|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|152
9204085|Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors, retinoic acid receptors (RARs).|tretinoin|RARs|16|27|Arg1:T10|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|153
23370008|The increase in SAA expression is specific to ritodrine-induced liver damage, because SAA expression was not induced by other hepatotoxic drugs such as acetaminophen, valproic acid, or metformin.|ritodrine|SAA|9|4|Arg1:T3|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|154
12881227|5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.|DMA|NHE2|12|25|Arg1:T9|Arg2:T33|CHEMICAL|GENE|INHIBITOR|155
23535516|Intravenous treatment, during coronary artery occlusion, with the melanocortin analogs [Nle(4), D-Phe(7)]α-melanocyte-stimulating hormone (NDP-α-MSH) and adrenocorticotropic hormone 1-24 [ACTH-(1-24)], induced a left ventricle up-regulation of pJAK2, pERK1/2 and pTyr-STAT3 (JAK-dependent), and a reduction in pJNK and TNF-α levels; these effects of NDP-α-MSH and ACTH-(1-24) were associated with over-expression of the pro-survival proteins HO-1 and Bcl-XL, and marked decrease of the myocardial infarct size.|Nle|α-melanocyte-stimulating hormone|14|24|Arg1:T1|Arg2:T7|CHEMICAL|GENE|PART-OF|156
23066089|Using site-directed mutagenesis, we identified three serines (Ser833, Ser836, and Ser840) within the membrane proximal region of the GluK5 C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs. Together, these data suggest that phosphorylation of key residues in the C-terminal domain changes the overall charge of this domain, resulting in potentiated agonist responses.|Ser|GluK5|10|24|Arg1:T9|Arg2:T31|CHEMICAL|GENE|PART-OF|157
15795320|These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.|pemetrexed|Akt|9|19|Arg1:T7|Arg2:T29|CHEMICAL|GENE|INHIBITOR|158
12837768|The potency of MrIA was greater for inhibition of uptake by hNET of [3H]norepinephrine (Ki 1.89 microM) than [3H]dopamine (Ki 4.33 microM), and the human dopamine transporter and serotonin transporter were not inhibited by MrIA (to 7 microM).|[3H]norepinephrine|hNET|14|12|Arg1:T5|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|159
22301814|The treatment with arsenic exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine).|arsenic|aspartate aminotransferase|4|21|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|160
23091188|Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.|LPV|BSEP|6|15|Arg1:T22|Arg2:T53|CHEMICAL|GENE|INHIBITOR|161
1375507|The present studies were undertaken to determine whether stable analogues of prostacyclin, a potent endothelium-derived platelet inhibitor and vasodilator, could inhibit tissue factor expression by human monocytic cells.|prostacyclin|tissue factor|12|24|Arg1:T12|Arg2:T28|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|162
23578390|Fluoride treatment also increased phosphorylation of JNK and ERK, but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively.|Fluoride|JNK|1|7|Arg1:T8|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|163
17477831|  Acetyl-coenzyme A carboxylase (ACC) enzymes exist as two isoforms, ACC1 and ACC2, which play critical roles in fatty acid biosynthesis and oxidation.|fatty acid|ACC|22|5|Arg1:T4|Arg2:T21|CHEMICAL|GENE|PRODUCT-OF|164
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|dFdC|cytidine deaminase|3|10|Arg1:T5|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|165
8819507|Ka values in nM for rauwolscine (19), WB-4101 (265), SKF-104078 (197), spiroxatrine (128), and prazosin (1531) for blocking relaxation in rat arteries were consistent with their affinities for binding at the alpha-2D adrenoceptor subtype.|rauwolscine|alpha-2D adrenoceptor|6|46|Arg1:T19|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|166
3588607|Xanthines are classical antagonists for adenosine receptors for many of their pharmacological actions may be due to blockade of adenosine receptors.|Xanthines|adenosine receptors|1|20|Arg1:T3|Arg2:T40|CHEMICAL|GENE|INHIBITOR|167
1730582|  Mouse ornithine decarboxylase (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (DFMO).|DFMO|Mouse ornithine decarboxylase|46|1|Arg1:T17|Arg2:T31|CHEMICAL|GENE|INHIBITOR|168
16424790|We compared the effects of Captopril (an ACE inhibitor with -SH group), enalapril (an ACE-inhibitor without -SH group), N-acetylcysteine (only -SH group not ACE inhibitor) on endothelial dysfunction injured by methionine-induced hyperhomocysteinemia (HHcy) in rats.|SH|ACE|13|9|Arg1:T26|Arg2:T63|CHEMICAL|GENE|INHIBITOR|169
10064839|Furthermore, since they have equipotent anticonvulsant effects and similar binding affinities to sigma-1 receptors, the very low affinity of DF at PCP sites may suggest that acting on the PCP sites may not be the requisite for mediating the anticonvulsant activity of these DM analogs.|PCP|sigma-1 receptors|24|14|Arg1:T19|Arg2:T53|CHEMICAL|GENE|DIRECT-REGULATOR|170
16336752|Tyrosine kinase inhibitors are quinazoline-derived, low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors, including EGFR, Erb2, and vascular endothelial growth factor receptor, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of EGFR signaling.|quinazoline|vascular endothelial growth factor receptor|5|30|Arg1:T2|Arg2:T8|CHEMICAL|GENE|INHIBITOR|171
18620538|Apo-alpha-lactalbumin, obtained by treatment with EDTA, displays one binding site for fatty acids, the association constants for oleic and palmitic acids being 1.9.10(6) and 4.2.10(5) M(-1), respectively.|oleic and palmitic acids|Apo-alpha-lactalbumin|21|1|Arg1:T3|Arg2:T9|CHEMICAL|GENE|DIRECT-REGULATOR|172
17488480|These results suggest that the pro-inflammatory effect of H(2)S may be mediated by SP-NK-1R related pathway in mouse pancreatic acinar cells.|H(2)S|NK-1R|9|19|Arg1:T13|Arg2:T43|CHEMICAL|GENE|PRODUCT-OF|173
12392782|They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.|MK-886|FLAP|48|45|Arg1:T11|Arg2:T24|CHEMICAL|GENE|INHIBITOR|174
17768678|Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.|Phenelzine|monoamine oxidase|1|13|Arg1:T34|Arg2:T44|CHEMICAL|GENE|INHIBITOR|175
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|Hydrogen sulphide|cystathionine-gamma-lyase|1|18|Arg1:T1|Arg2:T49|CHEMICAL|GENE|PRODUCT-OF|176
16938288|However, the expression of AT1R was not suppressed by other AT1R antagonists such as candesartan or olmesartan.|olmesartan|AT1R|18|12|Arg1:T2|Arg2:T13|CHEMICAL|GENE|ANTAGONIST|177
1680855|Somatostatin which also inhibits insulin secretion was less efficient (inhibition by 20%).|Somatostatin|insulin|1|5|Arg1:T16|Arg2:T48|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|178
23625804|We recently showed that the first domain of human CCS (hCCSD1) is responsible for copper transfer to its protein partner, human SOD1 (hSOD1).|copper|hCCSD1|17|12|Arg1:T2|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|179
18081314|The detailed conformational change and 3D structure of the PGIS-bound U46619 were further demonstrated by 2D 1H NMR experiments using the transferred NOE technique.|U46619|PGIS|11|10|Arg1:T17|Arg2:T40|CHEMICAL|GENE|DIRECT-REGULATOR|180
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|choline|OCT|16|23|Arg1:T7|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|181
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|STI571|RTKs|16|28|Arg1:T2|Arg2:T28|CHEMICAL|GENE|INHIBITOR|182
16988497|CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.|EFAs|D5D|22|32|Arg1:T3|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|183
16965760|It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.|LiCl|GPCR|11|19|Arg1:T15|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|184
21475861|Although the inhibition of cyclooxygenases by aspirin, which leads to its anti-inflammatory/analgesic properties, has been well studied, the mechanisms involved in its chemopreventive effects as well as some of its adverse effects are as yet ill-defined.|aspirin|cyclooxygenases|7|5|Arg1:T9|Arg2:T18|CHEMICAL|GENE|INHIBITOR|185
10510456|2 In a chronic transfection model using CHO-K1 cells, cisapride inhibited HERG tail currents after a step to +25 mV with similar potency at room and physiological temperatures (IC50 16.|cisapride|HERG|11|13|Arg1:T6|Arg2:T16|CHEMICAL|GENE|INHIBITOR|186
23703578|The HCV-PIs boceprevir and telaprevir are both, to different extents, inhibitors of CYP3A.|boceprevir|CYP3A|3|15|Arg1:T3|Arg2:T28|CHEMICAL|GENE|INHIBITOR|187
16920841|Liver BHMT activity was 1.3-fold higher in rats fed the Met deficient diet containing choline, which was reflected in corresponding increases in mRNA content and immunodetectable protein.|choline|BHMT|15|2|Arg1:T18|Arg2:T37|CHEMICAL|GENE|INDIRECT-UPREGULATOR|188
20801130|The high resolution NMR solution structure of the cTnC-cTnI-dfbp-o ternary complex showed that dfbp-o bound at the hydrophobic interface formed by cTnC and cTnI making critical interactions with residues such as Arg147 of cTnI.|dfbp-o|cTnI|14|34|Arg1:T3|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|189
2899826|Chlorpromazine, levomepromazine, and their metabolites had 5-30 times higher binding affinities for muscarinic cholinergic receptors than fluphenazine, perphenazine and their metabolites.|levomepromazine|muscarinic cholinergic receptors|3|15|Arg1:T11|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|190
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|ferulic acid|CA|22|49|Arg1:T3|Arg2:T27|CHEMICAL|GENE|INHIBITOR|191
12881227|5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.|DMA|NHE1|12|23|Arg1:T9|Arg2:T32|CHEMICAL|GENE|INHIBITOR|192
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane|SERT|1|53|Arg1:T1|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|193
8636122|The region delineated by the fourth and fifth transmembrane helices of CB1 proved to be crucial for high affinity binding of SR 141716A.|SR 141716A|CB1|22|12|Arg1:T9|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|194
10988273|A prerequisite for this hypothesis was the unproved assumption that rabbit and human alpha(2A)-adrenoceptors are equally activated by rilmenidine.|rilmenidine|alpha(2A)-adrenoceptors|23|14|Arg1:T10|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|195
9851542|The tacrine pressor response was inhibited in a dose-dependent manner by the i.c.v. administration of the non-selective muscarinic receptor antagonist atropine (ID50 = 1.45 microg), the muscarinic M1 receptor antagonist pirenzepine (ID50 = 4.33 microg), the muscarinic M2 receptor antagonist methoctramine (ID50 = 1.39 microg) and the muscarinic M3 receptor antagonist para-fluoro-hexahydro-sila-difenidol (ID50 = 31.19 microg).|atropine|muscarinic receptor|22|19|Arg1:T3|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|196
23414340|Pretreatment of rats with glutathione (GSH) depletors (phorone or BSO) delayed the elimination of DMAs(V) and the accumulation of RBC-bound DMAs, whereas the indirect methyltransferase inhibitor periodate-oxidized adenosine was without effect.|adenosine|methyltransferase|36|33|Arg1:T9|Arg2:T47|CHEMICAL|GENE|INHIBITOR|197
23296837|Reductions in striatal dopamine and tyrosine hydroxylase content were also less pronounced with EHT treatment.|EHT|tyrosine hydroxylase|14|6|Arg1:T16|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|198
23535516|Intravenous treatment, during coronary artery occlusion, with the melanocortin analogs [Nle(4), D-Phe(7)]α-melanocyte-stimulating hormone (NDP-α-MSH) and adrenocorticotropic hormone 1-24 [ACTH-(1-24)], induced a left ventricle up-regulation of pJAK2, pERK1/2 and pTyr-STAT3 (JAK-dependent), and a reduction in pJNK and TNF-α levels; these effects of NDP-α-MSH and ACTH-(1-24) were associated with over-expression of the pro-survival proteins HO-1 and Bcl-XL, and marked decrease of the myocardial infarct size.|D-Phe|α-melanocyte-stimulating hormone|19|24|Arg1:T2|Arg2:T7|CHEMICAL|GENE|PART-OF|199
11961111|We report herein the location of the binding site for the inhaled anesthetic halothane at the amino acid residue level of resolution in the ligand binding cavity in a prototypical G protein-coupled receptor, bovine rhodopsin.|amino acid|bovine rhodopsin|17|35|Arg1:T3|Arg2:T13|CHEMICAL|GENE|PART-OF|200
10752671|  Flutamide, an effective competitive inhibitor of the androgen receptor used orally for palliative treatment of prostatic carcinoma and regulation of prostatic hyperplasia was evaluated for its genotoxic effects in the intact rat and in primary cultures of human hepatocytes.|Flutamide|androgen receptor|1|9|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INHIBITOR|201
23024204|By contrast, 1,12-diamino-3,6,9-triazadodecane(SpmTrien), a charge-deficient spermine analog, was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wild-type primary hepatocytes.|SpmTrien|human recombinant SSAT2|6|20|Arg1:T19|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|202
23587425|Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.|imidazo[1,2-c]pyrimidine|MK2|16|6|Arg1:T4|Arg2:T10|CHEMICAL|GENE|INHIBITOR|203
23220749|Our study shows that human TRPA1 is a target for apomorphine, suggesting that an activation of TRPA1 might contribute to adverse side effects such as nausea and painful injections, which can occur during treatment with apomorphine.|apomorphine|TRPA1|11|18|Arg1:T4|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|204
19429089|Moreover, kinetic analysis revealed that inhibition by reserpine, a typical VMAT2 inhibitor, was uncompetitive, decreasing maximum velocity and affinity for dopamine.|reserpine|VMAT2|9|13|Arg1:T19|Arg2:T30|CHEMICAL|GENE|INHIBITOR|205
23221006|These observations suggest that uptake of phenformin into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of complex I respiration.|phenformin|complex I|7|26|Arg1:T5|Arg2:T22|CHEMICAL|GENE|INHIBITOR|206
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine|DAT|20|63|Arg1:T22|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|207
3345199|  Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.|1,2,2-trimethyl-propylmethylphosphonofluoridate|Acetylcholinesterase|11|1|Arg1:T18|Arg2:T26|CHEMICAL|GENE|INHIBITOR|208
23261676|Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.|Isoproterenol|glutathione peroxidase|1|35|Arg1:T15|Arg2:T31|CHEMICAL|GENE|INHIBITOR|209
15704203|  Denufosol tetrasodium (INS37217) is a selective P2Y(2) agonist that stimulates ciliary beat frequency and Cl(-) secretion in normal and cystic fibrosis (CF) airway epithelia, and is being investigated as an inhaled treatment for CF.|INS37217|P2Y(2)|4|9|Arg1:T9|Arg2:T20|CHEMICAL|GENE|AGONIST|210
23318833|TAA also increased the numbers of ED2(+), cyclooxygenase-2(+), and heme oxygenase-1(+) liver cells, as well as the number of CD3(+) lymphocytes.|TAA|heme oxygenase-1|1|18|Arg1:T12|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|211
3345199|  Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.|soman|Acetylcholinesterase|9|1|Arg1:T17|Arg2:T26|CHEMICAL|GENE|INHIBITOR|212
1730582|This lysine is contained in the sequence PFYAVKC, which is found in all known ODCs from eukaryotes.|lysine|ODCs|2|16|Arg1:T24|Arg2:T40|CHEMICAL|GENE|PART-OF|213
15939622|COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.|carprofen|COX-2|13|3|Arg1:T16|Arg2:T23|CHEMICAL|GENE|INHIBITOR|214
12897749|CONCLUSIONS: Inhibition of PDE4 by rolipram unmasks beta(2)-adrenergic blockade of LTC(4) synthesis caused by FMLP/B.|rolipram|PDE4|7|5|Arg1:T19|Arg2:T39|CHEMICAL|GENE|INHIBITOR|215
7711211|The estrogenic agent 3 beta,5 alpha-NET and estradiol at a dose of 1.0 mg also inhibited the UG gene expression induced by P4.|estradiol|UG|8|18|Arg1:T14|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|216
10225363|The effect of sumatriptan, but not of LY 344864, was prevented by pretreatment with the antagonist SDZ 21-009, which displays high affinity for rat 5-HT1B receptors.|SDZ 21-009|rat 5-HT1B|19|27|Arg1:T11|Arg2:T22|CHEMICAL|GENE|ANTAGONIST|217
23410005|Our previous work, built on the early pioneering multikinase inhibitor LY294002, resulted in the only PI3K vascular-targeted PI3K inhibitor prodrug, SF1126, which has now completed Phase I clinical trials.|LY294002|PI3K|12|20|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INHIBITOR|218
10931813|Isoproterenol (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, d-sotalol (100 micromol/L) to block I(Kr) (LQT2 model), and ATX-II (20 nmol/L) to augment late I(Na) (LQT3 model).|Isoproterenol|I(Kr)|1|25|Arg1:T8|Arg2:T22|CHEMICAL|GENE|INHIBITOR|219
23578607|6-DHSG was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (GST).|6-DHSG|GST|1|30|Arg1:T20|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|220
23543413|We confirm the correlation between higher hCTR1 levels and higher Pt-drug uptake in tumor cells sensitive to the drug.|Pt|hCTR1|11|7|Arg1:T12|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|221
23623750|Cynomolgus FMO6 metabolized benzydamine only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.|benzydamine|Cynomolgus FMO6|4|1|Arg1:T8|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|222
1730582|  Mouse ornithine decarboxylase (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (DFMO).|pyridoxal 5'-phosphate|Mouse ornithine decarboxylase|25|1|Arg1:T6|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|223
19023039|Triphosphate nucleotides (ATP, GTP, and UTP) rapidly and reversibly inhibited Panx1 currents via mechanism(s) independent of purine receptors.|UTP|Panx1|9|15|Arg1:T10|Arg2:T18|CHEMICAL|GENE|INHIBITOR|224
15353299|While fluoropyrimidine antimetabolites have other sites of action, antifolates ZD1694 (raltitrexed, Tomudex) and AG337 (Thymitag) are more specific and potent TS inhibitors.|Thymitag|TS|20|27|Arg1:T6|Arg2:T23|CHEMICAL|GENE|INHIBITOR|225
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|risperidone|5-HT(2A) receptors|34|19|Arg1:T5|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|226
16336752|Tyrosine kinase inhibitors are quinazoline-derived, low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors, including EGFR, Erb2, and vascular endothelial growth factor receptor, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of EGFR signaling.|quinazoline|Erb2|5|27|Arg1:T2|Arg2:T7|CHEMICAL|GENE|INHIBITOR|227
1730582|Cysteine 360, which was the major adduct accounting for about 90% of the total labeling, is contained within the sequence -WGPTCDGL(I)D-, which is present in all known eukaryote ODCs. These results provide strong evidence that these two peptides form essential parts of the catalytic site of ODC.|Cysteine|WGPTCDGL(I)D|1|25|Arg1:T4|Arg2:T33|CHEMICAL|GENE|PART-OF|228
23047022|  Although acetylcholinesterase (AChE) is primarily a hydrolytic enzyme, metabolising the neurotransmitter acetylcholine in cholinergic synapses, it also has some non-catalytic functions in the brain which are far less well characterised.|acetylcholine|acetylcholinesterase|15|2|Arg1:T1|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|229
19370562|Other cholinesterase inhibitors, including rivastigmine, with superior properties in terms of specificity of action and low risk of adverse effects, have now been introduced.|rivastigmine|cholinesterase|6|2|Arg1:T14|Arg2:T20|CHEMICAL|GENE|INHIBITOR|230
17146052|i.p. injection of a subthreshold dose of picrotoxin, a use-dependent gamma-aminobutyric acid receptor antagonist, reduces cortical electroencephalogram delta power and transiently inhibits spontaneous seizure activity in ADNFLE mutant mice.|picrotoxin|gamma-aminobutyric acid receptor|9|13|Arg1:T3|Arg2:T10|CHEMICAL|GENE|ANTAGONIST|231
23231502|Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.|pThr|Pin1|25|10|Arg1:T14|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|232
3134891|The irreversible complex between phenoxybenzamine and calmodulin may be useful for inhibiting certain calmodulin-dependent reactions and for studying the various biological functions of calmodulin.|phenoxybenzamine|calmodulin|5|14|Arg1:T8|Arg2:T29|CHEMICAL|GENE|INHIBITOR|233
16344985|MATERIALS AND METHODS/RESULTS: By isolating rat brain microsomal long-chain fatty acyl-CoA synthetases (Acsl), we show in vitro that valproic acid is a non-competitive inhibitor of Acsl, as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme.|valproic acid|Acsl|23|30|Arg1:T18|Arg2:T35|CHEMICAL|GENE|INHIBITOR|234
16965760|It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.|lithium chloride|GPCR|8|19|Arg1:T14|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|235
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|gallic acid|carbonic anhydrase|25|46|Arg1:T5|Arg2:T26|CHEMICAL|GENE|INHIBITOR|236
10522750|The potentiation of the contractile effect induced by 5-HT is only somewhat modified by deendothelialization, but abolished by the thromboxane A2 receptor antagonists GR32191 and ridogrel.|ridogrel|thromboxane A2 receptor|27|21|Arg1:T20|Arg2:T37|CHEMICAL|GENE|ANTAGONIST|237
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|MNI|SNAT1|19|37|Arg1:T19|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|238
15191400|  Auranofin, an antirheumatic gold compound, is an inhibitor of selenocysteine enzymes, such as thioredoxin reductase and glutathione peroxidase.|Auranofin|thioredoxin reductase|1|17|Arg1:T1|Arg2:T17|CHEMICAL|GENE|INHIBITOR|239
15474503|Each statin induced apoA-I expression (mRNA and protein) dose-dependently: the rank order of the apoA-I induction pitavastatin (3 microM)>simvastatin (10 microM)>atorvastatin (30 microM).|atorvastatin|apoA-I|32|18|Arg1:T5|Arg2:T29|CHEMICAL|GENE|INDIRECT-UPREGULATOR|240
23261590|In addition, we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.|neoechinulin A|IL-6|7|31|Arg1:T10|Arg2:T39|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|241
12244038|  Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.|Gemfibrozil|cytokine|1|8|Arg1:T1|Arg2:T56|CHEMICAL|GENE|INHIBITOR|242
23410005|Synthesis and cancer stem cell-based activity of substituted 5-morpholino-7H-thieno[3,2-b]pyran-7-ones designed as next generation PI3K inhibitors.|5-morpholino-7H-thieno[3,2-b]pyran-7-ones|PI3K|9|18|Arg1:T4|Arg2:T14|CHEMICAL|GENE|INHIBITOR|243
16371234|Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia.|prostaglandin E2|prostaglandin E synthases|12|6|Arg1:T16|Arg2:T49|CHEMICAL|GENE|PRODUCT-OF|244
17479245|Intravenous arginine significantly increased the acute glucagon response (129 +/- 12 vs 36 +/- 6 ng/l in controls; p < 0.01), notably without affecting plasma glucose.|arginine|glucagon|2|7|Arg1:T3|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|245
22931533|Galantamine is a reversible, competitive acetylcholinesterase (AChE) inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors (nAChR-APL) that shares many common structural elements with morphinan-based opioids.|Galantamine|AChE|1|9|Arg1:T2|Arg2:T9|CHEMICAL|GENE|INHIBITOR|246
11292635|Bumetanide-sensitive Cl- secretion was dependent on extracellular Na+ and either K+ or NH, consistent with the ion dependency of NKCC1-mediated Cl- transport.|Cl-|NKCC1|22|21|Arg1:T24|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|247
23440512|The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.|atRA|polymorphic retinoic acid (RA) response elements|19|46|Arg1:T5|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|248
11474486|Fibrates bind to the peroxisome proliferator-activated receptor (PPAR)-alpha, and thiazolidinediones are ligands of PPAR-gamma.|thiazolidinediones|PPAR-gamma|14|18|Arg1:T8|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|249
23539296|Here, we have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes.|anisomycin|p38|13|10|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|250
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|gardiquimod|human TLR7|7|18|Arg1:T5|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|251
7554708|Moreover, the production of TXB2 during whole blood clotting was assessed as an index of the cyclooxygenase activity of platelet PGHS-1 ex vivo.|TXB2|PGHS-1|6|22|Arg1:T16|Arg2:T32|CHEMICAL|GENE|PRODUCT-OF|252
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|2'CMP|proline-42-to-alanine|33|17|Arg1:T5|Arg2:T15|CHEMICAL|GENE|INHIBITOR|253
23266505|Activation of an apoptotic signal transduction pathway involved in the upregulation of calpain and apoptosis-inducing factor in aldosterone-induced primary cultured cardiomyocytes.|aldosterone|apoptosis-inducing factor|18|15|Arg1:T19|Arg2:T38|CHEMICAL|GENE|INDIRECT-UPREGULATOR|254
23318471|These findings, derived from a variety of analytical and functional approaches, provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature: TES-stimulated vasodilation mediated primarily by peroxynitrite formed from xanthine oxidase-generated superoxide and NO.|peroxynitrite|xanthine oxidase|34|37|Arg1:T10|Arg2:T40|CHEMICAL|GENE|PRODUCT-OF|255
22301814|The treatment with arsenic exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine).|arsenic|albumin|4|30|Arg1:T4|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|256
15255990|Cerebral histamine H1 receptor (H(1)R) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and [(11)C]-doxepin.|[(11)C]-doxepin|histamine H1 receptor|30|2|Arg1:T5|Arg2:T10|CHEMICAL|GENE|DIRECT-REGULATOR|257
16220064|The marked antihypertensive efficacy of olmesartan medoxomil may result from a unique pharmacological interaction of the drug with the AT1 receptor, resulting in a potent, long-lasting, dose-dependent blockade of A-II.|olmesartan medoxomil|A-II|6|33|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|258
10593931|Substitutions for Ile(183)-Val(191) and Ser(195)-Ile(197) at the N terminus and for Ser(258)-Ser(264) at the C terminus of the A3 domain markedly decreased factor XI coagulant activity.|N|A3 domain|22|40|Arg1:T5|Arg2:T16|CHEMICAL|GENE|PART-OF|259
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|p-hydroxybenzoic acid|CA|13|49|Arg1:T11|Arg2:T27|CHEMICAL|GENE|INHIBITOR|260
12487427|  Several studies have suggested that the accumulation of bradykinin, or that of one its metabolites BK1-8, is involved in the occurrence of side effects such as AE associated with the use of various ACEi. In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK (79/81 Br-Phe5) BrBK in the presence of two new dual ACE/NEP inhibitors (GW660511X and omapatrilat) currently under clinical trial.|GW660511X|ACE|80|77|Arg1:T33|Arg2:T75|CHEMICAL|GENE|INHIBITOR|261
17229632|RESULTS: We show that sorafenib is a potent inhibitor of ETV6-PDGFRbeta and FLT3 mutants, including some of the mutants that confer resistance to PKC412 and other FLT3 inhibitors.|sorafenib|FLT3|6|29|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INHIBITOR|262
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|PhIP|cyt b5|32|51|Arg1:T2|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|263
12373423|RESULTS: In drug discrimination studies, lisuride fully mimicked the 5-HT(1A) agonist LY 293284, only partially substituted for LSD and DOI, and failed to substitute for (+)-amphetamine.|LY 293284|5-HT(1A)|17|12|Arg1:T3|Arg2:T28|CHEMICAL|GENE|AGONIST|264
15939622|  We report on the inhibitory activity of the NSAIDs meloxicam, carprofen, phenylbutazone and flunixin, on blood cyclooxygenases in the horse using in vitro enzyme-linked assays.|carprofen|cyclooxygenases|12|20|Arg1:T11|Arg2:T18|CHEMICAL|GENE|INHIBITOR|265
15777622|Then the cells were treated with various concentrations of apoE3, lactoferrin and bovine serum albumin with or without 100 microg/ml of GMC, and the SGLT1-dependent methyl alpha-D-glucopyranoside (AMG) uptake and levels of SGLT1 expression were determined.|methyl alpha-D-glucopyranoside|SGLT1|28|27|Arg1:T15|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|266
14583450|  Ribonucleotide reductase (RR) is responsible for the de novo conversion of the ribonucleoside diphosphates to deoxyribonucleoside diphosphates, which are essential for DNA synthesis and repair.|deoxyribonucleoside diphosphates|RR|18|4|Arg1:T2|Arg2:T40|CHEMICAL|GENE|PRODUCT-OF|267
7599160|Intracellular protein-bound [57Co]Cbl fractionated with methionine synthase (MS) and methylmalonyl-CoA mutase (MU) activity.|[57Co]Cbl|methionine synthase|3|9|Arg1:T24|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|268
16480505|In general, rifampicin can act on a pattern: rifampicin activates the nuclear pregnane X receptor that in turn affects cytochromes P450, glucuronosyltransferases and p-glycoprotein activities.|rifampicin|nuclear pregnane X receptor|4|14|Arg1:T3|Arg2:T11|CHEMICAL|GENE|AGONIST-ACTIVATOR|269
23598904|These results suggest that ZIP8 plays a pivotal role in the transport and toxicity of Cd(2+) and Mn(2+) in RBL-2H3 cells.|Cd(2+)|ZIP8|16|5|Arg1:T1|Arg2:T26|CHEMICAL|GENE|SUBSTRATE|270
10988273|In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the alpha(2)-autoreceptors, sharing this property with rauwolscine, phentolamine, and idazoxan.|idazoxan|alpha(2)-autoreceptors|41|26|Arg1:T3|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|271
9990013|  The ATP-sensitive potassium (KATP) channels in pancreatic beta cells are critical in the regulation of glucose-induced insulin secretion.|glucose|insulin|18|19|Arg1:T1|Arg2:T33|CHEMICAL|GENE|INDIRECT-UPREGULATOR|272
2899826|7-Hydroxy levomepromazine, 3-hydroxy levomepromazine and 7-hydroxy fluphenazine had only 10% of the potency of the parent drug in histamine H1 receptor binding, while the 7-hydroxy-metabolites of chlorpromazine and perphenazine had about 75% of the potency of the parent drug in this binding system.|7-hydroxy fluphenazine|histamine H1 receptor|7|21|Arg1:T21|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|273
19293728|Although the D1-like receptor, by itself, had no effect on VSMC proliferation, stimulation with fenoldopam, a D1-like receptor agonist, inhibited the stimulatory effect of insulin.|fenoldopam|D1-like receptor|18|21|Arg1:T2|Arg2:T11|CHEMICAL|GENE|AGONIST|274
23017388|When further examined for its anticancer mechanism, SB365 effectively suppressed the AKT/mTOR pathway both in vitro and in vivo.|SB365|mTOR|9|14|Arg1:T7|Arg2:T15|CHEMICAL|GENE|INHIBITOR|275
23583806|Allicin treatment showed reduced production of pro-inflammatory cytokines and NO and increased HO-1 activity.|Allicin|HO-1|1|13|Arg1:T6|Arg2:T18|CHEMICAL|GENE|ACTIVATOR|276
23123662|In conclusion, rCtr1 can transport copper and platinum drugs, and sensitizes cells to their cytotoxicities.|platinum|rCtr1|9|4|Arg1:T10|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|277
23164921|Data at transcriptional level also demonstrated that catalpol potently attenuated gene expressions involved in inflammation, such as iNOS, COX-2 and TLR4.|catalpol|iNOS|8|19|Arg1:T9|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|278
23231502|Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.|Pro|Pin1|25|10|Arg1:T15|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|279
16893531|The exception was bupropion, a dual norepinephrine transporter/dopamine transporter blocker, which tended to increase spontaneous locomotor activity.|bupropion|norepinephrine transporter|4|8|Arg1:T1|Arg2:T23|CHEMICAL|GENE|INHIBITOR|280
23024204|By contrast, 1,12-diamino-3,6,9-triazadodecane(SpmTrien), a charge-deficient spermine analog, was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wild-type primary hepatocytes.|1,12-diamino-3,6,9-triazadodecane|human recombinant SSAT2|4|20|Arg1:T18|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|281
23539296|Here, we have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes.|anisomycin|MAPK|13|11|Arg1:T2|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|282
23221600|Human stearoyl-CoA desaturase 1 (SCD-1) gene expression is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptor to the gene promoter.|thyroid hormone|SCD-1|14|6|Arg1:T9|Arg2:T35|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|283
23314054|  We have previously reported a nanomolar inhibitor of antiapoptotic Mcl-1 protein, 3-thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1).|3-thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile|Mcl-1|13|10|Arg1:T3|Arg2:T7|CHEMICAL|GENE|INHIBITOR|284
8294418|Neither ryanodine nor EGTA inhibited down-regulation of alpha-AR mRNA by NE.|EGTA|alpha-AR|4|8|Arg1:T10|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|285
20421509|Together these studies support a unique mode of inhibition in which phenothiazines disrupt the S100A4/myosin-IIA interaction by sequestering S100A4 via small molecule-induced oligomerization.|phenothiazines|S100A4|12|15|Arg1:T9|Arg2:T32|CHEMICAL|GENE|INHIBITOR|286
9015795|For example, clozapine revealed a radioligand-independent value of 1.6 nM at the dopamine D4 receptor, agreeing with the value directly measured with [3H]-clozapine at D4.|clozapine|dopamine D4 receptor|4|14|Arg1:T3|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|287
23042954|To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.|(3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid|GluR5|37|28|Arg1:T10|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|288
23443810|Interestingly, miR-21 expression positively correlated with urine albumin creatine ratio (ACR), TIMP1, collagen IV (ColIV), and fibronectin (FN); while negatively correlated with creatine clearance ratio (Ccr) and MMP-9 protein.|creatine|miR-21|10|3|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INDIRECT-UPREGULATOR|289
17138644|These results highlight the importance of PR activation of the Src/MAPK signaling pathway for progesterone-induced transcription of select target genes and cell cycle progression.|progesterone|Src|15|11|Arg1:T4|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|290
22931530|α-Amino-α´-Halomethylketones: Synthetic Methodologies and Pharmaceutical Applications as Serine and Cysteine Protease Inhibitors.|α-Amino-α´-Halomethylketones|Serine and Cysteine Protease|1|9|Arg1:T5|Arg2:T9|CHEMICAL|GENE|INHIBITOR|291
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|spermidine|ODC|5|22|Arg1:T22|Arg2:T40|CHEMICAL|GENE|PRODUCT-OF|292
12086935|AMP-activated protein kinase (AMPK) activity increases in response to depletion of cellular energy stores, and this enzyme has been implicated in the stimulation of glucose uptake into skeletal muscle and the inhibition of liver gluconeogenesis.|glucose|AMP-activated protein kinase|28|1|Arg1:T11|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|293
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|5,8,11,14-eicosatetraynoic acid|PPARalpha1|15|6|Arg1:T12|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|294
23102509|The altered activities of key enzymes such as glucose-6-phosphatase and fructose-1,6-bisphosphatase of carbohydrate metabolism significantly (p<0.05) increased whereas hexokinase, pyruvate kinase, glucose-6-phosphate dehydrogenase and glycogen content significantly (p<0.05) decreased in the liver of diabetic rats and also increased activities of aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP).|carbohydrate|glucose-6-phosphatase|13|9|Arg1:T13|Arg2:T29|CHEMICAL|GENE|PRODUCT-OF|295
12373423|RESULTS: In drug discrimination studies, lisuride fully mimicked the 5-HT(1A) agonist LY 293284, only partially substituted for LSD and DOI, and failed to substitute for (+)-amphetamine.|lisuride|5-HT(1A)|8|12|Arg1:T2|Arg2:T28|CHEMICAL|GENE|AGONIST|296
17643344|Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.|melarsoprol|substance P receptor|13|5|Arg1:T12|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|297
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|FLX|D(1) receptors|27|56|Arg1:T4|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|298
18081314|The binding of U46619 to the PGIS protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at C-11, H2C, and H20 of U46619 were observed upon U46619 binding to the engineered PGIS in a concentration-dependent manner.|H2C|PGIS|29|7|Arg1:T13|Arg2:T38|CHEMICAL|GENE|PART-OF|299
10942908|The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase (BChE) activity (87% of control), whereas pyridostigmine plus exercise significantly decreased the BChE activity (79% of control), indicating an interactive effect of the combination.|pyridostigmine|BChE|23|29|Arg1:T13|Arg2:T21|CHEMICAL|GENE|INHIBITOR|300
16480505|In general, rifampicin can act on a pattern: rifampicin activates the nuclear pregnane X receptor that in turn affects cytochromes P450, glucuronosyltransferases and p-glycoprotein activities.|rifampicin|nuclear pregnane X receptor|11|14|Arg1:T4|Arg2:T11|CHEMICAL|GENE|ACTIVATOR|301
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Nexavar|TK|47|3|Arg1:T29|Arg2:T47|CHEMICAL|GENE|INHIBITOR|302
8384716|Degenerate oligonucleotides corresponding to conserved amino acids from transmembrane domains III, V, and VI of known receptors [5-HT1A, 5-HT1C, and 5-HT2; 5-HT is serotonin (5-hydroxytryptamine)] were used as primers for the sequential reactions.|amino acids|5-HT2|6|26|Arg1:T15|Arg2:T37|CHEMICAL|GENE|PART-OF|303
1435788|A major part of this processing requires endoproteolytic cleavage at specific pairs of basic amino acid residues, an event necessary for the maturation of a variety of important biologically active proteins, such as insulin and nerve growth factor.|amino acid|nerve growth factor|15|38|Arg1:T2|Arg2:T11|CHEMICAL|GENE|PART-OF|304
23511016|To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (DOTA), with pantoprazole, which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon.|Gd|proton pumps|16|44|Arg1:T1|Arg2:T10|CHEMICAL|GENE|DIRECT-REGULATOR|305
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|cinitapride|5-HT1|11|25|Arg1:T17|Arg2:T33|CHEMICAL|GENE|AGONIST|306
18068977|Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin.|atorvastatin|DPP-IV|9|6|Arg1:T3|Arg2:T14|CHEMICAL|GENE|INHIBITOR|307
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|Gleevec|c-Kit|18|38|Arg1:T3|Arg2:T30|CHEMICAL|GENE|INHIBITOR|308
1322047|These effects were not mimicked by oral administration of the beta 2-adrenoceptor agonist salbutamol even at high dose (52 mg/kg diet), and the effects of clenbuterol were not inhibited by addition of DL-propranolol (200 mg/kg diet).|clenbuterol|beta 2-adrenoceptor|29|11|Arg1:T4|Arg2:T16|CHEMICAL|GENE|AGONIST|309
15732037|Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF-1alpha and VEGF in the failing ventricular myocardium.|carvedilol|VEGF|3|15|Arg1:T3|Arg2:T30|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|310
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|nimesulide|COX-1|31|46|Arg1:T16|Arg2:T18|CHEMICAL|GENE|INHIBITOR|311
23512754|Besides, CDM not only synergized TNF-α production combined with IFN-γ, but also prolonged its expression in time.|CDM|TNF-α|3|7|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INDIRECT-UPREGULATOR|312
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Sutent|VEGF receptor|38|42|Arg1:T11|Arg2:T44|CHEMICAL|GENE|INHIBITOR|313
23414838|  High throughput screening led to the identification of a novel series of quinolone α7 nicotinic acetylcholine receptor (nAChR) agonists.|quinolone|nAChR|13|19|Arg1:T4|Arg2:T8|CHEMICAL|GENE|AGONIST|314
1911436|The affinity labeling nucleotide analog, 5'-[p-(fluorosulfonyl)benzoyl]adenosine (FSA), inactivates the dehydrogenase and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration (0.2-0.6 mM).|FSA|dehydrogenase|17|22|Arg1:T17|Arg2:T26|CHEMICAL|GENE|INHIBITOR|315
22370641|Epi increased the activity of the human WNT6 promoter through Cav1-dependent binding of β-catenin to the proximal WNT6 promoter.|Epi|human WNT6 promoter|1|7|Arg1:T10|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|316
23327993|The TXM peptides were effective in inhibiting AuF-induced MAPK, JNK and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.|AuF|MAPK|8|15|Arg1:T8|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|317
23618921|Here we show that fisetin rapidly increases the levels of both Nrf2 and ATF4 as well as Nrf2- and ATF4-dependent gene transcription via distinct mechanisms.|fisetin|Nrf2|5|12|Arg1:T19|Arg2:T35|CHEMICAL|GENE|INDIRECT-UPREGULATOR|318
15180525|STI571 binding to Flt3 is prevented by the phenylalanine 691 side-chain in the ATP binding center and mutating this site to threonine renders the corresponding Flt3 mutant sensitive to STI571.|STI571|Flt3|30|26|Arg1:T9|Arg2:T32|CHEMICAL|GENE|INHIBITOR|319
8730743|DMI administration for up to 21 days produced a progressive reduction in the number of 5-HT2A receptors in frontal cortex, without significant alterations in occipital cortex.|DMI|5-HT2A|1|16|Arg1:T3|Arg2:T16|CHEMICAL|GENE|INHIBITOR|320
23600914|These results suggest that ABCA1 actively eliminates 24-OHC in the presence of HDL as a lipid acceptor and protects neuronal cells.|24-OHC|ABCA1|8|5|Arg1:T2|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|321
23294326|These results suggest that ganglioside-bound Aβ (GAβ), which acts as an endogenous seed for Aβ fibril formation in AD brains, is generated on ASIGN on synaptosomal membranes.|ganglioside|Aβ|5|6|Arg1:T1|Arg2:T6|CHEMICAL|GENE|DIRECT-REGULATOR|322
2899826|7-Hydroxy levomepromazine, 3-hydroxy levomepromazine and 7-hydroxy fluphenazine had only 10% of the potency of the parent drug in histamine H1 receptor binding, while the 7-hydroxy-metabolites of chlorpromazine and perphenazine had about 75% of the potency of the parent drug in this binding system.|chlorpromazine|histamine H1 receptor|30|21|Arg1:T24|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|323
23230131|The higher in vitro catalytic efficiency of DCK24Val toward dFdC monophosphorylation may be relevant to dFdC clinical response.|dFdC|DCK|10|8|Arg1:T6|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|324
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane|DAT|19|55|Arg1:T10|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|325
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|BMP4|3|34|Arg1:T8|Arg2:T15|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|326
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|methimazole|FMO3|19|16|Arg1:T2|Arg2:T15|CHEMICAL|GENE|SUBSTRATE|327
11775064|As with GABA, the metabolism of alanine involves a pyridoxal phosphate-dependent transaminase.|alanine|pyridoxal phosphate-dependent transaminase|8|11|Arg1:T15|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|328
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|p-hydroxybenzoic acid|metalloenzyme|13|45|Arg1:T11|Arg2:T25|CHEMICAL|GENE|INHIBITOR|329
23250811|Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).|curcumin|NF-κB|9|43|Arg1:T14|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|330
9712175|Lintitript markedly increased postprandial plasma CCK release (P<0.001) while distinctly reducing postprandial PP levels (P<0.01) as compared to placebo.|Lintitript|PP|1|17|Arg1:T1|Arg2:T10|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|331
12636181|Experimental evidence from the use of agents with enhanced selectivity for BuChE (cymserine analogues, MF-8622) and the dual inhibitor of both AChE and BuChE, rivastigmine, indicates potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias.|rivastigmine|AChE|29|38|Arg1:T6|Arg2:T16|CHEMICAL|GENE|INHIBITOR|332
7560228|Triclosan inhibited both cyclooxygenase 1 and cyclo-oxygenase 2 with IC-50 values of 43 microM and 227 microM, respectively.|Triclosan|cyclooxygenase 1|1|4|Arg1:T17|Arg2:T28|CHEMICAL|GENE|INHIBITOR|333
17154506|Chase studies with citalopram and methylphenidate demonstrated that this uptake is the result of preferential binding to the SERT.|methylphenidate|SERT|6|19|Arg1:T12|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|334
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|2'-cytidine monophosphate|bovine pancreatic ribonuclease A|30|7|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INHIBITOR|335
23290724|Here, we identify a Zn²⁺-driven N-terminal to C-terminal tertiary interaction in PrP(C).|C|PrP(C)|9|13|Arg1:T6|Arg2:T12|CHEMICAL|GENE|PART-OF|336
23534442|New classes of pyrrole-derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as COX-2 selective inhibitors and NO donors were synthesized and are herein reported.|ethers|COX-2|12|17|Arg1:T7|Arg2:T19|CHEMICAL|GENE|INHIBITOR|337
9310349|The alendronate inhibition of these three PTPs and two substrates is consistent with the formation of a ternary complex comprised of enzyme, substrate, and inhibitor.|alendronate|PTPs|2|7|Arg1:T2|Arg2:T28|CHEMICAL|GENE|INHIBITOR|338
15985706|The gastric mucin secretory responses to isoproterenol, furthermore, were inhibited by PP2, a selective inhibitor of tyrosine kinase Src responsible for ligand-independent EGFR autophosphorylation, but not by ERK inhibitor, PD98059.|PP2|gastric mucin|14|2|Arg1:T12|Arg2:T37|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|339
23296102|Moreover, Acrolein resulted in activation of astrocytes, up-regulation of BACE-1 in cortex and down-regulation of ADAM-10 in hippocampus and cortex.|Acrolein|ADAM-10|3|18|Arg1:T10|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|340
22931533|The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.|galantamine|AChE|10|21|Arg1:T7|Arg2:T13|CHEMICAL|GENE|DIRECT-REGULATOR|341
23261676|Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.|Isoproterenol|NADH-dehydrogenases|1|52|Arg1:T15|Arg2:T33|CHEMICAL|GENE|INHIBITOR|342
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|17-phenyl trinor PGE2|EP1|17|14|Arg1:T14|Arg2:T34|CHEMICAL|GENE|AGONIST|343
9003761|TREK-1 currents are insensitive to pharmacological agents that block TWIK-1 activity such as quinine and quinidine.|quinidine|TWIK-1|16|10|Arg1:T7|Arg2:T24|CHEMICAL|GENE|INHIBITOR|344
15732037|Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.|carvedilol|BNP|3|14|Arg1:T1|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|345
9551716|In conclusion, these findings indicate that [3H]SR 142948A is a new potent antagonist radioligand which recognizes with high affinity both neurotensin NT1 and NT2 receptors and represents thus an excellent tool to study neurotensin receptors in the rat brain.|[3H]SR 142948A|NT2 receptors|8|28|Arg1:T10|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|346
20421509|Remarkably, TFP binding results in the assembly of five Ca(2+)-S100A4/TFP dimers into a tightly packed pentameric ring.|TFP|S100A4|3|16|Arg1:T19|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|347
23532634|ACTH-stimulated peak cortisol, delta cortisol, and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover.|delta cortisol|ACTH|5|1|Arg1:T7|Arg2:T30|CHEMICAL|GENE|PRODUCT-OF|348
20053189|Two pure GnRH antagonists have been developed, abarelix and degarelix, that are devoid of any agonist effect on the GnRH receptor and consequently do not result in testosterone flare.|abarelix|GnRH|9|3|Arg1:T14|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|349
10942908|The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase (BChE) activity (87% of control), whereas pyridostigmine plus exercise significantly decreased the BChE activity (79% of control), indicating an interactive effect of the combination.|pyridostigmine|butyrylcholinesterase|5|10|Arg1:T12|Arg2:T19|CHEMICAL|GENE|INHIBITOR|350
15991937|Losartan is well-absorbed orally as an active drug and is rapidly converted via oxidation in the human liver to a more potent metabolite (designated E3174) with an affinity 20- to 30-times greater for the AT(1) receptor (non-competitive inhibition).|Losartan|AT(1) receptor|1|37|Arg1:T14|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|351
15635044|Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.|Leu|rat GnRHR|25|48|Arg1:T15|Arg2:T49|CHEMICAL|GENE|PART-OF|352
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|p-coumaric acid|carbonic anhydrase|16|46|Arg1:T17|Arg2:T26|CHEMICAL|GENE|INHIBITOR|353
10640321|Parenteral administration of selective agonists of the delta-opioid receptor (SB 227122), mu-opioid receptor (codeine and hydrocodone), and kappa-opioid receptor (BRL 52974) produced dose-related inhibition of citric acid-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively.|SB 227122|delta-opioid receptor|11|8|Arg1:T7|Arg2:T23|CHEMICAL|GENE|AGONIST|354
23098818|The obtained results indicate that rat brain CYP2D isoforms catalyze the formation of serotonin from 5-methoxytryptamine, and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain.|serotonin|rat brain CYP2D|14|6|Arg1:T5|Arg2:T23|CHEMICAL|GENE|PRODUCT-OF|355
17459764|Given the anti-inflammatory properties of EPA, we suggest that induction of COX-2 in keratinocytes may be important in the anti-inflammatory and protective mechanism of action of PUFAs n-3 or n-6.|PUFAs n-3|COX-2|28|13|Arg1:T5|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|356
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|medrogestone|sulfatase|15|34|Arg1:T9|Arg2:T27|CHEMICAL|GENE|INHIBITOR|357
18973551|All neurotrophic effects were blocked by the unselective D2/D3 receptor antagonist sulpiride (5 microm) and by the selective D3 receptor antagonist SB-277011-A at a low dose (50 nm).|SB-277011-A|D3 receptor|24|21|Arg1:T4|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|358
23143891|In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, budesonide, and fluticasone propionate, by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.|triamcinolone acetonide|CYP3A|14|27|Arg1:T14|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|359
12837768|Of 18 mutations where hNET amino acid residues were exchanged with those of the human dopamine transporter, MrIA had increased potency for inhibition of [3H]norepinephrine uptake for three mutations (in predicted extracellular loops 3 and 4 and transmembrane domain (TMD) 8) and decreased potency for one mutation (in TMD6 and intracellular loop (IL) 3).|amino acid|hNET|6|5|Arg1:T9|Arg2:T23|CHEMICAL|GENE|PART-OF|360
16343532|Comparisons of the structures of the cyanobacterial toxin:phosphatase complexes explain the biochemical mechanism by which microcystins but not nodularins permanently modify their protein phosphatase targets by covalent addition to an active site cysteine residue.|cysteine|protein phosphatase|35|25|Arg1:T3|Arg2:T14|CHEMICAL|GENE|PART-OF|361
9310349|PTP inhibition by hisphosphonates or vanadate was diminished by the metal chelating agent EDTA, or by the reducing agent dithiothreitol, suggesting that a metal ion and the oxidation of a cysteine residue are required for full inhibition.|hisphosphonates|PTP|4|1|Arg1:T3|Arg2:T29|CHEMICAL|GENE|INHIBITOR|362
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|coumarin|cholinesterase|24|8|Arg1:T7|Arg2:T12|CHEMICAL|GENE|INHIBITOR|363
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|extracellular signal-regulated kinase|1|20|Arg1:T6|Arg2:T37|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|364
11732752|Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B.|4-methoxy-2-naphthylamide|aminopeptidase A|32|37|Arg1:T7|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|365
17040106|On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of arylhydroxylamine carcinogens was catalyzed by NADH cytochrome b5 reductase (b5R) and cytochrome b5 (cyt b5).|arylhydroxylamine|NADH cytochrome b5 reductase|23|28|Arg1:T17|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|366
23454145|Cell-pre-incubation with bradykinin induced changes in ABCG expression levels after 7-ketostigmasterol-incubation; however, the energetic metabolism inhibition reduced NPC1L1 expression only in 7-ketocholesterol-incubated cells.|7-ketocholesterol|NPC1L1|24|20|Arg1:T1|Arg2:T39|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|367
23322166|LPA1-induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of LPA by driving MRTF-dependent CTGF expression, which, in turn, drives fibroblast proliferation.-Sakai, N., Chun, J., Duffield, J.|LPA|CTGF|18|22|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INDIRECT-UPREGULATOR|368
10546982|Citalopram protected against the RTI-76-induced inhibition of SERT binding.|RTI-76|SERT|5|8|Arg1:T5|Arg2:T14|CHEMICAL|GENE|INHIBITOR|369
12487427|In addition the production of BrBK1-8 was enhanced in the presence of these inhibitors with a greater accumulation being observed with omapatrilat.|omapatrilat|BrBK1-8|22|6|Arg1:T2|Arg2:T52|CHEMICAL|GENE|INDIRECT-UPREGULATOR|370
19039322|Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.|bosutinib|kinase|8|6|Arg1:T12|Arg2:T33|CHEMICAL|GENE|INHIBITOR|371
23619613|As shown in a cell culture model, polySia-NCAM-140 was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by IL-1β or lipopolysaccharide induced metalloprotease-mediated ectodomain shedding, resulting in the secretion of soluble polySia-NCAM.|polySia|NCAM-140|9|10|Arg1:T9|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|372
19293728|A PKC or MAP kinase inhibitor blocked the inhibitory effect of fenoldopam on insulin receptor expression, indicating that PKC and MAP kinase were involved in the signaling pathway.|fenoldopam|insulin receptor|12|14|Arg1:T6|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|373
23261590|In this study, focus was given to evaluate the ability of neoechinulin A, an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-β 1-42 (Aβ42).|neoechinulin A|amyloid-β 1-42|13|31|Arg1:T5|Arg2:T30|CHEMICAL|GENE|INHIBITOR|374
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|tolfenamic acid|COX-1|28|46|Arg1:T15|Arg2:T18|CHEMICAL|GENE|INHIBITOR|375
2899826|The present study reports the in vitro binding affinities of the same compounds for muscarinic cholinergic receptors and for histamine H1 receptors in rat brain, using 3H-quinuclidinyl benzilate and 3H-mepyramine as radioligands.|3H-quinuclidinyl benzilate|histamine H1 receptors|28|20|Arg1:T7|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|376
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|dydrogesterone|sulfatase|10|34|Arg1:T8|Arg2:T27|CHEMICAL|GENE|INHIBITOR|377
15939622|COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.|meloxicam|COX-2|15|3|Arg1:T17|Arg2:T23|CHEMICAL|GENE|INHIBITOR|378
15985706|Both inhibitors, moreover, blunted the mucin secretory responses to beta-adrenergic agonist-generated second messenger, cAMP as well as adenylate cyclase activator, forskolin.|cAMP|adenylate cyclase|17|21|Arg1:T8|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|379
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|STI571|PDGFbeta-receptor|16|36|Arg1:T2|Arg2:T29|CHEMICAL|GENE|INHIBITOR|380
10999950|Pretreatment with lysosomal enzyme inhibitors [(2S, 3S)trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester or chloroquine] or proteasome inhibitors (proteasome inhibitor I, MG-132, or lactacystin) decreased the extent of U50,488H-induced down-regulation.|MG-132|proteasome|26|22|Arg1:T2|Arg2:T18|CHEMICAL|GENE|INHIBITOR|381
17015640|Moreover, licofelone inhibited COX-2 and 5-LOX protein expression in vascular lesions.|licofelone|5-LOX|3|7|Arg1:T2|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|382
20104269|CDCA induced dose-dependent expression of Cdx2 and MUC2 at both the mRNA and protein levels.|CDCA|Cdx2|1|6|Arg1:T8|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|383
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|SNAT2|7|62|Arg1:T18|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|384
23414340|Although glutathione S-transferase omega 1 (GSTO1) and arsenic methyltransferase have been shown or thought to catalyze DMAs(V) reduction, their role in DMAs(V) reduction in vivo, or in cell extracts is uncertain.|DMAs(V)|glutathione S-transferase omega 1|19|2|Arg1:T31|Arg2:T52|CHEMICAL|GENE|SUBSTRATE|385
16434489|Computer modeling suggests that the KITD816V mutation destabilizes the inactive conformation of the KIT activation loop to which imatinib binds, but it is not predicted to impair binding of KIT by dasatinib.|imatinib|KIT|19|6|Arg1:T2|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|386
15049511|The inhibitory effects of tranylcypromine, a nonselective irreversible inhibitor of monoamine oxidase (MAO), on three cytochrome P450 (CYP) enzymes, namely CYP2C9, CYP2C19, and CYP2D6, have been evaluated in vitro.|tranylcypromine|monoamine oxidase|5|12|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INHIBITOR|387
17218486|PEA was a potent and full agonist at each species of TAAR1, whereas TYR was a full agonist for the rodent TAAR1s but was a partial agonist at h-rChTAAR1.|PEA|TAAR1|1|12|Arg1:T3|Arg2:T40|CHEMICAL|GENE|AGONIST-ACTIVATOR|388
15635044|Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.|Ser|EL3|16|23|Arg1:T13|Arg2:T48|CHEMICAL|GENE|PART-OF|389
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Tarceva|kinase|30|44|Arg1:T8|Arg2:T45|CHEMICAL|GENE|INHIBITOR|390
9832994|These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.|methysergide|5-HT1|13|6|Arg1:T7|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|391
23098818|Human liver microsomes of the wild-type CYP2D6 metabolized 5-methoxytryptamine to serotonin more effectively than did the defective CYP2D6*4*4 ones.|5-methoxytryptamine|CYP2D6|9|18|Arg1:T3|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|392
15561973|As opposed to the rat and flounder orthologs, hNaDC-3 was hardly inhibited by lithium concentrations up to 5 mM.|lithium|hNaDC-3|15|10|Arg1:T7|Arg2:T34|CHEMICAL|GENE|INHIBITOR|393
12392782|The COX pathway generates inflammatory prostaglandins, while the 5-LOX pathway generates inflammatory leukotrienes.|prostaglandins|COX|6|2|Arg1:T1|Arg2:T16|CHEMICAL|GENE|PRODUCT-OF|394
23598904|Among the possible transporters involved in the uptake of Cd(2+) and Mn(2+), the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.|Cd(2+)|Zrt-, Irt-related protein 8|10|25|Arg1:T21|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|395
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|choline|transmembrane transporters|16|24|Arg1:T7|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|396
22872607|Exposure to PAHs, their metabolites, and ROS further increase AKRs isoform expression that may amplify oxidative damage.|PAHs|AKRs|3|12|Arg1:T8|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|397
7554708|The daily administration of low-dose aspirin (40 mg), a selective inhibitor of platelet PGHS-1, caused a cumulative inhibition of urinary 11-dehydro-TXB2 and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover.|aspirin|PGHS-1|6|17|Arg1:T4|Arg2:T24|CHEMICAL|GENE|INHIBITOR|398
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|H(2)S|CBS|4|25|Arg1:T15|Arg2:T38|CHEMICAL|GENE|PRODUCT-OF|399
15837926|PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.|methotrexate|glutamate carboxypeptidase|21|5|Arg1:T3|Arg2:T11|CHEMICAL|GENE|SUBSTRATE|400
16774921|The x-ray co-crystal structure of LeuRS showed that a C-terminal extension of about 60 amino acids forms a discrete domain, which is unique among the LeuRSs and interacts with the corner of the L-shaped tRNALeu.|amino acids|LeuRSs|15|27|Arg1:T11|Arg2:T22|CHEMICAL|GENE|PART-OF|401
23333261|Moreover, curcumin alleviated Sim2 expression, and reversely raised Drebrin expression in neurons treated with hyperglycaemia.|curcumin|Drebrin|3|11|Arg1:T1|Arg2:T7|CHEMICAL|GENE|INDIRECT-UPREGULATOR|402
15723099|The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047, suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is, at least in part, related to sigma1 receptor-activated modulation of AP-1 transcription factors.|BD 1047|sigma1 receptor|17|14|Arg1:T1|Arg2:T41|CHEMICAL|GENE|ANTAGONIST|403
20104269|CDCA induced dose-dependent expression of Cdx2 and MUC2 at both the mRNA and protein levels.|CDCA|MUC2|1|8|Arg1:T8|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|404
23395914|Upon studying the drug-drug interaction of darunavir with ketoconazole, data were indicative for an inhibitory effect of ketoconazole on P-gp as the main mechanism for the increased transport of darunavir across the small intestine.|darunavir|P-gp|31|21|Arg1:T5|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|405
20615127|Consistent with the results of a computer analysis, the binding of R316C to triiodothyronine (T3) was significantly decreased to 38% that of the wild type.|triiodothyronine|R316C|15|13|Arg1:T9|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|406
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|D-65476|kinase|19|44|Arg1:T13|Arg2:T35|CHEMICAL|GENE|INHIBITOR|407
10406837|Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats.|Torasemide|angiotensin II|1|3|Arg1:T13|Arg2:T24|CHEMICAL|GENE|INHIBITOR|408
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|Ara-C|Pro122Ser|40|20|Arg1:T10|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|409
23024204|Metabolism of triethylenetetramine and 1,12-diamino-3,6,9-triazadodecane by the spermidine/spermine-N(1)-acetyltransferase and thialysine acetyltransferase.|triethylenetetramine|thialysine acetyltransferase|3|14|Arg1:T23|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|410
8894610|Phenylephrine elicited a concentration-dependent positive inotropic effect via alpha 1-adrenoceptors in the presence of either (+/-)-bupranolol or S(-)-timolol.|Phenylephrine|alpha 1-adrenoceptors|1|9|Arg1:T18|Arg2:T33|CHEMICAL|GENE|AGONIST-ACTIVATOR|411
10640321|The sigma-receptor antagonist rimcazole (3 mg/kg, i.p.) inhibited the antitussive effect of dextromethorphan (30 mg/kg, i.p.), a sigma-receptor agonist, but not that of SB 227122.|dextromethorphan|sigma-receptor|17|2|Arg1:T3|Arg2:T21|CHEMICAL|GENE|AGONIST|412
23262271|Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant tyrosinase inhibition activities.|trans-dihydromorin|tyrosinase|6|26|Arg1:T3|Arg2:T6|CHEMICAL|GENE|INHIBITOR|413
10771044|In these tissues, JTH-601, prazosin (a non-selective alpha(1)-adrenoceptor antagonist), and tamsulosin (an alpha(1A)-adrenoceptor antagonist) competitively antagonized contraction in a concentration-dependent manner.|prazosin|alpha(1)-adrenoceptor|7|11|Arg1:T11|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|414
12086935|Metformin treatment for 10 weeks significantly increased AMPK alpha2 activity in the skeletal muscle, and this was associated with increased phosphorylation of AMPK on Thr172 and decreased acetyl-CoA carboxylase-2 activity.|Metformin|AMPK|1|24|Arg1:T16|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|415
23532634|ACTH-stimulated peak cortisol, delta cortisol, and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover.|delta DHEA|ACTH|9|1|Arg1:T8|Arg2:T30|CHEMICAL|GENE|PRODUCT-OF|416
17488480|Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue caerulein-treated acinar cells.|caerulein|SP|39|6|Arg1:T3|Arg2:T52|CHEMICAL|GENE|INDIRECT-UPREGULATOR|417
14984733|  Phosphatidylserine (PtdSer) is made in mammalian cells by two PtdSer synthases, PSS1 and PSS2.|Phosphatidylserine|PSS1|1|15|Arg1:T1|Arg2:T25|CHEMICAL|GENE|PRODUCT-OF|418
23194076|Diet, physical exercise and Orlistat administration increase serum Anti-Müllerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).|Orlistat|Anti-Müllerian Hormone|6|10|Arg1:T8|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|419
16434489|In this study, we demonstrate significant inhibitory activity of dasatinib against both wild-type KIT and the KITD816V mutation in the nanomolar range in in vitro and cell-based kinase assays.|dasatinib|KIT|11|15|Arg1:T11|Arg2:T30|CHEMICAL|GENE|INHIBITOR|420
17768678|Pretreatment with TCP completely abolished the PLZ-induced increase in brain ORN, suggesting, as with GABA, that a metabolite of PLZ formed by the action of MAO is responsible for the elevation of brain ORN observed.|PLZ|MAO|23|29|Arg1:T11|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|421
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|hydrogen peroxide|NRF2|38|21|Arg1:T4|Arg2:T7|CHEMICAL|GENE|ACTIVATOR|422
6227474|Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.|corticosterone|rat brain aldosterone receptors|11|3|Arg1:T24|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|423
23471969|An endogenous intracellular domain fragment of p75(NTR) (p75(ICD)) containing these 29 amino acids is produced by regulated proteolysis of the full-length receptor.|amino acids|p75(NTR)|20|7|Arg1:T2|Arg2:T15|CHEMICAL|GENE|PART-OF|424
23118019|Both 5'-AMN and 5'-MABN had high affinity for κ-receptors (K (i) 1.36 ± 0.98 and 0.27 ± 0.08, respectively) and were revealed as potent κ-antagonists (pA(2) 7.43 and 8.18, respectively) and μ-receptor antagonists (pA(2) 7.62 and 7.85, respectively) in the ileum.|5'-MABN|μ-receptor|4|43|Arg1:T17|Arg2:T19|CHEMICAL|GENE|ANTAGONIST|425
10771044|  We examined the effect of JTH-601 (3- inverted question markN-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom ethyl inverted question mark-4-methoxy-2,5,6-trimethylphenol hemifumarate), a new alpha(1L)-adrenoceptor antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs.|JTH-601|alpha(1L)-adrenoceptor|6|29|Arg1:T7|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|426
17256745|  UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine.|bile acids|BAAT|24|11|Arg1:T2|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|427
2899826|7-Hydroxy levomepromazine, 3-hydroxy levomepromazine and 7-hydroxy fluphenazine had only 10% of the potency of the parent drug in histamine H1 receptor binding, while the 7-hydroxy-metabolites of chlorpromazine and perphenazine had about 75% of the potency of the parent drug in this binding system.|perphenazine|histamine H1 receptor|32|21|Arg1:T25|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|428
20596674|In conclusion, the results suggest that the enhancement in the reduction of topo II activity by the combined MXF/VP-16 treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs.|VP-16|topo II|21|14|Arg1:T12|Arg2:T31|CHEMICAL|GENE|INHIBITOR|429
23481236|Cells were also evaluated in the presence of wortmannin, an inhibitor of phosphatidylinositol 3-kinases and thus AKt (0-100 nM).|wortmannin|AKt|9|18|Arg1:T17|Arg2:T47|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|430
23597506|However, enzymes contributing to oxidative metabolism of anandamide, namely cyclooxygenase-1 and Cyp2D6, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of anandamide.|anandamide|cyclooxygenase-1|9|12|Arg1:T2|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|431
17229632|We investigated the efficacy of sorafenib at inhibiting mutants of the receptor tyrosine kinases PDGFRbeta, KIT, and FLT3, which are implicated in the pathogenesis of myeloid malignancies.|sorafenib|FLT3|6|20|Arg1:T12|Arg2:T36|CHEMICAL|GENE|INHIBITOR|432
1730582|  Mouse ornithine decarboxylase (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (DFMO).|pyridoxal 5'-phosphate|ODC|25|5|Arg1:T6|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|433
23481236|Only FFAs that increased ceramides caused impairment of AKt and PTP1B phosphorylation at Ser 50.|ceramides|PTP1B|5|11|Arg1:T6|Arg2:T31|CHEMICAL|GENE|INHIBITOR|434
22898212|CBDP irreversibly inhibits butyrylcholinesterase (BChE) in human plasma by forming adducts on the active site serine (Ser-198).|CBDP|BChE|1|6|Arg1:T6|Arg2:T31|CHEMICAL|GENE|INHIBITOR|435
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|STI571|Bcr|16|22|Arg1:T38|Arg2:T54|CHEMICAL|GENE|INHIBITOR|436
11742712|  Pemetrexed disodium (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.|Pemetrexed disodium|dihydrofolate reductase|1|21|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INHIBITOR|437
15452358|These findings suggest that the anti-allodynia effect of CP-101,606 is ascribable to blockade of NR2B receptors at the brain, but not at the spinal cord.|CP-101,606|NR2B|9|15|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INHIBITOR|438
23230131|All four DCK proteins yielded comparable metabolic activity for Ara-C and dFdC monophosphorylation, except for DCK24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of dFdC monophosphorylation due to a 40% decrease in K(m) (P < 0.05).|Ara-C|DCK|10|3|Arg1:T18|Arg2:T42|CHEMICAL|GENE|SUBSTRATE|439
22996137|Disruption of microtubule prevented insulin-induced actin remodeling and distal insulin signal transduction, with reduction in surface glucose transporter isoform 4 (GLUT4) and glucose uptake.|glucose|glucose transporter isoform 4|26|18|Arg1:T3|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|440
23428346|We found that atorvastatin withdrawal decreased levels of nitric oxide and mitochondrial superoxide dismutase activity, whereas increased NADPH oxidase activity and immunoreactivity for the protein nitration marker 3-nitrotyrosine in the cerebral cortex.|3-nitrotyrosine|NADPH oxidase|29|19|Arg1:T9|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|441
16618126|"This aminophospholipid ""flippase"" selectively transports PS to the cytosolic leaflet of the bilayer and is sensitive to vanadate, Ca(2+), and modification by sulfhydryl reagents."|PS|flippase|8|4|Arg1:T24|Arg2:T43|CHEMICAL|GENE|SUBSTRATE|442
10640321|The nonselective opioid receptor antagonist, naloxone (3 mg/kg, i.m.), attenuated the antitussive effects of codeine or SB 227122, indicating that the antitussive activity of both compounds is opioid receptor-mediated.|codeine|opioid receptor|21|35|Arg1:T13|Arg2:T28|CHEMICAL|GENE|AGONIST|443
12901032|Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.|rofecoxib|COX-2|33|12|Arg1:T9|Arg2:T23|CHEMICAL|GENE|INHIBITOR|444
16324695|Moreover, the specific PKC-inhibitor 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl) maleimide (GF 109203X) markedly increased the potency and E(max) of isoprenaline for all conditions used, including control conditions, and the synergistic effects of PMA and fenoterol were completely prevented.|2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl) maleimide|PKC|6|5|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INHIBITOR|445
22578098|By synthesizing and testing a series of alanine point-mutated cyclic peptides, we identified which amino acid was important for the inhibition of the phospholamban function.|amino acid|phospholamban|16|25|Arg1:T1|Arg2:T9|CHEMICAL|GENE|PART-OF|446
9551716|Saturation and competition studies in the presence or absence of the histamine H1 receptor antagonist, levocabastine, revealed that [3H]SR 142948A bound with similar affinities to both the levocabastine-insensitive neurotensin NT1 receptors (20% of the total binding population) and the recently cloned levocabastine-sensitive neurotensin NT2 receptors (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively).|[3H]SR 142948A|neurotensin NT2 receptors|21|51|Arg1:T3|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|447
23318833|TAA increased the number and area of glutathione S-transferase placental form (GST-P)(+) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections.|TAA|glutathione S-transferase placental form|1|8|Arg1:T8|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|448
11585753|"The tyrosine kinase inhibitor ZD1839 (""Iressa"") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells."|Iressa|HER2|8|19|Arg1:T9|Arg2:T24|CHEMICAL|GENE|INHIBITOR|449
17205056|The demonstration that sorafenib exhibits potent target inhibition and efficacy in FLT3-driven models suggests that this compound may have a therapeutic benefit for patients with FLT3-driven leukemias.|sorafenib|FLT3|4|12|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INHIBITOR|450
23275442|The CSN/IRF5 interaction occurred on the carboxyl and amino termini of IRF5; a single internal deletion from amino acids 455 to 466 (Δ455-466) was found to significantly reduce IRF5 protein stability.|amino acids|IRF5|19|32|Arg1:T3|Arg2:T31|CHEMICAL|GENE|PART-OF|451
1730582|  Mouse ornithine decarboxylase (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (DFMO).|DFMO|ODC|46|5|Arg1:T17|Arg2:T36|CHEMICAL|GENE|INHIBITOR|452
10942908|Creatine phosphokinase activity in plasma increased slightly (compared to control, pyridostigmine or exercise group) in mice treated with pyridostigmine plus exercise, which may be indicative of perturbation in the integrity of the skeletal muscle due to combination.|pyridostigmine|Creatine phosphokinase|22|1|Arg1:T4|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|453
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate|Panx1|17|6|Arg1:T15|Arg2:T39|CHEMICAL|GENE|INHIBITOR|454
23228697|  Orlistat has been the most used anti-obesity drug and the mechanism of its action is to reduce lipid absorption by inhibiting gastrointestinal lipases.|Orlistat|lipases|1|23|Arg1:T1|Arg2:T17|CHEMICAL|GENE|INHIBITOR|455
15049511|Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.|tranylcypromine|monoamine oxidase|8|5|Arg1:T8|Arg2:T25|CHEMICAL|GENE|INHIBITOR|456
11089538|  Insulin-like growth factor (IGF)-binding protein (IGFBP)-related proteins (IGFBP-rPs) are newly described cysteine-rich proteins that share significant aminoterminal structural similarity with the conventional IGFBPs and are involved in a diversity of biological functions, including growth regulation.|cysteine|Insulin-like growth factor (IGF)-binding protein (IGFBP)-related proteins|20|1|Arg1:T1|Arg2:T7|CHEMICAL|GENE|PART-OF|457
17594192|  Phenserine, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase (AChE) and was shown to improve cognition in various experimental paradigms in rodents and dogs.|physostigmine|AChE|6|17|Arg1:T7|Arg2:T16|CHEMICAL|GENE|INHIBITOR|458
17477831|  Acetyl-coenzyme A carboxylase (ACC) enzymes exist as two isoforms, ACC1 and ACC2, which play critical roles in fatty acid biosynthesis and oxidation.|fatty acid|ACC2|22|15|Arg1:T4|Arg2:T26|CHEMICAL|GENE|PRODUCT-OF|459
17488480|Caerulein increased the levels of H(2)S and CSE mRNA expression while CBS mRNA expression was decreased.|Caerulein|CSE|1|12|Arg1:T20|Arg2:T46|CHEMICAL|GENE|INDIRECT-UPREGULATOR|460
23182946|Therefore, the present results show that the earlier cerebellar responses to (PhTe)(2) include disruption of cytoskeletal homeostasis that could be related with MAPK and PKA activation and reactive astrogliosis.|(PhTe)(2)|PKA|13|31|Arg1:T5|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|461
16516814|In addition to this evidence (for the involvement of EP2 receptors), evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of Na,K-ATPase beta subunit gene transcription includes the stimulatory effect of 17-phenyl trinor PGE2, as well as the inhibitory effects of SC-51089.|17-phenyl trinor PGE2|Na,K-ATPase beta|40|28|Arg1:T5|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|462
12165285|In no other subject any activation of platelets by GP IIb/IIIa inhibitors was observed and there were no statistically significant differences between HPA-1 genotypes with respect to the effects of GP IIb/IIIa inhibitors on basal or ADP-stimulated CD62P expression.|ADP|CD62P|37|38|Arg1:T1|Arg2:T11|CHEMICAL|GENE|INDIRECT-UPREGULATOR|463
23024204|Thus, despite the similar structures of TETA and SpmTrien, SSAT2 is the main acetylator of TETA, whereas SpmTrien is primarily acetylated by SSAT1.|SpmTrien|SSAT1|21|26|Arg1:T5|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|464
1543672|In contrast, inhibition of rat liver squalene epoxidase only occurs at higher drug concentrations (Ki = 77 microM), and is competitive with squalene.|squalene|rat liver squalene epoxidase|27|6|Arg1:T2|Arg2:T24|CHEMICAL|GENE|INHIBITOR|465
8894610|(+/-)-Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1B-adrenoceptors by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine.|(+/-)-Tamsulosin|alpha 1B-adrenoceptors|1|17|Arg1:T25|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|466
1730582|  Mouse ornithine decarboxylase (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (DFMO).|alpha-difluoromethylornithine|ODC|44|5|Arg1:T16|Arg2:T36|CHEMICAL|GENE|INHIBITOR|467
23584358|There were statistically significant increases in the activities of aspartate aminotransferase, alanine aminotransferase, levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and 8-iso-prostane, and decreases in the activity of superoxide dismutase and level of glutathione in the group treated with paracetamol.|paracetamol|TNF-α|49|22|Arg1:T8|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|468
20724158|METHODS: We conducted a case-control study to measure the association between selective cox-2 inhibitors, particularly celecoxib, rofecoxib, valdecoxib and non-specific NSAID subgroups, and breast cancer risk.|rofecoxib|cox-2|20|14|Arg1:T5|Arg2:T14|CHEMICAL|GENE|INHIBITOR|469
23139413|"Binding of the agonist angiotensin II (AngII) and inverse agonist losartan in wild-type AT1R changed the accessibility of reporter cysteines, and the pattern was consistent with ligand-specific ""lid"" conformations of ECL2."|losartan|AT1R|13|16|Arg1:T5|Arg2:T25|CHEMICAL|GENE|AGONIST-INHIBITOR|470
23623750|Cynomolgus FMO6 metabolized benzydamine only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.|benzydamine|FMO1|4|27|Arg1:T8|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|471
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|phenolic acids|EC 4.2.1.1|4|51|Arg1:T4|Arg2:T28|CHEMICAL|GENE|INHIBITOR|472
10712236|Inhibition of S-adenosylmethionine decarboxylase by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC.|spermine|S-adenosylmethionine decarboxylase|24|3|Arg1:T6|Arg2:T33|CHEMICAL|GENE|PRODUCT-OF|473
16988497|A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.|linoleic acid|D6D|34|50|Arg1:T14|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|474
15805193|Phenytoin is principally metabolized by CYP2C9, and both are probable substrates of the drug transporter P-glycoprotein.|Phenytoin|P-glycoprotein|1|17|Arg1:T6|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|475
10064839|We found that DF, DM, and DR were relative high-affinity ligands at sigma-1 receptors (Ki=151, 205, 144 nM, respectively) while all of them were with low affinity at sigma-2 receptors (Ki=4-11 microM).|DM|sigma-1 receptors|6|15|Arg1:T47|Arg2:T55|CHEMICAL|GENE|DIRECT-REGULATOR|476
7885191|The channel activators avermectin and moxidectin usually retain their inhibitory potency in the Rdl subunit mutants.|avermectin|Rdl|4|14|Arg1:T12|Arg2:T52|CHEMICAL|GENE|INHIBITOR|477
17094978|CONCLUSION(S): Short-term exposure of mifepristone in new starters of DMPA increases the expression of endometrial ERalpha, PRAB, PRB, and SRC-1 and promotes cell proliferation.|mifepristone|SRC-1|9|27|Arg1:T3|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|478
23481236|Only FFAs that increased ceramides caused impairment of AKt and PTP1B phosphorylation at Ser 50.|ceramides|AKt|5|9|Arg1:T6|Arg2:T30|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|479
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|retinoic acid|nuclear receptors|17|25|Arg1:T10|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|480
23164921|Biochemical analyses showed that NO and ROS production and iNOS activity were significantly reduced by catalpol.|catalpol|iNOS|16|10|Arg1:T8|Arg2:T15|CHEMICAL|GENE|INHIBITOR|481
17382376|In summary, the therapeutic effect of clozapine in reversing PPI impairment was mimicked by the H(1) antagonist pyrilamine, while pyrilamine had a mixed effect on cognition.|pyrilamine|H(1)|25|17|Arg1:T9|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|482
3735252|Inhibition of testicular LDH-X from laboratory animals and man by gossypol and its isomers.|gossypol|LDH-X|11|4|Arg1:T11|Arg2:T20|CHEMICAL|GENE|INHIBITOR|483
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|hydroxylamines|human b5R|8|48|Arg1:T19|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|484
23146664|We propose that inhibition of PAK1 expression by 5-ASA can impede with neoplastic progression in colorectal carcinogenesis.|5-ASA|PAK1|9|6|Arg1:T5|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|485
20531964|A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR tyrosine kinase inhibitors sunitinib and/or sorafenib.|sorafenib|tyrosine kinase|36|31|Arg1:T10|Arg2:T17|CHEMICAL|GENE|INHIBITOR|486
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|phenol|EC 4.2.1.1|7|51|Arg1:T9|Arg2:T28|CHEMICAL|GENE|INHIBITOR|487
12679340|In arginase, two cysteines at the C terminus of the protein are crucial for its epiarginase function but not for its catalytic activity and trimeric structure.|cysteines|arginase|5|2|Arg1:T6|Arg2:T26|CHEMICAL|GENE|PART-OF|488
23266505|The upregulation of calpain, tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of ALD.|EGTA|calpain|16|4|Arg1:T18|Arg2:T34|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|489
21606412|  PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.|cabozantinib|MET|5|12|Arg1:T3|Arg2:T18|CHEMICAL|GENE|INHIBITOR|490
23619613|In mature lung tissue of healthy donors, polySia was exclusively attached to the transmembrane isoform NCAM-140 and located to intracellular compartments of epithelial cells.|polySia|NCAM-140|9|17|Arg1:T5|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|491
16424790|Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.|captopril|ACE|3|19|Arg1:T45|Arg2:T67|CHEMICAL|GENE|INHIBITOR|492
23142507|The 3D-structure of HmTx consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).|Phe|HmTx|25|4|Arg1:T8|Arg2:T23|CHEMICAL|GENE|PART-OF|493
18974361|This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, isradipine, and nitrendipine) as potent T-channel blockers (IC(50) < 3 microM).|nitrendipine|T-channel|17|21|Arg1:T17|Arg2:T26|CHEMICAL|GENE|INHIBITOR|494
7837275|  An experimental strategy based on solution viscosity perturbation allowed us to study the energetics of amide-substrates, p-aminobenzamidine (p-ABZ) and proflavin binding to the catalytic site of two proteolyzed forms of alpha-thrombin, i.e. zeta- and gamma T-thrombin.|p-ABZ|alpha-thrombin|20|34|Arg1:T4|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|495
23066089|Using site-directed mutagenesis, we identified three serines (Ser833, Ser836, and Ser840) within the membrane proximal region of the GluK5 C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs. Together, these data suggest that phosphorylation of key residues in the C-terminal domain changes the overall charge of this domain, resulting in potentiated agonist responses.|serines|GluK5|8|24|Arg1:T8|Arg2:T31|CHEMICAL|GENE|PART-OF|496
15908512|Together, this pharmacological profile of subtype-selective betaAR antagonists indicates that in this model, beta1AR activation is responsible for the enhanced hippocampal CA3 network activity initiated by isoproterenol.|isoproterenol|beta1AR|29|16|Arg1:T12|Arg2:T24|CHEMICAL|GENE|AGONIST|497
3345199|Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro.|soman|human acetylcholinesterase|13|14|Arg1:T25|Arg2:T35|CHEMICAL|GENE|INHIBITOR|498
12414329|Selective inhibition of PDE5 is a rational therapeutic approach in ED, as proved by the clinical success of sildenafil.|sildenafil|PDE5|20|4|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INHIBITOR|499
11562773|By theoretical calculations we have determined most probable structure of amiloride/uPAs complexes.|amiloride|uPAs|11|12|Arg1:T4|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|500
16371234|Furthermore, PS liposome-induced PGE2 production was significantly suppressed by indomethacin, a preferential COX-1 inhibitor, but not by NS-398, a selective COX-2 inhibitor.|NS-398|COX-2|21|25|Arg1:T5|Arg2:T25|CHEMICAL|GENE|INHIBITOR|501
20724158|CONCLUSION: Consistent with animal models and laboratory investigations, higher doses of selective COX-2 inhibitors were more protective against breast cancer than non-specific NSAIDs. With exposure to rofecoxib, a selective COX-2 inhibitor, breast cancer risk reduction was appreciable (46%), suggesting a possible role for selective COX-2 inhibitors in breast cancer prophylaxis.|rofecoxib|COX-2|30|54|Arg1:T3|Arg2:T11|CHEMICAL|GENE|INHIBITOR|502
22898212|Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase.|histidine|human butyrylcholinesterase|18|21|Arg1:T28|Arg2:T34|CHEMICAL|GENE|PART-OF|503
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|SNAT2|12|62|Arg1:T21|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|504
12881227|In conclusion, only specific apical NHE3 inhibition increased DBS, whereas prostaglandin synthesis, Na+-HCO3- cotransporter activation, or intracellular HCO3- formation by carbonic anhydrase was not involved.|HCO3|carbonic anhydrase|22|25|Arg1:T5|Arg2:T23|CHEMICAL|GENE|PRODUCT-OF|505
18081314|The binding of U46619 to the PGIS protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at C-11, H2C, and H20 of U46619 were observed upon U46619 binding to the engineered PGIS in a concentration-dependent manner.|U46619|PGIS|34|7|Arg1:T15|Arg2:T38|CHEMICAL|GENE|PART-OF|506
16432501|Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.|salmeterol|beta2-adrenoceptor|9|4|Arg1:T19|Arg2:T24|CHEMICAL|GENE|AGONIST|507
16344985|CONCLUSIONS: This study shows that valproic acid acts as a non-competitive inhibitor of brain microsomal Acsl, and that inhibition is substrate-selective.|valproic acid|brain microsomal Acsl|7|15|Arg1:T6|Arg2:T30|CHEMICAL|GENE|INHIBITOR|508
23479738|A highly potent inhibition of the peroxidase catalytic reaction by NO/SNO was seen in assays employing the coupled Prx-Trx system.|SNO|peroxidase|12|7|Arg1:T4|Arg2:T34|CHEMICAL|GENE|INHIBITOR|509
23443810|Interestingly, miR-21 expression positively correlated with urine albumin creatine ratio (ACR), TIMP1, collagen IV (ColIV), and fibronectin (FN); while negatively correlated with creatine clearance ratio (Ccr) and MMP-9 protein.|creatine|miR-21|34|3|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|510
8294418|  The mechanism by which norepinephrine (NE) down-regulates alpha 1B-adrenergic receptor (alpha-AR) mRNA was studied in rabbit aortic smooth muscle cells.|NE|alpha 1B-adrenergic receptor|7|10|Arg1:T8|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|511
17218486|The discovery that METH and AMPH activate the rTAAR1 motivated us to study the effect of these drugs on the mouse TAAR1 (mTAAR1) and a human-rat chimera (hrChTAAR1).|METH|rTAAR1|4|9|Arg1:T22|Arg2:T49|CHEMICAL|GENE|ACTIVATOR|512
17094978|RESULT(S): The expression of endometrial ERalpha, PRAB, PRB, and SRC-1 was increased significantly after 1 week of mifepristone, but the increase was no longer seen after 10 weeks.|mifepristone|SRC-1|25|17|Arg1:T1|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|513
14501155|The 5-HT(1/2/5/7)-receptor antagonist methysergide and the 5-HT(2A/2B/2C)-receptor antagonist LY 53857 enhanced clomipramine-induced hyperglycemia, while the 5-HT(1A/1B)-receptor antagonist (-)-propranolol and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it.|LY 53857|5-HT(2A/2B/2C)-receptor|17|11|Arg1:T8|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|514
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|cinnamic aldehyde|NRF2|34|27|Arg1:T3|Arg2:T8|CHEMICAL|GENE|ACTIVATOR|515
9476974|Monoamine uptake inhibitors structurally analogous to cocaine (cocaethylene, CFT, betaCIT, CPT, (+)-cocaine, norcocaine, and benztropine) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities (BTCP, indatraline, GBR 12935, mazindol, nomifensine, and zimeldine) either did not produce a rapid pressor response or produced only a small pressor response.|indatraline|monoamine transporter|47|41|Arg1:T26|Arg2:T47|CHEMICAL|GENE|INHIBITOR|516
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|BAPTA|mGlu1|39|7|Arg1:T3|Arg2:T48|CHEMICAL|GENE|INHIBITOR|517
23246481|Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1.|H2O2|caveolin-1|3|11|Arg1:T15|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|518
7825862|6-Methoxy-2-naphthylacetic acid, the active metabolite of Relafen, inhibits murine PGHS-2 preferentially.|Relafen|PGHS-2|8|12|Arg1:T6|Arg2:T15|CHEMICAL|GENE|INHIBITOR|519
7885191|In contrast, the Ala-->Gly replacement has less impact in protecting the chloride channel from the action of insecticidal blockers.|Ala|chloride channel|5|16|Arg1:T18|Arg2:T53|CHEMICAL|GENE|PART-OF|520
23044488|  Human serum butyrylcholinesterase (HuBChE) is currently the most suitable bioscavenger for the prophylaxis of highly toxic organophosphate (OP) nerve agents.|organophosphate|Human serum butyrylcholinesterase|19|1|Arg1:T1|Arg2:T4|CHEMICAL|GENE|SUBSTRATE|521
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Ile|D281A|20|34|Arg1:T3|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|522
12881227|Nevertheless, coperfusion with 0.1 and 0.3 mM 5-nitro-2-(3-phenylpropylamino) benzoic acid, which inhibits the cystic fibrosis transmembrane conductor regulator (CFTR), dose dependently inhibited S3226-induced DBS.|5-nitro-2-(3-phenylpropylamino) benzoic acid|CFTR|9|25|Arg1:T20|Arg2:T42|CHEMICAL|GENE|INHIBITOR|523
23182954|Ozone plus PM(2.5) exposure, however, induced CRP, IL-6, CK, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.|Ozone|CK|1|16|Arg1:T4|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|524
11089538|Although the data collected on IGFBP-rP3 in prostate are modest, its role as a growth stimulator and/or protooncogene is supported by its preferential expression in cancerous cells and its down-regulation by atRA.|atRA|IGFBP-rP3|33|6|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|525
23111283|Western blot analysis indicated that TSN inhibits the CDC42/MEKK1/JNK pathway.|TSN|JNK|6|10|Arg1:T10|Arg2:T19|CHEMICAL|GENE|INHIBITOR|526
16774921|Functional divergence of a unique C-terminal domain of leucyl-tRNA synthetase to accommodate its splicing and aminoacylation roles.|leucyl|leucyl-tRNA synthetase|9|9|Arg1:T16|Arg2:T25|CHEMICAL|GENE|PART-OF|527
1978244|Radioligand binding studies with the nonselective alpha 1-adrenoceptor antagonist radioligand 125I-BE2254 showed that 73-87% of the binding sites in rabbit aorta are CEC sensitive and they are predominantly low affinity sites both for WB4101 (pKd = 8.1) and for 5-methylurapidil (pKd = 7.1).|125I-BE2254|alpha 1-adrenoceptor|11|7|Arg1:T21|Arg2:T35|CHEMICAL|GENE|ANTAGONIST|528
10931813|Isoproterenol (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, d-sotalol (100 micromol/L) to block I(Kr) (LQT2 model), and ATX-II (20 nmol/L) to augment late I(Na) (LQT3 model).|d-sotalol|I(Kr)|18|25|Arg1:T10|Arg2:T22|CHEMICAL|GENE|INHIBITOR|529
20596674|Apoptosis studies (DAPI staining and caspase 3 activity) showed a marked increase in the presence of MXF and VP-16 compared to VP-16 alone.|VP-16|caspase 3|24|7|Arg1:T7|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|530
9551716|In conclusion, these findings indicate that [3H]SR 142948A is a new potent antagonist radioligand which recognizes with high affinity both neurotensin NT1 and NT2 receptors and represents thus an excellent tool to study neurotensin receptors in the rat brain.|[3H]SR 142948A|neurotensin NT1|8|25|Arg1:T10|Arg2:T29|CHEMICAL|GENE|ANTAGONIST|531
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|ferulic acid|carbonic anhydrase|22|46|Arg1:T3|Arg2:T26|CHEMICAL|GENE|INHIBITOR|532
20347047|The contractions to 5-HT were inhibited by ketanserin and alosetron indicating involvement of 5-HT(2A) and 5-HT(3) receptors, respectively.|alosetron|5-HT(3)|10|19|Arg1:T12|Arg2:T14|CHEMICAL|GENE|INHIBITOR|533
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Ile|AngII|20|40|Arg1:T3|Arg2:T18|CHEMICAL|GENE|PART-OF|534
17643344|In this study we investigated the effects of combination chemotherapy with melarsoprol and a humanised SP receptor antagonist aprepitant (EMEND) in this mouse model.|aprepitant|humanised SP receptor|19|15|Arg1:T6|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|535
15723099|The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan.|dimemorfan|sigma1 receptor|4|9|Arg1:T33|Arg2:T42|CHEMICAL|GENE|ACTIVATOR|536
17507169|The present findings confirm that PVN CB1 receptors, localized mainly in GABAergic synapses that control in an inhibitory fashion excitatory synapses, exert an inhibitory control on penile erection, demonstrating for the first time that chronic blockade of CB1 receptors by SR 141716A increases the density of these receptors in the PVN.|SR 141716A|CB1 receptors|44|41|Arg1:T5|Arg2:T19|CHEMICAL|GENE|INHIBITOR|537
23250811|Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).|curcumin|TLR4|9|40|Arg1:T14|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|538
15837926|PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.|N-acetyl-l-aspartyl-l-glutamate|PSMA|26|1|Arg1:T4|Arg2:T10|CHEMICAL|GENE|SUBSTRATE|539
23500776|EROD activity induction in peripheral blood lymphocytes, liver and brain tissues of rats orally exposed to polycyclic aromatic hydrocarbons.|polycyclic aromatic hydrocarbons|EROD|18|1|Arg1:T12|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|540
7986344|The folding rate monitored by 2'CMP binding to the major slow-folding species of Pro42Ala RNase A is faster than the folding rate monitored by tyrosine burial; however, the folding rate monitored by inhibitor binding to the minor slow-folding species is decreased significantly over the folding rate monitored by tyrosine burial, indicating that the major and minor slow-folding species of Pro42Ala fold to the native state with different transition-state conformations in the rate-determining step.|tyrosine|Pro42Ala|25|14|Arg1:T11|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|541
19039322|Here, we characterized the target profile of the dual SRC/ABL inhibitor bosutinib employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro kinase assays against a large recombinant kinase panel.|bosutinib|SRC|13|11|Arg1:T3|Arg2:T20|CHEMICAL|GENE|INHIBITOR|542
23099431|  GHRP-6 is a growth hormone secretagogue that also enhances tissue viability in different organs.|GHRP-6|growth hormone|1|4|Arg1:T1|Arg2:T10|CHEMICAL|GENE|INDIRECT-UPREGULATOR|543
15944809|Experimental as well as clinical reports support the hypothesis that calcium channel blockers such as verapamil may be an appropriate therapeutic approach in LQTS.|verapamil|calcium channel|16|11|Arg1:T8|Arg2:T12|CHEMICAL|GENE|INHIBITOR|544
23439561|We conclude that mPGES1 mediates acid-induced increase in PGE2 production and cell proliferation.|PGE2|mPGES1|9|4|Arg1:T4|Arg2:T30|CHEMICAL|GENE|PRODUCT-OF|545
20421509|Using a unique biosensor-based assay, trifluoperazine (TFP) was identified as an inhibitor that disrupts the S100A4/myosin-IIA interaction.|trifluoperazine|myosin-IIA|7|20|Arg1:T11|Arg2:T38|CHEMICAL|GENE|INHIBITOR|546
17229632|INTERPRETATION AND CONCLUSIONS: These results warrant further clinical studies of sorafenib for the treatment of myeloid malignancies expressing activated forms of PDGFRbeta and FLT3.|sorafenib|PDGFRbeta|12|23|Arg1:T7|Arg2:T24|CHEMICAL|GENE|INHIBITOR|547
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|SC-51089|EP1|40|14|Arg1:T16|Arg2:T34|CHEMICAL|GENE|AGONIST|548
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|Crocin|Bcl2|1|28|Arg1:T1|Arg2:T33|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|549
17015640|Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.|Licofelone|cyclooxygenase|1|7|Arg1:T17|Arg2:T33|CHEMICAL|GENE|INHIBITOR|550
23123662|Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.|copper|rCtr1|18|10|Arg1:T20|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|551
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|Ara-C|Ala70Thr|40|10|Arg1:T10|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|552
1435788|A major part of this processing requires endoproteolytic cleavage at specific pairs of basic amino acid residues, an event necessary for the maturation of a variety of important biologically active proteins, such as insulin and nerve growth factor.|amino acid|insulin|15|36|Arg1:T2|Arg2:T10|CHEMICAL|GENE|PART-OF|553
12383039|  OBJECTIVE: Fondaparinux sodium is the first in a new class of synthetic factor Xa inhibitors that binds reversibly with high affinity to antithrombin III.|Fondaparinux sodium|factor Xa|3|14|Arg1:T2|Arg2:T8|CHEMICAL|GENE|INHIBITOR|554
15985706|Using [(3)H]glucosamine-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.|wortmannin|PI3K|39|45|Arg1:T7|Arg2:T33|CHEMICAL|GENE|INHIBITOR|555
11775064|The elevation in brain alanine levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of PLZ on alanine transaminase (ALA-T), although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced.|alanine|ALA-T|5|29|Arg1:T23|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|556
23318471|These findings, derived from a variety of analytical and functional approaches, provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature: TES-stimulated vasodilation mediated primarily by peroxynitrite formed from xanthine oxidase-generated superoxide and NO.|NO|xanthine oxidase|41|37|Arg1:T13|Arg2:T40|CHEMICAL|GENE|PRODUCT-OF|557
23619613|"Interestingly, polySia chains of secreted NCAM neutralized the cytotoxic activity of extracellular histones as well as DNA/histone-network-containing ""neutrophil extracellular traps"", which are formed during invasion of microorganisms."|polySia|NCAM|3|7|Arg1:T2|Arg2:T15|CHEMICAL|GENE|DIRECT-REGULATOR|558
23481236|We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 μM).|TAGs|PTP1B|10|30|Arg1:T11|Arg2:T44|CHEMICAL|GENE|DIRECT-REGULATOR|559
23230131|All three CDA proteins showed similar K(m) and V(max) for Ara-C and dFdC deamination, except for CDA70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for Ara-C deamination.|Ara-C|CDA|43|24|Arg1:T17|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|560
23414838|Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists.|quinolone|α7 nicotinic acetylcholine receptor|7|8|Arg1:T6|Arg2:T10|CHEMICAL|GENE|AGONIST|561
23618921|Although fisetin greatly increases the stability of both Nrf2 and ATF4, only the effect on ATF4 is dependent on protein kinase activity.|fisetin|Nrf2|2|9|Arg1:T2|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|562
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|survivin|3|38|Arg1:T8|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|563
15898717|This 40 kDa PEG-conjugated IFNalpha(2a) ((40)PEG-IFNalpha(2a)) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a lysine side-chain of IFNalpha(2a).|lysine|IFNalpha(2a)|32|35|Arg1:T3|Arg2:T14|CHEMICAL|GENE|PART-OF|564
17015640|Licofelone reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, monocyte chemoattractant protein-1 (MCP-1) gene expression, and the activation of nuclear factor-kappaB in rabbit atheroma.|Licofelone|MCP-1|1|21|Arg1:T16|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|565
10640321|  In this study, the activity of the delta-opioid receptor subtype-selective agonist, SB 227122, was investigated in a guinea pig model of citric acid-induced cough.|SB 227122|delta-opioid receptor|14|9|Arg1:T18|Arg2:T26|CHEMICAL|GENE|AGONIST|566
15180525|STI571 binding to Flt3 is prevented by the phenylalanine 691 side-chain in the ATP binding center and mutating this site to threonine renders the corresponding Flt3 mutant sensitive to STI571.|STI571|Flt3|1|4|Arg1:T5|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|567
15795320|These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.|pemetrexed|dCK|44|46|Arg1:T9|Arg2:T30|CHEMICAL|GENE|INDIRECT-UPREGULATOR|568
17229632|We investigated the efficacy of sorafenib at inhibiting mutants of the receptor tyrosine kinases PDGFRbeta, KIT, and FLT3, which are implicated in the pathogenesis of myeloid malignancies.|sorafenib|receptor tyrosine kinases|6|12|Arg1:T12|Arg2:T33|CHEMICAL|GENE|INHIBITOR|569
16494569|CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired pyridoxal kinase for the conversion of pyridoxine and pyridoxal to PLP.|pyridoxal|pyridoxal kinase|27|19|Arg1:T11|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|570
22872607|  Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.|o-quinones|AKRs|24|4|Arg1:T6|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|571
17081103|GPxs reduce hydroperoxides to the corresponding alcohols by means of glutathione (GSH).|alcohols|GPxs|7|1|Arg1:T1|Arg2:T27|CHEMICAL|GENE|PRODUCT-OF|572
10701840|Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.|geldanamycin|extracellular signal regulated kinase (ERK)-2|3|19|Arg1:T5|Arg2:T25|CHEMICAL|GENE|INHIBITOR|573
1375507|Iloprost was the most potent: 50% inhibition occurred at 5 nM, a concentration close to the reported dissociation constant for iloprost binding to the platelet prostacyclin receptor.|prostacyclin|prostacyclin receptor|29|29|Arg1:T18|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|574
23623750|Cynomolgus FMO6 metabolized benzydamine only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.|benzydamine|FMO3|4|31|Arg1:T8|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|575
16774921|In striking contrast, deletion of the corresponding C-terminal domain of Escherichia coli LeuRS abolished aminoacylation of tRNALeu and also amino acid editing of mischarged tRNA molecules.|amino acid|Escherichia coli LeuRS|21|12|Arg1:T2|Arg2:T24|CHEMICAL|GENE|PART-OF|576
14600253|  The choroid plexus uptake of [(3)H]cefadroxil was studied in peptide transporter 2 (PEPT2) wild-type and null mice as a function of temperature, transport inhibitors, pH, and saturability.|[(3)H]cefadroxil|PEPT2|6|20|Arg1:T7|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|577
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|solute carrier 1|14|30|Arg1:T23|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|578
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|Gleevec|RTKs|18|28|Arg1:T3|Arg2:T28|CHEMICAL|GENE|INHIBITOR|579
12217700|  The bacterial enzyme maltodextrin phosphorylase (MalP) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as glucose-1-phosphate (Glc1P).|Glc1P|maltodextrin phosphorylase|30|4|Arg1:T14|Arg2:T27|CHEMICAL|GENE|PRODUCT-OF|580
10702256|The functional protein contains 1160 amino acids with a large central mucin domain, three consensus sites for glycosaminoglycan attachment, two epidermal growth factor-like repeats, a putative hyaluronan-binding motif, and a potential transmembrane domain near the C-terminal.|C|hyaluronan-binding motif|40|30|Arg1:T1|Arg2:T8|CHEMICAL|GENE|PART-OF|581
2899826|The present study reports the in vitro binding affinities of the same compounds for muscarinic cholinergic receptors and for histamine H1 receptors in rat brain, using 3H-quinuclidinyl benzilate and 3H-mepyramine as radioligands.|3H-quinuclidinyl benzilate|muscarinic cholinergic receptors|28|15|Arg1:T7|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|582
23042954|To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.|(3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid|GluK1|37|26|Arg1:T10|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|583
15198222|CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.|tolfenamic acid|COX-2|19|28|Arg1:T5|Arg2:T23|CHEMICAL|GENE|INHIBITOR|584
22872607|  Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.|polycyclic aromatic hydrocarbons|AKRs|14|4|Arg1:T11|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|585
23519153|Of note, reciprocal expression of Asmt and Bhmt is an important clue that altered S-adenosylhomocysteine metabolism underlies brain injury in WD, which is directly correlated to the decreased expression of S-adenosylhomocysteine hydrolase in hepatic tissue in LEC rats.|S-adenosylhomocysteine|S-adenosylhomocysteine hydrolase|16|33|Arg1:T2|Arg2:T14|CHEMICAL|GENE|SUBSTRATE|586
23609606|No effects were observed when fenclozic acid was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells.|fenclozic acid|BSEP|6|36|Arg1:T3|Arg2:T16|CHEMICAL|GENE|INHIBITOR|587
12244038|  Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.|NO|iNOS|11|20|Arg1:T14|Arg2:T29|CHEMICAL|GENE|PRODUCT-OF|588
17380207|  Because of their low asparagine synthetase (ASNS) expression and asparagine biosynthesis, acute lymphoblastic leukemia (ALL) cells are exquisitely sensitive to asparagine depletion.|asparagine|ASNS|12|8|Arg1:T5|Arg2:T11|CHEMICAL|GENE|PRODUCT-OF|589
23583806|Allicin treatment showed reduced production of pro-inflammatory cytokines and NO and increased HO-1 activity.|Allicin|cytokines|1|8|Arg1:T6|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|590
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imiquimod|TLR8|5|15|Arg1:T4|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|591
23479738|In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity.|Cys|Prx1|17|25|Arg1:T30|Arg2:T32|CHEMICAL|GENE|PART-OF|592
16618126|The purified Atp8a1 is inactive in detergent micelles or in micelles containing phosphatidylcholine, phosphatidic acid, or phosphatidylinositol, is minimally activated by phosphatidylglycerol or phosphatidylethanolamine (PE), and is maximally activated by PS.|PS|Atp8a1|37|3|Arg1:T7|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|593
17658513|Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).|BMY-7378|alpha(1D)-adrenoceptor|23|46|Arg1:T3|Arg2:T13|CHEMICAL|GENE|ANTAGONIST|594
23574017|The slower CL was due to the reduction of hepatic biliary excretion (67.0% decrease) and hepatic CYP3A subfamily-mediated metabolism (21.9% decrease) of doxorubicin.|doxorubicin|CYP3A|29|20|Arg1:T2|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|595
10546982|The decrease and recovery of [3H]-5-HT uptake correlated highly (r = 0.93) with the recovery of SERT binding.|[3H]-5-HT|SERT|6|22|Arg1:T1|Arg2:T11|CHEMICAL|GENE|SUBSTRATE|596
11551210|Cembranoids are naturally occurring, uncharged noncompetitive inhibitors of peripheral and neuronal AChRs, which have no demonstrable general anesthetic activity in vivo.|Cembranoids|AChRs|1|13|Arg1:T9|Arg2:T27|CHEMICAL|GENE|INHIBITOR|597
23643745|The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.|SCH23390|D1|26|24|Arg1:T4|Arg2:T43|CHEMICAL|GENE|ANTAGONIST|598
20091113|Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.|D-amphetamine|SLC6A3|14|6|Arg1:T6|Arg2:T10|CHEMICAL|GENE|ACTIVATOR|599
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|sodium-coupled neutral amino acid transporter 1|7|52|Arg1:T18|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|600
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|NS-187|c-KIT|53|57|Arg1:T15|Arg2:T46|CHEMICAL|GENE|INHIBITOR|601
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|AH 6809|EP1|46|49|Arg1:T17|Arg2:T36|CHEMICAL|GENE|ANTAGONIST|602
17504182|Mifepriston'e blocks glucocorticoid receptor activation without modifying cortisol synthesis.|Mifepriston'e|glucocorticoid receptor|1|5|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INHIBITOR|603
17040106|Polyclonal antisera to either b5R or cyt b5 significantly inhibited N-hydroxy-4-aminobiphenyl (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).|NHOH-4-ABP|b5R|13|5|Arg1:T5|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|604
23410005|Our previous work, built on the early pioneering multikinase inhibitor LY294002, resulted in the only PI3K vascular-targeted PI3K inhibitor prodrug, SF1126, which has now completed Phase I clinical trials.|SF1126|PI3K|24|18|Arg1:T2|Arg2:T7|CHEMICAL|GENE|INHIBITOR|605
17015640|Rofecoxib only diminished COX-2 protein expression and MCP-1 gene expression in vascular atheroma.|Rofecoxib|MCP-1|1|8|Arg1:T3|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|606
19472276|The progress of the enzymatic reaction of the hydrolysis of acetylthiocholine at pH 8 in the presence of AChE and the inhibitor studied is determined by measuring at 230 nm the peak area of the reaction product thiocholine (TCh).|acetylthiocholine|AChE|11|19|Arg1:T4|Arg2:T11|CHEMICAL|GENE|SUBSTRATE|607
12487427|GW660511X and omapatrilat increased the production of both BrBK1-8 and Br-Phe5 but not that of BrBK4-8 and BrBK2-8.|GW660511X|BrBK1-8|1|9|Arg1:T22|Arg2:T65|CHEMICAL|GENE|INDIRECT-UPREGULATOR|608
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|SU 11248|VEGF receptor|35|42|Arg1:T10|Arg2:T44|CHEMICAL|GENE|INHIBITOR|609
12244038|Interestingly, gemfibrozil strongly inhibited the activation of NF-kappaB, AP-1, and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells.|gemfibrozil|AP-1|3|11|Arg1:T4|Arg2:T46|CHEMICAL|GENE|INHIBITOR|610
17256745|  UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine.|taurine|Bile acid-coenzyme A:amino acid N-acyltransferase|27|3|Arg1:T3|Arg2:T21|CHEMICAL|GENE|PRODUCT-OF|611
15939622|As expected, comparison of IC50 indicated that meloxicam and carprofen are more selective inhibitors of COX-2 than phenylbutazone and flunixin; meloxicam was the most advantageous for horses of four NSAIDs examined.|meloxicam|COX-2|9|17|Arg1:T1|Arg2:T19|CHEMICAL|GENE|INHIBITOR|612
9876137|  Cocaine block of human cardiac (hH1) and rat skeletal (mu1) muscle sodium channels was examined under whole-cell voltage clamp in transiently transfected HEK293t cells.|Cocaine|rat skeletal (mu1) muscle sodium channels|1|10|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INHIBITOR|613
20724158|CONCLUSION: Consistent with animal models and laboratory investigations, higher doses of selective COX-2 inhibitors were more protective against breast cancer than non-specific NSAIDs. With exposure to rofecoxib, a selective COX-2 inhibitor, breast cancer risk reduction was appreciable (46%), suggesting a possible role for selective COX-2 inhibitors in breast cancer prophylaxis.|rofecoxib|COX-2|30|34|Arg1:T3|Arg2:T10|CHEMICAL|GENE|INHIBITOR|614
1375507|The inhibitory effects of iloprost on tissue factor expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and dibutyryl cyclic AMP but not dibutyryl cyclic GMP.|isobutylmethylxanthine|tissue factor|14|7|Arg1:T6|Arg2:T25|CHEMICAL|GENE|INHIBITOR|615
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|5,8,11,14-eicosatetraynoic acid|PPARalpha2|15|30|Arg1:T12|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|616
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|muscarine|muscarinic acetylcholine receptor|21|12|Arg1:T8|Arg2:T16|CHEMICAL|GENE|AGONIST|617
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|trimethylamine|FMO1|21|14|Arg1:T3|Arg2:T13|CHEMICAL|GENE|SUBSTRATE|618
15866288|Effects of inhibition of urokinase-type plasminogen activator (u-PA) by amiloride in the cornea and tear fluid of eyes irradiated with UVB.|amiloride|urokinase-type plasminogen activator|12|5|Arg1:T7|Arg2:T17|CHEMICAL|GENE|INHIBITOR|619
23128353|In addition, glucosamine attenuated p21 protein stability via the proteasomal proteolytic pathway, as well as inducing p21 nuclear accumulation.|glucosamine|p21|4|19|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INDIRECT-UPREGULATOR|620
17488480|To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and NK1-R in acinar cells.|NaHS|NK1-R|32|58|Arg1:T11|Arg2:T41|CHEMICAL|GENE|INDIRECT-UPREGULATOR|621
10640321|The delta-receptor antagonist, SB 244525 (10 mg/kg, i.p.), inhibited the antitussive effect of SB 227122 (20 mg/kg, i.p.).|SB 244525|delta-receptor|5|2|Arg1:T15|Arg2:T29|CHEMICAL|GENE|ANTAGONIST|622
12244038|Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes.|nitric-oxide|nitric-oxide synthase|11|11|Arg1:T18|Arg2:T68|CHEMICAL|GENE|PRODUCT-OF|623
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|guanidine|transmembrane transporters|14|24|Arg1:T6|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|624
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|alpha-difluoroalkylthiolate|beta-lyases|25|10|Arg1:T26|Arg2:T54|CHEMICAL|GENE|PRODUCT-OF|625
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|clerosterol|COX-2|13|39|Arg1:T6|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|626
23146664|PAK1 expression was elevated in APC(min) polyps and 5-ASA treatment reduced its expression.|5-ASA|PAK1|12|1|Arg1:T3|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|627
17111172|CONCLUSIONS: We were able to demonstrate a moderate 5-HT(2A) and D(1) occupancy under clinically relevant doses of flupentixol, albeit lower than expected from in vitro data and clearly below saturation.|flupentixol|D(1)|25|15|Arg1:T3|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|628
15737409|NPC1L1 could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant sterols.|cholesterol|sterol transporter|16|9|Arg1:T17|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|629
16846546|METHODS: Cyclooxygenase activity and selectivity was determined in vitro by measuring prostaglandin E(2) (PGE(2)) production following incubation of varying concentrations of NSAID with human recombinant COX-1 or COX-2 and arachidonic acid.|PGE(2)|Cyclooxygenase|19|3|Arg1:T20|Arg2:T37|CHEMICAL|GENE|PRODUCT-OF|630
23274058|Jaceosidin, isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation.|Jaceosidin|ATM|1|21|Arg1:T17|Arg2:T34|CHEMICAL|GENE|ACTIVATOR|631
12727196|Purified PAOh1/SMO oxidizes both spermine (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine.|N(1)-acetylspermine|SMO|15|3|Arg1:T4|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|632
8294418|In NE-desensitized cells, phorbol esters and bradykinin each caused the expected down-regulation of alpha-AR mRNA.|phorbol esters|alpha-AR|5|15|Arg1:T17|Arg2:T33|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|633
16324695|  Preincubation (30 min) of bovine tracheal smooth muscle with various concentrations (0.1, 1 and 10 microM) of fenoterol decreased isoprenaline-induced maximal relaxation (E(max)) of methacholine-contracted preparations in a concentration dependent fashion, indicating desensitization of the beta(2)-adrenoceptor.|isoprenaline|beta(2)-adrenoceptor|25|47|Arg1:T7|Arg2:T20|CHEMICAL|GENE|AGONIST|634
23597506|However, enzymes contributing to oxidative metabolism of anandamide, namely cyclooxygenase-1 and Cyp2D6, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of anandamide.|anandamide|Cyp2D6|31|14|Arg1:T3|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|635
19039322|Finally, bosutinib is the first kinase inhibitor shown to target CAMK2G, recently implicated in myeloid leukemia cell proliferation.|bosutinib|kinase|3|7|Arg1:T2|Arg2:T18|CHEMICAL|GENE|INHIBITOR|636
10702256|Removal of N- and O-linked oligosaccharides reduces the M(r) to approximately 160,000, suggesting that approximately 60% of the mass of SPACRCAN is carbohydrate.|N|SPACRCAN|3|26|Arg1:T2|Arg2:T11|CHEMICAL|GENE|PART-OF|637
9310349|Alendronate inhibited PTPmeg1 with an IC50 value of 23 microM, PTPsigma with an IC50 value of 2 microM, and did not inhibit PTP epsilon at concentrations up to 1 mM.|Alendronate|PTPsigma|1|12|Arg1:T22|Arg2:T26|CHEMICAL|GENE|INHIBITOR|638
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|quinoxaline|Flt3|10|43|Arg1:T10|Arg2:T34|CHEMICAL|GENE|INHIBITOR|639
20185318|Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.|polyphenols|mammalian isoforms I-XIV|13|4|Arg1:T21|Arg2:T35|CHEMICAL|GENE|INHIBITOR|640
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|VB1|Cdc25c|5|48|Arg1:T3|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|641
23479738|In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity.|Cys|Prx1|15|25|Arg1:T29|Arg2:T32|CHEMICAL|GENE|PART-OF|642
1375507|Iloprost was the most potent: 50% inhibition occurred at 5 nM, a concentration close to the reported dissociation constant for iloprost binding to the platelet prostacyclin receptor.|iloprost|prostacyclin receptor|24|29|Arg1:T17|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|643
17000933|The beneficial role of 17beta-estradiol on blood pressure, cardiac hypertrophy, vascular osteopontin expression, perivascular fibrosis, and impaired NO-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of medroxyprogesterone acetate.|medroxyprogesterone acetate|osteopontin|34|14|Arg1:T4|Arg2:T30|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|644
22931533|The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.|eseroline|nAChR|7|14|Arg1:T6|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|645
23539296|Here, we have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes.|anisomycin|CYP2B6|13|17|Arg1:T2|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|646
2899826|  In vitro binding affinities of chlorpromazine, fluphenazine, levomepromazine, perphenazine and some of their metabolites for dopamine D2 receptors, alpha 1- and alpha 2 adrenoceptors in rat brain were previously reported from our laboratories.|perphenazine|dopamine D2 receptors|12|19|Arg1:T19|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|647
17229632|Sorafenib (BAY43-9006, Nexavar) is a small molecule B-RAF inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against receptor tyrosine kinases from the platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR) families.|Nexavar|B-RAF|5|11|Arg1:T9|Arg2:T26|CHEMICAL|GENE|INHIBITOR|648
23618901|Suppression of TβR1 by the pharmacological inhibitor (SB431542) markedly reduced VEGF release by HFL-1 in response to CSE and this effect was confirmed by TβR1 siRNA.|SB431542|VEGF|9|13|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|649
12373557|Stereospecific inhibition of monoamine uptake transporters by meta-hydroxyephedrine isomers.|meta-hydroxyephedrine|monoamine uptake transporters|8|4|Arg1:T15|Arg2:T21|CHEMICAL|GENE|INHIBITOR|650
7825862|Aspirin irreversibly inhibits PGHS-1, preventing this isozyme from forming PGH2 or any other oxygenated product; in contrast, aspirin treatment of PGHS-2 causes this enzyme to form 15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid (15-HETE) instead of PGH2.|15-HETE|PGHS-2|33|24|Arg1:T10|Arg2:T17|CHEMICAL|GENE|PRODUCT-OF|651
11551210|Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction.|Cembranoid|nicotinic acetylcholine receptor|1|8|Arg1:T21|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|652
1705137|The effects of two reversible, predominantly monoamine oxidase-A (MAO-A) inhibitors, moclobemide (150 mg three times daily) and toloxatone (400-200-400 mg day-1) on monoamine metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects.|moclobemide|monoamine oxidase-A|15|8|Arg1:T41|Arg2:T48|CHEMICAL|GENE|INHIBITOR|653
23574017|Doxorubicin is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.|Doxorubicin|Mrp2|1|19|Arg1:T7|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|654
17350061|Several genes involved with steroid metabolism also showed remarkable expression changes, including increased expression of 17beta-hydroxysteroid dehydrogenase-7 (HSD17beta7; involved in estradiol production) and decreased expression of HSD17beta5 (involved in testosterone production).|estradiol|17beta-hydroxysteroid dehydrogenase-7|24|17|Arg1:T4|Arg2:T30|CHEMICAL|GENE|PRODUCT-OF|655
23583257|Nox4 oxidase activity is thought to be constitutive and regulated at the transcriptional level; however, we challenge this point of view and suggest that specific quinone derivatives could modulate this activity.|quinone|Nox4|28|1|Arg1:T4|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|656
23643933|TSA selectively induced uc002mbe.2 in four studied HCC cell lines.|TSA|uc002mbe.2|1|4|Arg1:T2|Arg2:T11|CHEMICAL|GENE|INDIRECT-UPREGULATOR|657
11742712|  Pemetrexed disodium (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.|Pemetrexed disodium|thymidylate synthase|1|18|Arg1:T1|Arg2:T14|CHEMICAL|GENE|INHIBITOR|658
23041257|DBDCT also caused the phosphorylation of JNK and p38(MAPK).|DBDCT|p38|1|9|Arg1:T1|Arg2:T18|CHEMICAL|GENE|ACTIVATOR|659
9015795|The atypical neuroleptics remoxipride, clozapine, perlapine, seroquel, and melperone had low affinity for the dopamine D2 receptor (radioligand-independent dissociation constants of 30 to 90 nM).|melperone|D2 receptor|13|20|Arg1:T14|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|660
12181285|However, desipramine at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of MPP+, indicating the NAT and not an OCT as their primary site of action.|MPP+|NAT|23|27|Arg1:T10|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|661
23322769|Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes.|manumycin A|hApoA-I|13|27|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|662
11034389|Peptide sequences selected using MICA4 were rich in basic or hydroxyl-containing amino acids, and the surface of the GAD65 PLP-binding domain surrounding Lys358, which is known to be critical for MICA4 binding, was likewise rich in these amino acids.|amino acids|GAD65 PLP-binding domain|41|20|Arg1:T4|Arg2:T15|CHEMICAL|GENE|PART-OF|663
22370641|These results showed that WNT6 and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to anthracycline drugs.|anthracycline|WNT6|20|5|Arg1:T4|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|664
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Imatinib|Abl|9|23|Arg1:T35|Arg2:T55|CHEMICAL|GENE|INHIBITOR|665
17594192|As a consequence, phenserine reduces beta-amyloid peptide (Abeta) formation in vitro and in vivo.|phenserine|beta-amyloid|5|7|Arg1:T13|Arg2:T28|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|666
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|STI571|ABL|3|27|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INHIBITOR|667
22370641|Epi increased both WNT6/Wnt6 and Cav1 expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg).|Epi|Cav1|1|6|Arg1:T11|Arg2:T32|CHEMICAL|GENE|INDIRECT-UPREGULATOR|668
1590750|The results suggest that individuals with high Vmax beta 2-ADH and deficient in low-Km mitochondrial ALDH2, accounting for approximately 45% of the Chinese population, may end up with acetaldehyde accumulation during alcohol consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.|acetaldehyde|beta 2-ADH|32|9|Arg1:T3|Arg2:T20|CHEMICAL|GENE|PRODUCT-OF|669
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|mZBrENT|SERT|32|53|Arg1:T2|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|670
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|cinnamic aldehyde|aldo-keto reductase (AKR) 1C1|34|44|Arg1:T3|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|671
16774921|In striking contrast, deletion of the corresponding C-terminal domain of Escherichia coli LeuRS abolished aminoacylation of tRNALeu and also amino acid editing of mischarged tRNA molecules.|C|Escherichia coli LeuRS|9|12|Arg1:T14|Arg2:T24|CHEMICAL|GENE|PART-OF|672
1356794|  In the hot-plate test in mice, the antinociceptive action of the alpha 2-adrenoceptor agonist, UK 14,304, was abolished by the alpha 2-adrenoceptor antagonist, idazoxan, the potent alpha 2A-adrenoceptor antagonist, RX 821002 and the preferential alpha 2A-adrenoceptor antagonist, BRL 44408.|idazoxan|alpha 2-adrenoceptor|28|24|Arg1:T1|Arg2:T12|CHEMICAL|GENE|ANTAGONIST|673
12196163|Among the [Fe-S] cluster biosynthetic proteins are included a pyridoxal phosphate-dependent enzyme (NifS) that is involved in the activation of sulphur from l-cysteine, and a molecular scaffold protein (NifU) upon which [Fe-S] cluster precursors are formed.|l-cysteine|NifS|27|16|Arg1:T11|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|674
23261676|Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.|Isoproterenol|cytochrome-C-oxidase|1|54|Arg1:T15|Arg2:T34|CHEMICAL|GENE|INHIBITOR|675
23529825|  Oral lorcaserin (BELVIQ(®)), a selective serotonin 5-HT2C receptor agonist, is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults, or overweight adults with at least one weight-related comorbidity (e.g. dyslipidaemia, hypertension, type 2 diabetes).|lorcaserin|5-HT2C|2|13|Arg1:T10|Arg2:T14|CHEMICAL|GENE|AGONIST|676
15908512|In contrast, the selective beta2AR antagonists ICI-118,551 and butoxamine inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively).|butoxamine|beta2AR|10|6|Arg1:T10|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|677
10546982|In preliminary studies, in vitro incubation of rat cerebral cortex with RTI-76 produced a wash and temperature resistant inhibition of SERT binding densities (Bmax).|RTI-76|SERT|13|22|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|678
15049511|The results demonstrated that tranylcypromine is a competitive inhibitor of CYP2C19 (Ki = 32 microM) and CYP2D6 (Ki = 367 microM) and a noncompetitive inhibitor of CYP2C9 (Ki = 56 microM).|tranylcypromine|CYP2D6|5|19|Arg1:T4|Arg2:T18|CHEMICAL|GENE|INHIBITOR|679
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|[(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester|DAT|30|63|Arg1:T24|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|680
23172777|3D-QSAR-assisted drug design: identification of a potent quinazoline-based Aurora kinase inhibitor.|quinazoline|Aurora kinase|9|10|Arg1:T5|Arg2:T11|CHEMICAL|GENE|INHIBITOR|681
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Imatinib|Bcr|9|22|Arg1:T35|Arg2:T54|CHEMICAL|GENE|INHIBITOR|682
10406837|Our findings suggest that torasemide blocks the vasoconstrictor action of Ang II in vitro.|torasemide|Ang II|5|11|Arg1:T6|Arg2:T17|CHEMICAL|GENE|INHIBITOR|683
23583257|Nox4 oxidase activity is thought to be constitutive and regulated at the transcriptional level; however, we challenge this point of view and suggest that specific quinone derivatives could modulate this activity.|quinone|oxidase|28|2|Arg1:T4|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|684
11034583|METHODS: Part A compared the effects of placebo to four doses of a 5-HT(4) receptor antagonist (SB-207266) on the cisapride mediated increase in plasma aldosterone (a 5-HT(4) mediated response) and orocaecal transit in 18 subjects.|SB-207266|5-HT(4)|22|34|Arg1:T7|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|685
15939622|However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.|carprofen|COX-2|31|38|Arg1:T10|Arg2:T21|CHEMICAL|GENE|INHIBITOR|686
12636181|  Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.|acetylcholine|Acetylcholinesterase|25|1|Arg1:T2|Arg2:T7|CHEMICAL|GENE|SUBSTRATE|687
12063741|As a prodrug leflunomide is completely converted to its active metabolite A 77 1726 (M1) which blocks the dihydroorotate dehydrogenase, a key enzyme of the pyrimidine de novo synthesis.|leflunomide|dihydroorotate dehydrogenase|4|21|Arg1:T1|Arg2:T11|CHEMICAL|GENE|INHIBITOR|688
23296102|Moreover, Acrolein resulted in activation of astrocytes, up-regulation of BACE-1 in cortex and down-regulation of ADAM-10 in hippocampus and cortex.|Acrolein|BACE-1|3|12|Arg1:T10|Arg2:T12|CHEMICAL|GENE|INDIRECT-UPREGULATOR|689
16938288|CONCLUSION: Our data provides a novel insight into an effect of telmisartan: telmisartan inhibits AT1R gene expression through PPARgamma activation.|telmisartan|AT1R|15|17|Arg1:T7|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|690
16917142|Tamoxifen blocks the action of estrogen by binding to the ER, and possesses both ER-agonist and antagonist properties.|Tamoxifen|ER|1|16|Arg1:T11|Arg2:T31|CHEMICAL|GENE|AGONIST|691
12086935|Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.|Metformin|AMP-activated protein kinase|1|3|Arg1:T18|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|692
7599160|Cells propagated in medium containing N5-methyltetrahydrofolate and homocysteine showed a substantial increase in MS activity which paralleled the increase in the intracellular concentration of Me-Cbl and the Cbl bound to the enzyme.|homocysteine|MS|8|14|Arg1:T4|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|693
20531964|A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR tyrosine kinase inhibitors sunitinib and/or sorafenib.|sorafenib|VEGFR|36|30|Arg1:T10|Arg2:T16|CHEMICAL|GENE|INHIBITOR|694
23231502|Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.|Pro|peptidyl-prolyl cis/trans-isomerase A1|25|6|Arg1:T15|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|695
9310349|Among the other bisphosphonates studied, alendronate was more potent and selective for PTPmeg1.|bisphosphonates|PTPmeg1|4|14|Arg1:T15|Arg2:T36|CHEMICAL|GENE|INHIBITOR|696
12392782|They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.|NS-398|COX-2|11|9|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INHIBITOR|697
18081314|The distances between the protons H20 and H2, H18 and H2, and H18 and H4 are shorter following their binding to the PGIS in solution-down to within 5 A.|H18|PGIS|15|25|Arg1:T23|Arg2:T41|CHEMICAL|GENE|PART-OF|698
17256745|  UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine.|bile acids|Bile acid-coenzyme A:amino acid N-acyltransferase|24|3|Arg1:T2|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|699
15049511|The results demonstrated that tranylcypromine is a competitive inhibitor of CYP2C19 (Ki = 32 microM) and CYP2D6 (Ki = 367 microM) and a noncompetitive inhibitor of CYP2C9 (Ki = 56 microM).|tranylcypromine|CYP2C9|5|31|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INHIBITOR|700
23506741|The mechanism of action of Fc11a-2 was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1β and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.|Fc11a-2|pro-IL-18|6|20|Arg1:T2|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|701
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|alanine|SNAT1|14|37|Arg1:T16|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|702
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|vitamin E|Bcl2|8|28|Arg1:T2|Arg2:T33|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|703
11695255|The time course of PGE2 production was consistent with early release due to COX-1 activity followed by increased production 2-3 hours after surgery, consistent with COX-2 expression.|PGE2|COX-1|5|14|Arg1:T15|Arg2:T26|CHEMICAL|GENE|PRODUCT-OF|704
23414838|  High throughput screening led to the identification of a novel series of quinolone α7 nicotinic acetylcholine receptor (nAChR) agonists.|quinolone|α7 nicotinic acetylcholine receptor|13|14|Arg1:T4|Arg2:T9|CHEMICAL|GENE|AGONIST|705
23353741|All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) inhibitory activity of murine macrophage RAW 264.7 cell line.|prostaglandin E2|COX-2|27|24|Arg1:T4|Arg2:T8|CHEMICAL|GENE|PRODUCT-OF|706
8098142|Histamine enhances the depolarizing afterpotential of immunohistochemically identified vasopressin neurons in the rat supraoptic nucleus via H1-receptor activation.|Histamine|H1-receptor|1|17|Arg1:T20|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|707
23479193|Synthesis and in-silico studies of some diaryltriazole derivatives as potential cyclooxygenase inhibitors.|diaryltriazole|cyclooxygenase|7|11|Arg1:T5|Arg2:T10|CHEMICAL|GENE|INHIBITOR|708
8894610|(+/-)-Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1B-adrenoceptors by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine.|chlorethylclonidine|alpha 1B-adrenoceptors|22|17|Arg1:T2|Arg2:T28|CHEMICAL|GENE|INHIBITOR|709
23644213|These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor rivaroxaban with a mimic of the Arg-Gly-Asp (RGD) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity.|Arg-Gly-Asp|fibrinogen|22|28|Arg1:T2|Arg2:T10|CHEMICAL|GENE|PART-OF|710
14751502|To gauge the potential clinical utility of targeting both EGFR and HER2 to control growth and radiosensitize human breast cancers, we examined the effect of a dual EGFR/HER2 inhibitor, GW572016, on the proliferation and radiation response of either EGFR- or HER2-overexpressing human breast cancer cell lines.|GW572016|HER2|32|30|Arg1:T7|Arg2:T29|CHEMICAL|GENE|INHIBITOR|711
16988497|CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.|SFAs|D5D|6|17|Arg1:T1|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|712
23455597|Assessment of the abuse liability of ABT-288, a novel histamine H3 receptor antagonist.|ABT-288|histamine H3 receptor|7|11|Arg1:T15|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|713
2899826|7-Hydroxy levomepromazine, 3-hydroxy levomepromazine and 7-hydroxy fluphenazine had only 10% of the potency of the parent drug in histamine H1 receptor binding, while the 7-hydroxy-metabolites of chlorpromazine and perphenazine had about 75% of the potency of the parent drug in this binding system.|7-hydroxy|histamine H1 receptor|28|21|Arg1:T23|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|714
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|mZIENT|SERT|14|53|Arg1:T8|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|715
23584358|There were statistically significant increases in the activities of aspartate aminotransferase, alanine aminotransferase, levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and 8-iso-prostane, and decreases in the activity of superoxide dismutase and level of glutathione in the group treated with paracetamol.|paracetamol|tumor necrosis factor-alpha|49|18|Arg1:T8|Arg2:T33|CHEMICAL|GENE|INDIRECT-UPREGULATOR|716
23164921|Data at transcriptional level also demonstrated that catalpol potently attenuated gene expressions involved in inflammation, such as iNOS, COX-2 and TLR4.|catalpol|TLR4|8|23|Arg1:T9|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|717
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|cytarabine|Ala119Gly|38|17|Arg1:T9|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|718
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|2'CMP|bovine pancreatic ribonuclease A|33|7|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INHIBITOR|719
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate|Panx1|23|6|Arg1:T1|Arg2:T39|CHEMICAL|GENE|INHIBITOR|720
11961111|We report herein the location of the binding site for the inhaled anesthetic halothane at the amino acid residue level of resolution in the ligand binding cavity in a prototypical G protein-coupled receptor, bovine rhodopsin.|halothane|bovine rhodopsin|14|35|Arg1:T2|Arg2:T13|CHEMICAL|GENE|DIRECT-REGULATOR|721
1978244|Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that alpha 1-adrenoceptor populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for WB4101 and pKd approximately 7.1 for 5-methyl-urapidil) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both WB4101 and 5-methyl-urapidil), which was in good agreement with radioligand binding studies.(ABSTRACT TRUNCATED AT 400 WORDS)|WB4101|alpha 1-adrenoceptor|41|14|Arg1:T14|Arg2:T32|CHEMICAL|GENE|ANTAGONIST|722
15184278|  BACKGROUND: To assess the sensitivity of biochemical, physiological, and pharmacological markers of peripheral norepinephrine (NE) transporter (NET) function, we chronically antagonized NET by a range of doses of duloxetine [(+)-N-methyl-3-(1-naphthalenyloxy)-2 thiophenepropanamine], which blocks the NE reuptake process.|NE|NET|53|30|Arg1:T19|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|723
10701840|Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.|geldanamycin|Lck|3|10|Arg1:T5|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|724
23146664|Moreover, 5-ASA treatment restored membranous expression of adhesion molecules E-cadherin and β-catenin.|5-ASA|E-cadherin|3|11|Arg1:T14|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|725
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|DFMO|ODC|12|22|Arg1:T25|Arg2:T40|CHEMICAL|GENE|INHIBITOR|726
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|ellagic acid|carbonic anhydrase|34|46|Arg1:T8|Arg2:T26|CHEMICAL|GENE|INHIBITOR|727
9399012|Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.|zolmitriptan|5HT1B/1D|4|17|Arg1:T19|Arg2:T27|CHEMICAL|GENE|AGONIST|728
23564313|Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.|vinblastine|inositol requiring enzyme 1α|3|54|Arg1:T7|Arg2:T32|CHEMICAL|GENE|ACTIVATOR|729
17224860|ABCA1-facilitated cholesterol efflux and lipid parameters did not differ between equol-producing and non-equol-producing women.|cholesterol|ABCA1|2|1|Arg1:T8|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|730
23123662|Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.|copper|rat Ctr1|11|3|Arg1:T28|Arg2:T43|CHEMICAL|GENE|SUBSTRATE|731
23542578|An intermediate GTX2,3-aldehyde was first synthesized by activating the NH2 group of the 2nd and 8th amino acid residues with three different aldehydes and two artificial complete antigens GTX2,3-aldehyde-bovine serum albumin (BSA) and GTX2,3-aldehyde- keyhole limpet hemocyanin (KLH) were then prepared by cross-linking the intermediate with BSA or KLH.|GTX2,3-aldehyde|bovine serum albumin|29|30|Arg1:T6|Arg2:T10|CHEMICAL|GENE|DIRECT-REGULATOR|732
20421509|Using a unique biosensor-based assay, trifluoperazine (TFP) was identified as an inhibitor that disrupts the S100A4/myosin-IIA interaction.|TFP|S100A4|9|19|Arg1:T12|Arg2:T37|CHEMICAL|GENE|INHIBITOR|733
1978244|Radioligand binding studies with the nonselective alpha 1-adrenoceptor antagonist radioligand 125I-BE2254 showed that 73-87% of the binding sites in rabbit aorta are CEC sensitive and they are predominantly low affinity sites both for WB4101 (pKd = 8.1) and for 5-methylurapidil (pKd = 7.1).|WB4101|alpha 1-adrenoceptor|35|7|Arg1:T25|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|734
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Imatinib|BCR|1|26|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INHIBITOR|735
16343532|A previous crystal structure of a microcystin bound to the catalytic subunit of protein phosphatase-1 (PP-1c) showed distinct changes in the active site region when compared with protein phosphatase-1 structures bound to other toxins.|microcystin|PP-1c|7|17|Arg1:T7|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|736
6227474|Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of steroid binding similar to that of the kidney mineralocorticoid receptor (aldosterone greater than desoxycorticosterone greater than corticosterone).|steroid|mineralocorticoid receptor|16|24|Arg1:T5|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|737
14751502|Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.|GW572016|HER2|7|5|Arg1:T11|Arg2:T41|CHEMICAL|GENE|INHIBITOR|738
23296837|The neuroinflammatory response to MPTP was markedly attenuated, and indices of oxidative stress and JNK activation were significantly prevented with EHT.|EHT|JNK|22|16|Arg1:T18|Arg2:T27|CHEMICAL|GENE|INHIBITOR|739
23429911|Moreover, the effects of the DRD3 agonist 7-hydroxy-N,N-dipropyl-2-aminotetralin (7-OH-DPAT)-induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant.|7-OH-DPAT|DRD3|13|7|Arg1:T2|Arg2:T8|CHEMICAL|GENE|AGONIST|740
3134891|It was also dependent upon temperature, the presence of a divalent cation such as calcium, and on pH, showing maximum binding at pH 6.5 with little binding at pH values below 4.2 or above 8.0. The site at which phenoxybenzamine bound to calmodulin appears to be similar to that at which certain antipsychotic agents bind, since several of them, including penfluridol, pimozide and spiroperidol, prevented the binding of phenoxybenzamine to calmodulin.|phenoxybenzamine|calmodulin|77|79|Arg1:T17|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|741
15811959|In vitro studies demonstrated that the retinoid X receptor (RXR) retinoid, bexarotene, at biologically relevant concentrations of 10(-6) M to 10(-8) M, upregulated both the p55 and p75 subunits of the IL-2R and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox.|bexarotene|p55|15|37|Arg1:T4|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|742
17040106|On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of arylhydroxylamine carcinogens was catalyzed by NADH cytochrome b5 reductase (b5R) and cytochrome b5 (cyt b5).|arylhydroxylamine|cytochrome b5|23|36|Arg1:T17|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|743
15353299|While fluoropyrimidine antimetabolites have other sites of action, antifolates ZD1694 (raltitrexed, Tomudex) and AG337 (Thymitag) are more specific and potent TS inhibitors.|raltitrexed|TS|13|27|Arg1:T3|Arg2:T23|CHEMICAL|GENE|INHIBITOR|744
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|[(3)H]dopamine|DAT|68|63|Arg1:T27|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|745
1978244|  Using the alpha 1-adrenoceptor subtype-selective antagonists chlorethylclonidine (CEC), WB4101, and 5-methyl-urapidil, we have examined the possible heterogeneity in the alpha 1-adrenoceptor populations in rabbit aorta.|chlorethylclonidine|alpha 1-adrenoceptor|7|3|Arg1:T20|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|746
12560076|Mouse brain serine racemase catalyzes specific elimination of L-serine to pyruvate.|L-serine|Mouse brain serine racemase|9|1|Arg1:T21|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|747
12373423|  RATIONALE: There is substantial evidence that lisuride can produce effects linked to 5-HT(1A) receptor occupancy.|lisuride|5-HT(1A)|8|14|Arg1:T20|Arg2:T38|CHEMICAL|GENE|DIRECT-REGULATOR|748
23298863|  6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide (TAK-441) is a potent, selective hedgehog signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer.|TAK-441|hedgehog|23|30|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|749
23172777|Three different 3D-QSAR models were built and validated by using a set of 66 pyrazole (Model I) and furanopyrimidine (Model II) compounds with IC(50) values toward Aurora kinase A ranging from 33 nM to 10.5 μM.|furanopyrimidine|Aurora kinase A|21|34|Arg1:T4|Arg2:T8|CHEMICAL|GENE|INHIBITOR|750
12560076|  D-Serine was previously identified in mammalian brain and was shown to be a co-agonist at the 'glycine' site of the N-methyl-D-aspartate (NMDA)-type receptors.|D-Serine|N-methyl-D-aspartate (NMDA)-type receptors|1|22|Arg1:T1|Arg2:T23|CHEMICAL|GENE|AGONIST|751
22902329|We previously demonstrated that the somatostatinergic system, implicated in neuronal survival control, can be modulated by α-tocopherol in the rat dentate gyrus, increasing cyclic adenosine monophosphate response element binding protein phosphorylation.|α-tocopherol|cyclic adenosine monophosphate response element binding protein|19|27|Arg1:T12|Arg2:T33|CHEMICAL|GENE|ACTIVATOR|752
18620538|Interaction of human alpha-lactalbumin with fatty acids: determination of binding parameters.|fatty acids|human alpha-lactalbumin|6|3|Arg1:T8|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|753
23123662|In conclusion, rCtr1 can transport copper and platinum drugs, and sensitizes cells to their cytotoxicities.|copper|rCtr1|7|4|Arg1:T9|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|754
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|Gemcitabine|DCK|1|19|Arg1:T1|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|755
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|2',2'-difluorodeoxycytidine|DCK|5|19|Arg1:T8|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|756
15498586|By contrast, telmisartan attenuated 11beta-hydroxysteroid dehydrogenase type 1 mRNA level in differentiated adipocytes.|telmisartan|11beta-hydroxysteroid dehydrogenase type 1|4|6|Arg1:T5|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|757
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imidazoquinoline|TLR8|2|15|Arg1:T3|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|758
12112047|Minocycline treatment prevents the formation of activated caspase-3, a known effector of apoptosis, as well as the appearance of a calpain cleaved substrate, a marker of excitotoxic/necrotic cell death.|Minocycline|caspase-3|1|8|Arg1:T6|Arg2:T8|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|759
15939622|COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.|flunixin|COX-1|11|1|Arg1:T15|Arg2:T22|CHEMICAL|GENE|INHIBITOR|760
23143891|In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, budesonide, and fluticasone propionate, by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.|fluticasone propionate|CYP3A|22|27|Arg1:T17|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|761
11585753|"ZD1839 (""Iressa""), a quinazoline tyrosine kinase inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials."|quinazoline tyrosine|tyrosine kinase|9|10|Arg1:T4|Arg2:T13|CHEMICAL|GENE|SUBSTRATE|762
23118019|Both 5'-AMN and 5'-MABN had high affinity for κ-receptors (K (i) 1.36 ± 0.98 and 0.27 ± 0.08, respectively) and were revealed as potent κ-antagonists (pA(2) 7.43 and 8.18, respectively) and μ-receptor antagonists (pA(2) 7.62 and 7.85, respectively) in the ileum.|5'-AMN|μ-receptor|2|43|Arg1:T16|Arg2:T19|CHEMICAL|GENE|ANTAGONIST|763
16920841|Independent of dietary choline, supplemental Met increased hepatic BHMT activity approximately 30%.|choline|BHMT|4|10|Arg1:T3|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|764
17488480|In this study, we investigated the presence of H(2)S and the expression of H(2)S synthesizing enzymes, CSE and CBS, in isolated mouse pancreatic acini.|H(2)S|CBS|19|29|Arg1:T17|Arg2:T45|CHEMICAL|GENE|PRODUCT-OF|765
23220644|Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.|5-hydroxytryptamines|phospholipase A2|3|9|Arg1:T6|Arg2:T17|CHEMICAL|GENE|INHIBITOR|766
18081314|The distances between the protons H20 and H2, H18 and H2, and H18 and H4 are shorter following their binding to the PGIS in solution-down to within 5 A.|H2|PGIS|8|25|Arg1:T20|Arg2:T41|CHEMICAL|GENE|PART-OF|767
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|L-cysteine|CSE|13|20|Arg1:T18|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|768
15795320|These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.|pemetrexed|hENT1|44|48|Arg1:T9|Arg2:T31|CHEMICAL|GENE|INDIRECT-UPREGULATOR|769
23538162|Rg1 attenuated the Aβ25-35-associated mitochondrial apoptotic events, accompanied by inhibiting HIF-1α expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination.|Rg1|HIF-1α|1|12|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|770
23044488|Amino acid residues at the N- and C-termini are essential for the folding of active human butyrylcholinesterase polypeptide.|Amino acid|human butyrylcholinesterase|1|16|Arg1:T3|Arg2:T14|CHEMICAL|GENE|PART-OF|771
12487427|GW660511X and omapatrilat reduced the production of BrBK1-5 and BrBK1-7 with more effect being observed with omapatrilat.|GW660511X|BrBK1-5|1|8|Arg1:T17|Arg2:T63|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|772
14600253|Glycylsarcosine coadministration could inhibit the uptake of cefadroxil in PEPT2(+/+) mice (p < 0.01) but not PEPT2(-/-) mice.|Glycylsarcosine|PEPT2|1|10|Arg1:T10|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|773
23587425|Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.|imidazo[1,2-a]pyrazine|CHK1|10|4|Arg1:T3|Arg2:T9|CHEMICAL|GENE|INHIBITOR|774
23164921|Catalpol inhibits LPS plus IFN-γ-induced inflammatory response in astrocytes primary cultures.|Catalpol|IFN-γ|1|5|Arg1:T11|Arg2:T20|CHEMICAL|GENE|INHIBITOR|775
17085856|The concomitant application of subconvulsive dose of pentetrazole (55.0 mg/kg) with low dose of flumazenil (5.0 mg/kg) - a BDZ receptor antagonist, immediately induced BDZ withdrawal signs in these animals.|flumazenil|BDZ receptor|17|24|Arg1:T9|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|776
23314320|The current U.S. military and civilian oxime countermeasure, 2-[(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride (2-PAM), is under consideration for replacement with a more effective acetylcholinesterase reactivator, 1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate (MMB-4).|MMB-4|acetylcholinesterase|42|32|Arg1:T6|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|777
14638499|Terbinafine resistance was transmitted with the mutated alleles in gene replacement experiments, proving that single amino acid substitutions in the Erg1 protein were sufficient to confer the resistance phenotype.|amino acid|Erg1|17|22|Arg1:T9|Arg2:T25|CHEMICAL|GENE|PART-OF|778
15474503|Further study revealed that pitavastatin increased ABCA1 mRNA in HMG-CoA reductase-dependent manner and that Rho and Rho kinase inhibitor (C3T and Y27632) increased apoA-I production in the HepG2 cells.|Y27632|apoA-I|23|26|Arg1:T15|Arg2:T40|CHEMICAL|GENE|INDIRECT-UPREGULATOR|779
23531488|Little is known regarding the transport activity and regulation of OATP2B1 variants with N-terminus truncation.|N|OATP2B1|14|11|Arg1:T5|Arg2:T19|CHEMICAL|GENE|PART-OF|780
23425605|MeHg significantly increased DA precursor accumulation in cells treated with 3-hydroxybenzylhydrazine (10µM), revealing that MeHg increases tyrosine hydroxylase activity.|MeHg|tyrosine hydroxylase|18|20|Arg1:T7|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|781
23395914|Upon studying the drug-drug interaction of darunavir with ketoconazole, data were indicative for an inhibitory effect of ketoconazole on P-gp as the main mechanism for the increased transport of darunavir across the small intestine.|ketoconazole|P-gp|19|21|Arg1:T4|Arg2:T17|CHEMICAL|GENE|INHIBITOR|782
1730582|Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine.|alpha-difluoromethylornithine|mouse ornithine decarboxylase|11|7|Arg1:T30|Arg2:T44|CHEMICAL|GENE|INHIBITOR|783
23535337|Under NaCl and sorbitol stresses, catalase (CAT) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.|sorbitol|CAT|4|9|Arg1:T9|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|784
23638842|RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive RS -GRA significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1β (IL-1β), and apoptosis (Bax and caspase 3 expression).|RS -GRA|interleukin-1β|19|36|Arg1:T1|Arg2:T10|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|785
23391336|The enzyme (TcCA) has a very high catalytic activity for the CO(2) hydration reaction, being similar kinetically to the human (h) isoform hCA II, although it is devoid of the His64 proton shuttle.|CO(2)|hCA II|14|31|Arg1:T1|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|786
23519153|Of note, reciprocal expression of Asmt and Bhmt is an important clue that altered S-adenosylhomocysteine metabolism underlies brain injury in WD, which is directly correlated to the decreased expression of S-adenosylhomocysteine hydrolase in hepatic tissue in LEC rats.|S-adenosylhomocysteine|Asmt|16|7|Arg1:T2|Arg2:T12|CHEMICAL|GENE|SUBSTRATE_PRODUCT-OF|787
8242725|  Two migraine patients were studied by in vivo SPECT using the dopamine D2-receptor specific radioligand 123I-3-iodo-6-methoxybenzamide (123I-IBZM) during ergotamine abuse and after withdrawal.|123I-IBZM|dopamine D2-receptor|18|12|Arg1:T2|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|788
1356794|The preferential alpha 2A-adrenoceptor partial agonist, guanfacine, partially inhibited UK 14,304-induced antinociception.|UK 14,304|alpha 2A-adrenoceptor|12|3|Arg1:T8|Arg2:T16|CHEMICAL|GENE|AGONIST|789
23266505|Additionally, AIF levels in the cytosol decreased due to EGTA but not due to calpeptin.|EGTA|AIF|11|3|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|790
12093311|This study was conducted in order to understand the association between acute renal failure and the two COX-2 inhibitors celecoxib and rofecoxib.|rofecoxib|COX-2|22|18|Arg1:T12|Arg2:T23|CHEMICAL|GENE|INHIBITOR|791
23250811|Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.|Curcumin|IL-27|1|9|Arg1:T15|Arg2:T38|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|792
23564313|In addition, vinblastine induces the DNA-binding activities of the transcription factor NF-κB, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.|vinblastine|ATF-2|4|20|Arg1:T1|Arg2:T16|CHEMICAL|GENE|ACTIVATOR|793
17391279|Indomethacin treatment led to an increase in lipid peroxidation, glutathione peroxidase and glucose-6-phosphate dehydrogenase activities and to a decrease in catalase activity and glutathione levels in gastric mucosa.|Indomethacin|glucose-6-phosphate dehydrogenase|1|14|Arg1:T11|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|794
15191400|  Auranofin, an antirheumatic gold compound, is an inhibitor of selenocysteine enzymes, such as thioredoxin reductase and glutathione peroxidase.|Auranofin|selenocysteine enzymes|1|12|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INHIBITOR|795
16344985|  RATIONALE: Several drugs used to treat bipolar disorder (lithium and carbamazepine), when administered chronically to rats, reduce the turnover of arachidonic acid, but not docosahexaenoic acid, in brain phospholipids by decreasing the activity of an arachidonic acid-selective phospholipase A(2).|lithium|phospholipase A(2)|11|45|Arg1:T16|Arg2:T31|CHEMICAL|GENE|INHIBITOR|796
17488480|Inhibition of endogenous production of H(2)S by PAG significantly suppressed SP concentration, PPT-A expression and NK1-R expression in the acini.|H(2)S|SP|6|15|Arg1:T5|Arg2:T35|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|797
23609606|No effects were observed when fenclozic acid was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells.|fenclozic acid|human cytochrome P450|6|25|Arg1:T3|Arg2:T14|CHEMICAL|GENE|INHIBITOR|798
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|Sorafenib|platelet-derived growth factor receptor beta|1|28|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INHIBITOR|799
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|PI3K|3|16|Arg1:T8|Arg2:T11|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|800
10583449|This hypothesis was tested by investigating whether, in subjects with essential hypertension, the natriuretic response to specific renin-angiotensin-aldosterone system (RAAS) blockade by renin-inhibitor remikiren could be predicted from pretreatment renal vascular tone.|remikiren|renin|28|27|Arg1:T12|Arg2:T21|CHEMICAL|GENE|INHIBITOR|801
16324695|Preincubation with 1 microM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) caused a small but significant decrease in isoprenaline-induced E(max), indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization.|isoprenaline|beta(2)-adrenoceptor|27|37|Arg1:T11|Arg2:T24|CHEMICAL|GENE|AGONIST|802
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|p-coumaric acid|CA|16|49|Arg1:T17|Arg2:T27|CHEMICAL|GENE|INHIBITOR|803
10606746|Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution.|(-)-galanthamine|acetylcholinesterase|6|3|Arg1:T18|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|804
9310349|Among the other bisphosphonates studied, alendronate was more potent and selective for PTPmeg1.|alendronate|PTPmeg1|7|14|Arg1:T16|Arg2:T36|CHEMICAL|GENE|INHIBITOR|805
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|alanine serine cysteine transporter 1|12|36|Arg1:T21|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|806
8294418|NE, phorbol esters, and bradykinin each decreased alpha-AR mRNA levels by 70-80%.|NE|alpha-AR|1|10|Arg1:T1|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|807
12244038|Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS.|gemfibrozil|PPAR-alpha|2|11|Arg1:T11|Arg2:T59|CHEMICAL|GENE|ACTIVATOR|808
12244038|  Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.|Gemfibrozil|inducible nitric-oxide synthase|1|16|Arg1:T1|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|809
23584358|In conclusion, agomelatine administration protects liver cells from paracetamol-induced hepatotoxicity via antioxidant activity and reduced proinflammatory cytokines, such as TNF-α and IL-6.|agomelatine|IL-6|4|24|Arg1:T11|Arg2:T41|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|810
23267767|The porcine heart malate dehydrogenase (MDH) refolding assay revealed that compound 1l inhibited human Hsp60 chaperone activity (IC(50): 6.80 ± 0.25 μM) and this inhibition activity was higher than that of ETB (IC(50): 10.9 ± 0.63 μM).|ETB|human Hsp60|40|16|Arg1:T4|Arg2:T13|CHEMICAL|GENE|INHIBITOR|811
12724156|The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the GluR5 kainate receptor antagonist LY293558.|LY293558|GluR5|21|17|Arg1:T1|Arg2:T40|CHEMICAL|GENE|ANTAGONIST|812
14757703|CGP 12177A but not isoprenaline initiated arrhythmias at lower concentrations following beta(1)-adrenoceptor overexpression.|CGP 12177A|beta(1)-adrenoceptor|1|12|Arg1:T6|Arg2:T25|CHEMICAL|GENE|INDIRECT-UPREGULATOR|813
16343532|Comparisons of the structures of the cyanobacterial toxin:phosphatase complexes explain the biochemical mechanism by which microcystins but not nodularins permanently modify their protein phosphatase targets by covalent addition to an active site cysteine residue.|microcystins|protein phosphatase|18|25|Arg1:T1|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|814
15121646|The estimated plasma ziprasidone concentration associated with 50% maximal 5-HT(2) receptor occupancy was almost four times lower than that for D(2) receptor occupancy.|ziprasidone|5-HT(2)|4|11|Arg1:T19|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|815
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imidazoquinoline|human TLR7|2|18|Arg1:T3|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|816
23614643|In support of this observation, elongation can be reversed by the tyrosine kinase inhibitor SU5402, mRNA for the FGFR antagonist sprouty4, or FGF8 morpholino.|SU5402|tyrosine kinase|16|13|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INHIBITOR|817
14583450|  Ribonucleotide reductase (RR) is responsible for the de novo conversion of the ribonucleoside diphosphates to deoxyribonucleoside diphosphates, which are essential for DNA synthesis and repair.|ribonucleoside diphosphates|Ribonucleotide reductase|15|1|Arg1:T5|Arg2:T7|CHEMICAL|GENE|SUBSTRATE|818
23017388|Taken together, our study demonstrated that SB365 inhibits the AKT/mTOR pathway, leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis.|SB365|AKT|8|11|Arg1:T8|Arg2:T16|CHEMICAL|GENE|INHIBITOR|819
23128353|With trypan blue-exclusion assay, we observed that glucosamine (10, 20, 50 mM) caused a decrease in cell number at 24 and 48 h; with a flow cytometric analysis, we also noted an enhanced cell accumulation within the G(0)/G(1) phase at 24 h and induction of late apoptosis at 24 and 48 h by glucosamine (10, 20, 50 mM) in A549 cells and HBECs. Examination of phosphorylation in retinoblastoma (Rb) protein, we found an inhibitory effect by glucosamine at 20 and 50 mM.|glucosamine|retinoblastoma (Rb) protein|99|87|Arg1:T8|Arg2:T19|CHEMICAL|GENE|INHIBITOR|820
17507169|  [N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide] (SR 141716A), a selective cannabinoid CB1 receptor antagonist, injected into the paraventricular nucleus of the hypothalamus (PVN) of male rats, induces penile erection.|SR 141716A|cannabinoid CB1 receptor|13|19|Arg1:T13|Arg2:T16|CHEMICAL|GENE|ANTAGONIST|821
20801130|The high resolution NMR solution structure of the cTnC-cTnI-dfbp-o ternary complex showed that dfbp-o bound at the hydrophobic interface formed by cTnC and cTnI making critical interactions with residues such as Arg147 of cTnI.|dfbp-o|cTnC|14|22|Arg1:T3|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|822
10702256|The functional protein contains 1160 amino acids with a large central mucin domain, three consensus sites for glycosaminoglycan attachment, two epidermal growth factor-like repeats, a putative hyaluronan-binding motif, and a potential transmembrane domain near the C-terminal.|amino acids|hyaluronan-binding motif|6|30|Arg1:T7|Arg2:T8|CHEMICAL|GENE|PART-OF|823
21606412|Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.|XL184|tyrosine kinase|3|10|Arg1:T7|Arg2:T21|CHEMICAL|GENE|INHIBITOR|824
10742288|In alpha(2A)-adrenoceptor transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).|A-54741|alpha(2A)-adrenoceptor|16|2|Arg1:T2|Arg2:T22|CHEMICAL|GENE|AGONIST|825
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|2',2'-difluorodeoxycytidine|CDA|5|13|Arg1:T8|Arg2:T43|CHEMICAL|GENE|SUBSTRATE|826
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imiquimod|human TLR7|5|18|Arg1:T4|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|827
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|SNAT1|7|59|Arg1:T18|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|828
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|Gleevec|PDGFbeta-receptor|18|36|Arg1:T3|Arg2:T29|CHEMICAL|GENE|INHIBITOR|829
17459764|The inhibitory effects of GW9662 and T0070907 (PPARgamma antagonists), on COX-2 expression and on stimulation of COX-2 promoter activity by EPA and GLA suggest that PPARgamma is implicated in COX-2 induction.|T0070907|PPARgamma|7|9|Arg1:T20|Arg2:T36|CHEMICAL|GENE|ANTAGONIST|830
23376356|LY294002, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.|LY294002|p38|1|11|Arg1:T1|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|831
23432124|  IKM-159 was developed and identified as a member of a new class of heterotricyclic glutamate analogues that act as AMPA receptor-selective antagonists.|IKM-159|AMPA receptor|1|20|Arg1:T1|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|832
12217700|  The bacterial enzyme maltodextrin phosphorylase (MalP) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as glucose-1-phosphate (Glc1P).|glucose-1-phosphate|MalP|28|7|Arg1:T13|Arg2:T33|CHEMICAL|GENE|PRODUCT-OF|833
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|dFdC|DCK|3|19|Arg1:T5|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|834
23511016|To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (DOTA), with pantoprazole, which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon.|Gd|proton pump|16|38|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INHIBITOR|835
17459764|These findings demonstrate that n-3 and n-6 PUFA increased PPARgamma activity is necessary for the COX-2 induction in HaCaT human keratinocyte cells.|n-3 and n-6 PUFA|PPARgamma|5|10|Arg1:T3|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|836
12487427|This study shows that the potency of GW660511X in comparison with omapatrilat is more than 100-fold lower in human, but less than 10-fold lower in rat plasma, suggesting that rat may not be a suitable in vivo model for the evaluation of ACE/NEP inhibition in relation to effects in humans.|GW660511X|ACE|8|45|Arg1:T28|Arg2:T70|CHEMICAL|GENE|INHIBITOR|837
15939622|As expected, comparison of IC50 indicated that meloxicam and carprofen are more selective inhibitors of COX-2 than phenylbutazone and flunixin; meloxicam was the most advantageous for horses of four NSAIDs examined.|phenylbutazone|COX-2|19|17|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INHIBITOR|838
12901032|Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.|salsalate|COX-2|22|12|Arg1:T6|Arg2:T23|CHEMICAL|GENE|INHIBITOR|839
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|flufenamic acid|Panx1|41|6|Arg1:T5|Arg2:T39|CHEMICAL|GENE|INHIBITOR|840
8242725|Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier?|123I-iodobenzamide|Dopamine D2-receptor|5|1|Arg1:T12|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|841
16424790|It was found that a single intragastric gavage by L-methionine resulted in inhibition of endothelium-dependent relaxation, markedly increased the serum level of malondialdehyde and decreased the activity of PON1 and SOD, similarly decreased the level of NO in the serum; but had no effects on endothelium-independent relaxation and angiotensin-converting enzyme activity compared with the control group.|L-methionine|SOD|10|32|Arg1:T6|Arg2:T56|CHEMICAL|GENE|INHIBITOR|842
9310349|These observations show substrate- and enzyme-specific PTP inhibition by alendronate and support the possibility that a certain PTP(s) may be the molecular target for alendronate action.|alendronate|PTP|10|7|Arg1:T9|Arg2:T30|CHEMICAL|GENE|INHIBITOR|843
23330546|  Bile acids are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.|Bile acids|pregnane X receptor|1|17|Arg1:T1|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|844
17658513|Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).|phenylephrine|alpha(1)-adrenoceptor|56|4|Arg1:T5|Arg2:T11|CHEMICAL|GENE|AGONIST|845
16516814|In addition to this evidence (for the involvement of EP2 receptors), evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of Na,K-ATPase beta subunit gene transcription includes the stimulatory effect of 17-phenyl trinor PGE2, as well as the inhibitory effects of SC-51089.|PGE1|Na,K-ATPase beta|24|28|Arg1:T2|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|846
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|phenol|carbonic anhydrase|7|46|Arg1:T9|Arg2:T26|CHEMICAL|GENE|INHIBITOR|847
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|buserelin|LHRH|11|5|Arg1:T5|Arg2:T23|CHEMICAL|GENE|AGONIST|848
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|tert-butylhydroquinone|NRF2|32|27|Arg1:T2|Arg2:T8|CHEMICAL|GENE|ACTIVATOR|849
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Imatinib|ABL|1|27|Arg1:T1|Arg2:T14|CHEMICAL|GENE|INHIBITOR|850
15665864|Our results suggest that easing of Fas-triggered fulminant hepatitis by minocycline may involve a mitochondrial apoptotic pathway, probably through preventing cytochrome c release and thereby blocking downstream caspase activation.|minocycline|caspase|11|29|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INHIBITOR|851
17418819|Under isotonic conditions, N-ethylmaleimide (NEM) produced KCC activation and transient cell shrinkage.|NEM|KCC|7|10|Arg1:T4|Arg2:T18|CHEMICAL|GENE|ACTIVATOR|852
20421509|Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization.|TFP|S100A4|24|19|Arg1:T8|Arg2:T29|CHEMICAL|GENE|INHIBITOR|853
17768678|PLZ is also a substrate for MAO, and studies suggest that a metabolite formed by the action of this enzyme on PLZ may be responsible for the increase in GABA observed.|PLZ|MAO|1|7|Arg1:T16|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|854
23428346|  Statins are inhibitors of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting step in cholesterol biosynthesis.|cholesterol|3-hydroxy-3-methylglutaryl coenzyme A reductase|16|7|Arg1:T4|Arg2:T35|CHEMICAL|GENE|PRODUCT-OF|855
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Gleevec|PDGFRB,|5|31|Arg1:T3|Arg2:T16|CHEMICAL|GENE|INHIBITOR|856
16480505|The concomitantly administered effects of rifampicin on other drugs can result in their altered metabolism or transportation that are metabolised by cytochromes P450 or transported by p-glycoprotein in the gastrointestinal tract and liver.|rifampicin|p-glycoprotein|6|27|Arg1:T2|Arg2:T10|CHEMICAL|GENE|SUBSTRATE|857
16971132|  In order to produce potent new leads for anticancer drugs, a new series of quinazoline analogs was designed to resemble methotrexate (MTX, 1) structure features and fitted with functional groups believed to enhance inhibition of mammalian DHFR activity.|quinazoline|mammalian DHFR|16|40|Arg1:T3|Arg2:T7|CHEMICAL|GENE|INHIBITOR|858
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|butaprost|EP2|26|23|Arg1:T15|Arg2:T35|CHEMICAL|GENE|AGONIST|859
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|STI571|PDGFRB,|3|31|Arg1:T2|Arg2:T16|CHEMICAL|GENE|INHIBITOR|860
23266505|The upregulation of calpain, tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of ALD.|EGTA|tBid|16|6|Arg1:T18|Arg2:T35|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|861
1666997|In vitro binding studies showed that both amoxapine and amitriptyline interact in the nanomolar range with 5-HT2 receptors labelled by [3H]ketanserin in cortical membranes.|amitriptyline|5-HT2|10|17|Arg1:T6|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|862
21606412|  PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.|XL184|VEGFR2|3|21|Arg1:T6|Arg2:T13|CHEMICAL|GENE|INHIBITOR|863
23541670|  We report the discovery of a novel series of ATP-competitive Janus kinase 3 (JAK3) inhibitors based on the 5H-pyrrolo[2,3-b]pyrazine scaffold.|5H-pyrrolo[2,3-b]pyrazine|Janus kinase 3|21|11|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INHIBITOR|864
16971132|Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.|4(3H)-quinazolinone|dihydrofolate reductase|17|3|Arg1:T4|Arg2:T12|CHEMICAL|GENE|INHIBITOR|865
16957773|Upon differentiation, osteoclasts express vesicular glutamate transporter 1 (VGLUT1), which is essential for vesicular storage and subsequent exocytosis of glutamate in neurons.|glutamate|VGLUT1|24|11|Arg1:T5|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|866
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|putrescine|ornithine decarboxylase|3|19|Arg1:T21|Arg2:T39|CHEMICAL|GENE|PRODUCT-OF|867
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|retinoic acid|LXR|17|27|Arg1:T10|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|868
15177307|  The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel cyclooxygenase-2 (COX-2) selective inhibitor lumiracoxib (Prexige), so that dose recommendations for clinical use can be provided.|lumiracoxib|cyclooxygenase-2|29|23|Arg1:T6|Arg2:T12|CHEMICAL|GENE|INHIBITOR|869
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|disulfide|RNase A|6|12|Arg1:T9|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|870
8636122|The CB1 and CB2 second extracellular loops, e2, were exchanged, modifications that had no effect on SR 141716A binding in the CB1 variant but that eliminated CP 55,940 binding in both mutants.|SR 141716A|CB1|20|25|Arg1:T10|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|871
16424790|These results suggested that Captopril can protect the vascular endothelium against the damages induced by L-methionine in rats, and the beneficial effects of Captopril may be related to attenuating the decrease in PON1 activity and NO levels.|L-methionine|PON1|16|34|Arg1:T20|Arg2:T62|CHEMICAL|GENE|INHIBITOR|872
23552263|Regarding urease inhibition, n-butanol was the most potent fraction (IC50: 97 µg/mL).|n-butanol|urease|5|2|Arg1:T4|Arg2:T18|CHEMICAL|GENE|INHIBITOR|873
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|SNAT2|14|62|Arg1:T23|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|874
12217700|The comparison between MalP structures shows that His377, through a hydrogen bond with the 6-hydroxyl group of Glc1P substrate, triggers a conformational change of the 380s loop.|Glc1P|MalP|19|4|Arg1:T2|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|875
15932636|Furthermore, experiments showed that treatment with DEC results in a reduction in the amount of COX-1 protein in peritoneal exudate cells.|DEC|COX-1|8|17|Arg1:T5|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|876
12244038|Similar to gemfibrozil, clofibrate, another fibrate drug, also inhibited the expression of iNOS.|gemfibrozil|iNOS|3|16|Arg1:T6|Arg2:T53|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|877
23379481|Upamostat (Mesupron®) is a new small molecule serine protease inhibitor.|Mesupron|serine protease|3|10|Arg1:T3|Arg2:T20|CHEMICAL|GENE|INHIBITOR|878
18439678|Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.|N|porcine TLR7|14|2|Arg1:T2|Arg2:T20|CHEMICAL|GENE|PART-OF|879
16213084|These results provide biochemical evidence of a H(+)-coupled and saturable transport system, presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown H(+)-coupled monocarboxylate transport system, for nicotinate in rat cerebrocortical astrocytes.|nicotinate|low-affinity monocarboxylate transporter|39|22|Arg1:T9|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|880
17658513|Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).|phenylephrine|alpha(1D)-adrenoceptor|56|46|Arg1:T5|Arg2:T13|CHEMICAL|GENE|AGONIST|881
7599160|Intracellular protein-bound [57Co]Cbl fractionated with methionine synthase (MS) and methylmalonyl-CoA mutase (MU) activity.|[57Co]Cbl|MU|3|18|Arg1:T24|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|882
15991937|Losartan is well-absorbed orally as an active drug and is rapidly converted via oxidation in the human liver to a more potent metabolite (designated E3174) with an affinity 20- to 30-times greater for the AT(1) receptor (non-competitive inhibition).|Losartan|AT(1) receptor|1|37|Arg1:T14|Arg2:T26|CHEMICAL|GENE|INHIBITOR|883
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|c-Myc|3|46|Arg1:T8|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|884
18081314|  High-resolution NMR spectroscopy was used to determine the docking of a substrate (prostaglandin H2) mimic (U46619) to the engineered prostacyclin (PGI2) synthase (PGIS) in solution.|prostaglandin H2|prostacyclin (PGI2) synthase|14|24|Arg1:T25|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|885
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|pyrrolo-isoxazole|cholinesterase|29|8|Arg1:T9|Arg2:T12|CHEMICAL|GENE|INHIBITOR|886
23246481|We found that wogonin can suppress the H2O2-stimulated actin remodeling and albumin uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.|H2O2|actin|8|9|Arg1:T7|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|887
9551716|  The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of neurotensin receptors, [3H]SR 142948A (2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methyl carbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]-amino]-ad amantane-2-carboxylic acid, hydrochloride), in the rat brain.|[3H]SR 142948A|neurotensin receptors|23|20|Arg1:T12|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|888
1590750|The results suggest that individuals with high Vmax beta 2-ADH and deficient in low-Km mitochondrial ALDH2, accounting for approximately 45% of the Chinese population, may end up with acetaldehyde accumulation during alcohol consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.|alcohol|beta 2-ADH|35|9|Arg1:T4|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|889
16248990|To test the role of nicotinic receptors in the drugs' effects on [3H]-ACh release, mecamylamine (MEC) 100 microM was used to block such receptors.|MEC|nicotinic receptors|22|6|Arg1:T3|Arg2:T20|CHEMICAL|GENE|INHIBITOR|890
23265892|  An investigation is detailed of the structure activity relationships (SAR) of two sulfone side chains of compound (-)-1a (SCH 900229), a potent, PS1-selective γ-secretase inhibitor and clinical candidate for the treatment of Alzheimer's disease.|SCH 900229|γ-secretase|25|33|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INHIBITOR|891
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Vatalanib|TK|36|3|Arg1:T24|Arg2:T47|CHEMICAL|GENE|INHIBITOR|892
10493852|We report here that lovastatin, a drug clinically used for lowering cholesterol levels, inhibits the interaction of human LFA-1 with its counter-receptor intercellular adhesion molecule-1.|lovastatin|human LFA-1|5|20|Arg1:T1|Arg2:T4|CHEMICAL|GENE|INHIBITOR|893
1356794|  In the hot-plate test in mice, the antinociceptive action of the alpha 2-adrenoceptor agonist, UK 14,304, was abolished by the alpha 2-adrenoceptor antagonist, idazoxan, the potent alpha 2A-adrenoceptor antagonist, RX 821002 and the preferential alpha 2A-adrenoceptor antagonist, BRL 44408.|RX 821002|alpha 2A-adrenoceptor|36|32|Arg1:T2|Arg2:T13|CHEMICAL|GENE|ANTAGONIST|894
23098818|Human liver microsomes of the wild-type CYP2D6 metabolized 5-methoxytryptamine to serotonin more effectively than did the defective CYP2D6*4*4 ones.|5-methoxytryptamine|CYP2D6|9|7|Arg1:T3|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|895
22709946|However, chronic treatment of cLH rats with MPEP did not reverse learned helplessness, indicating that the enhanced mGlu5 receptor function is not the only player in the behavioral phenotype of this genetic model of depression.|MPEP|mGlu5 receptor|9|20|Arg1:T1|Arg2:T9|CHEMICAL|GENE|ACTIVATOR|896
2899826|Muscarinic cholinergic and histamine H1 receptor binding of phenothiazine drug metabolites.|phenothiazine|histamine H1 receptor|9|4|Arg1:T27|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|897
23123662|The uptake of copper by both cultured rat DRG neurons and HEK/rCtr1 cells was saturable and inhibited by cold temperature, silver and zinc, consistent with it being mediated by rCtr1.|copper|rCtr1|4|13|Arg1:T26|Arg2:T42|CHEMICAL|GENE|SUBSTRATE|898
1666997|Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that amoxapine really acts in vivo as a 5-HT3 antagonist (IC50 = 50 micrograms/kg i.v.), whereas amitriptyline is essentially inactive on 5-HT3 receptors.|amoxapine|5-HT3|10|17|Arg1:T14|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|899
6227474|Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of steroid binding similar to that of the kidney mineralocorticoid receptor (aldosterone greater than desoxycorticosterone greater than corticosterone).|aldosterone|mineralocorticoid receptor|27|24|Arg1:T7|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|900
12244038|However, DeltahPPAR-alpha was unable to abrogate gemfibrozil-mediated inhibition of iNOS suggesting that gemfibrozil inhibits iNOS independent of PPAR-alpha.|gemfibrozil|iNOS|8|11|Arg1:T15|Arg2:T67|CHEMICAL|GENE|INHIBITOR|901
15353299|While fluoropyrimidine antimetabolites have other sites of action, antifolates ZD1694 (raltitrexed, Tomudex) and AG337 (Thymitag) are more specific and potent TS inhibitors.|ZD1694|TS|11|27|Arg1:T2|Arg2:T23|CHEMICAL|GENE|INHIBITOR|902
23146664|Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1.|Mesalamine|p-21 activated kinase-1|1|8|Arg1:T15|Arg2:T29|CHEMICAL|GENE|INHIBITOR|903
17380207|Asparagine secretion by MSCs was directly related to their ASNS expression levels, suggesting a mechanism - increased concentrations of asparagine in the leukemic cell microenvironment - for the protective effects we observed.|Asparagine|ASNS|1|10|Arg1:T1|Arg2:T6|CHEMICAL|GENE|PRODUCT-OF|904
15121646|CONCLUSIONS: These data affirm that ziprasidone is similar to other novel antipsychotics in having greater 5-HT(2) than D(2) receptor occupancy at therapeutic doses and suggest that the optimal effective dose of ziprasidone is closer to 120 mg/day than to the lower doses suggested by previous PET studies.|ziprasidone|5-HT(2)|7|17|Arg1:T3|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|905
23327993|The TXM peptides were effective in inhibiting AuF-induced MAPK, JNK and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.|AuF|p38|8|13|Arg1:T8|Arg2:T34|CHEMICAL|GENE|ACTIVATOR|906
22898212|CBDP irreversibly inhibits butyrylcholinesterase (BChE) in human plasma by forming adducts on the active site serine (Ser-198).|Ser|butyrylcholinesterase|20|4|Arg1:T9|Arg2:T30|CHEMICAL|GENE|PART-OF|907
1705137|Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.|toloxatone|monoamine oxidase-A|18|13|Arg1:T44|Arg2:T52|CHEMICAL|GENE|INHIBITOR|908
12881227|Nevertheless, 3 mM DMA, a higher concentration that inhibits NHE1, NHE2, and NHE3, significantly increased DBS.|DMA|NHE1|5|12|Arg1:T11|Arg2:T36|CHEMICAL|GENE|INHIBITOR|909
17350061|The expression of key genes important in methionine metabolism, such as methionine adenosyltransferase-1a, betaine-homocysteine methyltransferase and thioether S-methyltransferase, were suppressed.|methionine|methionine adenosyltransferase-1a|8|13|Arg1:T6|Arg2:T33|CHEMICAL|GENE|PRODUCT-OF|910
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|sulforaphane|NRF2|30|27|Arg1:T1|Arg2:T8|CHEMICAL|GENE|ACTIVATOR|911
23601203|Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.|Lys|HSA|28|11|Arg1:T6|Arg2:T12|CHEMICAL|GENE|PART-OF|912
10701840|Geldanamycin also disrupts the T-cell receptor-mediated activation of nuclear factor of activated T-cells (NF-AT).|Geldanamycin|NF-AT|1|15|Arg1:T6|Arg2:T29|CHEMICAL|GENE|INHIBITOR|913
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|trimethylamine|FMO3|21|16|Arg1:T3|Arg2:T15|CHEMICAL|GENE|SUBSTRATE|914
23261590|In addition, we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.|neoechinulin A|TNF-α|7|21|Arg1:T10|Arg2:T34|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|915
9476974|At nonconvulsant doses, the sodium channel blockers acetylprocainamide, dibucaine, dyclonine, prilocaine, proparacaine, quinidine, and tetracaine produced a small pressor response or no increase in BP.|acetylprocainamide|sodium channel|9|6|Arg1:T32|Arg2:T48|CHEMICAL|GENE|INHIBITOR|916
11309392|Diacylglycerol kinase (DGK) catalyzes the conversion of diacylglycerol to phosphatidic acid, making it an attractive candidate for a signal transduction component.|phosphatidic acid|DGK|12|4|Arg1:T8|Arg2:T27|CHEMICAL|GENE|PRODUCT-OF|917
17205056|In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, sorafenib blocked basal and ligand dependent FLT3-mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase1/2 and Stat5 phosphorylation.|sorafenib|extracellular signal-regulated kinase1/2|11|23|Arg1:T5|Arg2:T19|CHEMICAL|GENE|INHIBITOR|918
15121646|  OBJECTIVE: Ziprasidone is an atypical antipsychotic drug that shows a higher affinity for serotonin 5-HT(2) receptors compared with dopamine D(2) receptors in vitro.|Ziprasidone|dopamine D(2) receptors|3|23|Arg1:T2|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|919
23353741|All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) inhibitory activity of murine macrophage RAW 264.7 cell line.|PGE2|cyclooxygenase-2|30|22|Arg1:T5|Arg2:T7|CHEMICAL|GENE|PRODUCT-OF|920
23428368|Cardiac hypertrophy, structural remodeling, and expression of the genes associated with fatty acid metabolism were examined in rats treated with triiodothyronine (T3) alone (8 μg/100 g body weight (BW), i.p.) for 15 days or along with a peroxisome proliferator-activated receptor alpha agonist bezafibrate (Bzf; 30 μg/100 g BW, oral) and were found to improve in the Bzf co-treated condition.|Bzf|peroxisome proliferator-activated receptor alpha|55|48|Arg1:T4|Arg2:T10|CHEMICAL|GENE|AGONIST|921
11264758|Pranlukast is a new, orally active, selective inhibitor of CysLt1 leukotriene receptor.|Pranlukast|CysLt1|1|12|Arg1:T10|Arg2:T14|CHEMICAL|GENE|INHIBITOR|922
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|SC-51089|EP1|40|4|Arg1:T16|Arg2:T32|CHEMICAL|GENE|AGONIST|923
17382376|Thus, H(1) antagonism seems to play a role in part of the beneficial actions of antipsychotics, such as clozapine.|clozapine|H(1)|24|3|Arg1:T11|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|924
23550066|The CYP2B6*6 Allele Significantly Alters the N-demethylation of Ketamine Enantiomers In Vitro.|Ketamine|CYP2B6*6|9|2|Arg1:T12|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|925
16774921|Interestingly, deletion of the entire yeast mitochondrial LeuRS C-terminal domain enhanced its aminoacylation and amino acid editing activities.|C|yeast mitochondrial LeuRS|10|7|Arg1:T12|Arg2:T23|CHEMICAL|GENE|PART-OF|926
23044488|  Human serum butyrylcholinesterase (HuBChE) is currently the most suitable bioscavenger for the prophylaxis of highly toxic organophosphate (OP) nerve agents.|organophosphate|HuBChE|19|5|Arg1:T1|Arg2:T10|CHEMICAL|GENE|SUBSTRATE|927
23418674|The results suggested that both the EtOAc extract and berberine were able to activate PPARα/β/γ, and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine.|berberine|PPARs|27|25|Arg1:T4|Arg2:T12|CHEMICAL|GENE|AGONIST|928
22578098|The structures of active and inactive alanine-mutated cyclic peptides, and of phospholamban (1-36), were determined by NMR.|alanine|cyclic peptides|7|8|Arg1:T2|Arg2:T10|CHEMICAL|GENE|PART-OF|929
23142699|We show that the expression of PIM-1 is induced in response to estradiol in MCF-7 cells and that the induction is mediated by ERα-regulated enhancers located distally upstream from the gene.|estradiol|PIM-1|13|7|Arg1:T1|Arg2:T7|CHEMICAL|GENE|INDIRECT-UPREGULATOR|930
23230131|In conclusion, the Lys27Gln substitution does not significantly modulate CDA activity toward dFdC, and therefore would not contribute to interindividual variability in response to gemcitabine.|dFdC|CDA|14|11|Arg1:T3|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|931
18439678|Moreover, activation of transfected cells and porcine PBMC by TLR7 ligands was inhibited by bafilomycin A(1) indicating the requirement of endosomal/lysosomal acidification for activation of the receptors.|bafilomycin A(1)|TLR7|16|11|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|932
9204085|Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors, retinoic acid receptors (RARs).|adapalene|retinoic acid receptors|14|23|Arg1:T9|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|933
17229632|We investigated the efficacy of sorafenib at inhibiting mutants of the receptor tyrosine kinases PDGFRbeta, KIT, and FLT3, which are implicated in the pathogenesis of myeloid malignancies.|sorafenib|PDGFRbeta|6|15|Arg1:T12|Arg2:T34|CHEMICAL|GENE|INHIBITOR|934
7986344|The folding rate monitored by 2'CMP binding to the major slow-folding species of Pro42Ala RNase A is faster than the folding rate monitored by tyrosine burial; however, the folding rate monitored by inhibitor binding to the minor slow-folding species is decreased significantly over the folding rate monitored by tyrosine burial, indicating that the major and minor slow-folding species of Pro42Ala fold to the native state with different transition-state conformations in the rate-determining step.|2'CMP|RNase A|6|15|Arg1:T10|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|935
9476974|Monoamine uptake inhibitors structurally analogous to cocaine (cocaethylene, CFT, betaCIT, CPT, (+)-cocaine, norcocaine, and benztropine) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities (BTCP, indatraline, GBR 12935, mazindol, nomifensine, and zimeldine) either did not produce a rapid pressor response or produced only a small pressor response.|nomifensine|monoamine transporter|54|41|Arg1:T29|Arg2:T47|CHEMICAL|GENE|INHIBITOR|936
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|OSI-774|kinase|28|44|Arg1:T7|Arg2:T45|CHEMICAL|GENE|INHIBITOR|937
12901032|Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.|acetaminophen|cyclooxygenase-2|25|10|Arg1:T7|Arg2:T22|CHEMICAL|GENE|INHIBITOR|938
20185318|Phenols like the ones investigated here possess a CA inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the coumarins.|sulfonamides|CA|17|9|Arg1:T13|Arg2:T33|CHEMICAL|GENE|INHIBITOR|939
12614192|Many clinical studies, both pre- and post-marketing, have demonstrated the clinical efficacy and safety of sildenafil (Viagra, Pfizer) - the first approved selective PDE inhibitor for the treatment of ED.|sildenafil|PDE|18|29|Arg1:T3|Arg2:T11|CHEMICAL|GENE|INHIBITOR|940
22898212|CBDP irreversibly inhibits butyrylcholinesterase (BChE) in human plasma by forming adducts on the active site serine (Ser-198).|serine|BChE|18|6|Arg1:T8|Arg2:T31|CHEMICAL|GENE|PART-OF|941
1730582|The pyridoxal 5'-phosphate binding lysine in mouse ODC was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with endoproteinase Lys-C, radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing.|pyridoxal 5'-phosphate|mouse ODC|2|7|Arg1:T18|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|942
23601203|Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.|Arg|Human Serum Albumin|26|7|Arg1:T5|Arg2:T11|CHEMICAL|GENE|PART-OF|943
17094978|RESULT(S): The expression of endometrial ERalpha, PRAB, PRB, and SRC-1 was increased significantly after 1 week of mifepristone, but the increase was no longer seen after 10 weeks.|mifepristone|PRAB|25|12|Arg1:T1|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|944
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|Fenofibrate|phosphoenolpyruvate carboxykinase|1|21|Arg1:T15|Arg2:T39|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|945
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|SNAT4|12|65|Arg1:T21|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|946
23391336|Cloning, Characterization, and Sulfonamide and Thiol Inhibition Studies of an α-Carbonic Anhydrase from Trypanosoma cruzi, the Causative Agent of Chagas Disease.|Sulfonamide|α-Carbonic Anhydrase|6|13|Arg1:T7|Arg2:T15|CHEMICAL|GENE|INHIBITOR|947
23542578|An intermediate GTX2,3-aldehyde was first synthesized by activating the NH2 group of the 2nd and 8th amino acid residues with three different aldehydes and two artificial complete antigens GTX2,3-aldehyde-bovine serum albumin (BSA) and GTX2,3-aldehyde- keyhole limpet hemocyanin (KLH) were then prepared by cross-linking the intermediate with BSA or KLH.|GTX2,3-aldehyde|KLH|36|41|Arg1:T7|Arg2:T13|CHEMICAL|GENE|DIRECT-REGULATOR|948
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|bis(1H-2-indolyl)-1-methanone|kinase|14|44|Arg1:T12|Arg2:T35|CHEMICAL|GENE|INHIBITOR|949
10640321|Parenteral administration of selective agonists of the delta-opioid receptor (SB 227122), mu-opioid receptor (codeine and hydrocodone), and kappa-opioid receptor (BRL 52974) produced dose-related inhibition of citric acid-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively.|BRL 52974|kappa-opioid receptor|27|24|Arg1:T10|Arg2:T25|CHEMICAL|GENE|AGONIST|950
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|flavonoid|cholinesterase|26|8|Arg1:T8|Arg2:T12|CHEMICAL|GENE|INHIBITOR|951
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|DCVC|beta-lyases|21|10|Arg1:T25|Arg2:T54|CHEMICAL|GENE|PRODUCT-OF|952
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|AG1296|Flt3|11|43|Arg1:T11|Arg2:T34|CHEMICAL|GENE|INHIBITOR|953
23643745|The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.|SCH23390|D5|26|25|Arg1:T4|Arg2:T44|CHEMICAL|GENE|ANTAGONIST|954
23550066|We examined the N-demethylation of individual ketamine enantiomers using human liver microsomes (HLMs) genotyped for the CYP2B6*6 allele, insect cell expressed recombinant CYP2B6 and CYP3A4 enzymes and COS-1 cell expressed recombinant CYP2B6.1 and CYP2B6.6 protein variant.|ketamine|CYP2B6*6|7|19|Arg1:T9|Arg2:T26|CHEMICAL|GENE|SUBSTRATE|955
23535327|Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 2.|pyripyropene A|ACAT2|6|19|Arg1:T5|Arg2:T7|CHEMICAL|GENE|INHIBITOR|956
10064839|We found that DF, DM, and DR were relative high-affinity ligands at sigma-1 receptors (Ki=151, 205, 144 nM, respectively) while all of them were with low affinity at sigma-2 receptors (Ki=4-11 microM).|DF|sigma-2 receptors|4|36|Arg1:T46|Arg2:T52|CHEMICAL|GENE|DIRECT-REGULATOR|957
12636181|  Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.|acetylcholine|BuChE|25|14|Arg1:T2|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|958
1686208|Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.|chlorpheniramine|histamine H1-receptor|14|3|Arg1:T15|Arg2:T18|CHEMICAL|GENE|ANTAGONIST|959
23500776|  Little is known in terms of multi-matrix cytochrome P450 activity induction under repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons (PHH, PAH).|halogenated and polycyclic aromatic hydrocarbons|cytochrome P450|18|8|Arg1:T3|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|960
8294418|  The mechanism by which norepinephrine (NE) down-regulates alpha 1B-adrenergic receptor (alpha-AR) mRNA was studied in rabbit aortic smooth muscle cells.|NE|alpha-AR|7|14|Arg1:T8|Arg2:T35|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|961
15795105|The compounds 5'-azacytidine (AZC) and procainamide (PCA) belong to inhibitors of DNMT1, whose low activity correlates with increase in transcription of various genes.|AZC|DNMT1|5|16|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INHIBITOR|962
23473681|Taken together, we conclude that the thiourea series of compounds share a similar cellular mechanism that includes interaction with LolA in addition to the well-characterized target MreB.|thiourea|LolA|8|21|Arg1:T1|Arg2:T11|CHEMICAL|GENE|DIRECT-REGULATOR|963
17094978|RESULT(S): The expression of endometrial ERalpha, PRAB, PRB, and SRC-1 was increased significantly after 1 week of mifepristone, but the increase was no longer seen after 10 weeks.|mifepristone|ERalpha|25|10|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|964
16324695|Preincubation with 1 microM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) caused a small but significant decrease in isoprenaline-induced E(max), indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization.|phorbol 12-myristate 13-acetate|protein kinase C|14|7|Arg1:T9|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|965
1375507|Preincubation for 30 minutes with iloprost, ciprostene, and carbacyclin led to a dose-dependent inhibition of tissue factor expression induced by all three challenging agents.|iloprost|tissue factor|6|18|Arg1:T13|Arg2:T32|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|966
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|ASCT1|14|42|Arg1:T23|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|967
15723099|Dimemorfan pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression, activator protein (AP)-1 DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus.|KA|activator protein (AP)-1|6|12|Arg1:T26|Arg2:T40|CHEMICAL|GENE|ACTIVATOR|968
7599160|Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin (CN-Cbl) bound to transcobalamin II (transcobalamin, TC).|CN-Cbl|transcobalamin|33|40|Arg1:T10|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|969
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|4-methoxy-7-nitroindolinyl|SNAT1|17|37|Arg1:T17|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|970
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|Crocin|caspase 3|1|32|Arg1:T1|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|971
22445601|Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.|LY541850|mGlu2|10|13|Arg1:T12|Arg2:T29|CHEMICAL|GENE|AGONIST|972
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|vitamin E|CK-MB|8|17|Arg1:T2|Arg2:T31|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|973
12093311|This study was conducted in order to understand the association between acute renal failure and the two COX-2 inhibitors celecoxib and rofecoxib.|celecoxib|COX-2|20|18|Arg1:T11|Arg2:T23|CHEMICAL|GENE|INHIBITOR|974
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|DL-alpha-difluoromethylornithine|ornithine decarboxylase|10|19|Arg1:T24|Arg2:T39|CHEMICAL|GENE|INHIBITOR|975
18035186|Based on the results from those studies, we concluded that rasagiline PO QD, at the therapeutic dosage range of 0.5 to 1 rag/d, is effective and well tolerated and completely, selectively, and specifically inhibited MAO-B.|rasagiline|MAO-B|12|40|Arg1:T2|Arg2:T28|CHEMICAL|GENE|INHIBITOR|976
23578390|Fluoride treatment also increased phosphorylation of JNK and ERK, but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively.|Fluoride|ERK|1|9|Arg1:T8|Arg2:T16|CHEMICAL|GENE|ACTIVATOR|977
17205056|We show that sorafenib (BAY 43-9006, Nexavar) potently inhibits FLT3 enzymatic and signaling activities.|Nexavar|FLT3|9|13|Arg1:T4|Arg2:T15|CHEMICAL|GENE|INHIBITOR|978
23296102|Interestingly, Acrolein increased proteins' levels of amyloid precursor protein (APP), β-secretase (BACE-1) and the amyloid β-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.|Acrolein|amyloid precursor protein|3|9|Arg1:T5|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|979
11732752|Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B.|L-arginine|aminopeptidase B|42|44|Arg1:T10|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|980
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Iressa|kinase|23|44|Arg1:T5|Arg2:T45|CHEMICAL|GENE|INHIBITOR|981
16988497|A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.|alpha-linolenic acid|D6D|40|50|Arg1:T16|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|982
23305850|The treatment of U937 cells with NRF2 inducers including sulforaphane effectively elevated the expression of AKR1B1, 1B10, 1C1, 1C2, and 1C3.|sulforaphane|NRF2|10|7|Arg1:T5|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|983
1978244|The Schild plots for the competitive antagonists WB4101 and 5-methyl-urapidil against alpha 1a-adrenoceptor-selective agonist methoxamine-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for WB4101 and 9.09 +/- 0.05 (n = 3) for 5-methyl-urapidil.|5-methyl-urapidil|alpha 1a-adrenoceptor|10|12|Arg1:T9|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|984
2855368|  The interaction of naloxone estrone azine (N-EH) with various opioid receptor types was studied in vitro.|naloxone estrone azine|opioid receptor|4|12|Arg1:T3|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|985
12093311|  OBJECTIVE: Celecoxib and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (COX-2) isoenzyme at therapeutic concentrations.|Celecoxib|cyclo-oxygenase-2|3|20|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INHIBITOR|986
10701840|Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.|geldanamycin|kinase|3|27|Arg1:T5|Arg2:T26|CHEMICAL|GENE|INHIBITOR|987
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|putrescine|ODC|3|22|Arg1:T21|Arg2:T40|CHEMICAL|GENE|PRODUCT-OF|988
23261590|In addition, we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.|neoechinulin A|interleukin-6|7|29|Arg1:T10|Arg2:T38|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|989
17218486|PEA was a potent and full agonist at each species of TAAR1, whereas TYR was a full agonist for the rodent TAAR1s but was a partial agonist at h-rChTAAR1.|TYR|h-rChTAAR1|15|30|Arg1:T4|Arg2:T42|CHEMICAL|GENE|AGONIST|990
23391336|A large number of aromatic/heterocyclic sulfonamides and some 5-mercapto-1,3,4-thiadiazoles were investigated as TcCA inhibitors.|5-mercapto-1,3,4-thiadiazoles|TcCA|9|13|Arg1:T4|Arg2:T14|CHEMICAL|GENE|INHIBITOR|991
20615127|Consistent with the results of a computer analysis, the binding of R316C to triiodothyronine (T3) was significantly decreased to 38% that of the wild type.|T3|R316C|17|13|Arg1:T10|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|992
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|carprofen|COX-2|26|44|Arg1:T14|Arg2:T17|CHEMICAL|GENE|INHIBITOR|993
15121646|METHOD: The authors conducted a PET study to evaluate D(2) occupancy (using [(11)C]raclopride) and 5-HT(2) occupancy (using [(18)F]setoperone) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40, 80, 120, or 160 mg/day of ziprasidone, which reflected the recommended dose range.|[(11)C]raclopride|D(2)|18|11|Arg1:T13|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|994
16432501|Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.|formoterol|beta2-adrenoceptor|7|4|Arg1:T18|Arg2:T24|CHEMICAL|GENE|AGONIST|995
15777622|  Megalin, a family of endocytic receptors related to the low-density lipoprotein (LDL) receptor, is a major pathway for proximal tubular aminoglycoside accumulation.|aminoglycoside|low-density lipoprotein (LDL) receptor|25|11|Arg1:T6|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|996
23506741|Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.|Fc11a-2|IL-1β|29|17|Arg1:T9|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|997
23454148|Compared with normally-fed counterparts, PM-CP rats exhibited higher glutathione S-transferase, aminopeptidase N and cysteine S-conjugate beta-lyase (CCBL) and lower gamma-glutamyltransferase activities, PM-FU rats exhibited decreased dihydropyrimidine dehydrogenase and cytochrome P450 1A1/2 activities and PM-MMC rats showed higher quinone reductase and depleted xanthine oxidase activities.|MMC|quinone reductase|40|43|Arg1:T19|Arg2:T33|CHEMICAL|GENE|ACTIVATOR|998
11161433|When the anti-corticosterone drug aminoglutethimide (CYP11A1 inhibitor) was administered to B16F10 mice, corticosterone levels in splenic tissue or serum and CYP11A1 mRNA expression were decreased at 14 days after tumor inoculation.|aminoglutethimide|CYP11A1|5|24|Arg1:T4|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|999
23327993|The Trx mimetics peptides (TXM) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting TrxR with auranofin (AuF).|auranofin|TrxR|22|20|Arg1:T5|Arg2:T31|CHEMICAL|GENE|INHIBITOR|1000
23318685|  Peginesatide, a polyethylene glycol (PEG)ylated peptide-based erythropoiesis-stimulating agent, stimulates the erythropoietin receptor dimer that governs erythropoiesis.|PEG|erythropoietin receptor|7|16|Arg1:T5|Arg2:T10|CHEMICAL|GENE|ACTIVATOR|1001
11292635|The purpose of this study was to determine whether rat outer medullary collecting duct (OMCD) secretes Cl- and whether transepithelial Cl- transport occurs, in part, through Cl- uptake across the basolateral membrane mediated by NKCC1 in series with Cl- efflux across the apical membrane.|Cl-|NKCC1|43|39|Arg1:T9|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|1002
23266505|Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of calpain and AIF levels.|ALD|calpain|17|20|Arg1:T6|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1003
15177307|  The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel cyclooxygenase-2 (COX-2) selective inhibitor lumiracoxib (Prexige), so that dose recommendations for clinical use can be provided.|Prexige|COX-2|31|25|Arg1:T7|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1004
23146664|The mechanism of PAK1 inhibition and induction of membranous translocation of adhesion proteins by 5-ASA might be independent of its known anti-inflammatory action.|5-ASA|PAK1|15|4|Arg1:T6|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1005
10406837|This action can be related to the ability of torasemide to block the increase of [Ca(2+)](i) induced by Ang II in VSMCs. It is proposed that these actions might be involved in the antihypertensive effect of torasemide observed in vivo.|torasemide|Ang II|10|27|Arg1:T7|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1006
15944809|METHODS AND RESULTS: In 8 Langendorff-perfused rabbit hearts, veratridine (0.1 microM), an inhibitor of sodium channel inactivation, led to a marked increase in QT-interval and simultaneously recorded monophasic ventricular action potentials (MAPs) (p < 0.05) thereby mimicking LQT3.|veratridine|sodium channel|11|20|Arg1:T9|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1007
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|AH 6809|EP2|46|51|Arg1:T17|Arg2:T37|CHEMICAL|GENE|ANTAGONIST|1008
19039322|A comparison of bosutinib with dasatinib across the whole kinase panel revealed overlapping, but distinct, inhibition profiles.|dasatinib|kinase|6|10|Arg1:T10|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1009
23412396|  The monoacylglycerol lipase (MAGL) inhibitor JZL184 produces antinociceptive and anti-inflammatory effects.|JZL184|MAGL|8|5|Arg1:T11|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1010
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imidazoquinoline|human TLR7|2|18|Arg1:T3|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|1011
17218486|Interestingly, both isomers of METH were full agonists at mTAAR1 and h-rChTAAR1, whereas both were partial agonists at rTAAR1.|METH|h-rChTAAR1|6|13|Arg1:T5|Arg2:T44|CHEMICAL|GENE|AGONIST-ACTIVATOR|1012
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|neutral amino acid transporters|12|24|Arg1:T21|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1013
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|estradiol|17beta-hydroxysteroid-dehydrogenase type 1|28|36|Arg1:T13|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1014
10727528|Salicylic acid promotes dissociation of (125)I-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled ET-1.|Salicylic acid|ET-1|1|10|Arg1:T10|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|1015
17488480|These results suggest that the pro-inflammatory effect of H(2)S may be mediated by SP-NK-1R related pathway in mouse pancreatic acinar cells.|H(2)S|SP|9|18|Arg1:T13|Arg2:T42|CHEMICAL|GENE|PRODUCT-OF|1016
3134891|It was also dependent upon temperature, the presence of a divalent cation such as calcium, and on pH, showing maximum binding at pH 6.5 with little binding at pH values below 4.2 or above 8.0. The site at which phenoxybenzamine bound to calmodulin appears to be similar to that at which certain antipsychotic agents bind, since several of them, including penfluridol, pimozide and spiroperidol, prevented the binding of phenoxybenzamine to calmodulin.|phenoxybenzamine|calmodulin|44|47|Arg1:T12|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|1017
8730743|The time course of the reduction in the number of 5-HT2A receptors was similar to that of the DMI-induced behavioural changes whereas that for the reduction in beta-adrenoceptors was clearly different.|DMI|5-HT2A|19|11|Arg1:T4|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1018
23220618|And, the effects of the compounds on expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were tested in tumor necrosis factor-(TNF)-α activated HUVECs. Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, both agents elicited anticoagulant effects in mouse.|IMG|thrombin|62|68|Arg1:T12|Arg2:T35|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1019
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|benzamide|5-HT2|19|28|Arg1:T1|Arg2:T34|CHEMICAL|GENE|ANTAGONIST|1020
1705137|Before the next drug intake, MAO-A inhibition, as judged by the decrease of plasma DHPG concentration, was significantly different from placebo with moclobemide but not with toloxatone.|moclobemide|MAO-A|26|7|Arg1:T11|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1021
17015640|Licofelone almost abolished 5-LOX activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood.|thromboxane B2|5-LOX|17|4|Arg1:T7|Arg2:T25|CHEMICAL|GENE|PRODUCT-OF|1022
7926307|The drug had a potent cytotoxic effect on RIN cells expressing GLUT2, but had no effect on cells lacking GLUT2 expression, as indicated by histological analysis and measurement of the blood glucose levels of treated animals.|glucose|GLUT2|34|12|Arg1:T10|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|1023
20421509|Phenothiazines inhibit S100A4 function by inducing protein oligomerization.|Phenothiazines|S100A4|1|3|Arg1:T20|Arg2:T43|CHEMICAL|GENE|INHIBITOR|1024
23414340|Although thioredoxin reductase (TRR) inhibitors (aurothioglucose and Sb(III)) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.|aurothioglucose|TRR|9|5|Arg1:T17|Arg2:T49|CHEMICAL|GENE|INHIBITOR|1025
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|dFdC|Lys27Gln|43|8|Arg1:T11|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|1026
15732037|Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.|carvedilol|HIF-1alpha|3|10|Arg1:T1|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1027
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|retinoic acid|ABCA1|17|4|Arg1:T10|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1028
23220618|In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-α-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.|hyperoside|PAI-1|8|16|Arg1:T16|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1029
15198222|CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.|nimesulide|Canine COX-2|14|6|Arg1:T3|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1030
23412396|Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects.|JZL184|Monoacylglycerol Lipase|10|7|Arg1:T18|Arg2:T29|CHEMICAL|GENE|INHIBITOR|1031
17350061|Estrogen-regulated genes including cytokeratin 1-19 and Cyp2a4 were over-expressed, although Cyp3a25 was suppressed.|Estrogen|cytokeratin 1-19|1|4|Arg1:T24|Arg2:T42|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1032
19023039|Triphosphate nucleotides (ATP, GTP, and UTP) rapidly and reversibly inhibited Panx1 currents via mechanism(s) independent of purine receptors.|GTP|Panx1|6|15|Arg1:T9|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1033
23550066|ThioTEPA (CYP2B6 inhibitor, 25 μM) and the monoclonal antibody against CYP2B6 but not troleandomycin (CYP3A4 inhibitor, 25 μM) or the monoclonal antibody against CYP3A4 inhibited ketamine N-demethylation at clinically relevant concentrations.|ThioTEPA|CYP2B6|1|3|Arg1:T2|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1034
23123662|DRG neurons display substantial capacity for accumulating copper via a transport process mediated by rCtr1, but appear able to resist copper toxicity and use alternative mechanisms to take up oxaliplatin.|oxaliplatin|rCtr1|31|15|Arg1:T13|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|1035
9832994|These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.|pizotifen|5-HT2|11|7|Arg1:T6|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|1036
23273219|Synthesis, molecular modeling and evaluation of novel N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and Aβ aggregation.|N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone|Aβ|9|21|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1037
15866288|  The purpose of the present study was to test our hypothesis that amiloride, a specific u-PA inhibitor, effectively decreases u-PA activity in cornea as well as in tear fluid and favourably affects corneal healing.|amiloride|u-PA|13|17|Arg1:T6|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1038
14501155|The 5-HT(1/2/5/7)-receptor antagonist methysergide and the 5-HT(2A/2B/2C)-receptor antagonist LY 53857 enhanced clomipramine-induced hyperglycemia, while the 5-HT(1A/1B)-receptor antagonist (-)-propranolol and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it.|tropisetron|5-HT(3/4)-receptor|43|37|Arg1:T11|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|1039
16424790|Given the treatment with three doses of Captopril (15 approximately 45 mg/kg) markedly attenuated inhibition of vasodilator responses to ACh, and eliminated the increased level of malondialdehyde, the decreased level of NO, activity of PON1 and SOD in serum by single intragastric gavaged L-methionine.|Captopril|SOD|8|42|Arg1:T10|Arg2:T59|CHEMICAL|GENE|ACTIVATOR|1040
17205056|The demonstration that sorafenib exhibits potent target inhibition and efficacy in FLT3-driven models suggests that this compound may have a therapeutic benefit for patients with FLT3-driven leukemias.|sorafenib|FLT3|4|26|Arg1:T1|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1041
23601203|Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.|amino acid|Human Serum Albumin|21|7|Arg1:T3|Arg2:T11|CHEMICAL|GENE|PART-OF|1042
17018843|Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1 (PI3K-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor wortmannin or a dominant-negative SGK1.|wortmannin|PI3K|38|19|Arg1:T4|Arg2:T42|CHEMICAL|GENE|INHIBITOR|1043
15732037|Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.|carvedilol|NGF-beta|3|17|Arg1:T1|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1044
11695255|These studies demonstrate the ability to assess the time course and selective effects of COX-2 inhibitors in vivo and suggest that suppression of COX-2 mediated PGE2 is temporally related to NSAID analgesia.|PGE2|COX-2|26|24|Arg1:T9|Arg2:T18|CHEMICAL|GENE|PRODUCT-OF|1045
23479738|In this setting, S-nitrosocysteine (10 μm) effectively blocked the Trx-mediated regeneration of oxidized Prx1.|S-nitrosocysteine|Trx|5|13|Arg1:T5|Arg2:T37|CHEMICAL|GENE|INHIBITOR|1046
15498586|An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.|glucose|GLUT4|10|13|Arg1:T11|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|1047
23382074|Moreover, we show that USP22 is acetylated on multiple lysine residues and that alteration of a single lysine (K129) within the ZnF-UBP domain is sufficient to alter interaction of the DUBm with the core SAGA complex.|lysine|USP22|11|6|Arg1:T2|Arg2:T20|CHEMICAL|GENE|PART-OF|1048
22370641|Epi increased the activity of the human WNT6 promoter through Cav1-dependent binding of β-catenin to the proximal WNT6 promoter.|Epi|WNT6 promoter|1|18|Arg1:T10|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|1049
23220644|Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase.|5-hydroxytryptamines|leukotriene A4 hydrolase|3|12|Arg1:T6|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1050
12105857|CONCLUSIONS: These results collectively indicate that thalidomide prevents alcoholic liver injury through suppression of TNF-alpha production and abolishment of KC sensitization.|thalidomide|TNF-alpha|8|16|Arg1:T11|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1051
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|cyclin D1|3|40|Arg1:T8|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1052
17138644|Progestin activation of Src/MAPK occurred outside the nucleus with the B isoform of PR that was distributed between the cytoplasm and nucleus, but not with PR-A that was predominantly nuclear.|Progestin|Src|1|4|Arg1:T5|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|1053
23123662|Cultured rat DRG neurons endogenously expressed rCtr1 protein on their neuronal cell body plasma membranes and cytoplasm, and displayed substantial capacity for taking up copper, but were resistant to copper toxicity.|copper|rCtr1|26|7|Arg1:T24|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|1054
23123662|Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.|cisplatin|rCtr1|22|4|Arg1:T22|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|1055
22301814|The treatment with arsenic exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine).|arsenic|alkaline phosphatase|4|24|Arg1:T4|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1056
15353299|Thymidylate synthase (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.|2-deoxythymidine-5-monophosphate|TS|44|4|Arg1:T21|Arg2:T31|CHEMICAL|GENE|PRODUCT-OF|1057
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|SU11248|kinase|25|44|Arg1:T16|Arg2:T35|CHEMICAL|GENE|INHIBITOR|1058
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|dydrogesterone|17beta-hydroxysteroid-dehydrogenase type 1|10|36|Arg1:T8|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1059
15805193|Phenytoin is principally metabolized by CYP2C9, and both are probable substrates of the drug transporter P-glycoprotein.|Phenytoin|drug transporter|1|15|Arg1:T6|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|1060
23246481|The mechanism revealed that wogonin inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of VE-cadherin and β-catenin.|H2O2|caveolin-1|7|10|Arg1:T9|Arg2:T18|CHEMICAL|GENE|ACTIVATOR|1061
17344208|  Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.|glutamate|PRODH|23|4|Arg1:T4|Arg2:T19|CHEMICAL|GENE|PRODUCT-OF|1062
10712236|Inhibition of S-adenosylmethionine decarboxylase by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC.|DEGBG|S-adenosylmethionine decarboxylase|16|3|Arg1:T4|Arg2:T33|CHEMICAL|GENE|INHIBITOR|1063
23574017|Doxorubicin is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.|Doxorubicin|P-glycoprotein|1|9|Arg1:T7|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|1064
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|sodium-coupled neutral amino acid transporter 1|12|52|Arg1:T21|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|1065
7986344|The folding rate monitored by 2'CMP binding to the major slow-folding species of Pro42Ala RNase A is faster than the folding rate monitored by tyrosine burial; however, the folding rate monitored by inhibitor binding to the minor slow-folding species is decreased significantly over the folding rate monitored by tyrosine burial, indicating that the major and minor slow-folding species of Pro42Ala fold to the native state with different transition-state conformations in the rate-determining step.|2'CMP|Pro42Ala|6|14|Arg1:T10|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|1066
10640321|The nonselective opioid receptor antagonist, naloxone (3 mg/kg, i.m.), attenuated the antitussive effects of codeine or SB 227122, indicating that the antitussive activity of both compounds is opioid receptor-mediated.|SB 227122|opioid receptor|23|35|Arg1:T14|Arg2:T28|CHEMICAL|GENE|AGONIST|1067
6227474|However, due to the very high affinity of CBG for corticosterone at 4 C, this slight contamination resulted in significant alterations in the apparent affinity of steroids competing for aldosterone-binding sites.|corticosterone|CBG|12|10|Arg1:T14|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|1068
10225363|To establish the relative importance of these subtypes, we compared the effects of sumatriptan with those of a selective 5-HT1F receptor agonist (LY 344864) on c-fos protein expression in the trigeminal nucleus caudalis.|LY 344864|5-HT1F|25|21|Arg1:T2|Arg2:T18|CHEMICAL|GENE|AGONIST|1069
16516814|Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the PKC inhibitor Go 6976, thapsigargin, as well as the calmodulin antagonists W7 and W13.|Go 6976|PKC|32|30|Arg1:T8|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1070
23261590|In addition, we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.|neoechinulin A|tumour necrosis factor-α|7|17|Arg1:T10|Arg2:T33|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1071
23091188|Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.|lopinavir|protease|4|2|Arg1:T21|Arg2:T51|CHEMICAL|GENE|INHIBITOR|1072
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|hydrogen peroxide|NRF2|38|27|Arg1:T4|Arg2:T8|CHEMICAL|GENE|ACTIVATOR|1073
17350061|Several genes involved with steroid metabolism also showed remarkable expression changes, including increased expression of 17beta-hydroxysteroid dehydrogenase-7 (HSD17beta7; involved in estradiol production) and decreased expression of HSD17beta5 (involved in testosterone production).|estradiol|HSD17beta7|24|20|Arg1:T4|Arg2:T31|CHEMICAL|GENE|PRODUCT-OF|1074
14751502|Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of GW572016 to inhibit downstream ERK and Akt activation, despite inhibition of HER2 phosphorylation.|GW572016|HER2|13|25|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1075
20724158|METHODS: We conducted a case-control study to measure the association between selective cox-2 inhibitors, particularly celecoxib, rofecoxib, valdecoxib and non-specific NSAID subgroups, and breast cancer risk.|valdecoxib|cox-2|22|14|Arg1:T6|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1076
23625804|We recently showed that the first domain of human CCS (hCCSD1) is responsible for copper transfer to its protein partner, human SOD1 (hSOD1).|copper|human SOD1|17|24|Arg1:T2|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|1077
23643745|The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.|amisulpride|D2|33|29|Arg1:T6|Arg2:T45|CHEMICAL|GENE|ANTAGONIST|1078
11730729|In conclusion, fenoterol-induced constitutive beta(2)-adrenoceptor activity reduces muscarinic receptor agonist- and histamine-induced contractions of bovine tracheal smooth muscle, which can be reversed by the inverse agonist timolol.|timolol|beta(2)-adrenoceptor|33|6|Arg1:T7|Arg2:T22|CHEMICAL|GENE|AGONIST-INHIBITOR|1079
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|β-catenin|3|28|Arg1:T8|Arg2:T14|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1080
11730729|After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full muscarinic receptor agonist methacholine, the partial muscarinic receptor agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and histamine.|methacholine|muscarinic receptor|23|20|Arg1:T9|Arg2:T26|CHEMICAL|GENE|AGONIST|1081
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|risperidone|5-HT(2A)|34|51|Arg1:T5|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|1082
11695255|A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective cyclooxygenase (COX)-2 inhibitor (celecoxib) in comparison to a dual COX-1/COX-2 inhibitor (ketorolac).|celecoxib|cyclooxygenase (COX)-2|39|32|Arg1:T10|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1083
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|4-ABP|cyt b5|15|51|Arg1:T22|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1084
2899826|Their histamine H1 receptor binding affinities indicate that metabolites may contribute to the sedative effects of chlorpromazine and levomepromazine.|chlorpromazine|histamine H1 receptor|17|2|Arg1:T2|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|1085
23561088|These findings indicate that MBE and its anthocyanidins suppress the light-induced photoreceptor cell death by inhibiting ROS production, suggesting that the inhibition of phosphorylated-p38 may be involved in the underlying mechanism.|anthocyanidins|phosphorylated-p38|8|25|Arg1:T14|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1086
8294418|  The mechanism by which norepinephrine (NE) down-regulates alpha 1B-adrenergic receptor (alpha-AR) mRNA was studied in rabbit aortic smooth muscle cells.|norepinephrine|alpha 1B-adrenergic receptor|5|10|Arg1:T3|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1087
11585753|These studies suggest that HER2-overexpressing tumors are particularly susceptible to the inhibition of HER family tyrosine kinase signaling and suggest novel strategies to treat these particularly aggressive tumors.|tyrosine|tyrosine kinase|16|16|Arg1:T1|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|1088
15498586|Of note, we demonstrated for the first time that telmisartan augmented GLUT4 protein expression and 2-deoxy glucose uptake both in basal and insulin-stimulated state of adipocytes, which may contribute, at least partly, to its insulin-sensitizing ability.|2-deoxy glucose|GLUT4|17|13|Arg1:T8|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|1089
20596674|  Etoposide (VP-16) is a topoisomerase-II (topo II) inhibitor chemotherapeutic agent.|VP-16|topo II|3|9|Arg1:T4|Arg2:T34|CHEMICAL|GENE|INHIBITOR|1090
23228697|This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2, a carboxylesterase with little lipase activity.|orlistat|lipase|10|25|Arg1:T6|Arg2:T29|CHEMICAL|GENE|INHIBITOR|1091
17218486|Interestingly, both isomers of METH were full agonists at mTAAR1 and h-rChTAAR1, whereas both were partial agonists at rTAAR1.|METH|mTAAR1|6|11|Arg1:T5|Arg2:T43|CHEMICAL|GENE|AGONIST-ACTIVATOR|1092
12383039|  OBJECTIVE: Fondaparinux sodium is the first in a new class of synthetic factor Xa inhibitors that binds reversibly with high affinity to antithrombin III.|Fondaparinux sodium|antithrombin III|3|24|Arg1:T2|Arg2:T7|CHEMICAL|GENE|DIRECT-REGULATOR|1093
17218486|Interestingly, both isomers of METH were full agonists at mTAAR1 and h-rChTAAR1, whereas both were partial agonists at rTAAR1.|METH|rTAAR1|6|21|Arg1:T5|Arg2:T45|CHEMICAL|GENE|AGONIST|1094
23290724|  The cellular prion protein PrP(C) consists of two domains--a flexible N-terminal domain, which participates in copper and zinc regulation, and a largely helical C-terminal domain that converts to β sheet in the course of prion disease.|C|prion protein PrP(C)|31|3|Arg1:T3|Arg2:T10|CHEMICAL|GENE|PART-OF|1095
7560228|Hence, triclosan has the ability to inhibit both the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism with similar efficacy.|triclosan|lipoxygenase|3|13|Arg1:T5|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1096
9015795|However, because clozapine competes with endogenous dopamine, the in vivo concentration of clozapine (to occupy dopamine D4 receptors) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients.|dopamine|dopamine D4 receptors|8|19|Arg1:T7|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|1097
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|guanidine|OCT|14|23|Arg1:T6|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|1098
23477419|Of the new compounds, Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4) (analogue 12) displayed the highest affinity toward MOR, in the picomolar range (Ki(μ) = 3.72 pM).|Trp|MOR|19|39|Arg1:T10|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|1099
12392782|They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.|ibuprofen|COX-1|17|15|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1100
14751502|RESULTS: GW572016 inhibited constitutive and/or ligand-induced EGFR or HER2 tyrosine phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line.|tyrosine|HER2|11|10|Arg1:T10|Arg2:T39|CHEMICAL|GENE|PART-OF|1101
23231502|Incubation of purified Pin1 with HNE followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues His-157 and Cys-113.|His|Pin1|23|4|Arg1:T18|Arg2:T30|CHEMICAL|GENE|PART-OF|1102
23455597|  RATIONALE: Histamine H3 receptor antagonists, such as ABT-288, have been shown to possess cognitive-enhancing and wakefulness-promoting effects.|ABT-288|Histamine H3 receptor|10|3|Arg1:T10|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|1103
23628605|The precise fashion in which these proteins interact and move cholesterol from the OMM to P450scc, and the means by which cholesterol is loaded into the OMM, remain unclear.|cholesterol|P450scc|11|16|Arg1:T1|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|1104
22982218|In TPC1, BCPAP, FRO, WRO cell lines PJ34 induced a strong increase in NIS mRNA levels.|PJ34|NIS|11|17|Arg1:T2|Arg2:T10|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1105
23395914|The involvement of P-gp in the absorption of darunavir was clearly shown by coperfusion of darunavir with the P-gp inhibitor zosuquidar.|darunavir|P-gp|9|4|Arg1:T10|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|1106
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|Rosiglitazone|glucose transporter 4|25|50|Arg1:T21|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1107
16774921|We propose that the secondary role of yeast mitochondrial LeuRS in RNA splicing has impacted the functional evolution of this critical C-terminal domain.|C|yeast mitochondrial LeuRS|22|8|Arg1:T6|Arg2:T18|CHEMICAL|GENE|PART-OF|1108
12901032|Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.|salsalate|cyclooxygenase-2|22|10|Arg1:T6|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1109
10583449|This hypothesis was tested by investigating whether, in subjects with essential hypertension, the natriuretic response to specific renin-angiotensin-aldosterone system (RAAS) blockade by renin-inhibitor remikiren could be predicted from pretreatment renal vascular tone.|remikiren|renin|28|20|Arg1:T12|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1110
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|ASCT1|12|42|Arg1:T21|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|1111
23274058|These data suggest that jaceosidin, isolated from Japanese mugwort, modulates the ERK/ATM/Chk1/2 pathway, leading to inactivation of the Cdc2-cyclin B1 complex, followed by G2/M cell cycle arrest in endometrial cancer cells.|jaceosidin|Cdc2|5|22|Arg1:T6|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1112
8606397|One group of experimental animals was treated with 5-lipoxygenase (5-LO) inhibitor, diethylcarbamazine (DEC, Sigma, St. Louis, Missouri) (50 mg/kg, i.v.), immediately before blast.|DEC|5-LO|17|11|Arg1:T5|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1113
17594192|Phenserine apparently reduces translational efficiency of APP mRNA into protein, a process that may involve an interaction with iron and/or an iron-responsive element.|Phenserine|APP|1|7|Arg1:T10|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1114
17350061|Various genes controlled by estrogen, including X-inactive-specific transcript, anterior gradient-2, trefoil factor-1, CRP-ductin, ghrelin, and small proline-rich protein-2A, were dramatically over-expressed.|estrogen|anterior gradient-2|5|11|Arg1:T22|Arg2:T37|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1115
23564313|Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.|vinblastine|Ras homologous protein A|3|8|Arg1:T7|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|1116
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|glycogen synthase kinase 3β|1|34|Arg1:T6|Arg2:T42|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1117
16516814|In addition to this evidence (for the involvement of EP2 receptors), evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of Na,K-ATPase beta subunit gene transcription includes the stimulatory effect of 17-phenyl trinor PGE2, as well as the inhibitory effects of SC-51089.|SC-51089|Na,K-ATPase beta|51|28|Arg1:T6|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1118
17015640|Licofelone almost abolished 5-LOX activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood.|leukotriene B4|5-LOX|8|4|Arg1:T6|Arg2:T25|CHEMICAL|GENE|PRODUCT-OF|1119
23435910|Furthermore, sinapic acid reduced hepatic hydroxyproline content, which correlated with a reduction in the expression of type I collagen mRNA and histological analysis of collagen in liver tissue.|sinapic acid|type I collagen|3|19|Arg1:T14|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1120
2888789|Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actions.|Bevantolol|beta-1 adrenoceptor|1|4|Arg1:T7|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|1121
16893531|Coadministration of reboxetine and the dopamine transporter blocker GBR 12909 also increased spontaneous locomotor activity.|GBR 12909|dopamine transporter|9|6|Arg1:T6|Arg2:T25|CHEMICAL|GENE|INHIBITOR|1122
15474503|These results suggest that pitavastatin efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.|pitavastatin|HMG-CoA reductase|5|23|Arg1:T1|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1123
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|2',2'-difluorodeoxyuridine|Ala70Thr|48|10|Arg1:T12|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|1124
23432124|Racemic IKM-159 was crystallized with the ligand-binding domain of GluA2, and the structure revealed a complex containing (2R)-IKM-159 at the glutamate binding site.|(2R)-IKM-159|GluA2|19|10|Arg1:T10|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|1125
7560228|Triclosan also inhibited 5-lipoxygenase with an IC-50 of 43 microM.|Triclosan|5-lipoxygenase|1|4|Arg1:T2|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1126
23250811|Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.|Curcumin|TLR4|1|13|Arg1:T15|Arg2:T39|CHEMICAL|GENE|INHIBITOR|1127
16247743|Miglustat, an imino sugar that reversibly inhibits glucosylceramide synthase and reduces intracellular substrate burden, is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option.|imino sugar|glucosylceramide synthase|4|9|Arg1:T5|Arg2:T9|CHEMICAL|GENE|INHIBITOR|1128
11588409|Omapatrilat, the prototypical vasopeptidase inhibitor, inhibits not only ACE but also neutral endopeptidase.|Omapatrilat|ACE|1|11|Arg1:T9|Arg2:T21|CHEMICAL|GENE|INHIBITOR|1129
7599160|Intracellular protein-bound [57Co]Cbl fractionated with methionine synthase (MS) and methylmalonyl-CoA mutase (MU) activity.|[57Co]Cbl|MS|3|12|Arg1:T24|Arg2:T34|CHEMICAL|GENE|DIRECT-REGULATOR|1130
23172777|Based on these suggestions, the rational redesign of furanopyrimidine 24 (clog P=7.41; Aurora A IC(50) =43 nM; HCT-116 IC(50) =400 nM) led to the identification of quinazoline 67 (clog P=5.28; Aurora A IC(50) =25 nM; HCT-116 IC(50) =23 nM).|furanopyrimidine|Aurora A|10|16|Arg1:T1|Arg2:T6|CHEMICAL|GENE|INHIBITOR|1131
8294418|Neither ryanodine nor EGTA inhibited down-regulation of alpha-AR mRNA by NE.|ryanodine|alpha-AR|2|8|Arg1:T9|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1132
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|Wy-14643|PPARalpha1|13|6|Arg1:T11|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|1133
10988273|The antagonistic property of rilmenidine at human alpha(2A)-adrenoceptors indicates that in contrast to the suggestion based on rabbit data, the hypotensive property of the drug in humans is not due to activation of alpha(2A)-adrenoceptors but other, presumably I(1)-imidazoline receptors, are probably involved.|rilmenidine|human alpha(2A)-adrenoceptors|5|7|Arg1:T8|Arg2:T22|CHEMICAL|GENE|ANTAGONIST|1134
16789740|As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening.|anthranilic acid sulfonamides|MetAP2|18|13|Arg1:T2|Arg2:T7|CHEMICAL|GENE|DIRECT-REGULATOR|1135
23182954|Ozone plus PM(2.5) exposure, however, induced CRP, IL-6, CK, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.|Ozone|IL-6|1|14|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1136
23584358|There were statistically significant increases in the activities of aspartate aminotransferase, alanine aminotransferase, levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and 8-iso-prostane, and decreases in the activity of superoxide dismutase and level of glutathione in the group treated with paracetamol.|paracetamol|alanine aminotransferase|49|13|Arg1:T8|Arg2:T32|CHEMICAL|GENE|ACTIVATOR|1137
12181285|  Reuptake of extracellular noradrenaline (NA) into superior cervical ganglion (SCG) neurones is mediated by means of the noradrenaline transporter (NAT, uptake 1).|noradrenaline|noradrenaline transporter|4|22|Arg1:T17|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1138
12414329|This approach is validated by the clinical efficacy and safety of sildenafil, the pioneering drug for selective PDE5 inhibitor therapy for ED.|sildenafil|PDE5|12|19|Arg1:T10|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1139
7560228|Hence, triclosan has the ability to inhibit both the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism with similar efficacy.|arachidonic acid|lipoxygenase|16|13|Arg1:T6|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|1140
12086935|We recently reported that AMPK is activated by metformin in cultured rat hepatocytes, mediating the inhibitory effects of the drug on hepatic glucose production.|metformin|AMPK|9|5|Arg1:T12|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|1141
22718571|Anti-diabetic Activity of Swertiamarin is due to an Active Metabolite, Gentianine, that Upregulates PPAR-γ Gene Expression in 3T3-L1 cells.|Gentianine|PPAR-γ|12|16|Arg1:T13|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1142
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|butaprost|EP2 receptors|26|6|Arg1:T15|Arg2:T33|CHEMICAL|GENE|AGONIST|1143
12244038|Gemfibrozil induced peroxisome proliferator-responsive element (PPRE)-dependent luciferase activity, which was inhibited by the expression of DeltahPPAR-alpha, the dominant-negative mutant of human PPAR-alpha.|Gemfibrozil|peroxisome proliferator-responsive element|1|3|Arg1:T13|Arg2:T62|CHEMICAL|GENE|ACTIVATOR|1144
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|Wy-14643|PPARalpha2|13|30|Arg1:T11|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|1145
11392054|  Carbonic anhydrase (CA) is a zinc enzyme that catalyses the reversible hydration reaction of CO2 and plays a major role in the acid-base balance.|CO2|Carbonic anhydrase|17|1|Arg1:T24|Arg2:T25|CHEMICAL|GENE|SUBSTRATE_PRODUCT-OF|1146
10988273|In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the alpha(2)-autoreceptors, sharing this property with rauwolscine, phentolamine, and idazoxan.|oxymetazoline|alpha(2)-autoreceptors|9|26|Arg1:T16|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|1147
12181285|  Reuptake of extracellular noradrenaline (NA) into superior cervical ganglion (SCG) neurones is mediated by means of the noradrenaline transporter (NAT, uptake 1).|noradrenaline|NAT|4|25|Arg1:T17|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|1148
23220644|  Dual function inhibitors targeting phospholipase A(2) (PLA(2)) and leukotriene A(4) hydrolase (LTA(4)H) may balance the arachidonic acid (AA) metabolic network and be used as new anti-inflammatory drugs.|arachidonic acid|leukotriene A(4) hydrolase|33|17|Arg1:T1|Arg2:T13|CHEMICAL|GENE|PRODUCT-OF|1149
2982865|Multiple affinity states of opiate receptor can be demonstrated further by Scatchard analysis of saturation binding studies with [3H]DADLE.|[3H]DADLE|opiate receptor|19|5|Arg1:T3|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|1150
17344208|  Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.|proline|Proline dehydrogenase|21|1|Arg1:T2|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|1151
9204085|Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors, retinoic acid receptors (RARs).|adapalene|nuclear transcription factors|14|19|Arg1:T9|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|1152
16938288|Decreased AT1R promoter activity with unchanged mRNA stability suggested that telmisartan suppressed AT1R gene expression at the transcriptional level.|telmisartan|AT1R|11|13|Arg1:T10|Arg2:T36|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1153
8636122|Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.|SR 141716A|CB1|18|16|Arg1:T14|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|1154
17199504|  Adenine phosphoribosyltransferase plays a role in purine salvage by catalyzing the direct conversion of adenine to adenosine monophosphate.|adenosine monophosphate|Adenine phosphoribosyltransferase|17|1|Arg1:T3|Arg2:T12|CHEMICAL|GENE|PRODUCT-OF|1155
23435942|Cholinesterase inhibitors enhance cholinergic transmission directly by inhibiting the enzyme acetylcholinesterase (AChE) which hydrolyses acetylcholine.|acetylcholine|AChE|17|13|Arg1:T10|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|1156
23638842|RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive RS -GRA significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1β (IL-1β), and apoptosis (Bax and caspase 3 expression).|RS -GRA|IL-1β|19|38|Arg1:T1|Arg2:T11|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1157
16965760|  Phospholipase C beta (PLC-beta)-coupled G protein-coupled receptor (GPCR) activities traditionally are assessed by measuring Ca2+ triggered by D-myo-inositol 1,4,5-trisphosphate (IP3), a PLC-beta hydrolysis product, or by measuring the production of inositol phosphate using cumbersome radioactive assays.|inositol phosphate|PLC-beta|40|30|Arg1:T8|Arg2:T25|CHEMICAL|GENE|PRODUCT-OF|1158
23296837|In cultured primary microglia and astrocytes, EHT had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced NFκB activation, iNOS induction, and nitric oxide production.|EHT|NFκB|8|19|Arg1:T1|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1159
21712771|Antibodies to either the C- or N- terminus of VMAT-1 detected two proteins (73 and 55 kD) in transfected COS-1 cells.|N|VMAT-1|7|10|Arg1:T2|Arg2:T8|CHEMICAL|GENE|PART-OF|1160
9551716|  The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of neurotensin receptors, [3H]SR 142948A (2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methyl carbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]-amino]-ad amantane-2-carboxylic acid, hydrochloride), in the rat brain.|2-[[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methyl carbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]-amino]-ad amantane-2-carboxylic acid, hydrochloride|neurotensin receptors|29|20|Arg1:T14|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|1161
1705137|Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.|moclobemide|monoamine oxidase|16|4|Arg1:T43|Arg2:T51|CHEMICAL|GENE|INHIBITOR|1162
10424850|Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells.|Desipramine|norepinephrine transporter|1|7|Arg1:T7|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1163
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Imatinib|ABL|1|24|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|1164
10701840|Improper function of these proteins can be induced by selective disruption of their complexes with Hsp90 using the benzoquinonoid ansamycin geldanamycin.|geldanamycin|Hsp90|21|16|Arg1:T3|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1165
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|dFdC|Ala119Gly|43|17|Arg1:T11|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|1166
2859531|To study the mechanism underlying this phenomenon, the effects of the nonselective beta-adrenoceptor antagonists propranolol [no intrinsic sympathomimetic activity (ISA)], alprenolol (weak ISA) and mepindolol (strong ISA) on lymphocyte beta 2-adrenoceptor density--assessed by (+/-)-[125I]-iodocyanopindolol (ICYP) binding--and plasma renin activity (PRA) were investigated in male healthy volunteers aged 23-35 years.|propranolol|beta-adrenoceptor|16|14|Arg1:T5|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|1167
12614192|Many clinical studies, both pre- and post-marketing, have demonstrated the clinical efficacy and safety of sildenafil (Viagra, Pfizer) - the first approved selective PDE inhibitor for the treatment of ED.|Viagra|PDE|20|29|Arg1:T4|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1168
23481236|A clear relationship between PTP1B phosphorylation levels at Ser 50 and its negative effect on insulin signaling is shown.|Ser|PTP1B|9|5|Arg1:T8|Arg2:T35|CHEMICAL|GENE|PART-OF|1169
11089538|  Insulin-like growth factor (IGF)-binding protein (IGFBP)-related proteins (IGFBP-rPs) are newly described cysteine-rich proteins that share significant aminoterminal structural similarity with the conventional IGFBPs and are involved in a diversity of biological functions, including growth regulation.|cysteine|IGFBP-rPs|20|15|Arg1:T1|Arg2:T27|CHEMICAL|GENE|PART-OF|1170
23412396|Mice given daily injections of high dose JZL184 (≥16 mg/kg) for six days displayed decreased CB(1) receptor density and function in brain, as assessed in [(3)H]SR141716A binding and CP55,940-stimulated [(35)S]GTPγS binding assays, respectively.|[(3)H]SR141716A|CB(1)|32|18|Arg1:T14|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|1171
3735252|Gossypol and its isomers were non-competitive inhibitors of human and hamster LDH-X with respect to the coenzyme NADH, competitive inhibitors of human LDH-X and noncompetitive-competitive inhibitors of hamster LDH-X with respect to the substrate alpha-ketobutyrate.|NADH|human LDH-X|18|23|Arg1:T6|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1172
23123250|[-]-Huperzine A ([-]-Hup A), is a naturally occurring potent reversible AChE inhibitor that penetrates the blood-brain barrier.|[-]-Huperzine A|AChE|1|20|Arg1:T15|Arg2:T24|CHEMICAL|GENE|INHIBITOR|1173
10727528|Salicylic acid promotes dissociation of (125)I-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled ET-1.|(125)I|ETA receptor|6|10|Arg1:T11|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|1174
23298677|Induction of HO-1 through p38 MAPK/Nrf2 signaling pathway by ethanol extract of Inula helenium L.|ethanol|p38|10|5|Arg1:T8|Arg2:T39|CHEMICAL|GENE|ACTIVATOR|1175
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|2',2'-difluorodeoxyuridine|Pro122Ser|48|20|Arg1:T12|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|1176
23123662|DRG neurons display substantial capacity for accumulating copper via a transport process mediated by rCtr1, but appear able to resist copper toxicity and use alternative mechanisms to take up oxaliplatin.|copper|rCtr1|8|15|Arg1:T11|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|1177
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|benzamide|5-HT1|19|25|Arg1:T1|Arg2:T33|CHEMICAL|GENE|AGONIST|1178
16774921|The x-ray co-crystal structure of LeuRS showed that a C-terminal extension of about 60 amino acids forms a discrete domain, which is unique among the LeuRSs and interacts with the corner of the L-shaped tRNALeu.|C|LeuRSs|10|27|Arg1:T10|Arg2:T22|CHEMICAL|GENE|PART-OF|1179
12086935|The increase in AMPK alpha2 activity was likely due to a change in muscle energy status because ATP and phosphocreatine concentrations were lower after metformin treatment.|metformin|AMPK alpha2|25|4|Arg1:T5|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|1180
23531488|These variants are expected to encode either a full length (OATP2B1-FL) or shortened protein lacking 22 N-terminus amino acids (OATP2B-Short).|N|OATP2B1-FL|19|12|Arg1:T3|Arg2:T17|CHEMICAL|GENE|PART-OF|1181
16206183|There was close correspondence between peak increases in DA and DAT occupancy.|DA|DAT|9|11|Arg1:T7|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|1182
15939622|However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.|phenylbutazone|COX-2|5|18|Arg1:T6|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1183
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|Wy-14643|PPARalpha2|13|30|Arg1:T11|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|1184
10640321|Parenteral administration of selective agonists of the delta-opioid receptor (SB 227122), mu-opioid receptor (codeine and hydrocodone), and kappa-opioid receptor (BRL 52974) produced dose-related inhibition of citric acid-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively.|hydrocodone|mu-opioid receptor|20|15|Arg1:T9|Arg2:T24|CHEMICAL|GENE|AGONIST|1185
23534442|Finally, molecular modeling and (1)H- and (13)C-NMR studies performed on compounds 6c,d, 9c, and 10b allowed the right conformation of nitrooxyalkyl ester and ether side chain of these molecules within the COX-2 active site to be assessed.|nitrooxyalkyl ester and ether|COX-2|32|43|Arg1:T1|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|1186
23511016|Synthesis of a DOTA (Gd(3+))-conjugate of proton-pump inhibitor pantoprazole for gastric wall imaging studies.|pantoprazole|proton-pump|15|13|Arg1:T8|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1187
16774921|  Leucyl-tRNA synthetase (LeuRS) performs dual essential roles in group I intron RNA splicing as well as protein synthesis within the yeast mitochondria.|Leucyl|Leucyl-tRNA synthetase|1|1|Arg1:T1|Arg2:T17|CHEMICAL|GENE|PART-OF|1188
16618126|Similar to the plasma membrane PS transporter, Atp8a1 is activated only by the naturally occurring sn-1,2-glycerol isomer of PS and not the sn-2,3-glycerol stereoisomer.|sn-1,2-glycerol|Atp8a1|17|9|Arg1:T10|Arg2:T37|CHEMICAL|GENE|ACTIVATOR|1189
22718571|On the other hand, treatment with gentianine significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR-γ, GLUT-4 and adiponectin.|gentianine|GLUT-4|8|27|Arg1:T8|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1190
23598904|Among the possible transporters involved in the uptake of Cd(2+) and Mn(2+), the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.|Mn(2+)|Zrt-, Irt-related protein 8|15|25|Arg1:T22|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|1191
1375507|The inhibitory effects of iloprost on tissue factor expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and dibutyryl cyclic AMP but not dibutyryl cyclic GMP.|ibutyryl cyclic AMP|tissue factor|21|7|Arg1:T8|Arg2:T25|CHEMICAL|GENE|INHIBITOR|1192
16789740|As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening.|anthranilic acid sulfonamides|human MetAP2|18|25|Arg1:T2|Arg2:T8|CHEMICAL|GENE|DIRECT-REGULATOR|1193
23542578|An intermediate GTX2,3-aldehyde was first synthesized by activating the NH2 group of the 2nd and 8th amino acid residues with three different aldehydes and two artificial complete antigens GTX2,3-aldehyde-bovine serum albumin (BSA) and GTX2,3-aldehyde- keyhole limpet hemocyanin (KLH) were then prepared by cross-linking the intermediate with BSA or KLH.|GTX2,3-aldehyde|BSA|29|33|Arg1:T6|Arg2:T11|CHEMICAL|GENE|DIRECT-REGULATOR|1194
14757703|CGP 12177A mediates cardiostimulation by activation of the 'putative' beta(4)-adrenoceptor; however, it has recently been reported that disruption of the beta(1)-adrenoceptor gene abolishes this effect.|CGP 12177A|beta(4)-adrenoceptor|1|11|Arg1:T14|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|1195
23584358|In conclusion, agomelatine administration protects liver cells from paracetamol-induced hepatotoxicity via antioxidant activity and reduced proinflammatory cytokines, such as TNF-α and IL-6.|agomelatine|TNF-α|4|22|Arg1:T11|Arg2:T40|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1196
20012638|  Terbutaline (Bricanyl) and its prodrug Bambuterol (Bambec) are highly potent beta(2)-adrenoceptor agonists often used in asthma patients.|Bambec|beta(2)-adrenoceptor|10|15|Arg1:T13|Arg2:T22|CHEMICAL|GENE|AGONIST|1197
20421509|NMR chemical shift perturbations are consistent with the crystal structure and demonstrate that TFP binds to the target binding cleft of S100A4 in solution.|TFP|S100A4|14|22|Arg1:T18|Arg2:T42|CHEMICAL|GENE|DIRECT-REGULATOR|1198
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|STI571|PDGFRA|3|28|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1199
12244038|Inhibition of human iNOS promoter-driven luciferase activity by gemfibrozil in cytokine-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS.|gemfibrozil|human iNOS promoter|9|3|Arg1:T10|Arg2:T54|CHEMICAL|GENE|INHIBITOR|1200
19389876|In summary, ketoconazole had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan; therefore, no changes in ambrisentan dose should be necessary when the drug is administered concomitantly with known CYP3A4 inhibitors.|ketoconazole|CYP3A4|4|37|Arg1:T14|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1201
9832994|These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.|pizotifen|5-HT1|11|6|Arg1:T6|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|1202
11742712|  Pemetrexed disodium (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.|ALIMTA|glycinamide ribonucleotide formyltransferase|4|25|Arg1:T6|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1203
3134891|It was also dependent upon temperature, the presence of a divalent cation such as calcium, and on pH, showing maximum binding at pH 6.5 with little binding at pH values below 4.2 or above 8.0. The site at which phenoxybenzamine bound to calmodulin appears to be similar to that at which certain antipsychotic agents bind, since several of them, including penfluridol, pimozide and spiroperidol, prevented the binding of phenoxybenzamine to calmodulin.|pimozide|calmodulin|69|79|Arg1:T15|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|1204
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Lapatinib ditosylate|TK|18|3|Arg1:T17|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1205
17015640|Licofelone reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, monocyte chemoattractant protein-1 (MCP-1) gene expression, and the activation of nuclear factor-kappaB in rabbit atheroma.|Licofelone|monocyte chemoattractant protein-1|1|17|Arg1:T16|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1206
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|ferulic acid|EC 4.2.1.1|22|51|Arg1:T3|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1207
11588409|Like conventional ACE inhibitors, omapatrilat causes extracellular volume reduction and vasodilatation; moreover, it increases levels of atrial and brain natriuretic peptides and bradykinin.|omapatrilat|atrial and brain natriuretic peptides|6|20|Arg1:T10|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1208
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Erlotinib|kinase|26|44|Arg1:T6|Arg2:T45|CHEMICAL|GENE|INHIBITOR|1209
15991937|Losartan: a selective angiotensin II type 1 (AT1) receptor antagonist for the treatment of heart failure.|Losartan|angiotensin II type 1 (AT1) receptor|1|5|Arg1:T17|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|1210
7554708|The daily administration of low-dose aspirin (40 mg), a selective inhibitor of platelet PGHS-1, caused a cumulative inhibition of urinary 11-dehydro-TXB2 and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover.|11-dehydro-TXB2|PGHS-1|25|17|Arg1:T5|Arg2:T24|CHEMICAL|GENE|PRODUCT-OF|1211
12487427|Unlike GW660511X, omapatrilat abolished the production of BrBK1-5 and BrBK1-7, suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found.|omapatrilat|BrBK1-5|4|9|Arg1:T45|Arg2:T84|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1212
16938288|  OBJECTIVE: Telmisartan, an angiotensin II type 1 receptor (AT1R) antagonist, was found to have a unique property: it is a partial agonist of peroxisome proliferator-activated receptor gamma (PPARgamma).|Telmisartan|angiotensin II type 1 receptor|3|6|Arg1:T3|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|1213
16371234|These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with COX-1, especially mPGES-2, plays the pivotal role in PS liposome-induced PGE2 production by microglia.|PGE2|PGESs|28|10|Arg1:T6|Arg2:T33|CHEMICAL|GENE|PRODUCT-OF|1214
23623750|Rates of benzydamine N-oxygenation (catalyzed by FMO3) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in benzydamine N-oxygenation might be partly accounted for by the variable FMO3 expression.|N|FMO3|4|8|Arg1:T5|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|1215
23246481|We found that wogonin can suppress the H2O2-stimulated actin remodeling and albumin uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.|wogonin|actin|4|9|Arg1:T6|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1216
23230131|In conclusion, the Lys27Gln substitution does not significantly modulate CDA activity toward dFdC, and therefore would not contribute to interindividual variability in response to gemcitabine.|dFdC|Lys27Gln|14|5|Arg1:T3|Arg2:T26|CHEMICAL|GENE|SUBSTRATE|1217
11034389|For MICA3, a surface loop containing the sequence PEVKEK and two adjacent exposed helixes were identified in the PLP binding domain as well as a region of the C terminus of GAD65 that has previously been identified as critical for MICA3 binding.|C|GAD65|30|33|Arg1:T13|Arg2:T31|CHEMICAL|GENE|PART-OF|1218
20421509|Together these studies support a unique mode of inhibition in which phenothiazines disrupt the S100A4/myosin-IIA interaction by sequestering S100A4 via small molecule-induced oligomerization.|phenothiazines|myosin-IIA|12|16|Arg1:T9|Arg2:T33|CHEMICAL|GENE|INHIBITOR|1219
17094978|CONCLUSION(S): Short-term exposure of mifepristone in new starters of DMPA increases the expression of endometrial ERalpha, PRAB, PRB, and SRC-1 and promotes cell proliferation.|mifepristone|PRB|9|24|Arg1:T3|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1220
12244038|Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS.|gemfibrozil|PPAR-alpha|21|19|Arg1:T12|Arg2:T60|CHEMICAL|GENE|ACTIVATOR|1221
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|triptorelin|gonadotrophin-releasing hormone (GnRH) receptor|17|23|Arg1:T8|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|1222
16920841|  Choline dehydrogenase (CHDH) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in choline oxidation.|choline|CHDH|17|4|Arg1:T2|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|1223
9399012|  Zolmitriptan (Zomig; formerly 311C90) is a novel 5-hydroxytryptamine (5HT)1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura.|Zomig|5-hydroxytryptamine (5HT)1B/1D|3|11|Arg1:T3|Arg2:T25|CHEMICAL|GENE|AGONIST|1224
15474503|The induction of apoA-I by statins disappeared with addition of mevalonate, which indicates that the effect is HMG-CoA reductase inhibition-dependent.|mevalonate|apoA-I|11|4|Arg1:T6|Arg2:T31|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1225
15723099|Dimemorfan pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression, activator protein (AP)-1 DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus.|KA|c-fos|6|9|Arg1:T26|Arg2:T38|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1226
16344985|Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.|arachidonoyl-CoA|brain microsomal long-chain fatty acyl-CoA synthetases|10|12|Arg1:T28|Arg2:T36|CHEMICAL|GENE|PRODUCT-OF|1227
11730729|After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full muscarinic receptor agonist methacholine, the partial muscarinic receptor agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and histamine.|4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium|muscarinic receptor|30|27|Arg1:T11|Arg2:T27|CHEMICAL|GENE|AGONIST|1228
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|SC-51089|EP1|40|49|Arg1:T16|Arg2:T36|CHEMICAL|GENE|AGONIST|1229
15121646|  OBJECTIVE: Ziprasidone is an atypical antipsychotic drug that shows a higher affinity for serotonin 5-HT(2) receptors compared with dopamine D(2) receptors in vitro.|Ziprasidone|5-HT(2) receptors|3|16|Arg1:T2|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|1230
23643745|The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.|amisulpride|D3|33|30|Arg1:T6|Arg2:T46|CHEMICAL|GENE|ANTAGONIST|1231
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|5,8,11,14-eicosatetraynoic acid|PPARalpha2|15|30|Arg1:T12|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|1232
23550066|These results indicate a major role of CYP2B6 in ketamine N-demethylation in vitro and a significant impact of the CYP2B6*6 allele on enzyme-ketamine binding and catalytic activity.|ketamine|CYP2B6*6|24|20|Arg1:T6|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|1233
23535516|Blockade of JAK and ERK pathways with AG490 and U0126, respectively, abrogated the myocardial infarct size reduction by NDP-α-MSH.|U0126|ERK|10|5|Arg1:T4|Arg2:T31|CHEMICAL|GENE|INHIBITOR|1234
23570998|Further, both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, RunX2, osteoprotegerin and osteocalcin.|flavonoids|osteopontin|5|24|Arg1:T17|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1235
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|Phe|TMH7|10|30|Arg1:T4|Arg2:T46|CHEMICAL|GENE|PART-OF|1236
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|Imatinib|c-Kit|20|38|Arg1:T4|Arg2:T30|CHEMICAL|GENE|INHIBITOR|1237
23541670|Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors.|5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers|kinase|7|17|Arg1:T3|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1238
3345199|  Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.|oximes|AChE|19|3|Arg1:T6|Arg2:T32|CHEMICAL|GENE|ACTIVATOR|1239
7825862|Aspirin irreversibly inhibits PGHS-1, preventing this isozyme from forming PGH2 or any other oxygenated product; in contrast, aspirin treatment of PGHS-2 causes this enzyme to form 15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid (15-HETE) instead of PGH2.|Aspirin|PGHS-1|1|4|Arg1:T7|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1240
10546982|The turnover of SERT was determined from the rate of recovery of binding after administration of RTI-76, an irreversible inhibitor of ligand binding.|RTI-76|SERT|17|4|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INHIBITOR|1241
3134891|In addition, phenoxybenzamine showed little or no calcium-dependent binding to the S-100 protein, bovine serum albumin or cytochrome c.|calcium|cytochrome c|9|20|Arg1:T7|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|1242
19023039|Triphosphate nucleotides (ATP, GTP, and UTP) rapidly and reversibly inhibited Panx1 currents via mechanism(s) independent of purine receptors.|ATP|Panx1|4|15|Arg1:T8|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1243
23293129|Cotreatments of 5, 10 and 20 µg/mL concentrations of MEP with aflatoxin B(1) decreased the frequencies of SCE and the malondialdehyde level and increased amount of superoxide dismutase, glutathione and glutathione peroxidase which were decreased by aflatoxin.|aflatoxin|glutathione peroxidase|42|36|Arg1:T11|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1244
23024204|We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidine/spermine-N(1)-acetyltransferase (SSAT1) and by thialysine acetyltransferase (SSAT2) to its monoacetylated derivative (MAT).|TETA|thialysine acetyltransferase|5|24|Arg1:T8|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|1245
18068977|These results may have implications in the development of novel DPP-IV inhibitors based on the use of atorvastatin as a lead compound for the treatment of type 2 diabetes.|atorvastatin|DPP-IV|18|11|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INHIBITOR|1246
23473681|We previously employed a chemical genomic strategy to identify a novel small molecule, MAC13243, as a likely inhibitor of the bacterial lipoprotein targeting chaperone, LolA.|MAC13243|LolA|15|28|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1247
18973551|Quinpirole and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.|7-OH-DPAT|ERK|3|13|Arg1:T6|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|1248
7825862|We have cloned cDNAs for murine PGHS-1 and PGHS-2, expressed these enzymes in cos-1 cells, and compared the relative sensitivities of the two isozymes to some common NSAIDs. Indomethacin, piroxicam, and sulindac sulfide were found to preferentially inhibit PGHS-1.|piroxicam|PGHS-1|34|44|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1249
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid|mGlu1|25|7|Arg1:T2|Arg2:T48|CHEMICAL|GENE|INHIBITOR|1250
10701840|In this study, we demonstrate that geldanamycin treatment blocks interleukin (IL)-2 secretion, IL-2 receptor expression, and proliferation of stimulated T-lymphocytes.|geldanamycin|interleukin (IL)-2|8|11|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1251
17205056|The growth of the FLT3-independent RS4-11 cell line was only weakly inhibited by sorafenib.|sorafenib|FLT3|14|5|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1252
16988497|A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.|LNA|D6D|43|50|Arg1:T17|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1253
23357629|The keto and phenolic -OH are major factors that are prominently involved in interaction with COX-2 active site.|OH|COX-2|6|16|Arg1:T12|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|1254
12244038|Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes.|Gemfibrozil|nitric-oxide synthase|1|11|Arg1:T17|Arg2:T68|CHEMICAL|GENE|INHIBITOR|1255
10064839|Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.|dimemorfan|sigma-1 receptor|3|5|Arg1:T50|Arg2:T56|CHEMICAL|GENE|DIRECT-REGULATOR|1256
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|Hydrogen sulphide|CBS|1|25|Arg1:T1|Arg2:T38|CHEMICAL|GENE|PRODUCT-OF|1257
20596674|  Etoposide (VP-16) is a topoisomerase-II (topo II) inhibitor chemotherapeutic agent.|VP-16|topoisomerase-II|3|7|Arg1:T4|Arg2:T32|CHEMICAL|GENE|INHIBITOR|1258
11742712|  Pemetrexed disodium (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.|ALIMTA|dihydrofolate reductase|4|21|Arg1:T6|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1259
11551210|  Long-chain alkanols are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral nicotinic acetylcholine receptor (AChR) by binding to one or more specific sites on the AChR.|Long-chain alkanols|nicotinic acetylcholine receptor|1|17|Arg1:T1|Arg2:T24|CHEMICAL|GENE|INHIBITOR|1260
23091188|Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.|ritonavir|protease|9|2|Arg1:T23|Arg2:T51|CHEMICAL|GENE|INHIBITOR|1261
15184278|Plasma from duloxetine-treated subjects (ex vivo effect) dose-dependently decreased radioligand binding to human NET (maximum inhibition was 60%) (P=0.02).|duloxetine|human NET|3|15|Arg1:T21|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|1262
23506741|The mechanism of action of Fc11a-2 was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1β and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.|Fc11a-2|pro-caspase-1|6|16|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1263
14600253|At normal pH (7.4) and temperature (37 degrees C), the uptake of 1 microM cefadroxil was reduced by 83% in PEPT2(-/-) mice as compared with PEPT2(+/+) mice (p < 0.001).|cefadroxil|PEPT2|20|27|Arg1:T6|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|1264
23266505|The upregulation of calpain, tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of ALD.|ALD|caspase-3|21|8|Arg1:T1|Arg2:T36|CHEMICAL|GENE|ACTIVATOR|1265
23601203|Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.|Lys|Human Serum Albumin|28|7|Arg1:T6|Arg2:T11|CHEMICAL|GENE|PART-OF|1266
1666997|In vitro binding studies showed that both amoxapine and amitriptyline interact in the nanomolar range with 5-HT2 receptors labelled by [3H]ketanserin in cortical membranes.|amoxapine|5-HT2|8|17|Arg1:T5|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|1267
3345199|  Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.|soman|AChE|9|3|Arg1:T17|Arg2:T32|CHEMICAL|GENE|INHIBITOR|1268
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|DZN|caspase 3|44|32|Arg1:T6|Arg2:T34|CHEMICAL|GENE|ACTIVATOR|1269
23118019|Both 5'-AMN and 5'-MABN had high affinity for κ-receptors (K (i) 1.36 ± 0.98 and 0.27 ± 0.08, respectively) and were revealed as potent κ-antagonists (pA(2) 7.43 and 8.18, respectively) and μ-receptor antagonists (pA(2) 7.62 and 7.85, respectively) in the ileum.|5'-AMN|κ-receptors|2|9|Arg1:T16|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|1270
8384716|Within the conserved transmembrane domains, the sequences exhibit approximately 52%, 59%, 65%, and 68% amino acid identity with the known rat 5-HT1A, rat 5-HT1B, rat 5-HT1D, and human 5-HT1E receptors, respectively.|amino acid|rat 5-HT1A|23|29|Arg1:T21|Arg2:T41|CHEMICAL|GENE|PART-OF|1271
15985706|The inhibition of ERK, moreover, did not cause attenuation in mucin secretion in response to cAMP and forskolin.|forskolin|ERK|20|4|Arg1:T3|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1272
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|NF-κB|7|37|Arg1:T2|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1273
15777622|Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C.|gentamicin C|SGLT1|19|15|Arg1:T18|Arg2:T44|CHEMICAL|GENE|INHIBITOR|1274
9399012|These actions are consistent with a pre-junctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve, as confirmed by independent studies showing that zolmitriptan blocks elevations of calcitonin-gene-related peptide in jugular venous blood during electrical stimulation of the trigeminal ganglion.|zolmitriptan|calcitonin-gene-related peptide|27|31|Arg1:T2|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1275
8098142|In summary, these results show that the excitatory effect of histamine on immunohistochemically identified vasopressin neurons in the supraoptic nucleus is due in part to the H1-receptor-mediated enhancement of the depolarizing afterpotential independent of any change in the afterhyperpolarizing potential or membrane potential.|histamine|H1-receptor|12|28|Arg1:T8|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|1276
23182954|Ozone plus PM(2.5) exposure, however, induced CRP, IL-6, CK, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.|Ozone|CRP|1|12|Arg1:T4|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1277
17320868|At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the ER antagonist, ICI 182,780.|ICI 182,780|ER|24|21|Arg1:T19|Arg2:T32|CHEMICAL|GENE|ANTAGONIST|1278
16344985|Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.|arachidonic acid|brain microsomal long-chain fatty acyl-CoA synthetases|7|12|Arg1:T27|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|1279
17138644|Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src.|Progestin|MAPK|1|24|Arg1:T8|Arg2:T42|CHEMICAL|GENE|ACTIVATOR|1280
12679340|In OTCase, mutations of putative ornithine binding residues, Asp-182, Asn-184, Asn-185, Cys-289, and Glu-256 greatly reduced the affinity for ornithine and impaired the interaction with arginase.|ornithine|OTCase|26|2|Arg1:T14|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|1281
11166732|  Topotecan is a topoisomerase I inhibitor which is currently evaluated as an adjuvant agent for malignant glioma.|Topotecan|topoisomerase I|1|4|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INHIBITOR|1282
11732752|Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B.|4-methoxy-2-naphthylamide|aminopeptidase N|18|22|Arg1:T2|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|1283
12901032|Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.|acetaminophen|COX-2|25|12|Arg1:T7|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1284
23220618|And, the effects of the compounds on expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were tested in tumor necrosis factor-(TNF)-α activated HUVECs. Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, both agents elicited anticoagulant effects in mouse.|hyperoside|FXa|43|59|Arg1:T11|Arg2:T34|CHEMICAL|GENE|INHIBITOR|1285
11034583|METHODS: Part A compared the effects of placebo to four doses of a 5-HT(4) receptor antagonist (SB-207266) on the cisapride mediated increase in plasma aldosterone (a 5-HT(4) mediated response) and orocaecal transit in 18 subjects.|cisapride|5-HT(4)|26|15|Arg1:T8|Arg2:T20|CHEMICAL|GENE|AGONIST|1286
23220618|In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-α-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.|hyperoside|TNF-α|8|13|Arg1:T16|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1287
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|AG1296|kinase|11|44|Arg1:T11|Arg2:T35|CHEMICAL|GENE|INHIBITOR|1288
8730743|The DMI induced reduction in beta-adrenoceptors did not differ in OB and sham-operated control rats.|DMI|beta-adrenoceptors|2|6|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1289
7560228|In cell culture experiments, it was found that triclosan inhibited IL-1 beta induced prostaglandin E2 production by human gingival fibroblasts in a concentration dependent manner, and at relatively low concentrations.|triclosan|IL-1 beta|10|12|Arg1:T7|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1290
19293728|Although the D1-like receptor, by itself, had no effect on VSMC proliferation, stimulation with fenoldopam, a D1-like receptor agonist, inhibited the stimulatory effect of insulin.|fenoldopam|insulin|18|30|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1291
20801130|The affinities of dfbp and dfbp-o for the regulatory domain of cTnC were measured in the absence and presence of cTnI by NMR spectroscopy, and dfbp-o was found to bind more strongly than dfbp.|dfbp-o|cTnC|6|12|Arg1:T18|Arg2:T39|CHEMICAL|GENE|DIRECT-REGULATOR|1292
23024204|We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidine/spermine-N(1)-acetyltransferase (SSAT1) and by thialysine acetyltransferase (SSAT2) to its monoacetylated derivative (MAT).|TETA|SSAT2|5|27|Arg1:T8|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|1293
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|indolinones|kinase|22|44|Arg1:T14|Arg2:T35|CHEMICAL|GENE|INHIBITOR|1294
22898212|CBDP irreversibly inhibits butyrylcholinesterase (BChE) in human plasma by forming adducts on the active site serine (Ser-198).|CBDP|butyrylcholinesterase|1|4|Arg1:T6|Arg2:T30|CHEMICAL|GENE|INHIBITOR|1295
23479738|We found that, both in a cell-free system and in cells, NO/SNO donors such as S-nitrosocysteine and S-nitrosoglutathione readily induced the S-nitrosylation of Prx1, causing structural and functional alterations.|S|Prx1|24|26|Arg1:T25|Arg2:T50|CHEMICAL|GENE|PART-OF|1296
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Sar|AngII|10|40|Arg1:T1|Arg2:T18|CHEMICAL|GENE|PART-OF|1297
17488480|In addition, cells pre-treated with DL-propargylglycine (PAG, 3 mM), a CSE inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that CSE may be the main enzyme involved in H(2)S formation in mouse acinar cells.|H(2)S|CSE|43|35|Arg1:T27|Arg2:T50|CHEMICAL|GENE|PRODUCT-OF|1298
17350061|Various genes controlled by estrogen, including X-inactive-specific transcript, anterior gradient-2, trefoil factor-1, CRP-ductin, ghrelin, and small proline-rich protein-2A, were dramatically over-expressed.|estrogen|trefoil factor-1|5|14|Arg1:T22|Arg2:T38|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1299
15837926|Unlike transferrin receptor, the protease domain of PSMA contains a binuclear zinc site, catalytic residues, and a proposed substrate-binding arginine patch.|arginine|protease domain|23|6|Arg1:T7|Arg2:T19|CHEMICAL|GENE|PART-OF|1300
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Gln|D281A|15|34|Arg1:T2|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|1301
23432124|Racemic IKM-159 was crystallized with the ligand-binding domain of GluA2, and the structure revealed a complex containing (2R)-IKM-159 at the glutamate binding site.|Racemic IKM-159|GluA2|1|10|Arg1:T8|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|1302
23353658|In the in vitro model we observed high permeability of imperatorin and isoimperatorin with the P-gp-mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of cnidilin with 0.82.|imperatorin|P-gp|11|16|Arg1:T6|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|1303
23574017|Doxorubicin is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.|Doxorubicin|cytochrome P450 (CYP) 3A|1|27|Arg1:T7|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|1304
16220064|A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker.|olmesartan medoxomil|angiotensin receptor|10|14|Arg1:T10|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1305
14638499|Interestingly, all exchanges identified involved amino acids which are conserved in the squalene epoxidases of yeasts and mammals.|amino acids|squalene epoxidases|7|14|Arg1:T1|Arg2:T16|CHEMICAL|GENE|PART-OF|1306
12414329|Sildenafil exhibits inhibitory potency against PDE5 and a 10-fold lower dose-related inhibitory potency against rod outer segment PDE6, the predominant PDE in the phototransduction cascade in rods.|Sildenafil|PDE|1|22|Arg1:T11|Arg2:T12|CHEMICAL|GENE|INHIBITOR|1307
10742288|The selective alpha(1)-adrenoceptor ligands prazosin and doxazosin (each 3 microM) had no effect on noradrenaline responses.|prazosin|alpha(1)-adrenoceptor|9|3|Arg1:T14|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|1308
2899826|The present study reports the in vitro binding affinities of the same compounds for muscarinic cholinergic receptors and for histamine H1 receptors in rat brain, using 3H-quinuclidinyl benzilate and 3H-mepyramine as radioligands.|3H-mepyramine|muscarinic cholinergic receptors|31|15|Arg1:T8|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|1309
23250811|There was no significant difference in TLR4, NF-κB, and IL-27 mRNA and proteins between curcumin-treated and sulfasalazine-treated groups.|curcumin|TLR4|17|7|Arg1:T4|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1310
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|GW-572016|TK|23|3|Arg1:T19|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1311
23261645|Jaspamide also inhibited other channels including Cav1.2, Cav3.2, and HCN2; however, the Kv11.1 (hERG) channel was minimally affected.|Jaspamide|Cav3.2|1|9|Arg1:T10|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1312
8636122|  The antagonist SR 141716A has a high specificity for the central CB1 cannabinoid receptor and negligeable affinity for the peripheral CB2 receptor, making it an excellent tool for probing receptor structure-activity relationships.|SR 141716A|CB1|3|12|Arg1:T4|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|1313
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|4-aminobiphenyl|human b5R|13|48|Arg1:T21|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|1314
15991937|Clinical experience in heart failure is growing, and recent data suggest an improved survival with losartan versus captopril, a drug from the angiotensin-converting-enzyme inhibitor class with proven benefit in this population.|captopril|angiotensin-converting-enzyme|19|25|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1315
9990013|This direct biochemical evidence of cooperative interaction in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this cooperative binding of ATP and MgADP and, in cooperation with the MgADP bound at NBF2, causes ATP to be released from NBF1.|nucleotide|NBFs|9|14|Arg1:T5|Arg2:T34|CHEMICAL|GENE|DIRECT-REGULATOR|1316
23429911|Moreover, the effects of the DRD3 agonist 7-hydroxy-N,N-dipropyl-2-aminotetralin (7-OH-DPAT)-induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant.|7-hydroxy-N,N-dipropyl-2-aminotetralin|DRD3|9|22|Arg1:T1|Arg2:T9|CHEMICAL|GENE|AGONIST|1317
23159529|Glutaraldehyde crosslinked albumin nanoparticles with a size of approximately 100nm were loaded with the multikinase inhibitor 17864-L(x)-a platinum-bound sunitinib analogue-which couples the drug to methionine residues of albumin and is released in a reductive environment.|Glutaraldehyde|albumin|1|3|Arg1:T12|Arg2:T14|CHEMICAL|GENE|PART-OF|1318
17256745|  UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine.|taurine|BAAT|27|11|Arg1:T3|Arg2:T32|CHEMICAL|GENE|PRODUCT-OF|1319
23473681|We provide STD NMR data which confirms a physical interaction between LolA and the thiourea degradation product of MAC13243, with a Kd of ~150 μM.|thiourea|LolA|15|12|Arg1:T7|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|1320
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|gardiquimod|TLR8|7|15|Arg1:T5|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|1321
9310349|The hydrolysis of fluorescein diphosphate by PTP epsilon and PTPmeg1 was sensitive to alendronate, with IC50 values of less than 1 microM; PTPsigma, however, under the same conditions, was inhibited by only 50% with 141 microM alendronate.|diphosphate|PTPmeg1|5|10|Arg1:T17|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|1322
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Imatinib|PDGFRB,|1|31|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1323
23368735|In general, antiproliferative activity is greatly enhanced by low levels of the glutathione synthase inhibitor l-buthionine sulfoxime.|l-buthionine sulfoxime|glutathione synthase|17|14|Arg1:T13|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1324
16434489|Dasatinib (BMS-354825) is a novel orally bioavailable SRC/ABL inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).|BMS-354825|SRC|3|10|Arg1:T8|Arg2:T24|CHEMICAL|GENE|INHIBITOR|1325
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|SNAT4|14|65|Arg1:T23|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|1326
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|nimesulide|COX-2|31|44|Arg1:T16|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1327
12679340|In OTCase, mutations of putative ornithine binding residues, Asp-182, Asn-184, Asn-185, Cys-289, and Glu-256 greatly reduced the affinity for ornithine and impaired the interaction with arginase.|Asp|OTCase|11|2|Arg1:T9|Arg2:T28|CHEMICAL|GENE|PART-OF|1328
17658513|alpha(1)-Adrenoceptor antagonists were tested against the phenylephrine (alpha(1)-adrenoceptor agonist)-induced contraction in isolated hamster ureteral preparations using a functional experimental approach.|phenylephrine|alpha(1)-adrenoceptor|11|13|Arg1:T8|Arg2:T21|CHEMICAL|GENE|AGONIST|1329
12181285|The ensuing radioactive outflow from these cultures was enhanced by desipramine and reserpine, but reduced (in the presence of desipramine) by the OCT3 inhibitors cyanine 863, oestradiol and corticosterone.|oestradiol|OCT3|31|26|Arg1:T24|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1330
9876137|State-dependent cocaine block of sodium channel isoforms, chimeras, and channels coexpressed with the beta1 subunit.|cocaine|sodium channel|2|5|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1331
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|carbenoxolone|Panx1|15|6|Arg1:T14|Arg2:T39|CHEMICAL|GENE|INHIBITOR|1332
14638499|The amino acid changes caused by the point mutations were clustered in two regions of the Erg1 protein.|amino acid|Erg1|2|17|Arg1:T10|Arg2:T26|CHEMICAL|GENE|PART-OF|1333
23539296|In addition to CYP2B6, anisomycin co-treatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs. Thus, activated p38 MAPK is required for liganded-CAR to selectively activate a set of genes that encode drug metabolizing enzymes.|anisomycin|CYP2B6|6|4|Arg1:T4|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1334
15177307|  The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel cyclooxygenase-2 (COX-2) selective inhibitor lumiracoxib (Prexige), so that dose recommendations for clinical use can be provided.|lumiracoxib|COX-2|29|25|Arg1:T6|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1335
23091188|Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.|ritonavir|BSEP|9|15|Arg1:T23|Arg2:T53|CHEMICAL|GENE|INHIBITOR|1336
9990013|The KATP channel is a heterooligomeric complex of SUR1 subunits of the ATP-binding-cassette superfamily with two nucleotide-binding folds (NBF1 and NBF2) and the pore-forming Kir6.2 subunits.|ATP|NBF2|13|22|Arg1:T14|Arg2:T45|CHEMICAL|GENE|DIRECT-REGULATOR|1337
10095983|In the long term, orlistat has been shown to be more effective than placebo in reducing body weight and serum total and low-density lipoprotein cholesterol levels.|orlistat|low-density lipoprotein|6|24|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1338
23024204|By contrast, 1,12-diamino-3,6,9-triazadodecane(SpmTrien), a charge-deficient spermine analog, was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wild-type primary hepatocytes.|SpmTrien|SSAT1|6|27|Arg1:T19|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|1339
21712771|Transfection of the brain cDNA into COS-1 cells resulted in transporter activity that was blocked by the VMAT inhibitor reserpine and a proton ionophore, but not by tetrabenazine, which has a high affinity for VMAT-2.|tetrabenazine|VMAT-2|29|37|Arg1:T6|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|1340
19039322|Here, we characterized the target profile of the dual SRC/ABL inhibitor bosutinib employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro kinase assays against a large recombinant kinase panel.|bosutinib|ABL|13|12|Arg1:T3|Arg2:T21|CHEMICAL|GENE|INHIBITOR|1341
16424790|We compared the effects of Captopril (an ACE inhibitor with -SH group), enalapril (an ACE-inhibitor without -SH group), N-acetylcysteine (only -SH group not ACE inhibitor) on endothelial dysfunction injured by methionine-induced hyperhomocysteinemia (HHcy) in rats.|enalapril|ACE|16|19|Arg1:T27|Arg2:T64|CHEMICAL|GENE|INHIBITOR|1342
17040106|Polyclonal antisera to either b5R or cyt b5 significantly inhibited N-hydroxy-4-aminobiphenyl (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).|NHOH-4-ABP|cyt b5|13|7|Arg1:T5|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|1343
23598904|Among the possible transporters involved in the uptake of Cd(2+) and Mn(2+), the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.|Cd(2+)|ZIP8|10|23|Arg1:T21|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|1344
11861820|In addition to affecting DAT function, MDMA rapidly decreased vesicular DA transport as assessed in striatal vesicles prepared from treated rats.|DA|DAT|12|5|Arg1:T5|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|1345
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|hydrogen peroxide|aldo-keto reductase (AKR) 1C1|38|44|Arg1:T4|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1346
11732752|Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B.|L-glutamic acid|aminopeptidase A|34|37|Arg1:T8|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|1347
9832994|These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.|ritanserin|5-HT2A|42|40|Arg1:T14|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|1348
23550066|These results indicate a major role of CYP2B6 in ketamine N-demethylation in vitro and a significant impact of the CYP2B6*6 allele on enzyme-ketamine binding and catalytic activity.|ketamine|CYP2B6|10|8|Arg1:T5|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|1349
12897749|OBJECTIVE: To determine (a) whether PDE4 inhibition alone with rolipram blocked secretions of arachidonic acid (AA) and leukotriene C(4) (LTC(4)) caused by activation of eosinophils with formyl-met-leu-phe plus cytochalasin B (FMLP/B), (b) to determine if PDE4 inhibition plus beta(2)-adrenoceptor agonist act additively to augment endogenous cAMP concentration, and (c) to determine the mechanism by which additive inhibition of AA and LTC(4) synthesis is regulated by cAMP.|rolipram|PDE4|13|9|Arg1:T25|Arg2:T49|CHEMICAL|GENE|INHIBITOR|1350
15184278|  BACKGROUND: To assess the sensitivity of biochemical, physiological, and pharmacological markers of peripheral norepinephrine (NE) transporter (NET) function, we chronically antagonized NET by a range of doses of duloxetine [(+)-N-methyl-3-(1-naphthalenyloxy)-2 thiophenepropanamine], which blocks the NE reuptake process.|(+)-N-methyl-3-(1-naphthalenyloxy)-2 thiophenepropanamine|NET|39|30|Arg1:T18|Arg2:T34|CHEMICAL|GENE|ANTAGONIST|1351
23250811|Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).|curcumin|NF-κB|9|34|Arg1:T14|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1352
16432501|Two beta(2)-agonists, formoterol and salmeterol, are approved for treating asthma and have an extended duration of action and increased safety, associated with greater beta(2)-adrenoceptor selectivity.|salmeterol|beta(2)-adrenoceptor|10|31|Arg1:T11|Arg2:T23|CHEMICAL|GENE|AGONIST|1353
23435910|Additionally, the expression of hepatic fibrosis-related factors such as α-smooth muscle actin and transforming growth factor-β1 (TGF-β1), were reduced in rats treated with sinapic acid.|sinapic acid|TGF-β1|28|19|Arg1:T16|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1354
11775064|Acute and chronic PLZ administration increase brain GABA levels, an effect due, at least in part, to an inhibition of the activity of the GABA metabolizing enzyme, GABA transaminase (GABA-T).|PLZ|GABA-T|4|35|Arg1:T24|Arg2:T34|CHEMICAL|GENE|INHIBITOR|1355
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|TO901317|ABCA1|15|4|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1356
17344208|This is significant because superoxide production underlies the role of human PRODH in p53-mediated apoptosis, implying commonalities between eukaryotic and bacterial monofunctional PRODHs.|superoxide|human PRODH|5|11|Arg1:T8|Arg2:T16|CHEMICAL|GENE|PRODUCT-OF|1357
12105857|Furthermore, thalidomide abolished the LPS-induced increase in CD14 expression and [Ca2+]i elevation in KCs. Gut permeability was increased about 10-fold after 4 weeks of ethanol exposure, which was not affected by thalidomide.|thalidomide|CD14|3|9|Arg1:T5|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1358
15635044|Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.|Pro|EL3|7|23|Arg1:T11|Arg2:T48|CHEMICAL|GENE|PART-OF|1359
23597506|In terms of the mechanisms, we found that fatty acid amide hydrolase (FAAH) which degrades anandamide, was upregulated after nerve injury at both ages, so that this upregulation likely did not account for the age-dependent differences.|anandamide|fatty acid amide hydrolase|19|10|Arg1:T1|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|1360
22578098|By synthesizing and testing a series of alanine point-mutated cyclic peptides, we identified which amino acid was important for the inhibition of the phospholamban function.|amino acid|cyclic peptides|16|10|Arg1:T1|Arg2:T8|CHEMICAL|GENE|PART-OF|1361
23098818|Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the human isoform CYP2D6.|5-methoxytryptamine|human isoform CYP2D6|19|30|Arg1:T14|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|1362
2859531|The affinity of ICYP to beta 2-adrenoceptors was not changed during or after treatment.|ICYP|beta 2-adrenoceptors|4|6|Arg1:T1|Arg2:T13|CHEMICAL|GENE|DIRECT-REGULATOR|1363
23578390|Exposure of cells to 4mM NaF for 24h induced caspase-3 activation, ultrastructural alterations, and resulted in the translocation of Bax to the mitochondria and the release of cytochrome c from the mitochondrial inter-membrane space into the cytosol, indicating that fluoride-mediated apoptosis is mitochondria-dependent.|NaF|caspase-3|6|10|Arg1:T6|Arg2:T12|CHEMICAL|GENE|ACTIVATOR|1364
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|FLX|5-HT(2A)|27|51|Arg1:T4|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|1365
7711211|The inhibition of UG synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.|NET|UG|19|4|Arg1:T4|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1366
19039322|Finally, bosutinib is the first kinase inhibitor shown to target CAMK2G, recently implicated in myeloid leukemia cell proliferation.|bosutinib|CAMK2G|3|12|Arg1:T2|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1367
16988497|CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.|MUFAs|D6D|8|15|Arg1:T2|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1368
23497227|  A series of pyrido-quinazolines have been synthesised, characterised and tested for their in vitro EGFR tyrosine kinase inhibitory activity.|pyrido-quinazolines|tyrosine kinase|4|17|Arg1:T2|Arg2:T6|CHEMICAL|GENE|INHIBITOR|1369
7516184|The N-terminal portion of TSG-6 shows sequence homology to members of the cartilage link protein family of hyaluronan binding proteins.|N|TSG-6|2|5|Arg1:T5|Arg2:T28|CHEMICAL|GENE|PART-OF|1370
11034583|  BACKGROUND: Serotonin 5-HT(4) receptors are located on enteric cholinergic neurones and may regulate peristalsis.|Serotonin|Serotonin 5-HT(4) receptors|3|3|Arg1:T2|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|1371
23479738|In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity.|Cys|peroxidase|17|31|Arg1:T30|Arg2:T33|CHEMICAL|GENE|PART-OF|1372
12392782|They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.|REV 5901|5-LOX|36|34|Arg1:T10|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1373
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|Fenofibrate|enoyl-CoA hydratase|1|14|Arg1:T15|Arg2:T37|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1374
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|vitamin E|Bax|8|27|Arg1:T2|Arg2:T32|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1375
23428368|Cardiac hypertrophy, structural remodeling, and expression of the genes associated with fatty acid metabolism were examined in rats treated with triiodothyronine (T3) alone (8 μg/100 g body weight (BW), i.p.) for 15 days or along with a peroxisome proliferator-activated receptor alpha agonist bezafibrate (Bzf; 30 μg/100 g BW, oral) and were found to improve in the Bzf co-treated condition.|bezafibrate|peroxisome proliferator-activated receptor alpha|53|48|Arg1:T3|Arg2:T10|CHEMICAL|GENE|AGONIST|1376
19293728|Fenoldopam also inhibited insulin receptor mRNA and protein expression, which was time dependent and concentration dependent.|Fenoldopam|insulin receptor|1|4|Arg1:T5|Arg2:T15|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1377
23584358|Agomelatine, commonly known as melatonin receptor agonist, is a new antidepressant, which resynchronizes circadian rhythms with subjective and objective improvements in sleep quality and architecture, as melatonin does.|Agomelatine|melatonin receptor|1|6|Arg1:T27|Arg2:T36|CHEMICAL|GENE|AGONIST|1378
23231502|Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.|pSer|peptidyl-prolyl cis/trans-isomerase A1|24|6|Arg1:T13|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1379
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Glivec|ABL|7|27|Arg1:T4|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1380
19293728|The inhibitory effect of fenoldopam on insulin-mediated VSMC proliferation was receptor specific, because its effect could be blocked by SCH23390, a D1-like receptor antagonist.|SCH23390|D1-like receptor|21|24|Arg1:T4|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|1381
23100158|The significantly decreased levels of p-PI3K and p-AKT expression were observed in SGC-7901 cells after β-ionone treatments in a time- and dose-dependent manner (P < 0.01).|β-ionone|p-AKT|16|8|Arg1:T8|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1382
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|carbachol|mAChR|19|16|Arg1:T7|Arg2:T17|CHEMICAL|GENE|AGONIST|1383
9832994|These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.|methysergide|5-HT2|13|7|Arg1:T7|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|1384
9476974|Monoamine uptake inhibitors structurally analogous to cocaine (cocaethylene, CFT, betaCIT, CPT, (+)-cocaine, norcocaine, and benztropine) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities (BTCP, indatraline, GBR 12935, mazindol, nomifensine, and zimeldine) either did not produce a rapid pressor response or produced only a small pressor response.|GBR 12935|monoamine transporter|49|41|Arg1:T27|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1385
12375053|Pentosan polysulfate sodium (PPS) has been shown to exert antitumor activity by antagonizing the binding of bFGF to cell surface receptors.|sodium|bFGF|3|19|Arg1:T2|Arg2:T8|CHEMICAL|GENE|DIRECT-REGULATOR|1386
23395914|Involvement of P450 mediated metabolism in the absorption of darunavir could not be demonstrated in this rat model.|darunavir|P450|10|3|Arg1:T1|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|1387
16336752|Tyrosine kinase inhibitors are quinazoline-derived, low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors, including EGFR, Erb2, and vascular endothelial growth factor receptor, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of EGFR signaling.|quinazoline|tyrosine kinase domain|5|17|Arg1:T2|Arg2:T5|CHEMICAL|GENE|INHIBITOR|1388
14600253|Glycylsarcosine coadministration could inhibit the uptake of cefadroxil in PEPT2(+/+) mice (p < 0.01) but not PEPT2(-/-) mice.|cefadroxil|PEPT2|8|22|Arg1:T11|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|1389
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|methimazole|FMO1|19|14|Arg1:T2|Arg2:T13|CHEMICAL|GENE|SUBSTRATE|1390
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|quinoxaline|kinase|10|44|Arg1:T10|Arg2:T35|CHEMICAL|GENE|INHIBITOR|1391
15474503|These results suggest that pitavastatin efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.|pitavastatin|Rho|5|28|Arg1:T1|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1392
23238784|The CYP3A4 activity could be induced 2-fold by rifampicin, whereas CYP2C9 activity remained equally high.|rifampicin|CYP2C9|9|12|Arg1:T8|Arg2:T16|CHEMICAL|GENE|ACTIVATOR|1393
7885191|Drosophila GABA-gated chloride channel: modified [3H]EBOB binding site associated with Ala-->Ser or Gly mutants of Rdl subunit.|[3H]EBOB|Drosophila GABA-gated chloride channel|7|1|Arg1:T49|Arg2:T57|CHEMICAL|GENE|DIRECT-REGULATOR|1394
12636181|Experimental evidence from the use of agents with enhanced selectivity for BuChE (cymserine analogues, MF-8622) and the dual inhibitor of both AChE and BuChE, rivastigmine, indicates potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias.|rivastigmine|AChE|29|25|Arg1:T6|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1395
16206183|Similar to cocaine, other local anesthetics bind to the dopamine transporter (DAT) and inhibit DA uptake in rodent and monkey brain.|cocaine|dopamine transporter|3|11|Arg1:T2|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|1396
11691635|The specific activity of only ornithine aminotransferase (OAT), the rate-limiting enzyme in the conversion of ornithine to proline, increased in 2 weeks of hypertrophy.|ornithine|ornithine aminotransferase|19|6|Arg1:T2|Arg2:T8|CHEMICAL|GENE|SUBSTRATE|1397
12727196|Purified PAOh1/SMO oxidizes both spermine (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine.|spermine|SMO|5|3|Arg1:T3|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|1398
20801130|In the absence of cTnI, docking localized dfbp-o to the same position in the hydrophobic groove of cTnC.|dfbp-o|cTnC|9|19|Arg1:T4|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|1399
23327794|As a result of this study, microgrewiapine A (1) was found to be a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the hα3β4 and hα4β2 receptor subtypes.|microgrewiapine A|nicotinic receptor|8|32|Arg1:T9|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|1400
11695255|Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of prostaglandin E2 (PGE2; a product of both COX-1 and COX-2) and thromboxane B2 (as a biomarker for COX-1 activity) with parallel assessments of pain.|prostaglandin E2|COX-1|21|30|Arg1:T12|Arg2:T23|CHEMICAL|GENE|PRODUCT-OF|1401
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|tolfenamic acid|COX-2|28|44|Arg1:T15|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1402
23601710|Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure-activity relationships (SAR) of the C3-phenyl moiety.|1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione|HIV capsid|4|14|Arg1:T6|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1403
8384716|Within the conserved transmembrane domains, the sequences exhibit approximately 52%, 59%, 65%, and 68% amino acid identity with the known rat 5-HT1A, rat 5-HT1B, rat 5-HT1D, and human 5-HT1E receptors, respectively.|amino acid|rat 5-HT1D|23|35|Arg1:T21|Arg2:T43|CHEMICAL|GENE|PART-OF|1404
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imidazoquinoline|porcine TLR7|2|12|Arg1:T3|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|1405
23432124|(2R)-IKM-159 locks the GluA2 in an open form, consistent with a pharmacological action as competitive antagonist of AMPA receptors.|(2R)-IKM-159|AMPA receptors|1|22|Arg1:T11|Arg2:T16|CHEMICAL|GENE|ANTAGONIST|1406
22898212|CBDP irreversibly inhibits butyrylcholinesterase (BChE) in human plasma by forming adducts on the active site serine (Ser-198).|serine|butyrylcholinesterase|18|4|Arg1:T8|Arg2:T30|CHEMICAL|GENE|PART-OF|1407
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|sunitinib|platelet-derived growth factor receptor beta|3|28|Arg1:T5|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1408
7554708|The daily administration of low-dose aspirin (40 mg), a selective inhibitor of platelet PGHS-1, caused a cumulative inhibition of urinary 11-dehydro-TXB2 and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover.|TXB2|PGHS-1|29|17|Arg1:T7|Arg2:T24|CHEMICAL|GENE|PRODUCT-OF|1409
14600253|Mechanisms of cefadroxil uptake in the choroid plexus: studies in wild-type and PEPT2 knockout mice.|cefadroxil|PEPT2|3|14|Arg1:T15|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1410
12375053|Pentosan polysulfate sodium (PPS) has been shown to exert antitumor activity by antagonizing the binding of bFGF to cell surface receptors.|sodium|bFGF|3|19|Arg1:T2|Arg2:T8|CHEMICAL|GENE|ANTAGONIST|1411
23298677|Induction of HO-1 through p38 MAPK/Nrf2 signaling pathway by ethanol extract of Inula helenium L.|ethanol|MAPK|10|6|Arg1:T8|Arg2:T40|CHEMICAL|GENE|ACTIVATOR|1412
15635044|[Trp(7)]GnRH-I and [Trp(8)]GnRH-I but not [His(5)]GnRH-I exhibit a higher potency in activating wild-type gmGnRHR-2 than native GnRH-I, indicating that amino acids at positions 7 and 8 of GnRHs are more important than position 5 for differential recognition by type I and type II GnRHRs. As a whole, these data suggest a molecular coevolution of ligands and their receptors and facilitate the understanding of the molecular interaction between GnRHs and their cognate receptors.|amino acids|GnRHs|39|47|Arg1:T1|Arg2:T29|CHEMICAL|GENE|PART-OF|1413
10727715|In the present study, we compared the pharmacology of (+/-)pindolol, WAY-100635 (a 5-HT(1A) antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat.|(+/-)pindolol|5-HT(1A)|11|19|Arg1:T17|Arg2:T37|CHEMICAL|GENE|ANTAGONIST|1414
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|amino acids|TMH7|6|30|Arg1:T2|Arg2:T46|CHEMICAL|GENE|PART-OF|1415
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|AH 6809|EP1|46|4|Arg1:T17|Arg2:T32|CHEMICAL|GENE|AGONIST|1416
18620538|Apo-alpha-lactalbumin, obtained by treatment with EDTA, displays one binding site for fatty acids, the association constants for oleic and palmitic acids being 1.9.10(6) and 4.2.10(5) M(-1), respectively.|fatty acids|Apo-alpha-lactalbumin|14|1|Arg1:T2|Arg2:T9|CHEMICAL|GENE|DIRECT-REGULATOR|1417
9876137|  Cocaine block of human cardiac (hH1) and rat skeletal (mu1) muscle sodium channels was examined under whole-cell voltage clamp in transiently transfected HEK293t cells.|Cocaine|human cardiac (hH1)|1|4|Arg1:T1|Arg2:T10|CHEMICAL|GENE|INHIBITOR|1418
12724156|The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the GluR5 kainate receptor antagonist LY293558.|LY293558|kainate receptor|21|18|Arg1:T1|Arg2:T41|CHEMICAL|GENE|ANTAGONIST|1419
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|ASK-1|7|28|Arg1:T2|Arg2:T25|CHEMICAL|GENE|INHIBITOR|1420
12244038|Interestingly, gemfibrozil strongly inhibited the activation of NF-kappaB, AP-1, and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells.|gemfibrozil|C/EBPbeta|3|14|Arg1:T4|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1421
23296102|Interestingly, Acrolein increased proteins' levels of amyloid precursor protein (APP), β-secretase (BACE-1) and the amyloid β-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.|Acrolein|β-secretase|3|16|Arg1:T5|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1422
23643745|The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.|S33084|D3|38|36|Arg1:T7|Arg2:T47|CHEMICAL|GENE|ANTAGONIST|1423
23017388|Also, SB365 showed anti-angiogenic activity by decreasing the expression of HIF-1α and VEGF.|SB365|HIF-1α|3|12|Arg1:T4|Arg2:T12|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1424
23246481|Moreover, wogonin repressed anisomycin-induced phosphorylation of p38, cav-1 and vascular permeability.|wogonin|cav-1|3|10|Arg1:T10|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1425
11730729|After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full muscarinic receptor agonist methacholine, the partial muscarinic receptor agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and histamine.|histamine|muscarinic receptor|39|27|Arg1:T13|Arg2:T27|CHEMICAL|GENE|AGONIST|1426
7885191|In contrast, the Ala-->Gly replacement has less impact in protecting the chloride channel from the action of insecticidal blockers.|Gly|chloride channel|8|16|Arg1:T19|Arg2:T53|CHEMICAL|GENE|PART-OF|1427
15737409|NPC1L1 could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant sterols.|cholesterol|NPC1L1|16|1|Arg1:T17|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|1428
23638842|RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive RS -GRA significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1β (IL-1β), and apoptosis (Bax and caspase 3 expression).|RS -GRA|Bax|19|44|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1429
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|GSK-3β|3|17|Arg1:T8|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1430
9712175|The study demonstrates for the first time the marked gastrokinetic properties of the new CCK-A receptor antagonist lintitript in humans.|lintitript|CCK-A receptor|18|15|Arg1:T2|Arg2:T13|CHEMICAL|GENE|ANTAGONIST|1431
16917142|Tamoxifen blocks the action of estrogen by binding to the ER, and possesses both ER-agonist and antagonist properties.|Tamoxifen|ER|1|11|Arg1:T11|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|1432
23440512|The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.|all-trans retinoic acid|RXRs|15|41|Arg1:T4|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1433
10446934|Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.|losartan|angiotensinogen|16|6|Arg1:T8|Arg2:T31|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1434
23512754|In macrophages, levels of TNF-α, IFN-γ, NO, IL-6 and IL-10 were increased by CDM used alone or in combination with HSV-2.|CDM|TNF-α|18|6|Arg1:T11|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1435
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Imatinib mesylate|Abl|11|23|Arg1:T36|Arg2:T55|CHEMICAL|GENE|INHIBITOR|1436
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|neutral amino acid transporters|7|24|Arg1:T18|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1437
11264758|Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.|pranlukast|leukotriene receptor|4|8|Arg1:T12|Arg2:T16|CHEMICAL|GENE|ANTAGONIST|1438
12105857|Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production.|Thalidomide|TNF-alpha|1|15|Arg1:T21|Arg2:T31|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1439
12614192|With the use of sildenafil, it has been clearly, clinically demonstrated that the selective inhibition of PDE5 is an appropriate, effective, safe method for the treatment of ED of all aetiologies and severities.|sildenafil|PDE5|5|19|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INHIBITOR|1440
23584358|There were statistically significant increases in the activities of aspartate aminotransferase, alanine aminotransferase, levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and 8-iso-prostane, and decreases in the activity of superoxide dismutase and level of glutathione in the group treated with paracetamol.|paracetamol|aspartate aminotransferase|49|10|Arg1:T8|Arg2:T31|CHEMICAL|GENE|ACTIVATOR|1441
23220618|In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-α-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.|IMG|PAI-1|21|28|Arg1:T2|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1442
11961111|We report herein the location of the binding site for the inhaled anesthetic halothane at the amino acid residue level of resolution in the ligand binding cavity in a prototypical G protein-coupled receptor, bovine rhodopsin.|amino acid|G protein-coupled receptor|17|31|Arg1:T3|Arg2:T12|CHEMICAL|GENE|PART-OF|1443
23506741|Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.|Fc11a-2|IL-17A|29|21|Arg1:T9|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1444
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|EVn-50|cyclin B1|3|41|Arg1:T2|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1445
23538162|These protective effects were abolished by glucocorticoid receptor (GR) antagonist RU486 or p-ERK inhibitor U0126 rather than estrogen receptor α antagonist ICI 82,780.|RU486|GR|13|10|Arg1:T7|Arg2:T22|CHEMICAL|GENE|ANTAGONIST|1446
16835395|Epididymal tissue from wild-type mice responded in vitro to noradrenaline and isoprenaline with increased glycerol release, reduced IL-6 release, and increased cAMP accumulation.|isoprenaline|IL-6|12|19|Arg1:T5|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1447
23598904|Among the possible transporters involved in the uptake of Cd(2+) and Mn(2+), the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.|Cd(2+)|Slc39a8|10|34|Arg1:T21|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|1448
11775064|Acute and chronic PLZ administration increase brain GABA levels, an effect due, at least in part, to an inhibition of the activity of the GABA metabolizing enzyme, GABA transaminase (GABA-T).|GABA|GABA-T|28|35|Arg1:T9|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|1449
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|cinitapride|5-HT4|11|23|Arg1:T17|Arg2:T32|CHEMICAL|GENE|AGONIST|1450
12181285|Our observations indicate an OCT-mediated transmembrane transport of [3H]-MPP+.|[3H]-MPP+|OCT|9|5|Arg1:T15|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|1451
12392782|They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.|ibuprofen|COX-2|17|16|Arg1:T4|Arg2:T21|CHEMICAL|GENE|INHIBITOR|1452
23583257|In fact, we demonstrated a significant stimulation of Nox4 activity by 4 quinone derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx™, and chondrocyte cell lines.|quinone|Nox4|14|10|Arg1:T5|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|1453
23643933|Considerable attention has focused on the antitumor effect of histone deacetylase inhibitor (Trichostatin A, TSA) as well as the coding gene expression-induced apoptosis of cancer cells.|TSA|histone deacetylase|17|10|Arg1:T8|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1454
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|norelgestromin|17beta-hydroxysteroid-dehydrogenase type 1|22|36|Arg1:T12|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1455
23333261|Moreover, curcumin alleviated Sim2 expression, and reversely raised Drebrin expression in neurons treated with hyperglycaemia.|curcumin|Sim2|3|5|Arg1:T1|Arg2:T6|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1456
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|solute carrier 1|7|30|Arg1:T18|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|1457
17477831|  Acetyl-coenzyme A carboxylase (ACC) enzymes exist as two isoforms, ACC1 and ACC2, which play critical roles in fatty acid biosynthesis and oxidation.|fatty acid|ACC1|22|13|Arg1:T4|Arg2:T24|CHEMICAL|GENE|PRODUCT-OF|1458
9551716|Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.|[3H]SR 142948A|neurotensin receptor|12|8|Arg1:T24|Arg2:T33|CHEMICAL|GENE|ANTAGONIST|1459
17344208|  Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.|proline|P5CDH|21|14|Arg1:T2|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|1460
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|PhIP|human b5R|32|48|Arg1:T2|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|1461
23517558|Intestinal and hepatic first-pass extraction of the 11β-HSD1 inhibitor AMG 221 in rats with chronic vascular catheters.|AMG 221|11β-HSD1|10|8|Arg1:T6|Arg2:T8|CHEMICAL|GENE|INHIBITOR|1462
23261590|Neoechinulin A treatment significantly inhibited the generation of reactive oxygen and nitrogen species in Aβ42-activated BV-2 microglia cells.|Neoechinulin A|Aβ42|1|15|Arg1:T7|Arg2:T32|CHEMICAL|GENE|INHIBITOR|1463
23600914|To confirm the role of each transporter, we analyzed HEK293 cells stably expressing human ABCA1 or ABCG1; we clearly observed 24-OHC efflux in the presence of HDL, whereas efflux in the presence of apolipoprotein A-I was marginal.|24-OHC|ABCG1|23|18|Arg1:T12|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|1464
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|ASCT2|12|46|Arg1:T21|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|1465
23143891|In contrast, flunisolide was only metabolized via CYP3A4, with no significant turnover by CYP3A5 or CYP3A7.|flunisolide|CYP3A4|4|9|Arg1:T4|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|1466
23261645|Jaspamide also inhibited other channels including Cav1.2, Cav3.2, and HCN2; however, the Kv11.1 (hERG) channel was minimally affected.|Jaspamide|Cav1.2|1|7|Arg1:T10|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1467
23024204|Thus, despite the similar structures of TETA and SpmTrien, SSAT2 is the main acetylator of TETA, whereas SpmTrien is primarily acetylated by SSAT1.|TETA|SSAT2|18|12|Arg1:T4|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1468
3994963|  Phenoxybenzamine, an alpha-adrenergic antagonist containing a (chloroethyl)amine group, labels calmodulin in the presence of calcium.|Phenoxybenzamine|calmodulin|1|15|Arg1:T1|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|1469
12414329|Sildenafil exhibits inhibitory potency against PDE5 and a 10-fold lower dose-related inhibitory potency against rod outer segment PDE6, the predominant PDE in the phototransduction cascade in rods.|Sildenafil|PDE5|1|6|Arg1:T11|Arg2:T25|CHEMICAL|GENE|INHIBITOR|1470
12414329|PDE5 is the predominant PDE in the corpus cavernosum, and cGMP is its primary substrate.|cGMP|PDE5|12|1|Arg1:T7|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|1471
16434489|Computer modeling suggests that the KITD816V mutation destabilizes the inactive conformation of the KIT activation loop to which imatinib binds, but it is not predicted to impair binding of KIT by dasatinib.|dasatinib|KIT|33|31|Arg1:T3|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|1472
11474486|To elucidate the target genes regulated by these compounds, we treated Zucker diabetic fatty rats (ZDF) for 15 days with a PPAR-alpha-specific compound, fenofibrate, a PPAR-gamma-specific ligand, rosiglitazone, and a PPAR-alpha/-gamma coagonist, GW2331, and measured the levels of several messenger RNAs (mRNAs) in liver by real-time polymerase chain reaction.|rosiglitazone|PPAR-gamma|34|31|Arg1:T11|Arg2:T34|CHEMICAL|GENE|DIRECT-REGULATOR|1473
15795105|The compounds 5'-azacytidine (AZC) and procainamide (PCA) belong to inhibitors of DNMT1, whose low activity correlates with increase in transcription of various genes.|5'-azacytidine|DNMT1|3|16|Arg1:T1|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1474
23481236|We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 μM).|ceramides|PTP1B|19|30|Arg1:T14|Arg2:T44|CHEMICAL|GENE|DIRECT-REGULATOR|1475
15837926|PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.|N-acetyl-l-aspartyl-l-glutamate|glutamate carboxypeptidase|26|5|Arg1:T4|Arg2:T11|CHEMICAL|GENE|SUBSTRATE|1476
7837275|  An experimental strategy based on solution viscosity perturbation allowed us to study the energetics of amide-substrates, p-aminobenzamidine (p-ABZ) and proflavin binding to the catalytic site of two proteolyzed forms of alpha-thrombin, i.e. zeta- and gamma T-thrombin.|p-aminobenzamidine|alpha-thrombin|18|34|Arg1:T2|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|1477
23298863|  6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide (TAK-441) is a potent, selective hedgehog signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer.|TAK-441|Smo|23|37|Arg1:T3|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|1478
16920841|  Choline dehydrogenase (CHDH) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in choline oxidation.|choline|Choline dehydrogenase|17|1|Arg1:T2|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|1479
17658513|Noradrenaline and phenylephrine (alpha(1)-adrenoceptor agonist) each produced a concentration-dependent tonic contraction, their pD(2) values being 6.87+/-0.08 and 6.10+/-0.05, respectively.|Noradrenaline|alpha(1)-adrenoceptor|1|5|Arg1:T9|Arg2:T24|CHEMICAL|GENE|AGONIST|1480
16938288|Since the suppression of AT1R expression was prevented by pretreatment with GW9662, a PPARgamma antagonist, PPARgamma should have participated in the process.|GW9662|AT1R|12|5|Arg1:T4|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1481
17015640|Licofelone almost abolished 5-LOX activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood.|Licofelone|5-LOX|1|4|Arg1:T5|Arg2:T25|CHEMICAL|GENE|INHIBITOR|1482
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|Hydrogen sulphide|cystathionine-beta-synthase|1|23|Arg1:T1|Arg2:T34|CHEMICAL|GENE|PRODUCT-OF|1483
23587425|Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.|imidazo[1,2-a]pyrazine|MK2|10|6|Arg1:T3|Arg2:T10|CHEMICAL|GENE|INHIBITOR|1484
9607108|We propose that Cu(I) binds the type-1 copper ion-binding site in the A1 domain and provides the essential requirement for a stable interaction between the heavy and light chains.|Cu(I)|type-1 copper ion-binding site|4|10|Arg1:T2|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|1485
23432124|Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization.|IKM-159|(AMPA) receptor|18|13|Arg1:T12|Arg2:T19|CHEMICAL|GENE|ANTAGONIST|1486
18973551|Quinpirole and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.|SB-277011-A|extracellular signal-regulated kinase|24|9|Arg1:T7|Arg2:T26|CHEMICAL|GENE|INHIBITOR|1487
16434489|Computer modeling suggests that the KITD816V mutation destabilizes the inactive conformation of the KIT activation loop to which imatinib binds, but it is not predicted to impair binding of KIT by dasatinib.|imatinib|KIT|19|31|Arg1:T2|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|1488
23440512|The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.|all-trans retinoic acid|polymorphic retinoic acid (RA) response elements|15|46|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1489
2855368|  The interaction of naloxone estrone azine (N-EH) with various opioid receptor types was studied in vitro.|N-EH|opioid receptor|8|12|Arg1:T7|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|1490
23639362|Additionally, MPTP significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment.|MPTP|Bcl-2|3|6|Arg1:T5|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1491
17098734|Blocking retinyl ester formation by a targeted knock down of Lratb results in significantly increased retinoic acid levels, which lead to severe embryonic patterning defects.|retinyl ester|Lratb|2|11|Arg1:T10|Arg2:T22|CHEMICAL|GENE|PRODUCT-OF|1492
12392782|They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.|MK-886|5-LOX activating protein|48|41|Arg1:T11|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1493
23296102|Interestingly, Acrolein increased proteins' levels of amyloid precursor protein (APP), β-secretase (BACE-1) and the amyloid β-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.|Acrolein|amyloid β-peptide transporter|3|22|Arg1:T5|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1494
11255924|OBJECTIVES: The hypothesis of the present study was that differences among dopamine transporter (DAT) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as DA uptake inhibitors.|DA|dopamine transporter|34|13|Arg1:T15|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|1495
23584358|In conclusion, agomelatine administration protects liver cells from paracetamol-induced hepatotoxicity via antioxidant activity and reduced proinflammatory cytokines, such as TNF-α and IL-6.|paracetamol|TNF-α|10|22|Arg1:T12|Arg2:T40|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1496
20347047|The contractions to 5-HT were inhibited by ketanserin and alosetron indicating involvement of 5-HT(2A) and 5-HT(3) receptors, respectively.|ketanserin|5-HT(2A)|8|14|Arg1:T11|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1497
17594192|This effect probably involves interaction of phenserine with a regulatory element in the 5'-untranslated region of the APP gene that controls APP expression.|phenserine|APP|7|18|Arg1:T9|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|1498
23601203|Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.|Arg|HSA|26|11|Arg1:T5|Arg2:T12|CHEMICAL|GENE|PART-OF|1499
17000933|The beneficial role of 17beta-estradiol on blood pressure, cardiac hypertrophy, vascular osteopontin expression, perivascular fibrosis, and impaired NO-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of medroxyprogesterone acetate.|17beta-estradiol|osteopontin|5|14|Arg1:T1|Arg2:T30|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1500
16846546|Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.|bromfenac sodium|cyclooxygenase|14|3|Arg1:T28|Arg2:T42|CHEMICAL|GENE|INHIBITOR|1501
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|lavendustin A|tyrosine kinase|57|54|Arg1:T6|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1502
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|Sorafenib|VEGFR-3|1|25|Arg1:T4|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1503
23534442|New classes of pyrrole-derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as COX-2 selective inhibitors and NO donors were synthesized and are herein reported.|esters|COX-2|7|17|Arg1:T5|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1504
23091188|Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.|LPV|protease|6|2|Arg1:T22|Arg2:T51|CHEMICAL|GENE|INHIBITOR|1505
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|cytarabine|CDA|38|6|Arg1:T9|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|1506
23220618|And, the effects of the compounds on expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were tested in tumor necrosis factor-(TNF)-α activated HUVECs. Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, both agents elicited anticoagulant effects in mouse.|hyperoside|FXa|64|70|Arg1:T13|Arg2:T36|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1507
15474503|These results suggest that pitavastatin efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.|pitavastatin|apoA-I|5|8|Arg1:T1|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1508
23220644|In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (JMC08-4) for human nonpancreatic secretory phospholipase A(2) (hnps-PLA(2)) and human leukotriene A(4) hydrolase (LTA(4)H-h) was found.|JMC08-4|human nonpancreatic secretory phospholipase A(2)|21|24|Arg1:T2|Arg2:T7|CHEMICAL|GENE|INHIBITOR|1509
16957773|Upon differentiation, osteoclasts express vesicular glutamate transporter 1 (VGLUT1), which is essential for vesicular storage and subsequent exocytosis of glutamate in neurons.|glutamate|vesicular glutamate transporter 1|24|6|Arg1:T5|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|1510
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|Leu|TMH7|9|30|Arg1:T3|Arg2:T46|CHEMICAL|GENE|PART-OF|1511
2569356|The effect of histamine-H1 receptor antagonism with terfenadine on concentration-related AMP-induced bronchoconstriction in asthma.|terfenadine|histamine-H1 receptor|8|4|Arg1:T13|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|1512
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|VB1|cyclin B1|5|41|Arg1:T3|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1513
15452358|Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.|CP-101,606|NR2B|18|15|Arg1:T12|Arg2:T22|CHEMICAL|GENE|ANTAGONIST|1514
12487427|Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE/NEP inhibitors GW660511X and omapatrilat.|omapatrilat|ACE|20|16|Arg1:T50|Arg2:T89|CHEMICAL|GENE|INHIBITOR|1515
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|EVn-50|Histone 3|3|28|Arg1:T2|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|1516
23506741|In addition, the disease activity index, histopathologic scores and myeloperoxidase activity were also significantly reduced by Fc11a-2 treatment.|Fc11a-2|myeloperoxidase|19|12|Arg1:T8|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1517
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|heterocyclic amine|cyt b5|24|51|Arg1:T23|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1518
23098818|Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the human isoform CYP2D6.|O|CYP2D|17|8|Arg1:T13|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|1519
8294418|The protein phosphatase inhibitor okadaic acid prolonged the normally transient effect of NE for at least 24 h.|okadaic acid|protein phosphatase|5|2|Arg1:T18|Arg2:T34|CHEMICAL|GENE|INHIBITOR|1520
14984733|  Phosphatidylserine (PtdSer) is made in mammalian cells by two PtdSer synthases, PSS1 and PSS2.|Phosphatidylserine|PSS2|1|17|Arg1:T1|Arg2:T26|CHEMICAL|GENE|PRODUCT-OF|1521
17094978|CONCLUSION(S): Short-term exposure of mifepristone in new starters of DMPA increases the expression of endometrial ERalpha, PRAB, PRB, and SRC-1 and promotes cell proliferation.|mifepristone|ERalpha|9|20|Arg1:T3|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1522
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Gleevec|Bcr|14|22|Arg1:T37|Arg2:T54|CHEMICAL|GENE|INHIBITOR|1523
18081314|The binding of U46619 to the PGIS protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at C-11, H2C, and H20 of U46619 were observed upon U46619 binding to the engineered PGIS in a concentration-dependent manner.|U46619|PGIS|38|43|Arg1:T16|Arg2:T39|CHEMICAL|GENE|DIRECT-REGULATOR|1524
23623750|Amino acid sequences of cynomolgus FMO1-5, respectively, shared high sequence identities (94-98%) and were closely clustered in a phylogenetic tree, with human FMO1-5.|Amino acid|FMO1-5|1|6|Arg1:T9|Arg2:T33|CHEMICAL|GENE|PART-OF|1525
23425605|The tyrosine hydroxylase inhibitor α-methyltyrosine (300µM, 24h) completely abolished MeHg-induced DA release.|α-methyltyrosine|tyrosine hydroxylase|5|2|Arg1:T3|Arg2:T27|CHEMICAL|GENE|INHIBITOR|1526
3134891|  To determine the factors that influence the interaction between phenoxybenzamine and calmodulin, the binding of phenoxybenzamine to calmodulin was determined by equilibrium dialysis under a variety of experimental conditions.|phenoxybenzamine|calmodulin|17|19|Arg1:T2|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|1527
12901032|Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.|rofecoxib|cyclooxygenase-2|33|10|Arg1:T9|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1528
15121646|The relatively high D(2) receptor occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and quetiapine.|quetiapine|D(2) receptor|35|4|Arg1:T9|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|1529
12414329|PDE5 is the predominant PDE in the corpus cavernosum, and cGMP is its primary substrate.|cGMP|PDE|12|5|Arg1:T7|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|1530
23440512|The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.|atRA|nuclear receptors|19|36|Arg1:T5|Arg2:T12|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1531
23370008|Serum amyloid A upsurge precedes standard biomarkers of hepatotoxicity in ritodrine-injected mice.|ritodrine|Serum amyloid A|11|1|Arg1:T20|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1532
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|progestogens|17beta-hydroxysteroid-dehydrogenase type 1|8|36|Arg1:T7|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1533
17098734|During embryogenesis, lratb is expressed in mostly non-overlapping domains opposite to retinal dehydrogenase 2 (raldh2), the key enzyme for retinoic acid synthesis.|retinoic acid|retinal dehydrogenase 2|24|13|Arg1:T9|Arg2:T20|CHEMICAL|GENE|PRODUCT-OF|1534
18973551|Quinpirole and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.|Quinpirole|extracellular signal-regulated kinase|1|9|Arg1:T5|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|1535
10771044|In these tissues, JTH-601, prazosin (a non-selective alpha(1)-adrenoceptor antagonist), and tamsulosin (an alpha(1A)-adrenoceptor antagonist) competitively antagonized contraction in a concentration-dependent manner.|JTH-601|alpha(1)-adrenoceptor|5|11|Arg1:T10|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|1536
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|Sorafenib|PDGFR-beta|1|34|Arg1:T4|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1537
10701840|Through demonstrating the selective inhibition of kinase-related T-lymphocyte responses by geldanamycin, our results emphasize the substantial role of Hsp90-kinase complexes in T-cell activation.|geldanamycin|kinase|11|7|Arg1:T1|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1538
16213084|This process was reduced by a protonophore, carbonylcyanide p-trifluoromethoxyphenylhydrazone, and a typical monocarboxylate transporter (MCT) inhibitor, alpha-cyano-4-hydroxycinnamic acid, suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system.|nicotinate|monocarboxylate transport system|27|40|Arg1:T15|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|1539
9712175|We studied the role of endogenous CCK in the emptying of a solid/liquid meal administering the new, highly specific and potent CCK-A receptor antagonist lintitript.|lintitript|CCK-A receptor|26|23|Arg1:T3|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|1540
17218486|PEA was a potent and full agonist at each species of TAAR1, whereas TYR was a full agonist for the rodent TAAR1s but was a partial agonist at h-rChTAAR1.|TYR|rodent TAAR1s|15|22|Arg1:T4|Arg2:T41|CHEMICAL|GENE|AGONIST-ACTIVATOR|1541
1680855|  Adrenaline inhibits insulin secretion via pertussis toxin-sensitive mechanisms.|Adrenaline|insulin|1|3|Arg1:T1|Arg2:T45|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1542
10640321|In contrast, combined pretreatment with beta-funaltrexamine (mu-receptor antagonist; 20 mg/kg, s.c.) and norbinaltorphimine (kappa-receptor antagonist; 20 mg/kg, s.c.), at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists, respectively, was without effect on the antitussive response of SB 227122 (20 mg/kg, i.p.).|norbinaltorphimine|kappa-receptor|18|20|Arg1:T19|Arg2:T31|CHEMICAL|GENE|ANTAGONIST|1543
12636181|  Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.|acetylcholine|AChE|25|3|Arg1:T2|Arg2:T10|CHEMICAL|GENE|SUBSTRATE|1544
23322769|Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes.|manumycin A|ApoA-I|13|18|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1545
9476974|  Intravenous (I.V.) cocaine (0.03-3 mg/kg) produced dose-dependent, rapid, and brief increases in blood pressure (BP) in conscious rats pretreated with the dopamine receptor antagonist, SCH 23390.|SCH 23390|dopamine receptor|35|31|Arg1:T13|Arg2:T46|CHEMICAL|GENE|ANTAGONIST|1546
11264758|Pranlukast is a new, orally active, selective inhibitor of CysLt1 leukotriene receptor.|leukotriene|leukotriene receptor|13|13|Arg1:T6|Arg2:T15|CHEMICAL|GENE|DIRECT-REGULATOR|1547
1978244|Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that alpha 1-adrenoceptor populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for WB4101 and pKd approximately 7.1 for 5-methyl-urapidil) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both WB4101 and 5-methyl-urapidil), which was in good agreement with radioligand binding studies.(ABSTRACT TRUNCATED AT 400 WORDS)|5-methyl-urapidil|alpha 1-adrenoceptor|70|14|Arg1:T17|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|1548
23097088|Interestingly, there was a loss in the binding of ICAM2 to actin during CdCl₂-induced germ cell loss, suggesting that a loss of ICAM2-actin interactions might have facilitated junction restructuring.|CdCl₂|actin|15|13|Arg1:T1|Arg2:T7|CHEMICAL|GENE|INHIBITOR|1549
8384716|Degenerate oligonucleotides corresponding to conserved amino acids from transmembrane domains III, V, and VI of known receptors [5-HT1A, 5-HT1C, and 5-HT2; 5-HT is serotonin (5-hydroxytryptamine)] were used as primers for the sequential reactions.|amino acids|5-HT1C|6|23|Arg1:T15|Arg2:T36|CHEMICAL|GENE|PART-OF|1550
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|SoRI-20041|DAT|26|63|Arg1:T23|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|1551
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|ellagic acid|CA|34|49|Arg1:T8|Arg2:T27|CHEMICAL|GENE|INHIBITOR|1552
8894610|(+/-)-Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1B-adrenoceptors by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine.|phenylephrine|alpha 1B-adrenoceptors|12|17|Arg1:T1|Arg2:T28|CHEMICAL|GENE|AGONIST|1553
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|alpha-chloroenethiolate|beta-lyases|18|10|Arg1:T24|Arg2:T54|CHEMICAL|GENE|PRODUCT-OF|1554
15985706|The gastric mucin secretory responses to isoproterenol, furthermore, were inhibited by PP2, a selective inhibitor of tyrosine kinase Src responsible for ligand-independent EGFR autophosphorylation, but not by ERK inhibitor, PD98059.|PD98059|ERK|35|32|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1555
15498586|Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dose-dependent increase in mRNA levels for PPARgamma target genes such as aP2 and adiponectin.|telmisartan|PPARgamma|11|20|Arg1:T3|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1556
15908512|In contrast, the selective beta2AR antagonists ICI-118,551 and butoxamine inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively).|ICI-118,551|beta2AR|8|6|Arg1:T9|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|1557
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|clerosterol|iNOS|13|47|Arg1:T6|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1558
17382376|In summary, the therapeutic effect of clozapine in reversing PPI impairment was mimicked by the H(1) antagonist pyrilamine, while pyrilamine had a mixed effect on cognition.|pyrilamine|H(1)|22|17|Arg1:T8|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|1559
1375507|Preincubation for 30 minutes with iloprost, ciprostene, and carbacyclin led to a dose-dependent inhibition of tissue factor expression induced by all three challenging agents.|ciprostene|tissue factor|8|18|Arg1:T14|Arg2:T32|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1560
15777622|Then the cells were treated with various concentrations of apoE3, lactoferrin and bovine serum albumin with or without 100 microg/ml of GMC, and the SGLT1-dependent methyl alpha-D-glucopyranoside (AMG) uptake and levels of SGLT1 expression were determined.|AMG|SGLT1|31|27|Arg1:T16|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|1561
9299436|We have identified adenosine deaminase, an enzyme involved in purine metabolism whose deficiency is associated with severe combined immunodeficiency, as a Grb3-3 binding protein that is not able to bind to Grb2.|purine|adenosine deaminase|11|4|Arg1:T2|Arg2:T11|CHEMICAL|GENE|SUBSTRATE|1562
16494569|CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired pyridoxal kinase for the conversion of pyridoxine and pyridoxal to PLP.|PLP|pyridoxal kinase|29|19|Arg1:T12|Arg2:T21|CHEMICAL|GENE|PRODUCT-OF|1563
20531964|A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR tyrosine kinase inhibitors sunitinib and/or sorafenib.|sunitinib|VEGFR|34|30|Arg1:T9|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1564
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|aromatic amine|cyt b5|11|51|Arg1:T20|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1565
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|medrogestone|17beta-hydroxysteroid-dehydrogenase type 1|15|36|Arg1:T9|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1566
3588607|Xanthines are classical antagonists for adenosine receptors for many of their pharmacological actions may be due to blockade of adenosine receptors.|Xanthines|adenosine receptors|1|6|Arg1:T3|Arg2:T39|CHEMICAL|GENE|ANTAGONIST|1567
23583257|Nox4 oxidase activity is thought to be constitutive and regulated at the transcriptional level; however, we challenge this point of view and suggest that specific quinone derivatives could modulate this activity.|quinone|oxidase|28|2|Arg1:T4|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|1568
23574017|Doxorubicin is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.|Doxorubicin|P-gp|1|11|Arg1:T7|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|1569
23601203|Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.|Arg|HSA|24|11|Arg1:T4|Arg2:T12|CHEMICAL|GENE|PART-OF|1570
12086935|Metformin treatment for 10 weeks significantly increased AMPK alpha2 activity in the skeletal muscle, and this was associated with increased phosphorylation of AMPK on Thr172 and decreased acetyl-CoA carboxylase-2 activity.|Metformin|acetyl-CoA carboxylase-2|1|29|Arg1:T16|Arg2:T29|CHEMICAL|GENE|INHIBITOR|1571
16988497|CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.|SFAs|D6D|6|15|Arg1:T1|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1572
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|RTI-55|DAT|45|63|Arg1:T25|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|1573
10727528|Salicylic acid promotes dissociation of (125)I-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled ET-1.|Salicylic acid|ETA receptor|1|10|Arg1:T10|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|1574
23535516|Intravenous treatment, during coronary artery occlusion, with the melanocortin analogs [Nle(4), D-Phe(7)]α-melanocyte-stimulating hormone (NDP-α-MSH) and adrenocorticotropic hormone 1-24 [ACTH-(1-24)], induced a left ventricle up-regulation of pJAK2, pERK1/2 and pTyr-STAT3 (JAK-dependent), and a reduction in pJNK and TNF-α levels; these effects of NDP-α-MSH and ACTH-(1-24) were associated with over-expression of the pro-survival proteins HO-1 and Bcl-XL, and marked decrease of the myocardial infarct size.|D-Phe|α-MSH|19|28|Arg1:T2|Arg2:T8|CHEMICAL|GENE|PART-OF|1575
7516184|The protein that binds TSG-6 was purified from human serum and identified as inter-alpha-inhibitor (I alpha I) by N-terminal microsequencing.|N|inter-alpha-inhibitor|21|14|Arg1:T6|Arg2:T22|CHEMICAL|GENE|PART-OF|1576
15635044|Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.|Leu|rat GnRHR|30|48|Arg1:T16|Arg2:T49|CHEMICAL|GENE|PART-OF|1577
7885191|Drosophila GABA-gated chloride channel: modified [3H]EBOB binding site associated with Ala-->Ser or Gly mutants of Rdl subunit.|Ser|Rdl|18|23|Arg1:T51|Arg2:T58|CHEMICAL|GENE|PART-OF|1578
16917142|Tamoxifen blocks the action of estrogen by binding to the ER, and possesses both ER-agonist and antagonist properties.|Tamoxifen|ER|1|16|Arg1:T11|Arg2:T31|CHEMICAL|GENE|ANTAGONIST|1579
9832994|These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.|ritanserin|5-HT2C|42|41|Arg1:T14|Arg2:T26|CHEMICAL|GENE|ANTAGONIST|1580
9310349|The hydrolysis of fluorescein diphosphate by PTP epsilon and PTPmeg1 was sensitive to alendronate, with IC50 values of less than 1 microM; PTPsigma, however, under the same conditions, was inhibited by only 50% with 141 microM alendronate.|diphosphate|PTP epsilon|5|7|Arg1:T17|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|1581
11264758|Pranlukast is a new, orally active, selective inhibitor of CysLt1 leukotriene receptor.|Pranlukast|leukotriene receptor|1|13|Arg1:T10|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1582
10771044|JTH-601 is expected to be an effective alpha(1)-adrenoceptor antagonist for the treatment of urinary outlet obstruction by benign prostatic hypertrophy with a minimum effect on the cardiovascular system.|JTH-601|alpha(1)-adrenoceptor|1|8|Arg1:T5|Arg2:T22|CHEMICAL|GENE|ANTAGONIST|1583
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|Fenofibrate|acyl-coenzyme A (CoA) oxidase|1|7|Arg1:T15|Arg2:T36|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1584
15985706|The gastric mucin secretory responses to isoproterenol, furthermore, were inhibited by PP2, a selective inhibitor of tyrosine kinase Src responsible for ligand-independent EGFR autophosphorylation, but not by ERK inhibitor, PD98059.|PP2|Src|14|22|Arg1:T12|Arg2:T39|CHEMICAL|GENE|INHIBITOR|1585
23600914|  High cholesterol turnover catalyzed by cholesterol 24-hydroxylase is essential for neural functions, especially learning.|cholesterol|cholesterol 24-hydroxylase|2|6|Arg1:T9|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|1586
23123250|The synthetic stereoisomer, [+]-Hup A, is less toxic due to poor AChE inhibition and is suitable for both pre-/post-exposure treatments of nerve agent toxicity.|[+]-Hup A|AChE|5|17|Arg1:T18|Arg2:T27|CHEMICAL|GENE|INHIBITOR|1587
19389876|  Ambrisentan is an endothelin type A (ET(A))-selective receptor antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by CYP3A4.|Ambrisentan|CYP3A4|1|28|Arg1:T1|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|1588
23250811|This study explored whether curcumin improves colonic inflammation in a rat colitis model through inhibition of the TLR4/NF-κB signaling pathway and IL-27 expression.|curcumin|IL-27|5|22|Arg1:T10|Arg2:T32|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1589
15723099|Dextromethorphan and dimemorfan are high-affinity ligands at sigma1 receptors.|Dextromethorphan|sigma1 receptors|1|8|Arg1:T4|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|1590
11034583|METHODS: Part A compared the effects of placebo to four doses of a 5-HT(4) receptor antagonist (SB-207266) on the cisapride mediated increase in plasma aldosterone (a 5-HT(4) mediated response) and orocaecal transit in 18 subjects.|SB-207266|5-HT(4)|22|15|Arg1:T7|Arg2:T20|CHEMICAL|GENE|ANTAGONIST|1591
14692707|On the other hand, in patients with a mean serum carvedilol level (Cmin) of less than 2.5 nmol/l up to 2 weeks after the start ofcarvedilol therapy, the degree of reduction in the BNP value after the 3rd month was significantly larger, relative to the patient group with Cmin over 2.5 nmol/l.|carvedilol|BNP|30|38|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1592
17418819|Under isotonic conditions, N-ethylmaleimide (NEM) produced KCC activation and transient cell shrinkage.|N-ethylmaleimide|KCC|5|10|Arg1:T3|Arg2:T18|CHEMICAL|GENE|ACTIVATOR|1593
12881227|5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.|DMA|NHE3|12|29|Arg1:T9|Arg2:T34|CHEMICAL|GENE|INHIBITOR|1594
16424790|Given the treatment with three doses of Captopril (15 approximately 45 mg/kg) markedly attenuated inhibition of vasodilator responses to ACh, and eliminated the increased level of malondialdehyde, the decreased level of NO, activity of PON1 and SOD in serum by single intragastric gavaged L-methionine.|Captopril|PON1|8|40|Arg1:T10|Arg2:T58|CHEMICAL|GENE|ACTIVATOR|1595
20104269|We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the chenodeoxycholic acid (CDCA)-induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells (RGM-1 cells).|CDCA|Cdx2|26|31|Arg1:T4|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1596
10701840|Geldanamycin also disrupts the T-cell receptor-mediated activation of nuclear factor of activated T-cells (NF-AT).|Geldanamycin|T-cell receptor|1|5|Arg1:T6|Arg2:T27|CHEMICAL|GENE|INHIBITOR|1597
20801130|Dfbp-o also increased the affinity of cTnI for cTnC.|Dfbp-o|cTnC|1|9|Arg1:T21|Arg2:T41|CHEMICAL|GENE|DIRECT-REGULATOR|1598
9015795|However, because clozapine competes with endogenous dopamine, the in vivo concentration of clozapine (to occupy dopamine D4 receptors) can be derived to be about 13 nM, agreeing with the value of 12 to 20 nM in the plasma water or spinal fluid observed in treated patients.|clozapine|dopamine D4 receptors|15|19|Arg1:T8|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|1599
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|24-OHC|ABCG1|10|6|Arg1:T7|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1600
23024204|By contrast, 1,12-diamino-3,6,9-triazadodecane(SpmTrien), a charge-deficient spermine analog, was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wild-type primary hepatocytes.|1,12-diamino-3,6,9-triazadodecane|SSAT1|4|27|Arg1:T18|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|1601
11695255|A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective cyclooxygenase (COX)-2 inhibitor (celecoxib) in comparison to a dual COX-1/COX-2 inhibitor (ketorolac).|ketorolac|COX-2|49|47|Arg1:T11|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1602
23583257|Such model of Nox4 activity regulation could provide new insight into the understanding of the molecular mechanism of the electron transfer through the enzyme, i.e., its potential redox regulation, and could also define new therapeutic targets in diseases in which quinones and Nox4 are implicated.|quinones|Nox4|44|4|Arg1:T3|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|1603
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|CLS|iNOS|15|47|Arg1:T7|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1604
23578607|6-DHSG was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (GST).|GS-6-DHSG|glutathione-S-transferase|12|28|Arg1:T23|Arg2:T31|CHEMICAL|GENE|PRODUCT-OF|1605
18068977|In this report, we show that the hypolipidemic agent atorvastatin is a competitive inhibitor of porcine DPP-IV in vitro, with K(i)=57.8+/-2.3 microM.|atorvastatin|porcine DPP-IV|11|17|Arg1:T1|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1606
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|TO901317|LXR|15|27|Arg1:T8|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|1607
23587425|Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.|imidazo[1,2-c]pyrimidine|CHK1|16|4|Arg1:T4|Arg2:T9|CHEMICAL|GENE|INHIBITOR|1608
17768678|  Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.|Phenelzine|GABA-T|1|21|Arg1:T1|Arg2:T36|CHEMICAL|GENE|INHIBITOR|1609
20421509|The Ca(2+)-S100A4/prochlorperazine (PCP) complex exhibits a similar pentameric assembly.|PCP|S100A4|8|7|Arg1:T5|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|1610
14751502|RESULTS: GW572016 inhibited constitutive and/or ligand-induced EGFR or HER2 tyrosine phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line.|GW572016|HER2|3|10|Arg1:T9|Arg2:T39|CHEMICAL|GENE|INHIBITOR|1611
23273219|Synthesis, molecular modeling and evaluation of novel N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and Aβ aggregation.|N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone|cholinesterases|9|19|Arg1:T3|Arg2:T12|CHEMICAL|GENE|INHIBITOR|1612
15866288|When amiloride was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment, u-PA activity in both cornea and tear fluid was strongly inhibited.|amiloride|u-PA|2|25|Arg1:T1|Arg2:T10|CHEMICAL|GENE|INHIBITOR|1613
16938288|RESULTS: Telmisartan decreased the expression of AT1R at the mRNA and protein levels in a dose- and time-dependent manner.|Telmisartan|AT1R|3|8|Arg1:T9|Arg2:T34|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1614
23298698|Local PGE2 administration prevented the increase of airway IL-13 and osteopontin and kept lung plasmacytoid dendritic cell counts close to baseline.|PGE2|osteopontin|2|11|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1615
12217700|  The bacterial enzyme maltodextrin phosphorylase (MalP) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as glucose-1-phosphate (Glc1P).|glucose-1-phosphate|maltodextrin phosphorylase|28|4|Arg1:T13|Arg2:T27|CHEMICAL|GENE|PRODUCT-OF|1616
17205056|In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, sorafenib blocked basal and ligand dependent FLT3-mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase1/2 and Stat5 phosphorylation.|sorafenib|Stat5|11|27|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1617
12093311|  OBJECTIVE: Celecoxib and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (COX-2) isoenzyme at therapeutic concentrations.|rofecoxib|cyclo-oxygenase-2|5|20|Arg1:T10|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1618
17768678|  Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.|Phenelzine|MAO|1|14|Arg1:T1|Arg2:T40|CHEMICAL|GENE|INHIBITOR|1619
15985706|Using [(3)H]glucosamine-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.|PD153035|mucin|34|25|Arg1:T6|Arg2:T30|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1620
23298677|Induction of HO-1 through p38 MAPK/Nrf2 signaling pathway by ethanol extract of Inula helenium L.|ethanol|HO-1|10|3|Arg1:T8|Arg2:T38|CHEMICAL|GENE|ACTIVATOR|1621
14501155|The 5-HT(1/2/5/7)-receptor antagonist methysergide and the 5-HT(2A/2B/2C)-receptor antagonist LY 53857 enhanced clomipramine-induced hyperglycemia, while the 5-HT(1A/1B)-receptor antagonist (-)-propranolol and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it.|(-)-propranolol|5-HT(1A/1B)-receptor|31|25|Arg1:T10|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|1622
10727715|This effect has been attributed to the antagonist effects of pindolol at the 5-HT(1A) receptor.|pindolol|5-HT(1A)|11|14|Arg1:T16|Arg2:T36|CHEMICAL|GENE|ANTAGONIST|1623
12679340|The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.|Lys|OTCase|11|30|Arg1:T16|Arg2:T21|CHEMICAL|GENE|PART-OF|1624
23143891|CYP3A5, which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize triamcinolone acetonide, budesonide, and fluticasone propionate.|triamcinolone acetonide|CYP3A5|20|1|Arg1:T1|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|1625
23142507|The 3D-structure of HmTx consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).|Lys|HmTx|13|4|Arg1:T3|Arg2:T23|CHEMICAL|GENE|PART-OF|1626
9990013|This direct biochemical evidence of cooperative interaction in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this cooperative binding of ATP and MgADP and, in cooperation with the MgADP bound at NBF2, causes ATP to be released from NBF1.|ATP|NBF2|26|38|Arg1:T7|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|1627
17459764|Finally, PLA2 inhibitor methyl arachidonyl fluorophosphonate blocked the PUFA effects on COX-2 induction, promoter activity and arachidonic acid mobilization suggesting involvement of AA metabolites in PPAR activation.|arachidonyl fluorophosphonate|PLA2|6|3|Arg1:T23|Arg2:T41|CHEMICAL|GENE|INHIBITOR|1628
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|cinnamic aldehyde|NRF2|34|21|Arg1:T3|Arg2:T7|CHEMICAL|GENE|ACTIVATOR|1629
23539296|siRNA knockdown of p38 MAPK abrogated the ability of anisomycin to synergistically induce CYP2B6 mRNA.|anisomycin|CYP2B6|10|14|Arg1:T3|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1630
19023039|When Panx1 was coexpressed with purinergic P2X(7) receptor (P2X(7)R), DIDS was found to act as a P2X(7)R antagonist to inhibit ATP-evoked currents, but none of the other compounds inhibited P2X(7)R currents.|DIDS|P2X(7)R|20|27|Arg1:T11|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|1631
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|leuprorelin|Luteinizing hormone-releasing hormone|15|1|Arg1:T7|Arg2:T22|CHEMICAL|GENE|AGONIST|1632
1356794|The preferential alpha 2A-adrenoceptor partial agonist, guanfacine, partially inhibited UK 14,304-induced antinociception.|guanfacine|alpha 2A-adrenoceptor|8|3|Arg1:T7|Arg2:T16|CHEMICAL|GENE|AGONIST|1633
16417577|Galanin attenuates cyclic AMP regulatory element-binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures.|morphine|cyclic AMP regulatory element-binding protein|15|3|Arg1:T6|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|1634
11972613|Increased IL-5 activity in the serum was inhibited by both pranlukast and MCI-826 by over 90%.|pranlukast|IL-5|11|2|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1635
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imiquimod|TLR8|5|15|Arg1:T4|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|1636
23098818|The reaction was inhibited by the specific CYP2D inhibitors quinine and fluoxetine.|fluoxetine|CYP2D|12|8|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1637
9890894|These results suggest that a complex of Ig module II and heparan sulfate is the base common active core of the FGFR ectodomain and that flanking structural domains modify FGF affinity and determine specificity.|sulfate|Ig module II|13|8|Arg1:T4|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|1638
8294418|Phorbol esters and norepinephrine destabilize alpha 1B-adrenergic receptor mRNA in vascular smooth muscle cells.|norepinephrine|alpha 1B-adrenergic receptor|4|6|Arg1:T20|Arg2:T37|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1639
23261676|Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.|Isoproterenol|glutathione reductase|1|38|Arg1:T15|Arg2:T32|CHEMICAL|GENE|INHIBITOR|1640
2899826|Chlorpromazine, levomepromazine, and their metabolites had 5-30 times higher binding affinities for muscarinic cholinergic receptors than fluphenazine, perphenazine and their metabolites.|fluphenazine|muscarinic cholinergic receptors|19|15|Arg1:T12|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|1641
23578607|6-DHSG was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (GST).|GS-6-DHSG|GST|12|30|Arg1:T23|Arg2:T32|CHEMICAL|GENE|PRODUCT-OF|1642
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|Akt|3|17|Arg1:T8|Arg2:T12|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1643
1705137|Before the next drug intake, MAO-A inhibition, as judged by the decrease of plasma DHPG concentration, was significantly different from placebo with moclobemide but not with toloxatone.|toloxatone|MAO-A|30|7|Arg1:T12|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1644
20724158|METHODS: We conducted a case-control study to measure the association between selective cox-2 inhibitors, particularly celecoxib, rofecoxib, valdecoxib and non-specific NSAID subgroups, and breast cancer risk.|celecoxib|cox-2|18|14|Arg1:T4|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1645
14656380|Agonist competition assays with [3H]DHA showed the following rank order of potency: isoproterenol>epinephrine> norepinephrine, consistent with beta2AR interaction.|[3H]DHA|beta2AR|5|25|Arg1:T1|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|1646
1543672|  Terbinafine (Lamisil) has primarily fungicidal action against many fungi as a result of its specific mechanism of squalene epoxidase inhibition.|Lamisil|squalene epoxidase|3|20|Arg1:T7|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1647
16432501|Two beta(2)-agonists, formoterol and salmeterol, are approved for treating asthma and have an extended duration of action and increased safety, associated with greater beta(2)-adrenoceptor selectivity.|formoterol|beta(2)-adrenoceptor|8|31|Arg1:T10|Arg2:T23|CHEMICAL|GENE|AGONIST|1648
16618126|Weakly translocated lipids (PE, phosphatidylhydroxypropionate, and phosphatidylhomoserine) are also weak Atp8a1 activators.|phosphatidylhydroxypropionate|Atp8a1|7|15|Arg1:T20|Arg2:T44|CHEMICAL|GENE|ACTIVATOR|1649
23240892|PKAA/anti-TNF-α siRNA nanocomplexes significantly reduced the ALT (alanine transaminase) and the hepatic cellular damages in APAP-intoxicated mice.|PKAA|ALT|1|7|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1650
15837926|Unlike transferrin receptor, the protease domain of PSMA contains a binuclear zinc site, catalytic residues, and a proposed substrate-binding arginine patch.|arginine|PSMA|23|9|Arg1:T7|Arg2:T20|CHEMICAL|GENE|PART-OF|1651
10640321|In contrast, combined pretreatment with beta-funaltrexamine (mu-receptor antagonist; 20 mg/kg, s.c.) and norbinaltorphimine (kappa-receptor antagonist; 20 mg/kg, s.c.), at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists, respectively, was without effect on the antitussive response of SB 227122 (20 mg/kg, i.p.).|beta-funaltrexamine|mu-receptor|7|9|Arg1:T17|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|1652
20421509|Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization.|TFP|S100A4|24|28|Arg1:T8|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|1653
9204085|Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors, retinoic acid receptors (RARs).|tretinoin|retinoic acid receptors|16|23|Arg1:T10|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|1654
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|β-catenin|3|9|Arg1:T8|Arg2:T10|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1655
23539296|In addition to CYP2B6, anisomycin co-treatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs. Thus, activated p38 MAPK is required for liganded-CAR to selectively activate a set of genes that encode drug metabolizing enzymes.|anisomycin|CYP2C9|6|14|Arg1:T4|Arg2:T29|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1656
16784786|In eukaryotes, the most prominent Mo-enzymes are (1) sulfite oxidase, which catalyzes the final step in the degradation of sulfur-containing amino acids and is involved in detoxifying excess sulfite, (2) xanthine dehydrogenase, which is involved in purine catabolism and reactive oxygen production, (3) aldehyde oxidase, which oxidizes a variety of aldehydes and is essential for the biosynthesis of the phytohormone abscisic acid, and in autotrophic organisms also (4) nitrate reductase, which catalyzes the key step in inorganic nitrogen assimilation.|sulfur|sulfite oxidase|24|12|Arg1:T29|Arg2:T48|CHEMICAL|GENE|SUBSTRATE|1657
17382376|In the current project, we found that the selective H(1) antagonist pyrilamine also reversed the dizocilpine-induced impairment in PPI of tactile startle with an auditory prepulse.|pyrilamine|H(1)|16|11|Arg1:T19|Arg2:T31|CHEMICAL|GENE|ANTAGONIST|1658
23376356|LY294002, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.|LY294002|AKT|1|6|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1659
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|ellagic acid|EC 4.2.1.1|34|51|Arg1:T8|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1660
15723099|Dimemorfan pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression, activator protein (AP)-1 DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus.|Dimemorfan|c-fos|1|9|Arg1:T25|Arg2:T38|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1661
23542114|Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway.|Arsenic trioxide|Notch|1|18|Arg1:T7|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1662
23220644|  Dual function inhibitors targeting phospholipase A(2) (PLA(2)) and leukotriene A(4) hydrolase (LTA(4)H) may balance the arachidonic acid (AA) metabolic network and be used as new anti-inflammatory drugs.|arachidonic acid|PLA(2)|33|11|Arg1:T1|Arg2:T12|CHEMICAL|GENE|PRODUCT-OF|1663
15198222|CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.|carprofen|COX-2|22|28|Arg1:T6|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1664
11585753|"ZD1839 (""Iressa""), a quinazoline tyrosine kinase inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials."|Iressa|EGFR|4|16|Arg1:T3|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1665
22445601|LY541850 was claimed from human mGlu receptors expressed in non-neuronal cells to be a selective orthosteric mGlu2 agonist and mGlu3 antagonist.|LY541850|mGlu2|1|17|Arg1:T6|Arg2:T20|CHEMICAL|GENE|AGONIST|1666
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|carbachol|AChE|27|4|Arg1:T9|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1667
12487427|GW660511X and omapatrilat increased the production of both BrBK1-8 and Br-Phe5 but not that of BrBK4-8 and BrBK2-8.|omapatrilat|Br-Phe5|3|11|Arg1:T23|Arg2:T66|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1668
8819507|Ka values in nM for rauwolscine (19), WB-4101 (265), SKF-104078 (197), spiroxatrine (128), and prazosin (1531) for blocking relaxation in rat arteries were consistent with their affinities for binding at the alpha-2D adrenoceptor subtype.|SKF-104078|alpha-2D adrenoceptor|16|46|Arg1:T21|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|1669
11691635|The specific activity of only ornithine aminotransferase (OAT), the rate-limiting enzyme in the conversion of ornithine to proline, increased in 2 weeks of hypertrophy.|ornithine|OAT|19|9|Arg1:T2|Arg2:T9|CHEMICAL|GENE|SUBSTRATE|1670
22824191|In the present study we tested whether propranolol, a β-receptor antagonist commonly used as antihypertensive drug, could ameliorate the cognitive impairments and increases in AD-related markers shown by the senescence-accelerated mouse prone-8 (SAMP8).|propranolol|β-receptor|8|11|Arg1:T6|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|1671
10406837|Isometric contraction induced by a submaximal concentration of Ang II (10(-7) mol/L) was reduced in a dose-dependent way by torasemide (IC(50)=0.5+/-0.04 micromol/L).|torasemide|Ang II|25|9|Arg1:T2|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1672
23220618|And, the effects of the compounds on expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were tested in tumor necrosis factor-(TNF)-α activated HUVECs. Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, both agents elicited anticoagulant effects in mouse.|IMG|thrombin|41|57|Arg1:T10|Arg2:T33|CHEMICAL|GENE|INHIBITOR|1673
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|heterocyclic amine|human b5R|24|48|Arg1:T23|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|1674
23313557|Moreover, GCs have a synergistic effect on GW4064-induced FXR activation, whereas chenodeoxycholate and GW4064 have an additive effect.|GW4064|FXR|9|10|Arg1:T5|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|1675
9476974|Monoamine uptake inhibitors structurally analogous to cocaine (cocaethylene, CFT, betaCIT, CPT, (+)-cocaine, norcocaine, and benztropine) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities (BTCP, indatraline, GBR 12935, mazindol, nomifensine, and zimeldine) either did not produce a rapid pressor response or produced only a small pressor response.|zimeldine|monoamine transporter|57|41|Arg1:T30|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1676
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|p-coumaric acid|metalloenzyme|16|45|Arg1:T17|Arg2:T25|CHEMICAL|GENE|INHIBITOR|1677
15777622|In this study, using a model of gentamicin C (GMC)-induced reduction in SGLT1 activity, we examined whether ligands for megalin protect LLC-PK1 cells from the GMC-induced reduction in SGLT1 activity.|GMC|SGLT1|31|34|Arg1:T13|Arg2:T31|CHEMICAL|GENE|INHIBITOR|1678
16480505|The concomitantly administered effects of rifampicin on other drugs can result in their altered metabolism or transportation that are metabolised by cytochromes P450 or transported by p-glycoprotein in the gastrointestinal tract and liver.|rifampicin|cytochromes P450|6|22|Arg1:T2|Arg2:T9|CHEMICAL|GENE|SUBSTRATE|1679
1911436|The 3 beta-hydroxysteroid substrate, pregnenolone, protects isomerase as well as dehydrogenase from inactivation by FSA.|FSA|dehydrogenase|17|13|Arg1:T6|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1680
9310349|Alendronate inhibition of protein-tyrosine-phosphatase-meg1.|Alendronate|protein-tyrosine-phosphatase-meg1|1|4|Arg1:T23|Arg2:T42|CHEMICAL|GENE|INHIBITOR|1681
2855368|A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro.|naloxone-steroid hybrid azine|delta receptors|2|12|Arg1:T16|Arg2:T18|CHEMICAL|GENE|ANTAGONIST|1682
18081314|The distances between the protons H20 and H2, H18 and H2, and H18 and H4 are shorter following their binding to the PGIS in solution-down to within 5 A.|H2|PGIS|12|25|Arg1:T22|Arg2:T41|CHEMICAL|GENE|PART-OF|1683
23493568|Interestingly, insulin treatment of αXBPKD cells reduced tyrosine phosphorylation of IRS-1 (pY(896)), and phosphorylation of Akt, while enhancing serine phosphorylation (pS(307)) of IRS-1.|tyrosine|IRS-1|9|12|Arg1:T1|Arg2:T7|CHEMICAL|GENE|PART-OF|1684
3134891|This interaction was found to be similar in some respects to the interaction between phenothiazines and calmodulin.|phenothiazines|calmodulin|15|17|Arg1:T9|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|1685
12244038|Similar to gemfibrozil, clofibrate, another fibrate drug, also inhibited the expression of iNOS.|fibrate|iNOS|8|16|Arg1:T9|Arg2:T53|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1686
23261590|In this study, focus was given to evaluate the ability of neoechinulin A, an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-β 1-42 (Aβ42).|indole|Aβ42|17|34|Arg1:T6|Arg2:T31|CHEMICAL|GENE|INHIBITOR|1687
9551716|Saturation and competition studies in the presence or absence of the histamine H1 receptor antagonist, levocabastine, revealed that [3H]SR 142948A bound with similar affinities to both the levocabastine-insensitive neurotensin NT1 receptors (20% of the total binding population) and the recently cloned levocabastine-sensitive neurotensin NT2 receptors (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively).|[3H]SR 142948A|neurotensin NT1 receptors|21|34|Arg1:T3|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|1688
14523001|Cat-1, the transporter for the essential amino acids, arginine and lysine, is one of the up-regulated genes.|lysine|Cat-1|13|1|Arg1:T5|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|1689
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine|human b5R|26|48|Arg1:T24|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|1690
23531488|These variants are expected to encode either a full length (OATP2B1-FL) or shortened protein lacking 22 N-terminus amino acids (OATP2B-Short).|amino acids|OATP2B1-FL|20|12|Arg1:T4|Arg2:T17|CHEMICAL|GENE|PART-OF|1691
23497227|  A series of pyrido-quinazolines have been synthesised, characterised and tested for their in vitro EGFR tyrosine kinase inhibitory activity.|pyrido-quinazolines|EGFR|4|16|Arg1:T2|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1692
23534442|New classes of pyrrole-derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as COX-2 selective inhibitors and NO donors were synthesized and are herein reported.|pyrrole|COX-2|4|17|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1693
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|GW2331|phosphoenolpyruvate carboxykinase|3|21|Arg1:T16|Arg2:T39|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1694
12093311|  OBJECTIVE: Celecoxib and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (COX-2) isoenzyme at therapeutic concentrations.|Celecoxib|COX-2|3|22|Arg1:T3|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1695
10064839|This study therefore characterized the binding of DF to the sigma receptors and NMDA-linked PCP sites and examined the anticonvulsant as well as locomotor effects of DF in mice in comparison with those of DM and DR.|DF|sigma receptors|8|11|Arg1:T40|Arg2:T54|CHEMICAL|GENE|DIRECT-REGULATOR|1696
23123662|Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.|oxaliplatin|rCtr1|20|10|Arg1:T21|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|1697
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|caffeic acid|carbonic anhydrase|19|46|Arg1:T1|Arg2:T26|CHEMICAL|GENE|INHIBITOR|1698
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid|KARs|25|5|Arg1:T2|Arg2:T47|CHEMICAL|GENE|INHIBITOR|1699
23423570|Using cultured human keratinocytes and diabetic rat model, the current study showed that high-glucose environment enhanced IL-8 production via epidermal growth factor receptor (EGFR) -extracelluar signal-regulated kinase (ERK) pathway in a reactive oxygen species (ROS)-dependent manner in keratinocytes.|glucose|IL-8|16|18|Arg1:T3|Arg2:T7|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1700
12560076|Racemization of serine is catalyzed by serine racemase, a pyridoxal 5'-phosphate-dependent enzyme expressed mainly in brain and liver.|serine|serine racemase|3|7|Arg1:T4|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|1701
12881227|Moreover, S1611 and S3226, both specific inhibitors of NHE3 only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH.|S3226|NHE3|5|11|Arg1:T14|Arg2:T39|CHEMICAL|GENE|INHIBITOR|1702
23246481|The mechanism revealed that wogonin inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of VE-cadherin and β-catenin.|wogonin|cav-1|5|12|Arg1:T8|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1703
15866288|In conclusion, early application of amiloride inhibited u-PA activity in UVB-irradiated corneas as well as in tear fluid and diminished the development of corneal pathology.|amiloride|u-PA|7|9|Arg1:T2|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1704
23250811|Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).|curcumin|myeloperoxidase|9|28|Arg1:T14|Arg2:T37|CHEMICAL|GENE|INHIBITOR|1705
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|mZIENT|NET|14|58|Arg1:T8|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|1706
22898212|Mass spectral analysis of CBDP-inhibited BChE digested with Glu-C showed an o-hydroxybenzyl adduct (+106amu) on lysine 499, a residue far from the active site, but not on His-438.|His|BChE|32|6|Arg1:T20|Arg2:T33|CHEMICAL|GENE|PART-OF|1707
12724156|However, topiramate at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of GluR5 kainate receptor responses.|topiramate|GluR5|3|37|Arg1:T5|Arg2:T27|CHEMICAL|GENE|INHIBITOR|1708
15474503|Based on HMG-CoA reductase inhibition, pitavastatin-induced apoA-I more efficiently than simvastatin and atorvastatin.|simvastatin|apoA-I|12|8|Arg1:T11|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1709
1590750|The identity of the lung beta-ADHs was further demonstrated by their characteristic pH-activity profiles for ethanol oxidation, Km values for NAD and ethanol, and inhibition by 4-methylpyrazole or 1,10-phenanthroline.|ethanol|beta-ADHs|16|6|Arg1:T6|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|1710
12487427|GW660511X and omapatrilat increased the production of both BrBK1-8 and Br-Phe5 but not that of BrBK4-8 and BrBK2-8.|GW660511X|Br-Phe5|1|11|Arg1:T22|Arg2:T66|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1711
23274058|Additional mechanistic studies revealed that jaceosidin treatment resulted in an increase in phosphorylation of Cdc25C and ATM-Chk1/2.|jaceosidin|ATM|6|17|Arg1:T16|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|1712
16618126|Weakly translocated lipids (PE, phosphatidylhydroxypropionate, and phosphatidylhomoserine) are also weak Atp8a1 activators.|phosphatidylhomoserine|Atp8a1|10|15|Arg1:T21|Arg2:T44|CHEMICAL|GENE|ACTIVATOR|1713
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|MPP+|transmembrane transporters|12|24|Arg1:T5|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|1714
18081314|The binding of U46619 to the PGIS protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at C-11, H2C, and H20 of U46619 were observed upon U46619 binding to the engineered PGIS in a concentration-dependent manner.|U46619|PGIS|4|7|Arg1:T11|Arg2:T38|CHEMICAL|GENE|DIRECT-REGULATOR|1715
17040106|Polyclonal antisera to either b5R or cyt b5 significantly inhibited N-hydroxy-4-aminobiphenyl (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).|N-hydroxy-4-aminobiphenyl|b5R|11|5|Arg1:T4|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|1716
23262271|Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant tyrosinase inhibition activities.|steppogenin|tyrosinase|17|26|Arg1:T5|Arg2:T6|CHEMICAL|GENE|INHIBITOR|1717
15939622|  We report on the inhibitory activity of the NSAIDs meloxicam, carprofen, phenylbutazone and flunixin, on blood cyclooxygenases in the horse using in vitro enzyme-linked assays.|meloxicam|cyclooxygenases|10|20|Arg1:T9|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1718
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|DZN|cytochrome c|44|37|Arg1:T6|Arg2:T35|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1719
23538162|These data provided a novel insight to the mechanisms of Rg1protective effects on Aβ25-35-induced endothelial cells apoptosis, suggesting that GR-ERK signaling pathway might play an important role in it.|Rg1|Aβ25-35|11|14|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1720
14656380|Agonist competition assays with [3H]DHA showed the following rank order of potency: isoproterenol>epinephrine> norepinephrine, consistent with beta2AR interaction.|isoproterenol|beta2AR|17|25|Arg1:T2|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|1721
23391336|Cloning, Characterization, and Sulfonamide and Thiol Inhibition Studies of an α-Carbonic Anhydrase from Trypanosoma cruzi, the Causative Agent of Chagas Disease.|Thiol|α-Carbonic Anhydrase|8|13|Arg1:T8|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1722
23128353|Glucosamine at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and heme oxygenase-1 (HO-1), but also caused a reduction in p21 protein expression.|Glucosamine|p53|1|16|Arg1:T9|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1723
15635044|Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.|Pro|EL3|12|23|Arg1:T12|Arg2:T48|CHEMICAL|GENE|PART-OF|1724
7986344|Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A.|disulfide|bovine pancreatic ribonuclease A|5|9|Arg1:T14|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|1725
17382376|  Histamine H(1) blockade is one of the more prominent actions of the multi-receptor acting antipsychotic clozapine.|clozapine|Histamine H(1)|19|1|Arg1:T2|Arg2:T26|CHEMICAL|GENE|INHIBITOR|1726
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|CNT|5-HT1|13|25|Arg1:T21|Arg2:T33|CHEMICAL|GENE|AGONIST|1727
7926307|We conclude that expression of GLUT2 is required for efficient killing of neuroendocrine cells by STZ, and this effect is related to specific recognition of the drug as a transported substrate by GLUT2 but not GLUT1.|STZ|GLUT2|16|34|Arg1:T2|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|1728
15121646|METHOD: The authors conducted a PET study to evaluate D(2) occupancy (using [(11)C]raclopride) and 5-HT(2) occupancy (using [(18)F]setoperone) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40, 80, 120, or 160 mg/day of ziprasidone, which reflected the recommended dose range.|[(18)F]setoperone|5-HT(2)|34|27|Arg1:T15|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|1729
22445601|LY541850 was claimed from human mGlu receptors expressed in non-neuronal cells to be a selective orthosteric mGlu2 agonist and mGlu3 antagonist.|LY541850|mGlu3|1|20|Arg1:T6|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|1730
23293129|Cotreatments of 5, 10 and 20 µg/mL concentrations of MEP with aflatoxin B(1) decreased the frequencies of SCE and the malondialdehyde level and increased amount of superoxide dismutase, glutathione and glutathione peroxidase which were decreased by aflatoxin.|aflatoxin B(1)|superoxide dismutase|13|31|Arg1:T6|Arg2:T12|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1731
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|p38|7|21|Arg1:T2|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1732
23535337|Under NaCl and sorbitol stresses, catalase (CAT) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.|NaCl|CAT|2|9|Arg1:T8|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|1733
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Gefitinib|VEGF receptor|21|42|Arg1:T4|Arg2:T44|CHEMICAL|GENE|INHIBITOR|1734
20185318|Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.|phenolic acids|mammalian isoforms I-XIV|15|4|Arg1:T22|Arg2:T35|CHEMICAL|GENE|INHIBITOR|1735
16206183|DAT occupancy was between 66 and 82% and <10-41% for doses of dimethocaine and procaine that maintained maximum response rates, respectively.|dimethocaine|DAT|16|1|Arg1:T4|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|1736
10522750|The inhibitory effect of endothelin-1 on the contraction induced by 5-HT is abolished by deendothelialization, by the endothelin ET(B) receptor antagonist RES 701-1, by indomethacin, or by glibenclamide.|RES 701-1|endothelin ET(B) receptor|26|19|Arg1:T11|Arg2:T33|CHEMICAL|GENE|ANTAGONIST|1737
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|17-phenyl trinor PGE2|EP1|17|4|Arg1:T14|Arg2:T32|CHEMICAL|GENE|AGONIST|1738
17224860|However, as a novel finding, isoflavone treatment increased a subclass of high-density lipoprotein, the pre-beta high-density lipoprotein levels by 18% without affecting any other serum lipid concentrations.|isoflavone|high-density lipoprotein|8|14|Arg1:T6|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1739
12244038|However, DeltahPPAR-alpha was unable to abrogate gemfibrozil-mediated inhibition of iNOS suggesting that gemfibrozil inhibits iNOS independent of PPAR-alpha.|gemfibrozil|iNOS|14|16|Arg1:T16|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1740
16248990|After that, a wide range of concentrations of drugs, concomitantly with ATR (0.1 microM), was studied in the presence of haloperidol (HAL; 0.01 microM), a dopamine D2 antagonist.|haloperidol|dopamine D2|26|35|Arg1:T14|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|1741
23550066|  Ketamine is primarily metabolized to norketamine by hepatic cytochrome P450 (CYP) 2B6 and CYP3A4-mediated N-demethylation.|Ketamine|cytochrome P450 (CYP) 2B6|1|9|Arg1:T1|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|1742
17199504|  Adenine phosphoribosyltransferase plays a role in purine salvage by catalyzing the direct conversion of adenine to adenosine monophosphate.|adenine|Adenine phosphoribosyltransferase|15|1|Arg1:T2|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|1743
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Imatinib|KIT|1|22|Arg1:T1|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1744
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|Ara-C|CDA|40|6|Arg1:T10|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|1745
23440512|The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.|all-trans retinoic acid|nuclear receptors|15|36|Arg1:T4|Arg2:T12|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1746
14600253|Although a proton-stimulated uptake of cefadroxil was demonstrated in PEPT2(+/+) mice (pH 6.5 versus pH 7.4; p < 0.01), no pH dependence was observed in PEPT2(-/-) mice.|cefadroxil|PEPT2|6|10|Arg1:T12|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|1747
23479738|In this setting, S-nitrosocysteine (10 μm) effectively blocked the Trx-mediated regeneration of oxidized Prx1.|S-nitrosocysteine|oxidized Prx1|5|16|Arg1:T5|Arg2:T38|CHEMICAL|GENE|INHIBITOR|1748
23376356|LY294002, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.|LY294002|PI3K|1|5|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1749
7986344|The folding rate for wild-type RNase A is faster in the presence of the inhibitor 2'CMP than in its absence, indicating that the transition-state structure in the rate-determining step is stabilized by 2'CMP.|2'CMP|RNase A|16|6|Arg1:T7|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1750
15030294|Irbesartan may have antiatherosclerotic properties beyond those expected from blood pressure lowering per se: this AT1-blocker decreases the vascular oxidative stress and prevents the procoagulant as well as the pro-inflammatory effects of angiotensin II.|Irbesartan|AT1|1|17|Arg1:T8|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1751
23570998|Further, both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, RunX2, osteoprotegerin and osteocalcin.|flavonoids|RunX2|5|28|Arg1:T17|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1752
23538162|Taken together, our results suggested that Rg1 protected against Aβ25-35-induced apoptosis at least in part by two complementary GR-dependent ERK phosphorylation pathways: (1) down-regulating HIF-1α initiated protein nitrotyrosination, and (2) inhibiting mitochondrial apoptotic cascades.|Rg1|HIF-1α|8|29|Arg1:T11|Arg2:T28|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1753
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|alanine|SNAT2|8|40|Arg1:T15|Arg2:T42|CHEMICAL|GENE|SUBSTRATE|1754
1322047|Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation.|clenbuterol|beta 2-adrenoceptor|4|11|Arg1:T12|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|1755
15563928|In addition, both drugs significantly reduced PGE2 levels (P<0.05) 6-h following LPS injection, whereas the probable COX-1 prostanoid TXB2 was significantly reduced by phenylbutazone (P<0.05), but not etodolac.|phenylbutazone|COX-1|30|23|Arg1:T5|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1756
23506741|Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.|Fc11a-2|cytokines|29|10|Arg1:T9|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1757
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|DL-alpha-difluoromethylornithine|ODC|10|22|Arg1:T24|Arg2:T40|CHEMICAL|GENE|INHIBITOR|1758
11775064|Acute and chronic PLZ administration increase brain GABA levels, an effect due, at least in part, to an inhibition of the activity of the GABA metabolizing enzyme, GABA transaminase (GABA-T).|GABA|GABA transaminase|28|32|Arg1:T9|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|1759
23618921|Here we show that fisetin rapidly increases the levels of both Nrf2 and ATF4 as well as Nrf2- and ATF4-dependent gene transcription via distinct mechanisms.|fisetin|ATF4|5|20|Arg1:T19|Arg2:T38|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1760
9876137|Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block.|Cocaine|mu1 channels|1|11|Arg1:T5|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1761
10593931|Substitutions for Ile(183)-Val(191) and Ser(195)-Ile(197) at the N terminus and for Ser(258)-Ser(264) at the C terminus of the A3 domain markedly decreased factor XI coagulant activity.|C|A3 domain|36|40|Arg1:T6|Arg2:T16|CHEMICAL|GENE|PART-OF|1762
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|CT53518|kinase|37|44|Arg1:T21|Arg2:T35|CHEMICAL|GENE|INHIBITOR|1763
18035186|Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.|rasagiline|monoamine oxidase|4|8|Arg1:T26|Arg2:T36|CHEMICAL|GENE|INHIBITOR|1764
1730582|Using a similar procedure to analyze ODC labeled by reaction with [5-14C]DFMO, it was found that lysine 69 and cysteine 360 formed covalent adducts with the inhibitor.|lysine|ODC|21|7|Arg1:T2|Arg2:T32|CHEMICAL|GENE|PART-OF|1765
11585753|"ZD1839 (""Iressa""), a quinazoline tyrosine kinase inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials."|ZD1839|tyrosine kinase|1|10|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1766
1730582|Cysteine 360, which was the major adduct accounting for about 90% of the total labeling, is contained within the sequence -WGPTCDGL(I)D-, which is present in all known eukaryote ODCs. These results provide strong evidence that these two peptides form essential parts of the catalytic site of ODC.|WGPTCDGL(I)D|eukaryote ODCs|25|36|Arg1:T5|Arg2:T34|CHEMICAL|GENE|PART-OF|1767
23041257|DBDCT also caused the phosphorylation of JNK and p38(MAPK).|DBDCT|MAPK|1|11|Arg1:T1|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|1768
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|clerosterol|tumor necrosis factor-α|13|51|Arg1:T6|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1769
10942908|However, AChE activity in triceps muscle decreased significantly (78% of control) in the group treated with pyridostigmine plus exercise.|pyridostigmine|AChE|21|3|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1770
23600914|24(S)-hydroxycholesterol is actively eliminated from neuronal cells by ABCA1.|24(S)-hydroxycholesterol|ABCA1|1|13|Arg1:T13|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|1771
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|BMS-354825|ABL|12|16|Arg1:T3|Arg2:T42|CHEMICAL|GENE|INHIBITOR|1772
15777622|In this study, using a model of gentamicin C (GMC)-induced reduction in SGLT1 activity, we examined whether ligands for megalin protect LLC-PK1 cells from the GMC-induced reduction in SGLT1 activity.|gentamicin C|SGLT1|9|17|Arg1:T11|Arg2:T30|CHEMICAL|GENE|INHIBITOR|1773
23587425|Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.|imidazo[1,2-a]pyrazine|kinase|10|21|Arg1:T3|Arg2:T8|CHEMICAL|GENE|INHIBITOR|1774
12679340|In OTCase, mutations of putative ornithine binding residues, Asp-182, Asn-184, Asn-185, Cys-289, and Glu-256 greatly reduced the affinity for ornithine and impaired the interaction with arginase.|ornithine|OTCase|7|2|Arg1:T8|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|1775
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|dFdC|CDA|3|13|Arg1:T5|Arg2:T43|CHEMICAL|GENE|SUBSTRATE|1776
1590750|The results suggest that individuals with high Vmax beta 2-ADH and deficient in low-Km mitochondrial ALDH2, accounting for approximately 45% of the Chinese population, may end up with acetaldehyde accumulation during alcohol consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.|acetaldehyde|ALDH2|32|16|Arg1:T3|Arg2:T21|CHEMICAL|GENE|PRODUCT-OF|1777
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|MAPK|7|18|Arg1:T2|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1778
15353299|The availability of the 5-FU prodrugs offers the possibility of greater therapeutic selectivity based on the demonstration that thymidine phosphorylase, the activating enzyme for 5-FU, is expressed at a higher level in tumor tissue compared with normal tissue counterparts.|5-FU|thymidine phosphorylase|26|19|Arg1:T11|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|1779
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|cytarabine|Ala70Thr|38|10|Arg1:T9|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|1780
17229632|RESULTS: We show that sorafenib is a potent inhibitor of ETV6-PDGFRbeta and FLT3 mutants, including some of the mutants that confer resistance to PKC412 and other FLT3 inhibitors.|sorafenib|PDGFRbeta|6|13|Arg1:T2|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1781
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|gardiquimod|human TLR7|7|18|Arg1:T5|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|1782
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|ammonia|beta-lyases|14|10|Arg1:T23|Arg2:T54|CHEMICAL|GENE|PRODUCT-OF|1783
17352685|Results of early clinical trials with both topically (cipamfylline, CP80,633) and systemically (CC-10004) active PDE4 inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC-10004, also in psoriasis.|cipamfylline|PDE4|10|20|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|1784
23220644|In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (JMC08-4) for human nonpancreatic secretory phospholipase A(2) (hnps-PLA(2)) and human leukotriene A(4) hydrolase (LTA(4)H-h) was found.|JMC08-4|human leukotriene A(4) hydrolase|21|39|Arg1:T2|Arg2:T10|CHEMICAL|GENE|INHIBITOR|1785
11292635|Contribution of the Na+-K+-2Cl- cotransporter NKCC1 to Cl- secretion in rat OMCD.|Cl-|NKCC1|8|6|Arg1:T28|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|1786
12414329|Therefore, in men with ED, elevation of cGMP in corpus cavernosal tissue via selective inhibition of cGMP-specific PDE5 is a means of improving erectile function at minimal risk of adverse events.|cGMP|PDE5|19|20|Arg1:T9|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1787
10522750|The potentiation of the contractile effect induced by 5-HT is only somewhat modified by deendothelialization, but abolished by the thromboxane A2 receptor antagonists GR32191 and ridogrel.|GR32191|thromboxane A2 receptor|25|21|Arg1:T19|Arg2:T37|CHEMICAL|GENE|ANTAGONIST|1788
18081314|  High-resolution NMR spectroscopy was used to determine the docking of a substrate (prostaglandin H2) mimic (U46619) to the engineered prostacyclin (PGI2) synthase (PGIS) in solution.|U46619|prostacyclin (PGI2) synthase|19|24|Arg1:T1|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|1789
11972613|CONCLUSIONS: CysLTs produced after antigen provocation sequentially induced IL-5 production from some immune component cells via CysLT1 receptor activation.|CysLTs|CysLT1|3|18|Arg1:T6|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|1790
23570998|Further, both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, RunX2, osteoprotegerin and osteocalcin.|flavonoids|osteocalcin|5|32|Arg1:T17|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1791
23584358|There were statistically significant increases in the activities of aspartate aminotransferase, alanine aminotransferase, levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and 8-iso-prostane, and decreases in the activity of superoxide dismutase and level of glutathione in the group treated with paracetamol.|paracetamol|IL-6|49|27|Arg1:T8|Arg2:T37|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1792
9476974|At nonconvulsant doses, the sodium channel blockers acetylprocainamide, dibucaine, dyclonine, prilocaine, proparacaine, quinidine, and tetracaine produced a small pressor response or no increase in BP.|dibucaine|sodium channel|11|6|Arg1:T33|Arg2:T48|CHEMICAL|GENE|INHIBITOR|1793
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|24-OHC|ABCA1|10|4|Arg1:T7|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1794
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|progestogens|sulfatase|8|34|Arg1:T7|Arg2:T27|CHEMICAL|GENE|INHIBITOR|1795
23396144|In another experiment, topical application of CFB, CFE or CLS prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of COX-2, iNOS, and TNF-α.|CLS|iNOS|12|35|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1796
11752472|DHFS is present exclusively in the mitochondria, making this compartment the sole site of synthesis of dihydrofolate in the plant cell.|dihydrofolate|DHFS|18|1|Arg1:T19|Arg2:T34|CHEMICAL|GENE|PRODUCT-OF|1797
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|niflumic acid|Panx1|44|6|Arg1:T6|Arg2:T39|CHEMICAL|GENE|INHIBITOR|1798
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|4-ABP|human b5R|15|48|Arg1:T22|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|1799
17658513|Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).|phenylephrine|alpha(1A)-adrenoceptor|56|15|Arg1:T5|Arg2:T12|CHEMICAL|GENE|AGONIST|1800
17488480|To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and NK1-R in acinar cells.|sodium hydrosulphide|NK1-R|29|58|Arg1:T10|Arg2:T41|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1801
16988497|A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.|LNA|D5D|43|52|Arg1:T17|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1802
12487427|  Several studies have suggested that the accumulation of bradykinin, or that of one its metabolites BK1-8, is involved in the occurrence of side effects such as AE associated with the use of various ACEi. In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK (79/81 Br-Phe5) BrBK in the presence of two new dual ACE/NEP inhibitors (GW660511X and omapatrilat) currently under clinical trial.|omapatrilat|ACE|82|77|Arg1:T34|Arg2:T75|CHEMICAL|GENE|INHIBITOR|1803
11972613|Increased IL-5 activity in the serum was inhibited by both pranlukast and MCI-826 by over 90%.|MCI-826|IL-5|13|2|Arg1:T5|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1804
23477419|Of the new compounds, Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4) (analogue 12) displayed the highest affinity toward MOR, in the picomolar range (Ki(μ) = 3.72 pM).|(R)-βPro|MOR|11|39|Arg1:T9|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|1805
23382379|Both myosin-18A isoforms bound N-methylanthraniloyl-nucleotides, but the rate of ATP hydrolysis was very slow (<0.002 s(-1)) and not significantly enhanced by actin.|N-methylanthraniloyl-nucleotides|myosin-18A|5|2|Arg1:T2|Arg2:T7|CHEMICAL|GENE|DIRECT-REGULATOR|1806
20724158|  BACKGROUND: Recent epidemiologic and laboratory studies have suggested that non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the risk of breast cancer through inhibition of cyclooxygenase-2 (COX-2).|steroidal|COX-2|12|29|Arg1:T7|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1807
23115221|Administration of low, but not high, doses of oral nicotine in DSS-treated mice resulted in a significant decrease in disease severity, histologic damage scores, as well as colonic level of tumor necrosis factor-α.|nicotine|tumor necrosis factor-α|12|35|Arg1:T15|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1808
20104269|RGM-1 cells were treated with CDCA or GW4064, an FXR agonist, in the presence or absence of guggulsterone, an FXR antagonist.|CDCA|FXR|6|11|Arg1:T5|Arg2:T24|CHEMICAL|GENE|AGONIST|1809
11732752|Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B.|L-alanine|aminopeptidase N|20|22|Arg1:T3|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|1810
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|SNAT4|7|65|Arg1:T18|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|1811
20104269|RGM-1 cells were treated with CDCA or GW4064, an FXR agonist, in the presence or absence of guggulsterone, an FXR antagonist.|guggulsterone|FXR|20|23|Arg1:T7|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|1812
23481236|Cells were also evaluated in the presence of wortmannin, an inhibitor of phosphatidylinositol 3-kinases and thus AKt (0-100 nM).|wortmannin|phosphatidylinositol 3-kinases|9|14|Arg1:T17|Arg2:T46|CHEMICAL|GENE|INHIBITOR|1813
10606746|The inhibitor binds at the base of the active site gorge of TcAChE, interacting with both the choline-binding site (Trp-84) and the acyl-binding pocket (Phe-288, Phe-290).|Phe|acyl-binding pocket|29|26|Arg1:T6|Arg2:T23|CHEMICAL|GENE|PART-OF|1814
19293728|The inhibitory effect of fenoldopam on insulin-mediated VSMC proliferation was receptor specific, because its effect could be blocked by SCH23390, a D1-like receptor antagonist.|fenoldopam|insulin|5|7|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1815
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|2',2'-difluorodeoxycytidine|cytidine deaminase|5|10|Arg1:T8|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|1816
16434489|Dasatinib (BMS-354825) is a novel orally bioavailable SRC/ABL inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).|Dasatinib|SRC|1|10|Arg1:T7|Arg2:T24|CHEMICAL|GENE|INHIBITOR|1817
23584358|There were statistically significant increases in the activities of aspartate aminotransferase, alanine aminotransferase, levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and 8-iso-prostane, and decreases in the activity of superoxide dismutase and level of glutathione in the group treated with paracetamol.|paracetamol|interleukin-6|49|25|Arg1:T8|Arg2:T35|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1818
16938288|However, the expression of AT1R was not suppressed by other AT1R antagonists such as candesartan or olmesartan.|candesartan|AT1R|16|12|Arg1:T1|Arg2:T13|CHEMICAL|GENE|ANTAGONIST|1819
23639362|Additionally, MPTP significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment.|MPTP|caspase-3|3|34|Arg1:T5|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1820
17391279|Indomethacin treatment led to an increase in lipid peroxidation, glutathione peroxidase and glucose-6-phosphate dehydrogenase activities and to a decrease in catalase activity and glutathione levels in gastric mucosa.|Indomethacin|glutathione peroxidase|1|11|Arg1:T11|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|1821
23471969|An endogenous intracellular domain fragment of p75(NTR) (p75(ICD)) containing these 29 amino acids is produced by regulated proteolysis of the full-length receptor.|amino acids|p75(ICD)|20|12|Arg1:T2|Arg2:T16|CHEMICAL|GENE|PART-OF|1822
23098818|Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the human isoform CYP2D6.|serotonin|CYP2D|21|8|Arg1:T15|Arg2:T33|CHEMICAL|GENE|PRODUCT-OF|1823
12438517|Each dimeric analog showed higher affinities for alpha2A- and alpha2C-adrenoceptor versus the alpha2B-adrenoceptor; and yohimbine dimers with spacers of n = 2, 3, 4, 18, and 24 exhibited selectivity for the alpha2C-adrenoceptor.|yohimbine|alpha2C-adrenoceptor|16|37|Arg1:T6|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|1824
10727528|Salicylates inhibit (125)I-ET-1 binding to recombinant rat ETA receptors.|Salicylates|rat ETA receptors|1|10|Arg1:T8|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|1825
18974361|This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, isradipine, and nitrendipine) as potent T-channel blockers (IC(50) < 3 microM).|felodipine|T-channel|12|21|Arg1:T15|Arg2:T26|CHEMICAL|GENE|INHIBITOR|1826
1322047|  The potent anabolic effects of the beta 2-adrenoceptor agonist clenbuterol on skeletal muscle have been reported to be independent of actions on beta-adrenoceptors.|clenbuterol|beta 2-adrenoceptor|10|7|Arg1:T6|Arg2:T15|CHEMICAL|GENE|AGONIST|1827
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|proline|bovine pancreatic ribonuclease A|17|7|Arg1:T1|Arg2:T20|CHEMICAL|GENE|PART-OF|1828
21606412|  PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.|cabozantinib|VEGFR2|5|21|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1829
17594192|  Phenserine, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase (AChE) and was shown to improve cognition in various experimental paradigms in rodents and dogs.|Phenserine|AChE|1|17|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1830
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|phenylaminopyrimidine|PDGFbeta-receptor|15|36|Arg1:T1|Arg2:T29|CHEMICAL|GENE|INHIBITOR|1831
1680855|In contrast to adrenaline and somatostatin, galanin, another inhibitor of insulin secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner.|somatostatin|insulin|6|13|Arg1:T22|Arg2:T52|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1832
14751502|Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.|GW572016|EGFR|7|4|Arg1:T11|Arg2:T40|CHEMICAL|GENE|INHIBITOR|1833
20531964|  Everolimus (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (mammalian target of rapamycin) to reach the oncology clinic.|Everolimus|mTOR|1|19|Arg1:T1|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1834
9990013|These results suggest that SUR1 binds 8-azido-ATP strongly at NBF1 and that MgADP, either by direct binding to NBF2 or by hydrolysis of bound MgATP at NBF2, stabilizes prebound 8-azido-ATP binding at NBF1.|MgADP|NBF2|13|20|Arg1:T24|Arg2:T53|CHEMICAL|GENE|DIRECT-REGULATOR|1835
7516184|The protein that binds TSG-6 was purified from human serum and identified as inter-alpha-inhibitor (I alpha I) by N-terminal microsequencing.|N|I alpha I|21|16|Arg1:T6|Arg2:T23|CHEMICAL|GENE|PART-OF|1836
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|SU 11248|kinase|35|44|Arg1:T10|Arg2:T45|CHEMICAL|GENE|INHIBITOR|1837
17218486|Furthermore, because S-(+)-isomers of METH and AMPH are reported to be more potent and efficacious in vivo than R-(-), we determined the enantiomeric selectivity of all three species of TAAR1.|METH|TAAR1|10|39|Arg1:T25|Arg2:T53|CHEMICAL|GENE|ACTIVATOR|1838
12165285|Although a significant platelet hyperreactivity was observed in the patients, the HPA-1 genotype did not influence basal or ADP-induced CD62P expression.|ADP|CD62P|20|21|Arg1:T5|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1839
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|retinoic acid|RXR|17|28|Arg1:T10|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|1840
8606397|One group of experimental animals was treated with 5-lipoxygenase (5-LO) inhibitor, diethylcarbamazine (DEC, Sigma, St. Louis, Missouri) (50 mg/kg, i.v.), immediately before blast.|diethylcarbamazine|5-lipoxygenase|15|9|Arg1:T4|Arg2:T10|CHEMICAL|GENE|INHIBITOR|1841
23266505|Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of calpain and AIF levels.|spironoclactone|calpain|5|20|Arg1:T4|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1842
12881227|5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.|5-(N,N-dimethyl)-amiloride|NHE1|1|23|Arg1:T8|Arg2:T32|CHEMICAL|GENE|INHIBITOR|1843
15985706|Using [(3)H]glucosamine-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.|PD153035|kinase|34|31|Arg1:T6|Arg2:T32|CHEMICAL|GENE|INHIBITOR|1844
1375507|This effect was potentiated by isobutylmethylxanthine, an inhibitor of phosphodiesterase.|isobutylmethylxanthine|phosphodiesterase|6|11|Arg1:T5|Arg2:T24|CHEMICAL|GENE|INHIBITOR|1845
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|carprofen|COX-1|26|46|Arg1:T14|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1846
15837926|Unlike transferrin receptor, the protease domain of PSMA contains a binuclear zinc site, catalytic residues, and a proposed substrate-binding arginine patch.|arginine|transferrin receptor|23|2|Arg1:T7|Arg2:T18|CHEMICAL|GENE|PART-OF|1847
14656380|beta2AR density measured with [3H]dihydroalprenolol ([3H]DHA) increased either 13- or 77-fold in infected cells compared to mock infected controls depending on the culture conditions used.|[3H]dihydroalprenolol|beta2AR|5|1|Arg1:T8|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|1848
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|Ara-C|Lys27Gln|40|8|Arg1:T10|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|1849
15939622|  We report on the inhibitory activity of the NSAIDs meloxicam, carprofen, phenylbutazone and flunixin, on blood cyclooxygenases in the horse using in vitro enzyme-linked assays.|phenylbutazone|cyclooxygenases|14|20|Arg1:T12|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1850
15939622|As expected, comparison of IC50 indicated that meloxicam and carprofen are more selective inhibitors of COX-2 than phenylbutazone and flunixin; meloxicam was the most advantageous for horses of four NSAIDs examined.|carprofen|COX-2|11|17|Arg1:T2|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1851
12881227|5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.|5-(N,N-dimethyl)-amiloride|NHE3|1|29|Arg1:T8|Arg2:T34|CHEMICAL|GENE|INHIBITOR|1852
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|2',2'-difluorodeoxyuridine|CDA|48|6|Arg1:T12|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|1853
23428155|  The solubility-driven structural modification of (pyridin-3-yl) benzoxazinyl-oxazolidinones is described, which resulted in the development of a new series of benzoxazinyl-oxazolidinone analogues with high antibacterial activity against Gram-positive pathogens, including that against linezolid-resistant strains and low hERG inhibition.|benzoxazinyl-oxazolidinone|hERG|23|40|Arg1:T2|Arg2:T10|CHEMICAL|GENE|INHIBITOR|1854
1738111|Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.|[125I]iodocyanopindolol|5-hydroxytryptamine1B|10|3|Arg1:T47|Arg2:T64|CHEMICAL|GENE|DIRECT-REGULATOR|1855
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Sutent|kinase|38|44|Arg1:T11|Arg2:T45|CHEMICAL|GENE|INHIBITOR|1856
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Imatinib|PDGFRA|1|28|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1857
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|[(125)I]RTI-55|DAT|54|63|Arg1:T26|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|1858
23275442|The CSN/IRF5 interaction occurred on the carboxyl and amino termini of IRF5; a single internal deletion from amino acids 455 to 466 (Δ455-466) was found to significantly reduce IRF5 protein stability.|amino|IRF5|9|12|Arg1:T2|Arg2:T30|CHEMICAL|GENE|PART-OF|1859
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|solute carrier 1|12|30|Arg1:T21|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|1860
12897749|Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils.|LTC4|gIV-PLA2|3|10|Arg1:T34|Arg2:T53|CHEMICAL|GENE|PRODUCT-OF|1861
17459764|We demonstrate that only treatment of HaCaT with GLA and EPA or a PPARgamma ligand (roziglitazone), induced COX-2 expression (protein and mRNA).|GLA|COX-2|9|21|Arg1:T14|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1862
23128353|Glucosamine at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and heme oxygenase-1 (HO-1), but also caused a reduction in p21 protein expression.|Glucosamine|heme oxygenase-1|1|18|Arg1:T9|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1863
15704203|Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.|denufosol tetrasodium|P2Y2 receptor|5|12|Arg1:T17|Arg2:T22|CHEMICAL|GENE|AGONIST|1864
10640321|Parenteral administration of selective agonists of the delta-opioid receptor (SB 227122), mu-opioid receptor (codeine and hydrocodone), and kappa-opioid receptor (BRL 52974) produced dose-related inhibition of citric acid-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively.|codeine|mu-opioid receptor|18|15|Arg1:T8|Arg2:T24|CHEMICAL|GENE|AGONIST|1865
8384716|The specific binding is displaced by the selective 5-HT1D agonist sumatriptan but not by the mixed 5-HT1A/1D agonist 5-carboxyamidotryptamine.|sumatriptan|5-HT1D|11|9|Arg1:T6|Arg2:T25|CHEMICAL|GENE|AGONIST|1866
11732752|Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B.|L-leucine|leucine aminopeptidase|27|29|Arg1:T5|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|1867
3735252|Gossypol acetic acid (0-100 mumol/l) inhibited LDH-X prepared from the testes of the mouse greater than rabbit greater than human greater than rat greater than hamster.|Gossypol acetic acid|LDH-X|1|9|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INHIBITOR|1868
17090056|KIEs were measured on the arsenolysis of 5'-methylthioadenosine (MTA) catalyzed by MTAP and were corrected for the forward commitment to catalysis.|5'-methylthioadenosine|MTAP|8|14|Arg1:T17|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|1869
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|Pro|TMH7|25|30|Arg1:T9|Arg2:T46|CHEMICAL|GENE|PART-OF|1870
12487427|GW660511X and omapatrilat increased the production of both BrBK1-8 and Br-Phe5 but not that of BrBK4-8 and BrBK2-8.|omapatrilat|BrBK1-8|3|9|Arg1:T23|Arg2:T65|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1871
17350061|Various genes controlled by estrogen, including X-inactive-specific transcript, anterior gradient-2, trefoil factor-1, CRP-ductin, ghrelin, and small proline-rich protein-2A, were dramatically over-expressed.|estrogen|X-inactive-specific transcript|5|8|Arg1:T22|Arg2:T36|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1872
17379925|  Bile acid coenzyme A:amino acid N-acyltransferase (BAT) is responsible for the amidation of bile acids with the amino acids glycine and taurine.|bile acids|BAT|18|10|Arg1:T10|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|1873
20801130|Dfbp-o also increased the affinity of cTnI for cTnC.|Dfbp-o|cTnI|1|7|Arg1:T21|Arg2:T40|CHEMICAL|GENE|DIRECT-REGULATOR|1874
23111283|Western blot analysis indicated that TSN inhibits the CDC42/MEKK1/JNK pathway.|TSN|MEKK1|6|10|Arg1:T10|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1875
11792932|  PURPOSE: Testosterone-to-estradiol ratio levels in infertile men improve during treatment with the aromatase inhibitor, testolactone, and resulting changes in semen parameters.|testolactone|aromatase|17|14|Arg1:T1|Arg2:T44|CHEMICAL|GENE|INHIBITOR|1876
15866288|  The purpose of the present study was to test our hypothesis that amiloride, a specific u-PA inhibitor, effectively decreases u-PA activity in cornea as well as in tear fluid and favourably affects corneal healing.|amiloride|u-PA|13|22|Arg1:T6|Arg2:T9|CHEMICAL|GENE|INHIBITOR|1877
7560228|Hence, triclosan has the ability to inhibit both the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism with similar efficacy.|triclosan|cyclo-oxygenase|3|11|Arg1:T5|Arg2:T21|CHEMICAL|GENE|INHIBITOR|1878
14501155|The 5-HT(2B/2C)-receptor antagonist SB 206553 facilitated hyperglycemia induced by clomipramine, although the 5-HT(2A)-receptor antagonist ketanserin was without effect.|SB 206553|5-HT(2B/2C)-receptor|8|2|Arg1:T13|Arg2:T26|CHEMICAL|GENE|ANTAGONIST|1879
17488480|Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue caerulein-treated acinar cells.|caerulein|neurokinin-1 receptor|39|23|Arg1:T3|Arg2:T56|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1880
17488480|Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue caerulein-treated acinar cells.|caerulein|preprotachykinin-A|39|18|Arg1:T3|Arg2:T54|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1881
23541670|Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors.|5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers|JAK3|7|16|Arg1:T3|Arg2:T10|CHEMICAL|GENE|INHIBITOR|1882
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Dasatinib|non-receptor cytoplasmic kinase|10|17|Arg1:T2|Arg2:T43|CHEMICAL|GENE|INHIBITOR|1883
23313557|In Alexander cells, only when they were transfected with FXR+RXR, GW4064 caused up-regulation of SHP and OSTβ, and a down-regulation of CYP27A1.|GW4064|CYP27A1|13|25|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1884
23587425|Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.|imidazo[1,2-c]pyrimidine|kinase|16|21|Arg1:T4|Arg2:T8|CHEMICAL|GENE|INHIBITOR|1885
9851542|The tacrine pressor response was inhibited in a dose-dependent manner by the i.c.v. administration of the non-selective muscarinic receptor antagonist atropine (ID50 = 1.45 microg), the muscarinic M1 receptor antagonist pirenzepine (ID50 = 4.33 microg), the muscarinic M2 receptor antagonist methoctramine (ID50 = 1.39 microg) and the muscarinic M3 receptor antagonist para-fluoro-hexahydro-sila-difenidol (ID50 = 31.19 microg).|pirenzepine|muscarinic M1 receptor|35|31|Arg1:T4|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|1886
19023039|Triphosphate nucleotides (ATP, GTP, and UTP) rapidly and reversibly inhibited Panx1 currents via mechanism(s) independent of purine receptors.|Triphosphate nucleotides|Panx1|1|15|Arg1:T7|Arg2:T18|CHEMICAL|GENE|INHIBITOR|1887
23127600|These findings demonstrate that cinnamon polyphenols can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity, as well as attenuating cytotoxicity via inhibition of iNOS, NF-κB activation.|polyphenols|iNOS|6|43|Arg1:T1|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1888
16920841|Liver BHMT activity was 1.3-fold higher in rats fed the Met deficient diet containing choline, which was reflected in corresponding increases in mRNA content and immunodetectable protein.|choline|BHMT|15|2|Arg1:T18|Arg2:T37|CHEMICAL|GENE|ACTIVATOR|1889
17229632|The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors.|sorafenib|FLT3|4|10|Arg1:T16|Arg2:T45|CHEMICAL|GENE|INHIBITOR|1890
17218486|EC50 values for S-(+)-METH were 0.89, 0.92, and 4.44 microM for rTAAR1, mTAAR1, and h-rChTAAR1, respectively.|S-(+)-METH|rTAAR1|4|18|Arg1:T1|Arg2:T37|CHEMICAL|GENE|ACTIVATOR|1891
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Gleevec|ABL|5|27|Arg1:T3|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1892
17594192|Phenserine deserves attention for an additional quality of action: in addition to inhibiting AChE, it modulates the amount of beta-amyloid precursor protein (APP) in neuronal cell culture by reducing APP translation.|Phenserine|APP|1|34|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1893
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|VB1|Histone 3|5|28|Arg1:T3|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|1894
11732752|Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B.|4-methoxy-2-naphthylamide|aminopeptidase B|40|44|Arg1:T9|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|1895
20596674|MXF or VP-16 slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of topo II.|MXF|topo II|1|30|Arg1:T23|Arg2:T39|CHEMICAL|GENE|INHIBITOR|1896
17015640|  Licofelone, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.|Licofelone|LOX|1|11|Arg1:T1|Arg2:T30|CHEMICAL|GENE|INHIBITOR|1897
23623750|Rates of benzydamine N-oxygenation (catalyzed by FMO3) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in benzydamine N-oxygenation might be partly accounted for by the variable FMO3 expression.|benzydamine|FMO3|35|45|Arg1:T6|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|1898
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Imatinib mesylate|kinase|11|6|Arg1:T36|Arg2:T53|CHEMICAL|GENE|INHIBITOR|1899
8242725|  Two migraine patients were studied by in vivo SPECT using the dopamine D2-receptor specific radioligand 123I-3-iodo-6-methoxybenzamide (123I-IBZM) during ergotamine abuse and after withdrawal.|123I-3-iodo-6-methoxybenzamide|dopamine D2-receptor|16|12|Arg1:T1|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|1900
23614730|Results: The administration of prallethrin 1.6% w/w created significant increased changes in the levels of total WBC, lymphocytes, RBC, hemoglobin, packed cell volume, platelets, mean corpuscular volume, and mean corpuscular hemoglobin in rats after 24, 48, and 72 h of continuous inhalation; however, there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h.|prallethrin|hemoglobin|6|40|Arg1:T1|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1901
23429911|Moreover, the effects of the DRD3 agonist 7-hydroxy-N,N-dipropyl-2-aminotetralin (7-OH-DPAT)-induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant.|7-OH-DPAT|DRD3|13|22|Arg1:T2|Arg2:T9|CHEMICAL|GENE|AGONIST|1902
7554708|CONCLUSIONS: Nabumetone does dose-dependently inhibit the cyclooxygenase activity of platelet PGHS-1 of healthy subjects both in vivo and ex vivo.|Nabumetone|PGHS-1|3|12|Arg1:T8|Arg2:T27|CHEMICAL|GENE|INHIBITOR|1903
17016621|Similar to AMR and AMROH, adriamycin and etoposide (VP-16) are DNA topoisomerase II inhibitors.|etoposide|DNA topoisomerase II|9|14|Arg1:T6|Arg2:T21|CHEMICAL|GENE|INHIBITOR|1904
23024204|Metabolism of triethylenetetramine and 1,12-diamino-3,6,9-triazadodecane by the spermidine/spermine-N(1)-acetyltransferase and thialysine acetyltransferase.|triethylenetetramine|spermidine/spermine-N(1)-acetyltransferase|3|8|Arg1:T23|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|1905
17459764|Moreover stimulation of COX-2 promoter activity was increased by those PUFAs or rosiglitazone.|PUFAs|COX-2 promoter|11|4|Arg1:T17|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|1906
9990013|These results suggest that SUR1 binds 8-azido-ATP strongly at NBF1 and that MgADP, either by direct binding to NBF2 or by hydrolysis of bound MgATP at NBF2, stabilizes prebound 8-azido-ATP binding at NBF1.|8-azido-ATP|NBF1|7|10|Arg1:T23|Arg2:T52|CHEMICAL|GENE|DIRECT-REGULATOR|1907
23024204|Here, we show that siRNA-mediated knockdown of SSAT2 in HEPG2 cells and in primary hepatocytes from the SSAT1-deficient or wild-type mice reduced the metabolism of TETA to MAT.|TETA|SSAT2|27|9|Arg1:T17|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|1908
12181285|  Reuptake of extracellular noradrenaline (NA) into superior cervical ganglion (SCG) neurones is mediated by means of the noradrenaline transporter (NAT, uptake 1).||noradrenaline transporter|6|22|Arg1:T18|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|1909
17159811|In the interaction of GAL and CAR, AChE inhibition was stronger but without any statistical significance.|GAL|AChE|5|9|Arg1:T10|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1910
23318833|TAA also increased the numbers of ED2(+), cyclooxygenase-2(+), and heme oxygenase-1(+) liver cells, as well as the number of CD3(+) lymphocytes.|TAA|cyclooxygenase-2|1|12|Arg1:T12|Arg2:T28|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1911
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imidazoquinoline|TLR8|2|23|Arg1:T3|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|1912
23703578|Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.|cobicistat|CYP3A|22|16|Arg1:T8|Arg2:T30|CHEMICAL|GENE|INHIBITOR|1913
17224860|Thus, isoflavone supplementation did not affect ABCA1-dependent cholesterol efflux to serum.|cholesterol|ABCA1|9|8|Arg1:T5|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|1914
12679340|The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.|ornithine|OTCase|32|30|Arg1:T1|Arg2:T21|CHEMICAL|GENE|INHIBITOR|1915
23570998|Further, both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, RunX2, osteoprotegerin and osteocalcin.|flavonoids|osterix|5|26|Arg1:T17|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1916
2859531|Propranolol treatment (4 X 40 mg/day) increased the density of beta 2-adrenoceptors by 25% after 2 days; concomitantly PRA and heart rate were reduced.|Propranolol|beta 2-adrenoceptors|1|13|Arg1:T10|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1917
10606746|The inhibitor binds at the base of the active site gorge of TcAChE, interacting with both the choline-binding site (Trp-84) and the acyl-binding pocket (Phe-288, Phe-290).|Trp|TcAChE|22|13|Arg1:T4|Arg2:T21|CHEMICAL|GENE|PART-OF|1918
12636181|Experimental evidence from the use of agents with enhanced selectivity for BuChE (cymserine analogues, MF-8622) and the dual inhibitor of both AChE and BuChE, rivastigmine, indicates potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias.|rivastigmine|BuChE|29|27|Arg1:T6|Arg2:T15|CHEMICAL|GENE|INHIBITOR|1919
22931533|The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.|codeine|nAChR|5|14|Arg1:T5|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|1920
23274058|Moreover, jaceosidin treatment resulted in phosphorylation of ERK, and pretreatment with the ERK inhibitor, PD98059, attenuated cell growth inhibition by jaceosidin.|PD98059|ERK|18|15|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1921
23418674|The results suggested that both the EtOAc extract and berberine were able to activate PPARα/β/γ, and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine.|berberine|PPARα/β/γ|27|15|Arg1:T4|Arg2:T10|CHEMICAL|GENE|AGONIST-ACTIVATOR|1922
23542114|These data show that the ATO is a promising new approach to decrease glioblastoma proliferation and recurrence by downregulation of Notch pathway.|ATO|Notch|6|21|Arg1:T6|Arg2:T12|CHEMICAL|GENE|INHIBITOR|1923
23583257|In fact, we demonstrated a significant stimulation of Nox4 activity by 4 quinone derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx™, and chondrocyte cell lines.|tBuBQ|Nox4|21|10|Arg1:T8|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|1924
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|benzydamine|FMO3|11|6|Arg1:T10|Arg2:T48|CHEMICAL|GENE|SUBSTRATE|1925
20012638|  Terbutaline (Bricanyl) and its prodrug Bambuterol (Bambec) are highly potent beta(2)-adrenoceptor agonists often used in asthma patients.|Bricanyl|beta(2)-adrenoceptor|3|15|Arg1:T6|Arg2:T22|CHEMICAL|GENE|AGONIST|1926
23703578|Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.|telaprevir|CYP3A|34|16|Arg1:T9|Arg2:T30|CHEMICAL|GENE|INHIBITOR|1927
23327993|The TXM peptides were effective in inhibiting AuF-induced MAPK, JNK and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.|AuF|MAPK|8|9|Arg1:T8|Arg2:T32|CHEMICAL|GENE|ACTIVATOR|1928
20104269|We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the chenodeoxycholic acid (CDCA)-induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells (RGM-1 cells).|chenodeoxycholic acid|MUC2|23|33|Arg1:T3|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1929
3735252|  The inhibitory effect of (+)-, (-)-, (+/-)-gossypol and (+/-)-gossypol acetic acid upon testicular cytosolic LDH-X was measured in vitro.|(+/-)-gossypol acetic acid|LDH-X|20|29|Arg1:T5|Arg2:T12|CHEMICAL|GENE|INHIBITOR|1930
23638842|Recent literature shows that Brassica vegetables (Cruciferae) possess therapeutic effects particularly ascribed due to their content in glucosinolates, which upon myrosinase hydrolysis release the corresponding isothiocyanates.|glucosinolates|myrosinase|20|24|Arg1:T3|Arg2:T14|CHEMICAL|GENE|SUBSTRATE|1931
17221210|Finally, we showed that chlorate activated endocrine cell development by inducing neurogenin 3 (Neurog3) expression in early endocrine progenitor cells.|chlorate|neurogenin 3|6|13|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1932
23298863|Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK-441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice.|TAK-441|hedgehog|8|6|Arg1:T6|Arg2:T19|CHEMICAL|GENE|INHIBITOR|1933
17161452|Possession of CYP2C9*2 or CYP2C9*3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean warfarin dose.|warfarin|CYP2C9|25|5|Arg1:T8|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|1934
17015640|We examined the anti-inflammatory effect of licofelone on atherosclerotic lesions as well as in isolated neutrophils from whole blood of rabbits compared with a selective inhibitor of COX-2, rofecoxib.|rofecoxib|COX-2|30|28|Arg1:T12|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1935
23111283|Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL-60 cells.|Toosendanin|JNK|1|7|Arg1:T11|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1936
7714410|Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use.|emedastine|histamine H1|4|10|Arg1:T22|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|1937
20135071|In addition, the factor Xa inhibitor apixaban is in late-stage clinical development.|apixaban|factor Xa|8|5|Arg1:T12|Arg2:T24|CHEMICAL|GENE|INHIBITOR|1938
14656380|Agonist competition assays with [3H]DHA showed the following rank order of potency: isoproterenol>epinephrine> norepinephrine, consistent with beta2AR interaction.|norepinephrine|beta2AR|21|25|Arg1:T4|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|1939
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|SU5416|Flt3|23|43|Arg1:T15|Arg2:T34|CHEMICAL|GENE|INHIBITOR|1940
23298698|Lung inflammation, IL-4 production, and airway mast cell activity were also prevented under this early short-term treatment with PGE2.|PGE2|IL-4|21|4|Arg1:T7|Arg2:T16|CHEMICAL|GENE|INHIBITOR|1941
23024204|Metabolism of triethylenetetramine and 1,12-diamino-3,6,9-triazadodecane by the spermidine/spermine-N(1)-acetyltransferase and thialysine acetyltransferase.|1,12-diamino-3,6,9-triazadodecane|spermidine/spermine-N(1)-acetyltransferase|5|8|Arg1:T24|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|1942
11732752|Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B.|4-methoxy-2-naphthylamide|leucine aminopeptidase|25|29|Arg1:T4|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|1943
1911436|Analysis of coenzyme binding by human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase using 5'-[p-(fluorosulfonyl)benzoyl]adenosine, an affinity labeling cofactor analog.|5'-[p-(fluorosulfonyl)benzoyl]adenosine|human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase|18|6|Arg1:T18|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|1944
23532634|ACTH-stimulated peak cortisol, delta cortisol, and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover.|cortisol|ACTH|3|1|Arg1:T6|Arg2:T30|CHEMICAL|GENE|PRODUCT-OF|1945
1590750|The identity of the lung beta-ADHs was further demonstrated by their characteristic pH-activity profiles for ethanol oxidation, Km values for NAD and ethanol, and inhibition by 4-methylpyrazole or 1,10-phenanthroline.|1,10-phenanthroline|beta-ADHs|31|6|Arg1:T9|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1946
23318471|These findings, derived from a variety of analytical and functional approaches, provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature: TES-stimulated vasodilation mediated primarily by peroxynitrite formed from xanthine oxidase-generated superoxide and NO.|superoxide|xanthine oxidase|39|37|Arg1:T12|Arg2:T40|CHEMICAL|GENE|PRODUCT-OF|1947
7837275|  An experimental strategy based on solution viscosity perturbation allowed us to study the energetics of amide-substrates, p-aminobenzamidine (p-ABZ) and proflavin binding to the catalytic site of two proteolyzed forms of alpha-thrombin, i.e. zeta- and gamma T-thrombin.|proflavin|alpha-thrombin|23|34|Arg1:T5|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|1948
17111172|Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.|risperidone|serotonin (2A) receptors|28|14|Arg1:T14|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|1949
16336752|Tyrosine kinase inhibitors are quinazoline-derived, low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors, including EGFR, Erb2, and vascular endothelial growth factor receptor, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of EGFR signaling.|quinazoline|EGFR|5|25|Arg1:T2|Arg2:T6|CHEMICAL|GENE|INHIBITOR|1950
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|etodolac|COX-2|34|44|Arg1:T1|Arg2:T17|CHEMICAL|GENE|INHIBITOR|1951
23273219|  To develop new drugs for treatment of Alzheimer's disease, a group of N'-2-(4-Benzylpiperidin-/piperazin-1-yl)acylhydrazones was designed, synthesized and tested for their ability to inhibit acetylcholinesterase, butyrylcholinesterase and aggregation of amyloid beta peptides (1-40, 1-42 and 1-40_1-42).|N'-2-(4-Benzylpiperidin-/piperazin-1-yl)acylhydrazones|acetylcholinesterase|15|31|Arg1:T2|Arg2:T4|CHEMICAL|GENE|INHIBITOR|1952
12244038|Interestingly, gemfibrozil strongly inhibited the activation of NF-kappaB, AP-1, and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells.|gemfibrozil|NF-kappaB|3|9|Arg1:T4|Arg2:T45|CHEMICAL|GENE|INHIBITOR|1953
12679340|In OTCase, mutations of putative ornithine binding residues, Asp-182, Asn-184, Asn-185, Cys-289, and Glu-256 greatly reduced the affinity for ornithine and impaired the interaction with arginase.|Asn|OTCase|13|2|Arg1:T10|Arg2:T28|CHEMICAL|GENE|PART-OF|1954
16789740|Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.|anthranilic acid sulfonamides|methionine aminopeptidase-2|5|11|Arg1:T4|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|1955
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|Ala|TMH7|19|30|Arg1:T7|Arg2:T46|CHEMICAL|GENE|PART-OF|1956
23638842|RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive RS -GRA significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1β (IL-1β), and apoptosis (Bax and caspase 3 expression).|RS -GRA|cytokine|19|32|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1957
23228697|This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2, a carboxylesterase with little lipase activity.|orlistat|CES1|10|17|Arg1:T6|Arg2:T26|CHEMICAL|GENE|INHIBITOR|1958
8606397|One group of experimental animals was treated with 5-lipoxygenase (5-LO) inhibitor, diethylcarbamazine (DEC, Sigma, St. Louis, Missouri) (50 mg/kg, i.v.), immediately before blast.|diethylcarbamazine|5-LO|15|11|Arg1:T4|Arg2:T11|CHEMICAL|GENE|INHIBITOR|1959
23479738|In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity.|cysteines|Prx1|13|25|Arg1:T28|Arg2:T32|CHEMICAL|GENE|PART-OF|1960
1978244|The Schild plots for the competitive antagonists WB4101 and 5-methyl-urapidil against alpha 1a-adrenoceptor-selective agonist methoxamine-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for WB4101 and 9.09 +/- 0.05 (n = 3) for 5-methyl-urapidil.|WB4101|alpha 1a-adrenoceptor|8|12|Arg1:T8|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|1961
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imidazoquinoline|TLR8|2|15|Arg1:T3|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|1962
23017388|When further examined for its anticancer mechanism, SB365 effectively suppressed the AKT/mTOR pathway both in vitro and in vivo.|SB365|AKT|9|13|Arg1:T7|Arg2:T14|CHEMICAL|GENE|INHIBITOR|1963
23142507|The 3D-structure of HmTx consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).|Ala|HmTx|24|4|Arg1:T7|Arg2:T23|CHEMICAL|GENE|PART-OF|1964
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|leuprorelin|LHRH|15|5|Arg1:T7|Arg2:T23|CHEMICAL|GENE|AGONIST|1965
7711211|The estrogenic agent 3 beta,5 alpha-NET and estradiol at a dose of 1.0 mg also inhibited the UG gene expression induced by P4.|3 beta,5 alpha-NET|UG|4|18|Arg1:T13|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1966
17369066|In humans, methionine synthase deficiency results in the accumulation of methyltetrahydrofolate at the expense of folate derivatives required for purine and thymidylate biosynthesis.|methyltetrahydrofolate|methionine synthase|12|4|Arg1:T14|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|1967
14501155|These results suggest that clomipramine induces hyperglycemia in mice by blocking the 5-HT(2B )and/or 5-HT(2C) receptors, which results in facilitation of adrenaline release.|clomipramine|5-HT(2C)|5|18|Arg1:T17|Arg2:T29|CHEMICAL|GENE|INHIBITOR|1968
15939622|COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.|phenylbutazone|COX-1|9|1|Arg1:T14|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1969
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|FLX|dopamine D(2)|27|8|Arg1:T4|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|1970
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|promegestone|17beta-hydroxysteroid-dehydrogenase type 1|17|36|Arg1:T10|Arg2:T28|CHEMICAL|GENE|INHIBITOR|1971
12487427|Unlike GW660511X, omapatrilat abolished the production of BrBK1-5 and BrBK1-7, suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found.|omapatrilat|BrBK1-7|4|11|Arg1:T45|Arg2:T85|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1972
23246481|These results suggested that wogonin could inhibit H2O2-induced vascular permeability by downregulating the phosphorylation of cav-1, and that it might have a therapeutic potential for the diseases associated with the development of both oxidant and vascular permeability.|wogonin|cav-1|5|16|Arg1:T12|Arg2:T24|CHEMICAL|GENE|INHIBITOR|1973
20012638|  Terbutaline (Bricanyl) and its prodrug Bambuterol (Bambec) are highly potent beta(2)-adrenoceptor agonists often used in asthma patients.|Terbutaline|beta(2)-adrenoceptor|1|15|Arg1:T1|Arg2:T22|CHEMICAL|GENE|AGONIST|1974
3994963|Drug-protein interactions: isolation and characterization of covalent adducts of phenoxybenzamine and calmodulin.|phenoxybenzamine|calmodulin|11|13|Arg1:T12|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|1975
10694244|Troglitazone inhibited the antigen-induced production of LTB(4), C(4) and E(4) and the potency of the inhibition was comparable to that of zileuton, a specific inhibitor of 5-lipoxygenase (5-LOX) and a clinically used anti-asthmatic drug.|zileuton|5-LOX|32|40|Arg1:T18|Arg2:T37|CHEMICAL|GENE|INHIBITOR|1976
17199504|We have expressed and characterized recombinant, N-terminally His-tagged human adenine phosphoribosyltransferase.|N|human adenine phosphoribosyltransferase|8|10|Arg1:T6|Arg2:T14|CHEMICAL|GENE|PART-OF|1977
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|D-65476|Flt3|19|43|Arg1:T13|Arg2:T34|CHEMICAL|GENE|INHIBITOR|1978
23511016|To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (DOTA), with pantoprazole, which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon.|DOTA|proton pumps|27|44|Arg1:T2|Arg2:T10|CHEMICAL|GENE|DIRECT-REGULATOR|1979
17507169|Autoradiography studies with [(3)H](-)-CP 55,940 show that chronic treatment with SR 141716A for 15 days twice daily (1 mg/kg i.p.) significantly increases the density of CB1 receptors in the PVN.|[(3)H](-)-CP 55,940|CB1 receptors|4|38|Arg1:T2|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|1980
12901032|Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.|celecoxib|cyclooxygenase-2|29|10|Arg1:T8|Arg2:T22|CHEMICAL|GENE|INHIBITOR|1981
11792932|We evaluated the effect of anastrozole, a more selective aromatase inhibitor, on the hormonal and semen profiles of infertile men with abnormal baseline testosterone-to-estradiol ratios.|anastrozole|aromatase|6|11|Arg1:T7|Arg2:T42|CHEMICAL|GENE|INHIBITOR|1982
17350061|The expression of key genes important in methionine metabolism, such as methionine adenosyltransferase-1a, betaine-homocysteine methyltransferase and thioether S-methyltransferase, were suppressed.|methionine|betaine-homocysteine methyltransferase|8|16|Arg1:T6|Arg2:T34|CHEMICAL|GENE|PRODUCT-OF|1983
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|spermine|ODC|8|22|Arg1:T23|Arg2:T40|CHEMICAL|GENE|PRODUCT-OF|1984
7773533|Incubation of rat aortic membranes with the irreversible alpha 1B-adrenoceptor antagonist, chloroethylclonidine (CEC: 10 microM) did not change the KD of [3H]-prazosin binding in comparison to untreated membranes, but reduced by 88% the total number of binding sites (Bmax).|chloroethylclonidine|alpha 1B-adrenoceptor|13|9|Arg1:T5|Arg2:T31|CHEMICAL|GENE|ANTAGONIST|1985
17593236|  AIM: To assess the efficacy and safety of a 24-week treatment with sitagliptin, a highly selective once-daily oral dipeptidyl peptidase-4 (DPP-4) inhibitor, in patients with type 2 diabetes who had inadequate glycaemic control [glycosylated haemoglobin (HbA(1c)) >or=7.5% and <or=10.5%] while on glimepiride alone or in combination with metformin.|sitagliptin|DPP-4|14|24|Arg1:T1|Arg2:T7|CHEMICAL|GENE|INHIBITOR|1986
23030680|Cytochrome b5 has shown to be an essential component in P450 3A4 catalyzed 5-hydroxyelzasonan formation and provides insights on the disconnect between human liver microsomes data and that of rCYP.|5-hydroxyelzasonan|P450 3A4|14|11|Arg1:T1|Arg2:T12|CHEMICAL|GENE|PRODUCT-OF|1987
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane|NET|19|58|Arg1:T10|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|1988
17459764|We demonstrate that only treatment of HaCaT with GLA and EPA or a PPARgamma ligand (roziglitazone), induced COX-2 expression (protein and mRNA).|roziglitazone|COX-2|17|21|Arg1:T16|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1989
14656380|Agonist competition assays with [3H]DHA showed the following rank order of potency: isoproterenol>epinephrine> norepinephrine, consistent with beta2AR interaction.|epinephrine|beta2AR|19|25|Arg1:T3|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|1990
10493852|Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.|lovastatin|CD11a I-domain|7|11|Arg1:T3|Arg2:T15|CHEMICAL|GENE|DIRECT-REGULATOR|1991
17658513|Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).|Prazosin|alpha(1)-adrenoceptor|1|4|Arg1:T1|Arg2:T11|CHEMICAL|GENE|ANTAGONIST|1992
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|cinitapride|5-HT2|11|28|Arg1:T17|Arg2:T34|CHEMICAL|GENE|ANTAGONIST|1993
12487427|The production of Br-Phe5 was reduced with GW660511X while no significant change was observed with omapatrilat after 4 h of incubation.|GW660511X|Br-Phe5|8|4|Arg1:T4|Arg2:T53|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1994
23261676|Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.|Isoproterenol|cytochrome-C-oxidase|1|54|Arg1:T15|Arg2:T34|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|1995
23584358|There were statistically significant increases in the activities of aspartate aminotransferase, alanine aminotransferase, levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and 8-iso-prostane, and decreases in the activity of superoxide dismutase and level of glutathione in the group treated with paracetamol.|paracetamol|superoxide dismutase|49|38|Arg1:T8|Arg2:T38|CHEMICAL|GENE|INHIBITOR|1996
15795320|Synergistic cytotoxicity was demonstrated, and pemetrexed significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the human nucleoside equilibrative transporter 1 (hENT1) in all cell lines.|pemetrexed|human nucleoside equilibrative transporter 1|7|38|Arg1:T2|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|1997
16248990|To test the role of nicotinic receptors in the drugs' effects on [3H]-ACh release, mecamylamine (MEC) 100 microM was used to block such receptors.|mecamylamine|nicotinic receptors|20|6|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INHIBITOR|1998
20135071|Of these, the thrombin inhibitor dabigatran and factor Xa inhibitor rivaroxaban have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe.|rivaroxaban|factor Xa|12|9|Arg1:T11|Arg2:T23|CHEMICAL|GENE|INHIBITOR|1999
23230131|All four DCK proteins yielded comparable metabolic activity for Ara-C and dFdC monophosphorylation, except for DCK24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of dFdC monophosphorylation due to a 40% decrease in K(m) (P < 0.05).|dFdC|DCK|12|3|Arg1:T19|Arg2:T42|CHEMICAL|GENE|SUBSTRATE|2000
15939622|COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.|phenylbutazone|COX-2|9|3|Arg1:T14|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2001
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|quercetin|CA|31|49|Arg1:T7|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2002
17488480|To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and NK1-R in acinar cells.|sodium hydrosulphide|SP|29|51|Arg1:T10|Arg2:T39|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2003
23418674|The results suggested that both the EtOAc extract and berberine were able to activate PPARα/β/γ, and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine.|berberine|PPARα/β/γ|10|15|Arg1:T3|Arg2:T10|CHEMICAL|GENE|AGONIST-ACTIVATOR|2004
23313557|In Alexander cells, only when they were transfected with FXR+RXR, GW4064 caused up-regulation of SHP and OSTβ, and a down-regulation of CYP27A1.|GW4064|SHP|13|17|Arg1:T1|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2005
23322769|Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes.|manumycin A|FNTA|13|5|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INHIBITOR|2006
23512754|In macrophages, levels of TNF-α, IFN-γ, NO, IL-6 and IL-10 were increased by CDM used alone or in combination with HSV-2.|CDM|IFN-γ|18|8|Arg1:T11|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2007
9310349|Here we report that alendronate is a potent inhibitor of the protein-tyrosine-phosphatase-meg1 (PTPmeg1).|alendronate|PTPmeg1|5|14|Arg1:T11|Arg2:T33|CHEMICAL|GENE|INHIBITOR|2008
9476974|At nonconvulsant doses, the sodium channel blockers acetylprocainamide, dibucaine, dyclonine, prilocaine, proparacaine, quinidine, and tetracaine produced a small pressor response or no increase in BP.|quinidine|sodium channel|19|6|Arg1:T37|Arg2:T48|CHEMICAL|GENE|INHIBITOR|2009
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|mitogen-activated protein kinase|7|14|Arg1:T2|Arg2:T21|CHEMICAL|GENE|INHIBITOR|2010
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|TO901317|nuclear receptors|15|25|Arg1:T8|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|2011
23246481|The mechanism revealed that wogonin inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of VE-cadherin and β-catenin.|H2O2|cav-1|7|12|Arg1:T9|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|2012
23385325|We apply DFTB in a QM/MM framework to perform vibrational analysis of buried aspartic acids in bacteriorhodopsin and channelrhodopsin-2.|aspartic acids|bacteriorhodopsin|14|17|Arg1:T6|Arg2:T11|CHEMICAL|GENE|PART-OF|2013
17488480|Inhibition of endogenous production of H(2)S by PAG significantly suppressed SP concentration, PPT-A expression and NK1-R expression in the acini.|H(2)S|PPT-A|6|18|Arg1:T5|Arg2:T36|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2014
16434489|In this study, we demonstrate significant inhibitory activity of dasatinib against both wild-type KIT and the KITD816V mutation in the nanomolar range in in vitro and cell-based kinase assays.|dasatinib|D816V|11|19|Arg1:T11|Arg2:T33|CHEMICAL|GENE|INHIBITOR|2015
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|carbachol|muscarinic acetylcholine receptor|19|12|Arg1:T7|Arg2:T16|CHEMICAL|GENE|AGONIST|2016
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|sulforaphane|NRF2|30|21|Arg1:T1|Arg2:T7|CHEMICAL|GENE|ACTIVATOR|2017
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|gardiquimod|porcine TLR7|7|12|Arg1:T5|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|2018
9008235|Thus, PGHS-1 might be the primary target of the hair growth-inhibitory effects of NSAIDs. We thus speculated that activation of PGHS-1 might be a mechanism by which minoxidil (2,4-diamino-6-piperidinopyrimidine-3-oxyde) stimulates hair growth in vivo.|2,4-diamino-6-piperidinopyrimidine-3-oxyde|PGHS-1|32|23|Arg1:T7|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|2019
12070353|We show both in vitro and in vivo that low-dose theophylline enhances HDAC activity in epithelial cells and macrophages.|theophylline|HDAC|11|13|Arg1:T5|Arg2:T16|CHEMICAL|GENE|ACTIVATOR|2020
12217700|The comparison between MalP structures shows that His377, through a hydrogen bond with the 6-hydroxyl group of Glc1P substrate, triggers a conformational change of the 380s loop.|6-hydroxyl|MalP|16|4|Arg1:T1|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|2021
23322769|Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor manumycin A caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes.|manumycin A|farnesyltransferase|13|3|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2022
16774921|Functional divergence of a unique C-terminal domain of leucyl-tRNA synthetase to accommodate its splicing and aminoacylation roles.|C|leucyl-tRNA synthetase|6|9|Arg1:T15|Arg2:T25|CHEMICAL|GENE|PART-OF|2023
8636122|  The antagonist SR 141716A has a high specificity for the central CB1 cannabinoid receptor and negligeable affinity for the peripheral CB2 receptor, making it an excellent tool for probing receptor structure-activity relationships.|SR 141716A|cannabinoid receptor|3|13|Arg1:T4|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|2024
10225363|Sumatriptan and LY 344864 decreased the number of capsaicin-induced c-fos-like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1)).|capsaicin|c-fos|9|10|Arg1:T7|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2025
12636181|  Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.|ACh|Acetylcholinesterase|27|1|Arg1:T3|Arg2:T7|CHEMICAL|GENE|SUBSTRATE|2026
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|STI571|c-Kit|16|38|Arg1:T2|Arg2:T30|CHEMICAL|GENE|INHIBITOR|2027
11551210|  Long-chain alkanols are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral nicotinic acetylcholine receptor (AChR) by binding to one or more specific sites on the AChR.|Long-chain alkanols|AChR|1|33|Arg1:T1|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|2028
23600432|  Introduction: 5-Lipoxygenase (5-LO) is a crucial enzyme of the arachidonic acid (AA) cascade and catalyzes the formation of bioactive leukotrienes (LTs) with the help of FLAP, the 5-LO-activating protein.|arachidonic acid|5-Lipoxygenase|13|3|Arg1:T1|Arg2:T8|CHEMICAL|GENE|SUBSTRATE|2029
11588409|Omapatrilat, the prototypical vasopeptidase inhibitor, inhibits not only ACE but also neutral endopeptidase.|Omapatrilat|vasopeptidase|1|5|Arg1:T9|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2030
16618126|These results indicate that the ATPase activity of the secretory granule Atp8a1 is activated by phospholipids binding to a specific site whose properties (PS selectivity, dependence upon glycerol but not serine, stereochemistry, and vanadate sensitivity) are similar to, but distinct from, the properties of the substrate binding site of the plasma membrane flippase.|PS|Atp8a1|25|12|Arg1:T25|Arg2:T48|CHEMICAL|GENE|ACTIVATOR|2031
9876137|Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block.|Cocaine|hH1 channels|1|28|Arg1:T5|Arg2:T16|CHEMICAL|GENE|INHIBITOR|2032
15452358|  In order to examine the site of action of an NR2B subtype-selective NMDA antagonist CP-101,606, we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration.|CP-101,606|NR2B|15|11|Arg1:T10|Arg2:T18|CHEMICAL|GENE|ANTAGONIST|2033
23024204|The acetylation of TETA is increased in SSAT1-overexpressing mice compared with wild-type mice.|TETA|SSAT1|4|8|Arg1:T15|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|2034
17768678|To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the elevation in brain ORN observed, animals were pretreated with vehicle or the MAO inhibitor tranylcypromine (TCP) before vehicle or PLZ (15 mg/kg), and brains collected 3 h later.|TCP|MAO|36|32|Arg1:T32|Arg2:T42|CHEMICAL|GENE|INHIBITOR|2035
16434489|Computer modeling suggests that the KITD816V mutation destabilizes the inactive conformation of the KIT activation loop to which imatinib binds, but it is not predicted to impair binding of KIT by dasatinib.|imatinib|KIT activation loop|19|14|Arg1:T2|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|2036
9476974|At nonconvulsant doses, the sodium channel blockers acetylprocainamide, dibucaine, dyclonine, prilocaine, proparacaine, quinidine, and tetracaine produced a small pressor response or no increase in BP.|proparacaine|sodium channel|17|6|Arg1:T36|Arg2:T48|CHEMICAL|GENE|INHIBITOR|2037
23330546|  Bile acids are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.|Bile acids|farnesoid X receptor|1|13|Arg1:T1|Arg2:T14|CHEMICAL|GENE|ACTIVATOR|2038
9399012|Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.|Zomig|5HT1B/1D|6|17|Arg1:T20|Arg2:T27|CHEMICAL|GENE|AGONIST|2039
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|ASCT2|14|46|Arg1:T23|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|2040
7825862|6-Methoxy-2-naphthylacetic acid, the active metabolite of Relafen, inhibits murine PGHS-2 preferentially.|6-Methoxy-2-naphthylacetic acid|PGHS-2|1|12|Arg1:T5|Arg2:T15|CHEMICAL|GENE|INHIBITOR|2041
17205056|In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, sorafenib blocked basal and ligand dependent FLT3-mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase1/2 and Stat5 phosphorylation.|sorafenib|FLT3|11|17|Arg1:T5|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2042
9890894|Addition of a specific number of FGFR sequences to the C-terminus of Ig module II resulted in a gain in affinity for FGF-7.|C|Ig module II|11|13|Arg1:T2|Arg2:T12|CHEMICAL|GENE|PART-OF|2043
10771044|  We examined the effect of JTH-601 (3- inverted question markN-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom ethyl inverted question mark-4-methoxy-2,5,6-trimethylphenol hemifumarate), a new alpha(1L)-adrenoceptor antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs.|ethyl|alpha(1L)-adrenoceptor|20|29|Arg1:T3|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|2044
21606412|  PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.|XL184|MET|3|12|Arg1:T6|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2045
14984733|  Phosphatidylserine (PtdSer) is made in mammalian cells by two PtdSer synthases, PSS1 and PSS2.|Phosphatidylserine|PtdSer synthases|1|12|Arg1:T1|Arg2:T22|CHEMICAL|GENE|PRODUCT-OF|2046
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imiquimod|TLR8|5|23|Arg1:T4|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|2047
10931813|Isoproterenol (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, d-sotalol (100 micromol/L) to block I(Kr) (LQT2 model), and ATX-II (20 nmol/L) to augment late I(Na) (LQT3 model).|d-sotalol|ATX-II|18|35|Arg1:T10|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2048
23261676|Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.|Isoproterenol|glutathione peroxidase|1|35|Arg1:T15|Arg2:T31|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2049
9990013|This direct biochemical evidence of cooperative interaction in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this cooperative binding of ATP and MgADP and, in cooperation with the MgADP bound at NBF2, causes ATP to be released from NBF1.|nucleotide|SUR1|9|16|Arg1:T5|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|2050
16434489|In this study, we demonstrate significant inhibitory activity of dasatinib against both wild-type KIT and the KITD816V mutation in the nanomolar range in in vitro and cell-based kinase assays.|dasatinib|KIT|11|18|Arg1:T11|Arg2:T32|CHEMICAL|GENE|INHIBITOR|2051
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|quercetin|carbonic anhydrase|31|46|Arg1:T7|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2052
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|SNAT1|12|59|Arg1:T21|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|2053
23042954|To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.|LY293558|GluK1|55|26|Arg1:T11|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|2054
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|CLS|TNF- α|15|55|Arg1:T7|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2055
23376356|LY294002, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.|LY294002|MAPK|1|12|Arg1:T1|Arg2:T18|CHEMICAL|GENE|ACTIVATOR|2056
23619613|Processing of polysialylated NCAM was reproduced in a mouse model by bleomycin administration leading to an activation of the inflammasome and secretion of interleukin (IL)-1β.|bleomycin|interleukin (IL)-1β|12|24|Arg1:T7|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2057
17352685|  The phosphodiesterase (PDE) 4 is the predominant cyclic AMP degrading enzyme in a variety of inflammatory cells including eosinophils, neutrophils, macrophages, T cells and monocytes.|cyclic AMP|phosphodiesterase (PDE) 4|10|2|Arg1:T5|Arg2:T15|CHEMICAL|GENE|SUBSTRATE|2058
23601203|Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.|amino acid|HSA|21|11|Arg1:T3|Arg2:T12|CHEMICAL|GENE|PART-OF|2059
23102509|The altered activities of key enzymes such as glucose-6-phosphatase and fructose-1,6-bisphosphatase of carbohydrate metabolism significantly (p<0.05) increased whereas hexokinase, pyruvate kinase, glucose-6-phosphate dehydrogenase and glycogen content significantly (p<0.05) decreased in the liver of diabetic rats and also increased activities of aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP).|carbohydrate|fructose-1,6-bisphosphatase|13|11|Arg1:T13|Arg2:T30|CHEMICAL|GENE|PRODUCT-OF|2060
23066089|Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.|phorbol 12-myristate,13-acetate|GluK2|24|27|Arg1:T7|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|2061
23274058|Jaceosidin, isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation.|Jaceosidin|cdc25C|1|19|Arg1:T17|Arg2:T32|CHEMICAL|GENE|INHIBITOR|2062
3345199|  Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.|oximes|Acetylcholinesterase|19|1|Arg1:T6|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|2063
1375507|The inhibitory effects of iloprost on tissue factor expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and dibutyryl cyclic AMP but not dibutyryl cyclic GMP.|forskolin|tissue factor|18|7|Arg1:T7|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2064
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|2',2'-difluorodeoxycytidine|deoxycytidine kinase|5|16|Arg1:T8|Arg2:T45|CHEMICAL|GENE|SUBSTRATE|2065
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|gallic acid|CA|25|49|Arg1:T5|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2066
12560076|  D-Serine was previously identified in mammalian brain and was shown to be a co-agonist at the 'glycine' site of the N-methyl-D-aspartate (NMDA)-type receptors.|glycine|N-methyl-D-aspartate (NMDA)-type receptors|18|22|Arg1:T18|Arg2:T23|CHEMICAL|GENE|PART-OF|2067
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Arava|TK|55|3|Arg1:T32|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2068
23221006|Role of organic cation/carnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria.|phenformin|organic cation/carnitine transporter 1|10|3|Arg1:T17|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|2069
17138644|Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src.|Progestin|Src|1|23|Arg1:T8|Arg2:T41|CHEMICAL|GENE|ACTIVATOR|2070
20615127|Our findings suggest that R316C causes reduced association with and impaired release of NCoR, resulting in RTH predominantly at the pituitary level, and that slightly elevated serum TSH level with high dose of levothyroxine might be optimum for normal growth.|levothyroxine|TSH|36|30|Arg1:T5|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2071
11292635|Contribution of the Na+-K+-2Cl- cotransporter NKCC1 to Cl- secretion in rat OMCD.|Cl-|Na+-K+-2Cl- cotransporter|8|4|Arg1:T28|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2072
1730582|  Mouse ornithine decarboxylase (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (DFMO).|alpha-difluoromethylornithine|Mouse ornithine decarboxylase|44|1|Arg1:T16|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2073
20185318|Phenols like the ones investigated here possess a CA inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the coumarins.|Phenols|CA|1|9|Arg1:T12|Arg2:T33|CHEMICAL|GENE|INHIBITOR|2074
23250811|The anti-inflammatory actions of curcumin on colitis may involve inhibition of the TLR4/NF-κB signaling pathway and of IL-27 expression.|curcumin|IL-27|5|18|Arg1:T9|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2075
12837768|A comparison of the results with previous data for desipramine and cocaine inhibition of norepinephrine uptake by the mutant hNETs reveals that MrIA binding to hNET occurs at a site that is distinct from but overlaps with the binding sites for tricyclic antidepressants and cocaine.|norepinephrine|hNETs|15|20|Arg1:T2|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|2076
7599160|Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin (CN-Cbl) bound to transcobalamin II (transcobalamin, TC).|[57Co]cyanocobalamin|transcobalamin|28|40|Arg1:T9|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|2077
23318685|  Peginesatide, a polyethylene glycol (PEG)ylated peptide-based erythropoiesis-stimulating agent, stimulates the erythropoietin receptor dimer that governs erythropoiesis.|polyethylene glycol|erythropoietin receptor|4|16|Arg1:T2|Arg2:T10|CHEMICAL|GENE|ACTIVATOR|2078
23230131|The higher in vitro catalytic efficiency of DCK24Val toward dFdC monophosphorylation may be relevant to dFdC clinical response.|dFdC|DCK|16|8|Arg1:T7|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|2079
23600800|Recombinant P2X3/CASK expression in HEK cells increased serine phosphorylation of P2X3 receptors, typically associated with receptor upregulation.|serine|P2X3|8|11|Arg1:T5|Arg2:T27|CHEMICAL|GENE|PART-OF|2080
23318833|TAA also increased the numbers of ED2(+), cyclooxygenase-2(+), and heme oxygenase-1(+) liver cells, as well as the number of CD3(+) lymphocytes.|TAA|CD3|1|32|Arg1:T12|Arg2:T30|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2081
14757703|(125)I-Cyanopindolol saturation binding in Adv.beta(1) myocytes demonstrated approximately 18-fold increase in beta(1)-adrenoceptors.|(125)I-Cyanopindolol|beta(1)-adrenoceptors|1|18|Arg1:T8|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2082
10988273|In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the alpha(2)-autoreceptors, sharing this property with rauwolscine, phentolamine, and idazoxan.|phentolamine|alpha(2)-autoreceptors|38|26|Arg1:T2|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|2083
21606412|  PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.|cabozantinib|RET|5|25|Arg1:T3|Arg2:T14|CHEMICAL|GENE|INHIBITOR|2084
15837926|PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.|methotrexate|GCPII|21|8|Arg1:T3|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|2085
10931813|  BACKGROUND: This study examines the effects of nicorandil, a K(+) channel opener, on transmural dispersion of repolarization (TDR) and induction of torsade de pointes (TdP) under conditions mimicking the LQT1, LQT2, and LQT3 forms of the congenital long-QT syndrome (LQTS).|nicorandil|K(+) channel|9|12|Arg1:T7|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|2086
10640321|The nonselective opioid receptor antagonist, naloxone (3 mg/kg, i.m.), attenuated the antitussive effects of codeine or SB 227122, indicating that the antitussive activity of both compounds is opioid receptor-mediated.|SB 227122|opioid receptor|23|3|Arg1:T14|Arg2:T27|CHEMICAL|GENE|AGONIST|2087
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|ocal adhesion kinase|1|14|Arg1:T6|Arg2:T34|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2088
23127600|As revealed by glucose oxidase (GOD) and radioimmunoassay (RIA), both dimethyldiguanide (DC, 0.6gkg(-1)d(-1)) and CPS (0.3, 0.6, 1.2gkg(-1)d(-1)) treatments significantly resulted in down-regulation of blood glucose and insulin levels in serum, while the levels of oxidative stress markers were markedly lowered through ELISA assay.|dimethyldiguanide|insulin|16|54|Arg1:T7|Arg2:T14|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2089
15898717|This 40 kDa PEG-conjugated IFNalpha(2a) ((40)PEG-IFNalpha(2a)) is obtained by the covalent binding of one 40 kDa branched PEG-polymer to a lysine side-chain of IFNalpha(2a).|PEG|IFNalpha(2a)|4|5|Arg1:T2|Arg2:T12|CHEMICAL|GENE|PART-OF|2090
10593931|Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.|amino acids|factor IX|3|16|Arg1:T7|Arg2:T34|CHEMICAL|GENE|PART-OF|2091
15908512|The selective betaAR agonist isoproterenol caused an enhancement of hippocampal CA3 network activity, as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region.|isoproterenol|betaAR|5|3|Arg1:T13|Arg2:T29|CHEMICAL|GENE|AGONIST|2092
11585753|"The tyrosine kinase inhibitor ZD1839 (""Iressa"") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells."|ZD1839|HER2|5|12|Arg1:T8|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2093
12679340|In OTCase, mutations of putative ornithine binding residues, Asp-182, Asn-184, Asn-185, Cys-289, and Glu-256 greatly reduced the affinity for ornithine and impaired the interaction with arginase.|Glu|OTCase|20|2|Arg1:T13|Arg2:T28|CHEMICAL|GENE|PART-OF|2094
23024204|However, SSAT1-deficient mice metabolize TETA at the same rate as the wild-type mice, indicating the existence of another N-acetylase respons 2ible for its metabolism in mice.|TETA|N-acetylase|6|21|Arg1:T16|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2095
23598904|Among the possible transporters involved in the uptake of Cd(2+) and Mn(2+), the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.|Mn(2+)|Slc39a8|15|34|Arg1:T22|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|2096
23539296|In addition to CYP2B6, anisomycin co-treatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs. Thus, activated p38 MAPK is required for liganded-CAR to selectively activate a set of genes that encode drug metabolizing enzymes.|anisomycin|CYP2A7|6|12|Arg1:T4|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2097
1978244|The Schild plots for the competitive antagonists WB4101 and 5-methyl-urapidil against alpha 1a-adrenoceptor-selective agonist methoxamine-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for WB4101 and 9.09 +/- 0.05 (n = 3) for 5-methyl-urapidil.|WB4101|alpha 1a-adrenoceptor|41|12|Arg1:T11|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|2098
22872607|  Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.|oxygen|Aldo-keto reductases|28|1|Arg1:T7|Arg2:T12|CHEMICAL|GENE|PRODUCT-OF|2099
16618126|Weakly translocated lipids (PE, phosphatidylhydroxypropionate, and phosphatidylhomoserine) are also weak Atp8a1 activators.|PE|Atp8a1|5|15|Arg1:T19|Arg2:T44|CHEMICAL|GENE|ACTIVATOR|2100
10606746|The inhibitor binds at the base of the active site gorge of TcAChE, interacting with both the choline-binding site (Trp-84) and the acyl-binding pocket (Phe-288, Phe-290).|Phe|TcAChE|31|13|Arg1:T7|Arg2:T21|CHEMICAL|GENE|PART-OF|2101
23123662|Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.|carboplatin|rCtr1|24|10|Arg1:T23|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|2102
10727715|In addition, by comparing the combined administration of (+/-)pindolol with either WAY100635, GR127935 or isamoltane, we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D) receptor in addition to any activity it has at the presynaptic 5-HT(1A) receptor.|(+/-)pindolol|5-HT(1A)|26|62|Arg1:T12|Arg2:T35|CHEMICAL|GENE|ANTAGONIST|2103
15635044|Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.|Ala|rat GnRHR|35|48|Arg1:T17|Arg2:T49|CHEMICAL|GENE|PART-OF|2104
23543413|It has been claimed that hCTR1, the human high affinity copper transporter, is the major entry pathway for cDDP and related drugs via a mechanism that mimics copper.|cDDP|human high affinity copper transporter|21|9|Arg1:T8|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|2105
1978244|  Using the alpha 1-adrenoceptor subtype-selective antagonists chlorethylclonidine (CEC), WB4101, and 5-methyl-urapidil, we have examined the possible heterogeneity in the alpha 1-adrenoceptor populations in rabbit aorta.|CEC|alpha 1-adrenoceptor|9|3|Arg1:T22|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|2106
20421509|To examine the interaction of S100A4 with TFP, we determined the 2.3 A crystal structure of human Ca(2+)-S100A4 bound to TFP.|TFP|S100A4|26|24|Arg1:T15|Arg2:T40|CHEMICAL|GENE|DIRECT-REGULATOR|2107
17488480|In addition, cells pre-treated with DL-propargylglycine (PAG, 3 mM), a CSE inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that CSE may be the main enzyme involved in H(2)S formation in mouse acinar cells.|PAG|CSE|9|16|Arg1:T23|Arg2:T48|CHEMICAL|GENE|INHIBITOR|2108
23391485|Our results showed that low dose BPA and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of Oct4 and Nanog proteins, while only BPA could downregulate the expression of E-cadherin protein.|BPA|Nanog|7|25|Arg1:T10|Arg2:T13|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2109
23344961|To explore the molecular basis for CPT hypersensitivity in Top2β-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2β-deficient cells.|CPT|RNAP LS|17|27|Arg1:T10|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2110
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|INNO-406|c-KIT|51|57|Arg1:T14|Arg2:T46|CHEMICAL|GENE|INHIBITOR|2111
10593931|Amino acids between Ile(183) and Val(191) are necessary for proper factor IX activation, but additional sequence between Ser(195) and Ile(197) or between Phe(260) and Ser(265) is required for complete restoration of activation.|Amino acids|factor IX|1|17|Arg1:T2|Arg2:T11|CHEMICAL|GENE|PART-OF|2112
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|STI571|KIT|3|22|Arg1:T2|Arg2:T11|CHEMICAL|GENE|INHIBITOR|2113
15840827|  The two active sites of dimeric 5-aminolevulinate synthase (ALAS), a pyridoxal 5'-phosphate (PLP)-dependent enzyme, are located on the subunit interface with contribution of essential amino acids from each subunit.|amino acids|ALAS|32|10|Arg1:T5|Arg2:T23|CHEMICAL|GENE|PART-OF|2114
15985706|The gastric mucin secretory responses to isoproterenol, furthermore, were inhibited by PP2, a selective inhibitor of tyrosine kinase Src responsible for ligand-independent EGFR autophosphorylation, but not by ERK inhibitor, PD98059.|PP2|tyrosine kinase|14|20|Arg1:T12|Arg2:T38|CHEMICAL|GENE|INHIBITOR|2115
17643344|Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.|aprepitant|substance P receptor|10|5|Arg1:T11|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|2116
16965760|It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.|lithium chloride|inositol monophosphatase|8|23|Arg1:T14|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2117
12046981|  Olopatadine hydrochloride (olopatadine, 11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid monohydrochloride) is a novel antiallergic/histamine H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories.|Olopatadine hydrochloride|histamine H1-receptor|1|31|Arg1:T1|Arg2:T20|CHEMICAL|GENE|ANTAGONIST|2118
22391562|We have examined the effectiveness of two novel Chk1 selective inhibitors, AR323 and AR678, in a panel of melanoma cell lines and normal cell types.|AR678|Chk1|15|9|Arg1:T2|Arg2:T6|CHEMICAL|GENE|INHIBITOR|2119
23024204|We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidine/spermine-N(1)-acetyltransferase (SSAT1) and by thialysine acetyltransferase (SSAT2) to its monoacetylated derivative (MAT).|TETA|spermidine/spermine-N(1)-acetyltransferase|5|14|Arg1:T8|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|2120
17205056|We show that sorafenib (BAY 43-9006, Nexavar) potently inhibits FLT3 enzymatic and signaling activities.|BAY 43-9006|FLT3|6|13|Arg1:T3|Arg2:T15|CHEMICAL|GENE|INHIBITOR|2121
2899826|  In vitro binding affinities of chlorpromazine, fluphenazine, levomepromazine, perphenazine and some of their metabolites for dopamine D2 receptors, alpha 1- and alpha 2 adrenoceptors in rat brain were previously reported from our laboratories.|fluphenazine|dopamine D2 receptors|8|19|Arg1:T10|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|2122
17488480|To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and NK1-R in acinar cells.|NaHS|SP|32|51|Arg1:T11|Arg2:T39|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2123
23194825|Importantly, pre-treatment with buthionine sulfoximine (BSO), an inhibitor of γ-GCS, prevented α-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity.|BSO|γ-GCS|9|15|Arg1:T10|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2124
20448797|Telmisartan is an angiotensin II receptor blocker (ARB) displaying unique pharmacologic properties, including a longer half life than any other ARB, that result in large and sustained reductions of blood pressure.|Telmisartan|angiotensin II receptor|1|4|Arg1:T6|Arg2:T21|CHEMICAL|GENE|INHIBITOR|2125
15704203|Denufosol is metabolically more stable and better tolerated, and may enhance mucociliary clearance for a longer period of time than previously investigated P2Y(2) agonists.|Denufosol|P2Y(2)|1|24|Arg1:T14|Arg2:T21|CHEMICAL|GENE|AGONIST|2126
16213084|These results provide biochemical evidence of a H(+)-coupled and saturable transport system, presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown H(+)-coupled monocarboxylate transport system, for nicotinate in rat cerebrocortical astrocytes.|nicotinate|H(+)-coupled monocarboxylate transport system|39|29|Arg1:T9|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|2127
15255990|Cerebral histamine H1 receptor (H(1)R) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and [(11)C]-doxepin.|[(11)C]-doxepin|H(1)R|30|6|Arg1:T5|Arg2:T11|CHEMICAL|GENE|DIRECT-REGULATOR|2128
8894610|(+/-)-tamsulosin, an alpha 1A-adrenoceptor antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart.|(+/-)-tamsulosin|alpha 1A-adrenoceptor|1|7|Arg1:T26|Arg2:T35|CHEMICAL|GENE|ANTAGONIST|2129
16618126|Similar to the plasma membrane PS transporter, Atp8a1 is activated only by the naturally occurring sn-1,2-glycerol isomer of PS and not the sn-2,3-glycerol stereoisomer.|sn-1,2-glycerol|plasma membrane PS transporter|17|4|Arg1:T10|Arg2:T36|CHEMICAL|GENE|ACTIVATOR|2130
1375507|Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.|Prostacyclin|tissue factor|1|4|Arg1:T20|Arg2:T34|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2131
15991937|Losartan (parent compound), has moderate affinity for the AT(1) receptor (competitive inhibition).|Losartan|AT(1) receptor|1|12|Arg1:T13|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|2132
15498586|An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.|telmisartan|GLUT4|8|13|Arg1:T10|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2133
17477831|The mitochondrial ACC2 is primarily expressed in heart and skeletal muscle, where it is involved in the regulation of fatty acid oxidation.|fatty acid|ACC2|21|3|Arg1:T13|Arg2:T23|CHEMICAL|GENE|PRODUCT-OF|2134
17632107|Furthermore, the activities of the two torafugu PPARalphas were enhanced 4.3- and 7.6-fold by arachidonic acid, 4.4- and 5.2-fold by docosahexaenoic acid, and 6.7- and 8.0-fold by eicosapentaenoic acid each at 50 microM, respectively.|eicosapentaenoic acid|torafugu PPARalphas|31|8|Arg1:T5|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|2135
9990013|The KATP channel is a heterooligomeric complex of SUR1 subunits of the ATP-binding-cassette superfamily with two nucleotide-binding folds (NBF1 and NBF2) and the pore-forming Kir6.2 subunits.|ATP|nucleotide-binding folds|13|17|Arg1:T14|Arg2:T43|CHEMICAL|GENE|DIRECT-REGULATOR|2136
23500776|  Little is known in terms of multi-matrix cytochrome P450 activity induction under repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons (PHH, PAH).|PAH|cytochrome P450|26|8|Arg1:T5|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|2137
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|SLC1|14|34|Arg1:T23|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|2138
23250811|Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).|curcumin|IL-27|9|48|Arg1:T14|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2139
23066089|Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.|phorbol 12-myristate,13-acetate|PKC|24|22|Arg1:T7|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|2140
12487427|GW660511X and omapatrilat reduced the production of BrBK1-5 and BrBK1-7 with more effect being observed with omapatrilat.|omapatrilat|BrBK1-7|3|10|Arg1:T18|Arg2:T64|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2141
10727528|Salicylates inhibit (125)I-ET-1 binding to recombinant rat ETA receptors.|(125)I|ET-1|3|7|Arg1:T9|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|2142
15352500|"A novel membrane sensor for histamine H1-receptor antagonist ""fexofenadine""."|fexofenadine|histamine H1-receptor|10|6|Arg1:T13|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|2143
17488480|Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue caerulein-treated acinar cells.|caerulein|NK-1R|39|26|Arg1:T3|Arg2:T57|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2144
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|risperidone|D(1) receptors|34|56|Arg1:T5|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|2145
9990013|This direct biochemical evidence of cooperative interaction in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this cooperative binding of ATP and MgADP and, in cooperation with the MgADP bound at NBF2, causes ATP to be released from NBF1.|MgADP|NBF2|35|38|Arg1:T9|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|2146
11255924|Accordingly, self-administration of a group of local anesthetics that are DAT ligands was compared to their effects as DA uptake blockers in vitro in brain tissue.|DA|DAT|20|12|Arg1:T16|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|2147
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|SU101|TK|53|3|Arg1:T31|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2148
3134891|It was also dependent upon temperature, the presence of a divalent cation such as calcium, and on pH, showing maximum binding at pH 6.5 with little binding at pH values below 4.2 or above 8.0. The site at which phenoxybenzamine bound to calmodulin appears to be similar to that at which certain antipsychotic agents bind, since several of them, including penfluridol, pimozide and spiroperidol, prevented the binding of phenoxybenzamine to calmodulin.|penfluridol|calmodulin|67|79|Arg1:T14|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|2149
11562773|Amiloride is a specific inhibitor of uPA but does not inhibit tPA.|Amiloride|uPA|1|7|Arg1:T2|Arg2:T10|CHEMICAL|GENE|INHIBITOR|2150
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|trimethylamine|FMO3|21|15|Arg1:T3|Arg2:T14|CHEMICAL|GENE|SUBSTRATE|2151
9399012|  Zolmitriptan (Zomig; formerly 311C90) is a novel 5-hydroxytryptamine (5HT)1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura.|Zolmitriptan|5-hydroxytryptamine (5HT)1B/1D|1|11|Arg1:T1|Arg2:T25|CHEMICAL|GENE|AGONIST|2152
16494569|CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired pyridoxal kinase for the conversion of pyridoxine and pyridoxal to PLP.|pyridoxine|pyridoxal kinase|25|19|Arg1:T10|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|2153
15732037|Increased immunohistochemical labeling of HIF-1alpha, VEGF, and BNP in the ventricular myocardium was observed in the shunt group and carvedilol again normalized the labeling.|carvedilol|BNP|22|10|Arg1:T2|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2154
15723099|The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan.|dextromethorphan|sigma1 receptor|2|9|Arg1:T34|Arg2:T42|CHEMICAL|GENE|ACTIVATOR|2155
23376356|LY294002, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.|LY294002|c-Jun|1|17|Arg1:T1|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|2156
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Gln|AngII|15|40|Arg1:T2|Arg2:T18|CHEMICAL|GENE|PART-OF|2157
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|xanthostigmine|cholinesterase|19|8|Arg1:T5|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2158
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Sunitinib|kinase|33|44|Arg1:T9|Arg2:T45|CHEMICAL|GENE|INHIBITOR|2159
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Bay 43-9006|TK|44|3|Arg1:T28|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2160
15795320|Synergistic cytotoxicity was demonstrated, and pemetrexed significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the human nucleoside equilibrative transporter 1 (hENT1) in all cell lines.|pemetrexed|phosphorylated Akt|7|13|Arg1:T2|Arg2:T21|CHEMICAL|GENE|INHIBITOR|2161
2568748|Esmolol, a unique cardioselective beta 1-adrenergic receptor blocker with a half-life of 9 minutes, can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early beta-blocking therapy.|Esmolol|beta 1-adrenergic receptor|1|6|Arg1:T1|Arg2:T4|CHEMICAL|GENE|INHIBITOR|2162
16417577|Galanin attenuates cyclic AMP regulatory element-binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures.|naloxone|CREB|17|9|Arg1:T7|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|2163
23479738|In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity.|cysteines|peroxidase|13|31|Arg1:T28|Arg2:T33|CHEMICAL|GENE|PART-OF|2164
3134891|However, in contrast to the reversible binding of most phenothiazines to calmodulin, phenoxybenzamine bound to calmodulin irreversibly.|phenoxybenzamine|calmodulin|15|18|Arg1:T19|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|2165
17218486|EC50 values for S-(+)-METH were 0.89, 0.92, and 4.44 microM for rTAAR1, mTAAR1, and h-rChTAAR1, respectively.|S-(+)-METH|h-rChTAAR1|4|23|Arg1:T1|Arg2:T39|CHEMICAL|GENE|ACTIVATOR|2166
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Lapatinib|TK|16|3|Arg1:T16|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2167
12487427|Unlike GW660511X, omapatrilat abolished the production of BrBK1-5 and BrBK1-7, suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found.|GW660511X|ACE|20|16|Arg1:T48|Arg2:T86|CHEMICAL|GENE|INHIBITOR|2168
11695255|A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective cyclooxygenase (COX)-2 inhibitor (celecoxib) in comparison to a dual COX-1/COX-2 inhibitor (ketorolac).|ketorolac|COX-1|49|46|Arg1:T11|Arg2:T21|CHEMICAL|GENE|INHIBITOR|2169
12827214|On the other hand, ligands for the renal Na(+)-transporter (amiloride and triamterene) and for imidazoline recognition sites (guanabenz, guanfacine and agmatine) displaced the binding of [(3)H]prazosin to phentolamine-insensitive sites at micromolar concentrations.|triamterene|Na(+)-transporter|18|10|Arg1:T7|Arg2:T41|CHEMICAL|GENE|DIRECT-REGULATOR|2170
12897749|Inhibition corresponded to increased cAMP production caused by rolipram alone or rolipram plus salmeterol and blocked proportionately the phosphorylation and activation of gIV-PLA(2) in FMLP/B-activated eosinophils.|rolipram|gIV-PLA(2)|12|23|Arg1:T16|Arg2:T38|CHEMICAL|GENE|INHIBITOR|2171
15353299|While fluoropyrimidine antimetabolites have other sites of action, antifolates ZD1694 (raltitrexed, Tomudex) and AG337 (Thymitag) are more specific and potent TS inhibitors.|Tomudex|TS|15|27|Arg1:T4|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2172
23625804|Together, the information on both hCCS and hSOD1, along with a sequence analysis of eukaryotic CCSD1, allows us to propose important mechanistic aspects regarding the copper-transfer process from hCCS to hSOD1.|copper|hSOD1|29|34|Arg1:T6|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|2173
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|phenolic acids|CA|4|49|Arg1:T4|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2174
20185318|Phenols like the ones investigated here possess a CA inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the coumarins.|coumarins|CA|22|9|Arg1:T15|Arg2:T33|CHEMICAL|GENE|INHIBITOR|2175
15795105|However, the flowcytometric analysis revealed that AZC and PCA decreased intracellular contents of CD3-zeta chain in these cells in dose dependent manner.|AZC|CD3-zeta chain|8|15|Arg1:T7|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2176
23481236|Saturated palmitic and stearic acids increased ceramides, up-regulated PTP1B, and had AKt and PTP1B phosphorylation at Ser 50 impaired.|palmitic and stearic acids|AKt|2|14|Arg1:T2|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2177
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|caffeic acid|metalloenzyme|19|45|Arg1:T1|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2178
23623750|Rates of benzydamine N-oxygenation (catalyzed by FMO3) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in benzydamine N-oxygenation might be partly accounted for by the variable FMO3 expression.|N|FMO3|36|45|Arg1:T7|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|2179
23282066|Furthermore, MDZ caused mechanism-based inactivation of cytochrome P450 3A-dependent TRZ 1'-hydroxylation in mouse, rat and human intestinal microsomes with similar potencies.|MDZ|cytochrome P450 3A|3|8|Arg1:T1|Arg2:T14|CHEMICAL|GENE|INHIBITOR|2180
17459764|These findings demonstrate that n-3 and n-6 PUFA increased PPARgamma activity is necessary for the COX-2 induction in HaCaT human keratinocyte cells.|n-3 and n-6 PUFA|COX-2|5|16|Arg1:T3|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|2181
15811959|Our results demonstrate that the combination of denileukin diftitox and bexarotene is well tolerated and that even low doses (150 mg/day) of bexarotene are capable of in vivo upregulation of CD25 expression on circulating leukemia cells.|bexarotene|CD25|25|33|Arg1:T3|Arg2:T8|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2182
23041257|DBDCT up-regulated the expression of Bax, down-regulated the expression of Bcl-2, and significantly increased the ratio of Bax/Bcl-2.|DBDCT|Bax|1|6|Arg1:T13|Arg2:T25|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2183
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|CI-1033|TK|28|3|Arg1:T21|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2184
20596674|In conclusion, the results suggest that the enhancement in the reduction of topo II activity by the combined MXF/VP-16 treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs.|MXF|topo II|20|14|Arg1:T11|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2185
23246481|Moreover, wogonin repressed anisomycin-induced phosphorylation of p38, cav-1 and vascular permeability.|anisomycin|p38|5|8|Arg1:T11|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|2186
23643745|The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.|raclopride|D2|31|29|Arg1:T5|Arg2:T45|CHEMICAL|GENE|ANTAGONIST|2187
17594192|Phenserine is also unique because of differing actions of its enantiomers: (-)-phenserine is the active enantiomer for inhibition of AChE, whereas (+)-phenserine ('posiphen') has weak activity as an AChE inhibitor and can be dosed much higher.|posiphen|AChE|33|40|Arg1:T4|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2188
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|sunitinib|PDGFR-beta|3|34|Arg1:T5|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2189
16938288|  OBJECTIVE: Telmisartan, an angiotensin II type 1 receptor (AT1R) antagonist, was found to have a unique property: it is a partial agonist of peroxisome proliferator-activated receptor gamma (PPARgamma).|Telmisartan|PPARgamma|3|35|Arg1:T3|Arg2:T26|CHEMICAL|GENE|AGONIST|2190
10593931|To identify key amino acids involved in factor IX activation, recombinant factor XIa proteins containing alanine substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay.|amino acids|factor IX|4|8|Arg1:T3|Arg2:T13|CHEMICAL|GENE|PART-OF|2191
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|alanine|RNase A|18|12|Arg1:T2|Arg2:T22|CHEMICAL|GENE|PART-OF|2192
20104269|The effects of CDCA and GW4064 on expression of Cdx2 and MUC2 were abolished by guggulsterone.|guggulsterone|Cdx2|16|10|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2193
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|2'-cytidine monophosphate|Pro42Ala|30|20|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INHIBITOR|2194
23455597|CONCLUSIONS: The sum of these preclinical data, the first of their kind applied to H3 antagonists, indicates that ABT-288 is unlikely to possess a high potential for abuse in the human population and suggests that H3 antagonists, as a class, are similar in this regard.|ABT-288|H3|22|39|Arg1:T7|Arg2:T19|CHEMICAL|GENE|ANTAGONIST|2195
20104269|The effects of CDCA and GW4064 on expression of Cdx2 and MUC2 were abolished by guggulsterone.|guggulsterone|MUC2|16|12|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2196
16917142|Fulvestrant is a novel ER antagonist that destroys the ER and its signaling pathway and is not associated with tamoxifen-like agonist effects.|Fulvestrant|ER|1|10|Arg1:T4|Arg2:T24|CHEMICAL|GENE|INHIBITOR|2197
23382379|The myosin-18Aα isoform, additionally, has an N-terminal PDZ domain.|N|PDZ domain|9|10|Arg1:T6|Arg2:T17|CHEMICAL|GENE|PART-OF|2198
12373557|We hypothesized that the HED compounds would be most potent at the norepinephrine transporter (NET) compared to the serotonin or dopamine transporters and that the 1R diastereomers would be more effective than 1S diastereomers.|HED|norepinephrine transporter|5|13|Arg1:T10|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2199
17040106|Polyclonal antisera to either b5R or cyt b5 significantly inhibited N-hydroxy-4-aminobiphenyl (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).|N-hydroxy-4-aminobiphenyl|cyt b5|11|7|Arg1:T4|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|2200
23639362|Additionally, MPTP significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment.|MPTP|Bax|3|23|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2201
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|ellagic acid|metalloenzyme|34|45|Arg1:T8|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2202
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine|DAT|10|63|Arg1:T13|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|2203
1666997|Interestingly, amoxapine binds with a good affinity (IC50 = 0.30 microM) to 5-HT3 receptors labelled by [3H]zacopride in cortical membranes.|[3H]zacopride|5-HT3|20|16|Arg1:T13|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|2204
23370008|Importantly, expression of the acute-phase reactant serum amyloid A (SAA) significantly increased after ritodrine injection, with values indicating the largest fold-change.|ritodrine|SAA|17|12|Arg1:T19|Arg2:T32|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2205
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|atropine|AChE|33|4|Arg1:T10|Arg2:T15|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2206
17459764|The inhibitory effects of GW9662 and T0070907 (PPARgamma antagonists), on COX-2 expression and on stimulation of COX-2 promoter activity by EPA and GLA suggest that PPARgamma is implicated in COX-2 induction.|GW9662|PPARgamma|5|9|Arg1:T19|Arg2:T36|CHEMICAL|GENE|ANTAGONIST|2207
23265892|Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors.|tricyclic bispyran sulfone|γ-secretase|6|9|Arg1:T7|Arg2:T10|CHEMICAL|GENE|INHIBITOR|2208
23439561|Cycloxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) has been shown to be important in esophageal tumorigenesis.|PGE2|COX-2|9|3|Arg1:T5|Arg2:T25|CHEMICAL|GENE|PRODUCT-OF|2209
11585753|"The tyrosine kinase inhibitor ZD1839 (""Iressa"") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells."|ZD1839|tyrosine kinase|5|2|Arg1:T8|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2210
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|alanine|bovine pancreatic ribonuclease A|18|7|Arg1:T2|Arg2:T20|CHEMICAL|GENE|PART-OF|2211
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|NS398|COX-2|24|44|Arg1:T13|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2212
9832994|Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in plasma prolactin and ACTH levels after i.v. mCPP, pointing to a general state of arousal in these mCPP-treated animals.|mCPP|plasma prolactin|23|15|Arg1:T17|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2213
23314054|Fragment-based design, synthesis, and biological evaluation of N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide derivatives as novel Mcl-1 inhibitors.|N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide|Mcl-1|10|18|Arg1:T4|Arg2:T9|CHEMICAL|GENE|INHIBITOR|2214
16343532|Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin-LA: elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins.|motuporin|protein phosphatase-1|8|4|Arg1:T12|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|2215
23098818|Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the human isoform CYP2D6.|5-methoxytryptamine|CYP2D|19|8|Arg1:T14|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|2216
14583450|In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.|COOH|p53|32|28|Arg1:T4|Arg2:T46|CHEMICAL|GENE|PART-OF|2217
1978244|Radioligand binding studies with the nonselective alpha 1-adrenoceptor antagonist radioligand 125I-BE2254 showed that 73-87% of the binding sites in rabbit aorta are CEC sensitive and they are predominantly low affinity sites both for WB4101 (pKd = 8.1) and for 5-methylurapidil (pKd = 7.1).|CEC|alpha 1-adrenoceptor|24|7|Arg1:T23|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|2218
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Imatinib mesylate|Bcr|11|22|Arg1:T36|Arg2:T54|CHEMICAL|GENE|INHIBITOR|2219
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|clerosterol|TNF- α|13|55|Arg1:T6|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2220
12414329|Sildenafil exhibits inhibitory potency against PDE5 and a 10-fold lower dose-related inhibitory potency against rod outer segment PDE6, the predominant PDE in the phototransduction cascade in rods.|Sildenafil|PDE6|1|18|Arg1:T11|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2221
9399012|  Zolmitriptan (Zomig; formerly 311C90) is a novel 5-hydroxytryptamine (5HT)1B/1D receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura.|311C90|5-hydroxytryptamine (5HT)1B/1D|6|11|Arg1:T14|Arg2:T25|CHEMICAL|GENE|AGONIST|2222
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|Fenofibrate|apolipoprotein C-III|1|18|Arg1:T15|Arg2:T38|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2223
8294418|Both NE and phorbol esters increased the rate of alpha-AR mRNA degradation.|NE|alpha-AR|2|10|Arg1:T14|Arg2:T31|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2224
12181285|Amongst the three OCTs expressed in the SCG, OCT3 best fits the profile of substrates and antagonists that cause trans-stimulation and trans-inhibition, respectively, of [3H]-MPP+ release.|[3H]-MPP+|OCTs|28|4|Arg1:T16|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|2225
14583450|  Ribonucleotide reductase (RR) is responsible for the de novo conversion of the ribonucleoside diphosphates to deoxyribonucleoside diphosphates, which are essential for DNA synthesis and repair.|ribonucleoside diphosphates|RR|15|4|Arg1:T5|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|2226
23429911|Moreover, the effects of the DRD3 agonist 7-hydroxy-N,N-dipropyl-2-aminotetralin (7-OH-DPAT)-induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant.|7-hydroxy-N,N-dipropyl-2-aminotetralin|DRD3|9|7|Arg1:T1|Arg2:T8|CHEMICAL|GENE|AGONIST|2227
16213084|Because l-lactate reduced to 67% of the nicotinate uptake even at 10mM, it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 and/or MCT2.|nicotinate|MCT2|19|29|Arg1:T3|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|2228
23118019|Opioid receptor binding affinity and activity were assessed using [(3)H]-diprenorphine binding, guanosine-5'-O-(3-[35S]-thio) triphosphate ([(35)S]-GTPγS) binding and isolated guinea-pig ileum.|[(3)H]-diprenorphine|Opioid receptor|10|1|Arg1:T11|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|2229
23512754|In macrophages, levels of TNF-α, IFN-γ, NO, IL-6 and IL-10 were increased by CDM used alone or in combination with HSV-2.|CDM|IL-6|18|12|Arg1:T11|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2230
18081314|The binding of U46619 to the PGIS protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at C-11, H2C, and H20 of U46619 were observed upon U46619 binding to the engineered PGIS in a concentration-dependent manner.|C-11|PGIS|27|7|Arg1:T12|Arg2:T38|CHEMICAL|GENE|PART-OF|2231
23246481|Moreover, wogonin repressed anisomycin-induced phosphorylation of p38, cav-1 and vascular permeability.|anisomycin|cav-1|5|10|Arg1:T11|Arg2:T23|CHEMICAL|GENE|ACTIVATOR|2232
23597506|However, enzymes contributing to oxidative metabolism of anandamide, namely cyclooxygenase-1 and Cyp2D6, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of anandamide.|anandamide|cyclooxygenase-1|31|12|Arg1:T3|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|2233
12837768|A comparison of the results with previous data for desipramine and cocaine inhibition of norepinephrine uptake by the mutant hNETs reveals that MrIA binding to hNET occurs at a site that is distinct from but overlaps with the binding sites for tricyclic antidepressants and cocaine.|tricyclic|hNET|42|26|Arg1:T3|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|2234
9003761|Despite a low amino acid identity between TWIK-1 and TREK-1 (approximately 28%), both channel proteins share the same overall structural arrangement consisting of two pore-forming domains and four transmembrane segments (TMS).|amino acid|TREK-1|4|10|Arg1:T3|Arg2:T19|CHEMICAL|GENE|PART-OF|2235
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|CNT|5-HT4|13|23|Arg1:T21|Arg2:T32|CHEMICAL|GENE|AGONIST|2236
3735252|Gossypol and its isomers were non-competitive inhibitors of human and hamster LDH-X with respect to the coenzyme NADH, competitive inhibitors of human LDH-X and noncompetitive-competitive inhibitors of hamster LDH-X with respect to the substrate alpha-ketobutyrate.|Gossypol|human and hamster LDH-X|1|9|Arg1:T4|Arg2:T15|CHEMICAL|GENE|INHIBITOR|2237
23321689|However the α7 receptor antagonist methyllycaconitine was unable to reverse these anxiety-like effects seen with PNU-282987.|methyllycaconitine|α7 receptor|6|3|Arg1:T3|Arg2:T16|CHEMICAL|GENE|ANTAGONIST|2238
20104269|The maximum stimulation of Cdx2 and MUC2 mRNA induced by CDCA was observed at 3 h and by 6 h, respectively.|CDCA|MUC2|11|7|Arg1:T9|Arg2:T29|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2239
18081314|The noted conformational changes where the C-6 position is closer to the C-9 position of U46619 provided the first experimental data for understanding the molecular mechanism of the catalytic function of PGIS in the isomerization of PGH2 to prostacyclin.|U46619|PGIS|16|32|Arg1:T8|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|2240
23123662|Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.|copper|rCtr1|18|4|Arg1:T20|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|2241
3134891|Characteristics of the binding of phenoxybenzamine to calmodulin.|phenoxybenzamine|calmodulin|6|8|Arg1:T20|Arg2:T38|CHEMICAL|GENE|DIRECT-REGULATOR|2242
22931533|The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.|galantamine|nAChR|10|14|Arg1:T7|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|2243
15121646|The relatively high D(2) receptor occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and quetiapine.|risperidone|D(2) receptor|24|4|Arg1:T7|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|2244
7825862|We have cloned cDNAs for murine PGHS-1 and PGHS-2, expressed these enzymes in cos-1 cells, and compared the relative sensitivities of the two isozymes to some common NSAIDs. Indomethacin, piroxicam, and sulindac sulfide were found to preferentially inhibit PGHS-1.|Indomethacin|PGHS-1|32|44|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INHIBITOR|2245
1543672|  Terbinafine (Lamisil) has primarily fungicidal action against many fungi as a result of its specific mechanism of squalene epoxidase inhibition.|Terbinafine|squalene epoxidase|1|20|Arg1:T1|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2246
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|triptorelin|Luteinizing hormone-releasing hormone|17|1|Arg1:T8|Arg2:T22|CHEMICAL|GENE|AGONIST|2247
23583257|In fact, we demonstrated a significant stimulation of Nox4 activity by 4 quinone derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx™, and chondrocyte cell lines.|duroquinone|Nox4|24|10|Arg1:T9|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|2248
16343532|We have elucidated the crystal structures of the cyanotoxins, motuporin (nodularin-V) and dihydromicrocystin-LA bound to human protein phosphatase-1c (gamma isoform).|nodularin-V|human protein phosphatase-1c (gamma isoform)|13|19|Arg1:T10|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2249
3345199|  Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.|organophosphate|AChE|8|3|Arg1:T16|Arg2:T32|CHEMICAL|GENE|INHIBITOR|2250
12181285|Amongst the three OCTs expressed in the SCG, OCT3 best fits the profile of substrates and antagonists that cause trans-stimulation and trans-inhibition, respectively, of [3H]-MPP+ release.|[3H]-MPP+|OCT3|28|10|Arg1:T16|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|2251
9003761|TREK-1 currents are insensitive to pharmacological agents that block TWIK-1 activity such as quinine and quinidine.|quinine|TWIK-1|14|10|Arg1:T6|Arg2:T24|CHEMICAL|GENE|INHIBITOR|2252
20801130|The high resolution NMR solution structure of the cTnC-cTnI-dfbp-o ternary complex showed that dfbp-o bound at the hydrophobic interface formed by cTnC and cTnI making critical interactions with residues such as Arg147 of cTnI.|dfbp-o|cTnI|14|24|Arg1:T3|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|2253
8894610|(+/-)-Tamsulosin, over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1-adrenoceptors, did not affect the accumulation of [3H]inositol phosphates that was induced by 10 microM phenylephrine.|(+/-)-Tamsulosin|alpha 1-adrenoceptors|1|21|Arg1:T5|Arg2:T29|CHEMICAL|GENE|ANTAGONIST|2254
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|cytarabine|DCK|38|13|Arg1:T9|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|2255
10701840|The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.|geldanamycin|kinase|4|7|Arg1:T8|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2256
17594192|Phenserine is also unique because of differing actions of its enantiomers: (-)-phenserine is the active enantiomer for inhibition of AChE, whereas (+)-phenserine ('posiphen') has weak activity as an AChE inhibitor and can be dosed much higher.|(+)-phenserine|AChE|27|40|Arg1:T3|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2257
22982218|We also investigated the epigenetic status of NIS promoter after PJ34 treatment in TPC1 cell line: in addition to an increase of histone modification activation marks (H3K9K14ac, H3K4me3), surprisingly we observed also an increase of H3K27me3, a classical repressive mark.|PJ34|histone modification activation marks|11|24|Arg1:T5|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2258
15985706|Both inhibitors, moreover, blunted the mucin secretory responses to beta-adrenergic agonist-generated second messenger, cAMP as well as adenylate cyclase activator, forskolin.|forskolin|mucin|25|8|Arg1:T10|Arg2:T34|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2259
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|p-hydroxybenzoic acid|EC 4.2.1.1|13|51|Arg1:T11|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2260
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|benzydamine|Cynomolgus FMO1|11|1|Arg1:T10|Arg2:T46|CHEMICAL|GENE|SUBSTRATE|2261
18081314|The distances between the protons H20 and H2, H18 and H2, and H18 and H4 are shorter following their binding to the PGIS in solution-down to within 5 A.|H20|PGIS|6|25|Arg1:T19|Arg2:T41|CHEMICAL|GENE|PART-OF|2262
10606746|The inhibitor binds at the base of the active site gorge of TcAChE, interacting with both the choline-binding site (Trp-84) and the acyl-binding pocket (Phe-288, Phe-290).|Trp|choline-binding site|22|19|Arg1:T4|Arg2:T22|CHEMICAL|GENE|PART-OF|2263
23481236|We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 μM).|DAGs|PTP1B|15|30|Arg1:T13|Arg2:T44|CHEMICAL|GENE|DIRECT-REGULATOR|2264
23230131|All three CDA proteins showed similar K(m) and V(max) for Ara-C and dFdC deamination, except for CDA70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for Ara-C deamination.|Ara-C|CDA|17|3|Arg1:T14|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|2265
20135071|Of these, the thrombin inhibitor dabigatran and factor Xa inhibitor rivaroxaban have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe.|dabigatran|thrombin|7|5|Arg1:T10|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2266
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|triptorelin|LH|17|39|Arg1:T8|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2267
23118019|Opioid receptor binding affinity and activity were assessed using [(3)H]-diprenorphine binding, guanosine-5'-O-(3-[35S]-thio) triphosphate ([(35)S]-GTPγS) binding and isolated guinea-pig ileum.|guanosine-5'-O-(3-[35S]-thio) triphosphate|Opioid receptor|19|1|Arg1:T12|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|2268
12837768|A comparison of the results with previous data for desipramine and cocaine inhibition of norepinephrine uptake by the mutant hNETs reveals that MrIA binding to hNET occurs at a site that is distinct from but overlaps with the binding sites for tricyclic antidepressants and cocaine.|cocaine|hNET|45|26|Arg1:T4|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|2269
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|2'-cytidine monophosphate|proline-42-to-alanine|30|17|Arg1:T4|Arg2:T15|CHEMICAL|GENE|INHIBITOR|2270
1730582|Cysteine 360, which was the major adduct accounting for about 90% of the total labeling, is contained within the sequence -WGPTCDGL(I)D-, which is present in all known eukaryote ODCs. These results provide strong evidence that these two peptides form essential parts of the catalytic site of ODC.|Cysteine|eukaryote ODCs|1|36|Arg1:T4|Arg2:T34|CHEMICAL|GENE|PART-OF|2271
17380207|  Because of their low asparagine synthetase (ASNS) expression and asparagine biosynthesis, acute lymphoblastic leukemia (ALL) cells are exquisitely sensitive to asparagine depletion.|asparagine|asparagine synthetase|12|5|Arg1:T5|Arg2:T9|CHEMICAL|GENE|PRODUCT-OF|2272
10640321|The nonselective opioid receptor antagonist, naloxone (3 mg/kg, i.m.), attenuated the antitussive effects of codeine or SB 227122, indicating that the antitussive activity of both compounds is opioid receptor-mediated.|naloxone|opioid receptor|7|3|Arg1:T12|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|2273
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imiquimod|porcine TLR7|5|12|Arg1:T4|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|2274
23246481|These results suggested that wogonin could inhibit H2O2-induced vascular permeability by downregulating the phosphorylation of cav-1, and that it might have a therapeutic potential for the diseases associated with the development of both oxidant and vascular permeability.|H2O2|cav-1|8|16|Arg1:T13|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|2275
17643344|In this study we investigated the effects of combination chemotherapy with melarsoprol and a humanised SP receptor antagonist aprepitant (EMEND) in this mouse model.|EMEND|humanised SP receptor|21|15|Arg1:T7|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|2276
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|AH 6809|EP2|46|23|Arg1:T17|Arg2:T35|CHEMICAL|GENE|AGONIST|2277
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Nilotinib|c-KIT|48|57|Arg1:T13|Arg2:T46|CHEMICAL|GENE|INHIBITOR|2278
10546982|Following 6 h of in vivo intracerebroventricular injections of 100 nmol of RTI-76, there was a dose- and time-dependent reduction (- 60%) of SERT binding in hippocampus and striatum, without a change in the Kd. SERT binding densities recovered over several days, reaching control levels by day 14.|RTI-76|SERT|13|28|Arg1:T7|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|2279
23261676|Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.|Isoproterenol|glutathione reductase|1|38|Arg1:T15|Arg2:T32|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2280
10942908|The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase (BChE) activity (87% of control), whereas pyridostigmine plus exercise significantly decreased the BChE activity (79% of control), indicating an interactive effect of the combination.|pyridostigmine|BChE|5|12|Arg1:T12|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2281
12046981|  Olopatadine hydrochloride (olopatadine, 11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid monohydrochloride) is a novel antiallergic/histamine H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories.|olopatadine|histamine H1-receptor|4|31|Arg1:T10|Arg2:T20|CHEMICAL|GENE|ANTAGONIST|2282
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|GW2331|acyl-coenzyme A (CoA) oxidase|3|7|Arg1:T16|Arg2:T36|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2283
18973551|Quinpirole and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.|SB-277011-A|ERK|24|13|Arg1:T7|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2284
23550066|The intrinsic clearance for both ketamine enantiomers by the high affinity enzyme in HLMs with CYP2B6*1/*1 genotype were at least 2-fold and 6-fold higher, respectively, than those for CYP2B6*1/*6 genotype and CYP2B6*6/*6 genotype.|ketamine|CYP2B6*1|6|16|Arg1:T11|Arg2:T13|CHEMICAL|GENE|SUBSTRATE|2285
10424850|Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells.|3H-nisoxetine|norepinephrine transporter|4|7|Arg1:T8|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|2286
17658513|Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).|silodosin|alpha(1A)-adrenoceptor|12|15|Arg1:T2|Arg2:T12|CHEMICAL|GENE|ANTAGONIST|2287
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|Imatinib|RTKs|20|28|Arg1:T4|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2288
22931533|Galantamine is a reversible, competitive acetylcholinesterase (AChE) inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors (nAChR-APL) that shares many common structural elements with morphinan-based opioids.|Galantamine|nAChR|1|21|Arg1:T2|Arg2:T11|CHEMICAL|GENE|DIRECT-REGULATOR|2289
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|[3H]-MPP+|OCT|4|23|Arg1:T4|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|2290
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|STI571|ABL|3|24|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2291
11861820|To determine whether these responses were common to other amphetamines of abuse, effects of methylenedioxymethamphetamine (MDMA) on the plasmalemmal DA transporter (DAT) and vesicular monoamine transporter-2 (VMAT-2) were assessed.|monoamine|vesicular monoamine transporter-2|30|29|Arg1:T14|Arg2:T34|CHEMICAL|GENE|PART-OF|2292
2899826|Chlorpromazine, levomepromazine, and their metabolites had 5-30 times higher binding affinities for muscarinic cholinergic receptors than fluphenazine, perphenazine and their metabolites.|perphenazine|muscarinic cholinergic receptors|21|15|Arg1:T14|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|2293
12487427|Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE/NEP inhibitors GW660511X and omapatrilat.|GW660511X|NEP|18|17|Arg1:T49|Arg2:T90|CHEMICAL|GENE|INHIBITOR|2294
8294418|Actinomycin D caused alpha-AR mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of H-7 to decrease basal alpha-AR mRNA level.|Actinomycin D|alpha-AR|1|26|Arg1:T12|Arg2:T30|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2295
23618921|Although fisetin greatly increases the stability of both Nrf2 and ATF4, only the effect on ATF4 is dependent on protein kinase activity.|fisetin|ATF4|2|11|Arg1:T2|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2296
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|galantamine|cholinesterase|17|8|Arg1:T4|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2297
16365052|  Expression of L-type pyruvate kinase (L-PK) is upregulated in the liver by dietary carbohydrate.|carbohydrate|L-type pyruvate kinase|16|3|Arg1:T4|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2298
14523001|Cat-1, the transporter for the essential amino acids, arginine and lysine, is one of the up-regulated genes.|amino acids|Cat-1|8|1|Arg1:T3|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|2299
23159529|Albumin nanoparticles were surface-coated with bifunctional polyethylene glycol 3500 (PEG) and a nanobody-the single variable domain of an antibody-(Ega1) against the epidermal growth factor receptor (EGFR).|polyethylene glycol|Albumin|7|1|Arg1:T6|Arg2:T19|CHEMICAL|GENE|PART-OF|2300
16434489|Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.|Dasatinib|D816V|1|7|Arg1:T13|Arg2:T38|CHEMICAL|GENE|INHIBITOR|2301
14751502|CONCLUSION: GW572016 potently inhibits receptor phosphorylation in either EGFR- or HER2-overexpressing cell lines and has both antiproliferative and radiosensitizing effects.|GW572016|EGFR|3|10|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2302
22982218|Accordingly, in transfection experiments performed in TPC1 cells, treatment with PJ34 increased NIS promoter activity without affecting PARP-1 binding to the promoter sequence.|PJ34|NIS promoter|13|15|Arg1:T4|Arg2:T11|CHEMICAL|GENE|ACTIVATOR|2303
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|retinoic acid|ABCG1|17|6|Arg1:T10|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2304
11089538|Moreover, IGFBP-rP2 noticeably increased in response to TGF-beta1 and all-trans retinoic acid (atRA) in HPEC and PC-3 cells, and it decreased in response to IGF-I in HPEC.|all-trans retinoic acid|IGFBP-rP2|11|3|Arg1:T2|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2305
16988497|CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.|MUFAs|D5D|8|17|Arg1:T2|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2306
15732037|Increased immunohistochemical labeling of HIF-1alpha, VEGF, and BNP in the ventricular myocardium was observed in the shunt group and carvedilol again normalized the labeling.|carvedilol|VEGF|22|7|Arg1:T2|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2307
1911436|The affinity labeling nucleotide analog, 5'-[p-(fluorosulfonyl)benzoyl]adenosine (FSA), inactivates the dehydrogenase and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration (0.2-0.6 mM).|5'-[p-(fluorosulfonyl)benzoyl]adenosine|dehydrogenase|7|22|Arg1:T16|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2308
17344208|  Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.|glutamate|Proline dehydrogenase|23|1|Arg1:T4|Arg2:T12|CHEMICAL|GENE|PRODUCT-OF|2309
7599160|Cells propagated in medium containing N5-methyltetrahydrofolate and homocysteine showed a substantial increase in MS activity which paralleled the increase in the intracellular concentration of Me-Cbl and the Cbl bound to the enzyme.|N5-methyltetrahydrofolate|MS|6|14|Arg1:T3|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|2310
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|Pro|TMH7|20|30|Arg1:T8|Arg2:T46|CHEMICAL|GENE|PART-OF|2311
10701840|Improper function of these proteins can be induced by selective disruption of their complexes with Hsp90 using the benzoquinonoid ansamycin geldanamycin.|benzoquinonoid ansamycin|Hsp90|19|16|Arg1:T2|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2312
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|dFdC|Ile24Val|43|15|Arg1:T11|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2313
10727528|Salicylates inhibit (125)I-ET-1 binding to recombinant rat ETA receptors.|Salicylates|ET-1|1|7|Arg1:T8|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|2314
23538162|Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.|ginsenoside Rg1|β-amyloid peptide|8|12|Arg1:T12|Arg2:T29|CHEMICAL|GENE|INHIBITOR|2315
23538162|Taken together, our results suggested that Rg1 protected against Aβ25-35-induced apoptosis at least in part by two complementary GR-dependent ERK phosphorylation pathways: (1) down-regulating HIF-1α initiated protein nitrotyrosination, and (2) inhibiting mitochondrial apoptotic cascades.|Rg1|ERK|8|21|Arg1:T11|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|2316
10225363|c-fos expression was induced in urethane-anaesthetized rats by intracisternal capsaicin administration.|capsaicin|c-fos|10|1|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2317
17015640|  Licofelone, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.|Licofelone|cycloxygenase-1|1|31|Arg1:T1|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2318
20421509|Two TFP molecules bind within the hydrophobic target binding pocket of Ca(2+)-S100A4 with no significant conformational changes observed in the protein upon complex formation.|TFP|S100A4|2|17|Arg1:T16|Arg2:T41|CHEMICAL|GENE|DIRECT-REGULATOR|2319
10701840|Geldanamycin also disrupts the T-cell receptor-mediated activation of nuclear factor of activated T-cells (NF-AT).|Geldanamycin|nuclear factor of activated T-cells|1|9|Arg1:T6|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2320
23230131|All three CDA proteins showed similar K(m) and V(max) for Ara-C and dFdC deamination, except for CDA70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for Ara-C deamination.|dFdC|CDA|19|3|Arg1:T15|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|2321
11009561|The BH(4) treatment also partially improved the insulin sensitivity and blood pressure, as well as the serum triglyceride concentration, in the fructose-fed rats.|BH(4)|insulin|2|11|Arg1:T24|Arg2:T26|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2322
22872607|  Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.|oxygen|AKRs|28|4|Arg1:T7|Arg2:T19|CHEMICAL|GENE|PRODUCT-OF|2323
1730582|The pyridoxal 5'-phosphate binding lysine in mouse ODC was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with endoproteinase Lys-C, radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing.|lysine|mouse ODC|12|7|Arg1:T20|Arg2:T37|CHEMICAL|GENE|PART-OF|2324
18035186|Rasagiline [N-propargyl-l(R)-aminoindan] is a second-generation propargylamine pharmacophore that selectively and irreversibly inhibits brain MAO-B and is specifically designed for the treatment of Parkinson's disease (PD).|N-propargyl-l(R)-aminoindan|MAO-B|3|20|Arg1:T10|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2325
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|MNI|ASCT2|19|35|Arg1:T19|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|2326
16434489|Computer modeling suggests that the KITD816V mutation destabilizes the inactive conformation of the KIT activation loop to which imatinib binds, but it is not predicted to impair binding of KIT by dasatinib.|dasatinib|KIT|33|6|Arg1:T3|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|2327
16206183|Similar to cocaine, other local anesthetics bind to the dopamine transporter (DAT) and inhibit DA uptake in rodent and monkey brain.|cocaine|DAT|3|14|Arg1:T2|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|2328
23024204|By contrast, 1,12-diamino-3,6,9-triazadodecane(SpmTrien), a charge-deficient spermine analog, was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wild-type primary hepatocytes.|spermine|human recombinant SSAT2|11|20|Arg1:T20|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|2329
8636122|The replacement of the conserved cysteine residues in e2 of CB2 by serine also eliminated CP 55,940 binding, but replacement of those in CB1 resulted in the sequestration of the mutated receptors in the cell cytoplasm.|serine|CB2|13|11|Arg1:T13|Arg2:T29|CHEMICAL|GENE|PART-OF|2330
15837926|Elucidation of the PSMA structure combined with docking studies and a proposed catalytic mechanism provides insight into the recognition of inhibitors and the natural substrate N-acetyl-l-aspartyl-l-glutamate.|N-acetyl-l-aspartyl-l-glutamate|PSMA|26|4|Arg1:T8|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|2331
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|SLC38|12|49|Arg1:T21|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|2332
23228697|This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2, a carboxylesterase with little lipase activity.|orlistat|CESs|10|12|Arg1:T6|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2333
15452358|Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.|CP-101,606|NR2B|18|5|Arg1:T12|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|2334
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Gleevec|PDGFRA|5|28|Arg1:T3|Arg2:T15|CHEMICAL|GENE|INHIBITOR|2335
23024204|We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidine/spermine-N(1)-acetyltransferase (SSAT1) and by thialysine acetyltransferase (SSAT2) to its monoacetylated derivative (MAT).|polyamine|SSAT1|11|20|Arg1:T9|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|2336
15474503|Each statin induced apoA-I expression (mRNA and protein) dose-dependently: the rank order of the apoA-I induction pitavastatin (3 microM)>simvastatin (10 microM)>atorvastatin (30 microM).|pitavastatin|apoA-I|20|18|Arg1:T3|Arg2:T29|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2337
12181285|The ensuing radioactive outflow from these cultures was enhanced by desipramine and reserpine, but reduced (in the presence of desipramine) by the OCT3 inhibitors cyanine 863, oestradiol and corticosterone.|corticosterone|OCT3|33|26|Arg1:T25|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2338
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|glutamine|SLC1|12|34|Arg1:T21|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|2339
23601710|  Detailed structure-activity relationships of the C3-phenyl moiety that allow for the optimization of antiviral potency of a series of 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione inhibitors of HIV capsid (CA) assembly are described.|1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione|CA|20|33|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INHIBITOR|2340
1590750|The results suggest that individuals with high Vmax beta 2-ADH and deficient in low-Km mitochondrial ALDH2, accounting for approximately 45% of the Chinese population, may end up with acetaldehyde accumulation during alcohol consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.|alcohol|ALDH2|35|16|Arg1:T4|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|2341
23282066|Furthermore, MDZ caused mechanism-based inactivation of cytochrome P450 3A-dependent TRZ 1'-hydroxylation in mouse, rat and human intestinal microsomes with similar potencies.|TRZ|cytochrome P450 3A|11|8|Arg1:T2|Arg2:T14|CHEMICAL|GENE|SUBSTRATE|2342
23609606|No effects were observed when fenclozic acid was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells.|fenclozic acid|MRP2|6|38|Arg1:T3|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2343
15939622|  We report on the inhibitory activity of the NSAIDs meloxicam, carprofen, phenylbutazone and flunixin, on blood cyclooxygenases in the horse using in vitro enzyme-linked assays.|flunixin|cyclooxygenases|16|20|Arg1:T13|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2344
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane|DAT|1|55|Arg1:T1|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|2345
11775064|In the study reported here, the effects of acute PLZ treatment on the levels of various amino acids, some of which are also metabolized by pyridoxal phosphate-dependent transaminases were compared in rat whole brain.|amino acids|pyridoxal phosphate-dependent transaminases|18|28|Arg1:T18|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2346
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|Rosiglitazone|phosphoenolpyruvate carboxykinase|25|54|Arg1:T21|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2347
17488480|To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and NK1-R in acinar cells.|NaHS|PPT-A|32|56|Arg1:T11|Arg2:T40|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2348
23370008|Importantly, expression of the acute-phase reactant serum amyloid A (SAA) significantly increased after ritodrine injection, with values indicating the largest fold-change.|ritodrine|serum amyloid A|17|8|Arg1:T19|Arg2:T31|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2349
23598904|These results suggest that ZIP8 plays a pivotal role in the transport and toxicity of Cd(2+) and Mn(2+) in RBL-2H3 cells.|Mn(2+)|ZIP8|21|5|Arg1:T2|Arg2:T26|CHEMICAL|GENE|SUBSTRATE|2350
3994963|  Phenoxybenzamine, an alpha-adrenergic antagonist containing a (chloroethyl)amine group, labels calmodulin in the presence of calcium.|(chloroethyl)amine|calmodulin|8|15|Arg1:T7|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|2351
10701840|In this study, we demonstrate that geldanamycin treatment blocks interleukin (IL)-2 secretion, IL-2 receptor expression, and proliferation of stimulated T-lymphocytes.|geldanamycin|IL-2 receptor|8|18|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2352
1680855|These G-proteins are likely to be involved in the adrenaline-induced inhibition of dihydropyridine-sensitive Ca2+ currents and in other signal transduction pathways contributing to the adrenaline-induced inhibition of insulin secretion.|adrenaline|insulin|25|28|Arg1:T10|Arg2:T44|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2353
12105857|Moreover, thalidomide reduced the LPS-induced TNF-alpha production by KCs by decreasing TNF-alpha messenger RNA.|thalidomide|TNF-alpha|3|7|Arg1:T9|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2354
7554708|  BACKGROUND: The active metabolite of the anti-inflammatory drug nabumetone has been characterized as a selective inhibitor of the inducible prostaglandin H synthase (PGHS).|nabumetone|PGHS|10|25|Arg1:T17|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2355
23600800|The reduction of P2X3 expression levels was reversed by the proteasomal inhibitor MG-132.|MG-132|P2X3|13|4|Arg1:T2|Arg2:T33|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2356
16336752|Tyrosine kinase inhibitors are quinazoline-derived, low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors, including EGFR, Erb2, and vascular endothelial growth factor receptor, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of EGFR signaling.|quinazoline|EGFR|5|48|Arg1:T2|Arg2:T9|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2357
23305850|Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.|sulforaphane|aldo-keto reductase (AKR) 1C1|30|44|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2358
10702256|The functional protein contains 1160 amino acids with a large central mucin domain, three consensus sites for glycosaminoglycan attachment, two epidermal growth factor-like repeats, a putative hyaluronan-binding motif, and a potential transmembrane domain near the C-terminal.|amino acids|mucin domain|6|12|Arg1:T7|Arg2:T22|CHEMICAL|GENE|PART-OF|2359
23098818|Human liver microsomes of the wild-type CYP2D6 metabolized 5-methoxytryptamine to serotonin more effectively than did the defective CYP2D6*4*4 ones.|serotonin|CYP2D6|11|18|Arg1:T4|Arg2:T22|CHEMICAL|GENE|PRODUCT-OF|2360
15985706|The inhibition of ERK, moreover, did not cause attenuation in mucin secretion in response to cAMP and forskolin.|cAMP|ERK|18|4|Arg1:T2|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2361
23564313|Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.|vinblastine|IκBα|3|49|Arg1:T7|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|2362
17161452|Pharmacogenetic analysis of two genes, the warfarin metabolic enzyme CYP2C9 and warfarin target enzyme, vitamin K epoxide reductase complex 1 VKORC1, confirmed their influence on warfarin maintenance dose.|warfarin|CYP2C9|8|11|Arg1:T4|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|2363
16434489|Additionally, dasatinib leads to growth inhibition of a KITD816V-harboring human masto-cytosis cell line.|dasatinib|KIT|3|10|Arg1:T12|Arg2:T35|CHEMICAL|GENE|INHIBITOR|2364
22872607|  Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.|o-quinones|Aldo-keto reductases|24|1|Arg1:T6|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|2365
23561088|Maqui berry (Aristotelia chilensis) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light.|delphinidin glycoside|photoreceptor|10|13|Arg1:T15|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|2366
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|DIDS|Panx1|20|6|Arg1:T16|Arg2:T39|CHEMICAL|GENE|INHIBITOR|2367
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Glivec|KIT|7|22|Arg1:T4|Arg2:T11|CHEMICAL|GENE|INHIBITOR|2368
23396144|In another experiment, topical application of CFB, CFE or CLS prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of COX-2, iNOS, and TNF-α.|CLS|COX-2|12|33|Arg1:T1|Arg2:T14|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2369
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|Gemcitabine|CDA|1|13|Arg1:T1|Arg2:T43|CHEMICAL|GENE|SUBSTRATE|2370
10988273|The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with alpha(2A)-autoreceptors, at which, however, both rilmenidine and oxymetazoline exhibit different properties (antagonism and agonism, respectively).|rilmenidine|alpha(2A)-autoreceptors|29|17|Arg1:T6|Arg2:T20|CHEMICAL|GENE|ANTAGONIST|2371
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|SLC38|7|49|Arg1:T18|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|2372
1375507|Preincubation for 30 minutes with iloprost, ciprostene, and carbacyclin led to a dose-dependent inhibition of tissue factor expression induced by all three challenging agents.|carbacyclin|tissue factor|11|18|Arg1:T15|Arg2:T32|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2373
7768269|Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg).|(-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine|dopamine D1 receptor|38|31|Arg1:T24|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|2374
9015795|The atypical neuroleptics remoxipride, clozapine, perlapine, seroquel, and melperone had low affinity for the dopamine D2 receptor (radioligand-independent dissociation constants of 30 to 90 nM).|perlapine|D2 receptor|8|20|Arg1:T12|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|2375
10712236|The above results indicate that polyamine depletion delays the onset of apoptosis in IEC-6 cells and confers protection against DNA damaging agents, suggesting that polyamines might be involved in the caspase activating signal cascade.|polyamines|caspase|26|32|Arg1:T14|Arg2:T36|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2376
8294418|NE, phorbol esters, and bradykinin each decreased alpha-AR mRNA levels by 70-80%.|phorbol esters|alpha-AR|3|10|Arg1:T2|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2377
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|indolocarbazoles|Flt3|28|43|Arg1:T17|Arg2:T34|CHEMICAL|GENE|INHIBITOR|2378
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|L-cysteine|CBS|13|25|Arg1:T18|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|2379
11585753|"The tyrosine kinase inhibitor ZD1839 (""Iressa"") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells."|Iressa|HER2|8|12|Arg1:T9|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2380
12679340|The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.|Lys|OTCase|13|30|Arg1:T17|Arg2:T21|CHEMICAL|GENE|PART-OF|2381
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|caffeic acid|EC 4.2.1.1|19|51|Arg1:T1|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2382
15121646|The estimated plasma ziprasidone concentration associated with 50% maximal 5-HT(2) receptor occupancy was almost four times lower than that for D(2) receptor occupancy.|ziprasidone|D(2) receptor|4|25|Arg1:T19|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|2383
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|piperazonyl quinazoline|kinase|35|44|Arg1:T20|Arg2:T35|CHEMICAL|GENE|INHIBITOR|2384
16434489|Dasatinib (BMS-354825) is a novel orally bioavailable SRC/ABL inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).|Dasatinib|ABL|1|11|Arg1:T7|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2385
12392782|The COX pathway generates inflammatory prostaglandins, while the 5-LOX pathway generates inflammatory leukotrienes.|leukotrienes|5-LOX|14|10|Arg1:T2|Arg2:T17|CHEMICAL|GENE|PRODUCT-OF|2386
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|phenolic acids|metalloenzyme|4|45|Arg1:T4|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2387
11309392|Diacylglycerol kinase (DGK) catalyzes the conversion of diacylglycerol to phosphatidic acid, making it an attractive candidate for a signal transduction component.|phosphatidic acid|Diacylglycerol kinase|12|1|Arg1:T8|Arg2:T26|CHEMICAL|GENE|PRODUCT-OF|2388
3994963|Isolation and characterization of labeled peptides from phenoxybenzamine-modified calmodulins indicated that peptides encompassing residues 38-75, 107-126, and 127-148 contained phenoxybenzamine label.|phenoxybenzamine|calmodulins|22|9|Arg1:T11|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2389
23220618|And, the effects of the compounds on expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were tested in tumor necrosis factor-(TNF)-α activated HUVECs. Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, both agents elicited anticoagulant effects in mouse.|IMG|FXa|41|59|Arg1:T10|Arg2:T34|CHEMICAL|GENE|INHIBITOR|2390
12244038|  Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.|NO|inducible nitric-oxide synthase|11|16|Arg1:T14|Arg2:T20|CHEMICAL|GENE|PRODUCT-OF|2391
3994963|Each adduct had a reduced ability to activate cyclic nucleotide phosphodiesterase and myosin light chain kinase, and the chlorpromazine binding capacities of the phenoxybenzamine-calmodulin adducts were diminished to the extent of phenoxybenzamine incorporation into each adduct.|phenoxybenzamine|calmodulin|25|26|Arg1:T8|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|2392
23298677|The induction of HO-1 by EIH was inhibited by SB203580 but not by SP600125, PD98059, nor LY294002.|SB203580|HO-1|10|4|Arg1:T1|Arg2:T37|CHEMICAL|GENE|INHIBITOR|2393
20531964|  Everolimus (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (mammalian target of rapamycin) to reach the oncology clinic.|Everolimus|mammalian target of rapamycin|1|21|Arg1:T1|Arg2:T19|CHEMICAL|GENE|INHIBITOR|2394
23220749|Whereas the addition of apomorphine in the low micromolar range produced an irreversible activation of the channel, application of higher concentrations caused a reversible voltage-dependent inhibition of heterologously expressed TRPA1 channels, resulting from a reduction of single-channel open times.|apomorphine|TRPA1|5|31|Arg1:T12|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2395
23042954|To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.|LY293558|α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor|55|31|Arg1:T11|Arg2:T16|CHEMICAL|GENE|ANTAGONIST|2396
23230131|All four DCK proteins yielded comparable metabolic activity for Ara-C and dFdC monophosphorylation, except for DCK24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of dFdC monophosphorylation due to a 40% decrease in K(m) (P < 0.05).|dFdC|DCK|35|17|Arg1:T21|Arg2:T44|CHEMICAL|GENE|SUBSTRATE|2397
23330546|  Bile acids are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.|Bile acids|vitamin D receptor|1|26|Arg1:T1|Arg2:T11|CHEMICAL|GENE|ACTIVATOR|2398
20531964|  Everolimus (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (mammalian target of rapamycin) to reach the oncology clinic.|RAD001|mammalian target of rapamycin|3|21|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INHIBITOR|2399
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|triptorelin|LHRH|17|5|Arg1:T8|Arg2:T23|CHEMICAL|GENE|AGONIST|2400
23382074|Moreover, we show that USP22 is acetylated on multiple lysine residues and that alteration of a single lysine (K129) within the ZnF-UBP domain is sufficient to alter interaction of the DUBm with the core SAGA complex.|lysine|ZnF-UBP domain|19|25|Arg1:T3|Arg2:T22|CHEMICAL|GENE|PART-OF|2401
12487427|Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE/NEP inhibitors GW660511X and omapatrilat.|GW660511X|ACE|18|16|Arg1:T49|Arg2:T89|CHEMICAL|GENE|INHIBITOR|2402
23410005|This work resulted in the discovery of the 5-morpholino-7H-thieno[3,2-b]pyran-7-one system as the foundation of a new compound class of potential PI3K inhibitors having improved potency toward PI3K.|5-morpholino-7H-thieno[3,2-b]pyran-7-one|PI3K|9|31|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|2403
22872607|Despite the importance of AKRs in PAHs metabolism, there are no studies that evaluate, in general human populations, the effect of PAHs on AKRs expression in peripheral blood lymphocytes (PBLs).|PAHs|AKRs|7|5|Arg1:T9|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|2404
23570998|Quercetin and rutin also increased alkaline phosphatase activity by about 150 and 240% and demonstrated mineralization up to 110 and 200% respectively as compared to control (which was considered as 100%).|rutin|alkaline phosphatase|3|6|Arg1:T16|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|2405
16618126|The purified Atp8a1 is inactive in detergent micelles or in micelles containing phosphatidylcholine, phosphatidic acid, or phosphatidylinositol, is minimally activated by phosphatidylglycerol or phosphatidylethanolamine (PE), and is maximally activated by PS.|phosphatidylglycerol|Atp8a1|25|3|Arg1:T4|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|2406
10727528|Salicylates do not promote dissociation of (125)I-ET-1 ETB receptor complexes.|(125)I|ETB receptor|7|11|Arg1:T14|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|2407
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|okadaic acid|KARs|47|5|Arg1:T4|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2408
8925876|  The potency of the antipsychotic drug, risperidone, to antagonize alpha 1A-adrenoceptor-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of alpha 1-adrenoceptor subtype-discriminating antagonists.|risperidone|alpha 1B-adrenoceptor|8|27|Arg1:T3|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|2409
14751502|Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.|GW572016|kinase|7|5|Arg1:T11|Arg2:T42|CHEMICAL|GENE|INHIBITOR|2410
12086935|In the present study, we evaluated whether therapeutic doses of metformin increase AMPK activity in vivo in subjects with type 2 diabetes.|metformin|AMPK|12|14|Arg1:T15|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|2411
10727528|Salicylic acid promotes dissociation of (125)I-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled ET-1.|(125)I|ET-1|6|10|Arg1:T11|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|2412
1978244|Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that alpha 1-adrenoceptor populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for WB4101 and pKd approximately 7.1 for 5-methyl-urapidil) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both WB4101 and 5-methyl-urapidil), which was in good agreement with radioligand binding studies.(ABSTRACT TRUNCATED AT 400 WORDS)|WB4101|alpha 1-adrenoceptor|68|14|Arg1:T16|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|2413
15985706|The gastric mucin secretory responses to isoproterenol, furthermore, were inhibited by PP2, a selective inhibitor of tyrosine kinase Src responsible for ligand-independent EGFR autophosphorylation, but not by ERK inhibitor, PD98059.|PP2|EGFR|14|26|Arg1:T12|Arg2:T14|CHEMICAL|GENE|ACTIVATOR|2414
23703578|Drug-drug interactions are dependent on statins' pharmacokinetic profile: simvastatin, lovastatin and atorvastatin are metabolized through cytochrome P450 (CYP) 3A, while the metabolism of the other statins is independent of this CYP.|simvastatin|cytochrome P450 (CYP) 3A|11|19|Arg1:T20|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2415
23298863|The IC50 values for Gli1 mRNA inhibition in the tumor and skin by TAK-441 were estimated to be 0.0457 and 0.113 μg/ml, respectively.|TAK-441|Gli1|14|5|Arg1:T2|Arg2:T7|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2416
23370008|Our in vitro studies showed that cyclic adenosine 3',5'-monophosphate (cAMP) accumulation was not a primary cause of the ritodrine-induced SAA increase.|ritodrine|SAA|21|22|Arg1:T9|Arg2:T25|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2417
11961111|Radiosequence analysis of [(14)C]halothane-labeled rhodopsin revealed that halothane contacts an amino acid residue (Trp265) lining the ligand binding cavity in the transmembrane core of the receptor.|amino acid|rhodopsin|17|11|Arg1:T10|Arg2:T14|CHEMICAL|GENE|PART-OF|2418
9990013|These results suggest that SUR1 binds 8-azido-ATP strongly at NBF1 and that MgADP, either by direct binding to NBF2 or by hydrolysis of bound MgATP at NBF2, stabilizes prebound 8-azido-ATP binding at NBF1.|8-azido-ATP|NBF1|32|35|Arg1:T26|Arg2:T55|CHEMICAL|GENE|DIRECT-REGULATOR|2419
23294326|These results suggest that ganglioside-bound Aβ (GAβ), which acts as an endogenous seed for Aβ fibril formation in AD brains, is generated on ASIGN on synaptosomal membranes.|ganglioside|Aβ|5|9|Arg1:T1|Arg2:T7|CHEMICAL|GENE|DIRECT-REGULATOR|2420
1705137|Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.|moclobemide|monoamine oxidase-A|16|13|Arg1:T43|Arg2:T52|CHEMICAL|GENE|INHIBITOR|2421
9607108|We propose that Cu(I) binds the type-1 copper ion-binding site in the A1 domain and provides the essential requirement for a stable interaction between the heavy and light chains.|Cu(I)|A1 domain|4|16|Arg1:T2|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|2422
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|Tyr|Cdk1|37|35|Arg1:T6|Arg2:T25|CHEMICAL|GENE|PART-OF|2423
21606412|  PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.|cabozantinib|vascular endothelial growth factor receptor 2|5|14|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INHIBITOR|2424
3345199|  Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.|1,2,2-trimethyl-propylmethylphosphonofluoridate|AChE|11|3|Arg1:T18|Arg2:T32|CHEMICAL|GENE|INHIBITOR|2425
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|2',2'-difluorodeoxyuridine|Ile24Val|48|15|Arg1:T12|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2426
23128353|Glucosamine at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and heme oxygenase-1 (HO-1), but also caused a reduction in p21 protein expression.|Glucosamine|p21|1|30|Arg1:T9|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2427
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|ETYA|PPARalpha1|18|6|Arg1:T13|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|2428
23266505|ALD increased calpain expression and caspase-3 activity and promoted Bid cleavage.|ALD|caspase-3|1|6|Arg1:T17|Arg2:T32|CHEMICAL|GENE|ACTIVATOR|2429
9310349|Alendronate inhibited PTPmeg1 with an IC50 value of 23 microM, PTPsigma with an IC50 value of 2 microM, and did not inhibit PTP epsilon at concentrations up to 1 mM.|Alendronate|PTPmeg1|1|3|Arg1:T22|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2430
15665864|Our results suggest that easing of Fas-triggered fulminant hepatitis by minocycline may involve a mitochondrial apoptotic pathway, probably through preventing cytochrome c release and thereby blocking downstream caspase activation.|minocycline|cytochrome c|11|22|Arg1:T4|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2431
23250811|This study explored whether curcumin improves colonic inflammation in a rat colitis model through inhibition of the TLR4/NF-κB signaling pathway and IL-27 expression.|curcumin|TLR4|5|18|Arg1:T10|Arg2:T30|CHEMICAL|GENE|INHIBITOR|2432
23376356|The pharmacological inhibitors SB203580 (p38 inhibitor) and SP600125 (a JNK inhibitor) protected primary cultures of rat CGCs from LY294002-induced apoptosis.|SB203580|p38|4|6|Arg1:T2|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2433
8730743|The present results suggest that the action of DMI in this animal model is unlikely to be directly related to a reduction in beta-adrenoceptors but may be related to a reduction in frontal cortical 5-HT2A receptors.|DMI|5-HT2A|9|35|Arg1:T5|Arg2:T21|CHEMICAL|GENE|INHIBITOR|2434
23440512|The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.|all-trans retinoic acid|RARs|15|39|Arg1:T4|Arg2:T13|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2435
17344208|  Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.|glutamate|P5CDH|23|14|Arg1:T4|Arg2:T29|CHEMICAL|GENE|PRODUCT-OF|2436
9990013|This direct biochemical evidence of cooperative interaction in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this cooperative binding of ATP and MgADP and, in cooperation with the MgADP bound at NBF2, causes ATP to be released from NBF1.|glibenclamide|NBF2|19|38|Arg1:T6|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|2437
23601710|Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure-activity relationships (SAR) of the C3-phenyl moiety.|phenyl|HIV capsid|28|14|Arg1:T5|Arg2:T11|CHEMICAL|GENE|INHIBITOR|2438
23250811|This study explored whether curcumin improves colonic inflammation in a rat colitis model through inhibition of the TLR4/NF-κB signaling pathway and IL-27 expression.|curcumin|NF-κB|5|19|Arg1:T10|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2439
23511016|To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (DOTA), with pantoprazole, which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon.|DOTA|proton pump|27|38|Arg1:T2|Arg2:T9|CHEMICAL|GENE|INHIBITOR|2440
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|norelgestromin|sulfatase|22|34|Arg1:T12|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2441
3994963|Isolation and characterization of labeled peptides from phenoxybenzamine-modified calmodulins indicated that peptides encompassing residues 38-75, 107-126, and 127-148 contained phenoxybenzamine label.|phenoxybenzamine|calmodulins|8|9|Arg1:T10|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2442
23017388|Taken together, our study demonstrated that SB365 inhibits the AKT/mTOR pathway, leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis.|SB365|mTOR|8|12|Arg1:T8|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2443
23143891|CYP3A5, which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize triamcinolone acetonide, budesonide, and fluticasone propionate.|budesonide|CYP3A5|23|1|Arg1:T2|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|2444
20104269|We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the chenodeoxycholic acid (CDCA)-induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells (RGM-1 cells).|CDCA|MUC2|26|33|Arg1:T4|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2445
15939622|COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.|meloxicam|COX-1|15|1|Arg1:T17|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2446
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|amantadine|transmembrane transporters|18|24|Arg1:T8|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|2447
23600914|Because 24(S)-hydroxycholesterol (24-OHC), produced by 24-hydroxylase, induces apoptosis of neuronal cells, it is vital to eliminate it rapidly from cells.|24-OHC|24-hydroxylase|8|13|Arg1:T4|Arg2:T20|CHEMICAL|GENE|PRODUCT-OF|2448
23506741|The mechanism of action of Fc11a-2 was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1β and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.|Fc11a-2|pro-IL-1β|6|18|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2449
23024204|We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidine/spermine-N(1)-acetyltransferase (SSAT1) and by thialysine acetyltransferase (SSAT2) to its monoacetylated derivative (MAT).|polyamine|spermidine/spermine-N(1)-acetyltransferase|11|14|Arg1:T9|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|2450
16324695|Preincubation with 1 microM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) caused a small but significant decrease in isoprenaline-induced E(max), indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization.|phorbol 12-myristate 13-acetate|PKC|14|11|Arg1:T9|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|2451
17477831|The cytosolic ACC1 is expressed primarily in liver and adipose tissue, and uses malonyl-coenzyme A as a key building block in fatty acid biosynthesis.|fatty acid|ACC1|23|3|Arg1:T12|Arg2:T22|CHEMICAL|GENE|PRODUCT-OF|2452
9890894|Previously, we reported that a primary heparin or heparan sulfate binding site resides in a distinct sequence in immunoglobulin (Ig)-like module II of the three modules of FGFR.|sulfate|FGFR|11|32|Arg1:T5|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|2453
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|GSK-3β|1|39|Arg1:T6|Arg2:T43|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2454
23574017|Doxorubicin is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.|Doxorubicin|multidrug resistance-associated protein 2|1|14|Arg1:T7|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|2455
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|phosphoinositide 3-kinase|1|28|Arg1:T6|Arg2:T39|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2456
9990013|Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.|MgADP|sulfonylurea receptor|6|9|Arg1:T29|Arg2:T56|CHEMICAL|GENE|DIRECT-REGULATOR|2457
1543672|Terbinafine: mode of action and properties of the squalene epoxidase inhibition.|Terbinafine|squalene epoxidase|1|10|Arg1:T18|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2458
23376356|LY294002, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.|LY294002|kinase|1|13|Arg1:T1|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|2459
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|syringic acid|metalloenzyme|28|45|Arg1:T6|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2460
12881227|5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.|DMA|NHE|12|21|Arg1:T9|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2461
23273219|β-Amyloid aggregation results showed that all compounds exhibited remarkable Aβ fibril aggregation inhibition activity with a nearly similar potential as the reference compound rifampicin, which makes them promising anti-Alzheimer drug candidates.|rifampicin|Aβ|24|10|Arg1:T1|Arg2:T10|CHEMICAL|GENE|INHIBITOR|2462
11309392|Diacylglycerol kinase (DGK) catalyzes the conversion of diacylglycerol to phosphatidic acid, making it an attractive candidate for a signal transduction component.|diacylglycerol|DGK|10|4|Arg1:T7|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|2463
10701840|Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.|geldanamycin|Raf-1|3|12|Arg1:T5|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2464
12244038|Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS.|gemfibrozil|iNOS|21|24|Arg1:T12|Arg2:T61|CHEMICAL|GENE|INHIBITOR|2465
12724156|However, topiramate at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of GluR5 kainate receptor responses.|topiramate|GluR5|3|11|Arg1:T5|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2466
15737409|NPC1L1 could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant sterols.|sterols|sterol transporter|21|9|Arg1:T18|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|2467
10694244|These findings suggest that troglitazone inhibits antigen-induced LT production in the IgE-sensitized RBL-2H3 cells and A23187-stimulated rat peritoneal neutrophils by direct inhibition of 5-LOX activity.|troglitazone|5-LOX|5|24|Arg1:T6|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2468
12093311|  OBJECTIVE: Celecoxib and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (COX-2) isoenzyme at therapeutic concentrations.|rofecoxib|COX-2|5|22|Arg1:T10|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2469
10988273|Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of alpha(2)-adrenoceptor agonists in inhibiting the electrically (2 Hz) evoked [(3)H]norepinephrine release and of antagonists in counteracting the alpha(2)-adrenoceptor-mediated inhibition induced by moxonidine.|moxonidine|alpha(2)-adrenoceptor|52|44|Arg1:T14|Arg2:T29|CHEMICAL|GENE|INHIBITOR|2470
23530834|Biological evaluation revealed that most tested compounds were potent dipeptidyl peptidase 4 (DPP-4) inhibitors, among them, the cyclopropyl-substituted phenylalanine derivative 11h displayed the most potent DPP-4 inhibitory activity with an IC50 value of 0.247 μM.|cyclopropyl-substituted phenylalanine|DPP-4|22|30|Arg1:T2|Arg2:T8|CHEMICAL|GENE|INHIBITOR|2471
7711211|The inhibition of UG synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.|5 alpha-NET|PR|10|7|Arg1:T2|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2472
23098818|Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the human isoform CYP2D6.|O|human isoform CYP2D6|17|30|Arg1:T13|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|2473
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|FLX|5-HT(2A) receptors|27|19|Arg1:T4|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|2474
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|phenylaminopyrimidine|c-Kit|15|38|Arg1:T1|Arg2:T30|CHEMICAL|GENE|INHIBITOR|2475
17350061|Several genes involved with steroid metabolism also showed remarkable expression changes, including increased expression of 17beta-hydroxysteroid dehydrogenase-7 (HSD17beta7; involved in estradiol production) and decreased expression of HSD17beta5 (involved in testosterone production).|testosterone|HSD17beta5|35|31|Arg1:T5|Arg2:T32|CHEMICAL|GENE|PRODUCT-OF|2476
15991937|  Losartan (COZAAR) is the prototype of a new class of potent and selective angiotensin II (AII) type 1 (AT(1)) receptor antagonists with the largest published preclinical and clinical data base.|COZAAR|angiotensin II (AII) type 1 (AT(1)) receptor|3|16|Arg1:T2|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|2477
3994963|Adducts of calmodulin and phenoxybenzamine were separated by high-performance liquid chromatography into four major fractions: two containing 0.6 and 1.2 mol of drug per mol of protein and two different fractions each containing 2.0 mol/mol.|phenoxybenzamine|calmodulin|5|3|Arg1:T4|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|2478
7825862|Aspirin irreversibly inhibits PGHS-1, preventing this isozyme from forming PGH2 or any other oxygenated product; in contrast, aspirin treatment of PGHS-2 causes this enzyme to form 15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid (15-HETE) instead of PGH2.|15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid|PGHS-2|30|24|Arg1:T9|Arg2:T17|CHEMICAL|GENE|PRODUCT-OF|2479
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|Ara-C|Ile24Val|40|15|Arg1:T10|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2480
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|gardiquimod|TLR8|7|15|Arg1:T5|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|2481
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|Rosiglitazone|apolipoprotein C-III|25|28|Arg1:T21|Arg2:T40|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2482
16248990|This effect was reverted in the presence of atropine (ATR; 0.1 microM), which blocks the pre-synaptic muscarinic M2 receptor.|ATR|muscarinic M2 receptor|11|21|Arg1:T12|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2483
22931533|Galantamine is a reversible, competitive acetylcholinesterase (AChE) inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors (nAChR-APL) that shares many common structural elements with morphinan-based opioids.|Galantamine|acetylcholinesterase|1|7|Arg1:T2|Arg2:T8|CHEMICAL|GENE|INHIBITOR|2484
12636181|  Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.|ACh|AChE|27|3|Arg1:T3|Arg2:T10|CHEMICAL|GENE|SUBSTRATE|2485
12699699|The protein exhibited modest H(2)O(2)-dependent peroxidase activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).|ABTS|peroxidase|32|14|Arg1:T7|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|2486
23550066|ThioTEPA (CYP2B6 inhibitor, 25 μM) and the monoclonal antibody against CYP2B6 but not troleandomycin (CYP3A4 inhibitor, 25 μM) or the monoclonal antibody against CYP3A4 inhibited ketamine N-demethylation at clinically relevant concentrations.|troleandomycin|CYP3A4|17|19|Arg1:T3|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2487
22996137|Disruption of microtubule prevented insulin-induced actin remodeling and distal insulin signal transduction, with reduction in surface glucose transporter isoform 4 (GLUT4) and glucose uptake.|glucose|GLUT4|26|23|Arg1:T3|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|2488
16920841|  Choline dehydrogenase (CHDH) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in choline oxidation.|choline|BHMT|17|10|Arg1:T2|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|2489
20596674|  Etoposide (VP-16) is a topoisomerase-II (topo II) inhibitor chemotherapeutic agent.|Etoposide|topo II|1|9|Arg1:T1|Arg2:T34|CHEMICAL|GENE|INHIBITOR|2490
16371234|These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with COX-1, especially mPGES-2, plays the pivotal role in PS liposome-induced PGE2 production by microglia.|PGE2|COX-1|28|16|Arg1:T6|Arg2:T34|CHEMICAL|GENE|PRODUCT-OF|2491
7560228|The 15-lipoxygenase was similarly inhibited by triclosan with an IC-50 of 61 microM.|triclosan|15-lipoxygenase|7|2|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2492
23344961|To explore the molecular basis for CPT hypersensitivity in Top2β-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2β-deficient cells.|CPT|RNAP LS|17|47|Arg1:T10|Arg2:T30|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2493
23412396|  The monoacylglycerol lipase (MAGL) inhibitor JZL184 produces antinociceptive and anti-inflammatory effects.|JZL184|monoacylglycerol lipase|8|2|Arg1:T11|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2494
16965760|  Phospholipase C beta (PLC-beta)-coupled G protein-coupled receptor (GPCR) activities traditionally are assessed by measuring Ca2+ triggered by D-myo-inositol 1,4,5-trisphosphate (IP3), a PLC-beta hydrolysis product, or by measuring the production of inositol phosphate using cumbersome radioactive assays.|D-myo-inositol 1,4,5-trisphosphate|PLC-beta|23|30|Arg1:T5|Arg2:T25|CHEMICAL|GENE|PRODUCT-OF|2495
20421509|The Ca(2+)-S100A4/prochlorperazine (PCP) complex exhibits a similar pentameric assembly.|prochlorperazine|S100A4|7|7|Arg1:T4|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|2496
12244038|Inhibition of human iNOS promoter-driven luciferase activity by gemfibrozil in cytokine-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS.|gemfibrozil|iNOS|9|23|Arg1:T10|Arg2:T57|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2497
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|dFdC|CDA|43|6|Arg1:T11|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|2498
16516814|Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the PKC inhibitor Go 6976, thapsigargin, as well as the calmodulin antagonists W7 and W13.|W13|calmodulin|45|41|Arg1:T13|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|2499
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|MNI|SNAT2|19|40|Arg1:T19|Arg2:T42|CHEMICAL|GENE|SUBSTRATE|2500
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|dFdC|Pro122Ser|43|20|Arg1:T11|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|2501
20531964|  Everolimus (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (mammalian target of rapamycin) to reach the oncology clinic.|Afinitor((R)) Novartis|mTOR|5|19|Arg1:T6|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2502
16424790|It was found that a single intragastric gavage by L-methionine resulted in inhibition of endothelium-dependent relaxation, markedly increased the serum level of malondialdehyde and decreased the activity of PON1 and SOD, similarly decreased the level of NO in the serum; but had no effects on endothelium-independent relaxation and angiotensin-converting enzyme activity compared with the control group.|L-methionine|PON1|10|30|Arg1:T6|Arg2:T55|CHEMICAL|GENE|INHIBITOR|2503
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|gardiquimod|TLR8|7|23|Arg1:T5|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|2504
10225363|Sumatriptan and LY 344864 decreased the number of capsaicin-induced c-fos-like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1)).|Sumatriptan|c-fos|1|10|Arg1:T5|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2505
23172777|Three different 3D-QSAR models were built and validated by using a set of 66 pyrazole (Model I) and furanopyrimidine (Model II) compounds with IC(50) values toward Aurora kinase A ranging from 33 nM to 10.5 μM.|pyrazole|Aurora kinase A|15|34|Arg1:T3|Arg2:T8|CHEMICAL|GENE|INHIBITOR|2506
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|dFdC|DCK|43|13|Arg1:T11|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|2507
23534442|Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors.|nitric oxide|cyclooxygenase-2|14|12|Arg1:T16|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2508
23098818|The obtained results indicate that rat brain CYP2D isoforms catalyze the formation of serotonin from 5-methoxytryptamine, and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain.|5-methoxytryptamine|rat brain CYP2D|16|6|Arg1:T6|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|2509
12827214|On the other hand, ligands for the renal Na(+)-transporter (amiloride and triamterene) and for imidazoline recognition sites (guanabenz, guanfacine and agmatine) displaced the binding of [(3)H]prazosin to phentolamine-insensitive sites at micromolar concentrations.|amiloride|Na(+)-transporter|16|10|Arg1:T6|Arg2:T41|CHEMICAL|GENE|DIRECT-REGULATOR|2510
23538162|These protective effects were abolished by glucocorticoid receptor (GR) antagonist RU486 or p-ERK inhibitor U0126 rather than estrogen receptor α antagonist ICI 82,780.|ICI 82,780|estrogen receptor α|24|20|Arg1:T10|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|2511
16434489|Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.|Dasatinib|KIT|1|6|Arg1:T13|Arg2:T37|CHEMICAL|GENE|INHIBITOR|2512
17218486|The discovery that METH and AMPH activate the rTAAR1 motivated us to study the effect of these drugs on the mouse TAAR1 (mTAAR1) and a human-rat chimera (hrChTAAR1).|AMPH|rTAAR1|6|9|Arg1:T23|Arg2:T49|CHEMICAL|GENE|ACTIVATOR|2513
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Gleevec|BCR|5|26|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|2514
23100158|β-ionone was also shown to induce the expression of cleaved-caspase-3 and inhibit bcl-2 expression in SGC-7901 cells in a dose-dependent manner.|β-ionone|bcl-2|1|13|Arg1:T7|Arg2:T15|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2515
17594192|  Phenserine, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase (AChE) and was shown to improve cognition in various experimental paradigms in rodents and dogs.|physostigmine|acetylcholinesterase|6|15|Arg1:T7|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2516
23583257|In fact, we demonstrated a significant stimulation of Nox4 activity by 4 quinone derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx™, and chondrocyte cell lines.|AA-861|Nox4|17|10|Arg1:T6|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|2517
20596674|Apoptosis studies (DAPI staining and caspase 3 activity) showed a marked increase in the presence of MXF and VP-16 compared to VP-16 alone.|MXF|caspase 3|19|7|Arg1:T5|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2518
23143891|In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, budesonide, and fluticasone propionate, by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.|flunisolide|CYP3A|17|27|Arg1:T15|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|2519
16516814|Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the PKC inhibitor Go 6976, thapsigargin, as well as the calmodulin antagonists W7 and W13.|thapsigargin|PKC|35|30|Arg1:T10|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2520
23638842|RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive RS -GRA significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1β (IL-1β), and apoptosis (Bax and caspase 3 expression).|RS -GRA|nuclear factor (NF)-kB|19|23|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2521
12636181|The development of specific BuChE inhibitors and further experience with the dual enzyme inhibitor rivastigmine will improve understanding of the aetiology of AD and should lead to a wider variety of potent treatment options.|rivastigmine|BuChE|15|5|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INHIBITOR|2522
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|alanine|ASCT2|8|35|Arg1:T15|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|2523
8730743|The time course of the reduction in the number of 5-HT2A receptors was similar to that of the DMI-induced behavioural changes whereas that for the reduction in beta-adrenoceptors was clearly different.|DMI|beta-adrenoceptors|19|28|Arg1:T4|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2524
23532634|In four (10 %) patients the peak ACTH-stimulated cortisol values were lower than 18 μg/dL.|cortisol|ACTH|11|10|Arg1:T1|Arg2:T28|CHEMICAL|GENE|PRODUCT-OF|2525
1705137|The effects of two reversible, predominantly monoamine oxidase-A (MAO-A) inhibitors, moclobemide (150 mg three times daily) and toloxatone (400-200-400 mg day-1) on monoamine metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects.|toloxatone|monoamine oxidase-A|24|8|Arg1:T9|Arg2:T48|CHEMICAL|GENE|INHIBITOR|2526
8098142|The enhancement of the depolarizing afterpotential by histamine was mimicked by the histamine H1-receptor agonist 2-thiazolylethylamine and was reduced or blocked by the H1-receptor antagonist promethazine, but was not blocked or reduced in the presence of the histamine H2-receptor antagonist, cimetidine.|2-thiazolylethylamine|histamine H1-receptor|16|13|Arg1:T4|Arg2:T22|CHEMICAL|GENE|AGONIST|2527
6227474|Selective precipitation of cytosol receptors with 36% (NH4)2SO4 reduced CBG concentrations to negligible levels.|(NH4)2SO4|CBG|9|14|Arg1:T17|Arg2:T32|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2528
12679340|In arginase, two cysteines at the C terminus of the protein are crucial for its epiarginase function but not for its catalytic activity and trimeric structure.|C|arginase|8|2|Arg1:T7|Arg2:T26|CHEMICAL|GENE|PART-OF|2529
12679340|In OTCase, mutations of putative ornithine binding residues, Asp-182, Asn-184, Asn-185, Cys-289, and Glu-256 greatly reduced the affinity for ornithine and impaired the interaction with arginase.|Asn|OTCase|15|2|Arg1:T11|Arg2:T28|CHEMICAL|GENE|PART-OF|2530
20104269|We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the chenodeoxycholic acid (CDCA)-induced expression of Cdx2 and MUC2 in normal rat gastric epithelial cells (RGM-1 cells).|chenodeoxycholic acid|Cdx2|23|31|Arg1:T3|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2531
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|FLX|D(1)|27|14|Arg1:T4|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|2532
17350061|Various genes controlled by estrogen, including X-inactive-specific transcript, anterior gradient-2, trefoil factor-1, CRP-ductin, ghrelin, and small proline-rich protein-2A, were dramatically over-expressed.|estrogen|ghrelin|5|19|Arg1:T22|Arg2:T40|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2533
17344208|  Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.|proline|Delta(1)-pyrroline-5-carboxylate dehydrogenase|21|7|Arg1:T2|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|2534
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|bis(1H-2-indolyl)-1-methanone|Flt3|14|43|Arg1:T12|Arg2:T34|CHEMICAL|GENE|INHIBITOR|2535
15795105|However, the flowcytometric analysis revealed that AZC and PCA decreased intracellular contents of CD3-zeta chain in these cells in dose dependent manner.|PCA|CD3-zeta chain|10|15|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2536
16957773|VGLUT1 is localized in transcytotic vesicles and accumulates L-glutamate.|L-glutamate|VGLUT1|9|1|Arg1:T6|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|2537
18081314|For example, Trp282 could be one of the most important residues and is suspected to play a role in the determination of specific catalytic function, which has been established by the docking studies using the NMR structure of the PGIS-bound form of U46619 and the PGIS crystal structure.|U46619|PGIS|45|42|Arg1:T4|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|2538
15991937|Clinical experience in heart failure is growing, and recent data suggest an improved survival with losartan versus captopril, a drug from the angiotensin-converting-enzyme inhibitor class with proven benefit in this population.|losartan|angiotensin-converting-enzyme|17|25|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INHIBITOR|2539
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|alanine|ASCT2|14|35|Arg1:T16|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|2540
3134891|It was also dependent upon temperature, the presence of a divalent cation such as calcium, and on pH, showing maximum binding at pH 6.5 with little binding at pH values below 4.2 or above 8.0. The site at which phenoxybenzamine bound to calmodulin appears to be similar to that at which certain antipsychotic agents bind, since several of them, including penfluridol, pimozide and spiroperidol, prevented the binding of phenoxybenzamine to calmodulin.|spiroperidol|calmodulin|71|79|Arg1:T16|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|2541
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|para-aminobenzoic acid|cholinesterase|21|8|Arg1:T6|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2542
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|TO901317|RXR|15|28|Arg1:T8|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|2543
17018843|Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1 (PI3K-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor wortmannin or a dominant-negative SGK1.|wortmannin|phosphatidylinositol 3-kinase|38|12|Arg1:T4|Arg2:T40|CHEMICAL|GENE|INHIBITOR|2544
17085856|The non-selective adenosine receptor antagonist (caffeine), and the selective adenosine A1 receptor antagonist (DPCPX), injected 15 min before the application of pentetrazole and flumazenil, were able to intensify BDZ withdrawal signs in mice.|caffeine|adenosine receptor|7|3|Arg1:T13|Arg2:T26|CHEMICAL|GENE|ANTAGONIST|2545
17015640|Licofelone reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, monocyte chemoattractant protein-1 (MCP-1) gene expression, and the activation of nuclear factor-kappaB in rabbit atheroma.|Licofelone|nuclear factor-kappaB|1|30|Arg1:T16|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2546
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|syringic acid|carbonic anhydrase|28|46|Arg1:T6|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2547
10742288|In alpha(2A)-adrenoceptor transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).|UK-14304|alpha(2A)-adrenoceptor|31|2|Arg1:T4|Arg2:T22|CHEMICAL|GENE|AGONIST|2548
12724156|However, topiramate at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of GluR5 kainate receptor responses.|topiramate|kainate receptor|3|12|Arg1:T5|Arg2:T24|CHEMICAL|GENE|INHIBITOR|2549
10446934|Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.|cilazapril|angiotensinogen|18|6|Arg1:T9|Arg2:T31|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2550
18081314|The bound conformation of U46619 fits the crystal structure of the PGIS substrate binding pocket considerably better than that of the unbound U46619.|U46619|PGIS|5|12|Arg1:T27|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|2551
23473681|We previously employed a chemical genomic strategy to identify a novel small molecule, MAC13243, as a likely inhibitor of the bacterial lipoprotein targeting chaperone, LolA.|MAC13243|bacterial lipoprotein|15|23|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INHIBITOR|2552
18974361|This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, isradipine, and nitrendipine) as potent T-channel blockers (IC(50) < 3 microM).|efonidipine|T-channel|10|21|Arg1:T14|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2553
23410005|Our previous work, built on the early pioneering multikinase inhibitor LY294002, resulted in the only PI3K vascular-targeted PI3K inhibitor prodrug, SF1126, which has now completed Phase I clinical trials.|LY294002|PI3K|12|18|Arg1:T1|Arg2:T7|CHEMICAL|GENE|INHIBITOR|2554
23570998|Quercetin and rutin also increased alkaline phosphatase activity by about 150 and 240% and demonstrated mineralization up to 110 and 200% respectively as compared to control (which was considered as 100%).|Quercetin|alkaline phosphatase|1|6|Arg1:T15|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|2555
9990013|These results suggest that SUR1 binds 8-azido-ATP strongly at NBF1 and that MgADP, either by direct binding to NBF2 or by hydrolysis of bound MgATP at NBF2, stabilizes prebound 8-azido-ATP binding at NBF1.|8-azido-ATP|SUR1|7|5|Arg1:T23|Arg2:T51|CHEMICAL|GENE|DIRECT-REGULATOR|2556
17488480|Inhibition of endogenous production of H(2)S by PAG significantly suppressed SP concentration, PPT-A expression and NK1-R expression in the acini.|H(2)S|NK1-R|6|21|Arg1:T5|Arg2:T37|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2557
10752671|In the liver of rats given flutamide as initiating agent at the dose of 500 mg/kg/week for 6 successive weeks, gamma-glutamyltraspeptidase-positive foci were detected only in 3 of 10 rats.|flutamide|gamma-glutamyltraspeptidase|7|22|Arg1:T5|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2558
17040106|Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.|arylhydroxylamine|cytochrome b5|4|13|Arg1:T25|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|2559
23600914|Because 24(S)-hydroxycholesterol (24-OHC), produced by 24-hydroxylase, induces apoptosis of neuronal cells, it is vital to eliminate it rapidly from cells.|24(S)-hydroxycholesterol|24-hydroxylase|2|13|Arg1:T3|Arg2:T20|CHEMICAL|GENE|PRODUCT-OF|2560
12614192|Sildenafil is inhibitory of PDE5 at a rate tenfold higher than for the next PDE (PDE6), which produces visual changes through the retinal rods.|Sildenafil|PDE6|1|17|Arg1:T5|Arg2:T14|CHEMICAL|GENE|INHIBITOR|2561
23261590|In addition, we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.|neoechinulin A|IL-1β|7|26|Arg1:T10|Arg2:T36|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2562
17459764|n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells.|n-3 and n-6 polyunsaturated fatty acids|COX-2|1|11|Arg1:T26|Arg2:T43|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2563
10493852|We report here that lovastatin, a drug clinically used for lowering cholesterol levels, inhibits the interaction of human LFA-1 with its counter-receptor intercellular adhesion molecule-1.|lovastatin|intercellular adhesion molecule-1|5|25|Arg1:T1|Arg2:T5|CHEMICAL|GENE|INHIBITOR|2564
17658513|Noradrenaline and phenylephrine (alpha(1)-adrenoceptor agonist) each produced a concentration-dependent tonic contraction, their pD(2) values being 6.87+/-0.08 and 6.10+/-0.05, respectively.|phenylephrine|alpha(1)-adrenoceptor|3|5|Arg1:T10|Arg2:T24|CHEMICAL|GENE|AGONIST|2565
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|ASCT2|7|46|Arg1:T18|Arg2:T34|CHEMICAL|GENE|SUBSTRATE|2566
15353299|While fluoropyrimidine antimetabolites have other sites of action, antifolates ZD1694 (raltitrexed, Tomudex) and AG337 (Thymitag) are more specific and potent TS inhibitors.|AG337|TS|18|27|Arg1:T5|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2567
9015795|The atypical neuroleptics remoxipride, clozapine, perlapine, seroquel, and melperone had low affinity for the dopamine D2 receptor (radioligand-independent dissociation constants of 30 to 90 nM).|remoxipride|D2 receptor|4|20|Arg1:T10|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|2568
23535327|Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 2.|pyripyropene A|acyl-CoA:cholesterol acyltransferase 2|6|13|Arg1:T5|Arg2:T6|CHEMICAL|GENE|INHIBITOR|2569
7599160|Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin (CN-Cbl) bound to transcobalamin II (transcobalamin, TC).|CN-Cbl|transcobalamin II|33|37|Arg1:T10|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|2570
17205056|In leukemia cell lines MV4-11 and EOL-1, sorafenib treatment resulted in decreased cell proliferation and inhibition of FLT3 signaling.|sorafenib|FLT3|9|19|Arg1:T7|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2571
17768678|  Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.|Phenelzine|monoamine oxidase|1|11|Arg1:T1|Arg2:T39|CHEMICAL|GENE|INHIBITOR|2572
16434489|Dasatinib (BMS-354825) is a novel orally bioavailable SRC/ABL inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).|BMS-354825|ABL|3|11|Arg1:T8|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2573
23535337|Under NaCl and sorbitol stresses, catalase (CAT) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.|sorbitol|catalase|4|7|Arg1:T9|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|2574
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Tykerb|TK|21|3|Arg1:T18|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2575
10999950|Pretreatment with lysosomal enzyme inhibitors [(2S, 3S)trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester or chloroquine] or proteasome inhibitors (proteasome inhibitor I, MG-132, or lactacystin) decreased the extent of U50,488H-induced down-regulation.|lactacystin|proteasome|29|22|Arg1:T3|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2576
23266505|The upregulation of calpain, tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of ALD.|ALD|tBid|21|6|Arg1:T1|Arg2:T35|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2577
20801130|The high resolution NMR solution structure of the cTnC-cTnI-dfbp-o ternary complex showed that dfbp-o bound at the hydrophobic interface formed by cTnC and cTnI making critical interactions with residues such as Arg147 of cTnI.|dfbp-o|cTnC|10|9|Arg1:T2|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|2578
23327993|The Trx mimetics peptides (TXM) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting TrxR with auranofin (AuF).|AuF|TrxR|24|20|Arg1:T6|Arg2:T31|CHEMICAL|GENE|INHIBITOR|2579
9876137|Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block.|cocaine|hH1 channels|39|28|Arg1:T6|Arg2:T16|CHEMICAL|GENE|INHIBITOR|2580
23414340|Although glutathione S-transferase omega 1 (GSTO1) and arsenic methyltransferase have been shown or thought to catalyze DMAs(V) reduction, their role in DMAs(V) reduction in vivo, or in cell extracts is uncertain.|DMAs(V)|arsenic methyltransferase|19|10|Arg1:T31|Arg2:T54|CHEMICAL|GENE|SUBSTRATE|2581
15498586|Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dose-dependent increase in mRNA levels for PPARgamma target genes such as aP2 and adiponectin.|telmisartan|aP2|11|25|Arg1:T3|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2582
23444334|The treatment of mice with Fe-NTA alone enhances ornithine decarboxylase activity to 4.6 folds, protein carbonyl formation increased up to 2.9 folds and DNA synthesis expressed in terms of [(3)H] thymidine incorporation increased to 3.2 folds, and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds, compared with the corresponding saline-treated controls.|Fe-NTA|ornithine decarboxylase|6|9|Arg1:T4|Arg2:T14|CHEMICAL|GENE|ACTIVATOR|2583
11742712|  Pemetrexed disodium (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.|ALIMTA|thymidylate synthase|4|18|Arg1:T6|Arg2:T14|CHEMICAL|GENE|INHIBITOR|2584
12827214|However, other alpha(1)-adrenoceptor antagonists (tamsulosin, WB4101 and corynanthine) did not inhibit the binding at a range of concentrations that generally exhibit alpha(1)-adrenoceptor antagonism, and noradrenaline, rauwolscine and propranolol were without effect on the [(3)H]prazosin binding.|WB4101|alpha(1)-adrenoceptor|13|4|Arg1:T37|Arg2:T46|CHEMICAL|GENE|ANTAGONIST|2585
23583257|Interestingly, Nox4 activity is also stimulated by reducing agents that possibly act by reducing the disulfide bridge (Cys226, Cys270) located in the extracellular E-loop of Nox4.|Cys|Nox4|22|30|Arg1:T14|Arg2:T29|CHEMICAL|GENE|PART-OF|2586
17111172|In vitro data show comparable affinity to dopamine D(2), D(1) and 5-HT(2A) receptors and recently, FLX showed to be not inferior to risperidone in schizophrenic patients with predominant negative symptomatology, which was implicated with flupentixol's interaction with 5-HT(2A) and/or D(1) receptors.|risperidone|dopamine D(2)|34|8|Arg1:T5|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|2587
21475861|Studies over the past decades suggest that, besides cyclooxygenases, aspirin acetylates other cellular proteins.|aspirin|cyclooxygenases|12|10|Arg1:T10|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|2588
23531488|These variants are expected to encode either a full length (OATP2B1-FL) or shortened protein lacking 22 N-terminus amino acids (OATP2B-Short).|N|OATP2B-Short|19|23|Arg1:T3|Arg2:T18|CHEMICAL|GENE|PART-OF|2589
15474503|These results suggest that pitavastatin efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.|pitavastatin|ABCA1|5|37|Arg1:T1|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2590
10942908|Creatine phosphokinase activity in plasma increased slightly (compared to control, pyridostigmine or exercise group) in mice treated with pyridostigmine plus exercise, which may be indicative of perturbation in the integrity of the skeletal muscle due to combination.|pyridostigmine|Creatine phosphokinase|13|1|Arg1:T3|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|2591
23625804|NMR spectroscopy was also used to examine the hSOD1 mutants C57A, C146A, and C57A/C146A, which are unable to form the structurally conserved disulfide bond in SOD1, in order to investigate the role of these cysteines during hSOD1 copper acquisition.|cysteines|hSOD1|39|41|Arg1:T5|Arg2:T24|CHEMICAL|GENE|PART-OF|2592
18081314|The distances between the protons H20 and H2, H18 and H2, and H18 and H4 are shorter following their binding to the PGIS in solution-down to within 5 A.|H18|PGIS|10|25|Arg1:T21|Arg2:T41|CHEMICAL|GENE|PART-OF|2593
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Iressa|VEGF receptor|23|42|Arg1:T5|Arg2:T44|CHEMICAL|GENE|INHIBITOR|2594
17632107|Furthermore, the activities of the two torafugu PPARalphas were enhanced 4.3- and 7.6-fold by arachidonic acid, 4.4- and 5.2-fold by docosahexaenoic acid, and 6.7- and 8.0-fold by eicosapentaenoic acid each at 50 microM, respectively.|docosahexaenoic acid|torafugu PPARalphas|23|8|Arg1:T4|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|2595
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|phenolic acids|carbonic anhydrase|4|46|Arg1:T4|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2596
1666997|In vitro binding studies showed that both amoxapine and amitriptyline interact in the nanomolar range with 5-HT2 receptors labelled by [3H]ketanserin in cortical membranes.|[3H]ketanserin|5-HT2|21|17|Arg1:T7|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|2597
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|goserelin|LH|13|39|Arg1:T6|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2598
12373557|To extend structure-activity analyses of binding sites within monoamine transporters and to determine which stereoisomer displayed the best selectivity for PET imaging applications, we tested the HED compounds for their abilities to inhibit [(3)H]neurotransmitter uptake into platelets, transfected cells, and chromaffin vesicles.|HED|monoamine transporters|28|9|Arg1:T8|Arg2:T16|CHEMICAL|GENE|INHIBITOR|2599
12487427|This study shows that the potency of GW660511X in comparison with omapatrilat is more than 100-fold lower in human, but less than 10-fold lower in rat plasma, suggesting that rat may not be a suitable in vivo model for the evaluation of ACE/NEP inhibition in relation to effects in humans.|GW660511X|NEP|8|46|Arg1:T28|Arg2:T71|CHEMICAL|GENE|INHIBITOR|2600
23625804|Mechanistic Aspects of hSOD1 Maturation from the Solution Structure of Cu(I) -Loaded hCCS Domain 1 and Analysis of Disulfide-Free hSOD1 Mutants.|Cu(I)|hSOD1|11|4|Arg1:T8|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|2601
9204085|Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors, retinoic acid receptors (RARs).|tretinoin|nuclear transcription factors|16|19|Arg1:T10|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|2602
23511016|To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (DOTA), with pantoprazole, which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon.|pantoprazole|proton pumps|31|44|Arg1:T3|Arg2:T10|CHEMICAL|GENE|DIRECT-REGULATOR|2603
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|L-cysteine|cystathionine-gamma-lyase|13|18|Arg1:T18|Arg2:T49|CHEMICAL|GENE|SUBSTRATE|2604
8294418|  The mechanism by which norepinephrine (NE) down-regulates alpha 1B-adrenergic receptor (alpha-AR) mRNA was studied in rabbit aortic smooth muscle cells.|norepinephrine|alpha-AR|5|14|Arg1:T3|Arg2:T35|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2605
23274058|These data suggest that jaceosidin, isolated from Japanese mugwort, modulates the ERK/ATM/Chk1/2 pathway, leading to inactivation of the Cdc2-cyclin B1 complex, followed by G2/M cell cycle arrest in endometrial cancer cells.|jaceosidin|cyclin B1|5|23|Arg1:T6|Arg2:T24|CHEMICAL|GENE|INHIBITOR|2606
23321689|PNU-282987 on the other hand displayed an increase in anxiety-like behavior at a higher dose (10 mg/kg) that was significantly reduced by the serotonin 5-HT1a receptor antagonist WAY-100135.|WAY-100135|serotonin 5-HT1a receptor|30|26|Arg1:T2|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|2607
17085856|The non-selective adenosine receptor antagonist (caffeine), and the selective adenosine A1 receptor antagonist (DPCPX), injected 15 min before the application of pentetrazole and flumazenil, were able to intensify BDZ withdrawal signs in mice.|DPCPX|adenosine A1 receptor|18|13|Arg1:T15|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|2608
12699699|The protein exhibited modest H(2)O(2)-dependent peroxidase activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).|potassium iodide|peroxidase|19|14|Arg1:T5|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|2609
23246481|The mechanism revealed that wogonin inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of VE-cadherin and β-catenin.|wogonin|VE-cadherin|5|21|Arg1:T8|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2610
14984733|Moreover, a normal level of expression of PSS1 and/or PSS2 is not required for generating the pool of PtdSer externalized during apoptosis.|PtdSer|PSS2|20|11|Arg1:T6|Arg2:T19|CHEMICAL|GENE|PRODUCT-OF|2611
23414340|Although thioredoxin reductase (TRR) inhibitors (aurothioglucose and Sb(III)) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.|aurothioglucose|thioredoxin reductase|9|2|Arg1:T17|Arg2:T48|CHEMICAL|GENE|INHIBITOR|2612
11562773|Significant differences were observed in a different region (loop B93-B101), that we identified as binding site of amiloride to the tissue plasminogen activator (tPA).|amiloride|tPA|21|28|Arg1:T1|Arg2:T7|CHEMICAL|GENE|DIRECT-REGULATOR|2613
2530096|The memory-improving effect of minaprine on cycloheximide-induced amnesia was potentiated by a selective 5-HT2 antagonist, ritanserin.|ritanserin|5-HT2|17|14|Arg1:T17|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|2614
11161433|When the anti-corticosterone drug aminoglutethimide (CYP11A1 inhibitor) was administered to B16F10 mice, corticosterone levels in splenic tissue or serum and CYP11A1 mRNA expression were decreased at 14 days after tumor inoculation.|aminoglutethimide|CYP11A1|5|7|Arg1:T4|Arg2:T11|CHEMICAL|GENE|INHIBITOR|2615
15732037|Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF-1alpha and VEGF in the failing ventricular myocardium.|carvedilol|HIF-1alpha|3|13|Arg1:T3|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2616
14583450|  Ribonucleotide reductase (RR) is responsible for the de novo conversion of the ribonucleoside diphosphates to deoxyribonucleoside diphosphates, which are essential for DNA synthesis and repair.|deoxyribonucleoside diphosphates|Ribonucleotide reductase|18|1|Arg1:T2|Arg2:T7|CHEMICAL|GENE|PRODUCT-OF|2617
23125284|  The mitochondrial respiratory chain complex IV (cytochrome c oxidase) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular oxygen, yielding water.|oxygen|mitochondrial respiratory chain complex IV|24|2|Arg1:T1|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|2618
23164921|Data at transcriptional level also demonstrated that catalpol potently attenuated gene expressions involved in inflammation, such as iNOS, COX-2 and TLR4.|catalpol|COX-2|8|21|Arg1:T9|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2619
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|methimazole|FMO3|19|15|Arg1:T2|Arg2:T14|CHEMICAL|GENE|SUBSTRATE|2620
23497227|Synthesis and in vitro evaluation of N-Aryl pyrido-quinazolines derivatives as potent EGFR inhibitors.|N-Aryl pyrido-quinazolines|EGFR|7|12|Arg1:T5|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2621
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine|cyt b5|26|51|Arg1:T24|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|2622
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|muscarine|mAChR|21|16|Arg1:T8|Arg2:T17|CHEMICAL|GENE|AGONIST|2623
23042954|Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.|LY293558|AMPA receptor|7|5|Arg1:T13|Arg2:T18|CHEMICAL|GENE|ANTAGONIST|2624
17344208|  Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.|proline|PRODH|21|4|Arg1:T2|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|2625
12373423|These conclusions are surprising when one considers that the potent interaction of lisuride with 5-HT(1A) receptors has been demonstrated in several different laboratories and that activation of 5-HT(1A) and 5-HT(1B) receptors can modulate dopaminergically mediated responses.|lisuride|5-HT(1A)|13|15|Arg1:T19|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|2626
15795320|These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.|gemcitabine|Akt|7|19|Arg1:T6|Arg2:T29|CHEMICAL|GENE|INHIBITOR|2627
12719755|We investigated the effect of AT1 receptor blockade in the NTS on the response to stimulation of HDA in anaesthetised rats treated with the neuromuscular blocking agent pancuronium bromide.|pancuronium bromide|AT1 receptor|28|6|Arg1:T4|Arg2:T10|CHEMICAL|GENE|INHIBITOR|2628
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|ETYA|PPARalpha2|18|30|Arg1:T13|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|2629
1666997|Interestingly, amoxapine binds with a good affinity (IC50 = 0.30 microM) to 5-HT3 receptors labelled by [3H]zacopride in cortical membranes.|amoxapine|5-HT3|3|16|Arg1:T12|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|2630
7885191|The channel activators avermectin and moxidectin usually retain their inhibitory potency in the Rdl subunit mutants.|moxidectin|Rdl|6|14|Arg1:T13|Arg2:T52|CHEMICAL|GENE|INHIBITOR|2631
23391485|Our results showed that low dose BPA and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of Oct4 and Nanog proteins, while only BPA could downregulate the expression of E-cadherin protein.|BPA|Oct4|7|23|Arg1:T10|Arg2:T12|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2632
23600914|The expression of ABCA1 and ABCG1 was induced by 24-OHC, as well as TO901317 and retinoic acid, which are ligands of the nuclear receptors LXR/RXR.|TO901317|ABCG1|15|6|Arg1:T8|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2633
17594192|Phenserine deserves attention for an additional quality of action: in addition to inhibiting AChE, it modulates the amount of beta-amyloid precursor protein (APP) in neuronal cell culture by reducing APP translation.|Phenserine|AChE|1|15|Arg1:T8|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2634
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|SU5416|kinase|23|44|Arg1:T15|Arg2:T35|CHEMICAL|GENE|INHIBITOR|2635
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|amantadine|OCT|18|23|Arg1:T8|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|2636
23221600|Dietary carbohydrates increase SCD-1 gene expression in liver by sterol response element binding protein (SREBP)-1c-dependent and SREBP-1c -independent pathways.|carbohydrates|SCD-1|2|4|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2637
10742288|In alpha(2A)-adrenoceptor transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).|B-HT 920|alpha(2A)-adrenoceptor|36|2|Arg1:T5|Arg2:T22|CHEMICAL|GENE|AGONIST|2638
23538162|Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.|ginsenoside Rg1|glucocorticoid receptor|8|2|Arg1:T12|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|2639
11775064|The elevation in brain alanine levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of PLZ on alanine transaminase (ALA-T), although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced.|PLZ|ALA-T|24|29|Arg1:T25|Arg2:T38|CHEMICAL|GENE|INHIBITOR|2640
20801130|The structural and functional data reveal that the levosimendan class of Ca(2+)-sensitizers work by binding to the regulatory domain of cTnC and stabilizing the pivotal cTnC-cTnI regulatory unit via a network of hydrophobic and electrostatic interactions, in contrast to the destabilizing effects of antagonists such as W7 at the same interface.|levosimendan|cTnC|9|25|Arg1:T5|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|2641
23250811|Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).|curcumin|p65|9|44|Arg1:T14|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2642
15805193|Phenytoin is principally metabolized by CYP2C9, and both are probable substrates of the drug transporter P-glycoprotein.|Phenytoin|CYP2C9|1|6|Arg1:T6|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|2643
1911436|Analysis of coenzyme binding by human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase using 5'-[p-(fluorosulfonyl)benzoyl]adenosine, an affinity labeling cofactor analog.|5'-[p-(fluorosulfonyl)benzoyl]adenosine|steroid 5----4-ene-isomerase|18|12|Arg1:T18|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|2644
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Zactima|TK|31|3|Arg1:T22|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2645
23221600|Human stearoyl-CoA desaturase 1 (SCD-1) gene expression is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptor to the gene promoter.|thyroid hormone|Human stearoyl-CoA desaturase 1|14|1|Arg1:T9|Arg2:T33|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2646
1730582|This lysine is contained in the sequence PFYAVKC, which is found in all known ODCs from eukaryotes.|lysine|PFYAVKC|2|8|Arg1:T24|Arg2:T39|CHEMICAL|GENE|PART-OF|2647
7711211|The inhibition of UG synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.|5 alpha-NET|UG|10|4|Arg1:T2|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2648
20421509|Within each pentamer most of the contacts between S100A4 dimers occurs through the TFP moieties.|TFP|S100A4|14|9|Arg1:T2|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|2649
17016621|Enhancement of radiosensitivity by topoisomerase II inhibitor, amrubicin and amrubicinol, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction.|amrubicin|topoisomerase II|9|5|Arg1:T19|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2650
10701840|Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.|geldanamycin|Raf-1|3|12|Arg1:T5|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2651
15795105|The compounds 5'-azacytidine (AZC) and procainamide (PCA) belong to inhibitors of DNMT1, whose low activity correlates with increase in transcription of various genes.|PCA|DNMT1|10|16|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INHIBITOR|2652
12897749|RESULTS: Rolipram unmasked the inhibitory effect of beta(2)-adrenoceptor stimulation with salmeterol and significantly attenuated the stimulated release of AA and subsequent LTC(4).|salmeterol|beta(2)-adrenoceptor|16|9|Arg1:T11|Arg2:T37|CHEMICAL|GENE|ACTIVATOR|2653
8636122|The e2 domain thus plays some role in CP 55,940 binding but none in SR 141716A recognition, binding of the latter clearly implicating residues in the adjoining transmembrane helices.|SR 141716A|e2 domain|15|2|Arg1:T3|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|2654
23098818|Of the rat CYP isoforms studied, CYP2D isoforms were the most efficient in catalyzing the O-demethylation of 5-methoxytryptamine to serotonin, but they were less effective than the human isoform CYP2D6.|serotonin|human isoform CYP2D6|21|30|Arg1:T15|Arg2:T34|CHEMICAL|GENE|PRODUCT-OF|2655
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|2'-cytidine monophosphate|RNase A|30|12|Arg1:T4|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2656
8894610|  The influence of (+/-)-tamsulosin, a selective alpha 1A-adrenoceptor antagonist, on the positive inotropic effect and the accumulation of inositol phosphates that are induced via alpha 1-adrenoceptors was studied in comparison with that of another alpha 1A-adrenoceptor ligand oxymetazoline in the rabbit ventricular myocardium.|(+/-)-tamsulosin|alpha 1A-adrenoceptor|4|11|Arg1:T13|Arg2:T34|CHEMICAL|GENE|ANTAGONIST|2657
15498586|Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dose-dependent increase in mRNA levels for PPARgamma target genes such as aP2 and adiponectin.|telmisartan|adiponectin|11|27|Arg1:T3|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2658
12679340|The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.|lysine|OTCase|3|30|Arg1:T15|Arg2:T21|CHEMICAL|GENE|PART-OF|2659
7885191|Drosophila GABA-gated chloride channel: modified [3H]EBOB binding site associated with Ala-->Ser or Gly mutants of Rdl subunit.|Ala|Rdl|15|23|Arg1:T50|Arg2:T58|CHEMICAL|GENE|PART-OF|2660
17018843|Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1 (PI3K-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor wortmannin or a dominant-negative SGK1.|wortmannin|PI3K|38|36|Arg1:T4|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2661
3345199|  Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.|organophosphate|Acetylcholinesterase|8|1|Arg1:T16|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2662
10742288|The selective alpha(2)-adrenoceptor ligand rauwolscine antagonized acidification rate changes with an affinity independent of the agonist used; the affinity (mean pK(B)) against noradrenaline was 8.43.|rauwolscine|alpha(2)-adrenoceptor|9|3|Arg1:T12|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|2663
17768678|  Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.|PLZ|GABA-transaminase|3|19|Arg1:T6|Arg2:T43|CHEMICAL|GENE|INHIBITOR|2664
23638842|Recent literature shows that Brassica vegetables (Cruciferae) possess therapeutic effects particularly ascribed due to their content in glucosinolates, which upon myrosinase hydrolysis release the corresponding isothiocyanates.|isothiocyanates|myrosinase|29|24|Arg1:T4|Arg2:T14|CHEMICAL|GENE|PRODUCT-OF|2665
15866288|Effects of inhibition of urokinase-type plasminogen activator (u-PA) by amiloride in the cornea and tear fluid of eyes irradiated with UVB.|amiloride|u-PA|12|9|Arg1:T7|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2666
23182946|Therefore, the present results show that the earlier cerebellar responses to (PhTe)(2) include disruption of cytoskeletal homeostasis that could be related with MAPK and PKA activation and reactive astrogliosis.|(PhTe)(2)|MAPK|13|29|Arg1:T5|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|2667
16988497|A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.|LA|D6D|37|50|Arg1:T15|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2668
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|mZIENT|DAT|14|55|Arg1:T8|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|2669
21606412|  PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.|XL184|RET|3|25|Arg1:T6|Arg2:T14|CHEMICAL|GENE|INHIBITOR|2670
2888789|It is suggested that all the additional actions of bevantolol can be attributed to a partial agonist action on alpha-adrenoceptors.|bevantolol|alpha-adrenoceptors|10|20|Arg1:T5|Arg2:T9|CHEMICAL|GENE|AGONIST|2671
11292635|In conclusion, OMCD tubules from deoxycorticosterone pivalate-treated rats secrete Cl- into the luminal fluid through NKCC1-mediated Cl- uptake across the basolateral membrane in series with Cl- efflux across the apical membrane.|Cl-|NKCC1|18|17|Arg1:T3|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|2672
9607108|Mutation of a single amino acid residue in the potential BiP binding site increased the secretion efficiency of factor VIII by threefold.|amino acid|BiP binding site|5|11|Arg1:T1|Arg2:T16|CHEMICAL|GENE|PART-OF|2673
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|lavendustin A|mGlu1|57|7|Arg1:T6|Arg2:T48|CHEMICAL|GENE|INHIBITOR|2674
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|spermine|ornithine decarboxylase|8|19|Arg1:T23|Arg2:T39|CHEMICAL|GENE|PRODUCT-OF|2675
23250811|There was no significant difference in TLR4, NF-κB, and IL-27 mRNA and proteins between curcumin-treated and sulfasalazine-treated groups.|sulfasalazine|TLR4|19|7|Arg1:T5|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2676
11961111|Radiosequence analysis of [(14)C]halothane-labeled rhodopsin revealed that halothane contacts an amino acid residue (Trp265) lining the ligand binding cavity in the transmembrane core of the receptor.|[(14)C]halothane|rhodopsin|4|11|Arg1:T8|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|2677
17094978|RESULT(S): The expression of endometrial ERalpha, PRAB, PRB, and SRC-1 was increased significantly after 1 week of mifepristone, but the increase was no longer seen after 10 weeks.|mifepristone|PRB|25|14|Arg1:T1|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2678
16917142|Fulvestrant is a novel ER antagonist that destroys the ER and its signaling pathway and is not associated with tamoxifen-like agonist effects.|Fulvestrant|ER|1|5|Arg1:T4|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|2679
22872607|  Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.|PAHs|AKRs|18|4|Arg1:T3|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|2680
17111172|CONCLUSIONS: We were able to demonstrate a moderate 5-HT(2A) and D(1) occupancy under clinically relevant doses of flupentixol, albeit lower than expected from in vitro data and clearly below saturation.|flupentixol|5-HT(2A)|25|10|Arg1:T3|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2681
23623750|Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.|benzydamine|FMO5|11|9|Arg1:T10|Arg2:T49|CHEMICAL|GENE|SUBSTRATE|2682
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|gardiquimod|porcine TLR7|7|12|Arg1:T5|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|2683
12244038|These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.|gemfibrozil|NF-kappaB|5|17|Arg1:T5|Arg2:T50|CHEMICAL|GENE|INHIBITOR|2684
22865292|The lysosomal inhibitor chloroquine significantly increased RCAN1 accumulation in +/+ cells, consistent with the hypothesis that higher lysosomal pH impairs RCAN1 degradation, leading to a higher RCAN1/NFATc1 ratio and consequently NFATc1 inhibition.|chloroquine|RCAN1|4|7|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2685
23274058|Jaceosidin, isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation.|Jaceosidin|cdc2|1|20|Arg1:T17|Arg2:T33|CHEMICAL|GENE|INHIBITOR|2686
17138644|Progestin activation of Src/MAPK occurred outside the nucleus with the B isoform of PR that was distributed between the cytoplasm and nucleus, but not with PR-A that was predominantly nuclear.|Progestin|MAPK|1|5|Arg1:T5|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|2687
23030680|The rCYP data was normalized relative to the levels of each CYP form in native human liver microsomes to better assess the contribution of each rCYP in the metabolism of elzasonan.|elzasonan|rCYP|31|26|Arg1:T9|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|2688
23531488|Using a transient heterologous cell expression system, we find that the transport activities of the short OATP2B1 variant towards substrates estrone sulfate and rosuvastatin are similar to the well-characterized full length variant.|estrone sulfate|short OATP2B1|22|17|Arg1:T1|Arg2:T7|CHEMICAL|GENE|SUBSTRATE|2689
11034583|Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans.|serotonin|serotonin 5-HT(4) receptor|4|4|Arg1:T11|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|2690
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|spermidine|ornithine decarboxylase|5|19|Arg1:T22|Arg2:T39|CHEMICAL|GENE|PRODUCT-OF|2691
16343532|We have elucidated the crystal structures of the cyanotoxins, motuporin (nodularin-V) and dihydromicrocystin-LA bound to human protein phosphatase-1c (gamma isoform).|dihydromicrocystin-LA|human protein phosphatase-1c (gamma isoform)|16|19|Arg1:T11|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2692
18620538|  The interaction of holo- and apo-forms of human alpha-lactalbumin with fatty acids was studied by a partition equilibrium method.|fatty acids|human alpha-lactalbumin|11|8|Arg1:T7|Arg2:T11|CHEMICAL|GENE|DIRECT-REGULATOR|2693
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|ID2|3|36|Arg1:T8|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2694
9851542|The alpha1-adrenoceptor antagonist prazosin or the vasopressin V1 receptor antagonist, [beta-mercapto-beta,beta-cyclopenta-methylenepropionyl1, O-Me-Tyr2, Arg8] vasopressin partially but significantly reduced tacrine pressor effect and mostly abolished it when administered concomitantly.|[beta-mercapto-beta,beta-cyclopenta-methylenepropionyl1, O-Me-Tyr2, Arg8] vasopressin|vasopressin V1 receptor|12|7|Arg1:T20|Arg2:T35|CHEMICAL|GENE|ANTAGONIST|2695
2888789|  UNLABELLED: Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension.|Bevantolol|beta-1 adrenoceptor|3|6|Arg1:T3|Arg2:T10|CHEMICAL|GENE|ANTAGONIST|2696
22566187|These polyphenols, but not GvEx, showed a certain level of inhibition of human-cDNA-expressed CYPs. In a comparison of GLT and grapefruit juice, GLT showed weaker inhibition of CYP activities and of midazolam 1'-hydroxylation than grapefruit juice.|polyphenols|CYPs|2|16|Arg1:T12|Arg2:T16|CHEMICAL|GENE|INHIBITOR|2697
23024204|Metabolism of triethylenetetramine and 1,12-diamino-3,6,9-triazadodecane by the spermidine/spermine-N(1)-acetyltransferase and thialysine acetyltransferase.|1,12-diamino-3,6,9-triazadodecane|thialysine acetyltransferase|5|14|Arg1:T24|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|2698
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Gleevec|KIT|5|22|Arg1:T3|Arg2:T11|CHEMICAL|GENE|INHIBITOR|2699
17015640|  Licofelone, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.|Licofelone|5-lipoxygenase|1|9|Arg1:T1|Arg2:T29|CHEMICAL|GENE|INHIBITOR|2700
11588409|Omapatrilat, the prototypical vasopeptidase inhibitor, inhibits not only ACE but also neutral endopeptidase.|Omapatrilat|neutral endopeptidase|1|14|Arg1:T9|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2701
8636122|The e2 domain thus plays some role in CP 55,940 binding but none in SR 141716A recognition, binding of the latter clearly implicating residues in the adjoining transmembrane helices.|CP 55,940|e2 domain|9|2|Arg1:T2|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|2702
2899826|Levomepromazine was the most potent and fluphenazine the least potent of the four drugs in histamine H1 receptor binding.|fluphenazine|histamine H1 receptor|7|16|Arg1:T16|Arg2:T34|CHEMICAL|GENE|DIRECT-REGULATOR|2703
14725487|  Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the beta(2)-adrenoceptor agonist formoterol [eformoterol].|formoterol|beta(2)-adrenoceptor|26|20|Arg1:T2|Arg2:T22|CHEMICAL|GENE|AGONIST|2704
10701840|Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.|geldanamycin|Lck|3|10|Arg1:T5|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2705
23703578|The HCV-PIs boceprevir and telaprevir are both, to different extents, inhibitors of CYP3A.|telaprevir|CYP3A|5|15|Arg1:T4|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2706
23298863|Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK-441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice.|TAK-441|Gli1|8|13|Arg1:T6|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2707
12487427|Unlike GW660511X, omapatrilat abolished the production of BrBK1-5 and BrBK1-7, suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found.|omapatrilat|ACE|4|16|Arg1:T45|Arg2:T86|CHEMICAL|GENE|INHIBITOR|2708
22718571|On the other hand, treatment with gentianine significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR-γ, GLUT-4 and adiponectin.|gentianine|PPAR-γ|8|25|Arg1:T8|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2709
17594192|As a consequence, phenserine reduces beta-amyloid peptide (Abeta) formation in vitro and in vivo.|phenserine|Abeta|5|10|Arg1:T13|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2710
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|phenol|metalloenzyme|7|45|Arg1:T9|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2711
19370562|Tacrine, the first of the cholinesterase inhibitors to undergo extensive trials for this purpose, was associated with significant adverse effects including hepatotoxicity.|Tacrine|cholinesterase|1|7|Arg1:T13|Arg2:T19|CHEMICAL|GENE|INHIBITOR|2712
15452358|A receptor binding assay using rat forebrain and spinal cord membrane preparations demonstrated that [3H]CP-101,606 bound to the brain NR2B receptor with a greater extent compared to the spinal cord one.|[3H]CP-101,606|NR2B|15|23|Arg1:T11|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2713
15985706|Both inhibitors, moreover, blunted the mucin secretory responses to beta-adrenergic agonist-generated second messenger, cAMP as well as adenylate cyclase activator, forskolin.|forskolin|adenylate cyclase|25|21|Arg1:T10|Arg2:T36|CHEMICAL|GENE|ACTIVATOR|2714
17016621|Similar to AMR and AMROH, adriamycin and etoposide (VP-16) are DNA topoisomerase II inhibitors.|VP-16|DNA topoisomerase II|11|14|Arg1:T7|Arg2:T21|CHEMICAL|GENE|INHIBITOR|2715
23481236|Unsaturated FFAs increased DAGs, TAGs and PTP1B expression significantly, but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine (Ser) 50, Ser 398 and tyrosine 152.|serine|PTP1B|26|23|Arg1:T22|Arg2:T51|CHEMICAL|GENE|PART-OF|2716
22981796|Exposure to Cu NPs decreased cell viability to 73% (p<0.01) and significantly (p<0.05) elevated levels of lactate dehydrogenase, intracellular reactive oxygen species and interleukin-8 that mirrored our findings from subacute in vivo inhalation studies in mice.|Cu|interleukin-8|3|34|Arg1:T4|Arg2:T7|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2717
17459764|Moreover stimulation of COX-2 promoter activity was increased by those PUFAs or rosiglitazone.|rosiglitazone|COX-2 promoter|13|4|Arg1:T18|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|2718
20104269|RGM-1 cells were treated with CDCA or GW4064, an FXR agonist, in the presence or absence of guggulsterone, an FXR antagonist.|GW4064|FXR|8|11|Arg1:T6|Arg2:T24|CHEMICAL|GENE|AGONIST|2719
9015795|Most typical neuroleptics have radioligand-independent values of 0.3 to 5 nM at dopamine D2 receptors, making them more resistant to displacement by endogenous dopamine.|dopamine|dopamine D2 receptors|25|13|Arg1:T18|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|2720
16324695|Moreover, the specific PKC-inhibitor 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl) maleimide (GF 109203X) markedly increased the potency and E(max) of isoprenaline for all conditions used, including control conditions, and the synergistic effects of PMA and fenoterol were completely prevented.|GF 109203X|PKC|20|5|Arg1:T3|Arg2:T16|CHEMICAL|GENE|INHIBITOR|2721
1730582|Using a similar procedure to analyze ODC labeled by reaction with [5-14C]DFMO, it was found that lysine 69 and cysteine 360 formed covalent adducts with the inhibitor.|cysteine|ODC|24|7|Arg1:T3|Arg2:T32|CHEMICAL|GENE|PART-OF|2722
23228697|Contrary to the hypothesis, orlistat at 1 nM inhibited CES2 activity by 75% but no inhibition on CES1, placing CES2 one of the most sensitive targets of orlistat.|orlistat|CES2|31|23|Arg1:T12|Arg2:T33|CHEMICAL|GENE|INHIBITOR|2723
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|sodium-coupled neutral amino acid transporter 1|14|52|Arg1:T23|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2724
1730582|Using a similar procedure to analyze ODC labeled by reaction with [5-14C]DFMO, it was found that lysine 69 and cysteine 360 formed covalent adducts with the inhibitor.|[5-14C]DFMO|ODC|12|7|Arg1:T1|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|2725
14600253|At normal pH (7.4) and temperature (37 degrees C), the uptake of 1 microM cefadroxil was reduced by 83% in PEPT2(-/-) mice as compared with PEPT2(+/+) mice (p < 0.001).|cefadroxil|PEPT2|20|35|Arg1:T6|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|2726
12063741|As a prodrug leflunomide is completely converted to its active metabolite A 77 1726 (M1) which blocks the dihydroorotate dehydrogenase, a key enzyme of the pyrimidine de novo synthesis.|A 77 1726|dihydroorotate dehydrogenase|12|21|Arg1:T2|Arg2:T11|CHEMICAL|GENE|INHIBITOR|2727
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|AH 6809|EP1|46|14|Arg1:T17|Arg2:T34|CHEMICAL|GENE|AGONIST|2728
23506741|Taken together, our results demonstrate the ability of Fc11a-2 to inhibit NLRP3 inflammasome activation and its potential use in the treatment of inflammatory bowel diseases.|Fc11a-2|NLRP3|10|13|Arg1:T3|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2729
23123250|[-]-Huperzine A ([-]-Hup A), is a naturally occurring potent reversible AChE inhibitor that penetrates the blood-brain barrier.|[-]-Hup A|AChE|7|20|Arg1:T16|Arg2:T24|CHEMICAL|GENE|INHIBITOR|2730
23116965|Antiarrhythmic effects of (-)-epicatechin-3-gallate, a novel sodium channel agonist in cultured neonatal rat ventricular myocytes.|(-)-epicatechin-3-gallate|sodium channel|4|11|Arg1:T21|Arg2:T25|CHEMICAL|GENE|AGONIST|2731
16633143|Reboxetine, a selective norepinephrine reuptake inhibitor, exhibits high affinity and selectivity for the human norepinephrine transporter.|Reboxetine|human norepinephrine transporter|1|16|Arg1:T10|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|2732
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|CLS|COX-2|15|39|Arg1:T7|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2733
17488480|Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue caerulein-treated acinar cells.|caerulein|substance P|39|3|Arg1:T3|Arg2:T51|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2734
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|leuprorelin|LH|15|39|Arg1:T7|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2735
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|CLS|tumor necrosis factor-α|15|51|Arg1:T7|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2736
23142507|The 3D-structure of HmTx consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).|His|HmTx|14|4|Arg1:T4|Arg2:T23|CHEMICAL|GENE|PART-OF|2737
23703578|Drug-drug interactions are dependent on statins' pharmacokinetic profile: simvastatin, lovastatin and atorvastatin are metabolized through cytochrome P450 (CYP) 3A, while the metabolism of the other statins is independent of this CYP.|atorvastatin|cytochrome P450 (CYP) 3A|15|19|Arg1:T22|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2738
16988497|A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.|LA|D5D|37|52|Arg1:T15|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2739
17768678|  Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.|PLZ|GABA-T|3|21|Arg1:T6|Arg2:T36|CHEMICAL|GENE|INHIBITOR|2740
23529825|  Oral lorcaserin (BELVIQ(®)), a selective serotonin 5-HT2C receptor agonist, is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults, or overweight adults with at least one weight-related comorbidity (e.g. dyslipidaemia, hypertension, type 2 diabetes).|BELVIQ|5-HT2C|4|13|Arg1:T6|Arg2:T14|CHEMICAL|GENE|AGONIST|2741
17229632|Sorafenib (BAY43-9006, Nexavar) is a small molecule B-RAF inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against receptor tyrosine kinases from the platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR) families.|BAY43-9006|B-RAF|3|11|Arg1:T8|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2742
16434489|Additionally, dasatinib leads to growth inhibition of a KITD816V-harboring human masto-cytosis cell line.|dasatinib|D816V|3|11|Arg1:T12|Arg2:T36|CHEMICAL|GENE|INHIBITOR|2743
10694244|Troglitazone inhibited the antigen-induced production of LTB(4), C(4) and E(4) and the potency of the inhibition was comparable to that of zileuton, a specific inhibitor of 5-lipoxygenase (5-LOX) and a clinically used anti-asthmatic drug.|zileuton|5-lipoxygenase|32|38|Arg1:T18|Arg2:T36|CHEMICAL|GENE|INHIBITOR|2744
23534442|Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors.|1,5-diarylpyrrole nitrooxyalkyl ethers|cyclooxygenase-2|5|12|Arg1:T17|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2745
23423570|High-glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes: New insights on impaired diabetic wound healing.|glucose|interleukin-8|2|8|Arg1:T5|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2746
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|ferulic acid|metalloenzyme|22|45|Arg1:T3|Arg2:T25|CHEMICAL|GENE|INHIBITOR|2747
20421509|Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization.|TFP|myosin-IIA|6|12|Arg1:T7|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2748
23439561|Cycloxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) has been shown to be important in esophageal tumorigenesis.|prostaglandin E2|Cycloxygenase-2|6|1|Arg1:T3|Arg2:T18|CHEMICAL|GENE|PRODUCT-OF|2749
2899826|  In vitro binding affinities of chlorpromazine, fluphenazine, levomepromazine, perphenazine and some of their metabolites for dopamine D2 receptors, alpha 1- and alpha 2 adrenoceptors in rat brain were previously reported from our laboratories.|levomepromazine|dopamine D2 receptors|10|19|Arg1:T13|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|2750
17040106|On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of arylhydroxylamine carcinogens was catalyzed by NADH cytochrome b5 reductase (b5R) and cytochrome b5 (cyt b5).|arylhydroxylamine|b5R|23|33|Arg1:T17|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|2751
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|muscarine|AChE|21|4|Arg1:T8|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2752
2859531|Mepindolol treatment (2 X 5 mg/day) caused a 30% decrease of beta 2-adrenoceptor density and PRA after 2 days; both parameters remained reduced during treatment.|Mepindolol|beta 2-adrenoceptor|1|15|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2753
1978244|Radioligand binding studies with the nonselective alpha 1-adrenoceptor antagonist radioligand 125I-BE2254 showed that 73-87% of the binding sites in rabbit aorta are CEC sensitive and they are predominantly low affinity sites both for WB4101 (pKd = 8.1) and for 5-methylurapidil (pKd = 7.1).|5-methylurapidil|alpha 1-adrenoceptor|43|7|Arg1:T26|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|2754
23314054|A novel potent compound, N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide (12c), which binds Mcl-1 with an IC(50) value of 54 nM was obtained.|N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide|Mcl-1|6|18|Arg1:T2|Arg2:T8|CHEMICAL|GENE|DIRECT-REGULATOR|2755
23250811|Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).|curcumin|p28|9|49|Arg1:T14|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2756
20531964|A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR tyrosine kinase inhibitors sunitinib and/or sorafenib.|sunitinib|tyrosine kinase|34|31|Arg1:T9|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2757
17098734|During embryogenesis, lratb is expressed in mostly non-overlapping domains opposite to retinal dehydrogenase 2 (raldh2), the key enzyme for retinoic acid synthesis.|retinoic acid|raldh2|24|17|Arg1:T9|Arg2:T21|CHEMICAL|GENE|PRODUCT-OF|2758
12047490|COX-1 inhibition was measured as percentage inhibition of serum TXB2 generation in clotting whole blood, and as closure time with use of the platelet function analyser PFA-100.|TXB2|COX-1|10|1|Arg1:T15|Arg2:T24|CHEMICAL|GENE|PRODUCT-OF|2759
23435910|In conclusion, we find that sinapic acid exhibits hepatoprotective and antifibrotic effects against DMN-induced liver injury, most likely due to its antioxidant activities of scavenging radicals, its capacity to suppress TGF-β1 and its ability to attenuate activation of hepatic stellate cells.|sinapic acid|TGF-β1|7|34|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2760
14656380|beta2AR density measured with [3H]dihydroalprenolol ([3H]DHA) increased either 13- or 77-fold in infected cells compared to mock infected controls depending on the culture conditions used.|[3H]DHA|beta2AR|10|1|Arg1:T9|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|2761
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|GW2331|enoyl-CoA hydratase|3|14|Arg1:T16|Arg2:T37|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2762
23353741|All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) inhibitory activity of murine macrophage RAW 264.7 cell line.|PGE2|COX-2|30|24|Arg1:T5|Arg2:T8|CHEMICAL|GENE|PRODUCT-OF|2763
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|H(2)S|cystathionine-beta-synthase|4|23|Arg1:T15|Arg2:T34|CHEMICAL|GENE|PRODUCT-OF|2764
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Glivec|ABL|7|24|Arg1:T4|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2765
10771044|In these tissues, JTH-601, prazosin (a non-selective alpha(1)-adrenoceptor antagonist), and tamsulosin (an alpha(1A)-adrenoceptor antagonist) competitively antagonized contraction in a concentration-dependent manner.|tamsulosin|alpha(1A)-adrenoceptor|20|23|Arg1:T12|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|2766
23412396|Mice given daily injections of high dose JZL184 (≥16 mg/kg) for six days displayed decreased CB(1) receptor density and function in brain, as assessed in [(3)H]SR141716A binding and CP55,940-stimulated [(35)S]GTPγS binding assays, respectively.|CP55,940|CB(1)|41|18|Arg1:T15|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|2767
23628605|Mitochondria in the steroidogenic cells of the adrenal, gonad, placenta and brain contain the cholesterol side-chain cleavage enzyme, P450scc, and its two electron-transfer partners, ferredoxin reductase and ferredoxin.|cholesterol|P450scc|17|22|Arg1:T4|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|2768
17350061|Various genes controlled by estrogen, including X-inactive-specific transcript, anterior gradient-2, trefoil factor-1, CRP-ductin, ghrelin, and small proline-rich protein-2A, were dramatically over-expressed.|estrogen|small proline-rich protein-2A|5|22|Arg1:T22|Arg2:T41|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2769
1730582|The pyridoxal 5'-phosphate binding lysine in mouse ODC was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with endoproteinase Lys-C, radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing.|lysine|mouse ODC|5|7|Arg1:T19|Arg2:T37|CHEMICAL|GENE|PART-OF|2770
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|SoRI-20040|DAT|16|63|Arg1:T21|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|2771
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|FAK|1|17|Arg1:T6|Arg2:T35|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2772
11775064|In addition, we also showed that the elevation in alanine levels and the inhibition of alanine transaminase in the brain are retained after 14 days of PLZ treatment, and that PLZ produces a marked increase in extracellular levels of alanine.|PLZ|alanine transaminase|28|17|Arg1:T4|Arg2:T32|CHEMICAL|GENE|INHIBITOR|2773
11551210|Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction.|long-chain alkanol|nicotinic acetylcholine receptor|3|8|Arg1:T22|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|2774
7773533|Incubation of rat aortic membranes with the irreversible alpha 1B-adrenoceptor antagonist, chloroethylclonidine (CEC: 10 microM) did not change the KD of [3H]-prazosin binding in comparison to untreated membranes, but reduced by 88% the total number of binding sites (Bmax).|CEC|alpha 1B-adrenoceptor|15|9|Arg1:T6|Arg2:T31|CHEMICAL|GENE|ANTAGONIST|2775
23530834|Design, Synthesis, Biological Evaluation, and Docking Studies of (S)-Phenylalanine Derivatives with a 2-Cyanopyrrolidine Moiety as Potent Dipeptidyl Peptidase 4 Inhibitors.|2-Cyanopyrrolidine|Dipeptidyl Peptidase 4|19|23|Arg1:T4|Arg2:T10|CHEMICAL|GENE|INHIBITOR|2776
3345199|The effect of the four mono- and bisquaternary ammonium compounds tetramethylammonium (TMA), hexamethonium, decamethonium and suxamethonium on the reactivatability of soman-inhibited, solubilized AChE from human erythrocytes was investigated in vitro.|soman|AChE|25|28|Arg1:T15|Arg2:T33|CHEMICAL|GENE|INHIBITOR|2777
16633143|Reboxetine, a selective norepinephrine reuptake inhibitor, exhibits high affinity and selectivity for the human norepinephrine transporter.|Reboxetine|human norepinephrine transporter|1|16|Arg1:T10|Arg2:T19|CHEMICAL|GENE|INHIBITOR|2778
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Erlotinib|VEGF receptor|26|42|Arg1:T6|Arg2:T44|CHEMICAL|GENE|INHIBITOR|2779
14751502|RESULTS: GW572016 inhibited constitutive and/or ligand-induced EGFR or HER2 tyrosine phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line.|GW572016|EGFR|3|8|Arg1:T9|Arg2:T38|CHEMICAL|GENE|INHIBITOR|2780
17418819|A KCC inhibitor-[(dihydroindenyl)oxy] alkanoic acid (DIOA)-blocked RVD more in HCEC than RCEC.|[(dihydroindenyl)oxy] alkanoic acid|KCC|4|2|Arg1:T1|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2781
23473681|Taken together, we conclude that the thiourea series of compounds share a similar cellular mechanism that includes interaction with LolA in addition to the well-characterized target MreB.|thiourea|MreB|8|28|Arg1:T1|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|2782
23538162|These protective effects were abolished by glucocorticoid receptor (GR) antagonist RU486 or p-ERK inhibitor U0126 rather than estrogen receptor α antagonist ICI 82,780.|RU486|glucocorticoid receptor|13|7|Arg1:T7|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|2783
20596674|Apoptosis studies (DAPI staining and caspase 3 activity) showed a marked increase in the presence of MXF and VP-16 compared to VP-16 alone.|VP-16|caspase 3|21|7|Arg1:T6|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2784
23250811|There was no significant difference in TLR4, NF-κB, and IL-27 mRNA and proteins between curcumin-treated and sulfasalazine-treated groups.|sulfasalazine|NF-κB|19|9|Arg1:T5|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2785
23625804|We recently showed that the first domain of human CCS (hCCSD1) is responsible for copper transfer to its protein partner, human SOD1 (hSOD1).|copper|hSOD1|17|27|Arg1:T2|Arg2:T15|CHEMICAL|GENE|DIRECT-REGULATOR|2786
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|etodolac|COX-1|34|46|Arg1:T1|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2787
12636181|Experimental evidence from the use of agents with enhanced selectivity for BuChE (cymserine analogues, MF-8622) and the dual inhibitor of both AChE and BuChE, rivastigmine, indicates potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias.|rivastigmine|BuChE|29|40|Arg1:T6|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2788
23220618|In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-α-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.|IMG|PAI-1|6|16|Arg1:T15|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2789
22445601|Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.|LY541850|mGlu3|10|15|Arg1:T12|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|2790
9890894|Ig module I and the C-terminus of Ig module III are dispensable for high-affinity binding of FGF-1, FGF-2, and FGF-7.|C|Ig module III|6|8|Arg1:T6|Arg2:T34|CHEMICAL|GENE|PART-OF|2791
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|disulfide|bovine pancreatic ribonuclease A|6|7|Arg1:T9|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2792
23265892|  An investigation is detailed of the structure activity relationships (SAR) of two sulfone side chains of compound (-)-1a (SCH 900229), a potent, PS1-selective γ-secretase inhibitor and clinical candidate for the treatment of Alzheimer's disease.|SCH 900229|PS1|25|32|Arg1:T1|Arg2:T8|CHEMICAL|GENE|INHIBITOR|2793
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|Imatinib|PDGFbeta-receptor|20|36|Arg1:T4|Arg2:T29|CHEMICAL|GENE|INHIBITOR|2794
17488480|Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue caerulein-treated acinar cells.|caerulein|SP|39|15|Arg1:T3|Arg2:T53|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2795
16516814|The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).|AH 6809|EP2 receptors|46|6|Arg1:T17|Arg2:T33|CHEMICAL|GENE|AGONIST|2796
1543672|Terbinafine is a potent non-competitive inhibitor of squalene epoxidase from Candida (Ki = 30 nM).|Terbinafine|squalene epoxidase|1|8|Arg1:T15|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2797
23643933|Considerable attention has focused on the antitumor effect of histone deacetylase inhibitor (Trichostatin A, TSA) as well as the coding gene expression-induced apoptosis of cancer cells.|Trichostatin A|histone deacetylase|14|10|Arg1:T7|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2798
11034389|Peptide sequences selected using MICA4 were rich in basic or hydroxyl-containing amino acids, and the surface of the GAD65 PLP-binding domain surrounding Lys358, which is known to be critical for MICA4 binding, was likewise rich in these amino acids.|amino acids|GAD65 PLP-binding domain|12|20|Arg1:T2|Arg2:T15|CHEMICAL|GENE|PART-OF|2799
23506741|The mechanism of action of Fc11a-2 was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1β and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.|Fc11a-2|NLRP3|6|28|Arg1:T2|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2800
11861820|Also in contrast to effects of multiple METH injections, 1) MDMA caused little or no decrease in binding of the DAT ligand WIN35428, and 2) neither prevention of hyperthermia nor prior depletion of DA prevented the MDMA-induced reduction in plasmalemmal DA transport.|DA|DAT|45|23|Arg1:T1|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|2801
17224860|CONCLUSION: In postmenopausal women, isolated isoflavone treatment does not affect ABCA1-dependent cholesterol efflux potential from macrophages but increases circulating pre-beta high-density lipoprotein level, which could provide beneficial vascular effects.|cholesterol|ABCA1|14|13|Arg1:T12|Arg2:T26|CHEMICAL|GENE|SUBSTRATE|2802
12881227|Moreover, S1611 and S3226, both specific inhibitors of NHE3 only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH.|S1611|NHE3|3|11|Arg1:T13|Arg2:T39|CHEMICAL|GENE|INHIBITOR|2803
23194825|Neither the superoxide radical scavenger, tiron, nor the inhibitor of the dopamine (DA) transporter, GBR 12909, prevented the metabolites' toxicity.|GBR 12909|dopamine (DA) transporter|21|15|Arg1:T3|Arg2:T44|CHEMICAL|GENE|INHIBITOR|2804
22931533|Galantamine is a reversible, competitive acetylcholinesterase (AChE) inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors (nAChR-APL) that shares many common structural elements with morphinan-based opioids.|Galantamine|nicotinic acetylcholine receptors|1|17|Arg1:T2|Arg2:T10|CHEMICAL|GENE|DIRECT-REGULATOR|2805
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|syringic acid|CA|28|49|Arg1:T6|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2806
8098142|The enhancement of the depolarizing afterpotential by histamine was mimicked by the histamine H1-receptor agonist 2-thiazolylethylamine and was reduced or blocked by the H1-receptor antagonist promethazine, but was not blocked or reduced in the presence of the histamine H2-receptor antagonist, cimetidine.|cimetidine|histamine H2-receptor|43|39|Arg1:T7|Arg2:T24|CHEMICAL|GENE|ANTAGONIST|2807
11392054|  Carbonic anhydrase (CA) is a zinc enzyme that catalyses the reversible hydration reaction of CO2 and plays a major role in the acid-base balance.|CO2|CA|17|4|Arg1:T24|Arg2:T31|CHEMICAL|GENE|SUBSTRATE_PRODUCT-OF|2808
15049511|The inhibitory effects of tranylcypromine, a nonselective irreversible inhibitor of monoamine oxidase (MAO), on three cytochrome P450 (CYP) enzymes, namely CYP2C9, CYP2C19, and CYP2D6, have been evaluated in vitro.|tranylcypromine|MAO|5|15|Arg1:T2|Arg2:T9|CHEMICAL|GENE|INHIBITOR|2809
9551716|Saturation and competition studies in the presence or absence of the histamine H1 receptor antagonist, levocabastine, revealed that [3H]SR 142948A bound with similar affinities to both the levocabastine-insensitive neurotensin NT1 receptors (20% of the total binding population) and the recently cloned levocabastine-sensitive neurotensin NT2 receptors (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively).|levocabastine|histamine H1 receptor|17|12|Arg1:T2|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|2810
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|sunitinib|VEGFR-3|3|25|Arg1:T5|Arg2:T15|CHEMICAL|GENE|INHIBITOR|2811
10606746|The inhibitor binds at the base of the active site gorge of TcAChE, interacting with both the choline-binding site (Trp-84) and the acyl-binding pocket (Phe-288, Phe-290).|Phe|acyl-binding pocket|31|26|Arg1:T7|Arg2:T23|CHEMICAL|GENE|PART-OF|2812
9851542|Tacrine was chosen as a model to study the mechanisms underlying the cardiovascular effects of i.v. cholinesterase inhibitors.|Tacrine|cholinesterase|1|18|Arg1:T12|Arg2:T33|CHEMICAL|GENE|INHIBITOR|2813
23550066|The CYP2B6*6 allele is associated with reduced enzyme expression and activity that may lead to interindividual variability in ketamine metabolism.|ketamine|CYP2B6*6|19|2|Arg1:T7|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|2814
23432662|  Full agonists to the peroxisome proliferator-activated receptor (PPAR)γ, such as Rosiglitazone, have been associated with a series of undesired side effects, such as weight gain, fluid retention, cardiac hypertrophy, and hepatotoxicity.|Rosiglitazone|peroxisome proliferator-activated receptor (PPAR)γ|15|5|Arg1:T3|Arg2:T4|CHEMICAL|GENE|AGONIST-ACTIVATOR|2815
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|dFdU|CDA|50|6|Arg1:T13|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|2816
15184278|  BACKGROUND: To assess the sensitivity of biochemical, physiological, and pharmacological markers of peripheral norepinephrine (NE) transporter (NET) function, we chronically antagonized NET by a range of doses of duloxetine [(+)-N-methyl-3-(1-naphthalenyloxy)-2 thiophenepropanamine], which blocks the NE reuptake process.|duloxetine|NET|37|30|Arg1:T17|Arg2:T34|CHEMICAL|GENE|ANTAGONIST|2817
15474503|These results suggest that pitavastatin efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.|pitavastatin|apoA-I|5|18|Arg1:T1|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2818
11732752|The inhibition of aminopeptidase activity in the presence of bestatin and puromycin inhibitors was also investigated.|puromycin|aminopeptidase|12|4|Arg1:T13|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2819
23127916|  The two basic mainstays of gastrointestinal stromal tumours (GIST) treatment are surgery and imatinib, a selective tyrosine kinase inhibitor that allows achieving a stable or responding disease in about 80% of patients with unresectable/metastatic GIST.|imatinib|tyrosine kinase|16|20|Arg1:T6|Arg2:T13|CHEMICAL|GENE|INHIBITOR|2820
15498586|An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.|telmisartan|angiotensin II AT1 receptor|8|2|Arg1:T10|Arg2:T22|CHEMICAL|GENE|ANTAGONIST|2821
15198222|RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than COX-1.|NS398|COX-1|24|46|Arg1:T13|Arg2:T18|CHEMICAL|GENE|INHIBITOR|2822
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|rivastigmine|cholinesterase|15|8|Arg1:T3|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2823
23318471|Functional and biochemical studies indicated that TES signaling involved activity of the phosphoinositide 3 (PI3) kinase-protein kinase B (Akt) cascade initiated by activation of the androgen receptor and culminated in enhanced production of cGMP and microvascular vasodilation.|TES|androgen receptor|7|30|Arg1:T3|Arg2:T39|CHEMICAL|GENE|ACTIVATOR|2824
1730582|This lysine is contained in the sequence PFYAVKC, which is found in all known ODCs from eukaryotes.|PFYAVKC|ODCs|8|16|Arg1:T25|Arg2:T40|CHEMICAL|GENE|PART-OF|2825
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|Hydrogen sulphide|CSE|1|20|Arg1:T1|Arg2:T32|CHEMICAL|GENE|PRODUCT-OF|2826
23477419|Design, Synthesis, and Pharmacological Characterization of Novel Endomorphin-1 Analogues as Extremely Potent μ-Opioid Agonists.|Endomorphin-1|μ-Opioid|10|15|Arg1:T17|Arg2:T21|CHEMICAL|GENE|AGONIST|2827
17154506|MicroPET imaging in nonhuman primates with [11C]1 and [11C]2 demonstrated that both tracers behave similarly in vivo with high uptake being observed in the SERT-rich brain regions and peak uptake being achieved in about 55 min postinjection.|11C|SERT|13|31|Arg1:T9|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|2828
23228697|This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2, a carboxylesterase with little lipase activity.|orlistat|carboxylesterase|10|22|Arg1:T6|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2829
1978244|The Schild plots for the competitive antagonists WB4101 and 5-methyl-urapidil against alpha 1a-adrenoceptor-selective agonist methoxamine-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for WB4101 and 9.09 +/- 0.05 (n = 3) for 5-methyl-urapidil.|methoxamine|alpha 1a-adrenoceptor|15|12|Arg1:T10|Arg2:T30|CHEMICAL|GENE|AGONIST|2830
16424790|These results suggested that Captopril can protect the vascular endothelium against the damages induced by L-methionine in rats, and the beneficial effects of Captopril may be related to attenuating the decrease in PON1 activity and NO levels.|Captopril|PON1|25|34|Arg1:T21|Arg2:T62|CHEMICAL|GENE|ACTIVATOR|2831
1911436|Affinity alkylation with 2 alpha-bromoacetoxyprogesterone suggests that the dehydrogenase and isomerase substrate steroids bind at different sites on the same protein.|steroids|dehydrogenase|13|9|Arg1:T8|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|2832
17350061|Various genes controlled by estrogen, including X-inactive-specific transcript, anterior gradient-2, trefoil factor-1, CRP-ductin, ghrelin, and small proline-rich protein-2A, were dramatically over-expressed.|estrogen|CRP-ductin|5|17|Arg1:T22|Arg2:T39|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2833
21606412|Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.|Cabozantinib|tyrosine kinase|5|10|Arg1:T8|Arg2:T21|CHEMICAL|GENE|INHIBITOR|2834
16846546|Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.|ketorolac tromethamine|cyclooxygenase|11|3|Arg1:T29|Arg2:T42|CHEMICAL|GENE|INHIBITOR|2835
12070353|A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.|theophylline|histone deacetylase|7|11|Arg1:T12|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|2836
2899826|The present study reports the in vitro binding affinities of the same compounds for muscarinic cholinergic receptors and for histamine H1 receptors in rat brain, using 3H-quinuclidinyl benzilate and 3H-mepyramine as radioligands.|3H-mepyramine|histamine H1 receptors|31|20|Arg1:T8|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|2837
7560228|Triclosan inhibited both cyclooxygenase 1 and cyclo-oxygenase 2 with IC-50 values of 43 microM and 227 microM, respectively.|Triclosan|cyclo-oxygenase 2|1|7|Arg1:T17|Arg2:T29|CHEMICAL|GENE|INHIBITOR|2838
23111283|Western blot analysis indicated that TSN inhibits the CDC42/MEKK1/JNK pathway.|TSN|CDC42|6|9|Arg1:T10|Arg2:T17|CHEMICAL|GENE|INHIBITOR|2839
23357629|The keto and phenolic -OH are major factors that are prominently involved in interaction with COX-2 active site.|phenolic|COX-2|4|16|Arg1:T11|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2840
23261676|Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, α-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.|Isoproterenol|NADH-dehydrogenases|1|52|Arg1:T15|Arg2:T33|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2841
8384716|Within the conserved transmembrane domains, the sequences exhibit approximately 52%, 59%, 65%, and 68% amino acid identity with the known rat 5-HT1A, rat 5-HT1B, rat 5-HT1D, and human 5-HT1E receptors, respectively.|amino acid|rat 5-HT1B|23|32|Arg1:T21|Arg2:T42|CHEMICAL|GENE|PART-OF|2842
23477419|Of the new compounds, Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4) (analogue 12) displayed the highest affinity toward MOR, in the picomolar range (Ki(μ) = 3.72 pM).|Dmt|MOR|6|39|Arg1:T8|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|2843
23262271|Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant tyrosinase inhibition activities.|oxyresveratrol|tyrosinase|11|26|Arg1:T4|Arg2:T6|CHEMICAL|GENE|INHIBITOR|2844
23601753|The tetra-aspartate motif in the trypsinogen activation peptide binds calcium (KD ~1.6 mM), which stimulates autoactivation.|calcium|tetra-aspartate motif|10|2|Arg1:T5|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|2845
23261590|Neoechinulin A suppresses amyloid-β oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity.|Neoechinulin A|amyloid-β|1|4|Arg1:T14|Arg2:T41|CHEMICAL|GENE|INHIBITOR|2846
12727196|  The discovery of an inducible oxidase whose apparent substrate preference is spermine indicates that polyamine catabolism is more complex than that originally proposed.|spermine|oxidase|12|6|Arg1:T9|Arg2:T14|CHEMICAL|GENE|SUBSTRATE|2847
17205056|Antitumor activity of sorafenib in FLT3-driven leukemic cells.|sorafenib|FLT3|4|6|Arg1:T12|Arg2:T26|CHEMICAL|GENE|INHIBITOR|2848
9399012|Consistent with its selectivity for 5HT1B/1D receptors, zolmitriptan produces constriction of various isolated blood vessels, most notably cranial arteries.|zolmitriptan|5HT1B/1D|9|6|Arg1:T16|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|2849
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|alanine serine cysteine transporter 1|7|36|Arg1:T18|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|2850
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Ile|AngII|20|25|Arg1:T3|Arg2:T16|CHEMICAL|GENE|PART-OF|2851
7599160|Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin (CN-Cbl) bound to transcobalamin II (transcobalamin, TC).|[57Co]cyanocobalamin|TC|28|42|Arg1:T9|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|2852
17138644|These results highlight the importance of PR activation of the Src/MAPK signaling pathway for progesterone-induced transcription of select target genes and cell cycle progression.|progesterone|MAPK|15|12|Arg1:T4|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|2853
12487427|This study shows that the potency of GW660511X in comparison with omapatrilat is more than 100-fold lower in human, but less than 10-fold lower in rat plasma, suggesting that rat may not be a suitable in vivo model for the evaluation of ACE/NEP inhibition in relation to effects in humans.|omapatrilat|NEP|12|46|Arg1:T29|Arg2:T71|CHEMICAL|GENE|INHIBITOR|2854
8819507|Ka values in nM for rauwolscine (19), WB-4101 (265), SKF-104078 (197), spiroxatrine (128), and prazosin (1531) for blocking relaxation in rat arteries were consistent with their affinities for binding at the alpha-2D adrenoceptor subtype.|spiroxatrine|alpha-2D adrenoceptor|21|46|Arg1:T22|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|2855
23296102|Interestingly, Acrolein increased proteins' levels of amyloid precursor protein (APP), β-secretase (BACE-1) and the amyloid β-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.|Acrolein|A-disintegrin and metalloprotease (ADAM) 10|3|34|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2856
10931813|Isoproterenol (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, d-sotalol (100 micromol/L) to block I(Kr) (LQT2 model), and ATX-II (20 nmol/L) to augment late I(Na) (LQT3 model).|Isoproterenol|ATX-II|1|35|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INHIBITOR|2857
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|cytarabine|Lys27Gln|38|8|Arg1:T9|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|2858
23344961|Second, ICRF-187, a Top2 catalytic inhibitor known to deplete Top2β, specifically sensitized MEFs to CPT.|ICRF-187|Top2|3|6|Arg1:T7|Arg2:T24|CHEMICAL|GENE|INHIBITOR|2859
23231502|Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.|pSer|Pin1|24|10|Arg1:T13|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|2860
15991937|  Losartan (COZAAR) is the prototype of a new class of potent and selective angiotensin II (AII) type 1 (AT(1)) receptor antagonists with the largest published preclinical and clinical data base.|Losartan|angiotensin II (AII) type 1 (AT(1)) receptor|1|16|Arg1:T1|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|2861
12487427|  Several studies have suggested that the accumulation of bradykinin, or that of one its metabolites BK1-8, is involved in the occurrence of side effects such as AE associated with the use of various ACEi. In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK (79/81 Br-Phe5) BrBK in the presence of two new dual ACE/NEP inhibitors (GW660511X and omapatrilat) currently under clinical trial.|omapatrilat|NEP|82|78|Arg1:T34|Arg2:T76|CHEMICAL|GENE|INHIBITOR|2862
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|estradiol|sulfatase|28|34|Arg1:T13|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|2863
11730729|Effect of fenoterol-induced constitutive beta(2)-adrenoceptor activity on contractile receptor function in airway smooth muscle.|fenoterol|beta(2)-adrenoceptor|3|5|Arg1:T20|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|2864
17040106|On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of arylhydroxylamine carcinogens was catalyzed by NADH cytochrome b5 reductase (b5R) and cytochrome b5 (cyt b5).|arylhydroxylamine|cyt b5|23|39|Arg1:T17|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|2865
16774921|Herein, we determined that a fiveamino acid C-terminal deletion of LeuRS, which does not complement a null strain, can form a ternary complex with the bI4 intron and its maturase splicing partner.|C|LeuRS|9|12|Arg1:T9|Arg2:T20|CHEMICAL|GENE|PART-OF|2866
22898212|Mass spectral analysis of CBDP-inhibited BChE digested with Glu-C showed an o-hydroxybenzyl adduct (+106amu) on lysine 499, a residue far from the active site, but not on His-438.|o-hydroxybenzyl|BChE|12|6|Arg1:T18|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|2867
19429089|The present study examined the effect of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), on VMAT2 activity by measuring adenosine triphosphate-dependent [(3)H]dopamine uptake into synaptic vesicles prepared from rat striatum.|[(3)H]dopamine|VMAT2|27|21|Arg1:T8|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|2868
23344961|Altogether, our findings support a model in which Top2β deficiency promotes CPT-induced apoptosis in quiescent non-S-phase cells, possibly due to RNAP LS depletion and p53 accumulation.|CPT|RNAP LS|13|23|Arg1:T2|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2869
23318471|As predicted, TES enhanced the production of both peroxynitrite precursors (i.e., superoxide and nitic oxide), and xanthine oxidase was identified as the likely source of TES-stimulated superoxide production.|TES|xanthine oxidase|31|22|Arg1:T1|Arg2:T44|CHEMICAL|GENE|PRODUCT-OF|2870
22989703|Both apo-lycopenoic acids also decreased CSE-induced ROS production, 8-OHdG formation and reduced the increase in NOX-4 and COX-2 expressions caused by CSE.|apo-lycopenoic acids|NOX-4|2|17|Arg1:T15|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2871
23395914|The involvement of P-gp in the absorption of darunavir was clearly shown by coperfusion of darunavir with the P-gp inhibitor zosuquidar.|zosuquidar|P-gp|21|19|Arg1:T12|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2872
16434489|Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.|BMS-354825|D816V|3|7|Arg1:T14|Arg2:T38|CHEMICAL|GENE|INHIBITOR|2873
22370641|Epi increased both WNT6/Wnt6 and Cav1 expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg).|Epi|WNT6|1|4|Arg1:T11|Arg2:T30|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2874
17015640|Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.|Licofelone|5-lipoxygenase|1|9|Arg1:T17|Arg2:T34|CHEMICAL|GENE|INHIBITOR|2875
9310349|The hydrolysis of fluorescein diphosphate by PTP epsilon and PTPmeg1 was sensitive to alendronate, with IC50 values of less than 1 microM; PTPsigma, however, under the same conditions, was inhibited by only 50% with 141 microM alendronate.|alendronate|PTPsigma|43|25|Arg1:T20|Arg2:T39|CHEMICAL|GENE|INHIBITOR|2876
23703578|Atorvastatin is also a CYP3A substrate, but less potent drug-drug interactions have been reported with CYP3A inhibitors.|Atorvastatin|CYP3A|1|5|Arg1:T11|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|2877
16618126|However, N-methyl-phosphatidylserine, which is transported by the plasma membrane flippase at a rate equivalent to PS, is incapable of activating Atp8a1 activity.|N-methyl-phosphatidylserine|flippase|3|12|Arg1:T22|Arg2:T45|CHEMICAL|GENE|SUBSTRATE|2878
14757703|(3)H-CGP 12177A saturation binding, in the presence of propranolol, increased approximately 5-fold following overexpression of beta(1)-adrenoceptors.|propranolol|beta(1)-adrenoceptors|13|21|Arg1:T10|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2879
17161452|Possession of CYP2C9*2 or CYP2C9*3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean warfarin dose.|warfarin|CYP2C9|25|3|Arg1:T8|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|2880
23164921|In addition, our exploration further revealed that the suppressive action of catalpol on inflammation was mediated via inhibiting nuclear factor-κB (NF-κB) activation.|catalpol|NF-κB|13|23|Arg1:T10|Arg2:T12|CHEMICAL|GENE|INHIBITOR|2881
23435910|Additionally, the expression of hepatic fibrosis-related factors such as α-smooth muscle actin and transforming growth factor-β1 (TGF-β1), were reduced in rats treated with sinapic acid.|sinapic acid|α-smooth muscle actin|28|11|Arg1:T16|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2882
17320868|Moreover, ERalpha mediated the protection afforded by estrogen since only the ERalpha agonist, HPTE, but not the ERbeta agonist, DPN, protected against dopamine cell loss.|DPN|ERbeta|24|21|Arg1:T2|Arg2:T35|CHEMICAL|GENE|AGONIST|2883
16618126|The purified Atp8a1 is inactive in detergent micelles or in micelles containing phosphatidylcholine, phosphatidic acid, or phosphatidylinositol, is minimally activated by phosphatidylglycerol or phosphatidylethanolamine (PE), and is maximally activated by PS.|PE|Atp8a1|29|3|Arg1:T6|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|2884
1978244|  Using the alpha 1-adrenoceptor subtype-selective antagonists chlorethylclonidine (CEC), WB4101, and 5-methyl-urapidil, we have examined the possible heterogeneity in the alpha 1-adrenoceptor populations in rabbit aorta.|WB4101|alpha 1-adrenoceptor|12|3|Arg1:T24|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|2885
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|STI571|kinase|16|6|Arg1:T38|Arg2:T53|CHEMICAL|GENE|INHIBITOR|2886
17350061|The expression of key genes important in methionine metabolism, such as methionine adenosyltransferase-1a, betaine-homocysteine methyltransferase and thioether S-methyltransferase, were suppressed.|methionine|thioether S-methyltransferase|8|19|Arg1:T6|Arg2:T35|CHEMICAL|GENE|PRODUCT-OF|2887
10712236|Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.|DFMO|ornithine decarboxylase|12|19|Arg1:T25|Arg2:T39|CHEMICAL|GENE|INHIBITOR|2888
22445601|These results confirm the selective mGlu2 agonist and mGlu3 antagonist actions of LY541850.|LY541850|mGlu3|13|9|Arg1:T1|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|2889
23432124|(2R)-IKM-159 locks the GluA2 in an open form, consistent with a pharmacological action as competitive antagonist of AMPA receptors.|(2R)-IKM-159|GluA2|1|7|Arg1:T11|Arg2:T15|CHEMICAL|GENE|INHIBITOR|2890
7926307|We conclude that expression of GLUT2 is required for efficient killing of neuroendocrine cells by STZ, and this effect is related to specific recognition of the drug as a transported substrate by GLUT2 but not GLUT1.|STZ|GLUT2|16|6|Arg1:T2|Arg2:T15|CHEMICAL|GENE|SUBSTRATE|2891
10064839|Furthermore, since they have equipotent anticonvulsant effects and similar binding affinities to sigma-1 receptors, the very low affinity of DF at PCP sites may suggest that acting on the PCP sites may not be the requisite for mediating the anticonvulsant activity of these DM analogs.|DF|sigma-1 receptors|22|14|Arg1:T18|Arg2:T53|CHEMICAL|GENE|DIRECT-REGULATOR|2892
17229632|RESULTS: We show that sorafenib is a potent inhibitor of ETV6-PDGFRbeta and FLT3 mutants, including some of the mutants that confer resistance to PKC412 and other FLT3 inhibitors.|sorafenib|FLT3|6|14|Arg1:T2|Arg2:T19|CHEMICAL|GENE|INHIBITOR|2893
22370641|These results showed that WNT6 and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to anthracycline drugs.|anthracycline|Cav1|20|7|Arg1:T4|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2894
16417577|Galanin attenuates cyclic AMP regulatory element-binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures.|morphine|CREB|15|9|Arg1:T6|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|2895
20053189|Abarelix was the first GnRH antagonist to be developed and was approved by the USA Food and Drug Administration in 2004 for the initiation of hormonal castration in advanced or metastasizing hormone-dependent prostate carcinoma, when rapid androgen suppression is necessary.|Abarelix|GnRH|1|5|Arg1:T18|Arg2:T29|CHEMICAL|GENE|ANTAGONIST|2896
10988273|In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the alpha(2)-autoreceptors, sharing this property with rauwolscine, phentolamine, and idazoxan.|rilmenidine|alpha(2)-autoreceptors|7|26|Arg1:T15|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|2897
17224860|CONCLUSION: In postmenopausal women, isolated isoflavone treatment does not affect ABCA1-dependent cholesterol efflux potential from macrophages but increases circulating pre-beta high-density lipoprotein level, which could provide beneficial vascular effects.|isoflavone|pre-beta high-density lipoprotein|8|22|Arg1:T11|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2898
23535516|Blockade of JAK and ERK pathways with AG490 and U0126, respectively, abrogated the myocardial infarct size reduction by NDP-α-MSH.|AG490|JAK|8|3|Arg1:T3|Arg2:T30|CHEMICAL|GENE|INHIBITOR|2899
23440512|The pleiotropic effects of vitamin A are exerted mainly by one active metabolite, all-trans retinoic acid (atRA), which regulates the expression of a battery of target genes through several families of nuclear receptors (RARs, RXRs and PPARβ/δ), polymorphic retinoic acid (RA) response elements and multiple coregulators.|atRA|RXRs|19|41|Arg1:T5|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2900
23261645|Jaspamide also inhibited other channels including Cav1.2, Cav3.2, and HCN2; however, the Kv11.1 (hERG) channel was minimally affected.|Jaspamide|HCN2|1|12|Arg1:T10|Arg2:T16|CHEMICAL|GENE|INHIBITOR|2901
12244038|These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.|gemfibrozil|AP-1|5|19|Arg1:T5|Arg2:T51|CHEMICAL|GENE|INHIBITOR|2902
17575572|An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT-2331 using vibrational circular dichroism.|GT-2331|histamine H3 receptor|14|10|Arg1:T5|Arg2:T7|CHEMICAL|GENE|ANTAGONIST|2903
11474486|Fibrates bind to the peroxisome proliferator-activated receptor (PPAR)-alpha, and thiazolidinediones are ligands of PPAR-gamma.|Fibrates|peroxisome proliferator-activated receptor (PPAR)-alpha|1|5|Arg1:T4|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|2904
11009561|The BH(4) treatment was associated with a 2-fold increase in eNOS activity as well as a 70% reduction in endothelial O(2)(-) production compared with those in fructose-fed rats.|BH(4)|eNOS|2|14|Arg1:T21|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|2905
17488480|Caerulein increased the levels of H(2)S and CSE mRNA expression while CBS mRNA expression was decreased.|Caerulein|CBS|1|16|Arg1:T20|Arg2:T47|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2906
23614730|Results: The administration of prallethrin 1.6% w/w created significant increased changes in the levels of total WBC, lymphocytes, RBC, hemoglobin, packed cell volume, platelets, mean corpuscular volume, and mean corpuscular hemoglobin in rats after 24, 48, and 72 h of continuous inhalation; however, there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h.|prallethrin|hemoglobin|6|25|Arg1:T1|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2907
7986344|The folding rate monitored by 2'CMP binding to the major slow-folding species of Pro42Ala RNase A is faster than the folding rate monitored by tyrosine burial; however, the folding rate monitored by inhibitor binding to the minor slow-folding species is decreased significantly over the folding rate monitored by tyrosine burial, indicating that the major and minor slow-folding species of Pro42Ala fold to the native state with different transition-state conformations in the rate-determining step.|tyrosine|RNase A|25|15|Arg1:T11|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|2908
23194076|We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.|Orlistat|AMH|11|41|Arg1:T7|Arg2:T11|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2909
23240892|PKAA/anti-TNF-α siRNA nanocomplexes significantly reduced the ALT (alanine transaminase) and the hepatic cellular damages in APAP-intoxicated mice.|PKAA|alanine transaminase|1|9|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2910
23479738|In particular, nitrosylation promoted disulfide formation involving the pair of catalytic cysteines (Cys-52 and Cys-173) and disrupted the oligomeric structure of Prx1, leading to loss of peroxidase activity.|Cys|peroxidase|15|31|Arg1:T29|Arg2:T33|CHEMICAL|GENE|PART-OF|2911
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|goserelin|Luteinizing hormone-releasing hormone|13|1|Arg1:T6|Arg2:T22|CHEMICAL|GENE|AGONIST|2912
15811959|In vitro studies demonstrated that the retinoid X receptor (RXR) retinoid, bexarotene, at biologically relevant concentrations of 10(-6) M to 10(-8) M, upregulated both the p55 and p75 subunits of the IL-2R and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox.|bexarotene|p75|15|39|Arg1:T4|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2913
7885191|melanogaster has been attributed to a mutation resulting in an Ala302-->Ser replacement in the Rdl GABA receptor subunit and in D.|Ser|Rdl GABA receptor|14|18|Arg1:T40|Arg2:T56|CHEMICAL|GENE|PART-OF|2914
15866288|Therefore, comparative histochemical and biochemical studies of u-PA and the effects of amiloride were performed on rabbit corneas and tear fluid using the sensitive fluorogenic substrate Z-Gly-Gly-Arg-7-amino-4-trifluoromethylcoumarin.|Z-Gly-Gly-Arg-7-amino-4-trifluoromethylcoumarin|u-PA|28|9|Arg1:T4|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|2915
9015795|The atypical neuroleptics remoxipride, clozapine, perlapine, seroquel, and melperone had low affinity for the dopamine D2 receptor (radioligand-independent dissociation constants of 30 to 90 nM).|clozapine|D2 receptor|6|20|Arg1:T11|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|2916
23246481|Moreover, wogonin repressed anisomycin-induced phosphorylation of p38, cav-1 and vascular permeability.|wogonin|p38|3|8|Arg1:T10|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2917
23231502|Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.|pThr|peptidyl-prolyl cis/trans-isomerase A1|25|6|Arg1:T14|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|2918
16971132|  In order to produce potent new leads for anticancer drugs, a new series of quinazoline analogs was designed to resemble methotrexate (MTX, 1) structure features and fitted with functional groups believed to enhance inhibition of mammalian DHFR activity.|MTX|mammalian DHFR|24|40|Arg1:T2|Arg2:T7|CHEMICAL|GENE|INHIBITOR|2919
23344961|Altogether, our findings support a model in which Top2β deficiency promotes CPT-induced apoptosis in quiescent non-S-phase cells, possibly due to RNAP LS depletion and p53 accumulation.|CPT|p53|13|27|Arg1:T2|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2920
15474503|Based on HMG-CoA reductase inhibition, pitavastatin-induced apoA-I more efficiently than simvastatin and atorvastatin.|atorvastatin|apoA-I|14|8|Arg1:T12|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2921
7711211|Both 5 alpha-NET and 3 beta,5 alpha-NET blocked the PR down-regulation induced by P4 as assessed by Western and Northern blot methods.|3 beta,5 alpha-NET|PR|5|10|Arg1:T16|Arg2:T25|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2922
22301814|The treatment with arsenic exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine).|arsenic|alanine aminotransferase|4|18|Arg1:T4|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2923
15452358|  In order to examine the site of action of an NR2B subtype-selective NMDA antagonist CP-101,606, we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration.|CP-101,606|NMDA|15|13|Arg1:T10|Arg2:T19|CHEMICAL|GENE|ANTAGONIST|2924
23353658|In the in vitro model we observed high permeability of imperatorin and isoimperatorin with the P-gp-mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of cnidilin with 0.82.|isoimperatorin|P-gp|13|16|Arg1:T7|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|2925
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|Cys|TMH7|26|30|Arg1:T10|Arg2:T46|CHEMICAL|GENE|PART-OF|2926
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|BAPTA|KARs|39|5|Arg1:T3|Arg2:T47|CHEMICAL|GENE|INHIBITOR|2927
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Sar|AngII|10|25|Arg1:T1|Arg2:T16|CHEMICAL|GENE|PART-OF|2928
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|proline|RNase A|17|12|Arg1:T1|Arg2:T22|CHEMICAL|GENE|PART-OF|2929
23220749|In addition, we provide evidence that apomorphine also acts on endogenous TRPA1 in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP-1, from which serotonin is released upon activation of TRPA1.|apomorphine|TRPA1|8|39|Arg1:T2|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|2930
23439561|Cycloxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) has been shown to be important in esophageal tumorigenesis.|prostaglandin E2|COX-2|6|3|Arg1:T3|Arg2:T25|CHEMICAL|GENE|PRODUCT-OF|2931
16893531|The exception was bupropion, a dual norepinephrine transporter/dopamine transporter blocker, which tended to increase spontaneous locomotor activity.|bupropion|dopamine transporter|4|10|Arg1:T1|Arg2:T24|CHEMICAL|GENE|INHIBITOR|2932
23644213|Resulting from this study, a structurally novel class of submicromolar fibrinogen GPIIb/IIIa binding inhibitor bearing 1,2,4-oxadiazol-5(4H)-one moiety is also described.|1,2,4-oxadiazol-5(4H)-one|GPIIb/IIIa|17|13|Arg1:T3|Arg2:T11|CHEMICAL|GENE|INHIBITOR|2933
15908512|The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively.|isoproterenol|beta1AR|9|3|Arg1:T7|Arg2:T20|CHEMICAL|GENE|AGONIST|2934
23066089|Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.|phorbol 12-myristate,13-acetate|GluK5|24|28|Arg1:T7|Arg2:T30|CHEMICAL|GENE|ACTIVATOR|2935
17692748|  OBJECTIVES: The aim of this study was to determine whether cocaine's sympathomimetic actions can be reversed by a potent centrally acting alpha2 adrenergic receptor (AR) agonist (dexmedetomidine).|dexmedetomidine|AR|32|28|Arg1:T6|Arg2:T17|CHEMICAL|GENE|AGONIST|2936
23493568|Interestingly, insulin treatment of αXBPKD cells reduced tyrosine phosphorylation of IRS-1 (pY(896)), and phosphorylation of Akt, while enhancing serine phosphorylation (pS(307)) of IRS-1.|serine|IRS-1|27|36|Arg1:T2|Arg2:T9|CHEMICAL|GENE|PART-OF|2937
9990013|Here, we report that MgATP and MgADP, but not the Mg salt of gamma-thio-ATP, stabilize the binding of prebound 8-azido-[alpha-32P]ATP to SUR1.|8-azido-[alpha-32P]ATP|SUR1|23|29|Arg1:T21|Arg2:T47|CHEMICAL|GENE|DIRECT-REGULATOR|2938
8925876|  The potency of the antipsychotic drug, risperidone, to antagonize alpha 1A-adrenoceptor-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of alpha 1-adrenoceptor subtype-discriminating antagonists.|risperidone|alpha 1A-adrenoceptor|8|12|Arg1:T3|Arg2:T19|CHEMICAL|GENE|ANTAGONIST|2939
17334708|Mutation analysis of KYNU encoding kynureninase of the index case revealed homozygosity for a c.593 A > G substitution leading to a threonine-to-alanine (T198A) shift.|alanine|kynureninase|24|6|Arg1:T3|Arg2:T8|CHEMICAL|GENE|PART-OF|2940
22872607|  Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.|PAHs|Aldo-keto reductases|18|1|Arg1:T3|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|2941
23290724|Here, we identify a Zn²⁺-driven N-terminal to C-terminal tertiary interaction in PrP(C).|N|PrP(C)|7|13|Arg1:T5|Arg2:T12|CHEMICAL|GENE|PART-OF|2942
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|caffeic acid|CA|19|49|Arg1:T1|Arg2:T27|CHEMICAL|GENE|INHIBITOR|2943
15198222|CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.|etodolac|Canine COX-2|12|6|Arg1:T2|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2944
17016621|Similar to AMR and AMROH, adriamycin and etoposide (VP-16) are DNA topoisomerase II inhibitors.|adriamycin|DNA topoisomerase II|7|14|Arg1:T5|Arg2:T21|CHEMICAL|GENE|INHIBITOR|2945
17111172|Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.|flupentixol|serotonin (2A) receptors|24|14|Arg1:T12|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|2946
12046981|Olopatadine is a selective histamine H1-receptor antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as leukotriene and thromboxane from human polymorphonuclear leukocytes and eosinophils.|Olopatadine|histamine H1-receptor|1|5|Arg1:T13|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|2947
23024204|We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidine/spermine-N(1)-acetyltransferase (SSAT1) and by thialysine acetyltransferase (SSAT2) to its monoacetylated derivative (MAT).|TETA|SSAT1|5|20|Arg1:T8|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|2948
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|CEP-701|Flt3|31|43|Arg1:T19|Arg2:T34|CHEMICAL|GENE|INHIBITOR|2949
23506741|Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.|Fc11a-2|TNF-α|29|15|Arg1:T9|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2950
23530834|Design, Synthesis, Biological Evaluation, and Docking Studies of (S)-Phenylalanine Derivatives with a 2-Cyanopyrrolidine Moiety as Potent Dipeptidyl Peptidase 4 Inhibitors.|(S)-Phenylalanine|Dipeptidyl Peptidase 4|12|23|Arg1:T5|Arg2:T10|CHEMICAL|GENE|INHIBITOR|2951
23047022|  Although acetylcholinesterase (AChE) is primarily a hydrolytic enzyme, metabolising the neurotransmitter acetylcholine in cholinergic synapses, it also has some non-catalytic functions in the brain which are far less well characterised.|acetylcholine|AChE|15|4|Arg1:T1|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|2952
17016621|Enhancement of radiosensitivity by topoisomerase II inhibitor, amrubicin and amrubicinol, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction.|amrubicinol|topoisomerase II|11|5|Arg1:T20|Arg2:T22|CHEMICAL|GENE|INHIBITOR|2953
17507169|  [N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide] (SR 141716A), a selective cannabinoid CB1 receptor antagonist, injected into the paraventricular nucleus of the hypothalamus (PVN) of male rats, induces penile erection.|N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide|cannabinoid CB1 receptor|2|19|Arg1:T6|Arg2:T16|CHEMICAL|GENE|ANTAGONIST|2954
16920841|  Choline dehydrogenase (CHDH) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in choline oxidation.|choline|betaine-homocysteine methyltransferase|17|7|Arg1:T2|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|2955
21712771|The C-terminal antibodies detected both proteins in extracts of mouse medulla/pons, cortex, hypothalamus, and cerebellum but only the 73 kD protein and higher molecular weight immunoreactive proteins in mouse adrenal and rat PC12 cells, which are positive controls for rodent VMAT-1.|C|rodent VMAT-1|2|44|Arg1:T3|Arg2:T10|CHEMICAL|GENE|PART-OF|2956
23410005|Our previous work, built on the early pioneering multikinase inhibitor LY294002, resulted in the only PI3K vascular-targeted PI3K inhibitor prodrug, SF1126, which has now completed Phase I clinical trials.|SF1126|PI3K|24|20|Arg1:T2|Arg2:T8|CHEMICAL|GENE|INHIBITOR|2957
23583257|In fact, we demonstrated a significant stimulation of Nox4 activity by 4 quinone derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx™, and chondrocyte cell lines.|tBuBHQ|Nox4|19|10|Arg1:T7|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|2958
23123662|Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.|cisplatin|rCtr1|22|10|Arg1:T22|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|2959
15737409|NPC1L1 could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant sterols.|sterols|NPC1L1|21|1|Arg1:T18|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|2960
23418674|The results suggested that both the EtOAc extract and berberine were able to activate PPARα/β/γ, and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine.|EtOAc|PPARα/β/γ|7|15|Arg1:T2|Arg2:T10|CHEMICAL|GENE|AGONIST-ACTIVATOR|2961
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|alanine serine cysteine transporter 1|14|36|Arg1:T23|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|2962
9399012|Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.|311C90|5HT1B/1D|9|17|Arg1:T22|Arg2:T27|CHEMICAL|GENE|AGONIST|2963
12956944|The decrement of p-CREB protein in the nucleus accumbens remained at 24 h (-35 %) and 72 h (-28 %) of ethanol withdrawal, which recovered toward control level after 7 d of ethanol withdrawal.|ethanol|p-CREB|26|4|Arg1:T11|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2964
16920841|Independent of dietary choline, supplemental Met increased hepatic BHMT activity approximately 30%.|Met|BHMT|7|10|Arg1:T4|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|2965
12699699|The protein exhibited modest H(2)O(2)-dependent peroxidase activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).|H(2)O(2)|peroxidase|5|14|Arg1:T3|Arg2:T16|CHEMICAL|GENE|ACTIVATOR|2966
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|Crocin|Bax|1|27|Arg1:T1|Arg2:T32|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2967
17094978|CONCLUSION(S): Short-term exposure of mifepristone in new starters of DMPA increases the expression of endometrial ERalpha, PRAB, PRB, and SRC-1 and promotes cell proliferation.|mifepristone|PRAB|9|22|Arg1:T3|Arg2:T25|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2968
23570998|Further, both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, RunX2, osteoprotegerin and osteocalcin.|flavonoids|osteoprotegerin|5|30|Arg1:T17|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|2969
3994963|Each adduct had a reduced ability to activate cyclic nucleotide phosphodiesterase and myosin light chain kinase, and the chlorpromazine binding capacities of the phenoxybenzamine-calmodulin adducts were diminished to the extent of phenoxybenzamine incorporation into each adduct.|chlorpromazine|calmodulin|20|26|Arg1:T6|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|2970
23330546|  Bile acids are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.|Bile acids|constitutive androstane receptor|1|21|Arg1:T1|Arg2:T10|CHEMICAL|GENE|ACTIVATOR|2971
12636181|  Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.|ACh|butyrylcholinesterase|27|12|Arg1:T3|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|2972
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|quercetin|EC 4.2.1.1|31|51|Arg1:T7|Arg2:T28|CHEMICAL|GENE|INHIBITOR|2973
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|OSI-774|VEGF receptor|28|42|Arg1:T7|Arg2:T44|CHEMICAL|GENE|INHIBITOR|2974
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|4-aminobiphenyl|cyt b5|13|51|Arg1:T21|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|2975
8606397|One group of experimental animals was treated with 5-lipoxygenase (5-LO) inhibitor, diethylcarbamazine (DEC, Sigma, St. Louis, Missouri) (50 mg/kg, i.v.), immediately before blast.|DEC|5-lipoxygenase|17|9|Arg1:T5|Arg2:T10|CHEMICAL|GENE|INHIBITOR|2976
23100158|The significantly decreased levels of p-PI3K and p-AKT expression were observed in SGC-7901 cells after β-ionone treatments in a time- and dose-dependent manner (P < 0.01).|β-ionone|p-PI3K|16|6|Arg1:T8|Arg2:T16|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2977
23024204|By contrast, 1,12-diamino-3,6,9-triazadodecane(SpmTrien), a charge-deficient spermine analog, was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wild-type primary hepatocytes.|spermine|SSAT1|11|27|Arg1:T20|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|2978
9990013|This direct biochemical evidence of cooperative interaction in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this cooperative binding of ATP and MgADP and, in cooperation with the MgADP bound at NBF2, causes ATP to be released from NBF1.|glibenclamide|NBF1|19|46|Arg1:T6|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|2979
7768269|Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg).|raclopride|dopamine D2 receptor|58|54|Arg1:T26|Arg2:T29|CHEMICAL|GENE|ANTAGONIST|2980
2859531|To study the mechanism underlying this phenomenon, the effects of the nonselective beta-adrenoceptor antagonists propranolol [no intrinsic sympathomimetic activity (ISA)], alprenolol (weak ISA) and mepindolol (strong ISA) on lymphocyte beta 2-adrenoceptor density--assessed by (+/-)-[125I]-iodocyanopindolol (ICYP) binding--and plasma renin activity (PRA) were investigated in male healthy volunteers aged 23-35 years.|alprenolol|beta-adrenoceptor|27|14|Arg1:T6|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|2981
23128353|In addition, glucosamine attenuated p21 protein stability via the proteasomal proteolytic pathway, as well as inducing p21 nuclear accumulation.|glucosamine|p21|4|6|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2982
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|alanine|SNAT2|14|40|Arg1:T16|Arg2:T42|CHEMICAL|GENE|SUBSTRATE|2983
17138606|5-HT3 receptor antagonism with alosetron reduced responses to 5-HT in controls but not during inflammation.|alosetron|5-HT3 receptor|5|1|Arg1:T10|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|2984
12244038|These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.|gemfibrozil|iNOS|5|10|Arg1:T5|Arg2:T49|CHEMICAL|GENE|INHIBITOR|2985
17154506|MicroPET imaging in nonhuman primates with [11C]1 and [11C]2 demonstrated that both tracers behave similarly in vivo with high uptake being observed in the SERT-rich brain regions and peak uptake being achieved in about 55 min postinjection.|11C|SERT|8|31|Arg1:T7|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|2986
12181285|The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters.|MPP+|OCT|12|23|Arg1:T5|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|2987
18973551|Quinpirole and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.|Quinpirole|ERK|1|13|Arg1:T5|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|2988
23479738|A highly potent inhibition of the peroxidase catalytic reaction by NO/SNO was seen in assays employing the coupled Prx-Trx system.|NO|peroxidase|11|7|Arg1:T3|Arg2:T34|CHEMICAL|GENE|INHIBITOR|2989
23098818|The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study.|5-methoxytryptamine|cytochrome P450|13|5|Arg1:T19|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|2990
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Gefitinib|kinase|21|44|Arg1:T4|Arg2:T45|CHEMICAL|GENE|INHIBITOR|2991
10727528|It has no influence on the rate of association of (125)I-ET-1 to ETA receptors.|(125)I|ET-1|11|15|Arg1:T12|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|2992
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|EVn-50|Cdc25c|3|48|Arg1:T2|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2993
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|EVn-50|Cdk1|3|35|Arg1:T2|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|2994
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Gln|AngII|15|25|Arg1:T2|Arg2:T16|CHEMICAL|GENE|PART-OF|2995
12679340|The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.|Lys|OTCase|15|30|Arg1:T18|Arg2:T21|CHEMICAL|GENE|PART-OF|2996
15939622|As expected, comparison of IC50 indicated that meloxicam and carprofen are more selective inhibitors of COX-2 than phenylbutazone and flunixin; meloxicam was the most advantageous for horses of four NSAIDs examined.|flunixin|COX-2|21|17|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INHIBITOR|2997
16938288|Since the suppression of AT1R expression was prevented by pretreatment with GW9662, a PPARgamma antagonist, PPARgamma should have participated in the process.|GW9662|PPARgamma|12|15|Arg1:T4|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|2998
23266505|Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of calpain and AIF levels.|spironoclactone|AIF|5|22|Arg1:T4|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|2999
14757703|(3)H-CGP 12177A saturation binding, in the presence of propranolol, increased approximately 5-fold following overexpression of beta(1)-adrenoceptors.|(3)H-CGP 12177A|beta(1)-adrenoceptors|1|21|Arg1:T9|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3000
1686208|Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.|dimethindene|histamine H1-receptor|16|3|Arg1:T13|Arg2:T18|CHEMICAL|GENE|ANTAGONIST|3001
23030680|In vitro metabolism of the 5-hydroxytryptamine1B receptor antagonist elzasonan.|elzasonan|5-hydroxytryptamine1B|9|6|Arg1:T10|Arg2:T25|CHEMICAL|GENE|ANTAGONIST|3002
23473681|We provide STD NMR data which confirms a physical interaction between LolA and the thiourea degradation product of MAC13243, with a Kd of ~150 μM.|MAC13243|LolA|19|12|Arg1:T8|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|3003
17205056|We show that sorafenib (BAY 43-9006, Nexavar) potently inhibits FLT3 enzymatic and signaling activities.|sorafenib|FLT3|4|13|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INHIBITOR|3004
2899826|Their histamine H1 receptor binding affinities indicate that metabolites may contribute to the sedative effects of chlorpromazine and levomepromazine.|levomepromazine|histamine H1 receptor|19|2|Arg1:T3|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|3005
22931533|The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.|eseroline|AChE|7|21|Arg1:T6|Arg2:T13|CHEMICAL|GENE|DIRECT-REGULATOR|3006
10702256|Removal of N- and O-linked oligosaccharides reduces the M(r) to approximately 160,000, suggesting that approximately 60% of the mass of SPACRCAN is carbohydrate.|O|SPACRCAN|5|26|Arg1:T3|Arg2:T11|CHEMICAL|GENE|PART-OF|3007
17344208|The 2.0-A resolution structure of Thermus thermophilus PRODH reveals a distorted (betaalpha)(8) barrel catalytic core domain and a hydrophobic alpha-helical domain located above the carboxyl-terminal ends of the strands of the barrel.|carboxyl|Thermus thermophilus PRODH|30|6|Arg1:T10|Arg2:T24|CHEMICAL|GENE|PART-OF|3008
15840827|  The two active sites of dimeric 5-aminolevulinate synthase (ALAS), a pyridoxal 5'-phosphate (PLP)-dependent enzyme, are located on the subunit interface with contribution of essential amino acids from each subunit.|amino acids|5-aminolevulinate synthase|32|7|Arg1:T5|Arg2:T19|CHEMICAL|GENE|PART-OF|3009
23435942|Cholinesterase inhibitors enhance cholinergic transmission directly by inhibiting the enzyme acetylcholinesterase (AChE) which hydrolyses acetylcholine.|acetylcholine|acetylcholinesterase|17|11|Arg1:T10|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|3010
12217700|  The bacterial enzyme maltodextrin phosphorylase (MalP) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as glucose-1-phosphate (Glc1P).|Glc1P|MalP|30|7|Arg1:T14|Arg2:T33|CHEMICAL|GENE|PRODUCT-OF|3011
15837926|PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.|folate|glutamate carboxypeptidase|16|5|Arg1:T2|Arg2:T11|CHEMICAL|GENE|SUBSTRATE|3012
23159529|Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells.|17864|multikinase|13|11|Arg1:T13|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3013
23564313|Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.|vinblastine|kinase|3|51|Arg1:T7|Arg2:T31|CHEMICAL|GENE|ACTIVATOR|3014
22982218|We also investigated the epigenetic status of NIS promoter after PJ34 treatment in TPC1 cell line: in addition to an increase of histone modification activation marks (H3K9K14ac, H3K4me3), surprisingly we observed also an increase of H3K27me3, a classical repressive mark.|PJ34|H3K9K14ac|11|29|Arg1:T5|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3015
15723099|Dimemorfan pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression, activator protein (AP)-1 DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus.|KA|c-jun|6|10|Arg1:T26|Arg2:T39|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3016
16424790|Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.|sulfhydryl|ACE|12|19|Arg1:T48|Arg2:T67|CHEMICAL|GENE|INHIBITOR|3017
17221210|Finally, we showed that chlorate activated endocrine cell development by inducing neurogenin 3 (Neurog3) expression in early endocrine progenitor cells.|chlorate|Neurog3|6|16|Arg1:T8|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3018
16336752|Tyrosine kinase inhibitors are quinazoline-derived, low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors, including EGFR, Erb2, and vascular endothelial growth factor receptor, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of EGFR signaling.|quinazoline|Tyrosine kinase|5|1|Arg1:T2|Arg2:T4|CHEMICAL|GENE|INHIBITOR|3019
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Gleevec|Abl|14|23|Arg1:T37|Arg2:T55|CHEMICAL|GENE|INHIBITOR|3020
22996137|Though microtubule mediated actin remodeling through PKCζ, reorganization of microtubule depended on tyrosine phosphorylation of insulin receptor, the mechanism is different from insulin-induced actin remodeling, which relied on the activity of PI3-kinase and PKCζ.|tyrosine|insulin receptor|14|17|Arg1:T4|Arg2:T21|CHEMICAL|GENE|PART-OF|3021
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|Gleevec|kinase|14|6|Arg1:T37|Arg2:T53|CHEMICAL|GENE|INHIBITOR|3022
23512754|In macrophages, levels of TNF-α, IFN-γ, NO, IL-6 and IL-10 were increased by CDM used alone or in combination with HSV-2.|CDM|IL-10|18|14|Arg1:T11|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3023
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|ZK 222584|TK|39|3|Arg1:T26|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3024
10424850|  The antidepressant desipramine has been shown to decrease synaptic membrane concentrations of the norepinephrine re-uptake transporter (NET) in vivo and in vitro, on both an acute and a chronic basis.|desipramine|NET|3|18|Arg1:T1|Arg2:T10|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3025
7986344|  The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (2'CMP) inhibitor binding.|2'CMP|RNase A|33|12|Arg1:T5|Arg2:T22|CHEMICAL|GENE|INHIBITOR|3026
19429089|Moreover, kinetic analysis revealed that inhibition by reserpine, a typical VMAT2 inhibitor, was uncompetitive, decreasing maximum velocity and affinity for dopamine.|dopamine|VMAT2|25|13|Arg1:T20|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|3027
16213084|This process was reduced by a protonophore, carbonylcyanide p-trifluoromethoxyphenylhydrazone, and a typical monocarboxylate transporter (MCT) inhibitor, alpha-cyano-4-hydroxycinnamic acid, suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system.|alpha-cyano-4-hydroxycinnamic acid|monocarboxylate transporter|22|15|Arg1:T14|Arg2:T38|CHEMICAL|GENE|INHIBITOR|3028
22718571|Swertiamarin treatment had no significant effect on adipogenesis, or the mRNA expression of PPAR-γ and GLUT-4; however, there was a significant increase in the mRNA expression of adiponectin.|Swertiamarin|adiponectin|1|31|Arg1:T6|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3029
11585753|Growth inhibition of these tumor cell lines was associated with the dephosphorylation of EGFR, HER2, and HER3, accompanied by the loss of association of HER3 with phosphatidylinositol 3-kinase, and down-regulation of Akt activity.|phosphatidylinositol|phosphatidylinositol 3-kinase|30|30|Arg1:T7|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|3030
16971132|  In order to produce potent new leads for anticancer drugs, a new series of quinazoline analogs was designed to resemble methotrexate (MTX, 1) structure features and fitted with functional groups believed to enhance inhibition of mammalian DHFR activity.|methotrexate|mammalian DHFR|22|40|Arg1:T1|Arg2:T7|CHEMICAL|GENE|INHIBITOR|3031
23298698|Local PGE2 administration prevented the increase of airway IL-13 and osteopontin and kept lung plasmacytoid dendritic cell counts close to baseline.|PGE2|IL-13|2|9|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3032
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|buserelin|LH|11|39|Arg1:T5|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3033
1590750|These findings indicate that human pulmonary ethanol-metabolizing activities differ significantly with respect to genetic polymorphism at both the ADH2 and the ALDH2 loci.|ethanol|ALDH2|7|22|Arg1:T2|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|3034
17488480|  Hydrogen sulphide (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS).|H(2)S|cystathionine-gamma-lyase|4|18|Arg1:T15|Arg2:T49|CHEMICAL|GENE|PRODUCT-OF|3035
15474503|Based on HMG-CoA reductase inhibition, pitavastatin-induced apoA-I more efficiently than simvastatin and atorvastatin.|pitavastatin|apoA-I|7|8|Arg1:T9|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3036
23142507|The 3D-structure of HmTx consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).|Asp|HmTx|19|4|Arg1:T6|Arg2:T23|CHEMICAL|GENE|PART-OF|3037
23618901|Suppression of TβR1 by the pharmacological inhibitor (SB431542) markedly reduced VEGF release by HFL-1 in response to CSE and this effect was confirmed by TβR1 siRNA.|SB431542|TβR1|9|3|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3038
16938288|  OBJECTIVE: Telmisartan, an angiotensin II type 1 receptor (AT1R) antagonist, was found to have a unique property: it is a partial agonist of peroxisome proliferator-activated receptor gamma (PPARgamma).|Telmisartan|AT1R|3|12|Arg1:T3|Arg2:T32|CHEMICAL|GENE|ANTAGONIST|3039
23127600|These findings demonstrate that cinnamon polyphenols can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity, as well as attenuating cytotoxicity via inhibition of iNOS, NF-κB activation.|polyphenols|NF-κB|6|45|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3040
23228697|This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2, a carboxylesterase with little lipase activity.|orlistat|CES2|10|19|Arg1:T6|Arg2:T27|CHEMICAL|GENE|INHIBITOR|3041
11970990|Experimentation using isoforms of alefacept engineered to have amino acid substitutions in the IgG1 C(H)2 domain that impact Fc gamma R binding indicate that alefacept mediates cognate interactions between cells expressing human CD2 and CD16 to activate cells, e.g., increase extracellular signal-regulated kinase phosphorylation, up-regulate cell surface expression of the activation marker CD25, and induce release of granzyme B.|amino acid|IgG1 C(H)2 domain|9|14|Arg1:T1|Arg2:T23|CHEMICAL|GENE|PART-OF|3042
9310349|With either substrate, alendronate was a slow binding inhibitor of PTPmeg1.|alendronate|PTPmeg1|5|12|Arg1:T14|Arg2:T35|CHEMICAL|GENE|INHIBITOR|3043
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|alanine|SNAT1|14|59|Arg1:T23|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|3044
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|Gemcitabine|deoxycytidine kinase|1|16|Arg1:T1|Arg2:T45|CHEMICAL|GENE|SUBSTRATE|3045
11166732|High p53 protein levels, but not genetic or functional p53 status, were associated with increased topotecan-induced DNA/topoisomerase I complex formation.|topotecan|p53|18|2|Arg1:T3|Arg2:T10|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3046
8606397|Although DEC exerts local antioxidant activity with beneficial effects on lung tissue, this 5-LO inhibitor intensifies the blast overpressure caused hemodynamic insufficiency.|DEC|5-LO|2|15|Arg1:T2|Arg2:T9|CHEMICAL|GENE|INHIBITOR|3047
23538162|Taken together, our results suggested that Rg1 protected against Aβ25-35-induced apoptosis at least in part by two complementary GR-dependent ERK phosphorylation pathways: (1) down-regulating HIF-1α initiated protein nitrotyrosination, and (2) inhibiting mitochondrial apoptotic cascades.|Rg1|Aβ25-35|8|11|Arg1:T11|Arg2:T25|CHEMICAL|GENE|INHIBITOR|3048
23643933|Among these differentially expressed lncRNAs, the greatest change was noted for uc002mbe.2, which had more than 300 folds induction upon TSA treatment.|TSA|uc002mbe.2|23|13|Arg1:T1|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3049
10771044|  We examined the effect of JTH-601 (3- inverted question markN-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom ethyl inverted question mark-4-methoxy-2,5,6-trimethylphenol hemifumarate), a new alpha(1L)-adrenoceptor antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs.|4-methoxy-2,5,6-trimethylphenol hemifumarate|alpha(1L)-adrenoceptor|24|29|Arg1:T6|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|3050
11588409|Like conventional ACE inhibitors, omapatrilat causes extracellular volume reduction and vasodilatation; moreover, it increases levels of atrial and brain natriuretic peptides and bradykinin.|omapatrilat|ACE|6|3|Arg1:T10|Arg2:T23|CHEMICAL|GENE|INHIBITOR|3051
23539296|Here, we have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes.|anisomycin|CAR|13|20|Arg1:T2|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|3052
17015640|  Licofelone, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.|Licofelone|cyclooxygenase|1|14|Arg1:T1|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3053
23266505|  In this study, aldosterone (ALD)-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of calpain signaling were clarified.|ALD|calpain|7|25|Arg1:T10|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3054
16371234|Furthermore, PS liposome-induced PGE2 production was significantly suppressed by indomethacin, a preferential COX-1 inhibitor, but not by NS-398, a selective COX-2 inhibitor.|indomethacin|COX-1|11|15|Arg1:T4|Arg2:T24|CHEMICAL|GENE|INHIBITOR|3055
17594192|  Phenserine, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase (AChE) and was shown to improve cognition in various experimental paradigms in rodents and dogs.|Phenserine|acetylcholinesterase|1|15|Arg1:T1|Arg2:T27|CHEMICAL|GENE|INHIBITOR|3056
11585753|"The tyrosine kinase inhibitor ZD1839 (""Iressa"") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells."|tyrosine|tyrosine kinase|2|2|Arg1:T10|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|3057
20053189|Two pure GnRH antagonists have been developed, abarelix and degarelix, that are devoid of any agonist effect on the GnRH receptor and consequently do not result in testosterone flare.|degarelix|GnRH|11|3|Arg1:T15|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|3058
23164921|Collectively, these results suggest that catalpol can exert inhibitory effects on the inflammatory reaction in astrocytes and that inactivation of NF-κB could be the major determinant for its anti-inflammatory mechanism.|catalpol|NF-κB|7|22|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INHIBITOR|3059
11730729|  In the present study, we investigated the effect of fenoterol-induced constitutive beta(2)-adrenoceptor activity on muscarinic receptor agonist- and histamine-induced bovine tracheal smooth muscle contractions.|fenoterol|beta(2)-adrenoceptor|11|13|Arg1:T10|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|3060
17352685|Consequently, PDE4 inhibitors including cilomilast and AWD 12-281 have been tested in several models of allergic and irritant skin inflammation.|cilomilast|PDE4|6|3|Arg1:T6|Arg2:T18|CHEMICAL|GENE|INHIBITOR|3061
23506741|Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.|Fc11a-2|IL-18|29|19|Arg1:T9|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3062
15704203|  Denufosol tetrasodium (INS37217) is a selective P2Y(2) agonist that stimulates ciliary beat frequency and Cl(-) secretion in normal and cystic fibrosis (CF) airway epithelia, and is being investigated as an inhaled treatment for CF.|Denufosol tetrasodium|P2Y(2)|1|9|Arg1:T1|Arg2:T20|CHEMICAL|GENE|AGONIST|3063
12719755|Angiotensin AT1 receptor antagonist losartan and the defence reaction in the anaesthetised rat.|losartan|Angiotensin AT1 receptor|5|1|Arg1:T6|Arg2:T13|CHEMICAL|GENE|ANTAGONIST|3064
9851542|  The cardiovascular effects of three different acetylcholinesterase inhibitors: physostigmine, tacrine and rivastigmine injected by intravenous (i.v.) route were compared in freely moving Wistar rats.|tacrine|acetylcholinesterase|12|7|Arg1:T21|Arg2:T32|CHEMICAL|GENE|INHIBITOR|3065
1375507|These results suggest that prostacyclin may play a role in downregulating tissue factor expression in monocytes, at least in part via elevation of intracellular levels of cyclic AMP.|prostacyclin|tissue factor|5|12|Arg1:T10|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3066
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|p-hydroxybenzoic acid|carbonic anhydrase|13|46|Arg1:T11|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3067
23703578|Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.|Simvastatin|CYP3A|1|6|Arg1:T5|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|3068
11695255|Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of prostaglandin E2 (PGE2; a product of both COX-1 and COX-2) and thromboxane B2 (as a biomarker for COX-1 activity) with parallel assessments of pain.|PGE2|COX-2|24|32|Arg1:T13|Arg2:T24|CHEMICAL|GENE|PRODUCT-OF|3069
23221006|Inhibition by phenformin of oxygen consumption via complex I respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of phenformin on complex I respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts.|phenformin|complex I|3|8|Arg1:T15|Arg2:T18|CHEMICAL|GENE|INHIBITOR|3070
23159529|Albumin nanoparticles were surface-coated with bifunctional polyethylene glycol 3500 (PEG) and a nanobody-the single variable domain of an antibody-(Ega1) against the epidermal growth factor receptor (EGFR).|PEG|Albumin|11|1|Arg1:T7|Arg2:T19|CHEMICAL|GENE|PART-OF|3071
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|okadaic acid|mGlu1|47|7|Arg1:T4|Arg2:T48|CHEMICAL|GENE|INHIBITOR|3072
23481236|Unsaturated FFAs increased DAGs, TAGs and PTP1B expression significantly, but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine (Ser) 50, Ser 398 and tyrosine 152.|tyrosine|PTP1B|35|23|Arg1:T1|Arg2:T51|CHEMICAL|GENE|PART-OF|3073
12244038|  Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.|nitric-oxide|inducible nitric-oxide synthase|17|16|Arg1:T2|Arg2:T20|CHEMICAL|GENE|PRODUCT-OF|3074
23477419|Of the new compounds, Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4) (analogue 12) displayed the highest affinity toward MOR, in the picomolar range (Ki(μ) = 3.72 pM).|(2-furyl)Map|MOR|23|39|Arg1:T11|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|3075
23097088|Interestingly, there was a loss in the binding of ICAM2 to actin during CdCl₂-induced germ cell loss, suggesting that a loss of ICAM2-actin interactions might have facilitated junction restructuring.|CdCl₂|ICAM2|15|11|Arg1:T1|Arg2:T6|CHEMICAL|GENE|DIRECT-REGULATOR|3076
16248990|This effect was reverted in the presence of atropine (ATR; 0.1 microM), which blocks the pre-synaptic muscarinic M2 receptor.|atropine|muscarinic M2 receptor|9|21|Arg1:T11|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3077
23623750|Rates of benzydamine N-oxygenation (catalyzed by FMO3) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in benzydamine N-oxygenation might be partly accounted for by the variable FMO3 expression.|benzydamine|FMO3|3|8|Arg1:T4|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|3078
10988273|In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the alpha(2)-autoreceptors, sharing this property with rauwolscine, phentolamine, and idazoxan.|rauwolscine|alpha(2)-autoreceptors|36|26|Arg1:T1|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|3079
16213084|These results provide biochemical evidence of a H(+)-coupled and saturable transport system, presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown H(+)-coupled monocarboxylate transport system, for nicotinate in rat cerebrocortical astrocytes.|nicotinate|MCT4|39|25|Arg1:T9|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|3080
23481236|We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 μM).|triglycerides|PTP1B|8|30|Arg1:T10|Arg2:T44|CHEMICAL|GENE|DIRECT-REGULATOR|3081
16324695|Preincubation with 1 microM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) caused a small but significant decrease in isoprenaline-induced E(max), indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization.|PMA|PKC|18|11|Arg1:T10|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|3082
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imiquimod|human TLR7|5|18|Arg1:T4|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|3083
10593931|Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.|amino acids|factor XI apple 3 domain|3|7|Arg1:T7|Arg2:T33|CHEMICAL|GENE|PART-OF|3084
8925876|  The potency of the antipsychotic drug, risperidone, to antagonize alpha 1A-adrenoceptor-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of alpha 1-adrenoceptor subtype-discriminating antagonists.|risperidone|alpha 1-adrenoceptor|8|43|Arg1:T3|Arg2:T16|CHEMICAL|GENE|ANTAGONIST|3085
9008235|Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect.|minoxidil|prostaglandin synthase-1|7|4|Arg1:T12|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|3086
14751502|CONCLUSION: GW572016 potently inhibits receptor phosphorylation in either EGFR- or HER2-overexpressing cell lines and has both antiproliferative and radiosensitizing effects.|GW572016|HER2|3|12|Arg1:T5|Arg2:T21|CHEMICAL|GENE|INHIBITOR|3087
10640321|The nonselective opioid receptor antagonist, naloxone (3 mg/kg, i.m.), attenuated the antitussive effects of codeine or SB 227122, indicating that the antitussive activity of both compounds is opioid receptor-mediated.|codeine|opioid receptor|21|3|Arg1:T13|Arg2:T27|CHEMICAL|GENE|AGONIST|3088
7711211|The inhibition of UG synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.|NET|PR|19|7|Arg1:T4|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3089
20230007|Here, translocation studies using the human androgen receptor (hAR) and the human glucocorticoid receptor (hGR) were performed to aid in identifying the mechanism by which anabolic-androgenic steroids (AAS) were activating hAR and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR.|steroids|hAR|32|38|Arg1:T19|Arg2:T33|CHEMICAL|GENE|ACTIVATOR|3090
23353658|In the in vitro model we observed high permeability of imperatorin and isoimperatorin with the P-gp-mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of cnidilin with 0.82.|cnidilin|P-gp|30|16|Arg1:T8|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|3091
12373557|We hypothesized that the HED compounds would be most potent at the norepinephrine transporter (NET) compared to the serotonin or dopamine transporters and that the 1R diastereomers would be more effective than 1S diastereomers.|HED|NET|5|16|Arg1:T10|Arg2:T18|CHEMICAL|GENE|INHIBITOR|3092
16917142|Tamoxifen blocks the action of estrogen by binding to the ER, and possesses both ER-agonist and antagonist properties.|estrogen|ER|6|11|Arg1:T12|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|3093
18081314|For example, Trp282 could be one of the most important residues and is suspected to play a role in the determination of specific catalytic function, which has been established by the docking studies using the NMR structure of the PGIS-bound form of U46619 and the PGIS crystal structure.|U46619|PGIS|45|48|Arg1:T4|Arg2:T34|CHEMICAL|GENE|DIRECT-REGULATOR|3094
8730743|After 7 days of DMI administration the number of beta-adrenoceptors was lower in frontal and occipital cortex and hippocampus.|DMI|beta-adrenoceptors|5|10|Arg1:T11|Arg2:T23|CHEMICAL|GENE|INHIBITOR|3095
23041257|DBDCT up-regulated the expression of Bax, down-regulated the expression of Bcl-2, and significantly increased the ratio of Bax/Bcl-2.|DBDCT|Bcl-2|1|21|Arg1:T13|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3096
23385325|We apply DFTB in a QM/MM framework to perform vibrational analysis of buried aspartic acids in bacteriorhodopsin and channelrhodopsin-2.|aspartic acids|channelrhodopsin-2|14|19|Arg1:T6|Arg2:T12|CHEMICAL|GENE|PART-OF|3097
8894610|These results indicate that the positive inotropic effect, mediated via (+/-)-tamsulosin- and oxymetazoline-sensitive subtype of alpha 1-adrenoceptors, is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates.|oxymetazoline|alpha 1-adrenoceptors|17|20|Arg1:T15|Arg2:T31|CHEMICAL|GENE|AGONIST|3098
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane|SERT|19|53|Arg1:T10|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|3099
10510456|Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.|cisapride|human ether-a-go-go-related gene (HERG) potassium channel|13|4|Arg1:T12|Arg2:T17|CHEMICAL|GENE|INHIBITOR|3100
19039322|A comparison of bosutinib with dasatinib across the whole kinase panel revealed overlapping, but distinct, inhibition profiles.|bosutinib|kinase|4|10|Arg1:T9|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3101
15777622|In this study, using a model of gentamicin C (GMC)-induced reduction in SGLT1 activity, we examined whether ligands for megalin protect LLC-PK1 cells from the GMC-induced reduction in SGLT1 activity.|GMC|SGLT1|12|17|Arg1:T12|Arg2:T30|CHEMICAL|GENE|INHIBITOR|3102
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|2',2'-difluorodeoxyuridine|Lys27Gln|48|8|Arg1:T12|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|3103
3134891|The binding of phenoxybenzamine to calmodulin was fairly selective in that other alpha-adrenergic agents such as prazosin, yohimbine and clonidine failed to bind to calmodulin when examined under the same experimental conditions.|phenoxybenzamine|calmodulin|4|6|Arg1:T1|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|3104
12679340|In OTCase, mutations of putative ornithine binding residues, Asp-182, Asn-184, Asn-185, Cys-289, and Glu-256 greatly reduced the affinity for ornithine and impaired the interaction with arginase.|Cys|OTCase|17|2|Arg1:T12|Arg2:T28|CHEMICAL|GENE|PART-OF|3105
10546982|Citalopram protected against the RTI-76-induced inhibition of SERT binding.|Citalopram|SERT|1|8|Arg1:T4|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|3106
23123662|Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.|platinum|rat Ctr1|13|3|Arg1:T29|Arg2:T43|CHEMICAL|GENE|SUBSTRATE|3107
23142507|The enzyme is an acidic protein with a pI of 5.6 and an apparent molecular weight of 14018.4 Da. The nucleotide sequence of HmTx contains 649 bp, and the mature protein is predicted to have 131 amino acid residues-104 of which make up the large subunit, and 27 of which make up the small subunit.|amino acid|HmTx|39|25|Arg1:T2|Arg2:T19|CHEMICAL|GENE|PART-OF|3108
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|PKC412|kinase|29|44|Arg1:T18|Arg2:T35|CHEMICAL|GENE|INHIBITOR|3109
15121646|CONCLUSIONS: These data affirm that ziprasidone is similar to other novel antipsychotics in having greater 5-HT(2) than D(2) receptor occupancy at therapeutic doses and suggest that the optimal effective dose of ziprasidone is closer to 120 mg/day than to the lower doses suggested by previous PET studies.|ziprasidone|D(2) receptor|7|22|Arg1:T3|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|3110
9851542|The alpha1-adrenoceptor antagonist prazosin or the vasopressin V1 receptor antagonist, [beta-mercapto-beta,beta-cyclopenta-methylenepropionyl1, O-Me-Tyr2, Arg8] vasopressin partially but significantly reduced tacrine pressor effect and mostly abolished it when administered concomitantly.|prazosin|alpha1-adrenoceptor|4|2|Arg1:T17|Arg2:T34|CHEMICAL|GENE|ANTAGONIST|3111
16965760|It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.|D-myo-inositol 1-phosphate|inositol monophosphatase|15|23|Arg1:T16|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|3112
12956944|RESULTS: Ethanol given to rats in drinking water decreased the level of p-CREB protein in the nucleus accumbens (-75 %) at the time of exposure to ethanol.|Ethanol|p-CREB|3|14|Arg1:T8|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3113
23246481|We found that wogonin can suppress the H2O2-stimulated actin remodeling and albumin uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.|H2O2|albumin|8|12|Arg1:T7|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3114
15635044|Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.|Pro|rat GnRHR|41|48|Arg1:T18|Arg2:T49|CHEMICAL|GENE|PART-OF|3115
23625804|Together, the information on both hCCS and hSOD1, along with a sequence analysis of eukaryotic CCSD1, allows us to propose important mechanistic aspects regarding the copper-transfer process from hCCS to hSOD1.|copper|hCCS|29|32|Arg1:T6|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|3116
23143891|CYP3A5, which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize triamcinolone acetonide, budesonide, and fluticasone propionate.|fluticasone propionate|CYP3A5|26|1|Arg1:T3|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|3117
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|indolocarbazoles|kinase|28|44|Arg1:T17|Arg2:T35|CHEMICAL|GENE|INHIBITOR|3118
15177307|  The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel cyclooxygenase-2 (COX-2) selective inhibitor lumiracoxib (Prexige), so that dose recommendations for clinical use can be provided.|Prexige|cyclooxygenase-2|31|23|Arg1:T7|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3119
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|piperazonyl quinazoline|Flt3|35|43|Arg1:T20|Arg2:T34|CHEMICAL|GENE|INHIBITOR|3120
15563928|The objective of the present study was to compare the anti-inflammatory effects of the preferential COX-2 inhibitor etodolac with the non-selective COX inhibitor phenylbutazone in horses with lipopolysaccharide (LPS)-induced synovitis.|phenylbutazone|COX|24|22|Arg1:T9|Arg2:T25|CHEMICAL|GENE|INHIBITOR|3121
18068977|Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin.|atorvastatin|dipeptidyl peptidase-IV|9|3|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|3122
23481236|Only FFAs that increased ceramides caused impairment of AKt and PTP1B phosphorylation at Ser 50.|Ser|PTP1B|14|11|Arg1:T7|Arg2:T31|CHEMICAL|GENE|PART-OF|3123
23128353|Altogether, our results suggest that a high dose of glucosamine may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G(0)/G(1) phase, and that this occurs, at least in part, by a reduction in Rb phosphorylation together with modulation of p21, p53 and HO-1 expression, and nuclear p21 accumulation.|glucosamine|p21|11|66|Arg1:T2|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3124
20531964|  Everolimus (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (mammalian target of rapamycin) to reach the oncology clinic.|RAD001|mTOR|3|19|Arg1:T3|Arg2:T18|CHEMICAL|GENE|INHIBITOR|3125
12727196|Purified PAOh1/SMO oxidizes both spermine (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine.|N(1)-acetylspermine|PAOh1|15|2|Arg1:T4|Arg2:T15|CHEMICAL|GENE|SUBSTRATE|3126
9832994|Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in plasma prolactin and ACTH levels after i.v. mCPP, pointing to a general state of arousal in these mCPP-treated animals.|mCPP|ACTH|23|18|Arg1:T17|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3127
23618921|Here we show that fisetin rapidly increases the levels of both Nrf2 and ATF4 as well as Nrf2- and ATF4-dependent gene transcription via distinct mechanisms.|fisetin|ATF4|5|14|Arg1:T19|Arg2:T36|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3128
23564313|In addition, vinblastine induces the DNA-binding activities of the transcription factor NF-κB, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.|vinblastine|HSF1|4|15|Arg1:T1|Arg2:T14|CHEMICAL|GENE|ACTIVATOR|3129
17256745|The absence or presence of a cytosolic pool of BAAT has important implications for the intracellular transport of unconjugated/deconjugated bile salts.|bile salts|BAAT|20|10|Arg1:T9|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|3130
7554708|Moreover, the production of TXB2 during whole blood clotting was assessed as an index of the cyclooxygenase activity of platelet PGHS-1 ex vivo.|TXB2|cyclooxygenase|6|18|Arg1:T16|Arg2:T31|CHEMICAL|GENE|PRODUCT-OF|3131
14523001|Cat-1, the transporter for the essential amino acids, arginine and lysine, is one of the up-regulated genes.|arginine|Cat-1|11|1|Arg1:T4|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|3132
1322047|These effects were not mimicked by oral administration of the beta 2-adrenoceptor agonist salbutamol even at high dose (52 mg/kg diet), and the effects of clenbuterol were not inhibited by addition of DL-propranolol (200 mg/kg diet).|salbutamol|beta 2-adrenoceptor|14|11|Arg1:T3|Arg2:T16|CHEMICAL|GENE|AGONIST|3133
20421509|Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization.|TFP|S100A4|6|9|Arg1:T7|Arg2:T27|CHEMICAL|GENE|INHIBITOR|3134
23142699|We show that the expression of PIM-1 is induced in response to estradiol in MCF-7 cells and that the induction is mediated by ERα-regulated enhancers located distally upstream from the gene.|estradiol|ERα|13|24|Arg1:T1|Arg2:T8|CHEMICAL|GENE|ACTIVATOR|3135
11775064|The elevation in brain alanine levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of PLZ on alanine transaminase (ALA-T), although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced.|alanine|alanine transaminase|5|26|Arg1:T23|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|3136
12244038|  Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.|Gemfibrozil|iNOS|1|20|Arg1:T1|Arg2:T29|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3137
16213084|This process was reduced by a protonophore, carbonylcyanide p-trifluoromethoxyphenylhydrazone, and a typical monocarboxylate transporter (MCT) inhibitor, alpha-cyano-4-hydroxycinnamic acid, suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system.|alpha-cyano-4-hydroxycinnamic acid|MCT|22|18|Arg1:T14|Arg2:T39|CHEMICAL|GENE|INHIBITOR|3138
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|probenecid|Panx1|38|6|Arg1:T4|Arg2:T39|CHEMICAL|GENE|INHIBITOR|3139
8294418|Both NE and phorbol esters increased the rate of alpha-AR mRNA degradation.|phorbol esters|alpha-AR|4|10|Arg1:T15|Arg2:T31|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3140
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Glivec|PDGFRA|7|28|Arg1:T4|Arg2:T15|CHEMICAL|GENE|INHIBITOR|3141
23266505|Activation of an apoptotic signal transduction pathway involved in the upregulation of calpain and apoptosis-inducing factor in aldosterone-induced primary cultured cardiomyocytes.|aldosterone|calpain|18|13|Arg1:T19|Arg2:T37|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3142
7711211|The inhibition of UG synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.|3 beta,5 alpha-NET|UG|13|4|Arg1:T3|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3143
12244038|  Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.|nitric-oxide|iNOS|17|20|Arg1:T2|Arg2:T29|CHEMICAL|GENE|PRODUCT-OF|3144
16213084|Because l-lactate reduced to 67% of the nicotinate uptake even at 10mM, it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 and/or MCT2.|nicotinate|MCT1|19|27|Arg1:T3|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|3145
11861820|Also in contrast to effects of multiple METH injections, 1) MDMA caused little or no decrease in binding of the DAT ligand WIN35428, and 2) neither prevention of hyperthermia nor prior depletion of DA prevented the MDMA-induced reduction in plasmalemmal DA transport.|DA|DAT|38|23|Arg1:T24|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|3146
23542114|ATO inhibited the phosphorylation and activation of AKT and STAT3 through Notch signaling blockade.|ATO|AKT|1|8|Arg1:T5|Arg2:T9|CHEMICAL|GENE|INHIBITOR|3147
15285788|In competition experiments with human lung glucocorticoid receptors we have determined the relative receptor affinities (RRA) of these substances with reference to dexamethasone (RRA = 100).|dexamethasone|human lung glucocorticoid receptors|25|5|Arg1:T7|Arg2:T15|CHEMICAL|GENE|DIRECT-REGULATOR|3148
23221006|Inhibition by phenformin of oxygen consumption via complex I respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of phenformin on complex I respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts.|phenformin|complex I|28|30|Arg1:T3|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3149
9990013|The KATP channel is a heterooligomeric complex of SUR1 subunits of the ATP-binding-cassette superfamily with two nucleotide-binding folds (NBF1 and NBF2) and the pore-forming Kir6.2 subunits.|ATP|NBF1|13|20|Arg1:T14|Arg2:T44|CHEMICAL|GENE|DIRECT-REGULATOR|3150
23313557|In Alexander cells, only when they were transfected with FXR+RXR, GW4064 caused up-regulation of SHP and OSTβ, and a down-regulation of CYP27A1.|GW4064|OSTβ|13|19|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3151
23221006|  Phenformin causes lactic acidosis in clinical situations due to inhibition of mitochondrial respiratory chain complex I.|Phenformin|mitochondrial respiratory chain complex I|1|12|Arg1:T1|Arg2:T27|CHEMICAL|GENE|INHIBITOR|3152
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|ZD6474|TK|33|3|Arg1:T23|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3153
19389876|  Ambrisentan is an endothelin type A (ET(A))-selective receptor antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by CYP3A4.|Ambrisentan|endothelin type A (ET(A))-selective receptor|1|4|Arg1:T1|Arg2:T19|CHEMICAL|GENE|ANTAGONIST|3154
15180525|Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or c-Kit.|phenylaminopyrimidine|RTKs|15|28|Arg1:T1|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3155
10064839|We found that DF, DM, and DR were relative high-affinity ligands at sigma-1 receptors (Ki=151, 205, 144 nM, respectively) while all of them were with low affinity at sigma-2 receptors (Ki=4-11 microM).|DF|sigma-1 receptors|4|15|Arg1:T46|Arg2:T55|CHEMICAL|GENE|DIRECT-REGULATOR|3156
11695255|Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of prostaglandin E2 (PGE2; a product of both COX-1 and COX-2) and thromboxane B2 (as a biomarker for COX-1 activity) with parallel assessments of pain.|PGE2|COX-1|24|30|Arg1:T13|Arg2:T23|CHEMICAL|GENE|PRODUCT-OF|3157
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|nuclear factor-κB|7|34|Arg1:T2|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3158
17224860|We studied in a clinical trial whether isolated isoflavone treatment in postmenopausal women could affect reverse cholesterol transport as evaluated by adenosine triphosphate-binding cassette A1- (ABCA1), dependent cholesterol efflux from macrophages.|cholesterol|adenosine triphosphate-binding cassette A1|31|22|Arg1:T15|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|3159
12487427|GW660511X and omapatrilat reduced the production of BrBK1-5 and BrBK1-7 with more effect being observed with omapatrilat.|omapatrilat|BrBK1-5|17|8|Arg1:T21|Arg2:T63|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3160
9851542|The tacrine pressor response was inhibited in a dose-dependent manner by the i.c.v. administration of the non-selective muscarinic receptor antagonist atropine (ID50 = 1.45 microg), the muscarinic M1 receptor antagonist pirenzepine (ID50 = 4.33 microg), the muscarinic M2 receptor antagonist methoctramine (ID50 = 1.39 microg) and the muscarinic M3 receptor antagonist para-fluoro-hexahydro-sila-difenidol (ID50 = 31.19 microg).|para-fluoro-hexahydro-sila-difenidol|muscarinic M3 receptor|61|57|Arg1:T6|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|3161
16371234|Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia.|prostaglandin E2|COX-1|12|3|Arg1:T16|Arg2:T48|CHEMICAL|GENE|PRODUCT-OF|3162
17016621|Similar to AMR and AMROH, adriamycin and etoposide (VP-16) are DNA topoisomerase II inhibitors.|AMROH|DNA topoisomerase II|5|14|Arg1:T4|Arg2:T21|CHEMICAL|GENE|INHIBITOR|3163
23142507|The 3D-structure of HmTx consists of three conserved alpha-helices: h1 (Lys24-His34), h2 (Cys59-Asp71), and h3 (Ala80-Phe89).|Cys|HmTx|18|4|Arg1:T5|Arg2:T23|CHEMICAL|GENE|PART-OF|3164
17159811|  OBJECTIVES: The alkaloid galantamine (GAL), which exhibits a combined anticholinesterase and direct parasympathomimetic mechanism of action, is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases.|galantamine|anticholinesterase|5|14|Arg1:T4|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3165
17344208|  Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to glutamate.|glutamate|Delta(1)-pyrroline-5-carboxylate dehydrogenase|23|7|Arg1:T4|Arg2:T22|CHEMICAL|GENE|PRODUCT-OF|3166
23625804|We recently showed that the first domain of human CCS (hCCSD1) is responsible for copper transfer to its protein partner, human SOD1 (hSOD1).|copper|human CCS|17|9|Arg1:T2|Arg2:T11|CHEMICAL|GENE|DIRECT-REGULATOR|3167
23535337|Under NaCl and sorbitol stresses, catalase (CAT) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.|NaCl|catalase|2|7|Arg1:T8|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|3168
12105857|Thalidomide has been shown to suppress TNF-alpha production from macrophages.|Thalidomide|TNF-alpha|1|7|Arg1:T12|Arg2:T28|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3169
17148442|In addition to the N-terminal and Src homology 2 domains that mediate these interactions, SOCS proteins contain a C-terminal SOCS box.|N|Src homology 2 domains|5|7|Arg1:T1|Arg2:T9|CHEMICAL|GENE|PART-OF|3170
14600253|Glycylsarcosine coadministration could inhibit the uptake of cefadroxil in PEPT2(+/+) mice (p < 0.01) but not PEPT2(-/-) mice.|cefadroxil|PEPT2|8|10|Arg1:T11|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|3171
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Dasatinib|ABL|10|16|Arg1:T2|Arg2:T42|CHEMICAL|GENE|INHIBITOR|3172
10064839|We found that DF, DM, and DR were relative high-affinity ligands at sigma-1 receptors (Ki=151, 205, 144 nM, respectively) while all of them were with low affinity at sigma-2 receptors (Ki=4-11 microM).|DR|sigma-2 receptors|9|36|Arg1:T48|Arg2:T52|CHEMICAL|GENE|DIRECT-REGULATOR|3173
23318833|TAA increased the number and area of glutathione S-transferase placental form (GST-P)(+) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections.|TAA|GST-P|1|13|Arg1:T8|Arg2:T27|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3174
9310349|PTP inhibition by hisphosphonates or vanadate was diminished by the metal chelating agent EDTA, or by the reducing agent dithiothreitol, suggesting that a metal ion and the oxidation of a cysteine residue are required for full inhibition.|vanadate|PTP|6|1|Arg1:T4|Arg2:T29|CHEMICAL|GENE|INHIBITOR|3175
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|5-nitro-2-(3-phenylpropylamino)benzoic acid|Panx1|26|6|Arg1:T2|Arg2:T39|CHEMICAL|GENE|INHIBITOR|3176
23246481|Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1.|Wogonin|caveolin-1|1|11|Arg1:T14|Arg2:T25|CHEMICAL|GENE|INHIBITOR|3177
7885191|  The non-competitive blocker site of the GABA-gated chloride ion channel in normal susceptible strains of Drosophila melanogaster and simulans binds 4-n-[3H]propyl-4'-ethynylbicycloorthobenzoate ([3H]EBOB) at specific sites with KdS of 1.6-1.9 nM and BmaxS of 171-181 fmol/mg protein.|[3H]EBOB|GABA-gated chloride ion channel|27|7|Arg1:T21|Arg2:T54|CHEMICAL|GENE|DIRECT-REGULATOR|3178
7885191|  The non-competitive blocker site of the GABA-gated chloride ion channel in normal susceptible strains of Drosophila melanogaster and simulans binds 4-n-[3H]propyl-4'-ethynylbicycloorthobenzoate ([3H]EBOB) at specific sites with KdS of 1.6-1.9 nM and BmaxS of 171-181 fmol/mg protein.|4-n-[3H]propyl-4'-ethynylbicycloorthobenzoate|GABA-gated chloride ion channel|21|7|Arg1:T14|Arg2:T54|CHEMICAL|GENE|DIRECT-REGULATOR|3179
17015640|  Licofelone, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.|Licofelone|COX|1|16|Arg1:T1|Arg2:T32|CHEMICAL|GENE|INHIBITOR|3180
12086935|Metformin-induced increases in AMPK activity were associated with higher rates of glucose disposal and muscle glycogen concentrations.|Metformin|AMPK|1|4|Arg1:T6|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|3181
10702256|The functional protein contains 1160 amino acids with a large central mucin domain, three consensus sites for glycosaminoglycan attachment, two epidermal growth factor-like repeats, a putative hyaluronan-binding motif, and a potential transmembrane domain near the C-terminal.|C|mucin domain|40|12|Arg1:T1|Arg2:T22|CHEMICAL|GENE|PART-OF|3182
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|hydroxylamines|cyt b5|8|51|Arg1:T19|Arg2:T28|CHEMICAL|GENE|SUBSTRATE|3183
15723099|Dextromethorphan and dimemorfan are high-affinity ligands at sigma1 receptors.|dimemorfan|sigma1 receptors|3|8|Arg1:T9|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|3184
11732752|The inhibition of aminopeptidase activity in the presence of bestatin and puromycin inhibitors was also investigated.|bestatin|aminopeptidase|10|4|Arg1:T12|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3185
16965760|It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.|LiCl|inositol monophosphatase|11|23|Arg1:T15|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3186
12614192|The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of PDE5 that breaks down cGMP, the key pathway for the production of erectile function in humans.|cGMP|PDE5|25|21|Arg1:T2|Arg2:T10|CHEMICAL|GENE|SUBSTRATE|3187
23066089|The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.|lavendustin A|KARs|57|5|Arg1:T6|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3188
17350061|Estrogen-regulated genes including cytokeratin 1-19 and Cyp2a4 were over-expressed, although Cyp3a25 was suppressed.|Estrogen|Cyp2a4|1|7|Arg1:T24|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3189
15795320|Synergistic cytotoxicity was demonstrated, and pemetrexed significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the human nucleoside equilibrative transporter 1 (hENT1) in all cell lines.|pemetrexed|hENT1|7|44|Arg1:T2|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3190
9890894|Previously, we reported that a primary heparin or heparan sulfate binding site resides in a distinct sequence in immunoglobulin (Ig)-like module II of the three modules of FGFR.|sulfate|immunoglobulin (Ig)-like module II|11|20|Arg1:T5|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|3191
23600432|  Introduction: 5-Lipoxygenase (5-LO) is a crucial enzyme of the arachidonic acid (AA) cascade and catalyzes the formation of bioactive leukotrienes (LTs) with the help of FLAP, the 5-LO-activating protein.|arachidonic acid|5-LO|13|5|Arg1:T1|Arg2:T11|CHEMICAL|GENE|SUBSTRATE|3192
23391632|The mRNA level for nestin (Nes, biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-EDS, but not in the DEHP treated testes, suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP-treated testes.|EDS|Nes|26|7|Arg1:T4|Arg2:T31|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3193
17224860|We studied in a clinical trial whether isolated isoflavone treatment in postmenopausal women could affect reverse cholesterol transport as evaluated by adenosine triphosphate-binding cassette A1- (ABCA1), dependent cholesterol efflux from macrophages.|cholesterol|ABCA1|31|27|Arg1:T15|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|3194
15474503|Further study revealed that pitavastatin increased ABCA1 mRNA in HMG-CoA reductase-dependent manner and that Rho and Rho kinase inhibitor (C3T and Y27632) increased apoA-I production in the HepG2 cells.|pitavastatin|ABCA1|5|7|Arg1:T13|Arg2:T36|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3195
23318685|  Peginesatide, a polyethylene glycol (PEG)ylated peptide-based erythropoiesis-stimulating agent, stimulates the erythropoietin receptor dimer that governs erythropoiesis.|Peginesatide|erythropoietin receptor|1|16|Arg1:T1|Arg2:T10|CHEMICAL|GENE|ACTIVATOR|3196
23044488|Studies have indicated that the three-dimensional structure and the domains of HuBChE (acyl pocket, lip of the active center gorge, and the anionic substrate-binding domain) that are critical for the binding of substrate are also essential for the selectivity and binding of inhibitors including OPs. Therefore, we designed three HBPs by deleting some N- and C-terminal residues of HuBChE by maintaining the folds of the active site core that includes the three active site residues (S198, E325, and H438).|acyl|HuBChE|14|12|Arg1:T2|Arg2:T12|CHEMICAL|GENE|PART-OF|3197
9990013|The sulfonylurea glibenclamide caused release of prebound 8-azido-[alpha-32P]ATP from SUR1 in the presence of MgADP or MgATP in a concentration-dependent manner.|sulfonylurea glibenclamide|SUR1|2|14|Arg1:T27|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|3198
23414340|Although thioredoxin reductase (TRR) inhibitors (aurothioglucose and Sb(III)) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.|Sb(III)|TRR|11|5|Arg1:T18|Arg2:T49|CHEMICAL|GENE|INHIBITOR|3199
22982218|Accordingly, in transfection experiments performed in TPC1 cells, treatment with PJ34 increased NIS promoter activity without affecting PARP-1 binding to the promoter sequence.|PJ34|PARP-1|13|20|Arg1:T4|Arg2:T12|CHEMICAL|GENE|DIRECT-REGULATOR|3200
11861820|Also in contrast to effects of multiple METH injections, 1) MDMA caused little or no decrease in binding of the DAT ligand WIN35428, and 2) neither prevention of hyperthermia nor prior depletion of DA prevented the MDMA-induced reduction in plasmalemmal DA transport.|WIN35428|DAT|25|23|Arg1:T23|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|3201
17459764|We demonstrate that only treatment of HaCaT with GLA and EPA or a PPARgamma ligand (roziglitazone), induced COX-2 expression (protein and mRNA).|EPA|COX-2|11|21|Arg1:T15|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3202
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|Phe|TMH7|15|30|Arg1:T6|Arg2:T46|CHEMICAL|GENE|PART-OF|3203
7885191|Drosophila GABA-gated chloride channel: modified [3H]EBOB binding site associated with Ala-->Ser or Gly mutants of Rdl subunit.|Gly|Rdl|20|23|Arg1:T46|Arg2:T58|CHEMICAL|GENE|PART-OF|3204
23703578|All HIV PIs except nelfinavir are coadministered with a low dose of ritonavir, a potent CYP3A inhibitor to improve their pharmacokinetic properties.|ritonavir|CYP3A|13|17|Arg1:T2|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3205
9003761|Despite a low amino acid identity between TWIK-1 and TREK-1 (approximately 28%), both channel proteins share the same overall structural arrangement consisting of two pore-forming domains and four transmembrane segments (TMS).|amino acid|TWIK-1|4|8|Arg1:T3|Arg2:T18|CHEMICAL|GENE|PART-OF|3206
17768678|To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the elevation in brain ORN observed, animals were pretreated with vehicle or the MAO inhibitor tranylcypromine (TCP) before vehicle or PLZ (15 mg/kg), and brains collected 3 h later.|tranylcypromine|MAO|34|32|Arg1:T31|Arg2:T42|CHEMICAL|GENE|INHIBITOR|3207
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|Akt|1|34|Arg1:T6|Arg2:T41|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3208
23601710|  Detailed structure-activity relationships of the C3-phenyl moiety that allow for the optimization of antiviral potency of a series of 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione inhibitors of HIV capsid (CA) assembly are described.|1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione|HIV capsid|20|30|Arg1:T1|Arg2:T7|CHEMICAL|GENE|INHIBITOR|3209
10064839|We found that DF, DM, and DR were relative high-affinity ligands at sigma-1 receptors (Ki=151, 205, 144 nM, respectively) while all of them were with low affinity at sigma-2 receptors (Ki=4-11 microM).|DR|sigma-1 receptors|9|15|Arg1:T48|Arg2:T55|CHEMICAL|GENE|DIRECT-REGULATOR|3210
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|Ser|Histone 3|31|28|Arg1:T5|Arg2:T24|CHEMICAL|GENE|PART-OF|3211
23123662|Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.|carboplatin|rCtr1|24|4|Arg1:T23|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|3212
12414329|As free sildenafil plasma concentrations approach concentrations sufficient to inhibit retinal PDE6, usually at higher therapeutic doses, transient, reversible visual adverse events can occur, albeit infrequently.|sildenafil|PDE6|3|12|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INHIBITOR|3213
23618921|Here we show that fisetin rapidly increases the levels of both Nrf2 and ATF4 as well as Nrf2- and ATF4-dependent gene transcription via distinct mechanisms.|fisetin|Nrf2|5|18|Arg1:T19|Arg2:T37|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3214
23221006|Role of organic cation/carnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria.|phenformin|complex I|10|15|Arg1:T17|Arg2:T29|CHEMICAL|GENE|INHIBITOR|3215
20724158|  BACKGROUND: Recent epidemiologic and laboratory studies have suggested that non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the risk of breast cancer through inhibition of cyclooxygenase-2 (COX-2).|steroidal|cyclooxygenase-2|12|27|Arg1:T7|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3216
21606412|  PURPOSE: XL184 (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.|XL184|vascular endothelial growth factor receptor 2|3|14|Arg1:T6|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3217
22370641|Epi increased both WNT6/Wnt6 and Cav1 expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg).|Epi|Wnt6|1|5|Arg1:T11|Arg2:T31|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3218
23564313|Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.|vinblastine|apoptosis signal-regulating kinase 1|3|35|Arg1:T7|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|3219
23041257|DBDCT up-regulated the expression of Bax, down-regulated the expression of Bcl-2, and significantly increased the ratio of Bax/Bcl-2.|DBDCT|Bax|1|20|Arg1:T13|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3220
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|dFdC|deoxycytidine kinase|3|16|Arg1:T5|Arg2:T45|CHEMICAL|GENE|SUBSTRATE|3221
17459764|We demonstrate that only treatment of HaCaT with GLA and EPA or a PPARgamma ligand (roziglitazone), induced COX-2 expression (protein and mRNA).|roziglitazone|PPARgamma|17|14|Arg1:T16|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|3222
12086935|Metformin treatment for 10 weeks significantly increased AMPK alpha2 activity in the skeletal muscle, and this was associated with increased phosphorylation of AMPK on Thr172 and decreased acetyl-CoA carboxylase-2 activity.|Metformin|AMPK alpha2|1|8|Arg1:T16|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|3223
9310349|PTP inhibition by hisphosphonates or vanadate was diminished by the metal chelating agent EDTA, or by the reducing agent dithiothreitol, suggesting that a metal ion and the oxidation of a cysteine residue are required for full inhibition.|cysteine|PTP|33|1|Arg1:T8|Arg2:T29|CHEMICAL|GENE|PART-OF|3224
23042954|To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.|(3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid|α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor|37|31|Arg1:T10|Arg2:T16|CHEMICAL|GENE|ANTAGONIST|3225
7554708|CONCLUSIONS: Nabumetone does dose-dependently inhibit the cyclooxygenase activity of platelet PGHS-1 of healthy subjects both in vivo and ex vivo.|Nabumetone|cyclooxygenase|3|8|Arg1:T8|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3226
15908512|The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively.|atenolol|beta1AR|5|3|Arg1:T5|Arg2:T20|CHEMICAL|GENE|ANTAGONIST|3227
11742712|  Pemetrexed disodium (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.|Pemetrexed disodium|glycinamide ribonucleotide formyltransferase|1|25|Arg1:T1|Arg2:T16|CHEMICAL|GENE|INHIBITOR|3228
23250811|The anti-inflammatory actions of curcumin on colitis may involve inhibition of the TLR4/NF-κB signaling pathway and of IL-27 expression.|curcumin|NF-κB|5|14|Arg1:T9|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3229
23159529|Glutaraldehyde crosslinked albumin nanoparticles with a size of approximately 100nm were loaded with the multikinase inhibitor 17864-L(x)-a platinum-bound sunitinib analogue-which couples the drug to methionine residues of albumin and is released in a reductive environment.|methionine|albumin|29|32|Arg1:T5|Arg2:T18|CHEMICAL|GENE|PART-OF|3230
23564313|Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.|vinblastine|inhibitor of kappaBα|3|45|Arg1:T7|Arg2:T29|CHEMICAL|GENE|ACTIVATOR|3231
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Tarceva|VEGF receptor|30|42|Arg1:T8|Arg2:T44|CHEMICAL|GENE|INHIBITOR|3232
23376356|The pharmacological inhibitors SB203580 (p38 inhibitor) and SP600125 (a JNK inhibitor) protected primary cultures of rat CGCs from LY294002-induced apoptosis.|SP600125|JNK|10|13|Arg1:T3|Arg2:T23|CHEMICAL|GENE|INHIBITOR|3233
16938288|Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.|Telmisartan|peroxisome proliferator-activated receptor gamma|1|11|Arg1:T11|Arg2:T38|CHEMICAL|GENE|ACTIVATOR|3234
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine|DAT|1|63|Arg1:T43|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|3235
23344961|To explore the molecular basis for CPT hypersensitivity in Top2β-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2β-deficient cells.|CPT|RNA polymerase II large subunit|17|21|Arg1:T10|Arg2:T28|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3236
16206183|DAT occupancy was determined by displacement of 8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane (FECNT).|FECNT|DAT|25|1|Arg1:T3|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|3237
11309392|We took advantage of the previous observations that phosphatidylserine inhibits DGK-delta (reviewed by Sakane, F., Imai, S., Kai, M., Wada, I., and Kanoh, H.|phosphatidylserine|DGK-delta|9|11|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3238
12901032|Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.|celecoxib|COX-2|29|12|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INHIBITOR|3239
23139413|"Binding of the agonist angiotensin II (AngII) and inverse agonist losartan in wild-type AT1R changed the accessibility of reporter cysteines, and the pattern was consistent with ligand-specific ""lid"" conformations of ECL2."|cysteines|AT1R|22|16|Arg1:T6|Arg2:T25|CHEMICAL|GENE|PART-OF|3240
10583449|This hypothesis was tested by investigating whether, in subjects with essential hypertension, the natriuretic response to specific renin-angiotensin-aldosterone system (RAAS) blockade by renin-inhibitor remikiren could be predicted from pretreatment renal vascular tone.|remikiren|angiotensin|28|21|Arg1:T12|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3241
23290724|  The cellular prion protein PrP(C) consists of two domains--a flexible N-terminal domain, which participates in copper and zinc regulation, and a largely helical C-terminal domain that converts to β sheet in the course of prion disease.|N|prion protein PrP(C)|16|3|Arg1:T8|Arg2:T10|CHEMICAL|GENE|PART-OF|3242
12181285|  Reuptake of extracellular noradrenaline (NA) into superior cervical ganglion (SCG) neurones is mediated by means of the noradrenaline transporter (NAT, uptake 1).||NAT|6|25|Arg1:T18|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|3243
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|ERK|1|23|Arg1:T6|Arg2:T38|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3244
23246481|We found that wogonin can suppress the H2O2-stimulated actin remodeling and albumin uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.|wogonin|albumin|4|12|Arg1:T6|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3245
23511016|Synthesis of a DOTA (Gd(3+))-conjugate of proton-pump inhibitor pantoprazole for gastric wall imaging studies.|Gd(3+)|proton-pump|6|13|Arg1:T7|Arg2:T11|CHEMICAL|GENE|INHIBITOR|3246
20226815|In untrained and trained treated animals with the amnesic dose (1.0mg/kg) of METH SERT binding in several areas including hippocampus and cortex decreased, more remarkably in the trained animals.|METH|SERT|15|16|Arg1:T3|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|3247
15498586|Of note, we demonstrated for the first time that telmisartan augmented GLUT4 protein expression and 2-deoxy glucose uptake both in basal and insulin-stimulated state of adipocytes, which may contribute, at least partly, to its insulin-sensitizing ability.|telmisartan|GLUT4|11|13|Arg1:T7|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3248
12487427|  Several studies have suggested that the accumulation of bradykinin, or that of one its metabolites BK1-8, is involved in the occurrence of side effects such as AE associated with the use of various ACEi. In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK (79/81 Br-Phe5) BrBK in the presence of two new dual ACE/NEP inhibitors (GW660511X and omapatrilat) currently under clinical trial.|GW660511X|NEP|80|78|Arg1:T33|Arg2:T76|CHEMICAL|GENE|INHIBITOR|3249
18035186|Rasagiline [N-propargyl-l(R)-aminoindan] is a second-generation propargylamine pharmacophore that selectively and irreversibly inhibits brain MAO-B and is specifically designed for the treatment of Parkinson's disease (PD).|propargylamine|MAO-B|12|20|Arg1:T14|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3250
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|lysine|beta-lyases|46|10|Arg1:T32|Arg2:T54|CHEMICAL|GENE|PART-OF|3251
20012638|  Terbutaline (Bricanyl) and its prodrug Bambuterol (Bambec) are highly potent beta(2)-adrenoceptor agonists often used in asthma patients.|Bambuterol|beta(2)-adrenoceptor|8|15|Arg1:T11|Arg2:T22|CHEMICAL|GENE|AGONIST|3252
23481236|We studied accumulation of lipid metabolites [triglycerides (TAGs), diglycerides (DAGs)] and ceramides in relation to insulin signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells (L6 myotubes) with three saturated and three unsaturated free fatty acids (FFAs) (200 μM).|diglycerides|PTP1B|13|30|Arg1:T12|Arg2:T44|CHEMICAL|GENE|DIRECT-REGULATOR|3253
17632107|Furthermore, the activities of the two torafugu PPARalphas were enhanced 4.3- and 7.6-fold by arachidonic acid, 4.4- and 5.2-fold by docosahexaenoic acid, and 6.7- and 8.0-fold by eicosapentaenoic acid each at 50 microM, respectively.|arachidonic acid|torafugu PPARalphas|16|8|Arg1:T3|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|3254
11474486|Fenofibrate and GW2331 induced expression of acyl-coenzyme A (CoA) oxidase and enoyl-CoA hydratase and reduced apolipoprotein C-III and phosphoenolpyruvate carboxykinase mRNAs. Rosiglitazone modestly increased apolipoprotein C-III mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue.|GW2331|apolipoprotein C-III|3|18|Arg1:T16|Arg2:T38|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3255
1590750|The identity of the lung beta-ADHs was further demonstrated by their characteristic pH-activity profiles for ethanol oxidation, Km values for NAD and ethanol, and inhibition by 4-methylpyrazole or 1,10-phenanthroline.|4-methylpyrazole|beta-ADHs|29|6|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INHIBITOR|3256
11585753|"ZD1839 (""Iressa""), a quinazoline tyrosine kinase inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials."|ZD1839|EGFR|1|16|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INHIBITOR|3257
23344961|Second, ICRF-187, a Top2 catalytic inhibitor known to deplete Top2β, specifically sensitized MEFs to CPT.|ICRF-187|Top2β|3|12|Arg1:T7|Arg2:T25|CHEMICAL|GENE|INHIBITOR|3258
12614192|Sildenafil is inhibitory of PDE5 at a rate tenfold higher than for the next PDE (PDE6), which produces visual changes through the retinal rods.|Sildenafil|PDE|1|15|Arg1:T5|Arg2:T13|CHEMICAL|GENE|INHIBITOR|3259
23562365|Treatment with EVn-50 or VB1 resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of Histone 3 at Ser10, phosphorylation of Cdk1 at Tyr15, expression of cyclin B1, and decreased expression of Cdc25c.|VB1|Cdk1|5|35|Arg1:T3|Arg2:T25|CHEMICAL|GENE|ACTIVATOR|3260
17138644|These results highlight the importance of PR activation of the Src/MAPK signaling pathway for progesterone-induced transcription of select target genes and cell cycle progression.|progesterone|PR|15|7|Arg1:T4|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|3261
9008235|Thus, PGHS-1 might be the primary target of the hair growth-inhibitory effects of NSAIDs. We thus speculated that activation of PGHS-1 might be a mechanism by which minoxidil (2,4-diamino-6-piperidinopyrimidine-3-oxyde) stimulates hair growth in vivo.|minoxidil|PGHS-1|30|23|Arg1:T6|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|3262
16988497|A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.|linoleic acid|D5D|34|52|Arg1:T14|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3263
23542114|ATO inhibited the phosphorylation and activation of AKT and STAT3 through Notch signaling blockade.|ATO|STAT3|1|10|Arg1:T5|Arg2:T10|CHEMICAL|GENE|INHIBITOR|3264
17632107|The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid (ETYA) each at 10 microM, respectively, whereas that of PPARalpha2, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively.|ETYA|PPARalpha2|18|30|Arg1:T13|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|3265
11695255|The time course of PGE2 production was consistent with early release due to COX-1 activity followed by increased production 2-3 hours after surgery, consistent with COX-2 expression.|PGE2|COX-2|5|27|Arg1:T15|Arg2:T27|CHEMICAL|GENE|PRODUCT-OF|3266
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|donepezil|cholinesterase|13|8|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3267
12837768|The potency of MrIA was greater for inhibition of uptake by hNET of [3H]norepinephrine (Ki 1.89 microM) than [3H]dopamine (Ki 4.33 microM), and the human dopamine transporter and serotonin transporter were not inhibited by MrIA (to 7 microM).|[3H]dopamine|hNET|24|12|Arg1:T6|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|3268
23414340|Although thioredoxin reductase (TRR) inhibitors (aurothioglucose and Sb(III)) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.|Sb(III)|thioredoxin reductase|11|2|Arg1:T18|Arg2:T48|CHEMICAL|GENE|INHIBITOR|3269
23481236|Saturated palmitic and stearic acids increased ceramides, up-regulated PTP1B, and had AKt and PTP1B phosphorylation at Ser 50 impaired.|palmitic and stearic acids|PTP1B|2|16|Arg1:T2|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|3270
15191400|  Auranofin, an antirheumatic gold compound, is an inhibitor of selenocysteine enzymes, such as thioredoxin reductase and glutathione peroxidase.|Auranofin|glutathione peroxidase|1|20|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3271
20596674|  Etoposide (VP-16) is a topoisomerase-II (topo II) inhibitor chemotherapeutic agent.|Etoposide|topoisomerase-II|1|7|Arg1:T1|Arg2:T32|CHEMICAL|GENE|INHIBITOR|3272
23261590|In this study, focus was given to evaluate the ability of neoechinulin A, an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-β 1-42 (Aβ42).|indole|amyloid-β 1-42|17|31|Arg1:T6|Arg2:T30|CHEMICAL|GENE|INHIBITOR|3273
9008235|We demonstrate here that minoxidil is a potent activator of purified PGHS-1 (AC50 = 80 microM), as assayed by oxygen consumption and PGE2 production.|minoxidil|PGHS-1|5|12|Arg1:T8|Arg2:T20|CHEMICAL|GENE|ACTIVATOR|3274
12699699|The protein exhibited modest H(2)O(2)-dependent peroxidase activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).|guaiacol|peroxidase|17|14|Arg1:T4|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|3275
23273219|  To develop new drugs for treatment of Alzheimer's disease, a group of N'-2-(4-Benzylpiperidin-/piperazin-1-yl)acylhydrazones was designed, synthesized and tested for their ability to inhibit acetylcholinesterase, butyrylcholinesterase and aggregation of amyloid beta peptides (1-40, 1-42 and 1-40_1-42).|N'-2-(4-Benzylpiperidin-/piperazin-1-yl)acylhydrazones|butyrylcholinesterase|15|33|Arg1:T2|Arg2:T5|CHEMICAL|GENE|INHIBITOR|3276
12217700|In the active MalP enzyme, the residue Arg569 stabilizes the negative-charged Glc1P, whereas in the inactive form of GP this key residue is held away from the catalytic site by loop 280s and an allosteric transition of the mammalian enzyme is required for activation.|Glc1P|MalP|13|4|Arg1:T22|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|3277
15474503|Further study revealed that pitavastatin increased ABCA1 mRNA in HMG-CoA reductase-dependent manner and that Rho and Rho kinase inhibitor (C3T and Y27632) increased apoA-I production in the HepG2 cells.|Y27632|Rho|23|15|Arg1:T15|Arg2:T38|CHEMICAL|GENE|INHIBITOR|3278
15795105|The compounds 5'-azacytidine (AZC) and procainamide (PCA) belong to inhibitors of DNMT1, whose low activity correlates with increase in transcription of various genes.|procainamide|DNMT1|8|16|Arg1:T3|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3279
23266505|The upregulation of calpain, tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of ALD.|ALD|calpain|21|4|Arg1:T1|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3280
22898212|Mass spectral analysis of CBDP-inhibited BChE digested with Glu-C showed an o-hydroxybenzyl adduct (+106amu) on lysine 499, a residue far from the active site, but not on His-438.|lysine|BChE|18|6|Arg1:T19|Arg2:T33|CHEMICAL|GENE|PART-OF|3281
21712771|Antibodies to either the C- or N- terminus of VMAT-1 detected two proteins (73 and 55 kD) in transfected COS-1 cells.|C|VMAT-1|5|10|Arg1:T1|Arg2:T8|CHEMICAL|GENE|PART-OF|3282
2899826|Chlorpromazine, levomepromazine, and their metabolites had 5-30 times higher binding affinities for muscarinic cholinergic receptors than fluphenazine, perphenazine and their metabolites.|Chlorpromazine|muscarinic cholinergic receptors|1|15|Arg1:T9|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|3283
9476974|At nonconvulsant doses, the sodium channel blockers acetylprocainamide, dibucaine, dyclonine, prilocaine, proparacaine, quinidine, and tetracaine produced a small pressor response or no increase in BP.|dyclonine|sodium channel|13|6|Arg1:T34|Arg2:T48|CHEMICAL|GENE|INHIBITOR|3284
23344974|The initial fragment hits were thoroughly validated biophysically by isothermal titration calorimetry (ITC) and NMR techniques and observed by X-ray crystallography to bind in a shallow surface pocket that is occupied in the native complex by the side chain of a phenylalanine from the conserved FxxA interaction motif found in BRCA2.|phenylalanine|FxxA interaction motif|44|48|Arg1:T1|Arg2:T2|CHEMICAL|GENE|PART-OF|3285
23534442|New classes of pyrrole-derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as COX-2 selective inhibitors and NO donors were synthesized and are herein reported.|carbonates|COX-2|9|17|Arg1:T6|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3286
12827214|However, other alpha(1)-adrenoceptor antagonists (tamsulosin, WB4101 and corynanthine) did not inhibit the binding at a range of concentrations that generally exhibit alpha(1)-adrenoceptor antagonism, and noradrenaline, rauwolscine and propranolol were without effect on the [(3)H]prazosin binding.|tamsulosin|alpha(1)-adrenoceptor|11|4|Arg1:T36|Arg2:T46|CHEMICAL|GENE|ANTAGONIST|3287
19244097|N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine (SoRI-9804), N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine (SoRI-20040), and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine (SoRI-20041) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester (RTI-55) binding, slowed the dissociation rate of [(125)I]RTI-55 from the DAT, and partially inhibited [(3)H]dopamine uptake.|SoRI-9804|DAT|7|63|Arg1:T11|Arg2:T50|CHEMICAL|GENE|DIRECT-REGULATOR|3288
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|clerosterol|cyclooxygenase-2|13|37|Arg1:T6|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3289
9990013|The sulfonylurea glibenclamide caused release of prebound 8-azido-[alpha-32P]ATP from SUR1 in the presence of MgADP or MgATP in a concentration-dependent manner.|8-azido-[alpha-32P]ATP|SUR1|8|14|Arg1:T2|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|3290
23123662|Heterologous expression of rCtr1 in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.|oxaliplatin|rCtr1|20|4|Arg1:T21|Arg2:T39|CHEMICAL|GENE|SUBSTRATE|3291
16417577|Galanin attenuates cyclic AMP regulatory element-binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures.|naloxone|cyclic AMP regulatory element-binding protein|17|3|Arg1:T7|Arg2:T19|CHEMICAL|GENE|ACTIVATOR|3292
17229632|RESULTS: We show that sorafenib is a potent inhibitor of ETV6-PDGFRbeta and FLT3 mutants, including some of the mutants that confer resistance to PKC412 and other FLT3 inhibitors.|sorafenib|ETV6|6|12|Arg1:T2|Arg2:T17|CHEMICAL|GENE|INHIBITOR|3293
23523949|RESULTS: DZN induced histophatological damages and elevated the level of cardiac marker CK-MB.|DZN|CK-MB|3|14|Arg1:T22|Arg2:T44|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3294
17692748|  OBJECTIVES: The aim of this study was to determine whether cocaine's sympathomimetic actions can be reversed by a potent centrally acting alpha2 adrenergic receptor (AR) agonist (dexmedetomidine).|dexmedetomidine|alpha2 adrenergic receptor|32|24|Arg1:T6|Arg2:T15|CHEMICAL|GENE|AGONIST|3295
18081314|The binding of U46619 to the PGIS protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at C-11, H2C, and H20 of U46619 were observed upon U46619 binding to the engineered PGIS in a concentration-dependent manner.|H20|PGIS|32|7|Arg1:T14|Arg2:T38|CHEMICAL|GENE|PART-OF|3296
15939622|COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.|carprofen|COX-1|13|1|Arg1:T16|Arg2:T22|CHEMICAL|GENE|INHIBITOR|3297
23220644|  Dual function inhibitors targeting phospholipase A(2) (PLA(2)) and leukotriene A(4) hydrolase (LTA(4)H) may balance the arachidonic acid (AA) metabolic network and be used as new anti-inflammatory drugs.|arachidonic acid|phospholipase A(2)|33|5|Arg1:T1|Arg2:T8|CHEMICAL|GENE|PRODUCT-OF|3298
12070353|Thus we have shown that low-dose theophylline exerts an anti-asthma effect through increasing activation of HDAC which is subsequently recruited by corticosteroids to suppress inflammatory genes.|theophylline|HDAC|7|16|Arg1:T1|Arg2:T13|CHEMICAL|GENE|ACTIVATOR|3299
23625804|Mechanistic Aspects of hSOD1 Maturation from the Solution Structure of Cu(I) -Loaded hCCS Domain 1 and Analysis of Disulfide-Free hSOD1 Mutants.|Cu(I)|hCCS Domain 1|11|16|Arg1:T8|Arg2:T33|CHEMICAL|GENE|DIRECT-REGULATOR|3300
7560228|Hence, triclosan has the ability to inhibit both the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism with similar efficacy.|arachidonic acid|cyclo-oxygenase|16|11|Arg1:T6|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|3301
19023039|We found compounds that inhibited Panx1 currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.|indanyloxyacetic acid 94|Panx1|33|6|Arg1:T3|Arg2:T39|CHEMICAL|GENE|INHIBITOR|3302
16248990|Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.|galantamine|AChE|8|15|Arg1:T18|Arg2:T30|CHEMICAL|GENE|INHIBITOR|3303
12487427|Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE/NEP inhibitors GW660511X and omapatrilat.|omapatrilat|NEP|20|17|Arg1:T50|Arg2:T90|CHEMICAL|GENE|INHIBITOR|3304
7516184|The C-terminal half of TSG-6 contains a so-called CUB domain, characteristic for developmentally regulated proteins.|C|TSG-6|2|5|Arg1:T3|Arg2:T15|CHEMICAL|GENE|PART-OF|3305
22898212|CBDP irreversibly inhibits butyrylcholinesterase (BChE) in human plasma by forming adducts on the active site serine (Ser-198).|Ser|BChE|20|6|Arg1:T9|Arg2:T31|CHEMICAL|GENE|PART-OF|3306
9712175|Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans.|lintitript|CCK-A receptor|3|7|Arg1:T8|Arg2:T20|CHEMICAL|GENE|ANTAGONIST|3307
11970990|Experimentation using isoforms of alefacept engineered to have amino acid substitutions in the IgG1 C(H)2 domain that impact Fc gamma R binding indicate that alefacept mediates cognate interactions between cells expressing human CD2 and CD16 to activate cells, e.g., increase extracellular signal-regulated kinase phosphorylation, up-regulate cell surface expression of the activation marker CD25, and induce release of granzyme B.|amino acid|alefacept|9|5|Arg1:T1|Arg2:T22|CHEMICAL|GENE|PART-OF|3308
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|epsilon-amino|beta-lyases|43|10|Arg1:T31|Arg2:T54|CHEMICAL|GENE|PART-OF|3309
15665864|Moreover, minocycline efficiently suppressed the release of cytochrome c from mitochondria of the liver tissues from Jo2-challenged mice.|minocycline|cytochrome c|3|9|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3310
23142507|The enzyme is an acidic protein with a pI of 5.6 and an apparent molecular weight of 14018.4 Da. The nucleotide sequence of HmTx contains 649 bp, and the mature protein is predicted to have 131 amino acid residues-104 of which make up the large subunit, and 27 of which make up the small subunit.|nucleotide|HmTx|22|25|Arg1:T1|Arg2:T19|CHEMICAL|GENE|PART-OF|3311
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|4-methoxy-7-nitroindolinyl|SNAT2|17|40|Arg1:T17|Arg2:T42|CHEMICAL|GENE|SUBSTRATE|3312
12699699|The protein exhibited modest H(2)O(2)-dependent peroxidase activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).|2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid|peroxidase|23|14|Arg1:T6|Arg2:T16|CHEMICAL|GENE|SUBSTRATE|3313
15121646|The relatively high D(2) receptor occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and quetiapine.|clozapine|D(2) receptor|33|4|Arg1:T8|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|3314
23564313|Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.|vinblastine|c-jun-N-terminal kinase|3|40|Arg1:T7|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|3315
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Canertinib|TK|26|3|Arg1:T20|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3316
7711211|The inhibition of UG synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.|3 beta,5 alpha-NET|PR|13|7|Arg1:T3|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3317
23250811|Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.|Curcumin|NF-κB|1|14|Arg1:T15|Arg2:T40|CHEMICAL|GENE|INHIBITOR|3318
23220749|Our study shows that human TRPA1 is a target for apomorphine, suggesting that an activation of TRPA1 might contribute to adverse side effects such as nausea and painful injections, which can occur during treatment with apomorphine.|apomorphine|TRPA1|38|18|Arg1:T5|Arg2:T17|CHEMICAL|GENE|ACTIVATOR|3319
19429089|These results suggest that fluoxetine inhibited the activity of VMAT2 by a mechanism different from that of reserpine and did not directly interact with the active site of VMAT2.|fluoxetine|VMAT2|5|29|Arg1:T23|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3320
17594192|Phenserine is also unique because of differing actions of its enantiomers: (-)-phenserine is the active enantiomer for inhibition of AChE, whereas (+)-phenserine ('posiphen') has weak activity as an AChE inhibitor and can be dosed much higher.|(-)-phenserine|AChE|13|24|Arg1:T2|Arg2:T17|CHEMICAL|GENE|INHIBITOR|3321
20531964|  Everolimus (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (mammalian target of rapamycin) to reach the oncology clinic.|Afinitor((R)) Novartis|mammalian target of rapamycin|5|21|Arg1:T6|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3322
14583450|In PC3 cells, hydroxyurea inhibited hRRM2 and resulted in increased sensitivity to UV irradiation.|hydroxyurea|hRRM2|5|7|Arg1:T3|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3323
20091113|Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.|D-amphetamine|dopamine transporter|14|3|Arg1:T6|Arg2:T9|CHEMICAL|GENE|ACTIVATOR|3324
19429089|These results suggest that fluoxetine inhibited the activity of VMAT2 by a mechanism different from that of reserpine and did not directly interact with the active site of VMAT2.|reserpine|VMAT2|18|10|Arg1:T1|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3325
23125284|  The mitochondrial respiratory chain complex IV (cytochrome c oxidase) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular oxygen, yielding water.|oxygen|cytochrome c oxidase|24|8|Arg1:T1|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|3326
17040106|We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and cyt b5.|aromatic amine|human b5R|11|48|Arg1:T20|Arg2:T27|CHEMICAL|GENE|SUBSTRATE|3327
23091188|Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.|lopinavir|BSEP|4|15|Arg1:T21|Arg2:T53|CHEMICAL|GENE|INHIBITOR|3328
16938288|The deletion and mutation analysis of the AT1R gene promoter indicated that a GC box located in the proximal promoter region is responsible for the telmisartan-induced downregulation.|telmisartan|AT1R|26|8|Arg1:T5|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3329
15985706|Using [(3)H]glucosamine-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on mucin secretion was inhibited by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.|wortmannin|mucin|39|25|Arg1:T7|Arg2:T30|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3330
23333261|It was found that expression of Sim2 protein in cortical neurons was increased in streptozotocin-induced diabetes mellitus rat model.|streptozotocin|Sim2|15|7|Arg1:T3|Arg2:T16|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3331
16618126|These results indicate that the ATPase activity of the secretory granule Atp8a1 is activated by phospholipids binding to a specific site whose properties (PS selectivity, dependence upon glycerol but not serine, stereochemistry, and vanadate sensitivity) are similar to, but distinct from, the properties of the substrate binding site of the plasma membrane flippase.|PS|ATPase|25|6|Arg1:T25|Arg2:T47|CHEMICAL|GENE|ACTIVATOR|3332
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|vitamin E|caspase 3|8|32|Arg1:T2|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3333
11292635|In conclusion, OMCD tubules from deoxycorticosterone pivalate-treated rats secrete Cl- into the luminal fluid through NKCC1-mediated Cl- uptake across the basolateral membrane in series with Cl- efflux across the apical membrane.|Cl-|NKCC1|27|17|Arg1:T4|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|3334
23091188|Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.|RTV|protease|11|2|Arg1:T24|Arg2:T51|CHEMICAL|GENE|INHIBITOR|3335
17229632|Sorafenib (BAY43-9006, Nexavar) is a small molecule B-RAF inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against receptor tyrosine kinases from the platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR) families.|Sorafenib|B-RAF|1|11|Arg1:T6|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3336
10727715|In the present study, we compared the pharmacology of (+/-)pindolol, WAY-100635 (a 5-HT(1A) antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat.|WAY-100635|5-HT(1A)|16|19|Arg1:T18|Arg2:T37|CHEMICAL|GENE|ANTAGONIST|3337
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|PI3K|1|31|Arg1:T6|Arg2:T40|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3338
10446934|Endothelial NO synthase expression was increased by cilazapril but not by losartan.|cilazapril|Endothelial NO synthase|8|1|Arg1:T11|Arg2:T34|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3339
7599160|Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin (CN-Cbl) bound to transcobalamin II (transcobalamin, TC).|[57Co]cyanocobalamin|transcobalamin II|28|37|Arg1:T9|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|3340
23042954|To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.|LY293558|GluR5|55|28|Arg1:T11|Arg2:T15|CHEMICAL|GENE|ANTAGONIST|3341
23182946|Neurodegeneration was related with decreased [(3)H]glutamate uptake and decreased Akt immunoreactivity, however phospho-GSK-3-β (Ser9) was not altered in (PhTe)(2) injected rat.|Ser|phospho-GSK-3-β|22|20|Arg1:T3|Arg2:T18|CHEMICAL|GENE|PART-OF|3342
15635044|Furthermore, a combinatory mutation (Pro(7.31)-Pro(7.32)-Ser(7.33) motif to Ser-Glu-Pro in EL3 and Leu(7.38), Leu(7.43), Ala(7.46), and Pro(7.47) to those of rat GnRHR) in gmGnRH-2 exhibited an approximately 500-fold increased sensitivity to GnRH-I, indicating that these residues are critical for discriminating GnRH-II from GnRH-I.|Ser-Glu-Pro|EL3|21|23|Arg1:T14|Arg2:T48|CHEMICAL|GENE|PART-OF|3343
11034583|Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans.|SB-207266|serotonin 5-HT(4) receptor|11|4|Arg1:T12|Arg2:T22|CHEMICAL|GENE|ANTAGONIST|3344
23523949|Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.|Crocin|CK-MB|1|17|Arg1:T1|Arg2:T31|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3345
17016621|Similar to AMR and AMROH, adriamycin and etoposide (VP-16) are DNA topoisomerase II inhibitors.|AMR|DNA topoisomerase II|3|14|Arg1:T3|Arg2:T21|CHEMICAL|GENE|INHIBITOR|3346
8384716|Degenerate oligonucleotides corresponding to conserved amino acids from transmembrane domains III, V, and VI of known receptors [5-HT1A, 5-HT1C, and 5-HT2; 5-HT is serotonin (5-hydroxytryptamine)] were used as primers for the sequential reactions.|amino acids|5-HT1A|6|21|Arg1:T15|Arg2:T35|CHEMICAL|GENE|PART-OF|3347
23534442|Nitrooxy derivatives showed NO-dependent vasorelaxing properties, while most of the compounds proved to be very potent and selective COX-2 inhibitors in in vitro experimental models.|Nitrooxy|COX-2|1|20|Arg1:T11|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3348
10694244|Troglitazone inhibited LTB(4) production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to zileuton, suggesting that troglitazone inhibits LT production by direct inhibition of 5-LOX activity.|zileuton|5-LOX|20|32|Arg1:T25|Arg2:T29|CHEMICAL|GENE|INHIBITOR|3349
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|mZBrENT|DAT|32|55|Arg1:T2|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|3350
22898212|Mass spectral analysis of CBDP-inhibited BChE digested with Glu-C showed an o-hydroxybenzyl adduct (+106amu) on lysine 499, a residue far from the active site, but not on His-438.|CBDP|BChE|5|6|Arg1:T16|Arg2:T33|CHEMICAL|GENE|INHIBITOR|3351
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|CLS|cyclooxygenase-2|15|37|Arg1:T7|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3352
23564313|Also, vinblastine enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBα (IκBα) kinase, and inositol requiring enzyme 1α.|vinblastine|p38|3|43|Arg1:T7|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|3353
23017388|Also, SB365 showed anti-angiogenic activity by decreasing the expression of HIF-1α and VEGF.|SB365|VEGF|3|14|Arg1:T4|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3354
23584358|In conclusion, agomelatine administration protects liver cells from paracetamol-induced hepatotoxicity via antioxidant activity and reduced proinflammatory cytokines, such as TNF-α and IL-6.|agomelatine|cytokines|4|18|Arg1:T11|Arg2:T39|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3355
23412396|Mice given daily injections of high dose JZL184 (≥16 mg/kg) for six days displayed decreased CB(1) receptor density and function in brain, as assessed in [(3)H]SR141716A binding and CP55,940-stimulated [(35)S]GTPγS binding assays, respectively.|(35)S|CB(1)|43|18|Arg1:T16|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|3356
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Gleevec|ABL|5|24|Arg1:T3|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3357
10406837|The stimulatory effect of [Ca(2+)](i) induced by a submaximal concentration of Ang II (10(-7) mol/L) was blocked by torasemide (IC(50)=0.5+/-0.3 nmol/L).|torasemide|Ang II|32|20|Arg1:T5|Arg2:T16|CHEMICAL|GENE|INHIBITOR|3358
9851542|  The cardiovascular effects of three different acetylcholinesterase inhibitors: physostigmine, tacrine and rivastigmine injected by intravenous (i.v.) route were compared in freely moving Wistar rats.|physostigmine|acetylcholinesterase|10|7|Arg1:T19|Arg2:T32|CHEMICAL|GENE|INHIBITOR|3359
8294418|Actinomycin D caused alpha-AR mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of H-7 to decrease basal alpha-AR mRNA level.|Actinomycin D|alpha-AR|1|4|Arg1:T12|Arg2:T28|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3360
16343532|A previous crystal structure of a microcystin bound to the catalytic subunit of protein phosphatase-1 (PP-1c) showed distinct changes in the active site region when compared with protein phosphatase-1 structures bound to other toxins.|microcystin|protein phosphatase-1|7|14|Arg1:T7|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|3361
10771044|  We examined the effect of JTH-601 (3- inverted question markN-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom ethyl inverted question mark-4-methoxy-2,5,6-trimethylphenol hemifumarate), a new alpha(1L)-adrenoceptor antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs.|N-[2-(4-hydroxy-2-isopropyl-5-methylphenoxy)ethyl]-N-methylaminom|alpha(1L)-adrenoceptor|12|29|Arg1:T13|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|3362
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|apoptosis signal-regulating kinase 1|7|23|Arg1:T2|Arg2:T24|CHEMICAL|GENE|INHIBITOR|3363
23098818|The reaction was inhibited by the specific CYP2D inhibitors quinine and fluoxetine.|quinine|CYP2D|10|8|Arg1:T1|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3364
17256745|  UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine.|glycine|Bile acid-coenzyme A:amino acid N-acyltransferase|29|3|Arg1:T5|Arg2:T21|CHEMICAL|GENE|PRODUCT-OF|3365
16965760|  Phospholipase C beta (PLC-beta)-coupled G protein-coupled receptor (GPCR) activities traditionally are assessed by measuring Ca2+ triggered by D-myo-inositol 1,4,5-trisphosphate (IP3), a PLC-beta hydrolysis product, or by measuring the production of inositol phosphate using cumbersome radioactive assays.|IP3|PLC-beta|26|30|Arg1:T7|Arg2:T25|CHEMICAL|GENE|PRODUCT-OF|3366
23512754|Results indicate that CDM inhibits HSV-2 multiplication in epithelial cells and also increases cytokine production in macrophages, both important actions to the clearance of infecting virus in the mouse vagina.|CDM|cytokine|4|14|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3367
17256745|  UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine.|glycine|BAAT|29|11|Arg1:T5|Arg2:T32|CHEMICAL|GENE|PRODUCT-OF|3368
10640321|The delta-receptor antagonist, SB 244525 (10 mg/kg, i.p.), inhibited the antitussive effect of SB 227122 (20 mg/kg, i.p.).|SB 227122|delta-receptor|20|2|Arg1:T16|Arg2:T29|CHEMICAL|GENE|AGONIST|3369
10694244|Troglitazone inhibited LTB(4) production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to zileuton, suggesting that troglitazone inhibits LT production by direct inhibition of 5-LOX activity.|troglitazone|5-LOX|24|32|Arg1:T26|Arg2:T29|CHEMICAL|GENE|INHIBITOR|3370
10727528|Inhibition of the actions of ET-1 by salicylates is apparently competitive.|salicylates|ET-1|8|6|Arg1:T7|Arg2:T27|CHEMICAL|GENE|INHIBITOR|3371
14984733|Moreover, a normal level of expression of PSS1 and/or PSS2 is not required for generating the pool of PtdSer externalized during apoptosis.|PtdSer|PSS1|20|9|Arg1:T6|Arg2:T18|CHEMICAL|GENE|PRODUCT-OF|3372
11691635|The specific activity of only ornithine aminotransferase (OAT), the rate-limiting enzyme in the conversion of ornithine to proline, increased in 2 weeks of hypertrophy.|proline|ornithine aminotransferase|21|6|Arg1:T3|Arg2:T8|CHEMICAL|GENE|PRODUCT-OF|3373
23220618|And, the effects of the compounds on expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were tested in tumor necrosis factor-(TNF)-α activated HUVECs. Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, both agents elicited anticoagulant effects in mouse.|hyperoside|thrombin|64|68|Arg1:T13|Arg2:T35|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3374
1978244|Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that alpha 1-adrenoceptor populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for WB4101 and pKd approximately 7.1 for 5-methyl-urapidil) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both WB4101 and 5-methyl-urapidil), which was in good agreement with radioligand binding studies.(ABSTRACT TRUNCATED AT 400 WORDS)|5-methyl-urapidil|alpha 1-adrenoceptor|47|14|Arg1:T15|Arg2:T32|CHEMICAL|GENE|ANTAGONIST|3375
23164921|In addition, our exploration further revealed that the suppressive action of catalpol on inflammation was mediated via inhibiting nuclear factor-κB (NF-κB) activation.|catalpol|nuclear factor-κB|13|20|Arg1:T10|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3376
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|temsirolimus|mTOR|38|41|Arg1:T6|Arg2:T18|CHEMICAL|GENE|INHIBITOR|3377
20104269|The maximum stimulation of Cdx2 and MUC2 mRNA induced by CDCA was observed at 3 h and by 6 h, respectively.|CDCA|Cdx2|11|5|Arg1:T9|Arg2:T28|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3378
22982218|We also investigated the epigenetic status of NIS promoter after PJ34 treatment in TPC1 cell line: in addition to an increase of histone modification activation marks (H3K9K14ac, H3K4me3), surprisingly we observed also an increase of H3K27me3, a classical repressive mark.|PJ34|H3K4me3|11|31|Arg1:T5|Arg2:T18|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3379
8925876|However, at guinea-pig and mouse splenic alpha 1B-adrenoceptors, the affinity values of risperidone were 10-fold lower than those of prazosin.|risperidone|guinea-pig and mouse splenic alpha 1B-adrenoceptors|15|4|Arg1:T11|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|3380
14501155|The 5-HT(2B/2C)-receptor antagonist SB 206553 facilitated hyperglycemia induced by clomipramine, although the 5-HT(2A)-receptor antagonist ketanserin was without effect.|ketanserin|5-HT(2A)|24|18|Arg1:T15|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|3381
23623750|Cynomolgus FMO6 metabolized benzydamine only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.|benzydamine|FMO2|4|29|Arg1:T8|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|3382
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|alanine|SNAT1|8|37|Arg1:T15|Arg2:T41|CHEMICAL|GENE|SUBSTRATE|3383
12881227|5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.|5-(N,N-dimethyl)-amiloride|NHE|1|21|Arg1:T8|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3384
23517558|A catheterized rat model was used to define the intestinal and hepatic components of oral bioavailability for an 11β-HSD1 inhibitor, AMG 221.|AMG 221|11β-HSD1|22|19|Arg1:T2|Arg2:T7|CHEMICAL|GENE|INHIBITOR|3385
23318471|As predicted, TES enhanced the production of both peroxynitrite precursors (i.e., superoxide and nitic oxide), and xanthine oxidase was identified as the likely source of TES-stimulated superoxide production.|superoxide|xanthine oxidase|32|22|Arg1:T2|Arg2:T44|CHEMICAL|GENE|PRODUCT-OF|3386
17015640|Rofecoxib only diminished COX-2 protein expression and MCP-1 gene expression in vascular atheroma.|Rofecoxib|COX-2|1|4|Arg1:T3|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3387
17148442|In addition to the N-terminal and Src homology 2 domains that mediate these interactions, SOCS proteins contain a C-terminal SOCS box.|C|SOCS box|20|21|Arg1:T2|Arg2:T11|CHEMICAL|GENE|PART-OF|3388
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Glivec|BCR|7|26|Arg1:T4|Arg2:T13|CHEMICAL|GENE|INHIBITOR|3389
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Sorafenib|TK|42|3|Arg1:T27|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3390
15474503|Further study revealed that pitavastatin increased ABCA1 mRNA in HMG-CoA reductase-dependent manner and that Rho and Rho kinase inhibitor (C3T and Y27632) increased apoA-I production in the HepG2 cells.|Y27632|Rho kinase|23|17|Arg1:T15|Arg2:T39|CHEMICAL|GENE|INHIBITOR|3391
12086935|AMP-activated protein kinase (AMPK) activity increases in response to depletion of cellular energy stores, and this enzyme has been implicated in the stimulation of glucose uptake into skeletal muscle and the inhibition of liver gluconeogenesis.|glucose|AMPK|28|5|Arg1:T11|Arg2:T24|CHEMICAL|GENE|SUBSTRATE|3392
23249751|We begin by capturing RISC using a complementary 2'-O-methyl oligonucleotide tethered to beads.|2'-O-methyl|RISC|9|5|Arg1:T1|Arg2:T4|CHEMICAL|GENE|DIRECT-REGULATOR|3393
12046981|  Olopatadine hydrochloride (olopatadine, 11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid monohydrochloride) is a novel antiallergic/histamine H1-receptor antagonistic drug that was synthesized and evaluated in our laboratories.|11-[(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid monohydrochloride|histamine H1-receptor|6|31|Arg1:T12|Arg2:T20|CHEMICAL|GENE|ANTAGONIST|3394
23435942|This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogues developed for the treatment of AD.|tacrine|cholinesterase|11|8|Arg1:T1|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3395
12487427|GW660511X and omapatrilat reduced the production of BrBK1-5 and BrBK1-7 with more effect being observed with omapatrilat.|omapatrilat|BrBK1-7|17|10|Arg1:T21|Arg2:T64|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3396
23220618|In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-α-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.|IMG|t-PA|21|30|Arg1:T2|Arg2:T22|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3397
16965760|It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.|IP3|inositol monophosphatase|31|23|Arg1:T17|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|3398
15732037|Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.|carvedilol|VEGF|3|12|Arg1:T1|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3399
3345199|If the effectors were added after 5 min of aging they increased the activity of soman-inhibited AChE, but to a considerably smaller extent than HI 6.|soman|AChE|16|17|Arg1:T7|Arg2:T30|CHEMICAL|GENE|INHIBITOR|3400
1590750|The identity of the lung beta-ADHs was further demonstrated by their characteristic pH-activity profiles for ethanol oxidation, Km values for NAD and ethanol, and inhibition by 4-methylpyrazole or 1,10-phenanthroline.|ethanol|beta-ADHs|24|6|Arg1:T7|Arg2:T23|CHEMICAL|GENE|SUBSTRATE|3401
9476974|The sodium channel-blocking action of cocaine per se does not appear to be involved in the rapid pressor response to cocaine.|cocaine|sodium channel|6|2|Arg1:T9|Arg2:T45|CHEMICAL|GENE|INHIBITOR|3402
8636122|Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.|SR 141716A|CB1|18|7|Arg1:T14|Arg2:T31|CHEMICAL|GENE|DIRECT-REGULATOR|3403
23506741|Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-α, IL-1β, IL-18, IL-17A and IFN-γ, were markedly suppressed by Fc11a-2.|Fc11a-2|IFN-γ|29|23|Arg1:T9|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3404
17159811|RESULTS: Following administration of the highest of the GAL doses used (2.5; 5; 10 mg/kg i.m.), AChE activity decreased mainly in the frontal cortex, hippocampus and hypophysis.|GAL|AChE|10|24|Arg1:T9|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3405
11588409|Like conventional ACE inhibitors, omapatrilat causes extracellular volume reduction and vasodilatation; moreover, it increases levels of atrial and brain natriuretic peptides and bradykinin.|omapatrilat|bradykinin|6|26|Arg1:T10|Arg2:T25|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3406
17154506|Chase studies with citalopram and methylphenidate demonstrated that this uptake is the result of preferential binding to the SERT.|citalopram|SERT|4|19|Arg1:T11|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|3407
23481236|Unsaturated FFAs increased DAGs, TAGs and PTP1B expression significantly, but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine (Ser) 50, Ser 398 and tyrosine 152.|Ser|PTP1B|32|23|Arg1:T24|Arg2:T51|CHEMICAL|GENE|PART-OF|3408
11692072|In an earlier report, DRD2 E8 A/A genotype was associated with reduced responsiveness to the dopamine D2 agonist apomorphine; however, it is not clear whether both findings share the same biological basis.|apomorphine|dopamine D2|20|17|Arg1:T6|Arg2:T15|CHEMICAL|GENE|AGONIST|3409
10064839|We found that DF, DM, and DR were relative high-affinity ligands at sigma-1 receptors (Ki=151, 205, 144 nM, respectively) while all of them were with low affinity at sigma-2 receptors (Ki=4-11 microM).|DM|sigma-2 receptors|6|36|Arg1:T47|Arg2:T52|CHEMICAL|GENE|DIRECT-REGULATOR|3410
18081314|The distances between the protons H20 and H2, H18 and H2, and H18 and H4 are shorter following their binding to the PGIS in solution-down to within 5 A.|H4|PGIS|17|25|Arg1:T24|Arg2:T41|CHEMICAL|GENE|PART-OF|3411
23296102|Interestingly, Acrolein increased proteins' levels of amyloid precursor protein (APP), β-secretase (BACE-1) and the amyloid β-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.|Acrolein|receptor for advanced glycation end products|3|25|Arg1:T5|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3412
10742288|The selective alpha(1)-adrenoceptor ligands prazosin and doxazosin (each 3 microM) had no effect on noradrenaline responses.|doxazosin|alpha(1)-adrenoceptor|11|3|Arg1:T15|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|3413
16774921|Interestingly, deletion of the entire yeast mitochondrial LeuRS C-terminal domain enhanced its aminoacylation and amino acid editing activities.|amino acid|yeast mitochondrial LeuRS|16|7|Arg1:T13|Arg2:T23|CHEMICAL|GENE|PART-OF|3414
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|nomegestrol acetate|17beta-hydroxysteroid-dehydrogenase type 1|19|36|Arg1:T11|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3415
2859531|To study the mechanism underlying this phenomenon, the effects of the nonselective beta-adrenoceptor antagonists propranolol [no intrinsic sympathomimetic activity (ISA)], alprenolol (weak ISA) and mepindolol (strong ISA) on lymphocyte beta 2-adrenoceptor density--assessed by (+/-)-[125I]-iodocyanopindolol (ICYP) binding--and plasma renin activity (PRA) were investigated in male healthy volunteers aged 23-35 years.|mepindolol|beta-adrenoceptor|33|14|Arg1:T7|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|3416
15049511|The results demonstrated that tranylcypromine is a competitive inhibitor of CYP2C19 (Ki = 32 microM) and CYP2D6 (Ki = 367 microM) and a noncompetitive inhibitor of CYP2C9 (Ki = 56 microM).|tranylcypromine|CYP2C19|5|11|Arg1:T4|Arg2:T17|CHEMICAL|GENE|INHIBITOR|3417
17382376|It is currently not known how much this H(1) antagonism of clozapine contributes to the therapeutic or adverse side effects of clozapine.|clozapine|H(1)|15|9|Arg1:T12|Arg2:T29|CHEMICAL|GENE|ANTAGONIST|3418
17159811|  OBJECTIVES: The alkaloid galantamine (GAL), which exhibits a combined anticholinesterase and direct parasympathomimetic mechanism of action, is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases.|GAL|anticholinesterase|7|14|Arg1:T6|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3419
15908512|The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively.|metoprolol|beta1AR|7|3|Arg1:T6|Arg2:T20|CHEMICAL|GENE|ANTAGONIST|3420
23353741|All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) inhibitory activity of murine macrophage RAW 264.7 cell line.|prostaglandin E2|cyclooxygenase-2|27|22|Arg1:T4|Arg2:T7|CHEMICAL|GENE|PRODUCT-OF|3421
20421509|Using a unique biosensor-based assay, trifluoperazine (TFP) was identified as an inhibitor that disrupts the S100A4/myosin-IIA interaction.|trifluoperazine|S100A4|7|19|Arg1:T11|Arg2:T37|CHEMICAL|GENE|INHIBITOR|3422
11264758|Pranlukast is a new, orally active, selective inhibitor of CysLt1 leukotriene receptor.|leukotriene|CysLt1|13|12|Arg1:T6|Arg2:T14|CHEMICAL|GENE|DIRECT-REGULATOR|3423
23333577|Subsequently, pinosylvin suppressed the nuclear translocation of β-catenin, one of downstream molecules of PI3K/Akt/GSK-3β signaling, and these events led to the sequential downregulation of β-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.|pinosylvin|MMP7|3|43|Arg1:T8|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3424
23266505|The upregulation of calpain, tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of ALD.|EGTA|caspase-3|16|8|Arg1:T18|Arg2:T36|CHEMICAL|GENE|INHIBITOR|3425
16516814|Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the PKC inhibitor Go 6976, thapsigargin, as well as the calmodulin antagonists W7 and W13.|W7|calmodulin|43|41|Arg1:T12|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|3426
23538162|These protective effects were abolished by glucocorticoid receptor (GR) antagonist RU486 or p-ERK inhibitor U0126 rather than estrogen receptor α antagonist ICI 82,780.|U0126|p-ERK|17|15|Arg1:T8|Arg2:T23|CHEMICAL|GENE|INHIBITOR|3427
23220644|In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (JMC08-4) for human nonpancreatic secretory phospholipase A(2) (hnps-PLA(2)) and human leukotriene A(4) hydrolase (LTA(4)H-h) was found.|JMC08-4|LTA(4)H-h|21|47|Arg1:T2|Arg2:T11|CHEMICAL|GENE|INHIBITOR|3428
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|goserelin|LHRH|13|5|Arg1:T6|Arg2:T23|CHEMICAL|GENE|AGONIST|3429
8294418|In NE-desensitized cells, phorbol esters and bradykinin each caused the expected down-regulation of alpha-AR mRNA.|NE|alpha-AR|2|15|Arg1:T16|Arg2:T33|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3430
11585753|"ZD1839 (""Iressa""), a quinazoline tyrosine kinase inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials."|Iressa|tyrosine kinase|4|10|Arg1:T3|Arg2:T13|CHEMICAL|GENE|INHIBITOR|3431
17459764|Finally, PLA2 inhibitor methyl arachidonyl fluorophosphonate blocked the PUFA effects on COX-2 induction, promoter activity and arachidonic acid mobilization suggesting involvement of AA metabolites in PPAR activation.|arachidonyl fluorophosphonate|COX-2|6|13|Arg1:T23|Arg2:T42|CHEMICAL|GENE|INHIBITOR|3432
16247743|Miglustat, an imino sugar that reversibly inhibits glucosylceramide synthase and reduces intracellular substrate burden, is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option.|Miglustat|glucosylceramide synthase|1|9|Arg1:T4|Arg2:T9|CHEMICAL|GENE|INHIBITOR|3433
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|goserelin|gonadotrophin-releasing hormone (GnRH) receptor|13|23|Arg1:T6|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|3434
23519153|Of note, reciprocal expression of Asmt and Bhmt is an important clue that altered S-adenosylhomocysteine metabolism underlies brain injury in WD, which is directly correlated to the decreased expression of S-adenosylhomocysteine hydrolase in hepatic tissue in LEC rats.|S-adenosylhomocysteine|Bhmt|16|9|Arg1:T2|Arg2:T13|CHEMICAL|GENE|SUBSTRATE|3435
19149483|The following TK blockers for treatment of various human tumors are in clinical development: Lapatinib (Lapatinib ditosylate, Tykerb, GW-572016), Canertinib (CI-1033), Zactima (ZD6474), Vatalanib (PTK787/ZK 222584), Sorafenib (Bay 43-9006, Nexavar), and Leflunomide (SU101, Arava).|Leflunomide|TK|51|3|Arg1:T30|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3436
14725487|  Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the beta(2)-adrenoceptor agonist formoterol [eformoterol].|eformoterol|beta(2)-adrenoceptor|28|20|Arg1:T4|Arg2:T22|CHEMICAL|GENE|AGONIST|3437
10988273|In addition, a partial nucleotide and amino acid sequence of the rabbit alpha(2A)-adrenoceptor (a region known to substantially influence the pharmacological characteristics of the alpha(2)-adrenoceptor) revealed marked differences between the rabbit and the human alpha(2A)-adrenoceptor.|amino acid|rabbit alpha(2A)-adrenoceptor|8|13|Arg1:T5|Arg2:T17|CHEMICAL|GENE|PART-OF|3438
9476974|Monoamine uptake inhibitors structurally analogous to cocaine (cocaethylene, CFT, betaCIT, CPT, (+)-cocaine, norcocaine, and benztropine) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities (BTCP, indatraline, GBR 12935, mazindol, nomifensine, and zimeldine) either did not produce a rapid pressor response or produced only a small pressor response.|BTCP|monoamine transporter|45|41|Arg1:T25|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3439
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|Glivec|PDGFRB,|7|31|Arg1:T4|Arg2:T16|CHEMICAL|GENE|INHIBITOR|3440
17154506|  2beta-carbomethoxy-3beta-(3'-((Z)-2-iodoethenyl)phenyl)nortropane (mZIENT, 1) and 2beta-carbomethoxy-3beta-(3'-((Z)-2-bromoethenyl)phenyl)nortropane (mZBrENT, 2) were synthesized and evaluated for binding to the human serotonin, dopamine, and norepinephrine transporters (SERT, DAT, and NET, respectively) using transfected cells.|mZBrENT|NET|32|58|Arg1:T2|Arg2:T18|CHEMICAL|GENE|DIRECT-REGULATOR|3441
23564313|In addition, vinblastine induces the DNA-binding activities of the transcription factor NF-κB, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.|vinblastine|NF-κB|4|13|Arg1:T1|Arg2:T13|CHEMICAL|GENE|ACTIVATOR|3442
10727528|It has no influence on the rate of association of (125)I-ET-1 to ETA receptors.|(125)I|ETA receptors|11|16|Arg1:T12|Arg2:T34|CHEMICAL|GENE|DIRECT-REGULATOR|3443
23473681|We previously employed a chemical genomic strategy to identify a novel small molecule, MAC13243, as a likely inhibitor of the bacterial lipoprotein targeting chaperone, LolA.|MAC13243|chaperone|15|26|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INHIBITOR|3444
10640321|The sigma-receptor antagonist rimcazole (3 mg/kg, i.p.) inhibited the antitussive effect of dextromethorphan (30 mg/kg, i.p.), a sigma-receptor agonist, but not that of SB 227122.|rimcazole|sigma-receptor|4|2|Arg1:T2|Arg2:T21|CHEMICAL|GENE|ANTAGONIST|3445
16206183|DAT occupancy was determined by displacement of 8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane (FECNT).|8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane|DAT|8|1|Arg1:T1|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|3446
17479245|Isolated islets displayed improved glucose-stimulated insulin secretion after GRA treatment (0.061 +/- 0.007 vs 0.030 +/- 0.004 pmol islet(-1) h(-1) at 16.7 mmol/l glucose; p < 0.001), without affecting islet glucose oxidation.|glucose|insulin|5|6|Arg1:T5|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3447
17459764|Finally, PLA2 inhibitor methyl arachidonyl fluorophosphonate blocked the PUFA effects on COX-2 induction, promoter activity and arachidonic acid mobilization suggesting involvement of AA metabolites in PPAR activation.|AA|PPAR|25|28|Arg1:T2|Arg2:T27|CHEMICAL|GENE|ACTIVATOR|3448
23118019|Opioid receptor binding affinity and activity were assessed using [(3)H]-diprenorphine binding, guanosine-5'-O-(3-[35S]-thio) triphosphate ([(35)S]-GTPγS) binding and isolated guinea-pig ileum.|[(35)S]-GTPγS|Opioid receptor|29|1|Arg1:T13|Arg2:T21|CHEMICAL|GENE|DIRECT-REGULATOR|3449
15908512|In contrast, the selective beta2AR antagonists ICI-118,551 and butoxamine inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively).|isoproterenol|beta2AR|12|6|Arg1:T11|Arg2:T21|CHEMICAL|GENE|AGONIST|3450
23439561|Cycloxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) has been shown to be important in esophageal tumorigenesis.|PGE2|Cycloxygenase-2|9|1|Arg1:T5|Arg2:T18|CHEMICAL|GENE|PRODUCT-OF|3451
7837275|In conclusion, these data demonstrate that: (1) the Leu144-Gly150 loop and the FRS are both involved in the conformational transition linked to the binding of p-aminobenzamidine to the thrombin active site; (2) the extent of thrombin's capacity to undergo conformational transitions in alpha-, zeta- and gamma T forms is positively correlated to the free energy of activation for hydrolysis of macromolecular substrates interacting with both the catalytic domain and the FRS.|p-aminobenzamidine|thrombin|30|33|Arg1:T7|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|3452
3134891|  To determine the factors that influence the interaction between phenoxybenzamine and calmodulin, the binding of phenoxybenzamine to calmodulin was determined by equilibrium dialysis under a variety of experimental conditions.|phenoxybenzamine|calmodulin|10|12|Arg1:T13|Arg2:T34|CHEMICAL|GENE|DIRECT-REGULATOR|3453
9851542|The tacrine pressor response was inhibited in a dose-dependent manner by the i.c.v. administration of the non-selective muscarinic receptor antagonist atropine (ID50 = 1.45 microg), the muscarinic M1 receptor antagonist pirenzepine (ID50 = 4.33 microg), the muscarinic M2 receptor antagonist methoctramine (ID50 = 1.39 microg) and the muscarinic M3 receptor antagonist para-fluoro-hexahydro-sila-difenidol (ID50 = 31.19 microg).|methoctramine|muscarinic M2 receptor|48|44|Arg1:T5|Arg2:T26|CHEMICAL|GENE|ANTAGONIST|3454
9476974|Monoamine uptake inhibitors structurally analogous to cocaine (cocaethylene, CFT, betaCIT, CPT, (+)-cocaine, norcocaine, and benztropine) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities (BTCP, indatraline, GBR 12935, mazindol, nomifensine, and zimeldine) either did not produce a rapid pressor response or produced only a small pressor response.|mazindol|monoamine transporter|52|41|Arg1:T28|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3455
16371234|These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with COX-1, especially mPGES-2, plays the pivotal role in PS liposome-induced PGE2 production by microglia.|PGE2|mPGES-2|28|19|Arg1:T6|Arg2:T35|CHEMICAL|GENE|PRODUCT-OF|3456
17488480|In this study, we investigated the presence of H(2)S and the expression of H(2)S synthesizing enzymes, CSE and CBS, in isolated mouse pancreatic acini.|H(2)S|CSE|19|27|Arg1:T17|Arg2:T44|CHEMICAL|GENE|PRODUCT-OF|3457
22989703|Both apo-lycopenoic acids also decreased CSE-induced ROS production, 8-OHdG formation and reduced the increase in NOX-4 and COX-2 expressions caused by CSE.|apo-lycopenoic acids|COX-2|2|19|Arg1:T15|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3458
23250811|Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0.05).|curcumin|IL-27|9|37|Arg1:T14|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3459
17311416|Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and SNAT2.|4-methoxy-7-nitroindolinyl|ASCT2|17|35|Arg1:T17|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|3460
23182946|Six days after (PhTe)(2) injection we found persistent astrogliosis, increased propidium iodide (PI) positive cells in NeuN positive population evidenced by flow cytometry and reduced immunofluorescence for NeuN, suggesting that the in vivo exposure to (PhTe)(2) progressed to neuronal death.|(PhTe)(2)|NeuN|45|36|Arg1:T1|Arg2:T15|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3461
23583257|Nox4 oxidase activity is thought to be constitutive and regulated at the transcriptional level; however, we challenge this point of view and suggest that specific quinone derivatives could modulate this activity.|quinone|Nox4|28|1|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3462
12679340|The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.|Lys|OTCase|18|30|Arg1:T19|Arg2:T21|CHEMICAL|GENE|PART-OF|3463
23221006|These observations suggest that uptake of phenformin into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of complex I respiration.|phenformin|OCTN1|7|17|Arg1:T5|Arg2:T21|CHEMICAL|GENE|SUBSTRATE|3464
11089538|Moreover, IGFBP-rP2 noticeably increased in response to TGF-beta1 and all-trans retinoic acid (atRA) in HPEC and PC-3 cells, and it decreased in response to IGF-I in HPEC.|atRA|IGFBP-rP2|15|3|Arg1:T3|Arg2:T9|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3465
1705137|Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.|toloxatone|monoamine oxidase|18|4|Arg1:T44|Arg2:T51|CHEMICAL|GENE|INHIBITOR|3466
15177307|No influence of moderate hepatic impairment on the pharmacokinetics of lumiracoxib, an oral COX-2 selective inhibitor.|lumiracoxib|COX-2|11|15|Arg1:T11|Arg2:T14|CHEMICAL|GENE|INHIBITOR|3467
17768678|  Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.|PLZ|monoamine oxidase|3|11|Arg1:T6|Arg2:T39|CHEMICAL|GENE|INHIBITOR|3468
14600253|  The choroid plexus uptake of [(3)H]cefadroxil was studied in peptide transporter 2 (PEPT2) wild-type and null mice as a function of temperature, transport inhibitors, pH, and saturability.|[(3)H]cefadroxil|peptide transporter 2|6|16|Arg1:T7|Arg2:T22|CHEMICAL|GENE|SUBSTRATE|3469
15939622|However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.|flunixin|COX-2|11|18|Arg1:T7|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3470
23597506|However, enzymes contributing to oxidative metabolism of anandamide, namely cyclooxygenase-1 and Cyp2D6, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of anandamide.|anandamide|Cyp2D6|9|14|Arg1:T2|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|3471
23601203|Molecular docking studies were performed with Human Serum Albumin (HSA: PDB 1E78), showing binding pattern with amino acid residues Arg218, Arg222 and Lys444, identifies the ligand-HSA interaction for the transportation affinity of the ligand at the specific site of the target.|Arg|Human Serum Albumin|24|7|Arg1:T4|Arg2:T11|CHEMICAL|GENE|PART-OF|3472
22982218|  Since PARP-1 is supposed to be part of a multimeric repressor of sodium iodide symporter (NIS) expression, in this study the effect of the PARP inhibitor PJ34 on several properties of thyroid cancer cell lines was investigated.|PJ34|PARP|30|28|Arg1:T1|Arg2:T9|CHEMICAL|GENE|INHIBITOR|3473
7554708|  BACKGROUND: The active metabolite of the anti-inflammatory drug nabumetone has been characterized as a selective inhibitor of the inducible prostaglandin H synthase (PGHS).|nabumetone|prostaglandin H synthase|10|21|Arg1:T17|Arg2:T25|CHEMICAL|GENE|INHIBITOR|3474
19962254|As discussed in this review, various progestogens including dydrogesterone and its 20alpha-dihydro-derivative, medrogestone, promegestone, nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17beta-hydroxysteroid-dehydrogenase type 1 activities.|promegestone|sulfatase|17|34|Arg1:T10|Arg2:T27|CHEMICAL|GENE|INHIBITOR|3475
12724156|However, topiramate at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of GluR5 kainate receptor responses.|topiramate|kainate receptor|3|38|Arg1:T5|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3476
18439678|Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.|imiquimod|TLR7|14|4|Arg1:T6|Arg2:T32|CHEMICAL|GENE|ACTIVATOR|3477
14656380|The [3H]DHA binding was to a single receptor population with a dissociation constant of 0.42 nM, as would be expected for wild-type beta2AR.|[3H]DHA|beta2AR|2|27|Arg1:T10|Arg2:T11|CHEMICAL|GENE|DIRECT-REGULATOR|3478
14751502|To gauge the potential clinical utility of targeting both EGFR and HER2 to control growth and radiosensitize human breast cancers, we examined the effect of a dual EGFR/HER2 inhibitor, GW572016, on the proliferation and radiation response of either EGFR- or HER2-overexpressing human breast cancer cell lines.|GW572016|EGFR|32|29|Arg1:T7|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3479
23250811|There was no significant difference in TLR4, NF-κB, and IL-27 mRNA and proteins between curcumin-treated and sulfasalazine-treated groups.|sulfasalazine|IL-27|19|12|Arg1:T5|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3480
23261590|In addition, we found that neoechinulin A significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.|neoechinulin A|interleukin-1β|7|24|Arg1:T10|Arg2:T35|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3481
23296102|Interestingly, Acrolein increased proteins' levels of amyloid precursor protein (APP), β-secretase (BACE-1) and the amyloid β-peptide transporter receptor for advanced glycation end products, and decreased A-disintegrin and metalloprotease (ADAM) 10 levels.|Acrolein|BACE-1|3|18|Arg1:T5|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3482
17768678|  Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.|Phenelzine|GABA-transaminase|1|19|Arg1:T1|Arg2:T43|CHEMICAL|GENE|INHIBITOR|3483
18081314|  High-resolution NMR spectroscopy was used to determine the docking of a substrate (prostaglandin H2) mimic (U46619) to the engineered prostacyclin (PGI2) synthase (PGIS) in solution.|prostaglandin H2|PGIS|14|30|Arg1:T25|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|3484
17658513|Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).|8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride|alpha(1D)-adrenoceptor|25|46|Arg1:T4|Arg2:T13|CHEMICAL|GENE|ANTAGONIST|3485
23379481|Upamostat (Mesupron®) is a new small molecule serine protease inhibitor.|Upamostat|serine protease|1|10|Arg1:T2|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3486
17229632|INTERPRETATION AND CONCLUSIONS: These results warrant further clinical studies of sorafenib for the treatment of myeloid malignancies expressing activated forms of PDGFRbeta and FLT3.|sorafenib|FLT3|12|25|Arg1:T7|Arg2:T25|CHEMICAL|GENE|INHIBITOR|3487
14600253|These findings demonstrate that PEPT2 is the primary transporter responsible for cefadroxil uptake in the choroid plexus.|cefadroxil|PEPT2|12|5|Arg1:T5|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|3488
18974361|This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, isradipine, and nitrendipine) as potent T-channel blockers (IC(50) < 3 microM).|isradipine|T-channel|14|21|Arg1:T16|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3489
20185318|Phenols like the ones investigated here possess a CA inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the coumarins.|sulfamates|CA|18|9|Arg1:T14|Arg2:T33|CHEMICAL|GENE|INHIBITOR|3490
11292635|The physiological role of NKCC1-mediated Cl- uptake remains to be determined.|Cl-|NKCC1|6|5|Arg1:T5|Arg2:T30|CHEMICAL|GENE|SUBSTRATE|3491
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|indolinones|Flt3|22|43|Arg1:T14|Arg2:T34|CHEMICAL|GENE|INHIBITOR|3492
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|Ara-C|DCK|40|13|Arg1:T10|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|3493
17488480|Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue caerulein-treated acinar cells.|caerulein|PPT-A|39|20|Arg1:T3|Arg2:T55|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3494
9876137|Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block.|Cocaine|hH1 channels|1|4|Arg1:T5|Arg2:T13|CHEMICAL|GENE|INHIBITOR|3495
7926307|Consistent with these data, only GLUT2-expressing RIN or AtT-20ins cells transported STZ efficiently.|STZ|GLUT2|13|7|Arg1:T1|Arg2:T14|CHEMICAL|GENE|SUBSTRATE|3496
10701840|Moreover, geldanamycin decreases the amount and phosphorylation of Lck and Raf-1 kinases and prevents activation of the extracellular signal regulated kinase (ERK)-2 kinase.|geldanamycin|kinases|3|13|Arg1:T5|Arg2:T24|CHEMICAL|GENE|INHIBITOR|3497
12438517|  Yohimbine is a potent and selective alpha2- versus alpha1-adrenoceptor antagonist.|Yohimbine|alpha2- versus alpha1-adrenoceptor|1|7|Arg1:T1|Arg2:T17|CHEMICAL|GENE|ANTAGONIST|3498
19372559|Our results dissect the roles of HMGB1-associated proteins in DNA damage response: HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress, and PDIA3 has been found essential for H2AX phosphorylation (no gamma-H2AX accumulated after 24-72 hours of incubation with 1 micromol/L of cytarabine in PDIA3 knockdown cells).|cytarabine|p53|48|18|Arg1:T2|Arg2:T10|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3499
16424790|We compared the effects of Captopril (an ACE inhibitor with -SH group), enalapril (an ACE-inhibitor without -SH group), N-acetylcysteine (only -SH group not ACE inhibitor) on endothelial dysfunction injured by methionine-induced hyperhomocysteinemia (HHcy) in rats.|Captopril|ACE|6|9|Arg1:T22|Arg2:T63|CHEMICAL|GENE|INHIBITOR|3500
12244038|Similar to gemfibrozil, clofibrate, another fibrate drug, also inhibited the expression of iNOS.|clofibrate|iNOS|5|16|Arg1:T8|Arg2:T53|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3501
23543413|It has been claimed that hCTR1, the human high affinity copper transporter, is the major entry pathway for cDDP and related drugs via a mechanism that mimics copper.|cDDP|hCTR1|21|6|Arg1:T8|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|3502
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|PKC412|Flt3|29|43|Arg1:T18|Arg2:T34|CHEMICAL|GENE|INHIBITOR|3503
23118019|Both 5'-AMN and 5'-MABN had high affinity for κ-receptors (K (i) 1.36 ± 0.98 and 0.27 ± 0.08, respectively) and were revealed as potent κ-antagonists (pA(2) 7.43 and 8.18, respectively) and μ-receptor antagonists (pA(2) 7.62 and 7.85, respectively) in the ileum.|5'-MABN|κ-receptors|4|9|Arg1:T17|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|3504
11562773|Significant differences were observed in a different region (loop B93-B101), that we identified as binding site of amiloride to the tissue plasminogen activator (tPA).|amiloride|tissue plasminogen activator|21|24|Arg1:T1|Arg2:T6|CHEMICAL|GENE|DIRECT-REGULATOR|3505
10493852|Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.|lovastatin|LFA-1|7|4|Arg1:T3|Arg2:T14|CHEMICAL|GENE|INHIBITOR|3506
15121646|The relatively high D(2) receptor occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and quetiapine.|ziprasidone|D(2) receptor|19|4|Arg1:T6|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|3507
23538162|Rg1 attenuated the Aβ25-35-associated mitochondrial apoptotic events, accompanied by inhibiting HIF-1α expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination.|Rg1|Aβ25-35|1|4|Arg1:T5|Arg2:T19|CHEMICAL|GENE|INHIBITOR|3508
23703578|Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.|ritonavir|CYP3A|20|16|Arg1:T7|Arg2:T30|CHEMICAL|GENE|INHIBITOR|3509
17138644|Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src.|Progestin|PR|1|19|Arg1:T8|Arg2:T40|CHEMICAL|GENE|ACTIVATOR|3510
23118019|In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor.|naltrindole|κ-opioid receptor|8|12|Arg1:T18|Arg2:T23|CHEMICAL|GENE|DIRECT-REGULATOR|3511
12244038|These results suggest that gemfibrozil inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.|gemfibrozil|C/EBPbeta|5|22|Arg1:T5|Arg2:T52|CHEMICAL|GENE|INHIBITOR|3512
18439678|Both porcine TLR7 and TLR8 proteins were expressed in cell lines and were N-glycosylated.|N|TLR8|14|5|Arg1:T2|Arg2:T21|CHEMICAL|GENE|PART-OF|3513
23228697|Contrary to the hypothesis, orlistat at 1 nM inhibited CES2 activity by 75% but no inhibition on CES1, placing CES2 one of the most sensitive targets of orlistat.|orlistat|CES2|31|11|Arg1:T12|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3514
17229632|The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors.|sorafenib|PDGFRbeta|4|8|Arg1:T16|Arg2:T44|CHEMICAL|GENE|INHIBITOR|3515
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|cytarabine|Ile24Val|38|15|Arg1:T9|Arg2:T36|CHEMICAL|GENE|SUBSTRATE|3516
19149483|The most successful example of kinase blockers is Imatinib (Imatinib mesylate, Gleevec, STI571), the inhibitor of Bcr/Abl oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia.|STI571|Abl|16|23|Arg1:T38|Arg2:T55|CHEMICAL|GENE|INHIBITOR|3517
23250811|There was no significant difference in TLR4, NF-κB, and IL-27 mRNA and proteins between curcumin-treated and sulfasalazine-treated groups.|curcumin|NF-κB|17|9|Arg1:T4|Arg2:T25|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3518
23454148|Compared with normally-fed counterparts, PM-CP rats exhibited higher glutathione S-transferase, aminopeptidase N and cysteine S-conjugate beta-lyase (CCBL) and lower gamma-glutamyltransferase activities, PM-FU rats exhibited decreased dihydropyrimidine dehydrogenase and cytochrome P450 1A1/2 activities and PM-MMC rats showed higher quinone reductase and depleted xanthine oxidase activities.|MMC|xanthine oxidase|40|47|Arg1:T19|Arg2:T34|CHEMICAL|GENE|INHIBITOR|3519
17090056|KIEs were measured on the arsenolysis of 5'-methylthioadenosine (MTA) catalyzed by MTAP and were corrected for the forward commitment to catalysis.|MTA|MTAP|10|14|Arg1:T18|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|3520
23564313|In addition, vinblastine induces the DNA-binding activities of the transcription factor NF-κB, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.|vinblastine|HSP70|4|27|Arg1:T1|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3521
23246481|The mechanism revealed that wogonin inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of VE-cadherin and β-catenin.|wogonin|caveolin-1|5|10|Arg1:T8|Arg2:T18|CHEMICAL|GENE|INHIBITOR|3522
23230131|  Gemcitabine (dFdC, 2',2'-difluorodeoxycytidine) is metabolized by cytidine deaminase (CDA) and deoxycytidine kinase (DCK), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear.|Gemcitabine|cytidine deaminase|1|10|Arg1:T1|Arg2:T40|CHEMICAL|GENE|SUBSTRATE|3523
1978244|The Schild plots for the competitive antagonists WB4101 and 5-methyl-urapidil against alpha 1a-adrenoceptor-selective agonist methoxamine-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for WB4101 and 9.09 +/- 0.05 (n = 3) for 5-methyl-urapidil.|5-methyl-urapidil|alpha 1a-adrenoceptor|52|12|Arg1:T12|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|3524
16618126|The purified Atp8a1 is inactive in detergent micelles or in micelles containing phosphatidylcholine, phosphatidic acid, or phosphatidylinositol, is minimally activated by phosphatidylglycerol or phosphatidylethanolamine (PE), and is maximally activated by PS.|phosphatidylethanolamine|Atp8a1|27|3|Arg1:T5|Arg2:T35|CHEMICAL|GENE|ACTIVATOR|3525
16988497|A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and D5D genes.|alpha-linolenic acid|D5D|40|52|Arg1:T16|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3526
23623750|Cynomolgus FMO6 metabolized benzydamine only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.|benzydamine|FMO5|4|34|Arg1:T8|Arg2:T25|CHEMICAL|GENE|SUBSTRATE|3527
10446934|Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.|losartan|Human and rat renin|16|1|Arg1:T8|Arg2:T30|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3528
15198222|CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.|NS398|Canine COX-2|17|6|Arg1:T4|Arg2:T22|CHEMICAL|GENE|INHIBITOR|3529
11775064|Acute and chronic PLZ administration increase brain GABA levels, an effect due, at least in part, to an inhibition of the activity of the GABA metabolizing enzyme, GABA transaminase (GABA-T).|PLZ|GABA transaminase|4|32|Arg1:T24|Arg2:T33|CHEMICAL|GENE|INHIBITOR|3530
2899826|7-Hydroxy levomepromazine, 3-hydroxy levomepromazine and 7-hydroxy fluphenazine had only 10% of the potency of the parent drug in histamine H1 receptor binding, while the 7-hydroxy-metabolites of chlorpromazine and perphenazine had about 75% of the potency of the parent drug in this binding system.|7-Hydroxy levomepromazine|histamine H1 receptor|1|21|Arg1:T18|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|3531
23231502|Incubation of purified Pin1 with HNE followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues His-157 and Cys-113.|Cys|Pin1|25|4|Arg1:T19|Arg2:T30|CHEMICAL|GENE|PART-OF|3532
10712236|Inhibition of S-adenosylmethionine decarboxylase by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC.|diethylglyoxal bis-(guanylhydrazone)|S-adenosylmethionine decarboxylase|10|3|Arg1:T3|Arg2:T33|CHEMICAL|GENE|INHIBITOR|3533
11255924|OBJECTIVES: The hypothesis of the present study was that differences among dopamine transporter (DAT) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as DA uptake inhibitors.|DA|DAT|34|16|Arg1:T15|Arg2:T26|CHEMICAL|GENE|SUBSTRATE|3534
11309392|Diacylglycerol kinase (DGK) catalyzes the conversion of diacylglycerol to phosphatidic acid, making it an attractive candidate for a signal transduction component.|diacylglycerol|Diacylglycerol kinase|10|1|Arg1:T7|Arg2:T26|CHEMICAL|GENE|SUBSTRATE|3535
16365052|  Expression of L-type pyruvate kinase (L-PK) is upregulated in the liver by dietary carbohydrate.|carbohydrate|L-PK|16|7|Arg1:T4|Arg2:T12|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3536
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|cytarabine|Pro122Ser|38|20|Arg1:T9|Arg2:T38|CHEMICAL|GENE|SUBSTRATE|3537
17224860|However, as a novel finding, isoflavone treatment increased a subclass of high-density lipoprotein, the pre-beta high-density lipoprotein levels by 18% without affecting any other serum lipid concentrations.|isoflavone|pre-beta high-density lipoprotein|8|18|Arg1:T6|Arg2:T24|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3538
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|CT53518|Flt3|37|43|Arg1:T21|Arg2:T34|CHEMICAL|GENE|INHIBITOR|3539
17593236|Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.|sitagliptin|dipeptidyl peptidase-4|10|6|Arg1:T5|Arg2:T10|CHEMICAL|GENE|INHIBITOR|3540
9476974|At nonconvulsant doses, the sodium channel blockers acetylprocainamide, dibucaine, dyclonine, prilocaine, proparacaine, quinidine, and tetracaine produced a small pressor response or no increase in BP.|tetracaine|sodium channel|22|6|Arg1:T38|Arg2:T48|CHEMICAL|GENE|INHIBITOR|3541
23643745|The involvement of the various DA receptor subtypes in the motor effects of N/OFQ and NOP receptor antagonists was evaluated pharmacologically, using D1/D5 (SCH23390), D2/D3 (raclopride, amisulpride) and D3 (S33084) receptor antagonists, and by using D2 receptor knockout mice.|raclopride|D3|31|30|Arg1:T5|Arg2:T46|CHEMICAL|GENE|ANTAGONIST|3542
15030294|  Irbesartan is a long-acting angiotensin II antagonist acting specifically at the level of the Type 1-receptor subtype (AT1-receptor).|Irbesartan|angiotensin II|1|5|Arg1:T1|Arg2:T12|CHEMICAL|GENE|ANTAGONIST|3543
2899826|7-Hydroxy levomepromazine, 3-hydroxy levomepromazine and 7-hydroxy fluphenazine had only 10% of the potency of the parent drug in histamine H1 receptor binding, while the 7-hydroxy-metabolites of chlorpromazine and perphenazine had about 75% of the potency of the parent drug in this binding system.|3-hydroxy levomepromazine|histamine H1 receptor|4|21|Arg1:T20|Arg2:T35|CHEMICAL|GENE|DIRECT-REGULATOR|3544
18973551|Quinpirole and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.|7-OH-DPAT|extracellular signal-regulated kinase|3|9|Arg1:T6|Arg2:T26|CHEMICAL|GENE|ACTIVATOR|3545
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|2',2'-difluorodeoxyuridine|Ala119Gly|48|17|Arg1:T12|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|3546
18439678|Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.|imiquimod|TLR8|14|2|Arg1:T6|Arg2:T34|CHEMICAL|GENE|ACTIVATOR|3547
15939622|COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.|flunixin|COX-2|11|3|Arg1:T15|Arg2:T23|CHEMICAL|GENE|INHIBITOR|3548
12727196|Purified PAOh1/SMO oxidizes both spermine (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine.|spermine|PAOh1|5|2|Arg1:T3|Arg2:T15|CHEMICAL|GENE|SUBSTRATE|3549
23314054|A novel potent compound, N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide (12c), which binds Mcl-1 with an IC(50) value of 54 nM was obtained.|N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide|Mcl-1|6|18|Arg1:T2|Arg2:T8|CHEMICAL|GENE|INHIBITOR|3550
22718571|On the other hand, treatment with gentianine significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR-γ, GLUT-4 and adiponectin.|gentianine|adiponectin|8|29|Arg1:T8|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3551
12881227|Nevertheless, 3 mM DMA, a higher concentration that inhibits NHE1, NHE2, and NHE3, significantly increased DBS.|DMA|NHE3|5|17|Arg1:T11|Arg2:T38|CHEMICAL|GENE|INHIBITOR|3552
17593236|  AIM: To assess the efficacy and safety of a 24-week treatment with sitagliptin, a highly selective once-daily oral dipeptidyl peptidase-4 (DPP-4) inhibitor, in patients with type 2 diabetes who had inadequate glycaemic control [glycosylated haemoglobin (HbA(1c)) >or=7.5% and <or=10.5%] while on glimepiride alone or in combination with metformin.|sitagliptin|dipeptidyl peptidase-4|14|21|Arg1:T1|Arg2:T6|CHEMICAL|GENE|INHIBITOR|3553
16343532|Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin-LA: elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins.|dihydromicrocystin-LA|protein phosphatase-1|10|4|Arg1:T13|Arg2:T24|CHEMICAL|GENE|DIRECT-REGULATOR|3554
10593931|To identify key amino acids involved in factor IX activation, recombinant factor XIa proteins containing alanine substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay.|alanine|factor XIa|17|13|Arg1:T4|Arg2:T14|CHEMICAL|GENE|PART-OF|3555
1356794|  In the hot-plate test in mice, the antinociceptive action of the alpha 2-adrenoceptor agonist, UK 14,304, was abolished by the alpha 2-adrenoceptor antagonist, idazoxan, the potent alpha 2A-adrenoceptor antagonist, RX 821002 and the preferential alpha 2A-adrenoceptor antagonist, BRL 44408.|UK 14,304|alpha 2-adrenoceptor|17|13|Arg1:T11|Arg2:T18|CHEMICAL|GENE|AGONIST|3556
23391632|The mRNA level for nestin (Nes, biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-EDS, but not in the DEHP treated testes, suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHP-treated testes.|EDS|nestin|26|5|Arg1:T4|Arg2:T30|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3557
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|ASCT1|7|42|Arg1:T18|Arg2:T33|CHEMICAL|GENE|SUBSTRATE|3558
16206183|DAT occupancy was between 66 and 82% and <10-41% for doses of dimethocaine and procaine that maintained maximum response rates, respectively.|procaine|DAT|18|1|Arg1:T5|Arg2:T22|CHEMICAL|GENE|DIRECT-REGULATOR|3559
23330546|  Bile acids are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism.|Bile acids|nuclear receptors|1|8|Arg1:T1|Arg2:T13|CHEMICAL|GENE|ACTIVATOR|3560
23333577|Pinosylvin was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3β (GSK-3β) signaling pathway.|Pinosylvin|c-Src|1|20|Arg1:T6|Arg2:T36|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3561
22578098|By synthesizing and testing a series of alanine point-mutated cyclic peptides, we identified which amino acid was important for the inhibition of the phospholamban function.|alanine|cyclic peptides|8|10|Arg1:T7|Arg2:T8|CHEMICAL|GENE|PART-OF|3562
8730743|The present results suggest that the action of DMI in this animal model is unlikely to be directly related to a reduction in beta-adrenoceptors but may be related to a reduction in frontal cortical 5-HT2A receptors.|DMI|beta-adrenoceptors|9|24|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3563
23261590|The molecular mechanism studies suggested that neoechinulin A may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-κB (NF-κB) p65 and p50 subunits.|neoechinulin A|p65|7|39|Arg1:T2|Arg2:T28|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3564
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|cysteine S-conjugates|beta-lyases|3|10|Arg1:T20|Arg2:T54|CHEMICAL|GENE|SUBSTRATE|3565
12727196|The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues; however, specific oligamine analogues were found to be potent inhibitors of the oxidation of spermine by PAOh1/SMO.|spermine|PAOh1|30|32|Arg1:T7|Arg2:T17|CHEMICAL|GENE|SUBSTRATE|3566
12373423|Lisuride dose dependently decreased body temperature in rats with a potency similar to that of the selective 5-HT(1A) agonist LY 293284.|LY 293284|5-HT(1A)|23|18|Arg1:T12|Arg2:T31|CHEMICAL|GENE|AGONIST|3567
20801130|The affinities of dfbp and dfbp-o for the regulatory domain of cTnC were measured in the absence and presence of cTnI by NMR spectroscopy, and dfbp-o was found to bind more strongly than dfbp.|dfbp-o|cTnC|27|12|Arg1:T19|Arg2:T39|CHEMICAL|GENE|DIRECT-REGULATOR|3568
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|sunitinib|VEGFR-2|3|23|Arg1:T5|Arg2:T14|CHEMICAL|GENE|INHIBITOR|3569
8098142|The enhancement of the depolarizing afterpotential by histamine was mimicked by the histamine H1-receptor agonist 2-thiazolylethylamine and was reduced or blocked by the H1-receptor antagonist promethazine, but was not blocked or reduced in the presence of the histamine H2-receptor antagonist, cimetidine.|promethazine|H1-receptor|26|24|Arg1:T5|Arg2:T23|CHEMICAL|GENE|ANTAGONIST|3570
23395914|To evaluate to what extent the regional differences in expression of P-gp and P450 enzymes affect the absorption of a dual substrate, we investigated the transport of darunavir across different small intestinal segments (duodenum, proximal jejunum and ileum).|darunavir|P-gp|29|12|Arg1:T6|Arg2:T19|CHEMICAL|GENE|SUBSTRATE|3571
10988273|  On the basis of data obtained in rabbits, the imidazoline receptor ligand rilmenidine has been suggested to decrease blood pressure in humans by activating central alpha(2A)-adrenoceptors.|rilmenidine|imidazoline receptor|14|11|Arg1:T13|Arg2:T27|CHEMICAL|GENE|DIRECT-REGULATOR|3572
17488480|In addition, cells pre-treated with DL-propargylglycine (PAG, 3 mM), a CSE inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that CSE may be the main enzyme involved in H(2)S formation in mouse acinar cells.|DL-propargylglycine|CSE|7|16|Arg1:T22|Arg2:T48|CHEMICAL|GENE|INHIBITOR|3573
1356794|  In the hot-plate test in mice, the antinociceptive action of the alpha 2-adrenoceptor agonist, UK 14,304, was abolished by the alpha 2-adrenoceptor antagonist, idazoxan, the potent alpha 2A-adrenoceptor antagonist, RX 821002 and the preferential alpha 2A-adrenoceptor antagonist, BRL 44408.|BRL 44408|alpha 2A-adrenoceptor|45|41|Arg1:T3|Arg2:T14|CHEMICAL|GENE|ANTAGONIST|3574
18035186|Rasagiline [N-propargyl-l(R)-aminoindan] is a second-generation propargylamine pharmacophore that selectively and irreversibly inhibits brain MAO-B and is specifically designed for the treatment of Parkinson's disease (PD).|Rasagiline|MAO-B|1|20|Arg1:T9|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3575
23703578|Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.|lovastatin|CYP3A|3|6|Arg1:T6|Arg2:T29|CHEMICAL|GENE|SUBSTRATE|3576
3735252|  The inhibitory effect of (+)-, (-)-, (+/-)-gossypol and (+/-)-gossypol acetic acid upon testicular cytosolic LDH-X was measured in vitro.|(+)-, (-)-, (+/-)-gossypol|LDH-X|5|29|Arg1:T2|Arg2:T12|CHEMICAL|GENE|INHIBITOR|3577
10712236|Inhibition of S-adenosylmethionine decarboxylase by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC.|spermidine|S-adenosylmethionine decarboxylase|22|3|Arg1:T5|Arg2:T33|CHEMICAL|GENE|PRODUCT-OF|3578
2899826|  In vitro binding affinities of chlorpromazine, fluphenazine, levomepromazine, perphenazine and some of their metabolites for dopamine D2 receptors, alpha 1- and alpha 2 adrenoceptors in rat brain were previously reported from our laboratories.|chlorpromazine|dopamine D2 receptors|6|19|Arg1:T5|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|3579
8925876|However, at guinea-pig and mouse splenic alpha 1B-adrenoceptors, the affinity values of risperidone were 10-fold lower than those of prazosin.|prazosin|guinea-pig and mouse splenic alpha 1B-adrenoceptors|22|4|Arg1:T12|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|3580
23128353|Altogether, our results suggest that a high dose of glucosamine may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G(0)/G(1) phase, and that this occurs, at least in part, by a reduction in Rb phosphorylation together with modulation of p21, p53 and HO-1 expression, and nuclear p21 accumulation.|glucosamine|Rb|11|51|Arg1:T2|Arg2:T14|CHEMICAL|GENE|INHIBITOR|3581
15723099|Dimemorfan pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression, activator protein (AP)-1 DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus.|Dimemorfan|c-jun|1|10|Arg1:T25|Arg2:T39|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3582
14501155|These results suggest that clomipramine induces hyperglycemia in mice by blocking the 5-HT(2B )and/or 5-HT(2C) receptors, which results in facilitation of adrenaline release.|clomipramine|5-HT(2B )|5|13|Arg1:T17|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3583
23584358|In conclusion, agomelatine administration protects liver cells from paracetamol-induced hepatotoxicity via antioxidant activity and reduced proinflammatory cytokines, such as TNF-α and IL-6.|paracetamol|cytokines|10|18|Arg1:T12|Arg2:T39|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3584
11691635|The specific activity of only ornithine aminotransferase (OAT), the rate-limiting enzyme in the conversion of ornithine to proline, increased in 2 weeks of hypertrophy.|proline|OAT|21|9|Arg1:T3|Arg2:T9|CHEMICAL|GENE|PRODUCT-OF|3585
17379925|  Bile acid coenzyme A:amino acid N-acyltransferase (BAT) is responsible for the amidation of bile acids with the amino acids glycine and taurine.|bile acids|Bile acid coenzyme A:amino acid N-acyltransferase|18|1|Arg1:T10|Arg2:T14|CHEMICAL|GENE|SUBSTRATE|3586
23625804|The NMR solution structure of the copper(I)-loaded form of hCCSD1 reported here contributes further to characterization of the copper-transfer mechanism to hSOD1.|copper(I)|hCCSD1|7|14|Arg1:T3|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|3587
10446934|Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.|cilazapril|Human and rat renin|18|1|Arg1:T9|Arg2:T30|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3588
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|2',2'-difluorodeoxyuridine|DCK|48|13|Arg1:T12|Arg2:T35|CHEMICAL|GENE|SUBSTRATE|3589
17111172|Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.|haloperidol|serotonin (2A) receptors|30|14|Arg1:T15|Arg2:T37|CHEMICAL|GENE|DIRECT-REGULATOR|3590
16344985|  RATIONALE: Several drugs used to treat bipolar disorder (lithium and carbamazepine), when administered chronically to rats, reduce the turnover of arachidonic acid, but not docosahexaenoic acid, in brain phospholipids by decreasing the activity of an arachidonic acid-selective phospholipase A(2).|carbamazepine|phospholipase A(2)|13|45|Arg1:T19|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3591
10640321|These studies provide compelling evidence that the antitussive effects of SB 227122 in this guinea pig cough model are mediated by agonist activity at the delta-opioid receptor.|SB 227122|delta-opioid receptor|11|26|Arg1:T6|Arg2:T22|CHEMICAL|GENE|AGONIST|3592
12881227|5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.|5-(N,N-dimethyl)-amiloride|NHE2|1|25|Arg1:T8|Arg2:T33|CHEMICAL|GENE|INHIBITOR|3593
15180525|Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 kinase.|SU11248|Flt3|25|43|Arg1:T16|Arg2:T34|CHEMICAL|GENE|INHIBITOR|3594
23266505|Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of calpain and AIF levels.|ALD|AIF|17|22|Arg1:T6|Arg2:T23|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3595
9015795|The atypical neuroleptics remoxipride, clozapine, perlapine, seroquel, and melperone had low affinity for the dopamine D2 receptor (radioligand-independent dissociation constants of 30 to 90 nM).|seroquel|D2 receptor|10|20|Arg1:T13|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|3596
23327993|The TXM peptides were effective in inhibiting AuF-induced MAPK, JNK and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.|AuF|JNK|8|11|Arg1:T8|Arg2:T33|CHEMICAL|GENE|ACTIVATOR|3597
7560228|In cell culture experiments, it was found that triclosan inhibited IL-1 beta induced prostaglandin E2 production by human gingival fibroblasts in a concentration dependent manner, and at relatively low concentrations.|prostaglandin E2|IL-1 beta|15|12|Arg1:T8|Arg2:T23|CHEMICAL|GENE|PRODUCT-OF|3598
15732037|Increased immunohistochemical labeling of HIF-1alpha, VEGF, and BNP in the ventricular myocardium was observed in the shunt group and carvedilol again normalized the labeling.|carvedilol|HIF-1alpha|22|5|Arg1:T2|Arg2:T24|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3599
17229632|Sorafenib induced a cell cycle block and apoptosis in the acute myeloid leukemia cell lines MV4-11 and MOLM-13, both expressing FLT3 with an internal tandem duplication, whereas no effect was observed on four other acute myeloid leukemia cell lines.|Sorafenib|FLT3|1|22|Arg1:T3|Arg2:T21|CHEMICAL|GENE|INHIBITOR|3600
17224860|[H]-Cholesterol-labeled J774 macrophage cells, with and without ABCA1 up-regulation, were incubated with the samples, and ABCA1-dependent cholesterol efflux and serum lipid and lipoprotein levels were assessed.|cholesterol|ABCA1|23|22|Arg1:T18|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|3601
12956944|However, when naloxone was administered concurrently with ethanol treatment, it antagonized the down-regulation of p-CREB protein in the nucleus accumbens (142 %) of rats exposed to ethanol.|ethanol|p-CREB|9|17|Arg1:T1|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3602
10988273|The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with alpha(2A)-autoreceptors, at which, however, both rilmenidine and oxymetazoline exhibit different properties (antagonism and agonism, respectively).|oxymetazoline|alpha(2A)-autoreceptors|31|17|Arg1:T7|Arg2:T20|CHEMICAL|GENE|AGONIST|3603
6227474|Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of steroid binding similar to that of the kidney mineralocorticoid receptor (aldosterone greater than desoxycorticosterone greater than corticosterone).|desoxycorticosterone|mineralocorticoid receptor|30|24|Arg1:T8|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|3604
17418819|A KCC inhibitor-[(dihydroindenyl)oxy] alkanoic acid (DIOA)-blocked RVD more in HCEC than RCEC.|DIOA|KCC|13|2|Arg1:T2|Arg2:T17|CHEMICAL|GENE|INHIBITOR|3605
15737409|ABCG5 and ABCG8 themselves are regulated by cholesterol via liver X receptors (LXRs), which are also activated by oxysterols and some derivatives of plant sterols.|sterols|LXRs|28|14|Arg1:T15|Arg2:T31|CHEMICAL|GENE|ACTIVATOR|3606
10225363|Sumatriptan and LY 344864 decreased the number of capsaicin-induced c-fos-like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1)).|LY 344864|c-fos|3|10|Arg1:T6|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3607
23261590|In this study, focus was given to evaluate the ability of neoechinulin A, an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-β 1-42 (Aβ42).|neoechinulin A|Aβ42|13|34|Arg1:T5|Arg2:T31|CHEMICAL|GENE|INHIBITOR|3608
23511016|To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (DOTA), with pantoprazole, which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon.|pantoprazole|proton pump|31|38|Arg1:T3|Arg2:T9|CHEMICAL|GENE|INHIBITOR|3609
11585753|"The tyrosine kinase inhibitor ZD1839 (""Iressa"") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells."|Iressa|tyrosine kinase|8|2|Arg1:T9|Arg2:T25|CHEMICAL|GENE|INHIBITOR|3610
7711211|Both 5 alpha-NET and 3 beta,5 alpha-NET blocked the PR down-regulation induced by P4 as assessed by Western and Northern blot methods.|5 alpha-NET|PR|2|10|Arg1:T15|Arg2:T25|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3611
8294418|The protein kinase C inhibitor (+)-1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) abolished the effects of phorbol esters and NE and decreased basal mRNA levels by 52 +/- 3%.|H-7|protein kinase C|16|2|Arg1:T5|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3612
17311416|  Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].|amino acids|SLC1|7|34|Arg1:T18|Arg2:T31|CHEMICAL|GENE|SUBSTRATE|3613
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|quercetin|metalloenzyme|31|45|Arg1:T7|Arg2:T25|CHEMICAL|GENE|INHIBITOR|3614
23344974|The initial fragment hits were thoroughly validated biophysically by isothermal titration calorimetry (ITC) and NMR techniques and observed by X-ray crystallography to bind in a shallow surface pocket that is occupied in the native complex by the side chain of a phenylalanine from the conserved FxxA interaction motif found in BRCA2.|phenylalanine|BRCA2|44|53|Arg1:T1|Arg2:T3|CHEMICAL|GENE|PART-OF|3615
23395914|To evaluate to what extent the regional differences in expression of P-gp and P450 enzymes affect the absorption of a dual substrate, we investigated the transport of darunavir across different small intestinal segments (duodenum, proximal jejunum and ileum).|darunavir|P450 enzymes|29|14|Arg1:T6|Arg2:T20|CHEMICAL|GENE|SUBSTRATE|3616
11264758|Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.|leukotriene|leukotriene receptor|8|8|Arg1:T13|Arg2:T16|CHEMICAL|GENE|DIRECT-REGULATOR|3617
19149483|Others kinase inhibitors used recently in cancer therapy include Dasatinib (BMS-354825) specific for ABL non-receptor cytoplasmic kinase, Gefitinib (Iressa), Erlotinib (OSI-774, Tarceva) and Sunitinib (SU 11248, Sutent) specific for VEGF receptor kinase, AMN107 (Nilotinib) and INNO-406 (NS-187) specific for c-KIT kinase.|Sunitinib|VEGF receptor|33|42|Arg1:T9|Arg2:T44|CHEMICAL|GENE|INHIBITOR|3618
11562773|Binding site of amiloride to urokinase plasminogen activator depends on species.|amiloride|urokinase plasminogen activator|4|6|Arg1:T5|Arg2:T19|CHEMICAL|GENE|DIRECT-REGULATOR|3619
23531488|Using a transient heterologous cell expression system, we find that the transport activities of the short OATP2B1 variant towards substrates estrone sulfate and rosuvastatin are similar to the well-characterized full length variant.|rosuvastatin|short OATP2B1|25|17|Arg1:T2|Arg2:T7|CHEMICAL|GENE|SUBSTRATE|3620
16938288|The deletion and mutation analysis of the AT1R gene promoter indicated that a GC box located in the proximal promoter region is responsible for the telmisartan-induced downregulation.|telmisartan|GC box|26|14|Arg1:T5|Arg2:T18|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3621
23439561|We have shown that COX-2 mediates acid-induced PGE2 production.|PGE2|COX-2|8|5|Arg1:T6|Arg2:T36|CHEMICAL|GENE|PRODUCT-OF|3622
12487427|GW660511X and omapatrilat reduced the production of BrBK1-5 and BrBK1-7 with more effect being observed with omapatrilat.|GW660511X|BrBK1-7|1|10|Arg1:T17|Arg2:T64|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3623
8894610|  The influence of (+/-)-tamsulosin, a selective alpha 1A-adrenoceptor antagonist, on the positive inotropic effect and the accumulation of inositol phosphates that are induced via alpha 1-adrenoceptors was studied in comparison with that of another alpha 1A-adrenoceptor ligand oxymetazoline in the rabbit ventricular myocardium.|oxymetazoline|alpha 1A-adrenoceptor|43|40|Arg1:T17|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|3624
23542114|ATO inhibited the phosphorylation and activation of AKT and STAT3 through Notch signaling blockade.|ATO|Notch|1|12|Arg1:T5|Arg2:T11|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3625
22391562|We have examined the effectiveness of two novel Chk1 selective inhibitors, AR323 and AR678, in a panel of melanoma cell lines and normal cell types.|AR323|Chk1|13|9|Arg1:T1|Arg2:T6|CHEMICAL|GENE|INHIBITOR|3626
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imiquimod|porcine TLR7|5|12|Arg1:T4|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|3627
23511016|Synthesis of a DOTA (Gd(3+))-conjugate of proton-pump inhibitor pantoprazole for gastric wall imaging studies.|DOTA|proton-pump|4|13|Arg1:T6|Arg2:T11|CHEMICAL|GENE|INHIBITOR|3628
15723099|Dimemorfan pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression, activator protein (AP)-1 DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus.|Dimemorfan|activator protein (AP)-1|1|12|Arg1:T25|Arg2:T40|CHEMICAL|GENE|INHIBITOR|3629
10510456|6 In conclusion, HERG channel inhibition by cisapride exhibits features consistent with open and inactivated state binding and is sensitive to external potassium concentration.|cisapride|HERG|9|5|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INHIBITOR|3630
17352685|Consequently, PDE4 inhibitors including cilomilast and AWD 12-281 have been tested in several models of allergic and irritant skin inflammation.|AWD 12-281|PDE4|8|3|Arg1:T7|Arg2:T18|CHEMICAL|GENE|INHIBITOR|3631
7599160|Extracellular Cbl (protein bound and free) and intracellular Cbl (protein bound and free) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin (CN-Cbl) bound to transcobalamin II (transcobalamin, TC).|CN-Cbl|TC|33|42|Arg1:T10|Arg2:T32|CHEMICAL|GENE|DIRECT-REGULATOR|3632
23182946|Neurodegeneration was related with decreased [(3)H]glutamate uptake and decreased Akt immunoreactivity, however phospho-GSK-3-β (Ser9) was not altered in (PhTe)(2) injected rat.|(PhTe)(2)|Akt|28|16|Arg1:T4|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3633
23100158|β-ionone was also shown to induce the expression of cleaved-caspase-3 and inhibit bcl-2 expression in SGC-7901 cells in a dose-dependent manner.|β-ionone|caspase-3|1|11|Arg1:T7|Arg2:T14|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3634
17496727|The Ki for mycophenolic acid inhibition of the L263F variant was comparable with the wild-type, and the variant Km for inosine 5'-monophosphate and nicotinamide adenine dinucleotide did not change significantly.|mycophenolic acid|L263F|4|9|Arg1:T2|Arg2:T15|CHEMICAL|GENE|INHIBITOR|3635
23194076|Diet, physical exercise and Orlistat administration increase serum Anti-Müllerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).|Orlistat|AMH|6|13|Arg1:T8|Arg2:T25|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3636
11775064|In addition, we also showed that the elevation in alanine levels and the inhibition of alanine transaminase in the brain are retained after 14 days of PLZ treatment, and that PLZ produces a marked increase in extracellular levels of alanine.|alanine|alanine transaminase|11|17|Arg1:T1|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|3637
17154506|Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.|carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes|serotonin transporter|9|32|Arg1:T14|Arg2:T25|CHEMICAL|GENE|DIRECT-REGULATOR|3638
14751502|RESULTS: GW572016 inhibited constitutive and/or ligand-induced EGFR or HER2 tyrosine phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line.|tyrosine|EGFR|11|8|Arg1:T10|Arg2:T38|CHEMICAL|GENE|PART-OF|3639
11695255|Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of prostaglandin E2 (PGE2; a product of both COX-1 and COX-2) and thromboxane B2 (as a biomarker for COX-1 activity) with parallel assessments of pain.|prostaglandin E2|COX-2|21|32|Arg1:T12|Arg2:T24|CHEMICAL|GENE|PRODUCT-OF|3640
15946589|Imatinib (STI571, Gleevec, Glivec; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of KIT, ABL, BCR-ABL, PDGFRA, and PDGFRB, represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs. Unfortunately, imatinib resistance has emerged.|STI571|BCR|3|26|Arg1:T2|Arg2:T13|CHEMICAL|GENE|INHIBITOR|3641
18439678|Two imidazoquinoline molecules, imiquimod and gardiquimod, markedly activated both porcine TLR7 and TLR8 whereas only human TLR7, but not TLR8, was activated by the ligands.|imidazoquinoline|porcine TLR7|2|12|Arg1:T3|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|3642
23396144|fragile extract (CFB or CFE) and a single compound, clerosterol (CLS) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF- α).|clerosterol|inducible nitric oxide synthase|13|42|Arg1:T6|Arg2:T19|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3643
12636181|  Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.|ACh|BuChE|27|14|Arg1:T3|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|3644
12956944|The decrement of p-CREB protein in the nucleus accumbens remained at 24 h (-35 %) and 72 h (-28 %) of ethanol withdrawal, which recovered toward control level after 7 d of ethanol withdrawal.|ethanol|p-CREB|38|4|Arg1:T12|Arg2:T27|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3645
23391336|A large number of aromatic/heterocyclic sulfonamides and some 5-mercapto-1,3,4-thiadiazoles were investigated as TcCA inhibitors.|aromatic/heterocyclic sulfonamides|TcCA|5|13|Arg1:T3|Arg2:T14|CHEMICAL|GENE|INHIBITOR|3646
23146664|Moreover, 5-ASA treatment restored membranous expression of adhesion molecules E-cadherin and β-catenin.|5-ASA|β-catenin|3|13|Arg1:T14|Arg2:T17|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3647
17218486|EC50 values for S-(+)-METH were 0.89, 0.92, and 4.44 microM for rTAAR1, mTAAR1, and h-rChTAAR1, respectively.|S-(+)-METH|mTAAR1|4|20|Arg1:T1|Arg2:T38|CHEMICAL|GENE|ACTIVATOR|3648
23066089|Using site-directed mutagenesis, we identified three serines (Ser833, Ser836, and Ser840) within the membrane proximal region of the GluK5 C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs. Together, these data suggest that phosphorylation of key residues in the C-terminal domain changes the overall charge of this domain, resulting in potentiated agonist responses.|Ser|GluK5|12|24|Arg1:T10|Arg2:T31|CHEMICAL|GENE|PART-OF|3649
23220618|And, the effects of the compounds on expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were tested in tumor necrosis factor-(TNF)-α activated HUVECs. Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, both agents elicited anticoagulant effects in mouse.|IMG|FXa|62|70|Arg1:T12|Arg2:T36|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3650
23230131|Wild-type enzymes and variants of CDA (Lys27Gln and Ala70Thr) and DCK (Ile24Val, Ala119Gly, and Pro122Ser) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for cytarabine (Ara-C), dFdC, and its metabolite 2',2'-difluorodeoxyuridine (dFdU) as substrates.|Ara-C|Ala119Gly|40|17|Arg1:T10|Arg2:T37|CHEMICAL|GENE|SUBSTRATE|3651
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|leuprorelin|gonadotrophin-releasing hormone (GnRH) receptor|15|23|Arg1:T7|Arg2:T24|CHEMICAL|GENE|ACTIVATOR|3652
3134891|The irreversible complex between phenoxybenzamine and calmodulin may be useful for inhibiting certain calmodulin-dependent reactions and for studying the various biological functions of calmodulin.|phenoxybenzamine|calmodulin|5|7|Arg1:T8|Arg2:T28|CHEMICAL|GENE|DIRECT-REGULATOR|3653
10727715|In the present study, we compared the pharmacology of (+/-)pindolol, WAY-100635 (a 5-HT(1A) antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat.|isamoltane|5-HT(1B)|37|40|Arg1:T21|Arg2:T39|CHEMICAL|GENE|ANTAGONIST|3654
23435910|Additionally, the expression of hepatic fibrosis-related factors such as α-smooth muscle actin and transforming growth factor-β1 (TGF-β1), were reduced in rats treated with sinapic acid.|sinapic acid|transforming growth factor-β1|28|15|Arg1:T16|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3655
11292635|The purpose of this study was to determine whether rat outer medullary collecting duct (OMCD) secretes Cl- and whether transepithelial Cl- transport occurs, in part, through Cl- uptake across the basolateral membrane mediated by NKCC1 in series with Cl- efflux across the apical membrane.|Cl-|NKCC1|31|39|Arg1:T8|Arg2:T32|CHEMICAL|GENE|SUBSTRATE|3656
15635044|Point-mutation studies indicate that four amino acids, Leu/Phe(7.38), Leu/Phe(7.43), Ala/Pro(7.46), and Pro/Cys(7.47) in TMH7 are critical for ligand selectivity as well as receptor conformation.|Leu|TMH7|14|30|Arg1:T5|Arg2:T46|CHEMICAL|GENE|PART-OF|3657
23172777|Based on these suggestions, the rational redesign of furanopyrimidine 24 (clog P=7.41; Aurora A IC(50) =43 nM; HCT-116 IC(50) =400 nM) led to the identification of quinazoline 67 (clog P=5.28; Aurora A IC(50) =25 nM; HCT-116 IC(50) =23 nM).|quinazoline|Aurora A|38|44|Arg1:T2|Arg2:T7|CHEMICAL|GENE|INHIBITOR|3658
14600253|Although a proton-stimulated uptake of cefadroxil was demonstrated in PEPT2(+/+) mice (pH 6.5 versus pH 7.4; p < 0.01), no pH dependence was observed in PEPT2(-/-) mice.|cefadroxil|PEPT2|6|33|Arg1:T12|Arg2:T26|CHEMICAL|GENE|SUBSTRATE|3659
20801130|The affinities of dfbp and dfbp-o for the regulatory domain of cTnC were measured in the absence and presence of cTnI by NMR spectroscopy, and dfbp-o was found to bind more strongly than dfbp.|dfbp|cTnC|35|12|Arg1:T20|Arg2:T39|CHEMICAL|GENE|DIRECT-REGULATOR|3660
23703578|Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drug-drug interaction with potent CYP3A inhibitors such as ritonavir- or cobicistat-boosted HIV-PI or the hepatitis C virus (HCV) PI, telaprevir or boceprevir, and therefore their coadministration is contraindicated.|boceprevir|CYP3A|36|16|Arg1:T10|Arg2:T30|CHEMICAL|GENE|INHIBITOR|3661
1978244|  Using the alpha 1-adrenoceptor subtype-selective antagonists chlorethylclonidine (CEC), WB4101, and 5-methyl-urapidil, we have examined the possible heterogeneity in the alpha 1-adrenoceptor populations in rabbit aorta.|5-methyl-urapidil|alpha 1-adrenoceptor|15|3|Arg1:T1|Arg2:T28|CHEMICAL|GENE|ANTAGONIST|3662
23538162|Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.|ginsenoside Rg1|ERK|8|4|Arg1:T12|Arg2:T31|CHEMICAL|GENE|ACTIVATOR|3663
7711211|As determined by Western and Northern blot analyses, 5 alpha-NET inhibited the P4-induced UG gene expression in a dose-dependent manner.|5 alpha-NET|UG|10|15|Arg1:T11|Arg2:T23|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3664
9476974|At nonconvulsant doses, the sodium channel blockers acetylprocainamide, dibucaine, dyclonine, prilocaine, proparacaine, quinidine, and tetracaine produced a small pressor response or no increase in BP.|prilocaine|sodium channel|15|6|Arg1:T35|Arg2:T48|CHEMICAL|GENE|INHIBITOR|3665
8894610|These results indicate that the positive inotropic effect, mediated via (+/-)-tamsulosin- and oxymetazoline-sensitive subtype of alpha 1-adrenoceptors, is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates.|(+/-)-tamsulosin|alpha 1-adrenoceptors|12|20|Arg1:T14|Arg2:T31|CHEMICAL|GENE|ANTAGONIST|3666
16344985|Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.|Valproic acid|brain microsomal long-chain fatty acyl-CoA synthetases|1|12|Arg1:T25|Arg2:T36|CHEMICAL|GENE|INHIBITOR|3667
23266505|  In this study, aldosterone (ALD)-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of calpain signaling were clarified.|aldosterone|calpain|5|25|Arg1:T7|Arg2:T21|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3668
23597506|In terms of the mechanisms, we found that fatty acid amide hydrolase (FAAH) which degrades anandamide, was upregulated after nerve injury at both ages, so that this upregulation likely did not account for the age-dependent differences.|anandamide|FAAH|19|15|Arg1:T1|Arg2:T15|CHEMICAL|GENE|SUBSTRATE|3669
19389876|The potential for ketoconazole, the archetypal strong inhibitor of CYP3A4, to alter the pharmacokinetic profile of ambrisentan and its oxidative metabolite, 4-hydroxymethyl ambrisentan, was assessed in an open-label, nonrandomized, 2-period, single-sequence study in 16 healthy men.|ketoconazole|CYP3A4|4|11|Arg1:T4|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3670
23481236|Unsaturated FFAs increased DAGs, TAGs and PTP1B expression significantly, but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine (Ser) 50, Ser 398 and tyrosine 152.|Ser|PTP1B|28|23|Arg1:T23|Arg2:T51|CHEMICAL|GENE|PART-OF|3671
23066089|Using site-directed mutagenesis, we identified three serines (Ser833, Ser836, and Ser840) within the membrane proximal region of the GluK5 C-terminal domain that, in combination, are required for mGlu1-mediated potentiation of KARs. Together, these data suggest that phosphorylation of key residues in the C-terminal domain changes the overall charge of this domain, resulting in potentiated agonist responses.|C|GluK5|25|24|Arg1:T12|Arg2:T31|CHEMICAL|GENE|PART-OF|3672
16324695|Preincubation with 1 microM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) caused a small but significant decrease in isoprenaline-induced E(max), indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization.|PMA|protein kinase C|18|7|Arg1:T10|Arg2:T21|CHEMICAL|GENE|ACTIVATOR|3673
9551716|In conclusion, these findings indicate that [3H]SR 142948A is a new potent antagonist radioligand which recognizes with high affinity both neurotensin NT1 and NT2 receptors and represents thus an excellent tool to study neurotensin receptors in the rat brain.|[3H]SR 142948A|neurotensin NT1|8|25|Arg1:T10|Arg2:T29|CHEMICAL|GENE|DIRECT-REGULATOR|3674
12167474|Most halogenated cysteine S-conjugates are metabolized by cysteine S-conjugate beta-lyases to pyruvate, ammonia, and an alpha-chloroenethiolate (with DCVC) or an alpha-difluoroalkylthiolate (with TFEC) that may eliminate halide to give a thioacyl halide, which reacts with epsilon-amino groups of lysine residues in proteins.|pyruvate|beta-lyases|12|10|Arg1:T22|Arg2:T54|CHEMICAL|GENE|PRODUCT-OF|3675
18081314|  High-resolution NMR spectroscopy was used to determine the docking of a substrate (prostaglandin H2) mimic (U46619) to the engineered prostacyclin (PGI2) synthase (PGIS) in solution.|U46619|PGIS|19|30|Arg1:T1|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|3676
17229632|We investigated the efficacy of sorafenib at inhibiting mutants of the receptor tyrosine kinases PDGFRbeta, KIT, and FLT3, which are implicated in the pathogenesis of myeloid malignancies.|sorafenib|KIT|6|17|Arg1:T12|Arg2:T35|CHEMICAL|GENE|INHIBITOR|3677
23391336|The enzyme (TcCA) has a very high catalytic activity for the CO(2) hydration reaction, being similar kinetically to the human (h) isoform hCA II, although it is devoid of the His64 proton shuttle.|CO(2)|TcCA|14|4|Arg1:T1|Arg2:T9|CHEMICAL|GENE|SUBSTRATE|3678
17935273|Sorafenib and sunitinib are synthetic, orally active agents shown to directly inhibit vascular endothelial growth factor receptors -2 and -3 (VEGFR-2, VEGFR-3) and platelet-derived growth factor receptor beta (PDGFR-beta), while temsirolimus is an mTOR inhibitor.|Sorafenib|VEGFR-2|1|23|Arg1:T4|Arg2:T14|CHEMICAL|GENE|INHIBITOR|3679
20053189|Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.|buserelin|Luteinizing hormone-releasing hormone|11|1|Arg1:T5|Arg2:T22|CHEMICAL|GENE|AGONIST|3680
23305850|Whereas, the levels of both the basal and sulforaphane-inducible expression of AKR1C1 were significantly reduced in NRF2-silenced stable U937 cells compared to the control cells.|sulforaphane|AKR1C1|10|13|Arg1:T6|Arg2:T19|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3681
2899826|Levomepromazine was the most potent and fluphenazine the least potent of the four drugs in histamine H1 receptor binding.|Levomepromazine|histamine H1 receptor|1|16|Arg1:T15|Arg2:T34|CHEMICAL|GENE|DIRECT-REGULATOR|3682
23266505|ALD increased calpain expression and caspase-3 activity and promoted Bid cleavage.|ALD|calpain|1|3|Arg1:T17|Arg2:T31|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3683
23274058|Additional mechanistic studies revealed that jaceosidin treatment resulted in an increase in phosphorylation of Cdc25C and ATM-Chk1/2.|jaceosidin|Cdc25C|6|15|Arg1:T16|Arg2:T28|CHEMICAL|GENE|ACTIVATOR|3684
22981796|Exposure to Cu NPs decreased cell viability to 73% (p<0.01) and significantly (p<0.05) elevated levels of lactate dehydrogenase, intracellular reactive oxygen species and interleukin-8 that mirrored our findings from subacute in vivo inhalation studies in mice.|Cu|lactate dehydrogenase|3|26|Arg1:T4|Arg2:T8|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3685
16324695|Preincubation with 1 microM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) caused a small but significant decrease in isoprenaline-induced E(max), indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization.|PMA|PKC|18|35|Arg1:T10|Arg2:T23|CHEMICAL|GENE|ACTIVATOR|3686
20801130|The high resolution NMR solution structure of the cTnC-cTnI-dfbp-o ternary complex showed that dfbp-o bound at the hydrophobic interface formed by cTnC and cTnI making critical interactions with residues such as Arg147 of cTnI.|dfbp-o|cTnI|10|10|Arg1:T2|Arg2:T26|CHEMICAL|GENE|DIRECT-REGULATOR|3687
11695255|Celecoxib selectively suppressed PGE2 but not TxB2 at time points consistent with COX-2 activity, while producing analgesia.|Celecoxib|COX-2|1|13|Arg1:T6|Arg2:T16|CHEMICAL|GENE|INHIBITOR|3688
1911436|The affinity labeling nucleotide analog, 5'-[p-(fluorosulfonyl)benzoyl]adenosine (FSA), inactivates the dehydrogenase and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration (0.2-0.6 mM).|nucleotide|dehydrogenase|4|22|Arg1:T15|Arg2:T26|CHEMICAL|GENE|INHIBITOR|3689
22872607|  Aldo-keto reductases (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.|polycyclic aromatic hydrocarbons|Aldo-keto reductases|14|1|Arg1:T11|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|3690
12727196|The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues; however, specific oligamine analogues were found to be potent inhibitors of the oxidation of spermine by PAOh1/SMO.|spermine|SMO|30|33|Arg1:T7|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|3691
17040106|Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.|arylhydroxylamine|human NADH cytochrome b5 reductase|4|7|Arg1:T25|Arg2:T42|CHEMICAL|GENE|SUBSTRATE|3692
23139413|However, a lid conformation was induced by [Sar(1),Gln(2),Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII.|Sar|D281A|10|34|Arg1:T1|Arg2:T17|CHEMICAL|GENE|DIRECT-REGULATOR|3693
23231502|Furthermore, orbitrap MS data support the adduction of Cys-113 in the Pin1 active site upon HNE treatment of MDA-MB-231 cells.|Cys|Pin1|10|13|Arg1:T2|Arg2:T25|CHEMICAL|GENE|PART-OF|3694
23091188|Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (RTV) are reported BSEP inhibitors.|RTV|BSEP|11|15|Arg1:T24|Arg2:T53|CHEMICAL|GENE|INHIBITOR|3695
9211565|  This study was designed to determine the gastroprotective properties of cinitapride (CNT), a novel prokinetic benzamide derivative agonist of 5-HT4 and 5-HT1 receptors and 5-HT2 antagonist, on mucosal injury produced by 50% (v/v) ethanol.|CNT|5-HT2|13|28|Arg1:T21|Arg2:T34|CHEMICAL|GENE|ANTAGONIST|3696
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|gallic acid|EC 4.2.1.1|25|51|Arg1:T5|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3697
15939622|However at IC80, phenylbutazone (+134.4%) and flunixin (+29.7%) had greater COX-2 selectivity than at IC50, and meloxicam (-41.2%) and carprofen (-12.9%) had lower COX-2 selectivity than at IC50.|meloxicam|COX-2|25|38|Arg1:T8|Arg2:T21|CHEMICAL|GENE|INHIBITOR|3698
22445601|These results confirm the selective mGlu2 agonist and mGlu3 antagonist actions of LY541850.|LY541850|mGlu2|13|6|Arg1:T1|Arg2:T13|CHEMICAL|GENE|AGONIST|3699
23471969|Here, we report that a specific 29-amino acid peptide derived from the intracellular domain fragment of p75(NTR) interacts with and potentiates binding of NGF to TrkA-expressing cells, leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced Erk1/2 and Akt signaling.|amino acid|p75(NTR)|9|18|Arg1:T1|Arg2:T8|CHEMICAL|GENE|PART-OF|3700
11695255|Celecoxib selectively suppressed PGE2 but not TxB2 at time points consistent with COX-2 activity, while producing analgesia.|PGE2|COX-2|4|13|Arg1:T7|Arg2:T16|CHEMICAL|GENE|PRODUCT-OF|3701
12881227|Nevertheless, coperfusion with 0.1 and 0.3 mM 5-nitro-2-(3-phenylpropylamino) benzoic acid, which inhibits the cystic fibrosis transmembrane conductor regulator (CFTR), dose dependently inhibited S3226-induced DBS.|5-nitro-2-(3-phenylpropylamino) benzoic acid|cystic fibrosis transmembrane conductor regulator|9|19|Arg1:T20|Arg2:T41|CHEMICAL|GENE|INHIBITOR|3702
23240892|Cell culture studies demonstrated that PKAA is capable of delivering anti-TNF (tumor necrosis factor)-α siRNA to lipopolysaccharide (LPS)-stimulated macrophages and significantly inhibits the expression of TNF-α.|PKAA|TNF-α|6|32|Arg1:T15|Arg2:T17|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3703
8384716|HeLa cells transfected with the MR77 gene exhibited inhibition of adenylate cyclase in response to serotonin.|serotonin|adenylate cyclase|16|11|Arg1:T12|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3704
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|phenol|CA|7|49|Arg1:T9|Arg2:T27|CHEMICAL|GENE|INHIBITOR|3705
1590750|These findings indicate that human pulmonary ethanol-metabolizing activities differ significantly with respect to genetic polymorphism at both the ADH2 and the ALDH2 loci.|ethanol|ADH2|7|19|Arg1:T2|Arg2:T18|CHEMICAL|GENE|SUBSTRATE|3706
10742288|In alpha(2A)-adrenoceptor transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).|noradrenaline|alpha(2A)-adrenoceptor|42|2|Arg1:T6|Arg2:T22|CHEMICAL|GENE|AGONIST|3707
23047022|Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.|atropine|mAChR|33|31|Arg1:T10|Arg2:T18|CHEMICAL|GENE|ANTAGONIST|3708
12487427|GW660511X and omapatrilat reduced the production of BrBK1-5 and BrBK1-7 with more effect being observed with omapatrilat.|omapatrilat|BrBK1-5|3|8|Arg1:T18|Arg2:T63|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3709
9551716|In conclusion, these findings indicate that [3H]SR 142948A is a new potent antagonist radioligand which recognizes with high affinity both neurotensin NT1 and NT2 receptors and represents thus an excellent tool to study neurotensin receptors in the rat brain.|[3H]SR 142948A|NT2 receptors|8|28|Arg1:T10|Arg2:T30|CHEMICAL|GENE|DIRECT-REGULATOR|3710
23275442|The CSN/IRF5 interaction occurred on the carboxyl and amino termini of IRF5; a single internal deletion from amino acids 455 to 466 (Δ455-466) was found to significantly reduce IRF5 protein stability.|carboxyl|IRF5|7|12|Arg1:T1|Arg2:T30|CHEMICAL|GENE|PART-OF|3711
15795320|Synergistic cytotoxicity was demonstrated, and pemetrexed significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the human nucleoside equilibrative transporter 1 (hENT1) in all cell lines.|pemetrexed|dCK|7|24|Arg1:T2|Arg2:T22|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3712
9990013|This direct biochemical evidence of cooperative interaction in nucleotide binding of the two NBFs of SUR1 suggests that glibenclamide both blocks this cooperative binding of ATP and MgADP and, in cooperation with the MgADP bound at NBF2, causes ATP to be released from NBF1.|MgADP|NBF2|28|38|Arg1:T8|Arg2:T36|CHEMICAL|GENE|DIRECT-REGULATOR|3713
12636181|  Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase (BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels.|acetylcholine|butyrylcholinesterase|25|12|Arg1:T2|Arg2:T12|CHEMICAL|GENE|SUBSTRATE|3714
23250811|There was no significant difference in TLR4, NF-κB, and IL-27 mRNA and proteins between curcumin-treated and sulfasalazine-treated groups.|curcumin|IL-27|17|12|Arg1:T4|Arg2:T26|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3715
17477831|  Acetyl-coenzyme A carboxylase (ACC) enzymes exist as two isoforms, ACC1 and ACC2, which play critical roles in fatty acid biosynthesis and oxidation.|fatty acid|Acetyl-coenzyme A carboxylase|22|1|Arg1:T4|Arg2:T19|CHEMICAL|GENE|PRODUCT-OF|3716
23238784|The CYP3A4 activity could be induced 2-fold by rifampicin, whereas CYP2C9 activity remained equally high.|rifampicin|CYP3A4|9|2|Arg1:T8|Arg2:T15|CHEMICAL|GENE|ACTIVATOR|3717
16399380|Omega class GSTs have dehydroascorbate reductase and thioltransferase activities and also catalyze the reduction of monomethylarsonate, an intermediate in the pathway of arsenic biotransformation.|monomethylarsonate|Omega class GSTs|16|1|Arg1:T2|Arg2:T11|CHEMICAL|GENE|SUBSTRATE|3718
23246481|The mechanism revealed that wogonin inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of VE-cadherin and β-catenin.|wogonin|β-catenin|5|23|Arg1:T8|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3719
12560076|Mouse brain serine racemase catalyzes specific elimination of L-serine to pyruvate.|pyruvate|Mouse brain serine racemase|11|1|Arg1:T22|Arg2:T28|CHEMICAL|GENE|PRODUCT-OF|3720
2530096|The anti-amnesic effect of minaprine on the cycloheximide-induced memory impairment was also antagonized by a serotonin (5-HT) releaser, p-chloroamphetamine, and by a 5-HT precursor, 5-hydroxytryptophan, whereas a 5-HT1A-selective agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, was inactive.|8-hydroxy-2-(di-n-propylamino)tetralin|5-HT1A|37|34|Arg1:T14|Arg2:T22|CHEMICAL|GENE|AGONIST|3721
20185318|  A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).|p-coumaric acid|EC 4.2.1.1|16|51|Arg1:T17|Arg2:T28|CHEMICAL|GENE|INHIBITOR|3722
15837926|PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.|methotrexate|PSMA|21|1|Arg1:T3|Arg2:T10|CHEMICAL|GENE|SUBSTRATE|3723
11730729|In conclusion, fenoterol-induced constitutive beta(2)-adrenoceptor activity reduces muscarinic receptor agonist- and histamine-induced contractions of bovine tracheal smooth muscle, which can be reversed by the inverse agonist timolol.|fenoterol|beta(2)-adrenoceptor|4|6|Arg1:T4|Arg2:T22|CHEMICAL|GENE|ACTIVATOR|3724
17391279|Indomethacin treatment led to an increase in lipid peroxidation, glutathione peroxidase and glucose-6-phosphate dehydrogenase activities and to a decrease in catalase activity and glutathione levels in gastric mucosa.|Indomethacin|catalase|1|22|Arg1:T11|Arg2:T27|CHEMICAL|GENE|INHIBITOR|3725
12956944|However, when naloxone was administered concurrently with ethanol treatment, it antagonized the down-regulation of p-CREB protein in the nucleus accumbens (142 %) of rats exposed to ethanol.|ethanol|p-CREB|31|17|Arg1:T2|Arg2:T21|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3726
23357629|The keto and phenolic -OH are major factors that are prominently involved in interaction with COX-2 active site.|keto|COX-2|2|16|Arg1:T10|Arg2:T20|CHEMICAL|GENE|DIRECT-REGULATOR|3727
12244038|Gemfibrozil induced peroxisome proliferator-responsive element (PPRE)-dependent luciferase activity, which was inhibited by the expression of DeltahPPAR-alpha, the dominant-negative mutant of human PPAR-alpha.|Gemfibrozil|PPRE|1|7|Arg1:T13|Arg2:T63|CHEMICAL|GENE|ACTIVATOR|3728
23638842|RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive RS -GRA significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1β (IL-1β), and apoptosis (Bax and caspase 3 expression).|RS -GRA|caspase 3|19|46|Arg1:T1|Arg2:T13|CHEMICAL|GENE|INDIRECT-DOWNREGULATOR|3729
21712771|Transfection of the brain cDNA into COS-1 cells resulted in transporter activity that was blocked by the VMAT inhibitor reserpine and a proton ionophore, but not by tetrabenazine, which has a high affinity for VMAT-2.|reserpine|VMAT|20|18|Arg1:T5|Arg2:T20|CHEMICAL|GENE|INHIBITOR|3730
15353299|Thymidylate synthase (TS) continues to be a critical target for 5-fluorouracil (5-FU) and its prodrugs, UFT/LV (Orzel), capecitabine (Xeloda), and S-1, primarily because this enzyme is essential for the synthesis of 2-deoxythymidine-5-monophosphate, a precursor for DNA synthesis.|2-deoxythymidine-5-monophosphate|Thymidylate synthase|44|1|Arg1:T21|Arg2:T30|CHEMICAL|GENE|PRODUCT-OF|3731
12373423|Only pMPPI [4-iodo-N-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridynyl-benzamide hydrochloride], a selective 5-HT(1A) antagonist, was effective in inhibiting all 5-HT syndrome behaviors produced by lisuride, whereas pMPPI was without effect on any behavior induced by LSD.|4-iodo-N-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridynyl-benzamide hydrochloride|5-HT(1A)|4|22|Arg1:T8|Arg2:T30|CHEMICAL|GENE|ANTAGONIST|3732
15191400|There was significantly less thioredoxin reductase activity in rat liver extracts, whereas the level of glutathione activity remained unchanged, demonstrating that the dose of auranofin used was able to selectively inhibit one of these enzyme systems.|auranofin|thioredoxin reductase|27|5|Arg1:T8|Arg2:T16|CHEMICAL|GENE|INHIBITOR|3733
16248990|After that, a wide range of concentrations of drugs, concomitantly with ATR (0.1 microM), was studied in the presence of haloperidol (HAL; 0.01 microM), a dopamine D2 antagonist.|HAL|dopamine D2|28|35|Arg1:T15|Arg2:T27|CHEMICAL|GENE|ANTAGONIST|3734
23194825|Importantly, pre-treatment with buthionine sulfoximine (BSO), an inhibitor of γ-GCS, prevented α-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity.|buthionine sulfoximine|γ-GCS|6|15|Arg1:T9|Arg2:T47|CHEMICAL|GENE|INHIBITOR|3735
15474503|Each statin induced apoA-I expression (mRNA and protein) dose-dependently: the rank order of the apoA-I induction pitavastatin (3 microM)>simvastatin (10 microM)>atorvastatin (30 microM).|simvastatin|apoA-I|26|18|Arg1:T4|Arg2:T29|CHEMICAL|GENE|INDIRECT-UPREGULATOR|3736
17651117|Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to CD62P, CD42b, or junctional adhesion molecule C (JAM-C) in polyvinyl chloride tubing using a roller pump.|polyvinyl chloride|JAM-C|30|27|Arg1:T1|Arg2:T8|CHEMICAL|GENE|no_relation|3737
16324695|To investigate the capacity of activated PKC to regulate homologous desensitization, we incubated the smooth muscle strips with the combination of both 1 microM PMA and 1 microM fenoterol.|fenoterol|PKC|30|7|Arg1:T12|Arg2:T25|CHEMICAL|GENE|no_relation|3738
12901032|Adverse drug reactions were similar for each COX-2 inhibitor, but the rate of edema requiring medical intervention was higher in the rofecoxib group.|rofecoxib|COX-2|23|8|Arg1:T1|Arg2:T21|CHEMICAL|GENE|no_relation|3739
19372559|High-mobility group protein 1 (HMGB1) is a DNA damage sensor responsive to the incorporation of nonnatural nucleosides into DNA; several nuclear and cytosolic proteins are functionally integrated with HMGB1 in the context of DNA damage response.|nucleosides|HMGB1|19|32|Arg1:T3|Arg2:T19|CHEMICAL|GENE|no_relation|3740
19372559|The functional role of HMGB1 and HMGB1-associated proteins (high-mobility group protein B2, HMGB2; glyceraldehyde-3-phosphate dehydrogenase, GAPDH; protein disulfide isomerase family A member 3, PDIA3; and heat shock 70 kDa protein 8, HSPA8) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs. Using the cell proliferation assay, we found that knockdown of HMGB1-associated proteins resulted in 8-fold to 50-fold decreased chemosensitivity of A549 cells to cytarabine.|glyceraldehyde-3-phosphate|HMGB1|17|74|Arg1:T4|Arg2:T30|CHEMICAL|GENE|no_relation|3741
19372559|The functional role of HMGB1 and HMGB1-associated proteins (high-mobility group protein B2, HMGB2; glyceraldehyde-3-phosphate dehydrogenase, GAPDH; protein disulfide isomerase family A member 3, PDIA3; and heat shock 70 kDa protein 8, HSPA8) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs. Using the cell proliferation assay, we found that knockdown of HMGB1-associated proteins resulted in 8-fold to 50-fold decreased chemosensitivity of A549 cells to cytarabine.|disulfide|HMGB1|23|74|Arg1:T5|Arg2:T30|CHEMICAL|GENE|no_relation|3742
19372559|The functional role of HMGB1 and HMGB1-associated proteins (high-mobility group protein B2, HMGB2; glyceraldehyde-3-phosphate dehydrogenase, GAPDH; protein disulfide isomerase family A member 3, PDIA3; and heat shock 70 kDa protein 8, HSPA8) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs. Using the cell proliferation assay, we found that knockdown of HMGB1-associated proteins resulted in 8-fold to 50-fold decreased chemosensitivity of A549 cells to cytarabine.|cytarabine|HMGB1|87|74|Arg1:T6|Arg2:T30|CHEMICAL|GENE|no_relation|3743
10727715|The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.|5-HT|5-HT(1B/1D) receptors|23|9|Arg1:T30|Arg2:T43|CHEMICAL|GENE|no_relation|3744
10727715|The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.|(+/-)pindolol|5-HT(1B/1D) receptors|30|9|Arg1:T31|Arg2:T43|CHEMICAL|GENE|no_relation|3745
10727715|The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.|fluoxetine|5-HT(1B/1D) receptors|19|9|Arg1:T32|Arg2:T43|CHEMICAL|GENE|no_relation|3746
10727715|Combination of both 5-HT(1A) and 5-HT(1B/1D) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT (i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation, respectively), suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression.|5-HT|5-HT(1B/1D)|22|9|Arg1:T1|Arg2:T41|CHEMICAL|GENE|no_relation|3747
10727715|Combination of both 5-HT(1A) and 5-HT(1B/1D) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT (i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation, respectively), suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression.|WAY100635|5-HT(1B/1D)|26|9|Arg1:T2|Arg2:T41|CHEMICAL|GENE|no_relation|3748
10727715|Combination of both 5-HT(1A) and 5-HT(1B/1D) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT (i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation, respectively), suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression.|GR127935|5-HT(1B/1D)|27|9|Arg1:T3|Arg2:T41|CHEMICAL|GENE|no_relation|3749
10727715|Combination of both 5-HT(1A) and 5-HT(1B/1D) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT (i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation, respectively), suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression.|fluoxetine|5-HT(1B/1D)|27|9|Arg1:T4|Arg2:T41|CHEMICAL|GENE|no_relation|3750
10727715|Combination of both 5-HT(1A) and 5-HT(1B/1D) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT (i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation, respectively), suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression.|WAY100635|5-HT(1B/1D)|28|9|Arg1:T5|Arg2:T41|CHEMICAL|GENE|no_relation|3751
10727715|Combination of both 5-HT(1A) and 5-HT(1B/1D) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT (i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation, respectively), suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression.|isamoltane|5-HT(1B/1D)|29|9|Arg1:T6|Arg2:T41|CHEMICAL|GENE|no_relation|3752
10727715|Combination of both 5-HT(1A) and 5-HT(1B/1D) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT (i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation, respectively), suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression.|fluoxetine|5-HT(1B/1D)|29|9|Arg1:T7|Arg2:T41|CHEMICAL|GENE|no_relation|3753
10727715|Combination of both 5-HT(1A) and 5-HT(1B/1D) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT (i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation, respectively), suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression.|fluoxetine|5-HT(1B/1D)|16|9|Arg1:T29|Arg2:T41|CHEMICAL|GENE|no_relation|3754
9890894|  The assembly and activation of oligomeric complexes of FGF, the transmembrane receptor kinase (FGFR), and heparan sulfate transmit intracellular signals regulating growth and function of cells.|sulfate|FGFR|21|16|Arg1:T1|Arg2:T35|CHEMICAL|GENE|no_relation|3755
23298863|The objectives of these studies were to explore the possibility of establishing of a link between the pharmacokinetics of TAK-441 and the responses of Gli1 mRNA in tumor-associated stromal or skin cells and the antitumor effect of hedgehog inhibition.|TAK-441|hedgehog|20|38|Arg1:T4|Arg2:T16|CHEMICAL|GENE|no_relation|3756
23298863|To this end, we built pharmacokinetic and pharmacodynamic models that describe the relationship of the concentrations of TAK-441 plasma to the responses of Gli1 mRNA in the tumor (target) and skin (surrogate) and to tumor growth inhibition in mice bearing xenografts of human pancreatic tumors (PAN-04).|TAK-441|Gli1|19|25|Arg1:T5|Arg2:T17|CHEMICAL|GENE|no_relation|3757
23142699|Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors.|estrogen|estrogen receptor|6|6|Arg1:T3|Arg2:T21|CHEMICAL|GENE|no_relation|3758
23142699|In sum, identification of PIM-1 as an ERα target gene adds a novel potential mechanism by which estrogens can contribute to breast cancer cell proliferation and carcinogenesis.|estrogens|ERα|19|9|Arg1:T2|Arg2:T17|CHEMICAL|GENE|no_relation|3759
8142113|It has a particular selectivity profile for the known nuclear retinoic acid receptors with low affinity for RAR alpha and no transactivating potential for RXR alpha.|retinoic acid|RXR alpha|11|25|Arg1:T2|Arg2:T17|CHEMICAL|GENE|no_relation|3760
8142113|Furthermore, adapalene does not bind to members of the cellular retinoic acid binding protein family.|adapalene|retinoic acid binding protein|3|12|Arg1:T5|Arg2:T18|CHEMICAL|GENE|no_relation|3761
8142113|Furthermore, adapalene does not bind to members of the cellular retinoic acid binding protein family.|retinoic acid|retinoic acid binding protein|12|12|Arg1:T6|Arg2:T18|CHEMICAL|GENE|no_relation|3762
10727528|Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.|Aspirin|ETA receptors|1|7|Arg1:T17|Arg2:T37|CHEMICAL|GENE|no_relation|3763
10727528|Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.|sodium salicylate|ETA receptors|3|7|Arg1:T18|Arg2:T37|CHEMICAL|GENE|no_relation|3764
10727528|This study shows that aspirin and sodium salicylate, its major blood metabolite, reverse contractile actions of endothelin-1 (ET-1) in isolated rat aorta and human mammary arteries.|aspirin|ET-1|5|21|Arg1:T4|Arg2:T24|CHEMICAL|GENE|no_relation|3765
10727528|This study shows that aspirin and sodium salicylate, its major blood metabolite, reverse contractile actions of endothelin-1 (ET-1) in isolated rat aorta and human mammary arteries.|sodium salicylate|ET-1|7|21|Arg1:T5|Arg2:T24|CHEMICAL|GENE|no_relation|3766
10727528|They also prevent the intracellular Ca(2+) mobilizing action of ET-1 in cultured endothelial cells but not those of neuromedin B or UTP.|Ca(2+)|neuromedin B|6|22|Arg1:T6|Arg2:T26|CHEMICAL|GENE|no_relation|3767
10727528|It is concluded that salicylates are allosteric inhibitors of ETA receptors.|salicylates|ETA receptors|5|10|Arg1:T2|Arg2:T19|CHEMICAL|GENE|no_relation|3768
10727528|The results also suggest that: 1) irreversible ET-1 binding probably limits actions of receptor antagonists in vivo, and 2) an association of salicylates and ETA receptor antagonists should be used to evaluate the physiopathological role of ET-1 and may be of therapeutic interest in the treatment of ischemic heart disease.|salicylates|ET-1|27|41|Arg1:T3|Arg2:T22|CHEMICAL|GENE|no_relation|3769
23150495|Consistent with an adult-onset isolated GHD model, mutant animals are hypoglycemic and display increased insulin sensitivity and glucose clearance.|glucose|insulin|19|16|Arg1:T1|Arg2:T5|CHEMICAL|GENE|no_relation|3770
11792932|CONCLUSIONS: Men who are infertile with a low serum testosterone-to-estradiol ratio can be treated with an aromatase inhibitor.|testosterone|aromatase|11|18|Arg1:T17|Arg2:T43|CHEMICAL|GENE|no_relation|3771
11792932|CONCLUSIONS: Men who are infertile with a low serum testosterone-to-estradiol ratio can be treated with an aromatase inhibitor.|estradiol|aromatase|12|18|Arg1:T18|Arg2:T43|CHEMICAL|GENE|no_relation|3772
11972613|Cysteinyl leukotriene-dependent interleukin-5 production leading to eosinophilia during late asthmatic response in guinea-pigs.|Cysteinyl leukotriene|interleukin-5|1|3|Arg1:T16|Arg2:T31|CHEMICAL|GENE|no_relation|3773
11972613|  BACKGROUND: Allergic airway eosinophilia is suppressed by cysteinyl leukotriene (CysLT) receptor (CysLT1 receptor) antagonists in several species including humans and guinea-pigs, suggesting that CysLTs are directly or indirectly involved in induction of the response.|CysLTs|CysLT1|30|16|Arg1:T8|Arg2:T30|CHEMICAL|GENE|no_relation|3774
11972613|  BACKGROUND: Allergic airway eosinophilia is suppressed by cysteinyl leukotriene (CysLT) receptor (CysLT1 receptor) antagonists in several species including humans and guinea-pigs, suggesting that CysLTs are directly or indirectly involved in induction of the response.|cysteinyl leukotriene|CysLT1|9|16|Arg1:T12|Arg2:T30|CHEMICAL|GENE|no_relation|3775
11972613|  BACKGROUND: Allergic airway eosinophilia is suppressed by cysteinyl leukotriene (CysLT) receptor (CysLT1 receptor) antagonists in several species including humans and guinea-pigs, suggesting that CysLTs are directly or indirectly involved in induction of the response.|CysLT|CysLT1|12|16|Arg1:T15|Arg2:T30|CHEMICAL|GENE|no_relation|3776
11972613|OBJECTIVE: We examined the effect of CysLT antagonists (pranlukast and MCI-826) on antigen inhalation-induced eosinophilia in peripheral blood and lung, and on IL-5 activity in serum during late increase of airway resistance (late asthmatic response, LAR) in sensitized guinea-pigs.|CysLT|IL-5|8|27|Arg1:T9|Arg2:T23|CHEMICAL|GENE|no_relation|3777
11972613|OBJECTIVE: We examined the effect of CysLT antagonists (pranlukast and MCI-826) on antigen inhalation-induced eosinophilia in peripheral blood and lung, and on IL-5 activity in serum during late increase of airway resistance (late asthmatic response, LAR) in sensitized guinea-pigs.|pranlukast|IL-5|11|27|Arg1:T10|Arg2:T23|CHEMICAL|GENE|no_relation|3778
11972613|OBJECTIVE: We examined the effect of CysLT antagonists (pranlukast and MCI-826) on antigen inhalation-induced eosinophilia in peripheral blood and lung, and on IL-5 activity in serum during late increase of airway resistance (late asthmatic response, LAR) in sensitized guinea-pigs.|MCI-826|IL-5|13|27|Arg1:T11|Arg2:T23|CHEMICAL|GENE|no_relation|3779
11972613|METHODS: Guinea-pigs inhaled ovalbumin (OVA) + Al(OH)3 and OVA mists alternately for sensitization and challenge, respectively, once every 2 weeks.|Al(OH)3|OVA|10|16|Arg1:T13|Arg2:T27|CHEMICAL|GENE|no_relation|3780
11972613|At the fifth challenge, the effects of CysLT antagonists and an anti-IL-5 antibody (TRFK-5) on the occurrence of LAR, and blood and lung eosinophilia, which appeared at 5 h after challenge, were examined.|CysLT|IL-5|9|14|Arg1:T14|Arg2:T28|CHEMICAL|GENE|no_relation|3781
11972613|The influence of CysLT antagonists on IL-5 activity was assessed.|CysLT|IL-5|4|7|Arg1:T1|Arg2:T17|CHEMICAL|GENE|no_relation|3782
11972613|Thus, it is likely that CysLTs indirectly cause antigen-induced eosinophilia through IL-5 production.|CysLTs|IL-5|7|13|Arg1:T7|Arg2:T22|CHEMICAL|GENE|no_relation|3783
12123767|A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine.|mexiletine|SCN5A|14|3|Arg1:T9|Arg2:T20|CHEMICAL|GENE|no_relation|3784
12123767|  OBJECTIVE: Mutations in the cardiac sodium channel gene, SCN5A, cause congenital long QT syndrome (LQT3), Brugada syndrome, idiopathic ventricular fibrillation, and conduction disease by distinct cellular and clinical electrophysiological phenotypes.|sodium|SCN5A|7|11|Arg1:T5|Arg2:T15|CHEMICAL|GENE|no_relation|3785
12123767|RESULTS: The M1766L mutation caused a significant decrease in the sodium channel expression.|sodium|M1766L|12|4|Arg1:T1|Arg2:T10|CHEMICAL|GENE|no_relation|3786
12123767|In addition to this pronounced loss of function, M1766L also showed a 10-fold increase in the persistent late sodium current.|sodium|M1766L|20|10|Arg1:T3|Arg2:T11|CHEMICAL|GENE|no_relation|3787
12123767|CONCLUSIONS: These findings suggest that M1766L-SCN5A channel dysfunction may contribute to the basis of lethal arrhythmias, displays an overlapping electrophysiological phenotype, and represents the first sodium channelopathy rescued by drug.|sodium|SCN5A|29|8|Arg1:T4|Arg2:T13|CHEMICAL|GENE|no_relation|3788
12719755|Angiotensin II acting on angiotensin AT1 receptors at the central nervous system appears to have an important role in these modulatory processes.|Angiotensin II|angiotensin AT1 receptors|1|5|Arg1:T1|Arg2:T8|CHEMICAL|GENE|no_relation|3789
12719755|Angiotensin II acting on angiotensin AT1 receptors at the central nervous system appears to have an important role in these modulatory processes.|angiotensin|angiotensin AT1 receptors|5|5|Arg1:T2|Arg2:T8|CHEMICAL|GENE|no_relation|3790
12719755|The hypothalamic defence area (HDA) is a potential source of descending fibres containing angiotensin II that innervate the NTS.|angiotensin II|angiotensin II|16|16|Arg1:T3|Arg2:T9|CHEMICAL|GENE|no_relation|3791
23572389|E-cadherin is a transmembrane glycoprotein that mediates calcium-dependent interactions between adjacent epithelial cells.|calcium|E-cadherin|8|1|Arg1:T1|Arg2:T4|CHEMICAL|GENE|no_relation|3792
1666997|By contrast, neither amoxapine nor amitriptyline can be considered as possible ligands of 5-HT1A and 5-HT1B receptors because their affinities for these sites are in the micromolar range (or even worse).|amoxapine|5-HT1B|5|17|Arg1:T9|Arg2:T25|CHEMICAL|GENE|no_relation|3793
1666997|By contrast, neither amoxapine nor amitriptyline can be considered as possible ligands of 5-HT1A and 5-HT1B receptors because their affinities for these sites are in the micromolar range (or even worse).|amitriptyline|5-HT1B|7|17|Arg1:T10|Arg2:T25|CHEMICAL|GENE|no_relation|3794
1666997|The second part of this study consisted of looking for possible changes in central 5-HT receptors 24 h after either a single or a repeated (for 14 days) treatment with amoxapine (10 mg/kg i.p. each day) or amitriptyline (10 mg/kg i.p.).|amoxapine|5-HT receptors|33|15|Arg1:T1|Arg2:T18|CHEMICAL|GENE|no_relation|3795
1666997|The second part of this study consisted of looking for possible changes in central 5-HT receptors 24 h after either a single or a repeated (for 14 days) treatment with amoxapine (10 mg/kg i.p. each day) or amitriptyline (10 mg/kg i.p.).|amitriptyline|5-HT receptors|43|15|Arg1:T2|Arg2:T18|CHEMICAL|GENE|no_relation|3796
1666997|Finally we explored whether acute and/or chronic administration of amoxapine or amitriptyline affected the levels of opioid peptides and the mu and delta classes of opioid receptors in various regions of the brain and the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS)|amoxapine|mu and delta classes of opioid receptors|10|21|Arg1:T3|Arg2:T22|CHEMICAL|GENE|no_relation|3797
1666997|Finally we explored whether acute and/or chronic administration of amoxapine or amitriptyline affected the levels of opioid peptides and the mu and delta classes of opioid receptors in various regions of the brain and the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS)|amitriptyline|mu and delta classes of opioid receptors|12|21|Arg1:T4|Arg2:T22|CHEMICAL|GENE|no_relation|3798
23402628|  Selective oxidation of ω-tertiary amine self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and fibrinogen upon them.|ω-tertiary amine|fibrinogen|4|24|Arg1:T3|Arg2:T19|CHEMICAL|GENE|no_relation|3799
23402628|  Selective oxidation of ω-tertiary amine self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and fibrinogen upon them.|thiol|fibrinogen|7|24|Arg1:T8|Arg2:T19|CHEMICAL|GENE|no_relation|3800
23402628|  Selective oxidation of ω-tertiary amine self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and fibrinogen upon them.|tertiary amine N-oxides|fibrinogen|10|24|Arg1:T12|Arg2:T19|CHEMICAL|GENE|no_relation|3801
23402628|Oxidation with hydrogen peroxide was similarly assessed, and adhesion of lysozyme and fibrinogen from phosphate buffered saline was then assayed by QCM and imaged by AFM.|hydrogen peroxide|fibrinogen|3|14|Arg1:T9|Arg2:T21|CHEMICAL|GENE|no_relation|3802
23402628|Oxidation with hydrogen peroxide was similarly assessed, and adhesion of lysozyme and fibrinogen from phosphate buffered saline was then assayed by QCM and imaged by AFM.|phosphate|fibrinogen|16|14|Arg1:T10|Arg2:T21|CHEMICAL|GENE|no_relation|3803
23402628|Tertiary amine-functionalized sensors adsorbed multilayers of aggregated lysozyme, whereas tertiary amine N-oxides and triethylene glycol-terminated monolayers are consistent with small protein aggregates.|Tertiary amine|lysozyme|1|8|Arg1:T11|Arg2:T22|CHEMICAL|GENE|no_relation|3804
23402628|Tertiary amine-functionalized sensors adsorbed multilayers of aggregated lysozyme, whereas tertiary amine N-oxides and triethylene glycol-terminated monolayers are consistent with small protein aggregates.|tertiary amine N-oxides|lysozyme|11|8|Arg1:T13|Arg2:T22|CHEMICAL|GENE|no_relation|3805
23402628|Tertiary amine-functionalized sensors adsorbed multilayers of aggregated lysozyme, whereas tertiary amine N-oxides and triethylene glycol-terminated monolayers are consistent with small protein aggregates.|triethylene glycol|lysozyme|15|8|Arg1:T14|Arg2:T22|CHEMICAL|GENE|no_relation|3806
23504356|While studies of fenfluramine, secretin, opiates, and mood stabilizers generally find no effect, mixed results suggest more research is needed on antidepressants and atypical antipsychotics.|fenfluramine|secretin|4|6|Arg1:T1|Arg2:T3|CHEMICAL|GENE|no_relation|3807
23504356|Newer lines of research, including cholinergic and glutamatergic agents and oxytocin, will be of considerable interest in the future.|oxytocin|oxytocin|12|12|Arg1:T2|Arg2:T4|CHEMICAL|GENE|no_relation|3808
23506741|In the present study, we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole, a synthetic small molecular compound also named Fc11a-2, for the treatment of dextran sulfate sodium (DSS)-induced experimental colitis in mice via targeting NLRP3 inflammasome.|1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole|NLRP3|13|45|Arg1:T4|Arg2:T19|CHEMICAL|GENE|no_relation|3809
23506741|In the present study, we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole, a synthetic small molecular compound also named Fc11a-2, for the treatment of dextran sulfate sodium (DSS)-induced experimental colitis in mice via targeting NLRP3 inflammasome.|Fc11a-2|NLRP3|26|45|Arg1:T5|Arg2:T19|CHEMICAL|GENE|no_relation|3810
23506741|In the present study, we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole, a synthetic small molecular compound also named Fc11a-2, for the treatment of dextran sulfate sodium (DSS)-induced experimental colitis in mice via targeting NLRP3 inflammasome.|sulfate|NLRP3|33|45|Arg1:T6|Arg2:T19|CHEMICAL|GENE|no_relation|3811
23506741|In the present study, we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole, a synthetic small molecular compound also named Fc11a-2, for the treatment of dextran sulfate sodium (DSS)-induced experimental colitis in mice via targeting NLRP3 inflammasome.|sodium|NLRP3|34|45|Arg1:T7|Arg2:T19|CHEMICAL|GENE|no_relation|3812
16371234|The specific ligand for class B scavenger receptor (SR-B), high density lipoprotein, significantly suppressed PS liposome-induced PGE2 production.|PGE2|high density lipoprotein|21|13|Arg1:T14|Arg2:T44|CHEMICAL|GENE|no_relation|3813
16371234|Cyclooxygenase (COX)-2 and membrane-bound prostaglandin E synthase-1 (mPGES-1) were induced by treatment with lipopolysaccharide (LPS) but not with PS liposomes.|prostaglandin E|prostaglandin E synthase-1|8|8|Arg1:T15|Arg2:T47|CHEMICAL|GENE|no_relation|3814
16371234|Although SR-BI plays an essential role in PS liposome-induced PGE2 production, other PS-recognizing receptors, possibly PS-specific receptor, could also promote PGE2 production by transducing intracellular signals including p44/p42 ERK after PS liposomes treatment.|PGE2|ERK|10|32|Arg1:T7|Arg2:T41|CHEMICAL|GENE|no_relation|3815
16371234|Although SR-BI plays an essential role in PS liposome-induced PGE2 production, other PS-recognizing receptors, possibly PS-specific receptor, could also promote PGE2 production by transducing intracellular signals including p44/p42 ERK after PS liposomes treatment.|PGE2|ERK|24|32|Arg1:T8|Arg2:T41|CHEMICAL|GENE|no_relation|3816
23339678|Sixty-four female mice (ICR) were injected with ketorolac (0, 7.5, 15 and 30 µg/d) for 3 d starting from the day of eCG treatment.|ketorolac|eCG|10|29|Arg1:T4|Arg2:T8|CHEMICAL|GENE|no_relation|3817
20615127|As the RTH mutant, R316C, was new, the optimum dose of levothyroxine was unclear.|levothyroxine|R316C|15|6|Arg1:T6|Arg2:T28|CHEMICAL|GENE|no_relation|3818
20615127|SUMMARY: The patient was a newborn female having severe hypothyroidism with a free thyroxine level of 0.36 ng/dL and a serum TSH level of 177 microU/mL.|thyroxine|TSH|15|23|Arg1:T7|Arg2:T33|CHEMICAL|GENE|no_relation|3819
20615127|Supplementation with levothyroxine at a dose of >350 microg/day did not normalize the serum TSH level; however, the patient showed normal growth and intelligence at 14 years of age.|levothyroxine|TSH|3|16|Arg1:T8|Arg2:T34|CHEMICAL|GENE|no_relation|3820
20615127|However, a glutathione-S-transferase pull-down assay showed reduced binding of R316C with NCoR in the absence of T3 and impaired release in the presence of T3.|glutathione|NCoR|4|13|Arg1:T1|Arg2:T16|CHEMICAL|GENE|no_relation|3821
20615127|However, a glutathione-S-transferase pull-down assay showed reduced binding of R316C with NCoR in the absence of T3 and impaired release in the presence of T3.|S|NCoR|5|13|Arg1:T2|Arg2:T16|CHEMICAL|GENE|no_relation|3822
20615127|However, a glutathione-S-transferase pull-down assay showed reduced binding of R316C with NCoR in the absence of T3 and impaired release in the presence of T3.|T3|NCoR|18|13|Arg1:T3|Arg2:T16|CHEMICAL|GENE|no_relation|3823
20615127|However, a glutathione-S-transferase pull-down assay showed reduced binding of R316C with NCoR in the absence of T3 and impaired release in the presence of T3.|T3|NCoR|26|13|Arg1:T4|Arg2:T16|CHEMICAL|GENE|no_relation|3824
23290724|Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface.|Zinc|prion protein|1|8|Arg1:T9|Arg2:T15|CHEMICAL|GENE|no_relation|3825
17632107|  Structural and functional properties were investigated for four peroxisome proliferator-activated receptors (PPARs), PPARalpha1, PPARalpha2, PPARbeta, and PPARgamma, from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the acyl-CoA oxidase PPAR response element.|acyl-CoA|peroxisome proliferator-activated receptors|48|9|Arg1:T9|Arg2:T25|CHEMICAL|GENE|no_relation|3826
17632107|Although torafugu PPARs showed a high similarity in the primary structure to other vertebrate counterparts, torafugu PPARalpha2 and gamma contained additional sequences of 21 and 28 amino acids, respectively, as in the case of other teleost fish species when compared with African clawed frog counterparts.|amino acids|torafugu PPARalpha2 and gamma|28|17|Arg1:T10|Arg2:T24|CHEMICAL|GENE|no_relation|3827
17632107|The activities of torafugu PPARalpha1 and alpha2 were also enhanced 5.6- and 6.3-fold by ETYA at 1 microM, respectively, but not by Wy-14643 at this concentration.|ETYA|PPARalpha1 and alpha2|15|5|Arg1:T1|Arg2:T28|CHEMICAL|GENE|no_relation|3828
17632107|The activities of torafugu PPARalpha1 and alpha2 were also enhanced 5.6- and 6.3-fold by ETYA at 1 microM, respectively, but not by Wy-14643 at this concentration.|Wy-14643|PPARalpha1 and alpha2|25|5|Arg1:T2|Arg2:T28|CHEMICAL|GENE|no_relation|3829
17632107|On the other hand, the activities of torafugu PPARbeta and gamma were not changed by Wy-14643, ETYA, rosiglitazone, nor PUFAs. These results suggest that the activities of torafugu PPARbeta and gamma require undefined ligands.|Wy-14643|torafugu PPARbeta and gamma|17|33|Arg1:T6|Arg2:T20|CHEMICAL|GENE|no_relation|3830
17632107|On the other hand, the activities of torafugu PPARbeta and gamma were not changed by Wy-14643, ETYA, rosiglitazone, nor PUFAs. These results suggest that the activities of torafugu PPARbeta and gamma require undefined ligands.|ETYA|torafugu PPARbeta and gamma|19|33|Arg1:T7|Arg2:T20|CHEMICAL|GENE|no_relation|3831
17632107|On the other hand, the activities of torafugu PPARbeta and gamma were not changed by Wy-14643, ETYA, rosiglitazone, nor PUFAs. These results suggest that the activities of torafugu PPARbeta and gamma require undefined ligands.|rosiglitazone|torafugu PPARbeta and gamma|21|33|Arg1:T8|Arg2:T20|CHEMICAL|GENE|no_relation|3832
23500061|Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia-reperfusion injury: Use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier.|deoxycholic acid|SHP-1|14|5|Arg1:T4|Arg2:T17|CHEMICAL|GENE|no_relation|3833
23500061|Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia-reperfusion injury: Use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier.|polyethyleneimine|SHP-1|19|5|Arg1:T5|Arg2:T17|CHEMICAL|GENE|no_relation|3834
23500061|Herein, we report ischemic-reperfused myocardial infarction (MI) repair with siRNA against Src homology region 2 domain-containing tyrosine phosphatase-1 (SHP-1), which is known as a key factor involved in regulating the progress of apoptosis in many cell types.|tyrosine|SHP-1|20|23|Arg1:T1|Arg2:T13|CHEMICAL|GENE|no_relation|3835
23500061|A low molecular weight polyethyleneimine modified with deoxycholic acid (PEI1.8-DA)-based delivery strategy was suggested for the cardiac application of SHP-1 siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles.|polyethyleneimine|SHP-1|5|23|Arg1:T2|Arg2:T14|CHEMICAL|GENE|no_relation|3836
23500061|A low molecular weight polyethyleneimine modified with deoxycholic acid (PEI1.8-DA)-based delivery strategy was suggested for the cardiac application of SHP-1 siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles.|deoxycholic acid|SHP-1|8|23|Arg1:T3|Arg2:T14|CHEMICAL|GENE|no_relation|3837
20091113|We evaluated associations between mood, cognitive and cardiovascular responses to d-amphetamine and four polymorphisms in the dopamine transporter (SLC6A3): rs460000, rs3756450, rs37022 and rs6869645.|d-amphetamine|SLC6A3|12|21|Arg1:T2|Arg2:T8|CHEMICAL|GENE|no_relation|3838
20091113|We evaluated associations between mood, cognitive and cardiovascular responses to d-amphetamine and four polymorphisms in the dopamine transporter (SLC6A3): rs460000, rs3756450, rs37022 and rs6869645.|dopamine|SLC6A3|18|21|Arg1:T3|Arg2:T8|CHEMICAL|GENE|no_relation|3839
19244097|  Recent studies identified novel allosteric modulators of the dopamine (DA) transporter (DAT).|dopamine|DAT|9|15|Arg1:T30|Arg2:T55|CHEMICAL|GENE|no_relation|3840
19244097|  Recent studies identified novel allosteric modulators of the dopamine (DA) transporter (DAT).|DA|DAT|11|15|Arg1:T35|Arg2:T55|CHEMICAL|GENE|no_relation|3841
19244097|"In the present study, we report that SoRI-9804 and SoRI-20040, at doses that do not alter release, partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium (MPP(+))or[(3)H]dopamine from striatal synaptosomes (""DAT-mediated DA release"") in a dose-dependent manner."|SoRI-9804|DAT|9|53|Arg1:T28|Arg2:T53|CHEMICAL|GENE|no_relation|3842
19244097|"In the present study, we report that SoRI-9804 and SoRI-20040, at doses that do not alter release, partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium (MPP(+))or[(3)H]dopamine from striatal synaptosomes (""DAT-mediated DA release"") in a dose-dependent manner."|SoRI-20040|DAT|11|53|Arg1:T29|Arg2:T53|CHEMICAL|GENE|no_relation|3843
19244097|"In the present study, we report that SoRI-9804 and SoRI-20040, at doses that do not alter release, partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium (MPP(+))or[(3)H]dopamine from striatal synaptosomes (""DAT-mediated DA release"") in a dose-dependent manner."|d-amphetamine|DAT|23|53|Arg1:T31|Arg2:T53|CHEMICAL|GENE|no_relation|3844
19244097|"In the present study, we report that SoRI-9804 and SoRI-20040, at doses that do not alter release, partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium (MPP(+))or[(3)H]dopamine from striatal synaptosomes (""DAT-mediated DA release"") in a dose-dependent manner."|[(3)H]1-methyl-4-phenylpyridinium|DAT|27|53|Arg1:T32|Arg2:T53|CHEMICAL|GENE|no_relation|3845
19244097|"In the present study, we report that SoRI-9804 and SoRI-20040, at doses that do not alter release, partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium (MPP(+))or[(3)H]dopamine from striatal synaptosomes (""DAT-mediated DA release"") in a dose-dependent manner."|MPP(+)|DAT|35|53|Arg1:T33|Arg2:T53|CHEMICAL|GENE|no_relation|3846
19244097|"In the present study, we report that SoRI-9804 and SoRI-20040, at doses that do not alter release, partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium (MPP(+))or[(3)H]dopamine from striatal synaptosomes (""DAT-mediated DA release"") in a dose-dependent manner."|[(3)H]dopamine|DAT|41|53|Arg1:T34|Arg2:T53|CHEMICAL|GENE|no_relation|3847
19244097|"In the present study, we report that SoRI-9804 and SoRI-20040, at doses that do not alter release, partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium (MPP(+))or[(3)H]dopamine from striatal synaptosomes (""DAT-mediated DA release"") in a dose-dependent manner."|DA|DAT|54|53|Arg1:T36|Arg2:T53|CHEMICAL|GENE|no_relation|3848
19244097|SoRI-20041, which does not alter DAT-mediated DA release measured with [(3)H]DA, reversed the effect of SoRI-20040.|SoRI-20041|DAT|1|7|Arg1:T37|Arg2:T54|CHEMICAL|GENE|no_relation|3849
19244097|SoRI-20041, which does not alter DAT-mediated DA release measured with [(3)H]DA, reversed the effect of SoRI-20040.|DA|DAT|8|7|Arg1:T38|Arg2:T54|CHEMICAL|GENE|no_relation|3850
19244097|SoRI-20041, which does not alter DAT-mediated DA release measured with [(3)H]DA, reversed the effect of SoRI-20040.|[(3)H]DA|DAT|12|7|Arg1:T39|Arg2:T54|CHEMICAL|GENE|no_relation|3851
19244097|SoRI-20041, which does not alter DAT-mediated DA release measured with [(3)H]DA, reversed the effect of SoRI-20040.|SoRI-20040|DAT|24|7|Arg1:T40|Arg2:T54|CHEMICAL|GENE|no_relation|3852
19244097|SoRI-20040 and SoRI-9804 also partially inhibited DAT-mediated DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine, demonstrating that the observed partial inhibition is not specific for a particular DAT substrate.|DA|DAT|12|7|Arg1:T1|Arg2:T56|CHEMICAL|GENE|no_relation|3853
19244097|SoRI-20040 and SoRI-9804 also partially inhibited DAT-mediated DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine, demonstrating that the observed partial inhibition is not specific for a particular DAT substrate.|(+/-)-3,4-methylenedioxyamphetamine|DAT|14|7|Arg1:T2|Arg2:T56|CHEMICAL|GENE|no_relation|3854
19244097|SoRI-20040 and SoRI-9804 also partially inhibited DAT-mediated DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine, demonstrating that the observed partial inhibition is not specific for a particular DAT substrate.|SoRI-20040|DAT|1|7|Arg1:T41|Arg2:T56|CHEMICAL|GENE|no_relation|3855
19244097|SoRI-20040 and SoRI-9804 also partially inhibited DAT-mediated DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine, demonstrating that the observed partial inhibition is not specific for a particular DAT substrate.|SoRI-9804|DAT|3|7|Arg1:T42|Arg2:T56|CHEMICAL|GENE|no_relation|3856
19244097|SoRI-20040 and SoRI-9804 also partially inhibited DAT-mediated DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine, demonstrating that the observed partial inhibition is not specific for a particular DAT substrate.|DA|DAT|8|7|Arg1:T44|Arg2:T56|CHEMICAL|GENE|no_relation|3857
19244097|"The two major findings of this study are 1) the identification of both ""agonist"" (SoRI-9804 and SoRI-20040) and ""antagonist"" (SoRI-20041) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated."|SoRI-9804|DAT|19|50|Arg1:T14|Arg2:T49|CHEMICAL|GENE|no_relation|3858
19244097|"The two major findings of this study are 1) the identification of both ""agonist"" (SoRI-9804 and SoRI-20040) and ""antagonist"" (SoRI-20041) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated."|SoRI-20040|DAT|21|50|Arg1:T15|Arg2:T49|CHEMICAL|GENE|no_relation|3859
19244097|"The two major findings of this study are 1) the identification of both ""agonist"" (SoRI-9804 and SoRI-20040) and ""antagonist"" (SoRI-20041) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated."|SoRI-20041|DAT|28|50|Arg1:T16|Arg2:T49|CHEMICAL|GENE|no_relation|3860
19244097|"The two major findings of this study are 1) the identification of both ""agonist"" (SoRI-9804 and SoRI-20040) and ""antagonist"" (SoRI-20041) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated."|D-amphetamine|DAT|33|50|Arg1:T17|Arg2:T49|CHEMICAL|GENE|no_relation|3861
19244097|"The two major findings of this study are 1) the identification of both ""agonist"" (SoRI-9804 and SoRI-20040) and ""antagonist"" (SoRI-20041) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated."|DA|DAT|35|50|Arg1:T18|Arg2:T49|CHEMICAL|GENE|no_relation|3862
19244097|"The two major findings of this study are 1) the identification of both ""agonist"" (SoRI-9804 and SoRI-20040) and ""antagonist"" (SoRI-20041) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated."|[(3)H]DA|DAT|40|50|Arg1:T19|Arg2:T49|CHEMICAL|GENE|no_relation|3863
19244097|"The two major findings of this study are 1) the identification of both ""agonist"" (SoRI-9804 and SoRI-20040) and ""antagonist"" (SoRI-20041) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated."|d-amphetamine|DAT|49|50|Arg1:T20|Arg2:T49|CHEMICAL|GENE|no_relation|3864
11344206|There are 2 forms of PHA1: the autosomal recessive form with symptoms persisting into adulthood, caused by mutations in the amiloride-sensitive luminal sodium channel, and the autosomal dominant or sporadic form, which shows milder symptoms that remit with age.|amiloride|amiloride-sensitive luminal sodium channel|23|23|Arg1:T1|Arg2:T4|CHEMICAL|GENE|no_relation|3865
11344206|There are 2 forms of PHA1: the autosomal recessive form with symptoms persisting into adulthood, caused by mutations in the amiloride-sensitive luminal sodium channel, and the autosomal dominant or sporadic form, which shows milder symptoms that remit with age.|sodium|amiloride-sensitive luminal sodium channel|25|23|Arg1:T2|Arg2:T4|CHEMICAL|GENE|no_relation|3866
23500776|EROD activity, reflecting almost exclusively CYP1A1 and CYP1B1 activities, was measured in brain and liver microsomes as well as in peripheral blood lymphocytes (PBLs).|EROD|CYP1B1|1|9|Arg1:T9|Arg2:T18|CHEMICAL|GENE|no_relation|3867
23500776|After 28days of exposure to a 6μg/day dose, EROD activity was found to be 91, 152 and 94-fold increased in lymphocytes, liver and brain, respectively, compared to day 0.|EROD|EROD|10|10|Arg1:T10|Arg2:T20|CHEMICAL|GENE|no_relation|3868
23500776|Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive, convenient and non-destructive approach for (i) evaluating EROD activity in liver, which was found to represent 98% of the observed EROD activities in the three tested matrices and (ii) evaluating oral exposure of homogeneous groups of farm animals (race, diet) to CYP inducing PAH and PHH.|EROD|EROD|30|10|Arg1:T1|Arg2:T21|CHEMICAL|GENE|no_relation|3869
23500776|Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive, convenient and non-destructive approach for (i) evaluating EROD activity in liver, which was found to represent 98% of the observed EROD activities in the three tested matrices and (ii) evaluating oral exposure of homogeneous groups of farm animals (race, diet) to CYP inducing PAH and PHH.|EROD|EROD|45|10|Arg1:T2|Arg2:T21|CHEMICAL|GENE|no_relation|3870
23500776|Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive, convenient and non-destructive approach for (i) evaluating EROD activity in liver, which was found to represent 98% of the observed EROD activities in the three tested matrices and (ii) evaluating oral exposure of homogeneous groups of farm animals (race, diet) to CYP inducing PAH and PHH.|PHH|EROD|75|10|Arg1:T4|Arg2:T21|CHEMICAL|GENE|no_relation|3871
23500776|Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive, convenient and non-destructive approach for (i) evaluating EROD activity in liver, which was found to represent 98% of the observed EROD activities in the three tested matrices and (ii) evaluating oral exposure of homogeneous groups of farm animals (race, diet) to CYP inducing PAH and PHH.|EROD|EROD|10|10|Arg1:T11|Arg2:T21|CHEMICAL|GENE|no_relation|3872
12414329|Published literature on the nitric oxide-cyclic guanosine monophosphate (cGMP) pathway for penile erection and on PDE5 inhibition using sildenafil as the model for pharmacologic PDE5 inhibition are assessed.|nitric oxide|PDE5|5|27|Arg1:T3|Arg2:T18|CHEMICAL|GENE|no_relation|3873
12414329|Published literature on the nitric oxide-cyclic guanosine monophosphate (cGMP) pathway for penile erection and on PDE5 inhibition using sildenafil as the model for pharmacologic PDE5 inhibition are assessed.|cyclic guanosine monophosphate|PDE5|7|27|Arg1:T5|Arg2:T18|CHEMICAL|GENE|no_relation|3874
12414329|Published literature on the nitric oxide-cyclic guanosine monophosphate (cGMP) pathway for penile erection and on PDE5 inhibition using sildenafil as the model for pharmacologic PDE5 inhibition are assessed.|cGMP|PDE5|10|27|Arg1:T6|Arg2:T18|CHEMICAL|GENE|no_relation|3875
23481236|  Normal glucose regulation is achieved by having adequate insulin secretion and effective glucose uptake/disposal.|glucose|insulin|2|9|Arg1:T16|Arg2:T45|CHEMICAL|GENE|no_relation|3876
23481236|  Normal glucose regulation is achieved by having adequate insulin secretion and effective glucose uptake/disposal.|glucose|insulin|13|9|Arg1:T21|Arg2:T45|CHEMICAL|GENE|no_relation|3877
23481236|Excess lipids in peripheral tissues - skeletal muscle, liver and adipose tissue - may attenuate insulin signaling through the protein kinase B (AKt) pathway and up-regulate protein tyrosine phosphatase 1B (PTP1B), a negative regulator of insulin signaling.|tyrosine|insulin|31|42|Arg1:T9|Arg2:T42|CHEMICAL|GENE|no_relation|3878
1730582|The preceding amino acids do not conform to the consensus sequence of SXHK, which contains the pyridoxal 5'-phosphate binding lysine in a number of other decarboxylases including ODCs from E.|amino acids|ODCs|3|29|Arg1:T26|Arg2:T43|CHEMICAL|GENE|no_relation|3879
1730582|The preceding amino acids do not conform to the consensus sequence of SXHK, which contains the pyridoxal 5'-phosphate binding lysine in a number of other decarboxylases including ODCs from E.|pyridoxal 5'-phosphate|ODCs|18|29|Arg1:T27|Arg2:T43|CHEMICAL|GENE|no_relation|3880
1730582|The preceding amino acids do not conform to the consensus sequence of SXHK, which contains the pyridoxal 5'-phosphate binding lysine in a number of other decarboxylases including ODCs from E.|lysine|ODCs|21|29|Arg1:T28|Arg2:T43|CHEMICAL|GENE|no_relation|3881
9204085|The nuclear gene transcription factors RAR beta and RAR gamma mediate the retinoid activity of adapalene.|retinoid|RAR gamma|13|9|Arg1:T1|Arg2:T18|CHEMICAL|GENE|no_relation|3882
9204085|The nuclear gene transcription factors RAR beta and RAR gamma mediate the retinoid activity of adapalene.|adapalene|RAR gamma|16|9|Arg1:T3|Arg2:T18|CHEMICAL|GENE|no_relation|3883
16248990|  The main goal of the present study was to analyse the effects of (+/-)-huprine X ((+/-)-HX) and galantamine (GAL), with potentiating action on nicotinic receptors, and huperzine A (HPA), devoid of nicotinic activity, on [3H]-acetylcholine ([3H]-ACh) release in striatal slices of rat brain.|[3H]-acetylcholine|nicotinic receptors|51|35|Arg1:T8|Arg2:T21|CHEMICAL|GENE|no_relation|3884
16248990|  The main goal of the present study was to analyse the effects of (+/-)-huprine X ((+/-)-HX) and galantamine (GAL), with potentiating action on nicotinic receptors, and huperzine A (HPA), devoid of nicotinic activity, on [3H]-acetylcholine ([3H]-ACh) release in striatal slices of rat brain.|[3H]-ACh|nicotinic receptors|56|35|Arg1:T9|Arg2:T21|CHEMICAL|GENE|no_relation|3885
23294255|  The trypsin-like serine protease plasmin is a target for the development of antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce excessive blood loss.|serine|trypsin|3|2|Arg1:T1|Arg2:T7|CHEMICAL|GENE|no_relation|3886
23294255|The most potent inhibitor 8 binds to plasmin with an inhibition constant of 0.2 nM, whereas K(i) values >1 μM were determined for nearly all other tested trypsin-like serine proteases, with the exception of trypsin, which is also inhibited in the nanomolar range.|serine|trypsin|34|41|Arg1:T2|Arg2:T10|CHEMICAL|GENE|no_relation|3887
23493568|X-box binding protein 1 (XBP1) is a transcription factor that plays a crucial role in the unfolded protein response (UPR) and its deficiency in β-cells has been reported to impair insulin secretion leading to glucose intolerance.|glucose|insulin|39|35|Arg1:T4|Arg2:T18|CHEMICAL|GENE|no_relation|3888
23493568|αXBPKO mice exhibited glucose intolerance, mild insulin resistance and an inability to suppress glucagon secretion following glucose stimulation.|glucose|glucagon|4|15|Arg1:T5|Arg2:T26|CHEMICAL|GENE|no_relation|3889
23493568|αXBPKO mice exhibited glucose intolerance, mild insulin resistance and an inability to suppress glucagon secretion following glucose stimulation.|glucose|glucagon|18|15|Arg1:T6|Arg2:T26|CHEMICAL|GENE|no_relation|3890
23493568|Consequently the αXBPKD cells exhibited blunted suppression of glucagon secretion following insulin treatment in the presence of high glucose.|glucose|insulin|19|12|Arg1:T3|Arg2:T12|CHEMICAL|GENE|no_relation|3891
23270805|Coming full circle: contributions of central and peripheral oxytocin actions to energy balance.|oxytocin|oxytocin|10|10|Arg1:T7|Arg2:T12|CHEMICAL|GENE|no_relation|3892
23270805|  The neuropeptide oxytocin has emerged as an important anorexigen in the regulation of energy balance.|oxytocin|oxytocin|3|3|Arg1:T1|Arg2:T8|CHEMICAL|GENE|no_relation|3893
23270805|  The neuropeptide oxytocin has emerged as an important anorexigen in the regulation of energy balance.|anorexigen|oxytocin|9|3|Arg1:T4|Arg2:T8|CHEMICAL|GENE|no_relation|3894
23270805|Systemic administration of oxytocin recapitulates many of its effects when administered centrally, raising the questions of whether and to what extent circulating oxytocin contributes to energy regulation.|oxytocin|oxytocin|4|24|Arg1:T3|Arg2:T10|CHEMICAL|GENE|no_relation|3895
23270805|Systemic administration of oxytocin recapitulates many of its effects when administered centrally, raising the questions of whether and to what extent circulating oxytocin contributes to energy regulation.|oxytocin|oxytocin|24|24|Arg1:T5|Arg2:T10|CHEMICAL|GENE|no_relation|3896
23270805|Its therapeutic potential to treat metabolic conditions remains to be determined, but data from diet-induced and genetically obese rodent models as well as application of oxytocin in humans in other areas of research have revealed promising results thus far.|oxytocin|oxytocin|27|27|Arg1:T6|Arg2:T11|CHEMICAL|GENE|no_relation|3897
12487427|In human plasma the BrBK half-life values in the absence or in the presence of GW660511X (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.|BrBK|Br-Phe|5|53|Arg1:T35|Arg2:T83|CHEMICAL|GENE|no_relation|3898
12487427|In human plasma the BrBK half-life values in the absence or in the presence of GW660511X (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.|GW660511X|Br-Phe|16|53|Arg1:T37|Arg2:T83|CHEMICAL|GENE|no_relation|3899
12487427|In human plasma the BrBK half-life values in the absence or in the presence of GW660511X (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.|omapatrilat|Br-Phe|22|53|Arg1:T38|Arg2:T83|CHEMICAL|GENE|no_relation|3900
12487427|In human plasma the BrBK half-life values in the absence or in the presence of GW660511X (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.|BrBK|Br-Phe|43|53|Arg1:T39|Arg2:T83|CHEMICAL|GENE|no_relation|3901
12487427|In human plasma the BrBK half-life values in the absence or in the presence of GW660511X (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.|BrBK1-8|Br-Phe|47|53|Arg1:T40|Arg2:T83|CHEMICAL|GENE|no_relation|3902
12487427|In human plasma the BrBK half-life values in the absence or in the presence of GW660511X (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.|BrBK1-7|Br-Phe|49|53|Arg1:T41|Arg2:T83|CHEMICAL|GENE|no_relation|3903
12487427|In human plasma the BrBK half-life values in the absence or in the presence of GW660511X (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.|BrBK1-5|Br-Phe|51|53|Arg1:T42|Arg2:T83|CHEMICAL|GENE|no_relation|3904
12487427|In human plasma the BrBK half-life values in the absence or in the presence of GW660511X (3.8 microM) or omapatrilat (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe.|Br-Phe|Br-Phe|53|53|Arg1:T43|Arg2:T83|CHEMICAL|GENE|no_relation|3905
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|BrBK|BrBK2-8|5|59|Arg1:T6|Arg2:T62|CHEMICAL|GENE|no_relation|3906
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|GW660511X|BrBK2-8|16|59|Arg1:T7|Arg2:T62|CHEMICAL|GENE|no_relation|3907
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|omapatrilat|BrBK2-8|22|59|Arg1:T8|Arg2:T62|CHEMICAL|GENE|no_relation|3908
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|BrBK|BrBK2-8|43|59|Arg1:T9|Arg2:T62|CHEMICAL|GENE|no_relation|3909
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|BrBK1-8|BrBK2-8|47|59|Arg1:T10|Arg2:T62|CHEMICAL|GENE|no_relation|3910
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|BrBK1-7|BrBK2-8|49|59|Arg1:T11|Arg2:T62|CHEMICAL|GENE|no_relation|3911
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|BrBK1-5|BrBK2-8|51|59|Arg1:T12|Arg2:T62|CHEMICAL|GENE|no_relation|3912
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|Br-Phe5|BrBK2-8|53|59|Arg1:T13|Arg2:T62|CHEMICAL|GENE|no_relation|3913
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|BrBK2-9|BrBK2-8|55|59|Arg1:T14|Arg2:T62|CHEMICAL|GENE|no_relation|3914
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|BrBK4-8|BrBK2-8|57|59|Arg1:T15|Arg2:T62|CHEMICAL|GENE|no_relation|3915
12487427|In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X (530 nM) or omapatrilat (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and BrBK was degraded into BrBK1-8, BrBK1-7, BrBK1-5 and Br-Phe5 plus BrBK2-9, BrBK4-8 and BrBK2-8 metabolites not found in human plasma.|BrBK2-8|BrBK2-8|59|59|Arg1:T16|Arg2:T62|CHEMICAL|GENE|no_relation|3916
23282066|Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam.|midazolam|CYP3A|26|16|Arg1:T12|Arg2:T16|CHEMICAL|GENE|no_relation|3917
23282066|Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam.|triazolam|CYP3A|28|16|Arg1:T13|Arg2:T16|CHEMICAL|GENE|no_relation|3918
23267767|Development of hypoxia-inducible factor (HIF)-1α inhibitors: effect of ortho-carborane substituents on HIF transcriptional activity under hypoxia.|ortho-carborane|hypoxia-inducible factor (HIF)-1α|13|3|Arg1:T5|Arg2:T15|CHEMICAL|GENE|no_relation|3919
23267767|  A series of substituted ortho-carboranylphenoxyacetanilides were synthesized and evaluated for their ability to inhibit hypoxia-induced HIF-1 transcriptional activity using a cell-based reporter assay in HeLa cells expressing the HRE-dependent firefly luciferase reporter construct (HRE-Luc) and constitutively expressing CMV-driven Renilla luciferase reporter, and their ability to inhibit cell growth (GI(50)) using the MTT assay.|ortho-carboranylphenoxyacetanilides|HRE|5|35|Arg1:T1|Arg2:T8|CHEMICAL|GENE|no_relation|3920
23267767|  A series of substituted ortho-carboranylphenoxyacetanilides were synthesized and evaluated for their ability to inhibit hypoxia-induced HIF-1 transcriptional activity using a cell-based reporter assay in HeLa cells expressing the HRE-dependent firefly luciferase reporter construct (HRE-Luc) and constitutively expressing CMV-driven Renilla luciferase reporter, and their ability to inhibit cell growth (GI(50)) using the MTT assay.|MTT|HRE|60|35|Arg1:T2|Arg2:T8|CHEMICAL|GENE|no_relation|3921
10637238|PATIENTS AND METHODS: Between January 1988 and December 1992, 231 patients with estrogen receptor (ER)-positive or ER-unknown metastatic breast cancer were randomized to receive either chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil inverted question markCAF) or chemohormonal therapy (CAF plus tamoxifen and Halotestin inverted question markfluoxymesterone; Pharmacia-Upjohn, Kalamazoo, MI inverted question markCAFTH) as front-line therapy for metastatic breast cancer.|estrogen|ER|15|22|Arg1:T5|Arg2:T18|CHEMICAL|GENE|no_relation|3922
10637238|PATIENTS AND METHODS: Between January 1988 and December 1992, 231 patients with estrogen receptor (ER)-positive or ER-unknown metastatic breast cancer were randomized to receive either chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil inverted question markCAF) or chemohormonal therapy (CAF plus tamoxifen and Halotestin inverted question markfluoxymesterone; Pharmacia-Upjohn, Kalamazoo, MI inverted question markCAFTH) as front-line therapy for metastatic breast cancer.|cyclophosphamide|ER|33|22|Arg1:T6|Arg2:T18|CHEMICAL|GENE|no_relation|3923
10637238|PATIENTS AND METHODS: Between January 1988 and December 1992, 231 patients with estrogen receptor (ER)-positive or ER-unknown metastatic breast cancer were randomized to receive either chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil inverted question markCAF) or chemohormonal therapy (CAF plus tamoxifen and Halotestin inverted question markfluoxymesterone; Pharmacia-Upjohn, Kalamazoo, MI inverted question markCAFTH) as front-line therapy for metastatic breast cancer.|doxorubicin|ER|35|22|Arg1:T7|Arg2:T18|CHEMICAL|GENE|no_relation|3924
10637238|PATIENTS AND METHODS: Between January 1988 and December 1992, 231 patients with estrogen receptor (ER)-positive or ER-unknown metastatic breast cancer were randomized to receive either chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil inverted question markCAF) or chemohormonal therapy (CAF plus tamoxifen and Halotestin inverted question markfluoxymesterone; Pharmacia-Upjohn, Kalamazoo, MI inverted question markCAFTH) as front-line therapy for metastatic breast cancer.|fluorouracil|ER|38|22|Arg1:T8|Arg2:T18|CHEMICAL|GENE|no_relation|3925
10637238|PATIENTS AND METHODS: Between January 1988 and December 1992, 231 patients with estrogen receptor (ER)-positive or ER-unknown metastatic breast cancer were randomized to receive either chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil inverted question markCAF) or chemohormonal therapy (CAF plus tamoxifen and Halotestin inverted question markfluoxymesterone; Pharmacia-Upjohn, Kalamazoo, MI inverted question markCAFTH) as front-line therapy for metastatic breast cancer.|tamoxifen|ER|49|22|Arg1:T9|Arg2:T18|CHEMICAL|GENE|no_relation|3926
10637238|PATIENTS AND METHODS: Between January 1988 and December 1992, 231 patients with estrogen receptor (ER)-positive or ER-unknown metastatic breast cancer were randomized to receive either chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil inverted question markCAF) or chemohormonal therapy (CAF plus tamoxifen and Halotestin inverted question markfluoxymesterone; Pharmacia-Upjohn, Kalamazoo, MI inverted question markCAFTH) as front-line therapy for metastatic breast cancer.|Halotestin|ER|51|22|Arg1:T10|Arg2:T18|CHEMICAL|GENE|no_relation|3927
10637238|PATIENTS AND METHODS: Between January 1988 and December 1992, 231 patients with estrogen receptor (ER)-positive or ER-unknown metastatic breast cancer were randomized to receive either chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil inverted question markCAF) or chemohormonal therapy (CAF plus tamoxifen and Halotestin inverted question markfluoxymesterone; Pharmacia-Upjohn, Kalamazoo, MI inverted question markCAFTH) as front-line therapy for metastatic breast cancer.|fluoxymesterone|ER|55|22|Arg1:T11|Arg2:T18|CHEMICAL|GENE|no_relation|3928
12167474|Nine mammalian pyridoxal 5'-phosphate (PLP)-containing enzymes catalyze cysteine S-conjugate beta-lyase reactions, including mitochondrial aspartate aminotransferase (mitAspAT), and mitochondrial branched-chain amino acid aminotransferase (BCAT(m)).|cysteine S-conjugate|BCAT(m)|11|31|Arg1:T1|Arg2:T41|CHEMICAL|GENE|no_relation|3929
12167474|Nine mammalian pyridoxal 5'-phosphate (PLP)-containing enzymes catalyze cysteine S-conjugate beta-lyase reactions, including mitochondrial aspartate aminotransferase (mitAspAT), and mitochondrial branched-chain amino acid aminotransferase (BCAT(m)).|aspartate|BCAT(m)|18|31|Arg1:T2|Arg2:T41|CHEMICAL|GENE|no_relation|3930
12167474|Nine mammalian pyridoxal 5'-phosphate (PLP)-containing enzymes catalyze cysteine S-conjugate beta-lyase reactions, including mitochondrial aspartate aminotransferase (mitAspAT), and mitochondrial branched-chain amino acid aminotransferase (BCAT(m)).|branched-chain amino acid|BCAT(m)|26|31|Arg1:T3|Arg2:T41|CHEMICAL|GENE|no_relation|3931
12167474|Nine mammalian pyridoxal 5'-phosphate (PLP)-containing enzymes catalyze cysteine S-conjugate beta-lyase reactions, including mitochondrial aspartate aminotransferase (mitAspAT), and mitochondrial branched-chain amino acid aminotransferase (BCAT(m)).|pyridoxal 5'-phosphate|BCAT(m)|3|31|Arg1:T34|Arg2:T41|CHEMICAL|GENE|no_relation|3932
12167474|Nine mammalian pyridoxal 5'-phosphate (PLP)-containing enzymes catalyze cysteine S-conjugate beta-lyase reactions, including mitochondrial aspartate aminotransferase (mitAspAT), and mitochondrial branched-chain amino acid aminotransferase (BCAT(m)).|PLP|BCAT(m)|6|31|Arg1:T35|Arg2:T41|CHEMICAL|GENE|no_relation|3933
12167474|Most of the cysteine S-conjugate beta-lyases are syncatalytically inactivated.|cysteine S-conjugate|beta-lyases|4|6|Arg1:T5|Arg2:T42|CHEMICAL|GENE|no_relation|3934
12167474|Interestingly, the alpha-ketoglutarate- and branched-chain alpha-keto acid dehydrogenase complexes (KGDHC and BCDHC), but not the pyruvate dehydrogenase complex (PDHC), are susceptible to inactivation.|alpha-ketoglutarate|PDHC|4|24|Arg1:T7|Arg2:T47|CHEMICAL|GENE|no_relation|3935
12167474|Interestingly, the alpha-ketoglutarate- and branched-chain alpha-keto acid dehydrogenase complexes (KGDHC and BCDHC), but not the pyruvate dehydrogenase complex (PDHC), are susceptible to inactivation.|branched-chain alpha-keto acid|PDHC|6|24|Arg1:T8|Arg2:T47|CHEMICAL|GENE|no_relation|3936
